Citrus Sinensis ID: 005893
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GYA4 | 669 | Cysteine-rich receptor-li | no | no | 0.909 | 0.911 | 0.430 | 1e-142 | |
| O65468 | 676 | Cysteine-rich receptor-li | no | no | 0.879 | 0.872 | 0.442 | 1e-142 | |
| Q9M0X5 | 675 | Cysteine-rich receptor-li | no | no | 0.909 | 0.903 | 0.403 | 1e-137 | |
| Q9C5S9 | 674 | Cysteine-rich receptor-li | no | no | 0.858 | 0.854 | 0.442 | 1e-136 | |
| Q8W4G6 | 627 | Cysteine-rich receptor-li | no | no | 0.833 | 0.891 | 0.429 | 1e-135 | |
| O65479 | 666 | Putative cysteine-rich re | no | no | 0.934 | 0.941 | 0.409 | 1e-134 | |
| Q8L7G3 | 659 | Cysteine-rich receptor-li | no | no | 0.859 | 0.875 | 0.421 | 1e-133 | |
| Q8H199 | 658 | Cysteine-rich receptor-li | no | no | 0.858 | 0.875 | 0.402 | 1e-132 | |
| Q9LZU4 | 676 | Cysteine-rich receptor-li | no | no | 0.901 | 0.894 | 0.401 | 1e-132 | |
| Q9C5S8 | 659 | Cysteine-rich receptor-li | no | no | 0.915 | 0.931 | 0.403 | 1e-131 |
| >sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 507 bits (1305), Expect = e-142, Method: Compositional matrix adjust.
Identities = 290/673 (43%), Positives = 405/673 (60%), Gaps = 63/673 (9%)
Query: 24 HDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLISLA-LNAS-AAKFSDASSGNDSDR 81
DP + Y+TC ++A + ++ +NLK +L SL+ NAS + F +A+ G DR
Sbjct: 35 QDPTY----VYHTCQNTANYTSNS-TYNNNLKTLLASLSSRNASYSTGFQNATVGQAPDR 89
Query: 82 VYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLRYAYGNFFGQLDVS 141
V GL+ C +S + C C++ A D CPN+ +A ++ + C LRY+ N L +
Sbjct: 90 VTGLFNCRGDVSTEVCRRCVSFAVNDTLTRCPNQKEATLYYDECVLRYSNQNILSTLITT 149
Query: 142 GNIPKYNRKNIS--EPERYRSVVNNTLNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALV 199
G + N +N++ + + +V TLN +A S++ + T + FT + Y LV
Sbjct: 150 GGVILVNTRNVTSNQLDLLSDLVLPTLNQAATVAL--NSSKKFGTRKNNFTALQSFYGLV 207
Query: 200 QCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSRSCYLRYELYAFYNGDTEASVSVG 259
QCT DL+ DC CL I I + GAR+++ SC RYE+YAFY TE++V
Sbjct: 208 QCTPDLTRQDCSRCLQLVINQIPT---DRIGARIINPSCTSRYEIYAFY---TESAVPPP 261
Query: 260 NQA-------------SGKSNQRRMWMIIILAAVAAFLLLVVASTGYFFAAKKVARKRKG 306
SGK ++ +I I+ + +LL +A GY F + R RK
Sbjct: 262 PPPPSISTPPVSAPPRSGKDGNSKVLVIAIVVPIIVAVLLFIA--GYCFLTR---RARKS 316
Query: 307 MVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGG 366
DD A +D T+ AT +F +SN +GQGG
Sbjct: 317 YYTPS------------------AFAGDDITTADSLQLDYRTIQTATDDFVESNKIGQGG 358
Query: 367 FGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426
FG VYKG LSDG E+AVKRLS S QG EF NEV+L+ KLQH+NLV+LLGFC+DG+E++
Sbjct: 359 FGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERV 418
Query: 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASN 486
LVYE++PN SLD LFDP K+G L W++R I+ G+ +GILYLH+DSRL IIHRDLKASN
Sbjct: 419 LVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASN 478
Query: 487 VLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGV 546
+LLD DMNPKI+DFGMARIF + E NT+RIVGTYGYM+PEYAM G YS+KSDV+SFGV
Sbjct: 479 ILLDADMNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGV 538
Query: 547 LLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIH 606
L++EII+G++N+ F Q+ GA +L++YAW LW+ G L+L+DP + + C +E +R +H
Sbjct: 539 LVLEIISGKKNSSFYQTDGAH--DLVSYAWGLWSNGRPLELVDPAIVENCQRNEVVRCVH 596
Query: 607 IGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSF----GRVTDDDDNN----YC 658
IGLLCVQED +RPT+S++V+ML T+TL P++P F G+ D D
Sbjct: 597 IGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLG 656
Query: 659 SVNGLTISDLSPR 671
SV+ +I+D+ PR
Sbjct: 657 SVDDASITDIHPR 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 507 bits (1305), Expect = e-142, Method: Compositional matrix adjust.
Identities = 287/649 (44%), Positives = 391/649 (60%), Gaps = 59/649 (9%)
Query: 52 SNLKKVLISLA-LNAS-AAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDIT 109
+NLK +L S A NAS + F + +G DRV GL++C +S + C+NC+ + +
Sbjct: 58 TNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFLCRGDLSPEVCSNCVAFSVNESL 117
Query: 110 KLCPNKTDAIVWEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNISEPERYRS----VVNNT 165
CPN+ +A+ + E C LRY++ NF + G + N NIS + R +V +
Sbjct: 118 TRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMRNPNNISSIQNQRDQFIDLVQSN 177
Query: 166 LNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCC 225
+N AA S+ ++T + T+ TLY LVQCT DL+ DC +CL +I ++
Sbjct: 178 MNQAANEAA--NSSRKFSTIKTELTSLQTLYGLVQCTPDLARQDCFSCLTSSINRMMP-- 233
Query: 226 YFSRGARLLSRSCYLRYELYAFYNGDTEASVS------------VGNQASGKS-NQRRMW 272
F GAR SC RYELYAFYN + S GKS N +
Sbjct: 234 LFRIGARQFWPSCNSRYELYAFYNETAIGTPSPPPLFPGSTPPLTSPSIPGKSGNSTVLV 293
Query: 273 MIIILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVRKQIQLHKIGDASKTGLRYQHVRG 332
+ I++ AV F+ LV GY F A++ + AS+ G
Sbjct: 294 VAIVVLAVLLFIALV----GYCFLAQRTKKT-----------FDTASASEVG-------- 330
Query: 333 RDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ 392
DD A +D T+ AT++F++SN +G+GGFG VYKG S+GKE+AVKRLS S Q
Sbjct: 331 -DDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQ 389
Query: 393 GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCW 452
G AEF EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+ L W
Sbjct: 390 GEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDW 449
Query: 453 SKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512
+R NI+ GI +GILYLH+DSRL IIHRDLKASN+LLD D+NPKI+DFGMARIF + +
Sbjct: 450 MQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQ 509
Query: 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLL 572
NT+RIVGTYGYMAPEYAM G +S+KSDV+SFGVL++EII+GR+N+ F++S GA +LL
Sbjct: 510 DNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQ--DLL 567
Query: 573 AYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632
+ W LW ALDL+DPL+ + C E +R IHIGLLCVQED RPT+S+V +ML
Sbjct: 568 THTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSN 627
Query: 633 TITLCQPQKPAF--SFGRVTDDDDNNY--------CSVNGLTISDLSPR 671
T+TL P++P F V D D++ S++ I+DL PR
Sbjct: 628 TVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1258), Expect = e-137, Method: Compositional matrix adjust.
Identities = 267/661 (40%), Positives = 399/661 (60%), Gaps = 51/661 (7%)
Query: 14 IFIYSLTATL-HDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLISLAL--NASAAKF 70
+F++ + T+ DP + Y+ C ++ S ++ + +NL+ VL SL+ A A+ F
Sbjct: 14 VFLFMILKTVTSDPTY----LYHICPNTTTYSRNSSYL-TNLRTVLSSLSSPNAAYASLF 68
Query: 71 SDASSG--NDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLR 128
+A++G NDS+RVYG+++C +S + C +C+ A + + CP + A++W + C +R
Sbjct: 69 DNAAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVR 128
Query: 129 YAYGNFFGQLDVSGNIPKYNRKNISEPE--RYRSVVNNTLNNLTKLAAFDPSNEMYATGE 186
Y+ + GQ+ + + N++NI+E + R+ + L ++ AA S+ +AT +
Sbjct: 129 YSNQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAAL--SSRKFATEK 186
Query: 187 VPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSRSCYLRYELYA 246
FT T+Y+LVQCT DL+ DC++CL + I + CC S G R+++ SC RYELY
Sbjct: 187 ANFTVFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYP 246
Query: 247 FYN-----------GDTEASVSVGNQASGKSNQRRMWMIIILAAV-AAFLLLVVASTGYF 294
FYN + + N S K + + +I+ AV + +L++ + +
Sbjct: 247 FYNETIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWL 306
Query: 295 FAAKKVARKRKGMVRKQIQ-LHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVAT 353
+AR+R + + + L + G S L++Q ++ AT
Sbjct: 307 -----LARRRNNKLSAETEDLDEDGITSTETLQFQ-----------------FSAIEAAT 344
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
+ FS+SN LG GGFG VYKG L G+ +A+KRLS S QG EF NEV ++ KLQH+NL
Sbjct: 345 NKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLA 404
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
KLLG+C+DG+EK+LVYEF+PN SLD LFD KR +L W +R I+ GI +GILYLH DS
Sbjct: 405 KLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDS 464
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
RL IIHRDLKASN+LLD DM+PKISDFGMARIF + + NT RIVGTYGYM+PEYA+ G
Sbjct: 465 RLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHG 524
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
YS+KSDV+SFGVL++E+ITG++N+ F + G +L+ Y W LW E + L+L+D +
Sbjct: 525 KYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLG--DLVTYVWKLWVENSPLELVDEAMR 582
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVTDDD 653
+E +R IHI LLCVQED+ +RP+M ++VM+ T+TL P++ F + D
Sbjct: 583 GNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLPIPKRSGFLLRTMKDSR 642
Query: 654 D 654
D
Sbjct: 643 D 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1246), Expect = e-136, Method: Compositional matrix adjust.
Identities = 286/646 (44%), Positives = 386/646 (59%), Gaps = 70/646 (10%)
Query: 64 NAS-AAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWE 122
NAS + F +A++G DRV GL++C +S + C NC+ + LCP +A+ +
Sbjct: 61 NASYSTGFQNATAGKAPDRVTGLFLCRGDVSPEVCRNCVAFSVNQTLNLCPKVREAVFYY 120
Query: 123 EVCQLRYAYGNFFGQ-LDVSGNIPKYNRKNISEPER----YRSVVNNTLNNLTKLAAFDP 177
E C LRY++ N + G N IS ++ + S V++T++ AA +
Sbjct: 121 EQCILRYSHKNILSTAITNEGEFILSNTNTISPNQKQIDGFTSFVSSTMSEAAGKAA-NS 179
Query: 178 SNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSR-GARLLSR 236
S ++Y T T LY L+QCT DL+ DC +CL +I + SR GARL
Sbjct: 180 SRKLY-TVNTELTAYQNLYGLLQCTPDLTRADCLSCLQSSINGMA----LSRIGARLYWP 234
Query: 237 SCYLRYELYAFYNGDT----------------EASVSVGNQAS----GKS-NQRRMWMII 275
SC RYELY FYN E+ VS +S GKS N + + +
Sbjct: 235 SCTARYELYPFYNESAIETPPLPPPPPPPPPRESLVSTPPISSSSLPGKSGNSTVLVVAV 294
Query: 276 ILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVRKQIQLHKIGDASKTGLRYQHVRGRDD 335
++ AV F+ LV GY F AKK K+K AS+ G DD
Sbjct: 295 VVLAVLLFIALV----GYCFLAKK---KKKTF--------DTASASEVG---------DD 330
Query: 336 DLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNA 395
A +D T+ AT++F++SN +G+GGFG VYKG S+GKE+AVKRLS S QG A
Sbjct: 331 MATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGEA 390
Query: 396 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR 455
EF EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+ L W +R
Sbjct: 391 EFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLDWMQR 450
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
NI+ GI +GILYLH+DSRL IIHRDLKASN+LLD D+NPKI+DFGMARIF + + NT
Sbjct: 451 YNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDNT 510
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575
+RIVGTYGYMAPEYAM G +S+KSDV+SFGVL++EII+GR+N+ F +S GA +LL +A
Sbjct: 511 SRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDGAQ--DLLTHA 568
Query: 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETIT 635
W LW ALDL+DPL+ + C E +R IHIGLLCVQED RP +S+V +ML T+T
Sbjct: 569 WRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAISTVFMMLTSNTVT 628
Query: 636 LCQPQKPAFSFG--RVTDDDDNNY--------CSVNGLTISDLSPR 671
L P++P F V D D++ S++ +I+DL PR
Sbjct: 629 LPVPRQPGFFIQCRAVKDPLDSDQSTTTKSFPASIDDESITDLYPR 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 482 bits (1241), Expect = e-135, Method: Compositional matrix adjust.
Identities = 263/613 (42%), Positives = 368/613 (60%), Gaps = 54/613 (8%)
Query: 52 SNLKKVLISL-ALNAS-AAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDIT 109
+NL+ +L SL A NAS + F A +G DRV GL++C +S C NC+ + D
Sbjct: 45 TNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDVSPAVCRNCVAFSINDTL 104
Query: 110 KLCPNKTDAIVWEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNIS----EPERYRSVVNNT 165
CP++ ++ + + C LRY+ N L G + N NIS + R++ V++T
Sbjct: 105 VQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMN-GNISIDQNQMNRFKDFVSST 163
Query: 166 LNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCC 225
+N AA P + T + +T TLY LVQCT DL+ DC +CL +I +
Sbjct: 164 MNQAAVKAASSP--RKFYTVKATWTALQTLYGLVQCTPDLTRQDCFSCLESSIKLM---P 218
Query: 226 YFSRGARLLSRSCYLRYELYAFYNGDTEASVSVGNQAS-------------GKS-NQRRM 271
+ G R L SC RYEL+AFYN T + GKS N +
Sbjct: 219 LYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPLVTSPSLPGKSWNSNVL 278
Query: 272 WMIIILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVRKQIQLHKIGDASKTGLRYQHVR 331
+ I+L + A LLL+ GY FA ++ ++S +
Sbjct: 279 VVAIVLTILVAALLLIA---GYCFA------------------KRVKNSSDNAPAFD--- 314
Query: 332 GRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE 391
DD+ + +D + AT+ FS++N +GQGGFG VYKG S+G E+AVKRLS S
Sbjct: 315 --GDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSG 372
Query: 392 QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLC 451
QG+ EF NEV+++ KLQH+NLV+LLGF + G E++LVYE+MPN SLD LFDP K+ L
Sbjct: 373 QGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLD 432
Query: 452 WSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511
W++R ++ GI +GILYLH+DSRL IIHRDLKASN+LLD DMNPK++DFG+ARIF +
Sbjct: 433 WTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQT 492
Query: 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571
+ NT+RIVGT+GYMAPEYA+ G +S+KSDV+SFGVL++EII+G++N F ++ GA +L
Sbjct: 493 QENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAH--DL 550
Query: 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631
+ +AW LW+ G ALDL+DP++ D C E +R IHI LLCVQED +RP +S++ +ML
Sbjct: 551 VTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTS 610
Query: 632 ETITLCQPQKPAF 644
T+TL P +P F
Sbjct: 611 NTVTLPVPLQPGF 623
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 277/676 (40%), Positives = 392/676 (57%), Gaps = 49/676 (7%)
Query: 18 SLTATLHDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLISLAL-NAS-AAKFSDASS 75
S TA+ +P + Y+ CS + S ++ +NLK +L SL+ NAS + F +A++
Sbjct: 18 SFTASAQNPFY----LYHNCSITTTYSSNS-TYSTNLKTLLSSLSSRNASYSTGFQNATA 72
Query: 76 GNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLRYAYGNFF 135
G D V GL++C +S + C +CI + + CPN+ +A+ + E C LRY+ N
Sbjct: 73 GQAPDMVTGLFLCRGNVSPEVCRSCIALSVNESLSRCPNEREAVFYYEQCMLRYSNRNIL 132
Query: 136 GQLDVSGNIPKYNRKN-IS-EPERYRSVVNNTLNNLTKLAAFDPSNEM--YATGEVPFTN 191
L+ G + N +N IS + +R+R +V N +N LAA + + + +A +
Sbjct: 133 STLNTDGGVFMQNARNPISVKQDRFRDLVLNPMN----LAAIEAARSIKRFAVTKFDLNA 188
Query: 192 SDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSRSCYLRYELYAFYNGD 251
+LY +VQCT DL+ DC CL ++I + Y G R SC RY+ Y FYN
Sbjct: 189 LQSLYGMVQCTPDLTEQDCLDCLQQSINQV---TYDKIGGRTFLPSCTSRYDNYEFYNEF 245
Query: 252 TEASVSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVASTGYFFAAKKVARKRK------ 305
+ + GK + +I ++ + LL VA FF+ ++ RK+
Sbjct: 246 NVGTPQDSSPRPGKGGNSSVIVIAVVVPITVLFLLFVA----FFSVRRAKRKKTIGAIPL 301
Query: 306 -GMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQ 364
+ RK+ ++ + + G DD A D + + AT F N LGQ
Sbjct: 302 FKVKRKETEVTEPPAETTDG---------DDITTAGSLQFDFKAIVAATDIFLPINKLGQ 352
Query: 365 GGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424
GGFG VYKG G ++AVKRLS S QG EF NEV+++ KLQH+NLVKLLG+C++G+E
Sbjct: 353 GGFGEVYKGTFPSGVQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEE 412
Query: 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKA 484
K+LVYEF+PN SLD LFDP +G L WS+R I+ GI +GILYLH+DSRL IIHRDLKA
Sbjct: 413 KILVYEFVPNKSLDYFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKA 472
Query: 485 SNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSF 544
N+LLD DMNPK++DFGMARIF + E NT R+VGTYGYMAPEYAM G +S+KSDV+SF
Sbjct: 473 GNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSF 532
Query: 545 GVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRY 604
GVL++EI++G +N+ +Q G+ + NL+ Y W LW+ G+ +L+DP D E R
Sbjct: 533 GVLVLEIVSGMKNSSLDQMDGSIS-NLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRC 591
Query: 605 IHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVTDDDDNNYC------ 658
IHI LLCVQEDA DRPTMS++V ML +I L P+ P F F R + C
Sbjct: 592 IHIALLCVQEDANDRPTMSAIVQMLTTSSIALAVPRPPGF-FLRSKQEQAERACPSMDTS 650
Query: 659 ---SVNGLTISDLSPR 671
S++ +I+ ++PR
Sbjct: 651 DLFSIDEASITSVAPR 666
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1221), Expect = e-133, Method: Compositional matrix adjust.
Identities = 266/631 (42%), Positives = 372/631 (58%), Gaps = 54/631 (8%)
Query: 64 NAS-AAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWE 122
NAS + F +A+ G DRV GL++C +S + C NC+T A + CPN+ +A+ +
Sbjct: 60 NASYSTGFQNATVGQALDRVTGLFLCRGDVSPEVCRNCVTFAVNNTFSRCPNQREAVFYY 119
Query: 123 EVCQLRYAYGNFFGQ-LDVSGNIPKYNRKNIS----EPERYRSVVNNTLNNLTKLAAFDP 177
E C LRY++ N + G N +IS + ++ ++V + +N + AA +P
Sbjct: 120 EECILRYSHKNILSTAITNEGEFILRNPNHISPIQNQINQFTNLVLSNMNQIAIEAADNP 179
Query: 178 SNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSR-GARLLSR 236
++T + T T Y LVQCT DLS +C CL +I + FSR GAR
Sbjct: 180 --RKFSTIKTELTALQTFYGLVQCTPDLSRQNCMNCLTSSINRMP----FSRIGARQFWP 233
Query: 237 SCYLRYELYAFYN------GDTEASVSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVAS 290
SC RYELY FYN S KS + ++ ++ + +L+ +A
Sbjct: 234 SCNSRYELYDFYNETAIGTPPPPLPPLASPSLSDKSGNSNVVVVAVVVPIIVAVLIFIA- 292
Query: 291 TGYFFAAKKVARKRKGMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLD 350
GY F AK+ A+K G DD + +D +
Sbjct: 293 -GYCFFAKR-AKKTYGTT--------------------PALDEDDKTTIESLQLDYRAIQ 330
Query: 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHK 410
AT++FS++N +G+GGFG VYKG S+G E+AVKRLS SEQG+ EF NEV+++ L+HK
Sbjct: 331 AATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANLRHK 390
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
NLV++LGF ++ +E++LVYE++ N SLD LFDP K+G L W++R +I+ GI +GILYLH
Sbjct: 391 NLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGILYLH 450
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
+DSRL IIHRDLKASN+LLD DMNPKI+DFGMARIF + + NT+RIVGTYGYM+PEYA
Sbjct: 451 QDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSPEYA 510
Query: 531 MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590
M G +S+KSDV+SFGVL++EII+GR+N F ++ A +L+ +AW LW G ALDL+DP
Sbjct: 511 MRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQ--DLVTHAWRLWRNGTALDLVDP 568
Query: 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAF------ 644
+ D+C E +R HIGLLCVQED RP MS++ VML T+ L PQ+P F
Sbjct: 569 FIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFFVRSRP 628
Query: 645 SFGRVTDDDDNN----YCSVNGLTISDLSPR 671
R+ D S++ ++SDL PR
Sbjct: 629 GTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 473 bits (1218), Expect = e-132, Method: Compositional matrix adjust.
Identities = 267/664 (40%), Positives = 377/664 (56%), Gaps = 88/664 (13%)
Query: 52 SNLKKVLISLALNASA-AKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITK 110
+N +L SL N SA F ++S G DRVY L MC+ D C++CI A+ +
Sbjct: 39 TNRGLLLSSLPSNVSARGGFYNSSIGQGPDRVYALGMCIEGAEPDVCSDCIEYASNLLLD 98
Query: 111 LCPNKTDAIVWEE---VCQLRYAYGNFFGQLDVSGNIPKYNRKNISEPERYRSVVNNTLN 167
C N+T+ + W E +C +RY+ +FFG L +EP Y V++ +
Sbjct: 99 TCLNQTEGLAWPEKRILCMVRYSNSSFFGSLK-------------AEPHFYIHNVDDITS 145
Query: 168 NLTKL-------------AAFDPSNE--MYATGEVPFTNSDTLYALVQCTKDLSADDCDA 212
NLT+ + PS++ YA T +YAL+QCT DLS +DC
Sbjct: 146 NLTEFDQVWEELARRMIASTTSPSSKRKYYAADVAALTAFQIIYALMQCTPDLSLEDCHI 205
Query: 213 CLNKAIADILSCCYFSRGARLLSRSCYLRYELYAFYNGDTEASVS-------------VG 259
CL +++ D +CC +G + SC R+EL+ F + S++ V
Sbjct: 206 CLRQSVGDYETCCNGKQGGIVYRASCVFRWELFPFSEAFSRISLAPPPQSPAFPTLPAVT 265
Query: 260 NQASGKSNQRR----MWMIIILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVRKQIQLH 315
N A+ K + +W III + FL+L+ + G+ V R+RK
Sbjct: 266 NTATKKGSITISIGIVWAIIIPTVIVVFLVLL--ALGFV-----VYRRRKSY-------- 310
Query: 316 KIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVL 375
S T + H D + ++ AT+ FS+SN++G+GGFG V+ GVL
Sbjct: 311 ---QGSSTDITITH-----------SLQFDFKAIEDATNKFSESNIIGRGGFGEVFMGVL 356
Query: 376 SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435
+G E+A+KRLS S QG EF NEV+++ KL H+NLVKLLGFC++G+EK+LVYEF+PN
Sbjct: 357 -NGTEVAIKRLSKASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVPNK 415
Query: 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495
SLD LFDP K+G L W+KR NI+ GI +GILYLH+DSRL IIHRDLKASN+LLD DMNP
Sbjct: 416 SLDYFLFDPTKQGQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADMNP 475
Query: 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
KI+DFGMARIF + NT +I GT GYM PEY +G +S +SDV+SFGVL++EII GR
Sbjct: 476 KIADFGMARIFGIDQSGANTKKIAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEIICGR 535
Query: 556 RNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQED 615
N +QS T NL+ YAW LW + L+L+DP +++ C +E R IHI LLCVQ +
Sbjct: 536 NNRFIHQS-DTTVENLVTYAWRLWRNDSPLELVDPTISENCETEEVTRCIHIALLCVQHN 594
Query: 616 AFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVTDDDDN--------NYCSVNGLTISD 667
DRP++S++ +ML + L PQ+P F F +++ + + N ++N +TI+D
Sbjct: 595 PTDRPSLSTINMMLINNSYVLPDPQQPGFFFPIISNQERDGLDSMNRSNPQTINDVTITD 654
Query: 668 LSPR 671
PR
Sbjct: 655 FEPR 658
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LZU4|CRK4_ARATH Cysteine-rich receptor-like protein kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1213), Expect = e-132, Method: Compositional matrix adjust.
Identities = 271/675 (40%), Positives = 385/675 (57%), Gaps = 70/675 (10%)
Query: 35 NTCSSSAADSGHAGAIYSNLKKVLISLAL-NAS-AAKFSDASSGNDSDRVYGLYMCLNYI 92
++C SS ++NLK +L SL+ NAS + F A++G DRV GL++C +
Sbjct: 34 HSCPSSILTYSRNSTYFTNLKTLLSSLSSRNASYSTGFQTATAGQAPDRVTGLFLCRGDV 93
Query: 93 SNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNI 152
S + C NC+ + ++ CP + +++ + C LRY++ N + G+ N NI
Sbjct: 94 SQEVCRNCVAFSVKETLYWCPYNKEVVLYYDECMLRYSHRNILSTVTYDGSAILLNGANI 153
Query: 153 S-----EPERYRSVVNNTLNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDLSA 207
S + + +R +V++TLN L + A + S + Y + LY LVQCT DL+
Sbjct: 154 SSSNQNQVDEFRDLVSSTLN-LAAVEAANSSKKFYTRKVI---TPQPLYLLVQCTPDLTR 209
Query: 208 DDCDACLNKAIADILSCCYFSRGARLLSRSCYLRYELYAFYNGDTEASVSVGNQASGKSN 267
DC CL K+I + + G R SC RYE Y+FYN S S + +
Sbjct: 210 QDCLRCLQKSIKGM---SLYRIGGRFFYPSCNSRYENYSFYNETATRSSSPPSLPPRSTP 266
Query: 268 QRRMWM------------------IIILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVR 309
Q+++ + I+++ + A LLL VA FF+ +
Sbjct: 267 QQQLKLAPPPLISERGKGRNSSVIIVVVVPIIALLLLFVA----FFSLR----------- 311
Query: 310 KQIQLHKIGDASKTGLRYQH---VRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGG 366
A KT Y+ DD A D + ++ AT+ F ++N LGQGG
Sbjct: 312 ----------AKKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGG 361
Query: 367 FGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426
FG VYKG+ G ++AVKRLS S QG EF NEV+++ KLQH+NLV+LLGFC++ DE++
Sbjct: 362 FGEVYKGIFPSGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERI 421
Query: 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASN 486
LVYEF+PN SLD +FD + LL W++R I+ GI +GILYLH+DSRL IIHRDLKA N
Sbjct: 422 LVYEFVPNKSLDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGN 481
Query: 487 VLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGV 546
+LL DMN KI+DFGMARIF + E NT RIVGTYGYM+PEYAM G +S+KSDV+SFGV
Sbjct: 482 ILLGDDMNAKIADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGV 541
Query: 547 LLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIH 606
L++EII+G++N+ Q G +A NL+ Y W LW+ G+ L+L+DP D +E R IH
Sbjct: 542 LVLEIISGKKNSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIH 601
Query: 607 IGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVTDD----------DDNN 656
I LLCVQE+A DRPTMS++V ML +I L PQ+P F F + + +
Sbjct: 602 IALLCVQEEAEDRPTMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSA 661
Query: 657 YCSVNGLTISDLSPR 671
CSV+ +I++++PR
Sbjct: 662 LCSVDDASITNVTPR 676
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 470 bits (1209), Expect = e-131, Method: Compositional matrix adjust.
Identities = 273/677 (40%), Positives = 390/677 (57%), Gaps = 63/677 (9%)
Query: 19 LTATLHDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLISLALNASAAKFSDAS--SG 76
++A L DP + N S ++ +SNL+ +L SL+ N + S G
Sbjct: 22 VSAQLQDPTYVGHVCTNRISRNSI-------YFSNLQTLLTSLSSNNAYFSLGSHSLTKG 74
Query: 77 NDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLRYAYGNFFG 136
+SD V+GLY+C +S ++C C+ A +D CP + ++ + C L Y+ N F
Sbjct: 75 QNSDMVFGLYLCKGDLSPESCRECVIFAAKDTRSRCPGGKEFLIQYDECMLGYSDRNIFM 134
Query: 137 QLDVSGNIPKYNRKNISEPERYRSVVNNTLNNLTKLAAFDPSN---EMYATGEVPFTNSD 193
+ I +N + ++ + R N+ + +L K +A + +N + +A + F++S
Sbjct: 135 DTVTTTTIITWNTQKVTADQSDR--FNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQ 192
Query: 194 TLYALVQCTKDLSADDCDACLNKAIADILSCCYFSR-GARLLSRSCYLRYELYAFYNGDT 252
+LYA VQC DL+++DC CL ++I ++ YF++ G R L SC RYE+Y FY
Sbjct: 193 SLYASVQCIPDLTSEDCVMCLQQSIKEL----YFNKVGGRFLVPSCNSRYEVYPFYKETI 248
Query: 253 EAS-------------VSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVASTGYFFAAKK 299
E + VS + GK + +I I+ VA +L+ VA + F A K
Sbjct: 249 EGTVLPPPVSAPPLPLVSTPSFPPGKGKNSTVIIIAIVVPVAISVLICVAV--FSFHASK 306
Query: 300 VARKRKGMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDS 359
A+K + DD A D + ++ AT FS
Sbjct: 307 RAKKTYDTPEE-----------------------DDITTAGSLQFDFKVIEAATDKFSMC 343
Query: 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
N LGQGGFG VYKG L +G ++AVKRLS S QG EF NEV+++ KLQH+NLVKLLGFC
Sbjct: 344 NKLGQGGFGQVYKGTLPNGVQVAVKRLSKTSGQGEKEFKNEVVVVAKLQHRNLVKLLGFC 403
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
++ +EK+LVYEF+ N SLD LFD R + L W+ R I+ GI +GILYLH+DSRL IIH
Sbjct: 404 LEREEKILVYEFVSNKSLDYFLFDSRMQSQLDWTTRYKIIGGIARGILYLHQDSRLTIIH 463
Query: 480 RDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKS 539
RDLKA N+LLD DMNPK++DFGMARIF + E +T R+VGTYGYM+PEYAM G +S+KS
Sbjct: 464 RDLKAGNILLDADMNPKVADFGMARIFEIDQTEAHTRRVVGTYGYMSPEYAMYGQFSMKS 523
Query: 540 DVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPD 599
DV+SFGVL++EII+GR+N+ Q A+ NL+ Y W LW++G+ LDL+D D+ +
Sbjct: 524 DVYSFGVLVLEIISGRKNSSLYQ-MDASFGNLVTYTWRLWSDGSPLDLVDSSFRDSYQRN 582
Query: 600 EFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVTDD-----DD 654
E +R IHI LLCVQED +RPTMS++V ML +I L PQ P F F + D
Sbjct: 583 EIIRCIHIALLCVQEDTENRPTMSAIVQMLTTSSIALAVPQPPGFFFRSNHEQAGPSMDK 642
Query: 655 NNYCSVNGLTISDLSPR 671
++ CS++ +I+ L+PR
Sbjct: 643 SSLCSIDAASITILAPR 659
|
Involved in multiple distinct defense responses. May function as a disease resistance (R) protein. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | ||||||
| 302144055 | 698 | unnamed protein product [Vitis vinifera] | 0.985 | 0.946 | 0.603 | 0.0 | |
| 359483378 | 678 | PREDICTED: cysteine-rich receptor-like p | 0.976 | 0.966 | 0.603 | 0.0 | |
| 255555023 | 648 | ATP binding protein, putative [Ricinus c | 0.962 | 0.996 | 0.588 | 0.0 | |
| 356540317 | 647 | PREDICTED: cysteine-rich receptor-like p | 0.904 | 0.938 | 0.595 | 0.0 | |
| 224076497 | 591 | predicted protein [Populus trichocarpa] | 0.874 | 0.993 | 0.573 | 0.0 | |
| 357480739 | 644 | Cysteine-rich receptor-like protein kina | 0.938 | 0.978 | 0.560 | 0.0 | |
| 224113911 | 657 | predicted protein [Populus trichocarpa] | 0.959 | 0.980 | 0.560 | 0.0 | |
| 359477817 | 670 | PREDICTED: cysteine-rich receptor-like p | 0.962 | 0.964 | 0.483 | 1e-167 | |
| 147776074 | 815 | hypothetical protein VITISV_005300 [Viti | 0.904 | 0.744 | 0.498 | 1e-165 | |
| 255555025 | 663 | Serine/threonine-protein kinase PBS1, pu | 0.912 | 0.923 | 0.465 | 1e-158 |
| >gi|302144055|emb|CBI23160.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2052), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/684 (60%), Positives = 501/684 (73%), Gaps = 23/684 (3%)
Query: 1 MVHIISVTKVIQLIFIYSLTATLHDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLIS 60
M+ V+K IQL+FI S+ + D D PPYN CS++ G SNL+ +L S
Sbjct: 25 MMSSQGVSKAIQLLFISSVLSGFPDLVCAD-PPYNVCSTTTT-YGLNSLFQSNLENLLDS 82
Query: 61 LALNASAAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIV 120
L A + F + S GN DRV G ++CLNY++ND C NCI+TA + KLCPN +AIV
Sbjct: 83 LPSKAFVSHFDNTSIGNGLDRVNGAFLCLNYVANDQCRNCISTAAYHVKKLCPNMNEAIV 142
Query: 121 WEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNISEPE----RYRSVVNNTLNNLTKLAAFD 176
WE+ CQ+ Y+ F G L +GNIP N KN+S+ E R+RSVVN+TL NL K AAF+
Sbjct: 143 WEDECQILYSNETFLGHLSTTGNIPLDNMKNVSDLESEQLRFRSVVNDTLQNLIKQAAFN 202
Query: 177 PSNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSR 236
S +MYAT V FT+ D LYALVQCT DLS D+C CL A +IL+ YFSRGARLLSR
Sbjct: 203 SSTDMYATKPVVFTDVDILYALVQCTPDLSPDNCSICLQTATTEILAVYYFSRGARLLSR 262
Query: 237 SCYLRYELYAFYNGDTE--ASVSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVASTGYF 294
SCYLRYE Y FY TE A VS N + K +R+ MI+I+ +V+ + LVVA+ ++
Sbjct: 263 SCYLRYEFYPFYEVATEPQAPVSPQNPGTRKDGRRKTGMILIITSVS--VSLVVATLAFY 320
Query: 295 ---FAAKKVARK-RKGMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDF-YIDLETL 349
A + +K RK + +++QL I D S TG H R L +Q+F +IDL T+
Sbjct: 321 VYCLATRNGKKKERKQYLNREVQLPDIDDPSYTGPYQFHGR---KSLNSQEFLFIDLATI 377
Query: 350 DVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH 409
AT NFS+ N LGQGGFGPVYKGVL DGKE+AVKRLSS SEQG+ EFTNEVLLI+KLQH
Sbjct: 378 HEATDNFSELNKLGQGGFGPVYKGVLRDGKEVAVKRLSSDSEQGSEEFTNEVLLIMKLQH 437
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
KNLV+LLGFCVD +E++LVYE+MPNSSLD LFDPR+R L WS+R+NI+ GI +GILYL
Sbjct: 438 KNLVRLLGFCVDREERMLVYEYMPNSSLDVFLFDPRRRAQLDWSRRLNIIGGIARGILYL 497
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
HEDSRLRIIHRDLKASNVLLD DM PKISDFGMARIF GSEGE NTA IVGT+GYMAPEY
Sbjct: 498 HEDSRLRIIHRDLKASNVLLDCDMKPKISDFGMARIFGGSEGEANTATIVGTHGYMAPEY 557
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589
AMEGLYS+KSDVFSFGVLL+EIITGRRN+GF+ S+ AP+L++YAW LWNEG +L+D
Sbjct: 558 AMEGLYSVKSDVFSFGVLLLEIITGRRNSGFHLSK--RAPSLISYAWQLWNEGKGSELMD 615
Query: 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRV 649
PLLTD+C +EFLR HIGLLCVQEDAFDRPTMSS VVML+ ET+TL QP++PAFS GR
Sbjct: 616 PLLTDSCCQNEFLRCYHIGLLCVQEDAFDRPTMSS-VVMLKSETVTLRQPERPAFSIGRF 674
Query: 650 TDDDDNNY--CSVNGLTISDLSPR 671
TD D+ N CSVNGLT+S++ PR
Sbjct: 675 TDCDEKNACGCSVNGLTVSNIGPR 698
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483378|ref|XP_002265659.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2034), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/683 (60%), Positives = 499/683 (73%), Gaps = 28/683 (4%)
Query: 7 VTKVIQLIFIYSLTATLHDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLISLALNAS 66
V+K IQL+FI S+ + D D PPYN CS++ G SNL+ +L SL A
Sbjct: 6 VSKAIQLLFISSVLSGFPDLVCAD-PPYNVCSTTTT-YGLNSLFQSNLENLLDSLPSKAF 63
Query: 67 AAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQ 126
+ F + S GN DRV G ++CLNY++ND C NCI+TA + KLCPN +AIVWE+ CQ
Sbjct: 64 VSHFDNTSIGNGLDRVNGAFLCLNYVANDQCRNCISTAAYHVKKLCPNMNEAIVWEDECQ 123
Query: 127 LRYAYGNFFGQLDVSGNIPKYNRKNISEPE----RYRSVVNNTLNNLTKLAAFDPSNEMY 182
+ Y+ F G L +GNIP N KN+S+ E R+RSVVN+TL NL K AAF+ S +MY
Sbjct: 124 ILYSNETFLGHLSTTGNIPLDNMKNVSDLESEQLRFRSVVNDTLQNLIKQAAFNSSTDMY 183
Query: 183 ATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSRSCYLRY 242
AT V FT+ D LYALVQCT DLS D+C CL A +IL+ YFSRGARLLSRSCYLRY
Sbjct: 184 ATKPVVFTDVDILYALVQCTPDLSPDNCSICLQTATTEILAVYYFSRGARLLSRSCYLRY 243
Query: 243 ELYAFYNGDTE--ASVSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVASTGYF---FAA 297
E Y FY TE A VS N + K +R+ MI+I+ +V+ + LVVA+ ++ A
Sbjct: 244 EFYPFYEVATEPQAPVSPQNPGTRKDGRRKTGMILIITSVS--VSLVVATLAFYVYCLAT 301
Query: 298 KKVARK-RKGMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDF-YIDLETLDVATSN 355
+ +K RK + +++QL I D S TG H R L +Q+F +IDL T+ AT N
Sbjct: 302 RNGKKKERKQYLNREVQLPDIDDPSYTGPYQFHGR---KSLNSQEFLFIDLATIHEATDN 358
Query: 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
FS+ N LGQGGFGPVYKGVL DGKE+AVKRLSS SEQG+ EFTNEVLLI+KLQHKNLV+L
Sbjct: 359 FSELNKLGQGGFGPVYKGVLRDGKEVAVKRLSSDSEQGSEEFTNEVLLIMKLQHKNLVRL 418
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
LGFCVD +E++LVYE+MPNSSLD LFDPR+R L WS+R+NI+ GI +GILYLHEDSRL
Sbjct: 419 LGFCVDREERMLVYEYMPNSSLDVFLFDPRRRAQLDWSRRLNIIGGIARGILYLHEDSRL 478
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY-----GYMAPEYA 530
RIIHRDLKASNVLLD DM PKISDFGMARIF GSEGE NTA IVGT+ GYMAPEYA
Sbjct: 479 RIIHRDLKASNVLLDCDMKPKISDFGMARIFGGSEGEANTATIVGTHFSLDSGYMAPEYA 538
Query: 531 MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590
MEGLYS+KSDVFSFGVLL+EIITGRRN+GF+ S+ AP+L++YAW LWNEG +L+DP
Sbjct: 539 MEGLYSVKSDVFSFGVLLLEIITGRRNSGFHLSK--RAPSLISYAWQLWNEGKGSELMDP 596
Query: 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVT 650
LLTD+C +EFLR HIGLLCVQEDAFDRPTMSS VVML+ ET+TL QP++PAFS GR T
Sbjct: 597 LLTDSCCQNEFLRCYHIGLLCVQEDAFDRPTMSS-VVMLKSETVTLRQPERPAFSIGRFT 655
Query: 651 DDDDNNY--CSVNGLTISDLSPR 671
D D+ N CSVNGLT+S++ PR
Sbjct: 656 DCDEKNACGCSVNGLTVSNIGPR 678
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555023|ref|XP_002518549.1| ATP binding protein, putative [Ricinus communis] gi|223542394|gb|EEF43936.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 779 bits (2012), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/673 (58%), Positives = 485/673 (72%), Gaps = 27/673 (4%)
Query: 1 MVHIISVTKVIQLIFIYSLTATLHDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLIS 60
M K+ + + + L + D A+ D PPY C + + + +NLK +L+S
Sbjct: 1 MGQFQRAAKIFEFLLLCFLVGSFLDFAYAD-PPYLLCPNINNQAANI-PFQNNLKNLLLS 58
Query: 61 LALNASAAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIV 120
L NAS K D+S GN++D+VY YMCLNY+++D C++CI TA++DI + C N +AIV
Sbjct: 59 LPSNASGLKVFDSSIGNNTDKVYSQYMCLNYVTSDKCSSCIQTASEDIKQSCANSAEAIV 118
Query: 121 WEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNISEPERYRSVVNNTLNNLTKLAAFDPSNE 180
WEEVCQLRY+ +F G LDVSGN N KNIS P+++RS+VN T++ L K AAF+ S
Sbjct: 119 WEEVCQLRYSNQSFLGHLDVSGNQFYDNEKNISNPDQFRSLVNQTVSGLIKKAAFNNSVN 178
Query: 181 MYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSRSCYL 240
MYATGE FT+++ LYALVQCT DLS+DDC CL A+A++ SCCYFSRGARLLSRSCYL
Sbjct: 179 MYATGEAAFTSTEKLYALVQCTTDLSSDDCSTCLQVALANLSSCCYFSRGARLLSRSCYL 238
Query: 241 RYELYAFYNGDTEASVSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVASTGYFFAAKKV 300
RYELYAFY G+ S NQ +GKS Q + WMI L A A L+++ S+ F ++ +
Sbjct: 239 RYELYAFYKGENGDPASAQNQGTGKSKQTKTWMIAFLTATTAILVVLALSS--FIYSRSM 296
Query: 301 ARKRKGMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSN 360
+ + Q G+D + ++D ++ AT NF +SN
Sbjct: 297 KK------------------DNPAFQNQSFHGKDGLSAKESGFMDFASIHAATDNFCESN 338
Query: 361 MLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+LGQGGFGPVYKG+LSDGKEIAVKRL++CSEQG EF E+ LI+KLQHKNLV+LLGFC
Sbjct: 339 LLGQGGFGPVYKGILSDGKEIAVKRLATCSEQGIEEFKTEIQLIMKLQHKNLVRLLGFCF 398
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
DG+EKLLVYEFMPNSSLD ILFDPRKR L W KRINI+NGI KGILYLHEDSRLRIIHR
Sbjct: 399 DGEEKLLVYEFMPNSSLDVILFDPRKRAQLDWCKRINIINGIAKGILYLHEDSRLRIIHR 458
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSD 540
DLK SN+LLD +MNPKISDFG ARIF GSEGE NT R+VGTYGYMAPEYAMEGLYS KSD
Sbjct: 459 DLKPSNILLDNEMNPKISDFGTARIF-GSEGEANTCRVVGTYGYMAPEYAMEGLYSTKSD 517
Query: 541 VFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDE 600
VFSFGVLL+EIITGR+NTG ++S+ APNL AYAWHLWN GN L+L+DPLL+D+C PDE
Sbjct: 518 VFSFGVLLLEIITGRKNTGSHKSK--NAPNLSAYAWHLWNRGNELELMDPLLSDSCCPDE 575
Query: 601 FLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVTDDDDNNY--C 658
F RY+HIGLLC+QEDA DRPTMS VV+ML+ E L QP KPAFS GR T++ + NY
Sbjct: 576 FSRYMHIGLLCLQEDACDRPTMSYVVLMLRSEAAALPQPGKPAFSVGRFTNNIEANYNDS 635
Query: 659 SVNGLTISDLSPR 671
S N LT SD+S R
Sbjct: 636 STNYLTTSDVSAR 648
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540317|ref|XP_003538636.1| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/648 (59%), Positives = 479/648 (73%), Gaps = 41/648 (6%)
Query: 27 AFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLISLALNASAAKFSDASS-GNDSDRVYGL 85
F D PPY CS+S++ + + +NL +L SL+ AS KF + SS G DRVYGL
Sbjct: 38 VFAD-PPYYICSTSSSFA-KGSSFENNLTNLLSSLSSIASNYKFYNTSSYGIGPDRVYGL 95
Query: 86 YMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLRYAYGNFFGQLDVSGNIP 145
YMCL+YI+N++C CITTAT+DI KLCP T+A+VWEE+CQLRY+ NF G L+V+GNI
Sbjct: 96 YMCLDYITNESCKTCITTATEDIVKLCPRATEAVVWEELCQLRYSNSNFMGMLNVTGNIG 155
Query: 146 KYNRKNISEPERYRSVVNNTLNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDL 205
N++N+SEPE++ S VN T++NLTK+A+F S MYATGEVPF + +T+YALVQCT+DL
Sbjct: 156 LDNKQNLSEPEKFESAVNQTISNLTKVASFGVSANMYATGEVPFED-ETIYALVQCTRDL 214
Query: 206 SADDCDACLNKAIADILSCCYFSRGARLLSRSCYLRYELYAFYNGDTEASVSVGNQASGK 265
+A DC CL AI DI CCY S G R+LSRSCYLRYE YAFY+G T + S + G+
Sbjct: 215 TASDCSRCLQSAIGDIPGCCYASIGGRVLSRSCYLRYEFYAFYHGATGPTDSSIGKKEGE 274
Query: 266 SNQRRMWMIIILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVRKQIQLHKIGDASKTGL 325
+N ++W+I + V +++ + F V KRK + I H+I
Sbjct: 275 NNSSKIWVITGIIVVVGLVIVF-----FIFGLYLVRNKRKRQSKNGIDNHQI-------- 321
Query: 326 RYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKR 385
+L +L VAT+NFSD N LGQGGFGPVYKG LSDG+E+A+KR
Sbjct: 322 -------------------NLGSLRVATNNFSDLNKLGQGGFGPVYKGKLSDGQEVAIKR 362
Query: 386 LSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPR 445
LS+CSEQG+ EF NEVLLI++LQHKNLVKLLGFCVDG+EKLLVYEF+PN SLD +LFDP
Sbjct: 363 LSTCSEQGSEEFINEVLLIMQLQHKNLVKLLGFCVDGEEKLLVYEFLPNGSLDVVLFDPN 422
Query: 446 KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
+R L W+KR++I+NGI +GILYLHEDSRL+IIHRDLKASN+LLDYDMNPKISDFGMARI
Sbjct: 423 QRERLDWTKRLDIINGIARGILYLHEDSRLKIIHRDLKASNILLDYDMNPKISDFGMARI 482
Query: 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565
FAGSEGE NTA IVGTYGYMAPEYAMEGLYSIKSDVF FGVLL+EII G+RN GF S+
Sbjct: 483 FAGSEGEANTATIVGTYGYMAPEYAMEGLYSIKSDVFGFGVLLLEIIAGKRNAGFYHSK- 541
Query: 566 ATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625
P+LL+YAWHLWNEG ++LIDPLL D+C DEFLRY+HIGLLCVQEDA+DRPTMSSV
Sbjct: 542 -NTPSLLSYAWHLWNEGKEMELIDPLLVDSCPGDEFLRYMHIGLLCVQEDAYDRPTMSSV 600
Query: 626 VVMLQGETITLCQPQKPAFSFGRVTDDDD--NNYCSVNGLTISDLSPR 671
V+ML+ E+ L QP++P FS GR ++ +Y S+N LT+SD+ P+
Sbjct: 601 VLMLKNESAMLGQPERPPFSLGRFNANEPGCEDY-SLNFLTLSDIVPQ 647
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224076497|ref|XP_002304952.1| predicted protein [Populus trichocarpa] gi|222847916|gb|EEE85463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/633 (57%), Positives = 452/633 (71%), Gaps = 46/633 (7%)
Query: 13 LIFIYSLTATLHDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLISLALNASAAKFSD 72
++ +Y A L D A+ D PPY CS+ + ++ +NL+ ++ SL+ NAS +K +
Sbjct: 1 ILLLYFSIANLLDLAYAD-PPYRLCSNKSNYIDNS-PFQNNLETLMASLSSNASVSKIFN 58
Query: 73 ASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLRYAYG 132
S+G D DRVY YMCLNY++N++C C+ A+QDI +LCP A+VWEE+CQLRY+
Sbjct: 59 TSTGIDPDRVYAQYMCLNYVTNESCRTCVAAASQDIRQLCPGDKKAVVWEELCQLRYSNQ 118
Query: 133 NFFGQLDVSGNIPKYNRKNISEPERYRSVVNNTLNNLTKLAAFDPSNEMYATGEVPFTNS 192
F G LDVSGN+P+YN KNIS PE VVN L++L K AAFDPS MYAT + PFT+S
Sbjct: 119 RFLGHLDVSGNVPQYNPKNISNPEHLSLVVNKILSSLIKKAAFDPSANMYATRDEPFTDS 178
Query: 193 DTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSRSCYLRYELYAFYNGDT 252
D+ ++LVQC+ DLS +DC CL A+ ++ +CCYFSRGAR+LSRSCYLRYELY FY+G T
Sbjct: 179 DSFFSLVQCSTDLSPNDCYTCLEVAVKNVTTCCYFSRGARVLSRSCYLRYELYDFYDGAT 238
Query: 253 EASVSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVRKQI 312
E+S S +GK LL+ G F
Sbjct: 239 ESSKS---PVTGKGTN---------------LLIDQLRHGKF------------------ 262
Query: 313 QLHKIGDASKTGLRYQHVRGRDDDLKAQDFYI-DLETLDVATSNFSDSNMLGQGGFGPVY 371
++ D +Q+ + D L ++ I DL +++ AT NFS++N+LGQGGFGPVY
Sbjct: 263 ---RVFDHPNHN-DFQNQDFQRDGLNDRESAIMDLASINAATDNFSETNLLGQGGFGPVY 318
Query: 372 KGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431
KG+LSDGKE+AVKRLS SEQG EFTNEVLLI+KLQHKNLVKLLGFCVDG+EKLLVYEF
Sbjct: 319 KGILSDGKEVAVKRLSDSSEQGKNEFTNEVLLIMKLQHKNLVKLLGFCVDGEEKLLVYEF 378
Query: 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY 491
MPN+SLD +LFDPRK L W RI+I+NGI KG LYLHEDSRLRIIHRDLKASN+LLD
Sbjct: 379 MPNNSLDVVLFDPRKGAQLSWRSRIHIINGIAKGTLYLHEDSRLRIIHRDLKASNILLDN 438
Query: 492 DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEI 551
+MNPKISDFGMARI +EGE NT RI GTYGYMAPEYAMEGLYS KSDVFSFGV+L+EI
Sbjct: 439 NMNPKISDFGMARIMEANEGEANTVRIAGTYGYMAPEYAMEGLYSTKSDVFSFGVILLEI 498
Query: 552 ITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLC 611
ITGR+N+GF++S+ AP+LLAYAW LWN G L++IDP+L D+C DEF R +HIGLLC
Sbjct: 499 ITGRKNSGFHKSK--RAPSLLAYAWELWNNGKELEMIDPVLVDSCCSDEFSRCVHIGLLC 556
Query: 612 VQEDAFDRPTMSSVVVMLQGE-TITLCQPQKPA 643
VQEDA +RP MSSVV+ML+ + +I L QPQ+PA
Sbjct: 557 VQEDASERPAMSSVVLMLKSDNSIDLPQPQRPA 589
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357480739|ref|XP_003610655.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355511990|gb|AES93613.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/683 (56%), Positives = 469/683 (68%), Gaps = 53/683 (7%)
Query: 1 MVHIISVTKVIQLIFIYSLTATLHDPAFGDSPPYNTCSS-SAADSGHAGAIYSNLKKVLI 59
M H V K IQ + L A D PPY CS+ + +G + + + +
Sbjct: 1 MFHYPIVFKFIQFFLVLYTLDFLSYLALAD-PPYEICSTRNIYANGSSFDNNLSNLLLSL 59
Query: 60 SLALNASAAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAI 119
+ S +KF + SSG DRVYGLYMCL+++SN+TC C+T A D KLCP +A+
Sbjct: 60 PFNDSNSISKFGNTSSGIGLDRVYGLYMCLDFVSNETCLKCVTNAIADTVKLCPQSKEAV 119
Query: 120 VWEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNISEPERYRSVVNNTLNNLTKLAAFDPSN 179
V+EE CQ+RY+ NF G L+V+GNI K N +NISEP ++ + VN LN LTK+A+F+ S
Sbjct: 120 VYEEFCQVRYSNKNFIGSLNVNGNIGKDNVQNISEPVKFETSVNKLLNGLTKIASFNVSA 179
Query: 180 EMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSRSCY 239
MYATGEVPF + T+YALVQCT+DL+A+DC CL AI DI CCY S GAR++SRSCY
Sbjct: 180 NMYATGEVPFEDK-TIYALVQCTRDLAANDCSRCLLSAIGDIPGCCYASIGARVMSRSCY 238
Query: 240 LRYELYAFYNGDTEASVSVGNQASGKS------NQRRMWMIIILAAVAAFLLLVVASTGY 293
LRYE Y FY G+ E + S N GKS N ++WMI ++A V L++++
Sbjct: 239 LRYEFYPFYLGEKEQTKSSTNLG-GKSKHFSSYNSSKIWMITVIA-VGVGLVIIIFICYL 296
Query: 294 FFAAKKVARKRKGMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDF-YIDLETLDVA 352
F + + K G + K DF +IDL +L VA
Sbjct: 297 CFLRNRQSNKGNGKISK------------------------------DFPFIDLASLRVA 326
Query: 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL 412
T NF+DSN LG+GGFGPVYKG+LSDG+E+A+KRLS CSEQG+ EF NEV+LILKLQHKNL
Sbjct: 327 TRNFTDSNKLGEGGFGPVYKGILSDGQEVAIKRLSICSEQGSEEFINEVMLILKLQHKNL 386
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
VKLLGFCVDG+EKLLVYE++PN SLD +LF+ + L W+KR++I+NGI +GILYLHED
Sbjct: 387 VKLLGFCVDGEEKLLVYEYLPNGSLDVVLFEQHAQ--LDWTKRLDIINGIARGILYLHED 444
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
SRL+IIHRDLKASNVLLD DMNPKISDFGMARIFAGSEGE NT IVGTYGYMAPEYAME
Sbjct: 445 SRLQIIHRDLKASNVLLDNDMNPKISDFGMARIFAGSEGEANTTTIVGTYGYMAPEYAME 504
Query: 533 GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592
GLYSIKSDVF FGVLL+EIITG RN GF S+ T P+LLAYAWHLWN+G L+L DPLL
Sbjct: 505 GLYSIKSDVFGFGVLLLEIITGIRNAGFCYSK--TTPSLLAYAWHLWNDGKGLELRDPLL 562
Query: 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVTDD 652
C D+FLRY++IGLLCVQEDAFDRPTMSSVV+ML E++ L QP KP FS GR+
Sbjct: 563 --LCPGDQFLRYMNIGLLCVQEDAFDRPTMSSVVLMLMNESVMLGQPGKPPFSVGRLNFI 620
Query: 653 DDNNY-----CSVNGLTISDLSP 670
D N SVN LT+SD+ P
Sbjct: 621 DQNELDLEEEYSVNFLTVSDILP 643
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113911|ref|XP_002316612.1| predicted protein [Populus trichocarpa] gi|222859677|gb|EEE97224.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 718 bits (1853), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/678 (56%), Positives = 472/678 (69%), Gaps = 34/678 (5%)
Query: 3 HIISVTKVIQLIFI-YSLTATL--HDPAFGDSPPYNTCSSSAADSGHAGAIYSNLKKVLI 59
+ +S IQL+ + Y ATL H F PPY CS+++ ++ +NL+ ++
Sbjct: 4 NFLSDANTIQLLLLLYFSIATLSQHSSNFLTHPPYKFCSNTSLYEANS-PFQNNLQTLMS 62
Query: 60 SLALNASAAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPNKTDAI 119
LA NAS + A +GND D VY YMC NYI N C+ CI A+QDI +LCPN +A
Sbjct: 63 YLASNASVSNQYHAYAGNDPDIVYAQYMCYNYIEN--CSACIYAASQDIMQLCPNNRNAT 120
Query: 120 VWEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNISEPERYRSVVNNTLNNLTKLAAFDPSN 179
VWEE+CQLR++ NF GQLD+SGNI N + I P +Y SVVN +NLTK AAFDP+
Sbjct: 121 VWEELCQLRFSNKNFIGQLDISGNIIVANTETIENPGQYISVVNENFSNLTKKAAFDPTQ 180
Query: 180 EMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLLSRSCY 239
MYATG++ ++ DTLY L QCT DLS+ DC CL AI +I SCCY RG RLLS+SCY
Sbjct: 181 NMYATGKLALSDIDTLYTLGQCTTDLSSHDCSTCLQVAIQNISSCCYIGRGQRLLSQSCY 240
Query: 240 LRYELYAFYNG--DTEASVSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVASTGYFFAA 297
RYELY FY G D+ ++++ G I A V AFL +AS +F
Sbjct: 241 FRYELYPFYEGTADSGETLTILKIVLGT---------CIPAVVLAFL---IASCIIYF-- 286
Query: 298 KKVARKRKGMVRKQIQ-LHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNF 356
++++RK + + L ++ +S + L G + + +DL + AT NF
Sbjct: 287 RRISRKETDEEKSHLDFLQELRKSSGSTL----AEGNKVSSEELPWMMDLSVIRAATDNF 342
Query: 357 SDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
S SN LGQGGFG VYKG+LSDG E+AVKRLS SEQG EF EVLLI+KLQHKNLV+LL
Sbjct: 343 SVSNKLGQGGFGSVYKGILSDGSEVAVKRLSRSSEQGVKEFKTEVLLIMKLQHKNLVRLL 402
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
GFCV+G+EKLLVYEFMPNSSLD LFDP KR L WS RI+I+NGI KG+LYLHEDSRLR
Sbjct: 403 GFCVEGEEKLLVYEFMPNSSLDVFLFDPTKRAELDWSSRIDIINGIAKGMLYLHEDSRLR 462
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
IIHRDLKASNVLLD +MNPKISDFGMARIF+ +E E NTARIVGTYGYMAPEYAMEGLYS
Sbjct: 463 IIHRDLKASNVLLDNEMNPKISDFGMARIFSSNEDEANTARIVGTYGYMAPEYAMEGLYS 522
Query: 537 IKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTC 596
KSDVFSFGVLL+EII+GR+ G++QS+ AP+LLAYAW LWNEGN +LID +L+D+C
Sbjct: 523 TKSDVFSFGVLLLEIISGRKKAGYHQSK--CAPSLLAYAWQLWNEGNKAELIDSMLSDSC 580
Query: 597 SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGRVTDDDD-- 654
+ DEF RY+HIGLLCVQEDA DRPTMSSVV+ML+ + L QP++PAF GR D+ +
Sbjct: 581 NADEFSRYMHIGLLCVQEDASDRPTMSSVVLMLKSQNSFLPQPERPAF-VGRFMDNLEAT 639
Query: 655 -NNYCSVNGLTISDLSPR 671
+N+ SVN +T+SD+ PR
Sbjct: 640 ASNF-SVNEMTLSDVGPR 656
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477817|ref|XP_003632027.1| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 595 bits (1533), Expect = e-167, Method: Compositional matrix adjust.
Identities = 334/691 (48%), Positives = 439/691 (63%), Gaps = 45/691 (6%)
Query: 5 ISVTKVIQLIFIYSL------TATLHDPAFGDSPPYNTCSSSAADSGHAGA--IYSNLKK 56
+SV V IF+YSL T + P F Y C++++ HAG+ SNL
Sbjct: 1 MSVVIVFLCIFLYSLPLAWSQTPANYQPGF----LYTFCNNNS----HAGSTKFQSNLG- 51
Query: 57 VLISLALN--ASAAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDITKLCPN 114
L+S +LN + FS G D D+VYGL++C +S C +CI AT I ++C +
Sbjct: 52 ALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIVQVCQH 111
Query: 115 KTDAIVWEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNISEPERYRSVVNNTLNNLTKLAA 174
K +AI+W C LRY+ +FF L++ + +N +N S P+++ + NLT A
Sbjct: 112 KKEAIIWYNECFLRYSNRSFFSNLEMKPTLYMWNTQNASAPDKFDQKLGEMFQNLTAQAT 171
Query: 175 FDPSNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSRGARLL 234
S++MYA G+V +N LY +VQCT+DL C CL++ + I + +G R+L
Sbjct: 172 --SSDDMYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRRCLDEVVGYIPNFMEGKQGGRVL 229
Query: 235 SRSCYLRYELYAFYNGD---TEASVSVGNQASGKSNQRRMWMIIILAAVAAFLLLVVAST 291
+ SCY+RYE+Y F + EA V G+ ++ W I + ++VVA
Sbjct: 230 APSCYIRYEVYPFAAVEDPVVEAQVPSSISPRGRKGRKTKW---IATGTSLSGIVVVAFC 286
Query: 292 GYFFAAKKVARKRKGMVRKQIQ------LHKIGDASKTGLRYQHVRGRDDDL-KAQDF-Y 343
Y+ V R+RKG ++ + L +G Y + D L K+++F
Sbjct: 287 VYY-----VIRRRKGADPEEKESKGDLCLLDLGGGRLDAEDYSSETLQGDMLAKSKEFPV 341
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLL 403
I + + AT +FS+ N LG+GGFGPVYKG LSDGKEIAVKRLSS S QG EF NEV+L
Sbjct: 342 IGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSSTSGQGLQEFKNEVIL 401
Query: 404 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIV 463
I KLQH+NLV+LLG C++G+E LL+YE+MPN SLD LFD + L W R +I+NGI
Sbjct: 402 IAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSIINGIA 461
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
+GI YLHEDSRLRIIHRDLK SN+LLD DMNPKISDFG+ARIFAGSE NTA+IVG+YG
Sbjct: 462 RGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKIVGSYG 521
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583
YMAPEYAMEGLYS KSDVFSFGV+L+EIITGR+N GF+ S +LL+YAW LWNEG
Sbjct: 522 YMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAGFHLS--GMGLSLLSYAWQLWNEGK 579
Query: 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPA 643
L+L+DPLL D+C PDEFLR HIGLLCVQEDAFDRPTMSSV++ML+ E++TL QP++PA
Sbjct: 580 GLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRPTMSSVIIMLRSESLTLRQPERPA 639
Query: 644 FSFGRVTDDDD---NNYCSVNGLTISDLSPR 671
FS GR ++ + + SVNGLT S PR
Sbjct: 640 FSVGRFANNQEIASGSSSSVNGLTASTTVPR 670
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147776074|emb|CAN65425.1| hypothetical protein VITISV_005300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1512), Expect = e-165, Method: Compositional matrix adjust.
Identities = 317/636 (49%), Positives = 413/636 (64%), Gaps = 29/636 (4%)
Query: 52 SNLKKVLISLALN--ASAAKFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDIT 109
SNL L+S +LN + FS G D D+VYGL++C +S C +CI AT I
Sbjct: 193 SNLG-ALLSRSLNNEGGISSFSMVYEGEDPDKVYGLFLCRPDVSKHICQSCIDAATLKIV 251
Query: 110 KLCPNKTDAIVWEEVCQLRYAYGNFFGQLDVSGNIPKYNRKNISEPERYRSVVNNTLNNL 169
++C +K +AI+W C LRY+ +FF L++ + +NR+N S P+++ + NL
Sbjct: 252 QVCQHKKEAIIWYNECFLRYSNRSFFSNLEMKPTLYMWNRQNASAPDKFDQKLGEMFQNL 311
Query: 170 TKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADILSCCYFSR 229
T A S+ MYA G+V +N LY +VQCT+DL C CL++ + I +
Sbjct: 312 TAKAT--SSDGMYAIGQVEVSNFLNLYGIVQCTRDLRMSYCRQCLDEVVGYIPNFMEGKE 369
Query: 230 GARLLSRSCYLRYELYAFYNGD---TEASVSVGNQASGKSNQRRMWMIIILAAVAAFLLL 286
G R+L+ SCY+RYE+Y F + EA V G+ ++ W I + ++
Sbjct: 370 GGRVLAPSCYIRYEIYPFAAVEDPIVEAQVPSSISPRGRKGRKTKW---IATGTSLSGIV 426
Query: 287 VVASTGYFFAAKKVARKRKGMVRKQIQ------LHKIGDASKTGLRYQHVRGRDDDL-KA 339
VVA Y+ V R+RKG ++ + L +G Y + D L K+
Sbjct: 427 VVAFCVYY-----VIRRRKGADPEEKESKGDLCLLDLGGGRLDAEDYSSETLQGDMLAKS 481
Query: 340 QDF-YIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFT 398
++F I + + AT +FS+ N LG+GGFGPVYKG LSDGKEIAVKRLS S QG EF
Sbjct: 482 KEFPVIGFDIVYEATQHFSNDNKLGEGGFGPVYKGTLSDGKEIAVKRLSRTSGQGLQEFK 541
Query: 399 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINI 458
NEV+LI KLQH+NLV+LLG C++G+E LL+YE+MPN SLD LFD + L W R +I
Sbjct: 542 NEVILIAKLQHRNLVRLLGCCLEGNELLLIYEYMPNKSLDFFLFDSTRGLELDWKTRFSI 601
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+NGI +GI YLHEDSRLRIIHRDLK SN+LLD DMNPKISDFG+ARIFAGSE NTA+I
Sbjct: 602 INGIARGISYLHEDSRLRIIHRDLKPSNILLDGDMNPKISDFGLARIFAGSENGTNTAKI 661
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL 578
VG+YGYMAPEYAMEGLYS KSDVFSFGV+L+EIITGR+N GF+ S +LL+YAW L
Sbjct: 662 VGSYGYMAPEYAMEGLYSNKSDVFSFGVVLLEIITGRKNAGFHLS--GMGLSLLSYAWQL 719
Query: 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQ 638
WNEG L+L+DPLL D+C PDEFLR HIGLLCVQEDAFDRPTMSSV++ML+ E+++L Q
Sbjct: 720 WNEGKGLELMDPLLGDSCCPDEFLRCYHIGLLCVQEDAFDRPTMSSVIIMLRSESLSLRQ 779
Query: 639 PQKPAFSFGRVTDDDD---NNYCSVNGLTISDLSPR 671
P++PAFS GR ++ + + SVNGLT S PR
Sbjct: 780 PERPAFSVGRFANNQEIASGSSSSVNGLTASTAVPR 815
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255555025|ref|XP_002518550.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223542395|gb|EEF43937.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1454), Expect = e-158, Method: Compositional matrix adjust.
Identities = 302/649 (46%), Positives = 404/649 (62%), Gaps = 37/649 (5%)
Query: 31 SPPYNTCS--SSAADSGHAGAIYSNLKKVLISLALNASAAKFSDASSGNDSDRVYGLYMC 88
+P + CS ++A + +NLK + +L F + S G DRV+G +C
Sbjct: 26 NPLFTDCSHGTTAENYTLNSPFENNLKLLFQNLTSMTPLTGFYNTSIGESPDRVHGQALC 85
Query: 89 LNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLRYAYGNFFGQLDVSGNIPKY- 147
I C CI A Q++ K+C +K DAI+W E CQ+RY+ FF +G +
Sbjct: 86 RGDIHATACRTCIENAVQELVKICKSK-DAIIWYESCQVRYSLRMFFSMQVYTGKYVDWE 144
Query: 148 -NRKNISEPERYRSVVNNTLNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDLS 206
+K IS P + V+ LNN++ AAF PS +M+ATGEV ++ DT+Y LVQCT+D+
Sbjct: 145 TQKKMISNPVHFYDVLKYLLNNISNKAAFSPSEKMFATGEVKYSQKDTIYGLVQCTRDIK 204
Query: 207 ADDCDACLNKAIADILSCCYFSRGARLLSRSCYLRYELYAFYNGDTEASVSVGNQASGKS 266
DDC +CL++A D+ CCY +G ++SR+C +RYELY+FYN +S ++ +
Sbjct: 205 GDDCRSCLDQAFGDLRGCCYSRQGGIIVSRNCNVRYELYSFYN----SSRNLLTYPTPNG 260
Query: 267 NQRRMWMIIILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVRKQIQLHKIGDASKTGLR 326
++ + WMI + + ++ V+ + FF +K ++ +GM S TG
Sbjct: 261 DKWKAWMIALALCIPTVVIAVLIGSCIFFHCRKGGQEEEGM-------------SMTGA- 306
Query: 327 YQHVRGRDDDLKAQD--FYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVK 384
+DL + + ++DL T+ AT NFS SN LGQG FG V+KG L DGKEIAVK
Sbjct: 307 --------NDLVSSEGLIFLDLTTIRAATDNFSYSNKLGQGSFGTVFKGALPDGKEIAVK 358
Query: 385 RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDP 444
RLS S QG EF NE++LI KLQH+NLV+LLG ++G+EKLLVYEFMPN SLD +FD
Sbjct: 359 RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLLGCGIEGEEKLLVYEFMPNKSLDLFIFDS 418
Query: 445 RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504
+R L W NI+ GI KG+LYLHEDSRL+IIHRDLK SNVLLD +M KISDFGMAR
Sbjct: 419 ERRKQLDWKTCYNIICGIAKGLLYLHEDSRLKIIHRDLKPSNVLLDNEMVAKISDFGMAR 478
Query: 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR 564
IF + NT R+VGTYGYM+PEYAMEGL+S+KSDVFSFGV+++EII+G++N GF +
Sbjct: 479 IFGEDQHTANTRRVVGTYGYMSPEYAMEGLFSVKSDVFSFGVMMLEIISGKKNNGFYITE 538
Query: 565 GATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSS 624
AP LL Y W L NEG L+ IDPLL + E +R IHIGLLCVQED DRPTMSS
Sbjct: 539 --LAPTLLVYVWQLRNEGKELEFIDPLLIEKVPIAEVVRCIHIGLLCVQEDPEDRPTMSS 596
Query: 625 VVVMLQGETITLCQPQKPAFSFGRV--TDDDDNNYCSVNGLTISDLSPR 671
VV++L E L +P++PAFS GR+ D SVN + S + PR
Sbjct: 597 VVLLLGSEPNALPEPKQPAFSVGRMFSIDRPSTTVPSVNQIIDSIILPR 645
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 671 | ||||||
| TAIR|locus:2121676 | 669 | CRK10 "cysteine-rich RLK (RECE | 0.500 | 0.502 | 0.566 | 6.7e-134 | |
| TAIR|locus:2121651 | 676 | CRK8 "cysteine-rich RLK (RECEP | 0.500 | 0.497 | 0.557 | 1.6e-132 | |
| TAIR|locus:2115728 | 675 | CRK25 "cysteine-rich RLK (RECE | 0.475 | 0.472 | 0.535 | 3e-127 | |
| TAIR|locus:2123111 | 669 | CRK34 "cysteine-rich RLK (RECE | 0.520 | 0.521 | 0.522 | 3.1e-125 | |
| TAIR|locus:2121636 | 659 | CRK7 "cysteine-rich RLK (RECEP | 0.500 | 0.509 | 0.528 | 2.7e-124 | |
| TAIR|locus:2077147 | 676 | CRK4 "cysteine-rich RLK (RECEP | 0.524 | 0.520 | 0.520 | 3.1e-123 | |
| TAIR|locus:2121686 | 645 | CRK19 "cysteine-rich RLK (RECE | 0.502 | 0.522 | 0.536 | 5.8e-122 | |
| TAIR|locus:2123116 | 700 | CRK30 "cysteine-rich RLK (RECE | 0.473 | 0.454 | 0.551 | 1.2e-121 | |
| TAIR|locus:2141201 | 679 | CRK29 "cysteine-rich RLK (RECE | 0.502 | 0.496 | 0.540 | 4.6e-120 | |
| TAIR|locus:2141762 | 665 | CRK26 "cysteine-rich RLK (RECE | 0.496 | 0.500 | 0.522 | 4.7e-118 |
| TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1032 (368.3 bits), Expect = 6.7e-134, Sum P(2) = 6.7e-134
Identities = 196/346 (56%), Positives = 258/346 (74%)
Query: 334 DDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG 393
DD A +D T+ AT +F +SN +GQGGFG VYKG LSDG E+AVKRLS S QG
Sbjct: 326 DDITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQG 385
Query: 394 NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWS 453
EF NEV+L+ KLQH+NLV+LLGFC+DG+E++LVYE++PN SLD LFDP K+G L W+
Sbjct: 386 EVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWT 445
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
+R I+ G+ +GILYLH+DSRL IIHRDLKASN+LLD DMNPKI+DFGMARIF + E
Sbjct: 446 RRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEE 505
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLA 573
NT+RIVGTYGYM+PEYAM G YS+KSDV+SFGVL++EII+G++N+ F Q+ GA +L++
Sbjct: 506 NTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAH--DLVS 563
Query: 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633
YAW LW+ G L+L+DP + + C +E +R +HIGLLCVQED +RPT+S++V+ML T
Sbjct: 564 YAWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNT 623
Query: 634 ITLCQPQKPAFSF-GRV------TDDDDNNYC-SVNGLTISDLSPR 671
+TL P++P F R+ TD + SV+ +I+D+ PR
Sbjct: 624 VTLPVPRQPGLFFQSRIGKDPLDTDTTSKSLLGSVDDASITDIHPR 669
|
|
| TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 1.6e-132, Sum P(2) = 1.6e-132
Identities = 194/348 (55%), Positives = 253/348 (72%)
Query: 334 DDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG 393
DD A +D T+ AT++F++SN +G+GGFG VYKG S+GKE+AVKRLS S QG
Sbjct: 331 DDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQG 390
Query: 394 NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWS 453
AEF EV+++ KLQH+NLV+LLGF + G+E++LVYE+MPN SLD +LFDP K+ L W
Sbjct: 391 EAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWM 450
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
+R NI+ GI +GILYLH+DSRL IIHRDLKASN+LLD D+NPKI+DFGMARIF + +
Sbjct: 451 QRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQD 510
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLA 573
NT+RIVGTYGYMAPEYAM G +S+KSDV+SFGVL++EII+GR+N+ F++S GA +LL
Sbjct: 511 NTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQ--DLLT 568
Query: 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633
+ W LW ALDL+DPL+ + C E +R IHIGLLCVQED RPT+S+V +ML T
Sbjct: 569 HTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNT 628
Query: 634 ITLCQPQKPAFSF--GRVTDDDDNNY--------CSVNGLTISDLSPR 671
+TL P++P F V D D++ S++ I+DL PR
Sbjct: 629 VTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676
|
|
| TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 909 (325.0 bits), Expect = 3.0e-127, Sum P(2) = 3.0e-127
Identities = 173/323 (53%), Positives = 227/323 (70%)
Query: 334 DDD--LKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE 391
D+D + ++ AT+ FS+SN LG GGFG VYKG L G+ +A+KRLS S
Sbjct: 323 DEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGST 382
Query: 392 QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLC 451
QG EF NEV ++ KLQH+NL KLLG+C+DG+EK+LVYEF+PN SLD LFD KR +L
Sbjct: 383 QGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLD 442
Query: 452 WSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511
W +R I+ GI +GILYLH DSRL IIHRDLKASN+LLD DM+PKISDFGMARIF +
Sbjct: 443 WQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQT 502
Query: 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571
+ NT RIVGTYGYM+PEYA+ G YS+KSDV+SFGVL++E+ITG++N+ F + G +L
Sbjct: 503 QANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLG--DL 560
Query: 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631
+ Y W LW E + L+L+D + +E +R IHI LLCVQED+ +RP+M ++VM+
Sbjct: 561 VTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNS 620
Query: 632 ETITLCQPQKPAFSFGRVTDDDD 654
T+TL P++ F + D D
Sbjct: 621 FTVTLPIPKRSGFLLRTMKDSRD 643
|
|
| TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 971 (346.9 bits), Expect = 3.1e-125, Sum P(2) = 3.1e-125
Identities = 188/360 (52%), Positives = 248/360 (68%)
Query: 322 KTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI 381
K + V+ D+ +T++ AT FSDSNM+G+GGFG VY+G LS G E+
Sbjct: 311 KKSYKTTEVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEV 370
Query: 382 AVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL 441
AVKRLS S QG EF NE +L+ KLQHKNLV+LLGFC++G+EK+LVYEF+PN SLD L
Sbjct: 371 AVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 430
Query: 442 FDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501
FDP K+G L W++R NI+ GI +GILYLH+DSRL IIHRDLKASN+LLD DMNPKI+DFG
Sbjct: 431 FDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFG 490
Query: 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFN 561
MARIF + + NT RI GT+GYM+PEYAM G +S+KSDV+SFGVL++EII+G++N+ F
Sbjct: 491 MARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSF- 549
Query: 562 QSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621
+ + NL+ +AW LW G+ L+L+DP + ++ E R IHI LLCVQED DRP
Sbjct: 550 YNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPL 609
Query: 622 MSSVVVMLQGETITLCQPQKPAFSF-GRVTDDDDNNYC---------SVNGLTISDLSPR 671
+ ++++ML T TL P+ P F GR + D Y S+N +I++ PR
Sbjct: 610 LPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669
|
|
| TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 967 (345.5 bits), Expect = 2.7e-124, Sum P(2) = 2.7e-124
Identities = 184/348 (52%), Positives = 247/348 (70%)
Query: 334 DDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG 393
DD + +D + AT++FS++N +G+GGFG VYKG S+G E+AVKRLS SEQG
Sbjct: 314 DDKTTIESLQLDYRAIQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQG 373
Query: 394 NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWS 453
+ EF NEV+++ L+HKNLV++LGF ++ +E++LVYE++ N SLD LFDP K+G L W+
Sbjct: 374 DTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWT 433
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
+R +I+ GI +GILYLH+DSRL IIHRDLKASN+LLD DMNPKI+DFGMARIF + +
Sbjct: 434 QRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQ 493
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLA 573
NT+RIVGTYGYM+PEYAM G +S+KSDV+SFGVL++EII+GR+N F ++ A +L+
Sbjct: 494 NTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQ--DLVT 551
Query: 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633
+AW LW G ALDL+DP + D+C E +R HIGLLCVQED RP MS++ VML T
Sbjct: 552 HAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNT 611
Query: 634 ITLCQPQKPAF------SFGRVTDDDDNNY----CSVNGLTISDLSPR 671
+ L PQ+P F R+ D S++ ++SDL PR
Sbjct: 612 MALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659
|
|
| TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 3.1e-123, Sum P(2) = 3.1e-123
Identities = 190/365 (52%), Positives = 250/365 (68%)
Query: 320 ASKTGLRYQH--VRGRDDDLK-AQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLS 376
A KT Y+ + DD+ A D + ++ AT+ F ++N LGQGGFG VYKG+
Sbjct: 312 AKKTRTNYEREPLTEESDDITTAGSLQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFP 371
Query: 377 DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSS 436
G ++AVKRLS S QG EF NEV+++ KLQH+NLV+LLGFC++ DE++LVYEF+PN S
Sbjct: 372 SGVQVAVKRLSKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKS 431
Query: 437 LDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496
LD +FD + LL W++R I+ GI +GILYLH+DSRL IIHRDLKA N+LL DMN K
Sbjct: 432 LDYFIFDSTMQSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAK 491
Query: 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
I+DFGMARIF + E NT RIVGTYGYM+PEYAM G +S+KSDV+SFGVL++EII+G++
Sbjct: 492 IADFGMARIFGMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKK 551
Query: 557 NTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDA 616
N+ Q G +A NL+ Y W LW+ G+ L+L+DP D +E R IHI LLCVQE+A
Sbjct: 552 NSNVYQMDGTSAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEA 611
Query: 617 FDRPTMSSVVVMLQGETITLCQPQKPAFSF--------GRVTDDDDNN--YCSVNGLTIS 666
DRPTMS++V ML +I L PQ+P F F G V N CSV+ +I+
Sbjct: 612 EDRPTMSAIVQMLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDDASIT 671
Query: 667 DLSPR 671
+++PR
Sbjct: 672 NVTPR 676
|
|
| TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 941 (336.3 bits), Expect = 5.8e-122, Sum P(2) = 5.8e-122
Identities = 184/343 (53%), Positives = 237/343 (69%)
Query: 334 DDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG 393
+D A D + ++ AT+ F N LGQGGFG VYKG LS G ++AVKRLS S QG
Sbjct: 304 NDITTAGSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQG 363
Query: 394 NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWS 453
EF NEV+++ KLQH+NLVKLLG+C++G+EK+LVYEF+PN SLD LFD + L W+
Sbjct: 364 EKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWT 423
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
+R I+ GI +GILYLH+DSRL IIHRDLKA N+LLD DMNPKI+DFGMARIF + E
Sbjct: 424 RRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEA 483
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLA 573
T R+VGTYGYM+PEYAM G +S+KSDV+SFGVL++EII+G +N+ Q + NL+
Sbjct: 484 MTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVG-NLVT 542
Query: 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633
Y W LW+ G+ +L+DP D E R IHI LLCVQEDA DRPTMSS+V ML
Sbjct: 543 YTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSL 602
Query: 634 ITLCQPQKPAFSFGRVTDD-----DDNNYCSVNGLTISDLSPR 671
I L +P+ P F F + D + +CSV+ +I+ ++PR
Sbjct: 603 IALAEPRPPGFFFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645
|
|
| TAIR|locus:2123116 CRK30 "cysteine-rich RLK (RECEPTOR-like protein kinase) 30" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 940 (336.0 bits), Expect = 1.2e-121, Sum P(2) = 1.2e-121
Identities = 178/323 (55%), Positives = 235/323 (72%)
Query: 335 DDLKAQDFY-IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG 393
DD+ + D++ ++ ATSNF SN +GQGGFG VYKG LS+G E+AVKRLS S+QG
Sbjct: 324 DDITTVGYLQFDIKDIEAATSNFLASNKIGQGGFGEVYKGTLSNGTEVAVKRLSRTSDQG 383
Query: 394 NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILF---DPRKRGLL 450
EF NEVLL+ KLQH+NLV+LLGF + G+EK+LV+EF+PN SLD LF +P K+G L
Sbjct: 384 ELEFKNEVLLVAKLQHRNLVRLLGFALQGEEKILVFEFVPNKSLDYFLFGSTNPTKKGQL 443
Query: 451 CWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510
W++R NI+ GI +G+LYLH+DSRL IIHRD+KASN+LLD DMNPKI+DFGMAR F +
Sbjct: 444 DWTRRYNIIGGITRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRDHQ 503
Query: 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570
E +T R+VGT+GYM PEY G +S KSDV+SFGVL++EI++GR+N+ F Q G+ N
Sbjct: 504 TEDSTGRVVGTFGYMPPEYVAHGQFSTKSDVYSFGVLILEIVSGRKNSSFYQMDGSVC-N 562
Query: 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
L+ Y W LWN ++L+L+DP ++ + DE R IHIGLLCVQE+ +RP +S++ ML
Sbjct: 563 LVTYVWRLWNTDSSLELVDPAISGSYEKDEVTRCIHIGLLCVQENPVNRPALSTIFQMLT 622
Query: 631 GETITLCQPQKPAFSFGRVTDDD 653
+ITL PQ P F F + D
Sbjct: 623 NSSITLNVPQPPGFFFRNRPESD 645
|
|
| TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 4.6e-120, Sum P(2) = 4.6e-120
Identities = 187/346 (54%), Positives = 238/346 (68%)
Query: 334 DDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG 393
D+ + + ETL AT NFS N LG+GGFG VYKGV G+EIAVKRLS S QG
Sbjct: 335 DEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQG 394
Query: 394 NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWS 453
+ EF NE+LL+ KLQH+NLV+L+GFC+ G+E+LLVYEF+ N+SLD +FD KR LL W
Sbjct: 395 DNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWV 454
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
R ++ GI +G+LYLHEDSR RIIHRDLKASN+LLD +MNPKI+DFG+A++F +
Sbjct: 455 VRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMT 514
Query: 514 N--TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571
+ T+RI GTYGYMAPEYAM G +S+K+DVFSFGVL+IEIITG+RN + A +L
Sbjct: 515 HRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDL 574
Query: 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631
L++ W W E L +IDP LT S +E LR IHIGLLCVQE A RPTM++V +ML
Sbjct: 575 LSWVWRSWREDTILSVIDPSLT-AGSRNEILRCIHIGLLCVQESAATRPTMATVSLMLNS 633
Query: 632 ETITLCQPQKPAFSF------GRVTDDDDNNYCSVNGLTISDLSPR 671
+ TL P +PAF V+ + S N +T+S+ SPR
Sbjct: 634 YSFTLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSNDVTVSEFSPR 679
|
|
| TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 900 (321.9 bits), Expect = 4.7e-118, Sum P(2) = 4.7e-118
Identities = 177/339 (52%), Positives = 240/339 (70%)
Query: 322 KTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI 381
K +R + ++++ D L ATS+FS N LG+GGFG VYKGVLSDG++I
Sbjct: 310 KENIRNSENKHENENISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKI 369
Query: 382 AVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL 441
AVKRLS ++QG EF NE LL+ KLQH+NLVKLLG+ ++G E+LLVYEF+P++SLD +
Sbjct: 370 AVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFI 429
Query: 442 FDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501
FDP + L W R I+ G+ +G+LYLH+DSRLRIIHRDLKASN+LLD +M PKI+DFG
Sbjct: 430 FDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFG 489
Query: 502 MARIF-AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560
MAR+F + T RIVGT+GYMAPEY M G +S K+DV+SFGVL++EII+G++N+GF
Sbjct: 490 MARLFDIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGF 549
Query: 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT--DTCSPDEFLRYIHIGLLCVQEDAFD 618
+ + +L+++AW W EG AL+L+D +L + S + +R I+IGLLCVQE +
Sbjct: 550 SSED--SMGDLISFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAE 607
Query: 619 RPTMSSVVVMLQGETITLCQPQKPAF-SFGRVTDDDDNN 656
RP+M+SVV+ML G TI L +P KPAF S D ++
Sbjct: 608 RPSMASVVLMLDGHTIALSEPSKPAFFSHSNAVSDSSSS 646
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00006934001 | SubName- Full=Chromosome chr10 scaffold_179, whole genome shotgun sequence; (654 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 671 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-53 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-35 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-31 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-29 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-27 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-24 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-23 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-22 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 1e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-22 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-22 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 7e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-19 | |
| pfam01657 | 106 | pfam01657, Stress-antifung, Salt stress response/a | 2e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-18 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 1e-53
Identities = 98/276 (35%), Positives = 129/276 (46%), Gaps = 31/276 (11%)
Query: 361 MLGQGGFGPVYKGVLSDGK-----EIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG+G FG VYKG L E+AVK L SEQ EF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
LLG C + + +V E+M L + L R + L S ++ I +G+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE---S 120
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV-GTYGYMAPEYAMEG 533
IHRDL A N L+ ++ KISDFG++R + + R +MAPE EG
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
++ KSDV+SFGVLL EI T G G + +L Y G L
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTL----GEQPYPGMSNEEVLEYL----KNGYRLPQPPN--- 227
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629
C P E + L C ED DRPT S +V +L
Sbjct: 228 --C-PPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-53
Identities = 99/276 (35%), Positives = 135/276 (48%), Gaps = 30/276 (10%)
Query: 361 MLGQGGFGPVYKGVLSDGK-----EIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG+G FG VYKG L E+AVK L SEQ EF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
LLG C + + ++V E+MP L L R + L S ++ I +G+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE---S 121
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
IHRDL A N L+ ++ KISDFG++R ++ +V ++ +MAPE EG
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
++ KSDV+SFGVLL EI T G G + +L Y +G L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL----GEEPYPGMSNAEVLEYL----KKGYRLPKP----- 226
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629
C P E + + L C ED DRPT S +V +L
Sbjct: 227 PNC-PPELYKLM---LQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 75/198 (37%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGF 418
LG G FG VYK GK +AVK L SE + + E+ ++ +L H N+V+L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
D D LV E+ L L + G L + I I++G+ YLH II
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NGII 120
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE-YAMEGLYSI 537
HRDLK N+LLD + KI+DFG+A+ S + T VGT YMAPE Y
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGYGP 178
Query: 538 KSDVFSFGVLLIEIITGR 555
K DV+S GV+L E++TG+
Sbjct: 179 KVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-51
Identities = 99/290 (34%), Positives = 136/290 (46%), Gaps = 47/290 (16%)
Query: 360 NMLGQGGFGPVYKGVLSDGK----EIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVK 414
LG+G FG VYKG L E+AVK L SE+ +F E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAIL------FDPRKRGLLCWSKRINIVNGIVKGILY 468
LLG C + + LV E+M L L F ++ L ++ I KG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVGTYGYMAP 527
L + +HRDL A N L+ D+ KISDFG++R ++ T + +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP-------NLLAYAWHLWN 580
E +G+++ KSDV+SFGVLL EI T GAT P +L Y
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT----------LGAT-PYPGLSNEEVLEYL----R 221
Query: 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+G L P + C PDE + L C Q D DRPT S +V L+
Sbjct: 222 KGYRLP--KP---EYC-PDELYELM---LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 8e-50
Identities = 73/194 (37%), Positives = 107/194 (55%), Gaps = 11/194 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE-FTNEVLLILKLQHKNLVKLLGFC 419
LG+GGFG VY GK++A+K + E E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
D + LV E+ SL +L + + L + + I+ I++G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 480 RDLKASNVLLDYD-MNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE-YAMEGLYSI 537
RDLK N+LLD D K++DFG++++ + + T IVGT YMAPE +G YS
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 538 KSDVFSFGVLLIEI 551
KSD++S GV+L E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-49
Identities = 99/281 (35%), Positives = 131/281 (46%), Gaps = 42/281 (14%)
Query: 362 LGQGGFGPVYKGVLSDGKE-----IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG VYKG L E +AVK L SE+ EF E ++ KL H N+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
LG C G+ +V E+MP L L + L + + I KG+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLES---K 121
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG---YMAPEYAME 532
+HRDL A N L+ ++ KISDFG++R E + R G +MAPE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYYRKR-GGGKLPIKWMAPESLKD 178
Query: 533 GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID--- 589
G ++ KSDV+SFGVLL EI T G P Y E L+L++
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFT----------LGEQ-P----YPGMSNEE--VLELLEDGY 221
Query: 590 PLLT-DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629
L + C PDE Y + L C D DRPT S +V L
Sbjct: 222 RLPRPENC-PDEL--Y-ELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 68/196 (34%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
LG+G FG VY GK +A+K + ++ E+ ++ KL+H N+V+L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
D D+ LV E+ L +L +KRG L + + I+ + YLH I+H
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS---KGIVH 120
Query: 480 RDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKS 539
RDLK N+LLD D + K++DFG+AR E VGT YMAPE + Y
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 540 DVFSFGVLLIEIITGR 555
D++S GV+L E++TG+
Sbjct: 178 DIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 80/277 (28%), Positives = 127/277 (45%), Gaps = 47/277 (16%)
Query: 360 NMLGQGGFGPVYKGVLSD-GKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
+LG+G FG VY + D G+ +AVK LS SE+ E+ ++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 417 GFCVDGDEK-LLVY-EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
G D ++ L ++ E++ SL ++L +K G L I++G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLH---S 119
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
I+HRD+K +N+L+D D K++DFG A+ E T + GT +MAPE
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 535 YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI------ 588
Y +D++S G +IE+ TG+ W GN + +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKP------------------PW--SELGNPMAALYKIGSS 219
Query: 589 --DPLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPT 621
P + + S + +FLR C++ D RPT
Sbjct: 220 GEPPEIPEHLSEEAKDFLR------KCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 70/205 (34%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 356 FSDSNMLGQGGFGPVYKG-VLSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKNL 412
F +G+GGFG VYK GKE+A+K L S ++ + NE+ ++ K +H N+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK--EKIINEIQILKKCKHPNI 59
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-LCWSKRINIV-NGIVKGILYLH 470
VK G + DE +V EF SL +L + L I V ++KG+ YLH
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQ---IAYVCKELLKGLEYLH 115
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
IIHRD+KA+N+LL D K+ DFG++ + ++ +VGT +MAPE
Sbjct: 116 S---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMAPEVI 169
Query: 531 MEGLYSIKSDVFSFGVLLIEIITGR 555
Y K+D++S G+ IE+ G+
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 13/205 (6%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS--SCSEQGNAEFTNEVLLILKLQHKN 411
N+ +++G+G FG VYKG+ L G +A+K++S E+ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+VK +G D ++ E+ N SL I+ +K G S V +++G+ YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE-YA 530
+IHRD+KA+N+L D K++DFG+A + + +VGT +MAPE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIE 172
Query: 531 MEGLYSIKSDVFSFGVLLIEIITGR 555
M G S SD++S G +IE++TG
Sbjct: 173 MSGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
F+ LG G FG V++G+ + +A+K L S +F EV + +L+HK+L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
L C G+ ++ E M SL A L P + L + I++ + +G+ YL E
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV-ASLIDMACQVAEGMAYLEEQ- 123
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
IHRDL A N+L+ D+ K++DFG+AR+ + +I Y + APE A G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179
Query: 534 LYSIKSDVFSFGVLLIEIIT 553
+S KSDV+SFG+LL E+ T
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 81/277 (29%), Positives = 131/277 (47%), Gaps = 39/277 (14%)
Query: 361 MLGQGGFGPVYKGV-LSDGK----EIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
+LG G FG VYKGV + +G+ +A+K L S + N E +E ++ + H ++V+
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKR----GLLCWSKRINIVNGIVKGILYLH 470
LLG C+ + L+ + MP L + + + LL W +I KG+ YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
E R++HRDL A NVL+ + KI+DFG+A++ E E + +MA E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 531 MEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589
+ +Y+ KSDV+S+GV + E++T G + + P+LL L
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKP--YEGIPAVEIPDLLE---------KGERLPQ 232
Query: 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626
P C+ D + + + C DA RPT ++
Sbjct: 233 P---PICTIDVY----MVLVKCWMIDAESRPTFKELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 72/198 (36%), Positives = 105/198 (53%), Gaps = 13/198 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V+ G + ++AVK L + A F E ++ KL+H LV+L C +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
+ +V E+M SL L + L + +++ I +G+ YL IHRD
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRL-PQLVDMAAQIAEGMAYLE---SRNYIHRD 128
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT---YGYMAPEYAMEGLYSIK 538
L A N+L+ ++ KI+DFG+AR+ E TAR G + APE A G ++IK
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDE---YTAR-EGAKFPIKWTAPEAANYGRFTIK 184
Query: 539 SDVFSFGVLLIEIIT-GR 555
SDV+SFG+LL EI+T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 359 SNMLGQGGFGPVYKGVL-----SDGKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQHKNL 412
LG+G FG V + G+++AVK L+ S EQ ++F E+ ++ L H+N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 413 VKLLGFCVDGDEK--LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
VK G C + L+ E++P+ SL L R R + + + + I KG+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG--EVNTARIVGTYGYMAPE 528
R IHRDL A N+L++ + KISDFG+A++ + V + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIIT 553
+S SDV+SFGV L E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 73/217 (33%), Positives = 106/217 (48%), Gaps = 35/217 (16%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRLS-SCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG+G FG V+ G + +AVK L + S +F E L+ QH+N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLD----------AILFDPR-KRGLLCWSKRINIVNGIV 463
G C +GD ++V+E+M + L+ A L P G L S+ + I I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA---RIVG 520
G++YL + +HRDL N L+ YD+ KI DFGM+R +V T R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTTDYYRVGG 182
Query: 521 T----YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+M PE M ++ +SDV+SFGV+L EI T
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 43/284 (15%)
Query: 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVL 402
DLE + V LGQG G VYK GK A+K++ E+ + E+
Sbjct: 2 DLERVKV----------LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK 51
Query: 403 LILKLQHKNLVKLLG-FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI--NIV 459
+ + +VK G F +G+ + V E+M SL +L +K G + + I
Sbjct: 52 TLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLL---KKVG--KIPEPVLAYIA 105
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV 519
I+KG+ YLH ++ IIHRD+K SN+L++ KI+DFG++++ + + NT V
Sbjct: 106 RQILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--V 161
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579
GT YM+PE YS +D++S G+ L+E G+ F + L+
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK--FPFLPPGQPSFFELMQAI---- 215
Query: 580 NEGNALDLIDPLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPT 621
+G L + SP+ +F+ C+Q+D RP+
Sbjct: 216 CDGPPPSLPA----EEFSPEFRDFIS------ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 73/229 (31%), Positives = 107/229 (46%), Gaps = 24/229 (10%)
Query: 351 VATSNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVK---RLSSCSEQGNAEFTNEVLL 403
V + + LG G FG VY+G+ D E+ V SCSEQ ++F E L+
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 404 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKR----GLLCWSKRINIV 459
+ K H+N+V+L+G + + ++ E M L + L + R R L +
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISDFGMARIFAGSEGEVNTA 516
+ KG YL E+ IHRD+ A N LL KI+DFGMAR +
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEII-------TGRRNT 558
R + +M PE ++G+++ K+DV+SFGVLL EI GR N
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 69/195 (35%), Positives = 107/195 (54%), Gaps = 12/195 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
+G+G FG V G G+++AVK L S A F E ++ L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
G+ +V E+M SL L R R ++ ++++ + +G+ YL E +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDV 541
L A NVL+ D+ K+SDFG+A+ + ++ ++ + APE E +S KSDV
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKKFSTKSDV 182
Query: 542 FSFGVLLIEIIT-GR 555
+SFG+LL EI + GR
Sbjct: 183 WSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 69/198 (34%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V++G+ ++ +AVK L + +F E ++ KL+H L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
+ +V E M SL L L + I++ + G+ YL + IHRD
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRD 128
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT---YGYMAPEYAMEGLYSIK 538
L A NVL+ + K++DFG+AR+ E AR G + APE A+ +SIK
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYE---AR-EGAKFPIKWTAPEAALYNRFSIK 184
Query: 539 SDVFSFGVLLIEIIT-GR 555
SDV+SFG+LL EI+T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (310), Expect = 1e-30
Identities = 80/277 (28%), Positives = 127/277 (45%), Gaps = 23/277 (8%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAE---FTNEVLLILKLQH-KNLVKLLG 417
LG+G FG VY D K +A+K L+ E + E F E+ ++ L H N+VKL
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
F D LV E++ SL+ +L ++G L S+ + I+ I+ + YLH I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGI 122
Query: 478 IHRDLKASNVLLDYDMN-PKISDFGMARIFAG----SEGEVNTARIVGTYGYMAPEYAM- 531
IHRD+K N+LLD D K+ DFG+A++ S + VGT GYMAPE +
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 532 --EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589
S SD++S G+ L E++TG F + ++A + + +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLK--IILELP--TPSLA 236
Query: 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626
L+ + + + +D +R + SS +
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 79/270 (29%), Positives = 128/270 (47%), Gaps = 37/270 (13%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNA-----EFTNEVLLILKLQHKNLVK 414
+LG G FG VY+G+ L DG AVK +S + + E+ L+ KLQH N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
LG + D + E +P SL +L +K G I+ G+ YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLL---KKYGSFPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-EG 533
+HRD+K +N+L+D + K++DFGMA+ G+ +MAPE +G
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQ---VVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
Y + +D++S G ++E+ TG+ ++Q G A ++ G + +L P +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGK--PPWSQLEGVAA---------VFKIGRSKEL--PPIP 224
Query: 594 DTCSPD--EFLRYIHIGLLCVQEDAFDRPT 621
D S + +F+ C+Q D RPT
Sbjct: 225 DHLSDEAKDFIL------KCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 84/277 (30%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAE----FTNEVLLILKLQHKNLVKLLG 417
+G+G FG VYKGVL E+AVK +C + F E ++ + H N+VKL+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
CV +V E +P SL + F +K+ L K + + G+ YL +S+
Sbjct: 60 VCVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NC 114
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSI 537
IHRDL A N L+ + KISDFGM+R G V+ + APE G Y+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 538 KSDVFSFGVLLIEIITGRRNTGFNQSRGATA-PNLLAYAWHLWNEGNALDLIDP---LLT 593
+SDV+S+G+LL E + G T P + + I+ +
Sbjct: 175 ESDVWSYGILLWETFSL----------GDTPYPG--------MSNQQTRERIESGYRMPA 216
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
P+E R + L C D +RP+ S + LQ
Sbjct: 217 PQLCPEEIYR---LMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 75/212 (35%), Positives = 109/212 (51%), Gaps = 22/212 (10%)
Query: 360 NMLGQGGFGPVYKG----VLSDGKE---IAVKRLSSCS-EQGNAEFTNEVLLILKLQHKN 411
N LG G FG VY+G +L G +AVK L + +Q EF E L+ H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG----LLCWSKRINIVNGIVKGIL 467
+VKLLG C+ + + ++ E M L + L D R LL + ++I + KG +
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 468 YLHEDSRLRIIHRDLKASNVLL-----DYDMNPKISDFGMAR-IFAGSEGEVNTARIVGT 521
YL ++ IHRDL A N L+ D D KI DFG+AR I+ ++
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MAPE ++G ++ +SDV+SFGVL+ EI+T
Sbjct: 178 R-WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 89/277 (32%), Positives = 123/277 (44%), Gaps = 36/277 (12%)
Query: 362 LGQGGFGPVYKGV--LSDGKEI--AVKRLSSCSEQGN-AEFTNEVLLILKLQHKNLVKLL 416
LG G FG V KGV + GKE+ AVK L EF E ++ +L H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G C G+ +LV E P L L +KR + S + + + G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYL---KKRREIPVSDLKELAHQVAMGMAYLESK---H 115
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVGTY--GYMAPEYAMEG 533
+HRDL A NVLL KISDFGM+R + AGS + A G + + APE G
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWYAPECINYG 173
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
+S KSDV+S+GV L E + G ++A + G L
Sbjct: 174 KFSSKSDVWSYGVTLWEAFS----YGAKPYGEMKGAEVIA----MLESGERLP------- 218
Query: 594 DTCSPDEFLRYIH-IGLLCVQEDAFDRPTMSSVVVML 629
P+E + I+ I L C + DRPT S +
Sbjct: 219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 60/201 (29%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 360 NMLGQGGFGPVYKGVLS-DGKE---IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
++G G FG V +G L GK+ +A+K L + S++ +F E ++ + H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
L G +++ E+M N SLD L G + + ++ GI G+ YL S
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA--RIVGTYGYMAPEYAME 532
+ +HRDL A N+L++ ++ K+SDFG++R SE T +I + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAY 182
Query: 533 GLYSIKSDVFSFGVLLIEIIT 553
++ SDV+SFG+++ E+++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQH 409
+ + +G+G G VYK + GKE+A+K RL +++ NE+L++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKH 74
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN------IVNGIV 463
N+V + GDE +V E+M SL I+ R+N + ++
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT--------QNFVRMNEPQIAYVCREVL 126
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
+G+ YLH +IHRD+K+ N+LL D + K++DFG A + + N+ +VGT
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPY 181
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
+MAPE Y K D++S G++ IE+ G
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 75/222 (33%), Positives = 103/222 (46%), Gaps = 38/222 (17%)
Query: 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLL 403
DLE L LG G G V K + GK +AVK + E A ++L
Sbjct: 2 DLEYLGE----------LGAGNSGVVSKVLHRPTGKIMAVKTIRL--EINEAIQ-KQILR 48
Query: 404 ILKLQHK----NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN-- 457
L + HK +V G + + + E+M SLD IL K RI
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL----KEV----QGRIPER 100
Query: 458 ----IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
I ++KG+ YLHE +IIHRD+K SN+L++ K+ DFG++ S +
Sbjct: 101 ILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT 158
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
VGT YMAPE YS+KSD++S G+ LIE+ TGR
Sbjct: 159 F----VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 73/197 (37%), Positives = 108/197 (54%), Gaps = 12/197 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V+ G + ++A+K L S A F E L+ +LQH LV+L V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYA-VVT 71
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
+ ++ E+M N SL L P L +K I++ I +G+ ++ R IHRD
Sbjct: 72 QEPIYIITEYMENGSLVDFLKTPEGIKLTI-NKLIDMAAQIAEGMAFIE---RKNYIHRD 127
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLYSIKS 539
L+A+N+L+ + KI+DFG+AR+ +E TAR + + APE G ++IKS
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 540 DVFSFGVLLIEIIT-GR 555
DV+SFG+LL EI+T GR
Sbjct: 185 DVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 362 LGQGGFGPVYKGVLSD------GKEIAVKRLSSCSEQG-NAEFTNEVLLILKLQHKNLVK 414
LGQG FG VY+G+ +A+K ++ + EF NE ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAIL-------FDPRKRGLLCWSKRINIVNGIVKGIL 467
LLG G L+V E M L + L + G K I + I G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVGT----Y 522
YL + +HRDL A N ++ D+ KI DFGM R I+ E + R G
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY-----ETDYYRKGGKGLLPV 185
Query: 523 GYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MAPE +G+++ KSDV+SFGV+L E+ T
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 9/201 (4%)
Query: 360 NMLGQGGFGPVYKGV-LSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
+G+G FG VY SDGK +K LS+ SE+ + NEV ++ KL H N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG-LLCWSKRINIVNGIVKGILYLHEDSRL 475
+ + +V E+ L + +K G + ++ + + YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
+I+HRD+K N+ L + K+ DFG++++ + + T +VGT Y++PE Y
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPELCQNKPY 180
Query: 536 SIKSDVFSFGVLLIEIITGRR 556
+ KSD++S G +L E+ T +
Sbjct: 181 NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 69/202 (34%), Positives = 97/202 (48%), Gaps = 20/202 (9%)
Query: 362 LGQGGFGPVYKGV--LSDGKEIAVKRLSSCSEQGNAEFT---NEVLLILKLQHKNLVKLL 416
LG+G FG V V GK A+K L E E ++ ++ H +VKL
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 417 GFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLC--WSKRINIVNGIVKGILYLHEDS 473
+ +EKL LV E+ P L + L K G ++ IV + YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARFY--AAEIVLALEYLH--- 110
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
L II+RDLK N+LLD D + K++DFG+A+ + NT GT Y+APE +
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168
Query: 534 LYSIKSDVFSFGVLLIEIITGR 555
Y D +S GVLL E++TG+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
+G G FG V+ G + +++A+K R + SE+ +F E +++KL H LV+L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
+ LV+EFM + L L +RG + + + +G+ YL + +IH
Sbjct: 69 TERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 480 RDLKASNVLLDYDMNPKISDFGMARI-----FAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
RDL A N L+ + K+SDFGM R + S G + + +PE
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEVFSFSK 177
Query: 535 YSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565
YS KSDV+SFGVL+ E+ + + N+S
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 8e-27
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 16/208 (7%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL----QHK 410
+ + LG+G G V K L + I + + N + ++L L++ +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSP 59
Query: 411 NLVKLLGFCVDGDEKLL--VYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGIL 467
+VK G +D + E+ SLD+I +KRG K + I ++KG+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YLH +IIHRD+K SN+LL K+ DFG++ G GT YMAP
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSFYMAP 172
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGR 555
E YSI SDV+S G+ L+E+ R
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 46/279 (16%)
Query: 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLS-SCSEQGNAE-----FTNEVLLILKLQHKNLV 413
+LG+G +G VY G+ + G+ IAVK++ S AE EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAIL--FDPRKRGLLC-WSKRINIVNGIVKGILYLH 470
+ LG C+D + + EF+P S+ +IL F P + C ++K+ I+ G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ------ILDGVAYLH 119
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV----GTYGYMA 526
+ ++HRD+K +NV+L + K+ DFG AR A + ++ GT +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586
PE E Y KSD++S G + E+ TG + A+ L A ++ G
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATG-------KPPLASMDRLAA----MFYIGAHRG 225
Query: 587 LIDPLLTDTCSPDEF----LRYIHIGLLCVQEDAFDRPT 621
L+ L PD F + ++ C+ D +RP+
Sbjct: 226 LMPRL------PDSFSAAAIDFVT---SCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 73/209 (34%), Positives = 117/209 (55%), Gaps = 20/209 (9%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKR--LSSCSEQGNAE-------FTNEVLLILKLQHK 410
++G G FG VY G+ S G+ +AVK+ L S S E+ L+ +LQH+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
N+V+ LG +D D + E++P S+ A+L G + N V I+KG+ YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH 123
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS--EGEVNTAR--IVGTYGYMA 526
+R IIHRD+K +N+L+D KISDFG+++ + + N AR + G+ +MA
Sbjct: 124 --NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
PE + Y+ K+D++S G L++E++TG+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 362 LGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V+ D +AVK L SE +F E L+ LQH+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 416 LGFCVDGDEKLLVYEFMPNSSL---------DAILFDPRKR---GLLCWSKRINIVNGIV 463
G C +G L+V+E+M + L DA + + G L + + I + I
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
G++YL + L +HRDL N L+ + KI DFGM+R ++ R +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+M PE + ++ +SD++SFGV+L EI T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 68/211 (32%), Positives = 107/211 (50%), Gaps = 17/211 (8%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN 411
+ +LG+G +G VY LS IA+K + + E+ L L+H+N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG--IVKGILYL 469
+V+ LG + + E +P SL A+L K G L +++ I I++G+ YL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 470 HEDSRLRIIHRDLKASNVLLD-YDMNPKISDFGMARIFAGSEGEVN--TARIVGTYGYMA 526
H+ +I+HRD+K NVL++ Y KISDFG ++ AG +N T GT YMA
Sbjct: 125 HD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG----INPCTETFTGTLQYMA 177
Query: 527 PEYAMEGL--YSIKSDVFSFGVLLIEIITGR 555
PE +G Y +D++S G ++E+ TG+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 57/201 (28%), Positives = 102/201 (50%), Gaps = 22/201 (10%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
LG+G +G VYK + G+ +A+K + E+ E E+ ++ + +VK G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN------IVNGIVKGILYLHEDSR 474
+ +V E+ S+ I+ + +K + I+ +KG+ YLH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIM-------KIT-NKTLTEEEIAAILYQTLKGLEYLH---S 117
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
+ IHRD+KA N+LL+ + K++DFG++ + + NT ++GT +MAPE E
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIG 175
Query: 535 YSIKSDVFSFGVLLIEIITGR 555
Y+ K+D++S G+ IE+ G+
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKN 411
+F N +G+G FG V+K V +D + A+K+ LS + + E +E ++ KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL---LCWSKRINIVNGIVKGILY 468
+++ +D + +V E+ N L +L R R L W I I+ G+ +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL----LGLAH 116
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
LH +I+HRD+K+ N+ LD N KI D G+A++ + + NT IVGT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITGR 555
+ Y+ KSDV++ GV+L E TG+
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT----NEVLLILKLQHKNLVKLL 416
+G+G +G VYK G+ +A+K++ E F E+ L+ KL+H N+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 417 GFCVDGDEK--LLVYEFMPNSSLDAILFDPRKR----GLLCWSKRINIVNGIVKGILYLH 470
+ +V+E+M + L +L P + + C+ K++ ++G+ YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHD-LTGLLDSPEVKFTESQIKCYMKQL------LEGLQYLH 117
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
+ I+HRD+K SN+L++ D K++DFG+AR + T R++ T Y PE
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173
Query: 531 M-EGLYSIKSDVFSFGVLLIEIITGR 555
+ Y + D++S G +L E+ G+
Sbjct: 174 LGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-26
Identities = 69/198 (34%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V+ G + ++AVK L + + F E ++ KL+H LV+L + V
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 422 GDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
+E + +V E+M SL L D R L +++ + G+ Y+ R+ IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKL-PNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLYSIK 538
DL+++N+L+ + KI+DFG+AR+ +E TAR + + APE A+ G ++IK
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 539 SDVFSFGVLLIEIITGRR 556
SDV+SFG+LL E++T R
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
LG G FG V+ G ++A+K R + SE +F E +++KL H NLV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
+V E+M N L L ++G L +++ + + + + YL + IH
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 480 RDLKASNVLLDYDMNPKISDFGMARI-----FAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
RDL A N L+ D K+SDFG+AR + S+G + + PE
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK------WAPPEVFDYSR 177
Query: 535 YSIKSDVFSFGVLLIEIITG 554
+S KSDV+SFGVL+ E+ +
Sbjct: 178 FSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 362 LGQGGFGPVYKGVL------SDGKEIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG+G FG VYKG L +A+K L + + EF E L+ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 415 LLGFCVDGDEKLLVYEFM-------------PNSSLDAILFDPRKRGLLCWSKRINIVNG 461
LLG C +++E++ P+S + A D + L S ++I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVG 520
I G+ YL S +HRDL A N L+ + KISDFG++R I++ V + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 521 TYGYMAPEYAMEGLYSIKSDVFSFGVLLIEI 551
+M PE + G ++ +SD++SFGV+L EI
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 68/198 (34%), Positives = 110/198 (55%), Gaps = 13/198 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LGQG FG V+ G + +A+K L + A F E ++ KL+H+ LV+L + V
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 422 GDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
+E + +V E+M SL L L + +++ I G+ Y+ R+ +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLYSIK 538
DL+A+N+L+ ++ K++DFG+AR+ +E TAR + + APE A+ G ++IK
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 539 SDVFSFGVLLIEIITGRR 556
SDV+SFG+LL E+ T R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 71/211 (33%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 362 LGQGGFGPVYKGV---LSDGKE---IAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V+ LS K+ +AVK L + +F E L+ LQH+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDA----------ILFD--PRK-RGLLCWSKRINIVNGI 462
G C DGD ++V+E+M + L+ IL D PR+ +G L S+ ++I + I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY 522
G++YL + +HRDL N L+ ++ KI DFGM+R ++ +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 523 GYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+M PE M ++ +SDV+SFGV+L EI T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 9e-25
Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 52/285 (18%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAE-----FTNEVLLILKLQ 408
N+ +LGQG FG VY D G+E+AVK++ + + E+ L+ LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 409 HKNLVKLLGFCVDGDEKLLVY-EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
H+ +V+ G C+ DE L ++ E+MP S+ L + G L + I++G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVE 118
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA-RIFAGSEGEVNTARIVGTYGYMA 526
YLH + I+HRD+K +N+L D N K+ DFG + R+ + GT +M+
Sbjct: 119 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586
PE Y K+DV+S G ++E++T P W E A+
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLT-------------EKPP--------WAEFEAMA 214
Query: 587 LI--------DPLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPT 621
I +P L SPD FLR E+A RP+
Sbjct: 215 AIFKIATQPTNPQLPSHVSPDARNFLR------RTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 73/201 (36%), Positives = 112/201 (55%), Gaps = 19/201 (9%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LGQG FG V+ G + ++A+K L + A F E ++ KL+H LV L + V
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 422 GDEKL-LVYEFMPNSSLDAILFDPRKRG---LLCWSKRINIVNGIVKGILYLHEDSRLRI 477
+E + +V EFM SL D K G L + +++ I G+ Y+ R+
Sbjct: 71 SEEPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLY 535
IHRDL+A+N+L+ ++ KI+DFG+AR+ +E TAR + + APE A+ G +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRF 180
Query: 536 SIKSDVFSFGVLLIEIITGRR 556
+IKSDV+SFG+LL E++T R
Sbjct: 181 TIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 26/212 (12%)
Query: 361 MLGQGGFGPVYKGVLS--DGK--EIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVK 414
+LG+G FG V +G LS DG ++AVK +L + EF +E + H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 415 LLGFCVDGDEK------LLVYEFMPNSSLDAILFDPRKRGL---LCWSKRINIVNGIVKG 465
L+G C + +++ FM + L + L R GL L + + I G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGS---EGEVNTARIVGT 521
+ YL S IHRDL A N +L DM ++DFG+++ I++G +G + +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
++A E + +Y+ KSDV++FGV + EI T
Sbjct: 180 -KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 72/195 (36%), Positives = 105/195 (53%), Gaps = 12/195 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V+ G ++ ++AVK L + A F E L+ LQH LV+L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 422 GDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
+ ++ E+M SL D + D + LL K I+ I +G+ Y+ R IHR
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLYSIK 538
DL+A+NVL+ + KI+DFG+AR+ +E TAR + + APE G ++IK
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 539 SDVFSFGVLLIEIIT 553
SDV+SFG+LL EI+T
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 70/203 (34%), Positives = 113/203 (55%), Gaps = 20/203 (9%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEI----AVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVK 414
+LG G FG VYKG+ + +G+ + A+K L+ + + N EF +E L++ + H +LV+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPR----KRGLLCWSKRINIVNGIVKGILYLH 470
LLG C+ +L V + MP+ L + + + + LL W +I KG++YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
E R++HRDL A NVL+ + KI+DFG+AR+ G E E N +MA E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 531 MEGLYSIKSDVFSFGVLLIEIIT 553
++ +SDV+S+GV + E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 76/265 (28%), Positives = 115/265 (43%), Gaps = 50/265 (18%)
Query: 362 LGQGGFGPVYKGVL-SDGKEIAVKRLSS---CSEQGNAEFTNEVLLILKL-QHKNLVKLL 416
+G+G F V KE A+K L E+ E ++ +L H ++KL
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 417 GFCVDGDEKL-LVYEFMPNSSL-DAILFDPRKRGLLCWSKRI--NIVNGIVKGILYLHED 472
+ +E L V E+ PN L I RK G ++ I+ + YLH
Sbjct: 69 -YTFQDEENLYFVLEYAPNGELLQYI----RKYG--SLDEKCTRFYAAEILLALEYLH-- 119
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF---------------AGSEGEVNTAR 517
IIHRDLK N+LLD DM+ KI+DFG A++ S+ E N R
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 518 ---IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL--- 571
VGT Y++PE E SD+++ G ++ +++TG+ F RG+
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK--PPF---RGSNEYLTFQK 233
Query: 572 ---LAYAW-HLWNEGNALDLIDPLL 592
L Y++ + +A DLI+ LL
Sbjct: 234 ILKLEYSFPPNFPP-DAKDLIEKLL 257
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 354 SNFSDSNMLGQGGFGPVY----KGVLSDGKE--IAVKRLSSCSEQG-NAEFTNEVLLILK 406
SN + LG+G FG V+ KG+ +G E + VK L ++ +EF E+ + K
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 407 LQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL------FDPRKRGLLCWSKRINIVN 460
L HKN+V+LLG C + + ++ E+ L L + K L +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG 520
I G+ +L S R +HRDL A N L+ K+S +++ SE ++
Sbjct: 125 QIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 521 TYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
++APE E +S KSDV+SFGVL+ E+ T
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 67/228 (29%), Positives = 111/228 (48%), Gaps = 28/228 (12%)
Query: 351 VATSNFSDSNM---LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT--NEVLLI 404
S D + LG+G FG VYK + G+ +A+K++ +E+ T E+ ++
Sbjct: 2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKIL 61
Query: 405 LKLQHKNLVKLLGFCVD-----GDEKLLVYEFMP--NSSLDAILFDPRKRGLLCWSKRIN 457
KL+H N+V L+ V+ ++ VY P + L +L +P + K
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK--C 119
Query: 458 IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG------SEG 511
+ +++GI YLHE+ I+HRD+KA+N+L+D KI+DFG+AR + G G
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 512 EVNTAR---IVGTYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
T + +V T Y PE + E Y+ D++ G + E+ T R
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 24/204 (11%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT----NEVLLILKLQHKNLVKLL 416
LG+G +G VYK G+ +A+K++ + E+ L+ +L+H N+VKLL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRL--DNEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIV----KGILYLHED 472
+ LV+E+ + L L D R L N++ I+ +G+ Y H
Sbjct: 65 DVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPL-----SPNLIKSIMYQLLRGLAYCH-- 115
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM- 531
S RI+HRDLK N+L++ D K++DFG+AR F G T +V T Y APE +
Sbjct: 116 SH-RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILLG 172
Query: 532 EGLYSIKSDVFSFGVLLIEIITGR 555
YS D++S G + E+ITG+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 83/302 (27%), Positives = 133/302 (44%), Gaps = 60/302 (19%)
Query: 362 LGQGGFGPVYK----GVLSDGKE--IAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVK 414
+GQG FG V++ G+L +AVK L S A+F E L+ + H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 415 LLGFCVDGDEKLLVYEFM--------------------PNSSLDAILFDPRKRGLLCWSK 454
LLG C G L++E+M +S+ A L C ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC-TE 131
Query: 455 RINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFA-----G 508
++ I + G+ YL E + +HRDL N L+ +M KI+DFG++R I++
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATA 568
SE + R +M PE Y+ +SDV+++GV+L EI + G G
Sbjct: 189 SENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS----YGMQPYYGMAH 238
Query: 569 PNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628
++ Y +GN L +C + L ++ LC + DRP+ +S+ +
Sbjct: 239 EEVIYYV----RDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRI 285
Query: 629 LQ 630
LQ
Sbjct: 286 LQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 67/203 (33%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 362 LGQGGFGPVYKG--VLSDGKEI--AVKRLSSCSEQGN-AEFTNEVLLILKLQHKNLVKLL 416
LG G FG V +G S GK I AVK L S +F E ++ L H+NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKR----GLLC-WSKRINIVNGIVKGILYLHE 471
G + ++V E P SL L LC ++ +I G+ YL
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI------ANGMRYLES 115
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVGTYGYMAPEYA 530
R IHRDL A N+LL D KI DFG+ R + + V + + + APE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172
Query: 531 MEGLYSIKSDVFSFGVLLIEIIT 553
+S SDV+ FGV L E+ T
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 3e-23
Identities = 84/282 (29%), Positives = 129/282 (45%), Gaps = 27/282 (9%)
Query: 362 LGQGGFGPV----YKGVLSD-GKEIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V Y G+ +AVK L C +Q + + E+ ++ L H+N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 416 LGFCVDGDEK--LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
G C + K L+ E++P SL L P+ + L ++ + I +G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHK--LNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG-----YMAPE 528
IHRDL A NVLLD D KI DFG+A+ A EG V G + A E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYR--VREDGDSPVFWYAVE 180
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588
E +S SDV+SFGV L E++T + QS ++ ++L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT---HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237
Query: 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ + C + + C + +A RPT S++ +L+
Sbjct: 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 84/291 (28%), Positives = 132/291 (45%), Gaps = 34/291 (11%)
Query: 350 DVATSNFSDSNMLGQGGFGPVY----KGVLSDGKE--IAVKRLS-SCSEQGNAEFTNEVL 402
+VA + S LGQG FG VY KGV+ D E +A+K ++ + S + EF NE
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 403 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKR-------GLLCWSKR 455
++ + ++V+LLG G L++ E M L + L R K
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
I + I G+ YL+ + + +HRDL A N ++ D KI DFGM R ++
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575
+ + +M+PE +G+++ SDV+SFGV+L EI T +G + +L +
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----LAEQPYQGMSNEQVLRFV 234
Query: 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626
EG LD P D C PD + +C Q + RP+ ++
Sbjct: 235 M----EGGLLD--KP---DNC-PDMLFELMR---MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVK----------RLSSCSEQGNAEFTNEVLLILKLQH 409
++G+G +G VY + ++ G+ +AVK R S + +E+ + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
N+V+ LGF + + E++P S+ + L R G +++G+ YL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE- 528
H I+HRDLKA N+L+D D KISDFG+++ + G+ +MAPE
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 529 -YAMEGLYSIKSDVFSFGVLLIEIITGRR 556
++ YS K D++S G +++E+ GRR
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 17/203 (8%)
Query: 361 MLGQGGFGPVYK---GVLSD--GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V L D G+ +AVK+L + + +F E+ ++ LQH N+VK
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 416 LGFCVD-GDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
G C G L LV E++P SL L R+R L K + + I KG+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYL---G 125
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG---TYGYMAPEYA 530
R +HRDL N+L++ + KI DFG+ ++ + E R G + Y APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWY-APESL 183
Query: 531 MEGLYSIKSDVFSFGVLLIEIIT 553
E +S+ SDV+SFGV+L E+ T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 70/195 (35%), Positives = 108/195 (55%), Gaps = 14/195 (7%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
+G+G FG V +G + G+++AVK + C A F E ++ KL HKNLV+LLG +
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQA-FLEETAVMTKLHHKNLVRLLGVILH 70
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
+ +V E M +L L R R L+ + + + +G+ YL +++HRD
Sbjct: 71 -NGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDV 541
L A N+L+ D K+SDFG+AR GS G V+ +++ + APE +S KSDV
Sbjct: 126 LAARNILVSEDGVAKVSDFGLAR--VGSMG-VDNSKL--PVKWTAPEALKHKKFSSKSDV 180
Query: 542 FSFGVLLIEIIT-GR 555
+S+GVLL E+ + GR
Sbjct: 181 WSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 6e-23
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 362 LGQGGFGPVYKGVL------SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V+ D +AVK L S+ +F E L+ LQH+++VK
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 416 LGFCVDGDEKLLVYEFMPNSSL---------DAILF---DPRKRGLLCWSKRINIVNGIV 463
G CV+GD ++V+E+M + L DA+L + L S+ ++I I
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE--LTQSQMLHIAQQIA 130
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
G++YL + +HRDL N L+ ++ KI DFGM+R ++ +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+M PE M ++ +SDV+S GV+L EI T
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS--SCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G FG V K SDGK + K + + +E+ + +EV ++ +L+H N+V+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 419 CVDGDEKLL--VYEFMPNSSLDAILFDPRK-RGLLCWSKRINIVNGIVKGILYLH--EDS 473
+D + L V E+ L ++ +K R + I+ ++ + H D
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
++HRDLK +N+ LD + N K+ DFG+A+I T VGT YM+PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYYMSPEQLNHM 185
Query: 534 LYSIKSDVFSFGVLLIEIITGR 555
Y KSD++S G L+ E+
Sbjct: 186 SYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-23
Identities = 78/269 (28%), Positives = 126/269 (46%), Gaps = 28/269 (10%)
Query: 360 NMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+ LG G +G VY+GV +AVK L + + EF E ++ +++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
C ++ EFM +L L + R + + + I + YL + + I
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLYS 536
HRDL A N L+ + K++DFG++R+ G+ TA + + APE +S
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 537 IKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTC 596
IKSDV++FGVLL EI T G + G L+ + L +G ++ P + C
Sbjct: 184 IKSDVWAFGVLLWEIAT----YGMSPYPGID----LSQVYELLEKGYRME--RP---EGC 230
Query: 597 SPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625
P + + C Q + DRP+ + +
Sbjct: 231 PPKVY----ELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 70/201 (34%), Positives = 105/201 (52%), Gaps = 12/201 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G G VY + L + +++A+KR L C + E EV + + H N+VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYYTS 67
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
V GDE LV ++ SL I+ RG L + ++ ++KG+ YLH + + I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---I 124
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR--IVGTYGYMAPEYAMEGL-- 534
HRD+KA N+LL D + KI+DFG++ A R VGT +MAPE ME +
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHG 183
Query: 535 YSIKSDVFSFGVLLIEIITGR 555
Y K+D++SFG+ IE+ TG
Sbjct: 184 YDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-22
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 2/90 (2%)
Query: 158 YRSVVNNTLNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKA 217
+ S +N L++L+ AA S + +A G DT+Y L QC DLSA DC +CL A
Sbjct: 19 FESNLNALLSSLSSNAASS-SGKGFAAGTSG-AAPDTVYGLAQCRGDLSASDCRSCLATA 76
Query: 218 IADILSCCYFSRGARLLSRSCYLRYELYAF 247
++++ CC +G R+ SC+LRYE Y F
Sbjct: 77 VSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 3e-22
Identities = 67/206 (32%), Positives = 109/206 (52%), Gaps = 13/206 (6%)
Query: 355 NFSDSNMLGQGGFGPVYK-GVLSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKN 411
+F LG+G +G VYK LSD + A+K L S S++ + NE+ ++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGILYLH 470
++ +DG++ +V E+ P L + +K+ L + I I +++G+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI-VGTYGYMAPEY 529
E +I+HRDLK++N+LL + KI D G++++ N A+ +GT YMAPE
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKK-----NMAKTQIGTPHYMAPEV 172
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGR 555
YS KSD++S G LL E+ T
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 61/214 (28%), Positives = 116/214 (54%), Gaps = 12/214 (5%)
Query: 350 DVATSNFSDSNMLGQGGFGPVYKGVLS-DGKE---IAVKRLSS-CSEQGNAEFTNEVLLI 404
++ S+ + ++G G FG V++G+L G++ +A+K L +E+ +F +E ++
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 405 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK 464
+ H N+++L G +++ E+M N +LD L D G + + ++ GI
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAA 118
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS-EGEVNTARIVGTYG 523
G+ YL S + +HRDL A N+L++ ++ K+SDFG++R+ EG T+
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR 175
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRR 556
+ APE ++ SDV+SFG+++ E+++ G R
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 65/199 (32%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 362 LGQGGFGPVYKGVLSD-GKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLG 417
LG+GGFG V + GK A K+L +G NE IL+ + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKK-ILEKVSSRFIVSLA 59
Query: 418 FCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
+ + + L LV M L +++ + G ++ I I+ G+ +LH + R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGF-PEARAIFYAAQIICGLEHLH---QRR 115
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
I++RDLK NVLLD N +ISD G+A G+ R GT GYMAPE +Y
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL--KGGKKIKGR-AGTPGYMAPEVLQGEVYD 172
Query: 537 IKSDVFSFGVLLIEIITGR 555
D F+ G L E+I GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 5e-22
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN-----EVLLILKLQHKNLVKL 415
LG+G + VYK G+ +A+K++ + + N E+ L+ +L+H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
L LV+EFM + L+ ++ D K +L + + + ++G+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFME-TDLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLH---SN 121
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-- 533
I+HRDLK +N+L+ D K++DFG+AR F GS T ++V T Y APE G
Sbjct: 122 WILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPELLF-GAR 178
Query: 534 LYSIKSDVFSFGVLLIEIITGR 555
Y + D++S G + E++
Sbjct: 179 HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 362 LGQGGFGPVYK-GVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILK----LQHKNLVKLL 416
+G+G G V+K G+ +A+K++ + N+ L +K QH +VKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G +LV E+MP S L +L D + K + ++KG+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NG 119
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE--YAMEGL 534
I+HRDLK +N+L+ D KI+DFG+AR+F+ E + + + V T Y APE Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGARK- 177
Query: 535 YSIKSDVFSFGVLLIEIITGR 555
Y D+++ G + E++ G
Sbjct: 178 YDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-22
Identities = 80/292 (27%), Positives = 129/292 (44%), Gaps = 48/292 (16%)
Query: 362 LGQGGFGPVYKGVLSDGK------EIAVKRLSSCSEQGN-AEFTNEVLLILKLQHKNLVK 414
LG+G FG V K K +AVK L + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG---------------------LLCWS 453
L G C LL+ E+ SL + L + RK G L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
I+ I +G+ YL E ++++HRDL A NVL+ KISDFG++R + V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLA 573
++ +MA E + +Y+ +SDV+SFGVLL EI+T G N G L
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGNPYPGIAPERL-- 238
Query: 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625
++L G ++ + CS + + ++ L C +++ RPT + +
Sbjct: 239 --FNLLKTGYRME-----RPENCSEEMY----NLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 356 FSDSNMLGQGGFGPVYKGV-LSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKNL 412
F+ +G+G FG VYK + + +A+K L +E + E+ + + + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYI 61
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
K G + G + ++ E+ S D K G L + I+ ++ G+ YLHE+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI-----VGTYGYMAP 527
IHRD+KA+N+LL + + K++DFG++ G++ + VGT +MAP
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAP 167
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITG 554
E + Y K+D++S G+ IE+ G
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 9e-22
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSS--CSEQGN-AEFTNEVLLILKLQHK 410
+F ++G+G FG V D K++ A+K ++ C E+G+ NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 411 NLVKL-LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
LV L F D + LV + + L L +K + I IV + YL
Sbjct: 61 FLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYL 116
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
H IIHRD+K N+LLD + I+DF +A + T GT GYMAPE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGYMAPEV 170
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGRR 556
YS+ D +S GV E + G+R
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 9e-22
Identities = 73/206 (35%), Positives = 109/206 (52%), Gaps = 33/206 (16%)
Query: 362 LGQGGFGPVYK------GVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG G FG VYK G L+ K I K SE+ ++ E+ ++ H +VKL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 416 LG-FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
LG F DG +++ EF P ++DAI+ + RGL ++ I +++ + YLH
Sbjct: 75 LGAFYWDGKLWIMI-EFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS--- 128
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR----IVGTYGYMAPEYA 530
++IIHRDLKA NVLL D + K++DFG+ S V T + +GT +MAPE
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGV------SAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 531 M-----EGLYSIKSDVFSFGVLLIEI 551
M + Y K+D++S G+ LIE+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 9e-22
Identities = 81/272 (29%), Positives = 129/272 (47%), Gaps = 30/272 (11%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V+ + ++AVK + S A F E ++ LQH LVKL V
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 422 GDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
+ ++ EFM SL D + D + L K I+ I +G+ ++ + + IHR
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIHR 126
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLYSIK 538
DL+A+N+L+ + KI+DFG+AR+ +E TAR + + APE G ++IK
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 539 SDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSP 598
SDV+SFG+LL+EI+T G G + P ++ + + C P
Sbjct: 184 SDVWSFGILLMEIVT----YGRIPYPGMSNPEVIRALERGYRMPR---------PENC-P 229
Query: 599 DEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+E +I + C + +RPT + +L
Sbjct: 230 EELY---NIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 62/206 (30%), Positives = 110/206 (53%), Gaps = 12/206 (5%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEI----AVKRL-SSCSEQGNAEFTNEVLLILKL 407
+ F +LG G FG VYKG+ + +G+++ A+K L + S + N E +E ++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 408 QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
+ ++ +LLG C+ +L + + MP L + + + + +N I KG+
Sbjct: 67 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMN 123
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YL E R++HRDL A NVL+ + KI+DFG+A++ E E + +MA
Sbjct: 124 YLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIIT 553
E + +Y+ +SDV+S+GV + E++T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 66/196 (33%), Positives = 104/196 (53%), Gaps = 14/196 (7%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV+LLG V+
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 422 GDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
L +V E+M SL L R R +L + + + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSD 540
DL A NVL+ D K+SDFG+ + + ++ +T ++ + APE E +S KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 541 VFSFGVLLIEIIT-GR 555
V+SFG+LL EI + GR
Sbjct: 182 VWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 359 SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNA--EFTNEVLLILKLQHKNLVKL 415
N +G G FG VY V L G+ +AVK + E +E+ ++ L+H NLVK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
G V ++ + E+ +L+ +L R +++G+ YLH
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV---YTLQLLEGLAYLHSH--- 118
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE----GEVNTARIVGTYGYMAPEYAM 531
I+HRD+K +N+ LD++ K+ DFG A + EV + + GT YMAPE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS--LAGTPAYMAPEVIT 176
Query: 532 EGLYSIK---SDVFSFGVLLIEIITGRR 556
G +D++S G +++E+ TG+R
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 361 MLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAE----FTNEVLLILKLQHKNLVKLL 416
+LG+G FG V+KG L D +AVK +C E E F +E ++ + H N+VKL+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G C +V E +P D + F +K+ L + + G+ YL +
Sbjct: 59 GVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--- 113
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMAR-----IFAGSEGEVNTARIVGTYGYMAPEYAM 531
IHRDL A N L+ + KISDFGM+R I++ S + + + APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPEALN 167
Query: 532 EGLYSIKSDVFSFGVLLIEIIT 553
G YS +SDV+S+G+LL E +
Sbjct: 168 YGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 64/194 (32%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
LG G FG V+ G ++A+K + SE+ +F E +++KL H LV+L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
+V EFM N L + + +++G L +++ + +G+ YL +S IH
Sbjct: 69 TQQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 480 RDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKS 539
RDL A N L+ K+SDFGM R E +++ + PE YS KS
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 540 DVFSFGVLLIEIIT 553
DV+SFGVL+ E+ T
Sbjct: 183 DVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-21
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNA--EFTNEVLLILKLQHKNLV 413
F+ +G+G FG VYKG+ + KE+ ++ E + + E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+ G + G + ++ E++ S D K G L + I+ I+KG+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSA----LDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
R IHRD+KA+NVLL + K++DFG+A ++ + NT VGT +MAPE +
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 534 LYSIKSDVFSFGVLLIEIITG 554
Y K+D++S G+ IE+ G
Sbjct: 177 AYDFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 7e-21
Identities = 84/299 (28%), Positives = 132/299 (44%), Gaps = 38/299 (12%)
Query: 362 LGQGGFGPVYKGVLSD------GKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQHKNLVK 414
LGQG FG VY+G D +AVK ++ S S + EF NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILF-------DPRKRGLLCWSKRINIVNGIVKGIL 467
LLG G L+V E M + L + L + R + I + I G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YL+ + +HRDL A N ++ +D KI DFGM R ++ + + +MAP
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587
E +G+++ SD++SFGV+L EI + +G + +L + +G LD
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS----LAEQPYQGLSNEQVLKFVM----DGGYLD- 241
Query: 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSF 646
P D C R + +C Q + RPT +V +L+ + P P SF
Sbjct: 242 -QP---DNCPE----RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL----HPSFPEVSF 288
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 62/199 (31%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKNLVKLLGF 418
+G+G +G VYK G+ +A+K++ E T E+ L+ +L H N++KLL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
+ LV+EFM ++ L ++ D ++ L S + + +++G+ + H I+
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCH---SHGIL 120
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE--YAMEGLYS 536
HRDLK N+L++ + K++DFG+AR F GS T +V T Y APE +G YS
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVV-TRWYRAPELLLGDKG-YS 177
Query: 537 IKSDVFSFGVLLIEIITGR 555
D++S G + E+++ R
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 56/200 (28%), Positives = 107/200 (53%), Gaps = 15/200 (7%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGN-AEFTNEVLLILKLQH---KNLVKL 415
++G+G +G VY+G + G+ +A+K ++ + + ++ EV L+ +L+ N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
G + G ++ E+ S+ ++ K G + I+ ++ + Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-L 534
+IHRD+KA+N+L+ N K+ DFG+A + + + +T VGT +MAPE EG
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVITEGKY 178
Query: 535 YSIKSDVFSFGVLLIEIITG 554
Y K+D++S G+ + E+ TG
Sbjct: 179 YDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
LG G FG V G ++A+K + S SE EF E +++KL H+ LV+L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
+V E+M N L L + KR S+ + + + +G+ YL + IH
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 480 RDLKASNVLLDYDMNPKISDFGMARI-----FAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
RDL A N L+D K+SDFG++R + S G R + PE +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSK 177
Query: 535 YSIKSDVFSFGVLLIEIIT 553
+S KSDV++FGVL+ E+ +
Sbjct: 178 FSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 354 SNFSDSNMLGQGGFGPVYKG-VLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL 412
S + +G+G G V S G+++AVK++ +Q NEV+++ QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
V++ + GDE +V EF+ +L I+ R + + + ++K + +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ 134
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR--IVGTYGYMAPEYA 530
+IHRD+K+ ++LL D K+SDFG F + R +VGT +MAPE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 531 MEGLYSIKSDVFSFGVLLIEIITG 554
Y + D++S G+++IE++ G
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 59/196 (30%), Positives = 107/196 (54%), Gaps = 14/196 (7%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEF-TNEVLLILKLQHKNLVKLLGFC 419
+GQG G VY + ++ G+E+A+K++ + +Q E NE+L++ + +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 420 VDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
+ GDE +V E++ SL D + G + + ++ + +LH + ++I
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSN---QVI 137
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIK 538
HRD+K+ N+LL D + K++DFG + + +T +VGT +MAPE Y K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 195
Query: 539 SDVFSFGVLLIEIITG 554
D++S G++ IE++ G
Sbjct: 196 VDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 17/202 (8%)
Query: 362 LGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLL-GFC 419
LG G FG VYK + A K + SE+ +F E+ ++ + +H N+V L +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIV-NGIVKGILYLHEDSRLRII 478
+ +L+ EF +LD+I+ +RGL +I V +++ + +LH ++I
Sbjct: 73 YENKLWILI-EFCDGGALDSIM-LELERGLT--EPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-----EG 533
HRDLKA N+LL D + K++DFG++ + + +T +GT +MAPE +
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDN 183
Query: 534 LYSIKSDVFSFGVLLIEIITGR 555
Y K+D++S G+ LIE+
Sbjct: 184 PYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 40/281 (14%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSC----SEQGNA--EFTNEVLLILKL 407
+ LG G F Y+ + G +AVK+++ SEQ E+ L+ +L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 408 QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
H +++++LG + L E+M S+ +L K G + IN +++G+
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLS 117
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGS---EGEVNTARIVGTYG 523
YLHE+ +IIHRD+K +N+L+D +I+DFG A A GE +++GT
Sbjct: 118 YLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ-GQLLGTIA 173
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583
+MAPE Y DV+S G ++IE+ T + P W+ N
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK------------PP------WNAEKHSN 215
Query: 584 ALDLIDPLLTDTCSPD--EFLR--YIHIGLLCVQEDAFDRP 620
L LI + + T +P E L + L C++ DRP
Sbjct: 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEI----AVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVK 414
+LG G FG V+KG+ + +G I A+K + S Q E T+ +L + L H +V+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
LLG C G LV + P SL + + R L + +N I KG+ YL E
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSL--LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
R++HR+L A N+LL D +I+DFG+A + + + + +MA E + G
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187
Query: 535 YSIKSDVFSFGVLLIEIIT 553
Y+ +SDV+S+GV + E+++
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 68/221 (30%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 352 ATSNFSD---SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE------FTNEV 401
A + S+ N +G G G VYK + G+ A+K + GN E E+
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREI 123
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI--NIV 459
++ + H N+VK E ++ EFM SL+ G ++ ++
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE---------GTHIADEQFLADVA 174
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV 519
I+ GI YLH R I+HRD+K SN+L++ N KI+DFG++RI A + N++ V
Sbjct: 175 RQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--V 229
Query: 520 GTYGYMAPEYA----MEGLYS-IKSDVFSFGVLLIEIITGR 555
GT YM+PE G Y D++S GV ++E GR
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 67/208 (32%), Positives = 113/208 (54%), Gaps = 21/208 (10%)
Query: 356 FSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSC-SEQGNAEFT-NEVLLILKLQ---H 409
+ + +G+G +G VYK L+ G+ +A+K++ SE+G T E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 410 KNLVKLLGFC--VDGDEKL---LVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIV 463
N+V+LL C D +L LV+E + + L L K GL + I +++ ++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLP--PETIKDLMRQLL 117
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
+G+ +LH RI+HRDLK N+L+ D KI+DFG+ARI+ E+ +V T
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLW 171
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEI 551
Y APE ++ Y+ D++S G + E+
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 7e-20
Identities = 84/277 (30%), Positives = 132/277 (47%), Gaps = 44/277 (15%)
Query: 356 FSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN---EVLLILKLQHKN 411
FSD +G G FG VY + + + +A+K++S +Q N ++ + EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINI---VNGIVKGILY 468
++ G + LV E+ S+ D L + K+ L + + I +G ++G+ Y
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPL----QEVEIAAVTHGALQGLAY 130
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
LH + +IHRD+KA N+LL K+ DFG A I A + VGT +MAPE
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPE 181
Query: 529 YAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL-WNEGNA 584
+ EG Y K DV+S G+ IE + R+ FN N ++ +H+ NE
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNM-------NAMSALYHIAQNE--- 230
Query: 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621
P L + F ++ C+Q+ DRPT
Sbjct: 231 ----SPALQSGHWSEYFRNFVDS---CLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQ 408
NF +G+G F VYK + L DG+ +A+K++ + + E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGIL 467
H N++K L ++ +E +V E L ++ +K+ L + I + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
++H RI+HRD+K +NV + K+ D G+ R F S +VGT YM+P
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSP 175
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEI 551
E E Y+ KSD++S G LL E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 87/300 (29%), Positives = 139/300 (46%), Gaps = 50/300 (16%)
Query: 333 RDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCSE 391
+D ++ F D E L F+D +G G FG VY E+ A+K++S +
Sbjct: 10 KDPEIAELFFKEDPEKL------FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 63
Query: 392 QGNAEFTN---EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG 448
Q N ++ + EV + +++H N ++ G + LV E+ S+ D L + K+
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKP 121
Query: 449 LLCWSKRINI---VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
L + + I +G ++G+ YLH + +IHRD+KA N+LL K++DFG A I
Sbjct: 122 L----QEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 506 FAGSEGEVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQ 562
+ + VGT +MAPE + EG Y K DV+S G+ IE + R+ FN
Sbjct: 175 ASPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNM 227
Query: 563 SRGATAPNLLAYAWHL-WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621
N ++ +H+ NE P L D F ++ C+Q+ DRPT
Sbjct: 228 -------NAMSALYHIAQNE-------SPTLQSNEWSDYFRNFVDS---CLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 20/203 (9%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEI----AVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
+LG G FG VYKG+ + DG+ + A+K L + S + N E +E ++ + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKR----GLLCWSKRINIVNGIVKGILYLH 470
LLG C+ +L V + MP L + + + R LL W +I KG+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
E +R++HRDL A NVL+ + KI+DFG+AR+ E E + +MA E
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 531 MEGLYSIKSDVFSFGVLLIEIIT 553
+ ++ +SDV+S+GV + E++T
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI---------AVKRL-SSCSEQGNAEFTNEVLLILKL--Q 408
LG+G FG V K + + AVK L +E+ ++ +E + ++K+ +
Sbjct: 19 PLGEGAFGQVVKA---EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE-MEMMKMIGK 74
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------- 461
HKN++ LLG C +V E+ + +L L R G S
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA-SPDDPRPPEETLTQKD 133
Query: 462 -------IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514
+ +G+ +L S+ + IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 134 LVSFAYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRK 190
Query: 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
T +MAPE + +Y+ +SDV+SFGVLL EI T
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 84/278 (30%), Positives = 132/278 (47%), Gaps = 46/278 (16%)
Query: 356 FSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGNAEFTN---EVLLILKLQHKN 411
F+D +G G FG VY E+ A+K++S +Q N ++ + EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIV---NGIVKGILY 468
++ G + LV E+ S+ D + + K+ L + + I +G ++G+ Y
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPL----QEVEIAAICHGALQGLAY 130
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR-IVGTYGYMAP 527
LH R IHRD+KA N+LL K++DFG A + V+ A VGT +MAP
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASL-------VSPANSFVGTPYWMAP 180
Query: 528 E--YAM-EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL-WNEGN 583
E AM EG Y K DV+S G+ IE + R+ FN N ++ +H+ N+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNM-------NAMSALYHIAQNDSP 232
Query: 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621
L D D F ++ C+Q+ DRP+
Sbjct: 233 TLSSND-------WSDYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 1e-19
Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 18/198 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+GQG G V+ + ++ G+E+A+K+++ + NE+L++ +L++ N+V L +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 421 DGDEKLLVYEFMPNSSLDAIL----FDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
GDE +V E++ SL ++ D + +C ++ + +LH + +
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVC--------RECLQALEFLHAN---Q 135
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
+IHRD+K+ NVLL D + K++DFG + + +T +VGT +MAPE Y
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 193
Query: 537 IKSDVFSFGVLLIEIITG 554
K D++S G++ IE++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-19
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 5/106 (4%)
Query: 34 YNTCSSSAADSGHAG--AIYSNLKKVLISLALNASAAK---FSDASSGNDSDRVYGLYMC 88
++ CSS+ + + SNL +L SL+ NA+++ F+ +SG D VYGL C
Sbjct: 1 FHLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQC 60
Query: 89 LNYISNDTCNNCITTATQDITKLCPNKTDAIVWEEVCQLRYAYGNF 134
+S C +C+ TA ++ + CPNK +W + C LRY F
Sbjct: 61 RGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106
|
This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 360 NMLGQGGFGPVYKGVL--SDGKEI--AVKRLSSCSEQGNAE-FTNEVLLILKLQHKNLVK 414
++G+G FG VY G L SDG++I AVK L+ ++ E F E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 415 LLGFCVDGD-EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
LLG C+ + L+V +M + L + + I + KG+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK- 117
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE----GEVNTARIVGTYGYMAPEY 529
+ +HRDL A N +LD K++DFG+AR E A++ +MA E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL--PVKWMALES 173
Query: 530 AMEGLYSIKSDVFSFGVLLIEIIT 553
++ KSDV+SFGVLL E++T
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 48/131 (36%), Positives = 72/131 (54%), Gaps = 19/131 (14%)
Query: 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL 489
EFM SLD I +K G + I +V+G+ YL+ RI+HRD+K SN+L+
Sbjct: 83 EFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILV 137
Query: 490 DYDMNPKISDFGMARIFAGSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSF 544
+ K+ DFG++ GE+ +T VGT YM+PE G Y++KSDV+S
Sbjct: 138 NSRGQIKLCDFGVS-------GELINSIADT--FVGTSTYMSPERIQGGKYTVKSDVWSL 188
Query: 545 GVLLIEIITGR 555
G+ +IE+ G+
Sbjct: 189 GISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 63/196 (32%), Positives = 104/196 (53%), Gaps = 14/196 (7%)
Query: 362 LGQGGFGPV-YKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G+G G V V S GK +AVK++ +Q NEV+++ QH+N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVN-GIVKGILYLHEDSRLRIIH 479
GDE +V EF+ +L I+ R ++I V ++K + LH +IH
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMN-----EEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 480 RDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR-IVGTYGYMAPEYAMEGLYSIK 538
RD+K+ ++LL +D K+SDFG A EV + +VGT +MAPE Y +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC---AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 539 SDVFSFGVLLIEIITG 554
D++S G+++IE++ G
Sbjct: 197 VDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 65/201 (32%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G +G VYKG G+ +A+K RL S E + E+ L+ +LQH N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 419 CVDGDEKLLVYEFMP---NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
+ L++EF+ LD++ L S I+ GI+ + H
Sbjct: 68 LMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCH---SR 120
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-L 534
R++HRDLK N+L+D K++DFG+AR F G V T +V T Y APE +
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSPR 178
Query: 535 YSIKSDVFSFGVLLIEIITGR 555
YS D++S G + E+ T +
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 362 LGQGGFGPVY----KGVLS---------DGKE--IAVKRL-SSCSEQGNAEFTNEVLLIL 405
LG+G FG V+ +G+ DG+ +AVK L + ++ +F E+ ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 406 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVN----- 460
+L++ N+++LLG CV D ++ E+M N L+ L + I V+
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 461 ----GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA 516
I G+ YL + L +HRDL N L+ KI+DFGM+R +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
R V +MA E + G ++ SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 56/198 (28%), Positives = 106/198 (53%), Gaps = 18/198 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+GQG G VY + ++ G+E+A+K+++ + NE+L++ + ++ N+V L +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 421 DGDEKLLVYEFMPNSSLDAIL----FDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
GDE +V E++ SL ++ D + +C ++ + +LH + +
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALDFLHSN---Q 135
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
+IHRD+K+ N+LL D + K++DFG + + +T +VGT +MAPE Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYG 193
Query: 537 IKSDVFSFGVLLIEIITG 554
K D++S G++ IE++ G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 68/205 (33%), Positives = 110/205 (53%), Gaps = 11/205 (5%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGN-AEFTNEVLLILKLQHKNL 412
NF LG+G + VYKG EI A+K + +E+G + E+ L+ +L+H+N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
V+L ++ +LV+E+M L + RG L + + ++KGI + HE+
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT-ARIVGTYGYMAPEYAM 531
R++HRDLK N+L++ K++DFG+AR F VNT + V T Y AP+ +
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---VNTFSNEVVTLWYRAPDVLL 173
Query: 532 EG-LYSIKSDVFSFGVLLIEIITGR 555
YS D++S G ++ E+ITGR
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 362 LGQGGFGPVYKGVL----SDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG + L D + K L+ SE+ + NE++++ LQH N++
Sbjct: 8 LGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
+D + L+ E+ +L + +K L + + IV + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVR-QKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
I+HRD+K N+ L K+ DFG+++I T +VGT YM+PE Y
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 536 SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDT 595
+ KSD+++ G +L E++T +R F+ A N L + +GN ++ +
Sbjct: 179 NFKSDIWALGCVLYELLTLKRT--FD------ATNPLNLVVKIV-QGNYTPVVSVYSS-- 227
Query: 596 CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629
E + +H +Q+D RPT V+
Sbjct: 228 ----ELISLVH---SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 25/216 (11%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLS------SCSEQGNAEFTNEVLLILK 406
+N+ +LGQG FG VY +D G+E+AVK++ S++ NA E+ L+
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKN 60
Query: 407 LQHKNLVKLLGFCVDGDEKLL--VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK 464
L H+ +V+ G D E+ L E MP S+ L + G L + I++
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILE 117
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-----IFAGSEGEVNTARIV 519
G+ YLH + I+HRD+K +N+L D N K+ DFG ++ +G+ +
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT----GMKSVT 170
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
GT +M+PE Y K+D++S G ++E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 69/203 (33%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 362 LGQGGFGPVY------KGVLSDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVK 414
LG+G FG V +G + G+++AVK L S A+ E+ ++ L H+N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 415 LLGFCV-DGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
G C DG + L+ EF+P+ SL L PR + + +++ I KG+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--G 126
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG--EVNTARIVGTYGYMAPEYA 530
SR + +HRDL A NVL++ + KI DFG+ + + V + Y APE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 531 MEGLYSIKSDVFSFGVLLIEIIT 553
++ + I SDV+SFGV L E++T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 5e-19
Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 36/273 (13%)
Query: 356 FSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGNAEFTN---EVLLILKLQHKN 411
F + +G G FG VY S E+ AVK++S +Q N ++ + EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
++ G + LV E+ S+ D L + K+ L + I +G ++G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQ-EVEIAAITHGALQGLAYLHS 139
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
+ +IHRD+KA N+LL K++DFG A + + VGT +MAPE +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVIL 190
Query: 532 ---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588
EG Y K DV+S G+ IE + R+ FN N ++ +H+ +
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNM-------NAMSALYHIAQNDS----- 237
Query: 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621
P L D F ++ C+Q+ +RP
Sbjct: 238 -PTLQSNEWTDSFRGFVD---YCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 66/202 (32%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G +G VYK G+ +A+K RL + E + E+ L+ +L H N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 419 CVDGDEKL-LVYEFMP---NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
V + KL LV+EF+ +D+ L+ K + +++GI Y H S
Sbjct: 67 -VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSY--LYQLLQGIAYCH--SH 118
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG- 533
R++HRDLK N+L+D + K++DFG+AR F G T +V T Y APE +
Sbjct: 119 -RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 534 LYSIKSDVFSFGVLLIEIITGR 555
YS D++S G + E++ R
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 8e-19
Identities = 55/198 (27%), Positives = 105/198 (53%), Gaps = 18/198 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+GQG G VY + ++ G+E+A+++++ + NE+L++ + ++ N+V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 421 DGDEKLLVYEFMPNSSLDAIL----FDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
GDE +V E++ SL ++ D + +C ++ + +LH + +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--------RECLQALEFLHSN---Q 136
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
+IHRD+K+ N+LL D + K++DFG + + + +VGT +MAPE Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYG 194
Query: 537 IKSDVFSFGVLLIEIITG 554
K D++S G++ IE+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 75/281 (26%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 361 MLGQGGFGPVYKGVLS-DGKE---IAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKL 415
++G G FG V +G L GK +A+K L S +E+ +F +E ++ + H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
G +++ EFM N +LD+ L + G + + ++ GI G+ YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG---TYGYMAPEYAME 532
+HRDL A N+L++ ++ K+SDFG++R + +G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 533 GLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591
++ SDV+S+G+++ E+++ G R Y W + N+ D+I+ +
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGER----------------PY-WDMSNQ----DVINAI 224
Query: 592 LTD--TCSPDEFLRYIHIGLL-CVQEDAFDRPTMSSVVVML 629
D P + +H +L C Q+D RP +V L
Sbjct: 225 EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 13/206 (6%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKN 411
NF +G+G +G VYK G+ +A+K RL + +E + E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 412 LVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
+VKLL + + KL LV+EF+ + L + D + + + +++G+ + H
Sbjct: 61 IVKLLD-VIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
R++HRDLK N+L++ + K++DFG+AR F G T +V T Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 531 M-EGLYSIKSDVFSFGVLLIEIITGR 555
+ YS D++S G + E++T R
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 53/178 (29%), Positives = 96/178 (53%), Gaps = 11/178 (6%)
Query: 378 GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437
G+++AVK + +Q NEV+++ QH+N+V++ + G+E ++ EF+ +L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI 497
I+ R L + + +++ + YLH +IHRD+K+ ++LL D K+
Sbjct: 106 TDIVSQTR----LNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158
Query: 498 SDFGM-ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
SDFG A+I S+ +VGT +MAPE Y + D++S G+++IE++ G
Sbjct: 159 SDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 68/215 (31%), Positives = 108/215 (50%), Gaps = 26/215 (12%)
Query: 362 LGQGGFGPVYK----GVLSDGKE----IAVKRLS-SCSEQGNAEFTNEV-LLILKLQHKN 411
LG+G FG V + G+ + +AVK L + +++ A+ +E+ L+ L +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAIL-----------FDPRK--RGLLCWSKRINI 458
++ LLG C ++ E+ +L L FD K L + ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+ +G+ YL +SR R IHRDL A NVL+ D KI+DFG+AR + T+
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MAPE + +Y+ +SDV+SFG+L+ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 57/182 (31%), Positives = 95/182 (52%), Gaps = 19/182 (10%)
Query: 378 GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437
GK++AVK++ +Q NEV+++ H+N+V + + GDE +V EF+ +L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 438 DAILFDPR----KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493
I+ R + +C S +++ + YLH +IHRD+K+ ++LL D
Sbjct: 107 TDIVTHTRMNEEQIATVCLS--------VLRALSYLHNQG---VIHRDIKSDSILLTSDG 155
Query: 494 NPKISDFGMARIFAGSEGEVNTAR-IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEII 552
K+SDFG A EV + +VGT +MAPE Y + D++S G+++IE+I
Sbjct: 156 RIKLSDFGFC---AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMI 212
Query: 553 TG 554
G
Sbjct: 213 DG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 30/212 (14%)
Query: 362 LGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGF- 418
+G+G +G VYK G+ +A+K + ++ E E ++ K H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 419 -----CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN------IVNGIVKGIL 467
+ D+ LV E S+ ++ +GL KR+ I+ ++G+
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAYILRETLRGLA 127
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YLHE+ ++IHRD+K N+LL + K+ DFG++ + G NT +GT +MAP
Sbjct: 128 YLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF--IGTPYWMAP 182
Query: 528 E-----YAMEGLYSIKSDVFSFGVLLIEIITG 554
E + Y +SDV+S G+ IE+ G
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKE---IAVKRLSS-CSEQGNAEFTNEVLLILKLQ 408
S ++G G FG V G L GK +A+K L + +E+ +F +E ++ +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD 63
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILY 468
H N++ L G ++V E+M N SLDA L + G + + ++ GI G+ Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG----- 523
L S + +HRDL A N+L++ ++ K+SDFG++R+ T R G
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPI 173
Query: 524 -YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRR 556
+ APE ++ SDV+S+G+++ E+++ G R
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 3e-18
Identities = 89/390 (22%), Positives = 162/390 (41%), Gaps = 68/390 (17%)
Query: 259 GNQASGKSNQRR-----MWMIIILAAVAAFLLLVVASTGYFFAAKKVARKRKGMVRKQIQ 313
G+ SG +R W I + AFL+L + + G+ F R R
Sbjct: 610 GDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI-----RGRNN------- 657
Query: 314 LHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLE---TLDVATSNFSDSNMLGQGGFGPV 370
L + V D + Q F + T++ S+ + N++ +G G
Sbjct: 658 -----------LELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGAS 706
Query: 371 YKG-VLSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426
YKG + +G + VK ++ S A+ KLQH N+VKL+G C
Sbjct: 707 YKGKSIKNGMQFVVKEINDVNSIPSSEIADMG-------KLQHPNIVKLIGLCRSEKGAY 759
Query: 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASN 486
L++E++ +L +L R L W +R I GI K + +LH ++ +L
Sbjct: 760 LIHEYIEGKNLSEVL-----RN-LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813
Query: 487 VLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGV 546
+++D P + + + +T + + Y+APE + KSD++ FG+
Sbjct: 814 IIIDGKDEPHLR-LSLPGLLC-----TDTKCFISS-AYVAPETRETKDITEKSDIYGFGL 866
Query: 547 LLIEIITGRRNT----GFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS--PDE 600
+LIE++TG+ G + S ++ +A + +++ + IDP + S +E
Sbjct: 867 ILIELLTGKSPADAEFGVHGS-------IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919
Query: 601 FLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ +++ L C D RP + V+ L+
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 362 LGQGGFGPV------YKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+GGFG V G + K++ KRL S + A E IL+ + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE---ILEKVNSPFIVN 57
Query: 416 LGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
L + + L LV M L +++ +RGL + I+ I GIL+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEM-ERVIHYSAQITCGILHLHS--- 113
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
+ I++RD+K NVLLD N ++SD G+A +G+ T R GT GYMAPE E
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR-AGTNGYMAPEILKEEP 170
Query: 535 YSIKSDVFSFGVLLIEIITGR 555
YS D F+ G + E++ GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 71/209 (33%), Positives = 109/209 (52%), Gaps = 39/209 (18%)
Query: 362 LGQGGFGPVYK------GVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG G FG VYK GVL+ K I K SE+ ++ E+ ++ H N+VKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTK-----SEEELEDYMVEIDILASCDHPNIVKL 67
Query: 416 L-GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIV-NGIVKGILYLHEDS 473
L F + + +L+ EF ++DA++ + +R L +I +V ++ + YLHE+
Sbjct: 68 LDAFYYENNLWILI-EFCAGGAVDAVMLE-LERPLT--EPQIRVVCKQTLEALNYLHEN- 122
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI------VGTYGYMAP 527
+IIHRDLKA N+L D + K++DFG++ NT I +GT +MAP
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAP 172
Query: 528 EYAM-----EGLYSIKSDVFSFGVLLIEI 551
E M + Y K+DV+S G+ LIE+
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 3e-18
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 361 MLGQGGFGPVYKGVLS-DGKE---IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
+LG G FG + +G L K +A+ L + CS++ F E L + + H N+V+L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
G G+ ++V E+M N +LD+ L + G L + + ++ G+ G+ YL E +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
+H+ L A VL++ D+ KIS F + SE T + APE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQ-EDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 536 SIKSDVFSFGVLLIEIIT-GRR 556
S SDV+SFG+++ E+++ G R
Sbjct: 186 SSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 4e-18
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 36/210 (17%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--------EVLLILKLQ-HKN 411
LG G FG VY G+ +A+K++ +F + EV + KL H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+VKL + DE V+E+M + L RK S +I+ I++G+ ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAHIH- 116
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN-----TARIVGTYGYMA 526
+ HRDLK N+L+ KI+DFG+AR E+ T V T Y A
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTD-YVSTRWYRA 166
Query: 527 PEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
PE + YS D+++ G ++ E+ T R
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQH-K 410
+ D +G+G FG V K + G +AVKR+ S E+ ++ ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLD---AILFDPRKRGLLCWSKRI--NIVNGIVKG 465
+VK G + + E M + SLD +++ K + I I VK
Sbjct: 64 YIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKS---VIPEEILGKIAVATVKA 119
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ YL E+ L+IIHRD+K SN+LLD + N K+ DFG++ S + R G YM
Sbjct: 120 LNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS---IAKTRDAGCRPYM 174
Query: 526 APE----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
APE A +G Y ++SDV+S G+ L E+ TG+
Sbjct: 175 APERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 25/210 (11%)
Query: 362 LGQGGFGPVYKGVLSDGKEI---AVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
LG+G FG V +G L+ I AVK +++ C+ +F +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 417 GFCVDGDEK------LLVYEFMPNSSLDAILFDPR---KRGLLCWSKRINIVNGIVKGIL 467
G C+ E +++ FM + L + L R L + + I G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA-RIFAGS---EGEVNTARIVGTYG 523
YL S IHRDL A N +L+ +MN ++DFG++ +I+ G +G + +
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV----K 179
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
++A E + +Y+ KSDV+SFGV + EI T
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 5e-18
Identities = 68/212 (32%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 355 NFSDSNMLGQGGFGPVYKGV---LSDGK---EIAVKRLSSCSEQGNAE-FTNEVLLILKL 407
N S LG G FG V + LS ++AVK L + E +E+ ++ L
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 408 -QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRK-----RGLLCWSKRINIVNG 461
H+N+V LLG C G L++ E+ L L R+ LL +S ++
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV----- 150
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
KG+ +L + IHRDL A NVLL + KI DFG+AR V
Sbjct: 151 -AKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP 206
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MAPE +Y+ +SDV+S+G+LL EI +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 5e-18
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 15/210 (7%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRL-----SSCSEQGNAEFTNEVLLILKLQ 408
N+ +LGQG FG VY D G+E+A K++ S + + + E+ L+ LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 409 HKNLVKLLGFCVDGDEKLLV--YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGI 466
H+ +V+ G D EK L E+MP S+ L + G L S I++G+
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGM 119
Query: 467 LYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA-RIFAGSEGEVNTARIVGTYGYM 525
YLH + I+HRD+K +N+L D N K+ DFG + R+ + GT +M
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 526 APEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
+PE Y K+DV+S G ++E++T +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 17/209 (8%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRL------SSCSEQGNAEFTNEVLLILKL 407
N+ +LG+G FG VY +D G+E+AVK++ S++ NA E+ L+ L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKNL 61
Query: 408 QHKNLVKLLGFCVDGDEKLL--VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG 465
+H +V+ G D +EK L E+MP S+ L + G L + I++G
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQG 118
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA-RIFAGSEGEVNTARIVGTYGY 524
+ YLH + I+HRD+K +N+L D N K+ DFG + RI + GT +
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 525 MAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
M+PE Y K+DV+S ++E++T
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 6e-18
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 362 LGQGGFGPVY---KGVLSDGKEIAVKRLSSCSEQGNAEFTN---EVLLILKLQHKNLVKL 415
+ +G +G V+ K S G A+K + + E ++ + Q +VKL
Sbjct: 1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 416 LGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
+ G + L LV E++P L ++L G L + IV + YLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVARIYIAEIVLALEYLH---S 111
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFG------MARIFAGSEGEVNTARIVGTYGYMAPE 528
IIHRDLK N+L+D + + K++DFG + R ++ E RIVGT Y+APE
Sbjct: 112 NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITG 554
+ +S D +S G +L E + G
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 24/212 (11%)
Query: 360 NMLGQGGFGPVYKGVLS-DGKEI--AVKRLSS-CSEQGNAEFTNEVLLILKL-QHKNLVK 414
+++G+G FG V + ++ DG ++ A+K L SE + +F E+ ++ KL H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAIL-------FDP---RKRGL---LCWSKRINIVNG 461
LLG C + + E+ P +L L DP ++ G L + + +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
+ G+ YL E + IHRDL A NVL+ ++ KI+DFG++R G E V
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRLP 181
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MA E +Y+ KSDV+SFGVLL EI++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 8e-18
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 362 LGQGGFGPVY------------KGVLSDGKE-----IAVKRL-SSCSEQGNAEFTNEVLL 403
LG+G FG V+ K D +AVK L ++ +F E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 404 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG--------LLCWSKR 455
+ +L+ N+++LL C+ D ++ E+M N L+ L + + +S
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVN 514
I + I G+ YL S L +HRDL N L+ + KI+DFGM+R +++G +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
R V +M+ E + G ++ SDV++FGV L EI+T
Sbjct: 190 -GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 362 LGQGGFGPVYK-GVLSDGKEIAVKRLS--SCSEQGNAEFT-NEVLLILKLQHKNLVKLLG 417
LG GGFG V V S + A+K + E G E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 418 FCVDGDEKLLVY---EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
+ D+K +Y E+ L IL R RGL + +V YLH
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTIL---RDRGLFDEYTARFYIACVVLAFEYLH---N 111
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
II+RDLK N+LLD + K+ DFG A+ + T GT Y+APE +
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKG 168
Query: 535 YSIKSDVFSFGVLLIEIITGR 555
Y D +S G+LL E++TGR
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 39/232 (16%)
Query: 349 LDVATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSCSEQG-NAEFTNEV 401
++++T F + LG+ FG VYKG L + +A+K L +E EF +E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILF-------------DPRKRG 448
++ +LQH N+V LLG +++ + +S L L D +
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 449 LLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508
L + ++IV I G+ +L S ++H+DL NVL+ +N KISD G+ R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR---- 172
Query: 509 SEGEVNTARIVGTYG-------YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
EV A G +M+PE M G +SI SD++S+GV+L E+ +
Sbjct: 173 ---EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 13/202 (6%)
Query: 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNA--EFTNEVLLILKLQHKNLV 413
F+ +G+G FG V+KG+ + +++ ++ E + + E+ ++ + +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 414 KLLGFCVDGDEKLLVYEFMPN-SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
K G + G + ++ E++ S+LD + P + ++ I+KG+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHSE 120
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
+ IHRD+KA+NVLL + K++DFG+A ++ + NT VGT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQ 175
Query: 533 GLYSIKSDVFSFGVLLIEIITG 554
Y K+D++S G+ IE+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 360 NMLGQGGFGPVYKGVLS-DGKEI--AVKRLSS-CSEQGNAEFTNEVLLILKL-QHKNLVK 414
+++G+G FG V K + DG + A+KR+ S+ + +F E+ ++ KL H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAIL-------FDP---RKRGL---LCWSKRINIVNG 461
LLG C L E+ P+ +L L DP L + ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
+ +G+ YL + + IHRDL A N+L+ + KI+DFG++R G E V
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 174
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MA E +Y+ SDV+S+GVLL EI++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 39/226 (17%)
Query: 362 LGQGGFGPVYKGVLSDGKE-----------------IAVKRL-SSCSEQGNAEFTNEVLL 403
LG+G FG V+ + + ++ +AVK L ++ +F EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 404 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL--------------FDPRKRGL 449
+ +L+ N+++LLG CVD D ++ E+M N L+ L P L
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 450 LC--WSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IF 506
+S +++ I G+ YL S L +HRDL N L+ ++ KI+DFGM+R ++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEII 552
AG + R V +MA E + G ++ SDV++FGV L EI+
Sbjct: 190 AGDYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 83/302 (27%), Positives = 133/302 (44%), Gaps = 49/302 (16%)
Query: 349 LDVATSNFSDSNMLGQGGFGPVYKG-VLSDG--KEIAVKRLSS-CSEQGNAEFTNEVLLI 404
L+ F D ++G+G FG V K + DG + A+KR+ S+ + +F E+ ++
Sbjct: 4 LEWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVL 61
Query: 405 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL-------FDP------RKRGLL 450
KL H N++ LLG C L E+ P+ +L L DP L
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 451 CWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510
+ ++ + +G+ YL S+ + IHRDL A N+L+ + KI+DFG++R G E
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQE 175
Query: 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570
V +MA E +Y+ SDV+S+GVLL EI++ G G T
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----LGGTPYCGMTCAE 231
Query: 571 L---LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627
L L + L N D + L+ C +E ++RP+ + ++V
Sbjct: 232 LYEKLPQGYRLEKPLNCDDEVYDLMRQ----------------CWREKPYERPSFAQILV 275
Query: 628 ML 629
L
Sbjct: 276 SL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 57/202 (28%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNA--EFTNEVLLILKLQHKNLV 413
F+ +G+G FG V+KG+ + +++ ++ E + + E+ ++ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 414 KLLGFCVDGDEKLLVYEFMPN-SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
K G + + ++ E++ S+LD L +P G L ++ I+ I+KG+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALD--LLEP---GPLDETQIATILREILKGLDYLHSE 120
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
+ IHRD+KA+NVLL K++DFG+A ++ ++ VGT +MAPE +
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 533 GLYSIKSDVFSFGVLLIEIITG 554
Y K+D++S G+ IE+ G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQH 409
+NF +G+G F VY+ L D K +A+K++ + + E+ L+ +L H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL--FDPRKRGL---LCWSKRINIVNGIVK 464
N++K L ++ +E +V E L ++ F +KR + W + + + +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE- 120
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY 524
H SR R++HRD+K +NV + K+ D G+ R F+ ++ +VGT Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 525 MAPEYAMEGLYSIKSDVFSFGVLLIEI 551
M+PE E Y+ KSD++S G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 66/199 (33%), Positives = 92/199 (46%), Gaps = 23/199 (11%)
Query: 362 LGQGGFGPVYKGVL-SDGKEIAVKRLSSCSE----QGNAEFTNEVLLILKLQHKNLVKLL 416
+G+G FG V+ G L +D +AVK SC E A+F E ++ + H N+V+L+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G C +V E + L R L + I +V G+ YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH--- 114
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMAR-----IFAGSEGEVNTARIVGTYGYMAPEYAM 531
IHRDL A N L+ KISDFGM+R ++A + G + APE
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP-----VKWTAPEALN 169
Query: 532 EGLYSIKSDVFSFGVLLIE 550
G YS +SDV+SFG+LL E
Sbjct: 170 YGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 64/199 (32%), Positives = 97/199 (48%), Gaps = 17/199 (8%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEF--------TNEVLLILKLQHKNLV 413
LG+G FG VY ++ D K +A +RL E E E L+ KL H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG-LLCWSKRINIVNGIVKGILYLHED 472
K ++ D ++ E+ LD L + + G L ++ ++ G+ Y+H+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
RI+HRDLKA N+ L ++ KI DFG++R+ GS T GT YM+PE
Sbjct: 126 ---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALKH 179
Query: 533 GLYSIKSDVFSFGVLLIEI 551
Y KSD++S G +L E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 14/198 (7%)
Query: 361 MLGQGGFGPVYKGVLSDGK----EIAVKRLSSCSEQGNAE-FTNEVLLILKLQHKNLVKL 415
+G+G FG VY+GV + +AVK +C+ E F E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
+G + + +V E P L + L + L + I + + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG-TYGYMAPEYAMEGL 534
R +HRD+ A NVL+ K+ DFG++R + A +MAPE
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRR 184
Query: 535 YSIKSDVFSFGVLLIEII 552
++ SDV+ FGV + EI+
Sbjct: 185 FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 32/213 (15%)
Query: 363 GQGGFGPVYKGVL---SDGKEIAVKRLSSCSEQG---NAEFTNEVLLILKLQHKNLVKLL 416
G+G +G VYK DGKE A+K+ EQ + E+ L+ +L+H+N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 417 GFCVDGDEKL--LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK--------GI 466
++ +K L++++ + I F + +KR++I +VK G+
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQ-------AKRVSIPPSMVKSLLWQILNGV 121
Query: 467 LYLHEDSRLRIIHRDLKASNVLLDYDMNP----KISDFGMARIF-AGSEGEVNTARIVGT 521
YLH + ++HRDLK +N+L+ + KI D G+AR+F A + + +V T
Sbjct: 122 HYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVT 178
Query: 522 YGYMAPEYAMEGLYSIKS-DVFSFGVLLIEIIT 553
Y APE + + K+ D+++ G + E++T
Sbjct: 179 IWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 53/170 (31%), Positives = 87/170 (51%), Gaps = 31/170 (18%)
Query: 399 NEVLLILKLQHK----NLVKLLG-FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWS 453
N+++ LK+ H+ +V G F DG+ + + E M SLD +L +K G + +
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL---KKAGRIPEN 99
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG--------MARI 505
I +++G+ YL E + +I+HRD+K SN+L++ K+ DFG MA
Sbjct: 100 ILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 157
Query: 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
F VGT YM+PE Y+++SD++S G+ L+E+ GR
Sbjct: 158 F------------VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 7e-17
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 23/211 (10%)
Query: 359 SNMLGQGGFGPVYKGVLSDGK-----EIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNL 412
S++L +G FG ++ G+L D K E+ VK + SE E L+ L H+N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 413 VKLLGFCV-DGDEKLLVYEFMPNSSLDAILFDPR---KRGLLCWSKR--INIVNGIVKGI 466
+ +L C+ DG+ ++Y +M +L L R S + +++ I G+
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 467 LYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAG---SEGEVNTARIVGTY 522
YLH + +IH+D+ A N ++D ++ KI+D ++R +F G+ N R V
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD-NENRPVK-- 184
Query: 523 GYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MA E + YS SDV+SFGVLL E++T
Sbjct: 185 -WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGNAEFT--NEVLLILKLQHKNLVKLLG 417
++G+G +G V K EI A+K+ + + + T EV ++ +L+H+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-------LCWSKRINIVNGIVKGILYLH 470
LV+E++ + L+ L + GL W +++ I Y H
Sbjct: 68 AFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQ--------LLQAIAYCH 117
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
IIHRD+K N+L+ K+ DFG AR V T Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR-PASPLTDYVATRWYRAPELL 173
Query: 531 M-EGLYSIKSDVFSFGVLLIEIITGR 555
+ + Y DV++ G ++ E++ G
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 362 LGQGGFGPVYKGVL-----SDGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKL 415
LG+ FG +YKG L + +A+K L + Q EF E L+ +L H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILF--------------DPRKRGLLCWSKRINIVNG 461
LG +++E++ L L D + L ++I
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVG 520
I G+ YL S +H+DL A N+L+ ++ KISD G++R I++ V ++
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 521 TYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+M PE M G +S SD++SFGV+L EI +
Sbjct: 190 IR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 59/207 (28%), Positives = 106/207 (51%), Gaps = 13/207 (6%)
Query: 355 NFSDSNMLGQGGFGPVY--KGVLSDGKEIAVKRLS--SCSEQGNAEFTNEVLLILKLQHK 410
+ ++G+G FG V+ + +D K + +K++ ++ NE ++ L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
N+++ ++ ++V E+ P +L A R LL I++ V+ +L LH
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTL-AEYIQKRCNSLL---DEDTILHFFVQILLALH 115
Query: 471 EDSRLRIIHRDLKASNVLLD-YDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
I+HRDLK N+LLD + M KI DFG+++I S+ + T +VGT Y++PE
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGTPCYISPEL 172
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGRR 556
Y+ KSD+++ G +L E+ + +R
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 362 LGQGGFGPVYKGVLSDGK---EIAVKRLSSCSEQG-NAEFTNEVLLILKLQHKNLVKLLG 417
LG G FG V KGV K ++A+K L + +E+ E E ++ +L + +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
C + + +LV E L+ L K+ + S + +++ + G+ YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN---F 116
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLY 535
+HRDL A NVLL KISDFG+++ G++ AR G + + APE +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 536 SIKSDVFSFGVLLIE 550
S +SDV+S+G+ + E
Sbjct: 176 SSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 59/183 (32%), Positives = 89/183 (48%), Gaps = 14/183 (7%)
Query: 381 IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDA 439
+AVK L S+ +F EV ++ +L N+ +LLG C ++ E+M N L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 440 IL--FDPRKRGLLCWSKRI------NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY 491
L GL C SK + + I G+ YL L +HRDL N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGK 165
Query: 492 DMNPKISDFGMAR-IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIE 550
+ KI+DFGM+R +++ V R +MA E + G ++ KSDV++FGV L E
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQ-GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWE 224
Query: 551 IIT 553
I+T
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSS---CSEQGNAEFTNEVLLILKLQH 409
+NF +G+G F VY+ L DG +A+K++ + A+ E+ L+ +L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL--FDPRKRGL---LCWSKRINIVNGIVK 464
N++K ++ +E +V E L ++ F +KR + W + + + +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE- 120
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY 524
H SR R++HRD+K +NV + K+ D G+ R F+ ++ +VGT Y
Sbjct: 121 -----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYY 172
Query: 525 MAPEYAMEGLYSIKSDVFSFGVLLIEI 551
M+PE E Y+ KSD++S G LL E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 31/208 (14%)
Query: 361 MLGQGGFGPVYKGVL-SDGKEIAVKRLSS----CSEQGNAEFTNEVLLILKLQHKNLVKL 415
+LG+G FG V L G+ AVK L + T + +L L H L +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 416 LGFCVDGDEKLL-VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IVKGILY 468
C ++L V EF+ L +F +K S+R + I +++
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQK------SRRFDEARARFYAAEITSALMF 111
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR--IFAGSEGEVNTARIVGTYGYMA 526
LH+ II+RDLK NVLLD++ + K++DFGM + IF G T+ GT Y+A
Sbjct: 112 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIA 164
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITG 554
PE E LY D ++ GVLL E++ G
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 41/214 (19%)
Query: 362 LGQGGFGPVYKG-VLSDGKEIAVKRLSSCSEQGNAEFTNEVLL---ILKLQH--KNLVKL 415
+G G G VYK G +AVK++ GN E +L+ ++ H +VK
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN----------IVNGIVKG 465
G+ + + + E M ++ LD +L KRI + IVK
Sbjct: 80 YGYFITDSDVFICMELM-STCLDKLL------------KRIQGPIPEDILGKMTVAIVKA 126
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ YL E +IHRD+K SN+LLD N K+ DFG++ S+ + +A G YM
Sbjct: 127 LHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA---GCAAYM 181
Query: 526 APEY----AMEGLYSIKSDVFSFGVLLIEIITGR 555
APE Y I++DV+S G+ L+E+ TG+
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 41/94 (43%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
IV G+ +LHE II+RDLK NVLLD + + KI+DFGM + G G V T+ GT
Sbjct: 105 IVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGT 159
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE Y D ++ GVLL E++ G+
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 11/193 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G G +G VYK ++ G+ +A+K + E+ ++ + +H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
D+ +V E+ SL I RG L + + +KG+ YLHE IHR
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHR 125
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA---MEGLYSI 537
D+K +N+LL D + K++DFG++ + + + +GT +MAPE A +G Y
Sbjct: 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDG 183
Query: 538 KSDVFSFGVLLIE 550
K D+++ G+ IE
Sbjct: 184 KCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 68/202 (33%), Positives = 98/202 (48%), Gaps = 17/202 (8%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLSS--CSEQGNAEFT--NEVLLILKLQHKNLVKL 415
+LG+G FG V L E A+K L E + E T +L L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 416 LGFCVDGDEKLL--VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
FC ++ L V E++ L +F + G ++ I+ G+ +LH+
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
II+RDLK NVLLD D + KI+DFGM + EG+ +T GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEILKGQ 171
Query: 534 LYSIKSDVFSFGVLLIEIITGR 555
Y+ D +SFGVLL E++ G+
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 4e-16
Identities = 64/207 (30%), Positives = 114/207 (55%), Gaps = 24/207 (11%)
Query: 362 LGQGGFGPVYKGVLSDGKEI-AVKRL-SSCSEQGNAEFT-NEVLLILKL-QHKNLVKLLG 417
LG+G +G V+K + KE+ A+K++ + +A+ T E++ + +L H N+VKLL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 418 -FCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRIN---IVNGIVKGILYLHED 472
+ D+ + LV+E+M + L A++ + +L + ++ I+ ++K + Y+H
Sbjct: 75 VIKAENDKDIYLVFEYM-ETDLHAVI----RANIL---EDVHKRYIMYQLLKALKYIH-- 124
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI---VGTYGYMAPEY 529
S +IHRDLK SN+LL+ D K++DFG+AR + E + V T Y APE
Sbjct: 125 SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 530 AMEG-LYSIKSDVFSFGVLLIEIITGR 555
+ Y+ D++S G +L E++ G+
Sbjct: 184 LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 25/212 (11%)
Query: 360 NMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFT--NEVLLILKLQHKNLVKLL 416
+G+G +G VYK D G+ +A+K++ +E+ T E+ ++ +L H+N+V L
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 417 GFCVDGDEKL----------LVYEFMPNSSLDAILFDPRKRGLLCWSKRIN--IVNGIVK 464
D + L LV+E+M D L + GL+ +S+ + +++
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY 524
G+ Y H+ + L HRD+K SN+LL+ K++DFG+AR++ E T +++ T Y
Sbjct: 128 GLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWY 183
Query: 525 MAPEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
PE + E Y DV+S G +L E+ T +
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 362 LGQGGFGPVYKGVLSDG-----------KEIAVKRLSS-CSEQGNAEFTNEVLLILKL-Q 408
LG+G FG V V+++ ++AVK L S +E+ ++ +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-------------LCWSKR 455
HKN++ LLG C ++ E+ +L L R G+ L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
++ + +G+ YL + + IHRDL A NVL+ D KI+DFG+AR + T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MAPE + +Y+ +SDV+SFGVLL EI T
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 42/103 (40%), Positives = 59/103 (57%), Gaps = 11/103 (10%)
Query: 458 IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517
I IVK + YLH +L +IHRD+K SNVL++ + K+ DFG++ S + A
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA- 164
Query: 518 IVGTYGYMAPE-----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
G YMAPE +G Y +KSDV+S G+ +IE+ TGR
Sbjct: 165 --GCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 361 MLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAE--FTNEVLLILKLQHKNLVKLLG 417
++G+G +G V K + G+ +A+K+ + + E+ ++ +L+H+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
LV+EF+ ++ LD + P K + I++GI + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK---YLFQILRGIEFCHSHN---I 121
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-EGLYS 536
IHRD+K N+L+ K+ DFG AR A GEV T V T Y APE + + Y
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYT-DYVATRWYRAPELLVGDTKYG 179
Query: 537 IKSDVFSFGVLLIEIITG 554
D+++ G L+ E++TG
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 356 FSDSNMLGQGGFGPVYKGVL----SDGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQH 409
F+ MLG+G FG V + L +++AVK L + S EF E + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 410 KNLVKLLGFCVDGDEK------LLVYEFMPNSSLDAILFDPR---KRGLLCWSKRINIVN 460
N++KL+G + K +++ FM + L L R + L + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGS---EGEVNTA 516
I G+ YL S IHRDL A N +L+ +M ++DFG+++ I++G +G +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+ ++A E + +Y+ SDV++FGV + EI+T
Sbjct: 178 PV----KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 14/208 (6%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGNAEFTN--EVLLILKLQHK 410
+ F N +G+G +G VY+ + EI A+K++ +E+ ++ E+ L+L L+H
Sbjct: 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHP 66
Query: 411 NLVKLLGFCVDG--DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILY 468
N+V+L V D LV E+ A L D S+ ++ +++G+ Y
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQDL--ASLLDNMPTPF-SESQVKCLMLQLLRGLQY 123
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
LHE+ IIHRDLK SN+LL KI+DFG+AR + G + T ++V T Y APE
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPE 178
Query: 529 YAMEGL-YSIKSDVFSFGVLLIEIITGR 555
+ Y+ D+++ G +L E++ +
Sbjct: 179 LLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 13/213 (6%)
Query: 356 FSDSNMLGQGGFGPVYK-GVLSDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKN 411
F +LG+GGFG V V + GK A K+L +G + NE ++ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+V L D LV M L ++ + G + + I G+ LH+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE-EGRAVFYAAEICCGLEDLHQ 120
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
+ RI++RDLK N+LLD + +ISD G+A EG+ R VGT GYMAPE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGR-VGTVGYMAPEVVK 174
Query: 532 EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR 564
Y+ D ++ G LL E+I G+ + F Q +
Sbjct: 175 NERYTFSPDWWALGCLLYEMIAGQ--SPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 72/231 (31%), Positives = 111/231 (48%), Gaps = 33/231 (14%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRL---SSCSEQGNAEFTN 399
+ LE+L T + +G+G +G VYK DG AVK L S E+ AE+
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN- 70
Query: 400 EVLLILKLQHKNLVKLLGFCVDGDEKL-----LVYEFMPNSSLDAILFDPRKRGLLCWSK 454
+L L H N+VK G D+ + LV E S+ ++ +GLL +
Sbjct: 71 -ILQSLP-NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQ 123
Query: 455 RIN------IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508
R++ I+ G + G+ +LH + RIIHRD+K +N+LL + K+ DFG++
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 509 SEGEVNTARIVGTYGYMAPEY-----AMEGLYSIKSDVFSFGVLLIEIITG 554
+ NT+ VGT +MAPE + Y + DV+S G+ IE+ G
Sbjct: 181 TRLRRNTS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 355 NFSDSNMLGQGGFGPVY--KGVLSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHK 410
+ +G+G FG +Y K SD + +K L+ + EV+L+ K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSL-------DAILFDPRKRGLLCWSKRINIVNGIV 463
N+V + +V E+ L +LF + +L W +I++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ--ILSWFVQISL----- 112
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGSEGEVNTARIVGTY 522
G+ ++H+ +I+HRD+K+ N+ L + M K+ DFG+AR S T VGT
Sbjct: 113 -GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC--VGTP 166
Query: 523 GYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
Y++PE Y+ K+D++S G +L E+ T
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 362 LGQGGFGPVYK----GVLSDG-KE---IAVKRLS-SCSEQGNAEFTNEVLLILKL-QHKN 411
LG+G FG V G+ D KE +AVK L +E+ ++ +E+ ++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-------------LCWSKRINI 458
++ LLG C ++ E+ +L L R G+ + + ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+ +G+ YL + + IHRDL A NVL+ + KI+DFG+AR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MAPE + +Y+ +SDV+SFGVL+ EI T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 62/207 (29%), Positives = 113/207 (54%), Gaps = 14/207 (6%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKN 411
+ N + +G +G VY+ G+ +A+K+L E+ T+ E+ ++LKLQH N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 412 LVKLLGFCV--DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
+V + V + D+ +V E++ + L +++ ++ L S+ ++ ++ G+ +L
Sbjct: 66 IVTVKEVVVGSNLDKIYMVMEYVEHD-LKSLMETMKQPFLQ--SEVKCLMLQLLSGVAHL 122
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
H++ I+HRDLK SN+LL+ KI DFG+AR + GS + T ++V T Y APE
Sbjct: 123 HDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVTLWYRAPEL 177
Query: 530 AM-EGLYSIKSDVFSFGVLLIEIITGR 555
+ YS D++S G + E++T +
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 38/214 (17%)
Query: 362 LGQGGFGPVYK------GVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHK----N 411
LG+G +G VYK GV KEI RL E ++F N++++ L + HK
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI---RL----ELDESKF-NQIIMELDILHKAVSPY 60
Query: 412 LVKLLG-FCVDGDEKLLVY---EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
+V G F ++G VY E+M SLD + + I +VKG+
Sbjct: 61 IVDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLK 116
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
+L E+ IIHRD+K +NVL++ + K+ DFG++ S + N +G YMAP
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAP 170
Query: 528 EY------AMEGLYSIKSDVFSFGVLLIEIITGR 555
E Y+++SDV+S G+ ++E+ GR
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 69/249 (27%), Positives = 114/249 (45%), Gaps = 34/249 (13%)
Query: 364 QGGFGPVY--KGVLSDGKEIAVKRLSSCSEQGNAEFTN----EVLLILKLQHKNLVKLLG 417
+G FG VY K + G A+K L + TN +++++ + + KL
Sbjct: 6 KGAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLC--WSKRINIVNGIVKGILYLHEDSRL 475
D LV E++ +++ + G L W+K + +V G+ LH+
Sbjct: 65 SFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAK--QYIAEVVLGVEDLHQRG-- 117
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
IIHRD+K N+L+D + K++DFG++R G N + VGT Y+APE + G+
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENK-KFVGTPDYLAPE-TILGVG 169
Query: 536 SIK-SDVFSFGVLLIEIITGRRNTGFN-QSRGATAPNLLA--YAWHLW-NEG---NALDL 587
K SD +S G ++ E + G F+ ++ A N+L+ W E A+DL
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPP--FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDL 227
Query: 588 IDPLLTDTC 596
I+ LL
Sbjct: 228 INRLLCMDP 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 62/198 (31%), Positives = 98/198 (49%), Gaps = 19/198 (9%)
Query: 362 LGQGGFGPVYKGVLS---DGKEIAVKRLSSCSEQGNAEFTNEVL----LILKLQHKNLVK 414
LG G FG V KG+ K +AVK L + + + +E+L ++ +L + +V+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKN--DNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
++G C + + +LV E L+ L +K + +V+ + G+ YL E +
Sbjct: 61 MIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN- 115
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAME 532
+HRDL A NVLL KISDFG+++ E A+ G + + APE
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-AKTHGKWPVKWYAPECMNY 172
Query: 533 GLYSIKSDVFSFGVLLIE 550
+S KSDV+SFGVL+ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 18/199 (9%)
Query: 360 NMLGQGGFGPVYKG-VLSDGKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
+LG G G VYK L + +AVK + + + + +E+ ++ K ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 418 -FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
F V+ + + EFM SLD P +L RI + +VKG+ YL L+
Sbjct: 67 AFFVE-NRISICTEFMDGGSLDVYRKIPEH--VL---GRIAV--AVVKGLTYLWS---LK 115
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
I+HRD+K SN+L++ K+ DFG++ S + VGT YMAPE Y
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT----YVGTNAYMAPERISGEQYG 171
Query: 537 IKSDVFSFGVLLIEIITGR 555
I SDV+S G+ +E+ GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 362 LGQGGFGPVYKGVLSDG-------KEIAVKRLS-----SCSEQGNAEFTNEVLLILK-LQ 408
LG G FG VYK + KEI V + ++ + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGIL 467
H N+V+ ++ D +V + + + L +++ +RI NI +V +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YLH++ R I+HRDL +N++L D I+DFG+A+ + E +VGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIIT 553
E Y K+DV++FG +L ++ T
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 64/203 (31%), Positives = 89/203 (43%), Gaps = 27/203 (13%)
Query: 362 LGQGGFGPVYKGVLSDGKEI-AVKRLSSCS--EQGNAEFTNEVLLILK-LQHKNLVKLLG 417
LG G FG V + A+K LS + E IL+ ++H LV L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IVKGILYLHE 471
D LV E++P L + L RK G R +V + YLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL---RKSG------RFPEPVARFYAAQVVLALEYLH- 118
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
L I++RDLK N+LLD D KI+DFG A+ G T + GT Y+APE +
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIIL 171
Query: 532 EGLYSIKSDVFSFGVLLIEIITG 554
Y D ++ G+L+ E++ G
Sbjct: 172 SKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 56/206 (27%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 362 LGQGGFGPVYKG--VLSDGKEIAVKRLS-SCSEQGNAEFTNEVLLILK----LQHKNLVK 414
+G+G +G V+K + + G+ +A+KR+ E+G T + +L+ +H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 415 LLGFCV----DGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
L C D + KL LV+E + + L L + G+ + + +++ +++G+ +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDFL 126
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
H R++HRDLK N+L+ K++DFG+ARI++ ++ +V T Y APE
Sbjct: 127 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEV 180
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGR 555
++ Y+ D++S G + E+ +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 41/94 (43%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I+ G+ +LH+ RII+RDLK NVLLD D N +ISD G+A +G+ T GT
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK--DGQSKTKGYAGT 160
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
G+MAPE Y D F+ GV L E+I R
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 73/254 (28%), Positives = 110/254 (43%), Gaps = 40/254 (15%)
Query: 362 LGQGGFGPVYKGVLSDGKEI-AVKRLS-SCSEQGNAEFTNEVL----LILKLQHKNLVKL 415
+GQGG+G V+ D EI A+KR+ S + N VL ++ + + LVKL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE--VRHVLTERDILTTTKSEWLVKL 66
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
L D + L E++P +L + L R + + + + LH L
Sbjct: 67 LYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAE-MFEAVDALH---EL 120
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR-IVGTYGYMAPEYAMEGL 534
IHRDLK N L+D + K++DFG+ S+G V A +VG+ YMAPE
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGL------SKGIVTYANSVVGSPDYMAPEVLRGKG 174
Query: 535 YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATA----PNLLAYA----WHLWNEGN--- 583
Y D +S G +L E + GF G+T NL + ++++
Sbjct: 175 YDFTVDYWSLGCMLYEFL-----CGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
Query: 584 ---ALDLIDPLLTD 594
A DLI L+ D
Sbjct: 230 SDEAWDLITKLIND 243
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 70/218 (32%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 356 FSDSNMLGQGGFGPVYK-GVLSDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKN 411
F +LG+GGFG V V + GK A K+L +G A NE ++ K+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 412 LVKLL-------GFCV------DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINI 458
+V L C+ GD K +Y FD +R + ++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG------FD-EERAVFYAAE---- 110
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA-RIFAGSEGEVNTAR 517
I G+ LH R RI++RDLK N+LLD + +ISD G+A I EGE R
Sbjct: 111 ---ITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI---PEGETIRGR 161
Query: 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
VGT GYMAPE Y+ D + G L+ E+I G+
Sbjct: 162 -VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 362 LGQGGFGPVY--------KGVLSDGKEIAVKRLSS-CSEQGNAEFTNEVLLILKL-QHKN 411
LG+G FG V K + +AVK L +++ ++ +E+ ++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-------------LCWSKRINI 458
++ LLG C ++ E+ +L L R G+ L + ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+ +G+ YL + + IHRDL A NVL+ D KI+DFG+AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MAPE + +Y+ +SDV+SFGVLL EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 57/211 (27%), Positives = 86/211 (40%), Gaps = 28/211 (13%)
Query: 362 LGQGGFGPVYKGVLSDGKEIA---VKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
+G G FG V G G A VK L +S + F EV +L H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 418 FCVDGDEKLLVYEFMPNSSLDAIL--------FDPRKRGLLCWSKRINIVNGIVKGILYL 469
C++ LLV EF P L L +K L + + G+L+L
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLLWL 116
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
H + IH DL N L D++ KI D+G+A + + ++APE
Sbjct: 117 H---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 530 AMEGLYSI-------KSDVFSFGVLLIEIIT 553
+ KS+++S GV + E+ T
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 356 FSDSNMLGQGGFGPVYK-GVLSDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKN 411
F +LG+GGFG V V + GK A KRL +G + NE ++ K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+V L D LV M L +++ G + + I+ G+ LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE-EERALFYAAEILCGLEDLHR 120
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
++ ++RDLK N+LLD + +ISD G+A EGE R VGT GYMAPE
Sbjct: 121 EN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEVLN 174
Query: 532 EGLYSIKSDVFSFGVLLIEIITGR 555
Y++ D + G L+ E+I G+
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 62/227 (27%), Positives = 104/227 (45%), Gaps = 26/227 (11%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLL 403
IDL L F ++G G +G VYKG ++A ++ +E E E+ +
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65
Query: 404 ILKL-QHKNLVKLLGFCV------DGDEKLLVYEFMPNSSLDAILFDPR----KRGLLCW 452
+ K H+N+ G + D+ LV EF S+ ++ + + K + +
Sbjct: 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY 125
Query: 453 SKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512
I I++G+ +LH ++IHRD+K NVLL + K+ DFG++ + G
Sbjct: 126 -----ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177
Query: 513 VNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITG 554
NT +GT +MAPE + Y +SD++S G+ IE+ G
Sbjct: 178 RNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVK 414
F ++G G +G VYKG ++A ++ + E E+ ++ K H+N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 415 LLGFCVD------GDEKLLVYEFMPNSSLDAILFDPRKRGLLC-WSKRINIVNGIVKGIL 467
G + D+ LV EF S+ ++ + + L W I I++G+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYI--CREILRGLS 125
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
+LH+ ++IHRD+K NVLL + K+ DFG++ + G NT +GT +MAP
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAP 180
Query: 528 EYAM-----EGLYSIKSDVFSFGVLLIEIITG 554
E + Y KSD++S G+ IE+ G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 35/213 (16%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEV--------LLILK-LQHKN 411
+G G +G V V G+++A+K++S+ F + + + +L+ L+H+N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRHEN 60
Query: 412 LVKLLGFCVDGD----EKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRIN-IVNGIVKG 465
++ LL + +V E M + L ++ P+ L I + I++G
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQP--LT--DDHIQYFLYQILRG 115
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN--TARIVGTYG 523
+ YLH + +IHRDLK SN+L++ + + KI DFG+AR E E T +V T
Sbjct: 116 LKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRW 171
Query: 524 YMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGR 555
Y APE + Y+ D++S G + E++T +
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 26/206 (12%)
Query: 362 LGQGGFGPVYKGVLSDGKE-IAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G +G VYK E IA+K RL E + E+ L+ ++QH N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD- 68
Query: 419 CVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLC--WSKRINIVNG----IVKGILYLHE 471
V +++L LV+E+ LD D +K ++K ++ I++GI Y H
Sbjct: 69 VVHSEKRLYLVFEY-----LD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH- 119
Query: 472 DSRLRIIHRDLKASNVLLDYDMNP-KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
S R++HRDLK N+L+D N K++DFG+AR F G T +V T Y APE
Sbjct: 120 -SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEIL 175
Query: 531 MEGL-YSIKSDVFSFGVLLIEIITGR 555
+ YS D++S G + E++ +
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 28/205 (13%)
Query: 361 MLGQGGFGP--VYKGVLSDG----KEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVK 414
++G+G FG + + V SD KEI + + SS E E +L+ K++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR----KEAVLLAKMKHPNIVA 62
Query: 415 LL-GFCVDGDEKLLVYEFMPNSSLDAILFDPRKR-----GLLCWSKRINIVNGIVKGILY 468
F DG +V E+ L + R + +L W ++ + G+ +
Sbjct: 63 FKESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQH 115
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
+HE R++HRD+K+ N+ L + K+ DFG AR+ T VGT Y+ PE
Sbjct: 116 IHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPE 170
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIIT 553
Y+ KSD++S G +L E+ T
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQ---HKNLVKL 415
+G G +G VYK G +A+K R+ + + EV L+ +L+ H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 416 LGFC----VDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
+ C D + K+ LV+E + + L L GL + + +++ ++G+ +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK-DLMRQFLRGLDFLH 125
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
+ I+HRDLK N+L+ K++DFG+ARI++ ++ +V T Y APE
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPEVL 179
Query: 531 MEGLYSIKSDVFSFGVLLIEI 551
++ Y+ D++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 15/209 (7%)
Query: 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFT--NEVLLILKLQ 408
A +++ + LG+G + VYKG+ +G+ +A+K +S +E+G FT E L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLK 61
Query: 409 HKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
H N+V LL + E L V+E+M ++ P GL ++ R+ + +++G+
Sbjct: 62 HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPG--GLHPYNVRLFMFQ-LLRGLA 117
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
Y+H I+HRDLK N+L+ Y K++DFG+AR A S + V T Y P
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPP 172
Query: 528 EYAMEGL-YSIKSDVFSFGVLLIEIITGR 555
+ + YS D++ G + IE++ G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 39/216 (18%)
Query: 362 LGQGGFGPVYKGVLS--DGKEIAVKRLS---SCSEQGNAEFTNEVLLILKL--QHKNLVK 414
+G+G +G V+K VL+ +G + AVK L E+ AE+ ILK H N+VK
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYN-----ILKALSDHPNVVK 79
Query: 415 LLGF-----CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN------IVNGIV 463
G +GD+ LV E S+ ++ +G L +R+ I++ +
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV-----KGFLKRGERMEEPIIAYILHEAL 134
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
G+ +LH + + IHRD+K +N+LL + K+ DFG++ + NT+ VGT
Sbjct: 135 MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPF 189
Query: 524 YMAPEY-----AMEGLYSIKSDVFSFGVLLIEIITG 554
+MAPE ++ Y + DV+S G+ IE+ G
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 46/214 (21%)
Query: 362 LGQGGFGPV----YKGVLSDGKEIAVKRL----SSCSEQGNAEFTNEVLLILKLQHKNLV 413
+G+G +G V ++ +DGK+ +K+L +S E+ AE E L+ +L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAE--QEAQLLSQLKHPNIV 62
Query: 414 K--------------LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIV 459
++GFC GD +Y + +K LL ++ +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGD----LYHKLKE----------QKGKLLPENQVVEWF 108
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV 519
I + YLHE I+HRDLK NV L K+ D G+AR+ +T ++
Sbjct: 109 VQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LI 163
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
GT YM+PE Y+ KSDV++ G + E+ T
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 70/220 (31%), Positives = 94/220 (42%), Gaps = 43/220 (19%)
Query: 356 FSDSNMLGQGGFGPVYK-GVLSDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKN 411
F +LG+GGFG V V + GK A K+L +G A NE ++ K+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 412 LVKL-------------LGFCVDGDEKLLVYEFMPNSSLD---AILFDPRKRGLLCWSKR 455
+V L L GD K +Y M N D AI + LC
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAE----LCCG-- 114
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
L + R RI++RDLK N+LLD + +ISD G+A EGE
Sbjct: 115 -------------LEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVR 159
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
R VGT GYMAPE Y+ D + G L+ E+I G+
Sbjct: 160 GR-VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 362 LGQGGFGPVYKGVLSDGKE-IAVKRLSSCSEQGNAEFTN----EVLLILKLQHKNLVKLL 416
+G G +G V + +A+K+LS + +A E+ L+ + H+N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 417 G-FCVDG-----DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
F + LV M + L+ I+ K L +V I++G+ Y+H
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
IIHRDLK SN+ ++ D KI DFG+AR ++ E+ V T Y APE
Sbjct: 136 S---AGIIHRDLKPSNIAVNEDCELKILDFGLARH---TDDEMTG--YVATRWYRAPEIM 187
Query: 531 MEGL-YSIKSDVFSFGVLLIEIITGR 555
+ + Y+ D++S G ++ E++TG+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 22/215 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT--NEVLLILKLQHK 410
S + +GQG FG V+K + +A+K++ +E+ T E+ ++ L+H+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 411 NLVKLLGFCVDGDEK--------LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGI 462
N+V L+ C LV+EF + L +L + + L K++ + +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTLSEIKKV--MKML 128
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN---TARIV 519
+ G+ Y+H R +I+HRD+KA+N+L+ D K++DFG+AR F+ S+ T R+V
Sbjct: 129 LNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185
Query: 520 GTYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIIT 553
T Y PE + E Y D++ G ++ E+ T
Sbjct: 186 -TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 361 MLGQGGFGPVYKGVLS-DGKEIAVKRLSS----CSEQGNAEFTNEVLLILKLQHKNLVKL 415
+LG+G FG V L G+ AVK L + + +L L ++ L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
+ V EF+ L +F + +G + IV G+ +LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG-- 116
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMAR--IFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
II+RDLK NV+LD D + KI+DFGM + +F G+ + GT Y+APE
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVF----GDNRASTFCGTPDYIAPEILQGL 171
Query: 534 LYSIKSDVFSFGVLLIEIITGR 555
Y+ D +SFGVLL E++ G+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHK-NLV 413
+F + LG G G V+K I ++L + N+++ L++ H+ N
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNSP 63
Query: 414 KLLGFC----VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
++GF DG E + E M SLD +L +K G + + ++KG+ YL
Sbjct: 64 YIVGFYGAFYSDG-EISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
E + +I+HRD+K SN+L++ K+ DFG++ G + VGT YM+PE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGR 555
YS++SD++S G+ L+E+ GR
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 39/96 (40%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR--IFAGSEGEVNTARIV 519
I G+ +LH II+RDLK NV+LD + + KI+DFGM + IF G T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFC 162
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
GT Y+APE Y D ++FGVLL E++ G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 360 NMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE------------FT--NEVLLI 404
LG+G +G V K GK +A+K++ + FT E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 405 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK 464
+++H+N++ L+ V+GD LV + M S L + D + R L S+ I+ I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKV-VDRKIR--LTESQVKCILLQILN 130
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA-------------GSEG 511
G+ LH+ +HRDL +N+ ++ KI+DFG+AR +
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 512 EVNTARIVGTYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
E T+++V T Y APE M Y D++S G + E++TG+
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-13
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 47/229 (20%)
Query: 361 MLGQGGFGPVYKGVLSD---GKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQHKNLVK 414
++G+GG G VY D + +A+K++ S + F E + L H +V
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 415 LLGFCVDGDEKLLVYEFMP---NSSLDAILFDPRKRGLLCWSKR----------INIVNG 461
+ C DGD VY MP +L ++L ++ L SK ++I +
Sbjct: 67 VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHK 121
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA----- 516
I I Y+H S+ ++HRDLK N+LL I D+G A IF E E
Sbjct: 122 ICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDE 177
Query: 517 ------------RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+IVGT YMAPE + S +D+++ GV+L +++T
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/200 (29%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 361 MLGQGGFGPVYKGVLS-DGKEIAVKRLSS----CSEQGNAEFTNEVLLILKLQHKNLVKL 415
MLG+G FG V+ L + A+K L + + +L L +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
+ V E++ L +F + + I+ G+ +LH
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
I++RDLK N+LLD D + KI+DFGM + G+ T GT Y+APE + Y
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY 173
Query: 536 SIKSDVFSFGVLLIEIITGR 555
+ D +SFGVLL E++ G+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 62/203 (30%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 362 LGQGGFGPVYKGVLSDG---KEIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
+G G FG V G ++ G ++ VK L S S Q +F E LQH NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI--NIVNGIVKGILYLHEDSRL 475
C + LLV EF P L L RK L+ + I G+L+LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME--- 532
IH DL N LL D+ KI D+G++ + V ++ ++APE E
Sbjct: 121 -FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 533 ----GLYSIKSDVFSFGVLLIEI 551
+ +S+V+S GV + E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 362 LGQGGFGPVYKGVLSDGKEI-AVKR--LSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G +G V+K + EI A+KR L E + E+ L+ +L+HKN+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD- 66
Query: 419 CVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
+ D+KL LV+E+ D + G + + + ++KG+ + H +
Sbjct: 67 VLHSDKKLTLVFEYCDQ---DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYS 536
+HRDLK N+L++ + K++DFG+AR F G +A +V T Y P+ LYS
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 537 IKSDVFSFGVLLIEIITGRR 556
D++S G + E+ R
Sbjct: 179 TSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 50/162 (30%), Positives = 87/162 (53%), Gaps = 15/162 (9%)
Query: 399 NEVLLILKLQHK-NLVKLLGFC----VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWS 453
N+++ L++ H+ N ++GF DG E + E M SLD +L + ++
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKRIPEEILG 106
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
K + +++G+ YL E + +I+HRD+K SN+L++ K+ DFG++ G +
Sbjct: 107 K---VSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDS 157
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
VGT YM+PE YS++SD++S G+ L+E+ GR
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 43/212 (20%)
Query: 362 LGQGGFGPVYKGVL----SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVK- 414
+G+G FG K +L DGK+ +K ++ S + E EV ++ ++H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 415 ------------LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGI 462
++ +C GD +Y+ + +LF + I++
Sbjct: 65 QESFEENGNLYIVMDYCEGGD----LYKKINAQR--GVLFPEDQ-----------ILDWF 107
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI-VGT 521
V+ L L +I+HRD+K+ N+ L D K+ DFG+AR+ + V AR +GT
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST---VELARTCIGT 164
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
Y++PE Y+ KSD+++ G +L E+ T
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT-NEVLLILKLQHKN 411
+ + + +G+G +G V G ++A+K++S Q + T E+ ++ + +H+N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 412 LVKLLGFCVDGD-----EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGI 466
++ +L + +V E M I + + + I++G+
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY-----FLYQILRGL 119
Query: 467 LYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI---VGTYG 523
Y+H + ++HRDLK SN+LL+ + + KI DFG+ARI +T + V T
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEYVATRW 174
Query: 524 YMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGR 555
Y APE + Y+ D++S G +L E+++ R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G G +G V + G+++A+K+LS SE E+ L+ +QH+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 419 ---CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN-IVNGIVKGILYLHEDSR 474
V GDE Y MP D + G ++ +V ++ G+ Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDL----QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG- 137
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
IIHRDLK N+ ++ D KI DFG+AR ++ E+ T +V T Y APE + +
Sbjct: 138 --IIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEM-TGYVV-TRWYRAPEVILNWM 190
Query: 535 -YSIKSDVFSFGVLLIEIITGR 555
Y+ D++S G ++ E++TG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKR-LSSCSEQGNAEFT-NEVLLILKLQHKN-LVKLLG 417
+G+G +G VYK + GK +A+K+ E+G E+ L+ L +V+LL
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 418 FCVDGDEK-------LLVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGILYL 469
V+ E+ LV+E++ + + + R G +K I + + ++KG+ +
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNP-KISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
H + ++HRDLK N+L+D KI+D G+ R F+ T IV T Y APE
Sbjct: 127 H---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY-THEIV-TLWYRAPE 181
Query: 529 YAMEGL-YSIKSDVFSFGVLLIEIITG 554
+ YS D++S G + E+
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 355 NFSDSNMLGQGGFGPVY----KGVLSDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL 407
NF +LG G +G V+ G GK A+K L + + AE T +L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 408 QHKN--LVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK 464
+ LV L + D KL L+ +++ L L+ +R S+ + IV
Sbjct: 61 VRRCPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVL 116
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY 524
+ +LH+ L II+RD+K N+LLD + + ++DFG+++ F E E GT Y
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEY 172
Query: 525 MAPEYAM--EGLYSIKSDVFSFGVLLIEIITG 554
MAPE G + D +S GVL E++TG
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 361 MLGQGGFGPVYKGVLSD-GKEIAVKRLSSCS---EQGNAEFTNE--VLLILKLQHKNLVK 414
++G+GGFG VY +D GK A+K L +QG NE +L ++ +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 415 LLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+ + +KL + + M L L + G+ ++ I+ G+ ++H +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEAEMRFYAAEIILGLEHMH--N 115
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
R +++RDLK +N+LLD + +ISD G+A F+ + + VGT+GYMAPE +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 534 L-YSIKSDVFSFGVLLIEIITG 554
+ Y +D FS G +L +++ G
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 361 MLGQGGFGPVY---KGVLSD-GKEIAVKRL--SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
+LGQG FG V+ K D G+ A+K L ++ + E ++ ++ H +VK
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 415 L-LGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
L F +G KL L+ +F+ L L SK + VK YL E
Sbjct: 63 LHYAFQTEG--KLYLILDFLRGGDLFTRL-----------SKEVMFTEEDVK--FYLAEL 107
Query: 473 S-------RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ L II+RDLK N+LLD + + K++DFG+++ + E GT YM
Sbjct: 108 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYM 165
Query: 526 APEYAMEGLYSIKSDVFSFGVLLIEIITG 554
APE ++ +D +SFGVL+ E++TG
Sbjct: 166 APEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 52/194 (26%), Positives = 97/194 (50%), Gaps = 12/194 (6%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G G +G VYK ++ G+ A+K + + A E++++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
D+ + EF SL I G L S+ + ++G+ YLH + +HR
Sbjct: 77 RRDKLWICMEFCGGGSLQDIY---HVTGPLSESQIAYVSRETLQGLYYLHSKGK---MHR 130
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM---EGLYSI 537
D+K +N+LL + + K++DFG++ + + + +GT +MAPE A +G Y+
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVERKGGYNQ 188
Query: 538 KSDVFSFGVLLIEI 551
D+++ G+ IE+
Sbjct: 189 LCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 21/159 (13%)
Query: 400 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIV 459
E +L+ + H +++++ V G +V +P+ S D + ++ L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI------FAGSEGEV 513
I++G+ YLH RIIHRD+K N+ ++ I D G A+ F G G V
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEII 552
T APE Y+ K+D++S G++L E++
Sbjct: 221 ETN---------APEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQ-GNAEFTNEVLLILK-LQHKNLVKLLGF 418
+G G +G V + GK++A+K++ + A+ T L IL+ +H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 419 CV----DGDEKLLVYEFMPNSSLDAILF--DPRKRGLLCWSKRINIVNGIVKGILYLHED 472
D + +V + M S L I+ P + + + +++G+ Y+H
Sbjct: 73 LRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-----FLYQLLRGLKYIHSA 126
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT--ARIVGTYGYMAPE-- 528
+ +IHRDLK SN+L++ D +I DFGMAR + S E V T Y APE
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITGRR 556
++ Y+ D++S G + E++ GRR
Sbjct: 184 LSLPE-YTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 69/281 (24%), Positives = 110/281 (39%), Gaps = 66/281 (23%)
Query: 362 LGQGGFGPVYKGVLSDGKEI-AVKRLSSC----SEQGNAEFTNEVLLILKLQHKNLVKLL 416
+G+G FG V+ D ++ A+K L Q A E ++ +VKL
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL- 66
Query: 417 GFCVDGDEKLL--VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IVKGILY 468
+ DE+ L V E+MP L LL R ++ I + +L
Sbjct: 67 -YYSFQDEEHLYLVMEYMPGGDL---------MNLLI---RKDVFPEETARFYIAELVLA 113
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA-RIFAGSEGEVNTAR---------- 517
L +L IHRD+K N+L+D D + K++DFG+ ++ + E
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173
Query: 518 ----------------IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF- 560
VGT Y+APE Y ++ D +S GV+L E++ G F
Sbjct: 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF--PPFY 231
Query: 561 NQSRGATAPNLLAYAWHL-------WNEGNALDLIDPLLTD 594
+ + T ++ + L + A+DLI LL D
Sbjct: 232 SDTLQETYNKIINWKESLRFPPDPPVSP-EAIDLICRLLCD 271
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 449 LLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508
L+ +S ++ +G+ +L SR + IHRDL A N+LL + KI DFG+AR
Sbjct: 175 LISYSFQV------ARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYK 225
Query: 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
V +MAPE + +Y+ +SDV+SFGVLL EI +
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 353 TSNFSDSNMLGQGGFGPV--YKGVLSDGKEIAVKRL-SSCSEQGNAEFTNEVLLILK-LQ 408
T+ + D +G G FG V + L+ G+ +A+K++ S A+ T L +LK L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 409 HKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRIN------IVNG 461
H+N++ L + E + V E + + L +L S+ + +
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL-GTDLHRLL----------TSRPLEKQFIQYFLYQ 116
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I++G+ Y+H ++HRDLK SN+L++ + + KI DFG+ARI + V T
Sbjct: 117 ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVST 168
Query: 522 YGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
Y APE + Y ++ D++S G + E++ G+
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 361 MLGQGGFGPVYKGVLSD-GKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKN--LVK 414
++G+GGFG VY +D GK A+K L +QG NE +++ + + +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 415 LLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+ + +KL + + M L L + G+ + I+ G+ ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--N 115
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
R +++RDLK +N+LLD + +ISD G+A F+ + + VGT+GYMAPE +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 534 L-YSIKSDVFSFGVLLIEIITGRRNTGFNQSR 564
Y +D FS G +L +++ G ++ F Q +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG--HSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL 412
S + D LG G G V+ V SD K +AVK++ Q E+ +I +L H N+
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64
Query: 413 VKLLGFCVDGDEKL--------------LVYEFMPNSSLDAILFDPRKRGLLCWSKRINI 458
VK+ L +V E+M + L + ++G L
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF 119
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIFAG--------S 509
+ +++G+ Y+H + ++HRDLK +NV ++ D+ KI DFG+ARI S
Sbjct: 120 MYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 510 EGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
EG V T Y +P + Y+ D+++ G + E++TG+
Sbjct: 177 EGLV-------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 34/91 (37%), Positives = 55/91 (60%)
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+L +H +IHRD+K++N+LL + K+ DFG ++++A + + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 526 APEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
APE YS K+D+FS GVLL E++T +R
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKE-IAVKRLS---SCSEQGNAEFTNEVLLILKLQH 409
+ +G G FG V+ + A+K ++ + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 410 KNLVKLLGFCVDGDEKLL--VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
+++L F + D++ L + E++P L + L R G S + + IV +
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL---RNSGRFSNSTGLFYASEIVCALE 115
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YLH I++RDLK N+LLD + + K++DFG A+ + T + GT Y+AP
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAP 167
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITG 554
E ++ D ++ G+L+ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGNAEFTN--EVLLILKLQHKNLVKLLG 417
++G+G +G V K + KEI A+K+ E + T E+ ++ L+ +N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
+ LV+E++ + L+ L + G+ R I ++K I + H++ I
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ-LIKAIHWCHKND---I 121
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG-EVNTARIVGTYGYMAPEYAMEGLYS 536
+HRD+K N+L+ ++ K+ DFG AR SEG N V T Y +PE + Y
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNL--SEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 537 IKSDVFSFGVLLIEIITGR 555
D++S G +L E+ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 362 LGQGGFGPVYKGV---LSDGKEIAV---------KRLSSCSEQGNAEFTNEVLLILKLQH 409
LGQG F ++KG+ + D E+ K + SE F ++ +L H
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSES----FFEAASMMSQLSH 58
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
K+LV G CV GDE ++V E++ SLD L + + L+ S ++ + + + +L
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFL 116
Query: 470 HEDSRLRIIHRDLKASNVLL-----DYDMNP---KISDFGMARIFAGSEGEVNTARIVGT 521
+ + H ++ A NVLL NP K+SD G++ E+ RI
Sbjct: 117 EDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLERI--- 168
Query: 522 YGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITG 554
++ PE S+ +D +SFG L EI +G
Sbjct: 169 -PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 20/192 (10%)
Query: 378 GKEIAVKRLSSCSEQGN---AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMP 433
G E+A+K L + + + A F E L +L H N+V LL L V+E++P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---D 490
+L +L G L + ++ ++ + H I+HRDLK N+++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116
Query: 491 YDMNPKISDFGMARIFAGSEGEVNTARI------VGTYGYMAPEYAMEGLYSIKSDVFSF 544
+ K+ DFG+ + G + + A + +GT Y APE + SD++++
Sbjct: 117 VRPHAKVLDFGIGTLLPGV-RDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 545 GVLLIEIITGRR 556
G++ +E +TG+R
Sbjct: 176 GLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 362 LGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAE--FTNEVLLILKLQHKNLVKLLGF 418
+G+G +G V+K + G+ +A+K+ + + E+ ++ +L+H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
+ LV+E+ ++ L+ + + RG+ + I+ ++ + + H + I
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIK-KIIWQTLQAVNFCH---KHNCI 122
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL-YSI 537
HRD+K N+L+ K+ DFG ARI G + V T Y APE + Y
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD--YVATRWYRAPELLVGDTQYGP 180
Query: 538 KSDVFSFGVLLIEIITG 554
DV++ G + E++TG
Sbjct: 181 PVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 42/105 (40%), Positives = 59/105 (56%), Gaps = 9/105 (8%)
Query: 449 LLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508
L+C+S ++ KG+ +L SR + IHRDL A N+LL + KI DFG+AR
Sbjct: 181 LICYSFQV------AKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
V +MAPE + +Y+I+SDV+SFGVLL EI +
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 362 LGQGGFGPVYKG-VLSDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQ-HKNLVKLL 416
+G+G F V K GK A+K + EQ N E+ + +L H N+++L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 417 GFCVDGDEK--LLVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGILYLHEDS 473
D LV+E M + + I + R KR+ + + ++K + ++H
Sbjct: 65 EVLFDRKTGRLALVFELMDMNLYELI----KGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-E 532
R I HRD+K N+L+ D K++DFG R G + + T Y APE + +
Sbjct: 118 RNGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 533 GLYSIKSDVFSFGVLLIEIIT 553
G Y K D+++ G + EI++
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 54/197 (27%), Positives = 98/197 (49%), Gaps = 18/197 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT---NEVLLILKLQHKNLVKLLG 417
+G G +G VYK L G+ AVK + E G+ +F+ E+ ++ + +H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL--EPGD-DFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
+ ++ + E+ SL I G L + + ++G+ YLH ++
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLAYLHSKGKM-- 128
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM---EGL 534
HRD+K +N+LL + + K++DFG+A + + + +GT +MAPE A G
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNGG 185
Query: 535 YSIKSDVFSFGVLLIEI 551
Y+ D+++ G+ IE+
Sbjct: 186 YNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 356 FSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNL 412
+ D +G G +G V + G ++A+K+L SE E+ L+ ++H+N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 413 VKLLGFCVDGDEKL-------LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG 465
+ LL D L LV FM + L ++ K L + +V ++KG
Sbjct: 77 IGLLD-VFTPDLSLDRFHDFYLVMPFM-GTDLGKLM----KHEKLSEDRIQFLVYQMLKG 130
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ Y+H IIHRDLK N+ ++ D KI DFG+AR SE T +V T Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE---MTGYVV-TRWYR 182
Query: 526 APEYAMEGL-YSIKSDVFSFGVLLIEIITGR 555
APE + + Y+ D++S G ++ E++TG+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 29/212 (13%)
Query: 362 LGQGGFGPVYKGVLSDG---KEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLG- 417
+G+G +G VYK DG ++ A+K++ +A E+ L+ +L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 418 FCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK--------GILY 468
F D K+ L++++ + I F R K + + G+VK GI Y
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKF---HRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNP-----KISDFGMARIFAGS-EGEVNTARIVGTY 522
LH + ++HRDLK +N+L+ P KI+D G AR+F + + +V T+
Sbjct: 124 LHAN---WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 523 GYMAPEYAMEGLYSIKS-DVFSFGVLLIEIIT 553
Y APE + + K+ D+++ G + E++T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 362 LGQGGFGPVYKGVLSDG---KEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLG- 417
+G+G +G VYK DG KE A+K++ +A E+ L+ +L+H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 418 FCVDGDEKL-LVYEFMPNSSLDAILFD-----PRKRGLLCWSKRINIVNGIVKGILYLHE 471
F D K+ L++++ + I F +K L S +++ I+ GI YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 472 DSRLRIIHRDLKASNVLLDYDMNP-----KISDFGMARIFAGS-EGEVNTARIVGTYGYM 525
+ ++HRDLK +N+L+ P KI+D G AR+F + + +V T+ Y
Sbjct: 127 N---WVLHRDLKPANILV-MGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 526 APEYAMEGLYSIKS-DVFSFGVLLIEIIT 553
APE + + K+ D+++ G + E++T
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 4/125 (3%)
Query: 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488
Y+ +S + +L D GL ++ + +G+ +L + +HRDL A NVL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTT-LDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269
Query: 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
L KI DFG+AR V+ +MAPE + LY+ SDV+S+G+LL
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILL 329
Query: 549 IEIIT 553
EI +
Sbjct: 330 WEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 13/200 (6%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLSSCS----EQGNAEFTNEVLLILKLQHKNLVKL 415
+LG+G FG V L E+ A+K L + + T + +L L +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
D V E++ L +F ++ + + +++LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG-- 116
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
+I+RDLK N+LLD + + K++DFGM + G V T GT Y+APE E Y
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY 173
Query: 536 SIKSDVFSFGVLLIEIITGR 555
D ++ GVL+ E++ G+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 70/240 (29%), Positives = 103/240 (42%), Gaps = 61/240 (25%)
Query: 348 TLDVATSNF------SDSNMLGQGGFGPV---YKGVLSDGKEIAVKRLSSCSEQGNAEFT 398
+++V S F + +G G G V Y V G+ +A+K+LS F
Sbjct: 4 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSR-------PFQ 54
Query: 399 N---------EVLLILKLQHKNLVKLLGFCVDGDEKL-------LVYEFMPNSSLDAILF 442
N E++L+ + HKN++ LL + L LV E M + I
Sbjct: 55 NVTHAKRAYRELVLMKLVNHKNIIGLLN-VFTPQKSLEEFQDVYLVMELMDANLCQVIQM 113
Query: 443 D-PRKR------GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495
D +R +LC GI +LH IIHRDLK SN+++ D
Sbjct: 114 DLDHERMSYLLYQMLC-------------GIKHLHSAG---IIHRDLKPSNIVVKSDCTL 157
Query: 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
KI DFG+AR AG+ + T +V Y Y APE + Y D++S G ++ E+I G
Sbjct: 158 KILDFGLART-AGTSFMM-TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR--IFAGSEGEVNTARIV 519
I G+ +LH II+RDLK NV+LD + + KI+DFGM + ++ G V T
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
GT Y+APE Y D ++FGVLL E++ G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 25/204 (12%)
Query: 362 LGQGGFGPVYKG--VLSDGKEIAVKRLSSCSEQGN-AEFTNEVLLILKLQHKNLVKLLGF 418
LG+G + VYKG L+D +A+K + E+G EV L+ L+H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVN------GIVKGILYLHED 472
LV+E++ + L L D C IN+ N +++G+ Y H
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDD-------C-GNSINMHNVKLFLFQLLRGLNYCH-- 121
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
R +++HRDLK N+L++ K++DFG+AR A S + V T Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 533 GL-YSIKSDVFSFGVLLIEIITGR 555
YS + D++ G + E+ TGR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR--IFAGSEGEVNTARIV 519
I G+ +LH II+RDLK NV+LD + + KI+DFGM + + G V T
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
GT Y+APE Y D +++GVLL E++ G+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I++G+ YLH I+HRD+K N+L++ + KI DFG+AR+ E + T +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 522 YGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGR 555
Y Y APE M Y+ D++S G + E++ R
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 62/182 (34%), Positives = 87/182 (47%), Gaps = 27/182 (14%)
Query: 449 LLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508
L+C+S ++ +G+ +L SR + IHRDL A N+LL + KI DFG+AR
Sbjct: 176 LICYSFQV------ARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYK 226
Query: 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATA 568
V +MAPE + +Y+ +SDV+SFGVLL EI S GA+
Sbjct: 227 DPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF----------SLGAS- 275
Query: 569 PNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIH-IGLLCVQEDAFDRPTMSSVVV 627
Y NE L D T +P+ I+ I L C Q D +RPT S++V
Sbjct: 276 ----PYPGVQINEEFCQRLKDG--TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329
Query: 628 ML 629
+L
Sbjct: 330 IL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 20/185 (10%)
Query: 378 GKEIAVKRLSS-CSEQGNAEFTNEVLLILK-LQHKNLVKLLGFCV------DGDEKLLVY 429
G +AVK+LS Q +A+ L++LK + HKN++ LL + + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL 489
E M + I + L + ++ ++ GI +LH IIHRDLK SN+++
Sbjct: 106 ELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 490 DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLI 549
D KI DFG+AR + T +V Y Y APE + Y D++S G ++
Sbjct: 157 KSDCTLKILDFGLAR--TACTNFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 550 EIITG 554
E++ G
Sbjct: 214 ELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFT--NEVLLILKLQHKNLVKLLGF 418
LG+G + VYKG G+ +A+K + E+G A FT E L+ L+H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIV-TLHD 70
Query: 419 CVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
+ + L LV+E++ ++ L + D GL + R+ + +++G+ Y H + R+
Sbjct: 71 IIHTKKTLTLVFEYL-DTDLKQYM-DDCGGGLSMHNVRLFLFQ-LLRGLAYCH---QRRV 124
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL-YS 536
+HRDLK N+L+ K++DFG+AR A S + V T Y P+ + YS
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLAR--AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 537 IKSDVFSFGVLLIEIITGR 555
D++ G + E+ TGR
Sbjct: 183 TSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 68/255 (26%), Positives = 104/255 (40%), Gaps = 45/255 (17%)
Query: 310 KQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGP 369
K +QLHK D+ T R + +K +DF NF + LG G FG
Sbjct: 5 KNLQLHKKKDSDST-----KEPKRKNKMKYEDF------------NFIRT--LGTGSFGR 45
Query: 370 VYKGVLSDGK--EIAVKRLSSC----SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD 423
V + +A+KR +Q + F+ +L + H V L G D
Sbjct: 46 VILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-INHPFCVNLYGSFKDES 104
Query: 424 EKLLVYEFMPNSSLDAILFD----PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
LV EF+ L P G ++ + I YL L I++
Sbjct: 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE-------YLQS---LNIVY 154
Query: 480 RDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKS 539
RDLK N+LLD D K++DFG A++ + T + GT Y+APE + + +
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVGHGKAA 209
Query: 540 DVFSFGVLLIEIITG 554
D ++ G+ + EI+ G
Sbjct: 210 DWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 74/267 (27%), Positives = 113/267 (42%), Gaps = 28/267 (10%)
Query: 355 NFSDSNMLGQGGFGPVY---KGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN 411
+F +++G+G FG V + D + V + S Q F E IL + +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 412 LVKLLGFCV-DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
+ L + D D LV E+ P L ++L R + +V I +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY- 529
+ + +HRD+K NVL+D + K++DFG A + VN+ VGT Y+APE
Sbjct: 120 Q---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT-ANKMVNSKLPVGTPDYIAPEVL 175
Query: 530 -AMEG----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN-------LLAYAWH 577
M G Y ++ D +S GV+ E+I GR + F++ A N L +
Sbjct: 176 TTMNGDGKGTYGVECDWWSLGVIAYEMIYGR--SPFHEGTSAKTYNNIMNFQRFLKFPED 233
Query: 578 LWNEGNALDLIDPLLTDTCSPDEFLRY 604
+ LDLI LL C E L Y
Sbjct: 234 PKVSSDFLDLIQSLL---CGQKERLGY 257
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFT--NEVLLILKLQHKNLVKLLGF 418
LG+G + VYKG +GK +A+K + E+G FT E L+ L+H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
+ LV+E++ + D GL + ++ + +++G+ Y+H+ I+
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY---IL 125
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL-YSI 537
HRDLK N+L+ K++DFG+AR A S + V T Y P+ + YS
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 538 KSDVFSFGVLLIEIITG 554
D++ G + +E+I G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 34/88 (38%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
+LHE II+RDLK NVLLD + + K++D+GM + G T+ GT Y+AP
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAP 165
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGR 555
E Y D ++ GVL+ E++ GR
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 2/90 (2%)
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
IL L +L I++RD+K N+LLD + + ++DFG+++ F E E T GT YM
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYM 173
Query: 526 APEYAM-EGLYSIKSDVFSFGVLLIEIITG 554
APE +G + D +S G+L+ E++TG
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 361 MLGQGGFGPVYKGVLSDGKE----IAVKRLSSCSEQGNAEFTN----EVLLILKLQHKNL 412
+LG+GG+G V++ G + A+K L + N + T E ++ ++H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 413 VKLL-GFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
V L+ F G KL L+ E++ L L + G+ ++ I + +LH
Sbjct: 63 VDLIYAFQTGG--KLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLALEHLH 117
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
+ II+RDLK N+LLD + K++DFG+ + + EG V T GT YMAPE
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTV-THTFCGTIEYMAPEIL 172
Query: 531 MEGLYSIKSDVFSFGVLLIEIITG 554
M + D +S G L+ +++TG
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQG-NAEFTNEVLLILK-LQHKNLVKLLGF 418
+G G +G V G +AVK+LS + +A+ T L +LK ++H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 419 CVDG------DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
++ LV M + L+ I+ K L ++ I++G+ Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLM-GADLNNIV----KCQKLTDDHVQFLIYQILRGLKYIHSA 139
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
IIHRDLK SN+ ++ D KI DFG+AR + V T Y APE +
Sbjct: 140 D---IIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLN 191
Query: 533 GL-YSIKSDVFSFGVLLIEIITGR 555
+ Y+ D++S G ++ E++TGR
Sbjct: 192 WMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
IV + +LH +L II+RD+K N+LLD + + ++DFG+++ F E E GT
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGT 169
Query: 522 YGYMAPEYAM--EGLYSIKSDVFSFGVLLIEIITG 554
YMAP+ +G + D +S GVL+ E++TG
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 9/95 (9%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR--IFAGSEGEVNTARIV 519
+V G+ YLHE+ +I++RDLK N+LLD + KI+DFG+ + + G T+
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFC 162
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
GT ++APE E Y+ D + GVL+ E++ G
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 362 LGQGGFGPVYKGVL---------SDGKEIAVKRLSSCSEQGNAE-FTNEVLLILKLQHKN 411
LGQG F +YKGVL G+E++V S+ ++ F L+ +L HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
LVKL G CV DE ++V E++ LD +F R++ + ++++ + + YL +
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLD--VFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 472 DSRLRIIHRDLKASNVLL-DYDMNP------KISDFGMARIFAGSEGEVNTARIVGTYGY 524
+++H ++ N+L+ Y +N K+SD G+ E V RI +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE--RI----PW 170
Query: 525 MAPEYAMEGLYSIKS--DVFSFGVLLIEI 551
+APE G S+ D +SFG L+EI
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 75/271 (27%), Positives = 112/271 (41%), Gaps = 34/271 (12%)
Query: 337 LKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPV----YKGVLSDGKEIAVKRLSS---C 389
+KA + +T S+F LG G FG V +KG G+ A+K L
Sbjct: 1 MKAAYMFTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREIL 57
Query: 390 SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL 449
+ E ++++L H +V ++ D + + EF+ L L RK G
Sbjct: 58 KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAG- 113
Query: 450 LCWSKRINIVNG-----IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504
+ N V +V YLH II+RDLK N+LLD + K++DFG A+
Sbjct: 114 ----RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
Query: 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR 564
T + GT Y+APE + D ++ GVLL E I G F+ +
Sbjct: 167 KVPD-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG-YPPFFDDTP 220
Query: 565 GATAPNLLA--YAWHLWNEGNALDLIDPLLT 593
+LA + W +G A DL+ LL
Sbjct: 221 FRIYEKILAGRLKFPNWFDGRARDLVKGLLQ 251
|
Length = 329 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 35/78 (44%), Positives = 48/78 (61%), Gaps = 4/78 (5%)
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVN-TARIVGTYGYMAPEYAMEGLY 535
IHRD+ A NVLL KI DFG+AR I S V AR+ +MAPE + +Y
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPESIFDCVY 291
Query: 536 SIKSDVFSFGVLLIEIIT 553
+++SDV+S+G+LL EI +
Sbjct: 292 TVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 63/248 (25%), Positives = 111/248 (44%), Gaps = 24/248 (9%)
Query: 319 DASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDG 378
D H +D + ++ ID + ++ N++G G FG VY+ + D
Sbjct: 32 DKKLDEEERSHNNNAGED-EDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDT 90
Query: 379 KE-IAVKRLSSCSEQGNAEFTNEVLLILK-LQHKNLVKLLGF----CVDGDEKLL----V 428
E +A+K++ + ++ N LLI+K L H N++ L + C +EK + V
Sbjct: 91 SEKVAIKKVLQ-----DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145
Query: 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488
EF+P + + R L + + + Y+H I HRDLK N+L
Sbjct: 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLL 202
Query: 489 LDYDMNP-KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGV 546
+D + + K+ DFG A+ G+ + + I + Y APE + Y+ D++S G
Sbjct: 203 IDPNTHTLKLCDFGSAKNLLA--GQRSVSYICSRF-YRAPELMLGATNYTTHIDLWSLGC 259
Query: 547 LLIEIITG 554
++ E+I G
Sbjct: 260 IIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 362 LGQGGFGPVYKG--VLSDGKEIAVKRLSSCSEQGN-AEFTNEVLLILKLQHKNLVKLLGF 418
LG+G + V+KG L++ +A+K + E+G EV L+ L+H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 419 CVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINI-VNGIVKGILYLHEDSRLR 476
V D+ L LV+E++ + L + D G + + I + I++G+ Y H R +
Sbjct: 73 -VHTDKSLTLVFEYL-DKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCH---RRK 124
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-EGLY 535
++HRDLK N+L++ K++DFG+AR A S + V T Y P+ + Y
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 536 SIKSDVFSFGVLLIEIITGR 555
S + D++ G + E+ +GR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 47/158 (29%), Positives = 72/158 (45%), Gaps = 26/158 (16%)
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV--NTARIVGTYGYMAPEYAMEGLY 535
IHRDL A N+LL + KI DFG+AR V AR+ +MAPE +Y
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL--PVKWMAPESIFNCVY 293
Query: 536 SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATA-PNLLAYA--WHLWNEGNALDLIDPLL 592
+ +SDV+S+G+LL EI S G++ P + + + + EG +
Sbjct: 294 TFESDVWSYGILLWEIF----------SLGSSPYPGMPVDSKFYKMIKEGYRML------ 337
Query: 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ C+P E + C D RPT +V +++
Sbjct: 338 SPECAPSEMYDIMKS---CWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 32/86 (37%), Positives = 50/86 (58%), Gaps = 5/86 (5%)
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
LH+ +I+RDLK N+LLDY + + DFG+ ++ + + NT GT Y+APE
Sbjct: 109 LHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYLAPE 163
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITG 554
+ Y+ D ++ GVLL E++TG
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 35/88 (39%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
+LHE II+RDLK NVLLD D + K++D+GM + G T+ GT Y+AP
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAP 165
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGR 555
E Y D ++ GVL+ E++ GR
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 13/198 (6%)
Query: 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFT--NEVLLILKLQHKNLVKLLGF 418
LG+G + V+KG +A+K + E+G A T EV L+ L+H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTLHDI 71
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
LV+E++ + D + L+ + +++G+ Y H + +I+
Sbjct: 72 IHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKIL 125
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL-YSI 537
HRDLK N+L++ K++DFG+AR A S + V T Y P+ + YS
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
Query: 538 KSDVFSFGVLLIEIITGR 555
D++ G +L E+ TGR
Sbjct: 184 PIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSS---CSEQGNAEFTNE 400
+ L + +F ++G+G FG V K++ A+K LS +A F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 401 VLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNSSLDAILFD---PRKRGLLCWSKR 455
++ + +V+L D+K L V E+MP L ++ + P K W++
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-----WARF 146
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
+V + +H + IHRD+K N+LLD + K++DFG + + G V
Sbjct: 147 Y--TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRC 200
Query: 516 ARIVGTYGYMAPEYAM----EGLYSIKSDVFSFGVLLIEIITG 554
VGT Y++PE +G Y + D +S GV L E++ G
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 35/88 (39%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YLHE II+RDLK NVLLD + + K++D+GM + G T+ GT Y+AP
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAP 165
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGR 555
E Y D ++ GVL+ E++ GR
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 65/201 (32%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 361 MLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-----EQGNAEFTNEVLLILKLQHKNLVK 414
++G+G FG V SDG AVK L + EQ + VLL L+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLL-KNLKHPFLVG 60
Query: 415 LLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
L + EKL V +++ L R+R L R + I YLH
Sbjct: 61 L-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS-- 114
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
L II+RDLK N+LLD + ++DFG+ + G E E T+ GT Y+APE +
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 534 LYSIKSDVFSFGVLLIEIITG 554
Y D + G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 62/200 (31%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCS-----EQGNAEFTNEVLLILKLQHKNLVKL 415
+G+G FG V +DGK AVK L + EQ + VLL ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLL-KNVKHPFLVGL 61
Query: 416 LGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
+ +KL V +++ L L R+R R I + YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL 534
L II+RDLK N+LLD + ++DFG+ + G E T+ GT Y+APE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQP 172
Query: 535 YSIKSDVFSFGVLLIEIITG 554
Y D + G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 32/76 (42%), Positives = 41/76 (53%)
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSI 537
+HRDL A NVL+ KI DFG+AR ++ +MAPE LY+
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320
Query: 538 KSDVFSFGVLLIEIIT 553
SDV+SFG+LL EI T
Sbjct: 321 LSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 29/204 (14%)
Query: 362 LGQGGFGPV---YKGVLSDGKEIAVKRLSS-CSEQGNAEFTNEVLLILK-LQHKNLVKLL 416
+G G G V Y VL + +A+K+LS Q +A+ L+++K + HKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 417 GFCV------DGDEKLLVYEFMPNSSLDAIL--FDPRKRGLLCWSKRINIVNGIVKGILY 468
+ + LV E M + I D + L + ++ GI +
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 134
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
LH IIHRDLK SN+++ D KI DFG+AR AG+ + T +V Y Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMM-TPYVVTRY-YRAPE 188
Query: 529 YAMEGLYSIKSDVFSFGVLLIEII 552
+ Y D++S G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 345 DLETLDVATSNFSDSNMLGQGGFGPV----YKGVLSDGKEIAVKRLSSCS--EQGNAEFT 398
+ L + ++ ++G+G FG V +K S K A+K LS ++ ++ F
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 399 NEVLLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNSSLDAILFD---PRKRGLLCWS 453
E I+ + V L FC D+K L V E+MP L ++ + P K W+
Sbjct: 91 WEERDIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-----WA 144
Query: 454 KRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
K + +L L + +IHRD+K N+LLD + K++DFG + G V
Sbjct: 145 KFYT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMV 198
Query: 514 NTARIVGTYGYMAPEY----AMEGLYSIKSDVFSFGVLLIEIITG 554
VGT Y++PE +G Y + D +S GV L E++ G
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 29/207 (14%)
Query: 362 LGQGGFGPV---YKGVLSDGKEIAVKRLSS-CSEQGNAEFTNEVLLILK-LQHKNLVKLL 416
+G G G V Y +L + +A+K+LS Q +A+ L+++K + HKN++ LL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 89
Query: 417 GFCV------DGDEKLLVYEFMPNSSLDAIL--FDPRKRGLLCWSKRINIVNGIVKGILY 468
+ + +V E M + I D + L + ++ GI +
Sbjct: 90 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ--------MLCGIKH 141
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
LH IIHRDLK SN+++ D KI DFG+AR AG+ + T +V Y Y APE
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMM-TPYVVTRY-YRAPE 195
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITGR 555
+ Y D++S G ++ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
IV + YLH +++RD+K N++LD D + KI+DFG+ + G GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE + Y D + GV++ E++ GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+L +H +L +HRD+K NVLLD + + +++DFG + +G V ++ VGT Y+
Sbjct: 112 VLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGTPDYI 170
Query: 526 APEY--AME---GLYSIKSDVFSFGVLLIEIITG 554
+PE AME G Y + D +S GV + E++ G
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 3/182 (1%)
Query: 376 SDGKEIAVKRLSSCSEQGNAEFT-NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434
SD KE V + +++ A + +E+ + H +VK D+ LL+ E+
Sbjct: 90 SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149
Query: 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN 494
L+ + K L + ++ + +L L E +++HRDLK++N+ L
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 495 PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
K+ DFG ++ ++ S + GT Y+APE YS K+D++S GV+L E++T
Sbjct: 208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267
Query: 555 RR 556
R
Sbjct: 268 HR 269
|
Length = 478 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
IV + YLH S +++RDLK N++LD D + KI+DFG+ + G + GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE + Y D + GV++ E++ GR
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 61/292 (20%), Positives = 104/292 (35%), Gaps = 39/292 (13%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
+ K +AVK+ L SCS++ E++ +LQH N++ +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGL----LCWSKRINIVNGIVKGILYLHEDSRL 475
+ E +V M S + +L GL + I+ ++ + Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIA-----FILKDVLNALDYIH---SK 120
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA------RIVGTYGYMAPEY 529
IHR +KAS++LL D +S + G+ V +++PE
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI-KHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 530 AMEGL--YSIKSDVFSFGVLLIEIITG-------RRNTGFNQSRGATAPNLLAYAWHLWN 580
+ L Y+ KSD++S G+ E+ G + T P LL + +
Sbjct: 180 LQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239
Query: 581 EGNALDLIDPLL-------TDTCSPDEFLRYIH-IGLLCVQEDAFDRPTMSS 624
E + D F + H LC+Q D RP+ S
Sbjct: 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
IV + YLH +++RDLK N++LD D + KI+DFG+ + G GT
Sbjct: 104 IVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE + Y D + GV++ E++ GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 362 LGQGGFGPVYKGVLSDGKE-IAVKRLSSCSEQ-GNAEFTNEVLLILK-LQHKNLVKLLGF 418
+G G +G V + ++ +AVK+LS + +A T L +LK ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 419 CV------DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
+ +E LV M + L+ I+ K L ++ +++G+ Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLM-GADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHSA 137
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
IIHRDLK SNV ++ D +I DFG+AR + + V T Y APE +
Sbjct: 138 G---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLN 189
Query: 533 GL-YSIKSDVFSFGVLLIEIITGR 555
+ Y+ D++S G ++ E++ G+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 11/97 (11%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI--- 518
IV + YLH +I++RDLK N++LD D + KI+DFG+ + EG + A +
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-----EGITDAATMKTF 155
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
GT Y+APE + Y D + GV++ E++ GR
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 6/97 (6%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI-FAGSEGEVNTARIVG 520
+++ + Y+H + + HRDLK N+L + D KI DFG+AR+ F + + V
Sbjct: 112 LLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA 168
Query: 521 TYGYMAPEY--AMEGLYSIKSDVFSFGVLLIEIITGR 555
T Y APE + Y+ D++S G + E++TG+
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 36/215 (16%)
Query: 362 LGQGGFGPV----YKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLI-----LKL----- 407
LGQG +G V S+ + +A+K++++ F+ ++L LKL
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNV-------FSKKILAKRALRELKLLRHFR 59
Query: 408 QHKNLVKLLGFCV---DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK 464
HKN+ L + +L +YE + + L I+ R L + + + I+
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQII---RSGQPLTDAHFQSFIYQILC 116
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI---VGT 521
G+ Y+H + ++HRDLK N+L++ D KI DFG+AR F+ + GE N + V T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE-NAGFMTEYVAT 172
Query: 522 YGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGR 555
Y APE + Y+ DV+S G +L E++ +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 57/211 (27%), Positives = 103/211 (48%), Gaps = 34/211 (16%)
Query: 362 LGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTN---------EVLLILKLQHKN 411
+G+G +G V S+ +++A+K++ NA F N E+ L+ L H+N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI------ANA-FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 412 LVKLLGFCVDGDEK------LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG 465
++ + + + +VYE M ++ L I+ R L + +++G
Sbjct: 66 VIAIKD-IMPPPHREAFNDVYIVYELM-DTDLHQII---RSSQTLSDDHCQYFLYQLLRG 120
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ Y+H + ++HRDLK SN+LL+ + + KI DFG+AR +G+ T +V T Y
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRWYR 175
Query: 526 APEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
APE + Y+ DV+S G + E++ +
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 16/201 (7%)
Query: 362 LGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGNAEFTN-----EVLLILKLQHKNLVKL 415
+G+G FG VY+ D + I A+K LS E + +L+ L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 416 LGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
L F D L LV ++M L + +K G + + +V + +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL---FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD- 116
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-EG 533
I++RDLK N+LLD + + DFG+++ NT GT Y+APE + E
Sbjct: 117 --IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEVLLDEK 172
Query: 534 LYSIKSDVFSFGVLLIEIITG 554
Y+ D +S GVL+ E+ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 73/271 (26%), Positives = 117/271 (43%), Gaps = 50/271 (18%)
Query: 333 RDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPV----YKGVLSDGKEIAVKRLSS 388
RD +KA+D+ + ++G+G FG V +K S K A+K LS
Sbjct: 36 RDLRMKAEDYEV--------------VKVIGRGAFGEVQLVRHK---STRKVYAMKLLSK 78
Query: 389 CS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFD-- 443
++ ++ F E I+ + V L + D L +V E+MP L ++ +
Sbjct: 79 FEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 138
Query: 444 -PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502
P K W++ + +L L + IHRD+K N+LLD + K++DFG
Sbjct: 139 VPEK-----WARFYT-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT 188
Query: 503 ARIFAGSEGEVNTARIVGTYGYMAPEY----AMEGLYSIKSDVFSFGVLLIEIITGRRNT 558
+ EG V VGT Y++PE +G Y + D +S GV L E++ G +T
Sbjct: 189 C-MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DT 245
Query: 559 GFNQSRGATAPNLLAYAWHLWNEGNALDLID 589
F A +L+ + N N+L D
Sbjct: 246 PF------YADSLVGTYSKIMNHKNSLTFPD 270
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 35/95 (36%), Positives = 55/95 (57%), Gaps = 8/95 (8%)
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA-RIFAGSEGEVNTARIVGTYGY 524
+L + +L +HRD+K NVLLD + + +++DFG R+ A +G V + VGT Y
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA--DGTVQSNVAVGTPDY 169
Query: 525 MAPEY--AME---GLYSIKSDVFSFGVLLIEIITG 554
++PE AME G Y + D +S GV + E++ G
Sbjct: 170 ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 51/193 (26%), Positives = 99/193 (51%), Gaps = 25/193 (12%)
Query: 378 GKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435
G + V+ L +C+E+ NEV+L +H N++ G ++ FM
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 436 SLDAILFDPRKRGLLCWSKRI--NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493
S +++L G+ S+ + NI+ G ++G+ YLH++ IHR++KAS++L+ D
Sbjct: 85 SANSLLKTYFPEGM---SEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDG 138
Query: 494 NPKISDFGMARIFA-GSEGEVNTARIVGTY--------GYMAPEYAMEGL--YSIKSDVF 542
+S G++ +++ G+ A++V + +++PE + L Y++KSD++
Sbjct: 139 LVSLS--GLSHLYSLVRNGQ--KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194
Query: 543 SFGVLLIEIITGR 555
S G+ E+ TGR
Sbjct: 195 SVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 362 LGQGGFGPVYKGVL-----------SDGKEIAV--KRLSSCSEQGNAEFTNEVLLILKLQ 408
LG+G +Y G+L S KEI V K L + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILY 468
HK++V L G CV E ++V EF+ LD LF RK +L + + + + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 469 LHEDSRLRIIHRDLKASNVLL-----DYDMNP--KISDFGMARIFAGSEGEVNTARIVGT 521
L ED L +H ++ N+LL D + P K+SD G+ + V RI
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE--RI--- 172
Query: 522 YGYMAPEYAMEG-LYSIKSDVFSFGVLLIEI 551
++APE + SI +D +SFG L EI
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 41/158 (25%), Positives = 65/158 (41%), Gaps = 9/158 (5%)
Query: 400 EVLLILKLQHKNLVKLLGFCVDG-DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINI 458
E+ ++ + H+ ++ L + K V MP D + R G L + I I
Sbjct: 136 EIDILKTISHRAIINL----IHAYRWKSTVCMVMPKYKCDLFTYVDRS-GPLPLEQAITI 190
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+++ + YLH IIHRD+K N+ LD N + DFG A
Sbjct: 191 QRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW 247
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
GT +PE Y K+D++S G++L E+
Sbjct: 248 SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 47/166 (28%), Positives = 81/166 (48%), Gaps = 25/166 (15%)
Query: 399 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE---FMPNSSLDAIL--------FDPRKR 447
NE+L + +L H+N++K+ E++L E +M D L FD + R
Sbjct: 212 NEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263
Query: 448 GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507
LL R I+ ++ + Y+H+ ++IHRD+K N+ L+ D + DFG A F
Sbjct: 264 PLL-KQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
E E VGT +PE Y +D++S G++L+++++
Sbjct: 319 -KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 400 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-LCWSKRINI 458
E ++ + H ++++L G L+ +P D + KR + +C + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAIC--DILAI 187
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+++ I YLHE+ RIIHRD+KA N+ +++ + + DFG A ++N +
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV----DINANKY 240
Query: 519 VGTYGYMA---PEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
G G +A PE Y D++S G++L E+ T
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 30/86 (34%), Positives = 50/86 (58%), Gaps = 6/86 (6%)
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY--AM 531
+L +HRD+K N+L+D + + +++DFG +G V ++ VGT Y++PE AM
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPEILQAM 178
Query: 532 E---GLYSIKSDVFSFGVLLIEIITG 554
E G Y + D +S GV + E++ G
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 36/129 (27%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM------------ARIFAGS 509
I + IL + +L IHRD+K N+LLD + K+SDFG+ RI + +
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 510 EGEVNTARI------------------------VGTYGYMAPEYAMEGLYSIKSDVFSFG 545
I VGT Y+APE ++ Y+ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 546 VLLIEIITG 554
V++ E++ G
Sbjct: 227 VIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 362 LGQGGFGPVYKGVLSDGKEIA---VKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
+G G FG V + +A VK L ++ S + EF + LQH N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILF---DPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
CV+ LLV+E+ L + L R+ L +R+ I G+ ++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC--EIAAGVTHMH---K 117
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-- 532
+H DL N L D+ K+ D+G+ + ++APE E
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 533 -GLYSIK----SDVFSFGVLLIEI 551
GL + + S+V++ GV L E+
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I + YLH L I++RDLK N+LLD + ++DFG+ + E T+ GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGT 159
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG-----RRNTG 559
Y+APE + Y D + G +L E++ G RNT
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 17/201 (8%)
Query: 361 MLGQGGFGPVYKGVLS-DGKEIAVKRLS-----SCSEQGNAEFTNEVLLILKLQHKNLVK 414
++G+G FG V DGK AVK L + EQ + VLL ++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLL-KNVKHPFLVG 60
Query: 415 LLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
L + EKL V +F+ L F ++ + I + YLH
Sbjct: 61 L-HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
+ I++RDLK N+LLD + ++DFG+ + G T GT Y+APE +
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 534 LYSIKSDVFSFGVLLIEIITG 554
Y D + G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 59/237 (24%), Positives = 95/237 (40%), Gaps = 43/237 (18%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSC---SEQGNAEFTNEVLLILKLQHK 410
+F ++G+G FG V D I A+K L ++ A E ++++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
+VK+ D L+ EF+P + +L K+ L + V I +H
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIH 118
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG------------------SEGE 512
+ L IHRD+K N+LLD + K+SDFG+ S
Sbjct: 119 Q---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 513 VNTAR---------------IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
+N+ R VGT Y+APE M+ Y+ D +S GV++ E++ G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 44/223 (19%)
Query: 362 LGQGGFGPVYKGVL-----------------------SDGKEIAV--KRLSSCSEQGNAE 396
LGQG +Y G L ++G+E+ V K L
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 397 FTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI 456
F L+ ++ H +L + G CV G E ++V EF+ + LD L + R + W +I
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 457 NIVNGIVKGILYLHEDSRLRIIHRDLKASNVL-----LDYDMNP--KISDFGMARIFAGS 509
+ + + YL ED L +H ++ A N+L L +P K+SD G++ F
Sbjct: 121 TVAQQLASALSYL-EDKNL--VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTAL 175
Query: 510 EGEVNTARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEI 551
E RI ++APE G S +D +SFG L+EI
Sbjct: 176 SREERVERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 65/270 (24%), Positives = 98/270 (36%), Gaps = 46/270 (17%)
Query: 362 LGQGGFGPVYKGVLSD-GKEIAVKRLS-SCSEQGN----AEFTNEVLLILKLQHKNLVKL 415
LG+G G V+ L GK A+K L + N E+L L H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD--HPFLPTL 66
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
LV ++ P L +L + L ++ + YLH L
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLL-QRQPGKCLSEEVARFYAAEVLLALEYLH---LL 122
Query: 476 RIIHRDLKASNVLL---------DYDMNPKISDFGMARIFAGSEGEVNTARI-------- 518
I++RDLK N+LL D+D++ + A +G ++
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182
Query: 519 ----------VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF-NQSRGAT 567
VGT Y+APE + D ++ G+LL E++ G T F +R T
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT--TPFKGSNRDET 240
Query: 568 APNLLA----YAWHLWNEGNALDLIDPLLT 593
N+L + +A DLI LL
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLV 270
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 34/105 (32%), Positives = 54/105 (51%), Gaps = 16/105 (15%)
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS------EG--EVN 514
V + YLH I+HRDLK N+L+ + K++DFG+++I S EG E +
Sbjct: 111 VLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 515 T-----ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
T ++ GT Y+APE + Y D ++ G++L E + G
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 42/161 (26%), Positives = 67/161 (41%), Gaps = 39/161 (24%)
Query: 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASN 486
L+ EF+P + +L K+ L + + V I +H+ L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131
Query: 487 VLLDYDMNPKISDFGMARIFAGSE------------------GEVNTAR----------- 517
+LLD + K+SDFG+ + +N+ R
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 518 ----IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
VGT Y+APE M+ Y+ D +S GV++ E++ G
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 33/131 (25%), Positives = 52/131 (39%), Gaps = 44/131 (33%)
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF------------------- 506
I +H ++ IHRD+K N+L+D D + K++DFG+ F
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 507 ------AGSEG-------EVNTAR---------IVGTYGYMAPEYAMEGLYSIKSDVFSF 544
E R +VGT Y+APE + Y+ D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 545 GVLLIEIITGR 555
GV+L E++ G+
Sbjct: 231 GVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 6e-05
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 19/150 (12%)
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGIL 467
+ N +KL +L+ +++ D LFD +K G L ++ I+ +V+ +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPK---ISDFGMARIFAGSEGEVNTARIVGTYGY 524
LH + IIH D+K NVL YD + D+G+ +I G+ + GT Y
Sbjct: 124 DLH---KHNIIHNDIKLENVL--YDRAKDRIYLCDYGLCKI-IGTPSCYD-----GTLDY 172
Query: 525 MAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
+PE Y + D ++ GVL E++TG
Sbjct: 173 FSPEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 42/197 (21%), Positives = 92/197 (46%), Gaps = 24/197 (12%)
Query: 370 VYKGVLSDGKEIAVKRLSSCSEQGNA----EFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425
+YKG+ + KE+ ++ +G+ NE+ + ++ N++K+ GF +D +
Sbjct: 36 IYKGIF-NNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 426 L----LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHR 480
L L+ E+ L +L + L + ++++ KG+ L++ ++ ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNK---PYK 147
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL--YSIK 538
+L + + L+ + KI G+ +I + + V Y + + + Y+IK
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILS-----SPPFKNVNFMVYFSYKMLNDIFSEYTIK 202
Query: 539 SDVFSFGVLLIEIITGR 555
D++S GV+L EI TG+
Sbjct: 203 DDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 44/188 (23%), Positives = 72/188 (38%), Gaps = 66/188 (35%)
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS----------EGEVNT 515
+L + +L IHRD+K N+L+D + K+SDFG++ F +G+ N
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 516 ARI-----------------------------------VGTYGYMAPEYAMEGLYSIKSD 540
RI VGT Y+APE ++ Y + D
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230
Query: 541 VFSFGVLLIEIITG-------------RRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587
+S G ++ E + G R+ + ++ P+ + HL E A DL
Sbjct: 231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET--LYFPDDI----HLSVE--AEDL 282
Query: 588 IDPLLTDT 595
I L+T+
Sbjct: 283 IRRLITNA 290
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 43/156 (27%), Positives = 69/156 (44%), Gaps = 6/156 (3%)
Query: 395 AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSK 454
A +E L+ +L H ++ LL V G LV +P D + + L ++
Sbjct: 205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ 261
Query: 455 RINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514
+ ++ I Y+H + IIHRD+K NVL++ + + DFG A GS
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIE 550
I GT APE Y+ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 3e-04
Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 32/223 (14%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSS---CSEQGNAEFTNEVLLILKLQHKNLVKLLG- 417
+G G FG V+ +E + S E+ ++ EV ++ +L+HKN+V+ +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 418 FCVDGDEKL-LVYEFMPNSSLDAILFDPRKR-GLLCWSKRINIVNGIVKGILYLHE---- 471
F ++KL ++ EF L + K G + ++I ++ + Y H
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 472 DSRLRIIHRDLKASNVLLDYDMN-----------------PKISDFGMARIFAGSEGEVN 514
+ R++HRDLK N+ L + KI DFG+++ G E +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-GIESMAH 199
Query: 515 TARIVGTYGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGR 555
+ VGT Y +PE + Y KSD+++ G ++ E+ +G+
Sbjct: 200 SC--VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 45/127 (35%)
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIF----------AGSE------------G 511
++ IHRD+K N+L+D D + K++DFG+ F GS
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 512 EVNTAR-----------------------IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
+V+ R +VGT Y+APE + Y+ D +S GV+L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 549 IEIITGR 555
E++ G+
Sbjct: 239 FEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 31/127 (24%), Positives = 52/127 (40%), Gaps = 45/127 (35%)
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGM----------------------ARIFAGSEG 511
++ IHRD+K N+L+D D + K++DFG+ + F+ G
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 512 EVNTAR-----------------------IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
+ R +VGT Y+APE + Y+ D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 549 IEIITGR 555
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 31/147 (21%), Positives = 57/147 (38%), Gaps = 17/147 (11%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV--KLLGFC 419
L G VY + + ++ +K S + A+ EV ++ L K L K+L
Sbjct: 6 LKGGLTNRVYL-LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILY-LHEDSRLRII 478
L+ E++ +LD + + ++ + + +L LH+ L +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED-IAE----------QLAELLAKLHQLPLLVLC 111
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARI 505
H DL N+L+D I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 44/181 (24%), Positives = 69/181 (38%), Gaps = 42/181 (23%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSD-----GKEIAVKRLSSCSEQGNAE-FTNEVLL----- 403
+F LG+G FG VYK L + + +K+ +E G E + NE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK---ATEYGAVEIWMNERVRRACPN 189
Query: 404 -ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL--------------DAILFDPRKRG 448
+ L + DE LV+ + S+L +L +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKV--QD 245
Query: 449 LLCWSKRIN-IVNGIVKGILY----LHEDSRLRIIHRDLKASNVLLDYDMNP-KISDFGM 502
L +R N I+ I++ IL+ LH I+HRD+K N++ KI D G
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGA 302
Query: 503 A 503
A
Sbjct: 303 A 303
|
Length = 566 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 20/51 (39%), Positives = 33/51 (64%), Gaps = 1/51 (1%)
Query: 454 KRINIVNGIVKGILY-LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503
+ IN++ G+++ +L L + R+ I+HRD+K N+L+ D KI DFG A
Sbjct: 306 RDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 16/38 (42%), Positives = 26/38 (68%), Gaps = 3/38 (7%)
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
YLH IIHRDLK N+L+ + + K++DFG++++
Sbjct: 119 YLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| PF01657 | 106 | Stress-antifung: Salt stress response/antifungal; | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.12 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.19 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.91 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.7 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.69 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.64 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.48 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.46 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.41 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.23 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.22 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.19 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.99 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.97 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.96 | |
| PLN02236 | 344 | choline kinase | 96.75 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.72 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.69 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.11 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.01 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.87 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.7 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.61 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.6 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.27 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.22 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.07 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.77 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.64 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.57 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.47 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-55 Score=460.02 Aligned_cols=289 Identities=47% Similarity=0.788 Sum_probs=254.7
Q ss_pred ccceechhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEE
Q 005893 340 QDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419 (671)
Q Consensus 340 ~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 419 (671)
....|++.++..+|++|...+.||+|+||.||+|.+++|+.||||++.....+...+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34568999999999999999999999999999999999999999998865443145699999999999999999999999
Q ss_pred EcCC-eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEe
Q 005893 420 VDGD-EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKIS 498 (671)
Q Consensus 420 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 498 (671)
.+.+ +.+||||||++|+|+++|+..... .++|.+|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 499999999999999999864444 89999999999999999999999988899999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH
Q 005893 499 DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL 578 (671)
Q Consensus 499 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~ 578 (671)
|||+++..........+.. .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+..... ....+..|++..
T Consensus 220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~--~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR--GELSLVEWAKPL 296 (361)
T ss_pred CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc--ccccHHHHHHHH
Confidence 9999976543111111111 7999999999999999999999999999999999999988765422 445599999999
Q ss_pred HhcCCcccccccccc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 579 WNEGNALDLIDPLLT-DTCSP-DEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+.++...+++|+.+. +.+.. +++.++.+++++|++.+|++||+|.||+++|+..
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 999999999999987 56554 6899999999999999999999999999999543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=389.66 Aligned_cols=256 Identities=32% Similarity=0.490 Sum_probs=207.9
Q ss_pred CcccccCCCCcccEEEEEecCCceEEEEEccccchh--chHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-eeeEEEeccC
Q 005893 357 SDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ--GNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVYEFMP 433 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~ 433 (671)
...+.||+|+||+||+|.+.+...||||++...... ...+|.+|+.+|.+++|||||+++|+|.+.. ...+|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 335669999999999999964444999999764322 2568999999999999999999999999988 7899999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccccCCCCc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~~ 512 (671)
+|+|..+++.. ....+++..+++|+.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 99999999653 46779999999999999999999999874 99999999999999997 99999999998754432
Q ss_pred cccccccccCCccchhhhc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAM--EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
.......||+.|||||++. ...|+.|+|||||||++|||+||+.||.... ..+.+......+...
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~--------~~~~~~~v~~~~~Rp----- 265 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA--------PVQVASAVVVGGLRP----- 265 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCCCC-----
Confidence 1222368999999999999 5699999999999999999999999996322 233333333333222
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETI 634 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~ 634 (671)
.+...++ ..+..++.+||+.||+.||++.|++.+|+....
T Consensus 266 ~~p~~~~----~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 266 PIPKECP----PHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCccCC----HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 2222233 346677779999999999999999999986543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=384.22 Aligned_cols=261 Identities=34% Similarity=0.516 Sum_probs=212.3
Q ss_pred cceechhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEE
Q 005893 341 DFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420 (671)
Q Consensus 341 ~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 420 (671)
.+.++.+++.. .+.||+|.||.||.|.++....||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|.
T Consensus 200 ~wei~r~~l~l-------~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 200 PWEIPREELKL-------IRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred CeeecHHHHHH-------HHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 45566666655 5779999999999999987779999999875 344567899999999999999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
.++..+||||||+.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+||
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDF 347 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDF 347 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccc
Confidence 99999999999999999999965 45667999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
||++....+.... .....-+..|.|||.+..+.++.|||||||||+||||+| |+.|++... ..++++ .+
T Consensus 348 GLAr~~~d~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----n~ev~~----~l 417 (468)
T KOG0197|consen 348 GLARLIGDDEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----NEEVLE----LL 417 (468)
T ss_pred ccccccCCCceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----HHHHHH----HH
Confidence 9999544443332 223345678999999999999999999999999999999 888875332 112222 22
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 580 NEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
..|..+. . ...+++ .+.+|+..||+.+|++|||++.+...|+..
T Consensus 418 e~GyRlp--~---P~~CP~----~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 418 ERGYRLP--R---PEGCPD----EVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred hccCcCC--C---CCCCCH----HHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 2222111 0 122333 366788899999999999999999988764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.00 Aligned_cols=247 Identities=30% Similarity=0.443 Sum_probs=203.3
Q ss_pred cccccCCCCcccEEEEEec-CCceEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-eeeEEEeccCC
Q 005893 358 DSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVYEFMPN 434 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~~ 434 (671)
..+.||+|..|+|||+.++ +++.+|+|++.. ......+++.+|++++++.+||+||.++|.|.... ...++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 3678999999999999975 688899999953 34455678999999999999999999999999999 49999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
|+|+.++. ..+.+++...-+|+.+|++||.|||+ .+ ||||||||+|||++..|++||+|||.++.+.+.
T Consensus 163 GSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 163 GSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 99999984 34669999999999999999999996 55 999999999999999999999999999987655
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
.-...+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+..... ......+..-....+. + |.+.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll~~Iv~~p-p-----P~lP 303 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELLCAIVDEP-P-----PRLP 303 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHHHHHhcCC-C-----CCCC
Confidence 12346899999999999999999999999999999999999999975411 2223333322222221 1 2333
Q ss_pred CC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 594 DT-CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 594 ~~-~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. ++++ +..++-.|++.||.+||++.|+++
T Consensus 304 ~~~fS~e----f~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 304 EGEFSPE----FRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cccCCHH----HHHHHHHHhcCCcccCCCHHHHhc
Confidence 33 4443 556666999999999999999985
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=400.01 Aligned_cols=261 Identities=30% Similarity=0.439 Sum_probs=217.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
...+....+.||+|.||+||+|+.. +.+.||||.++...+. ...+|++|++++.+|+|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3445555688999999999999853 3457999999976555 78899999999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCC-------C----CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC
Q 005893 425 KLLVYEFMPNSSLDAILFDPR-------K----RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 493 (671)
.++|+|||..|||.++|.... . ..+++..+.+.|+.|||.||.||-++. +|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 999999999999999996311 1 334889999999999999999999887 99999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHH
Q 005893 494 NPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLL 572 (671)
Q Consensus 494 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~ 572 (671)
.+||+||||+|.....++.....+..-.++||+||.++.++||.+||||||||+|||+++ |+.|+..... ++
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-----~E-- 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-----QE-- 713 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----HH--
Confidence 999999999998877776665545566789999999999999999999999999999999 9999854322 12
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 573 AYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
+....+.++..+. +.+....+..|++.||+.+|++||+++||-..|+.-.
T Consensus 714 --VIe~i~~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 714 --VIECIRAGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred --HHHHHHcCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 2334445554322 2333345788899999999999999999999998643
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=358.83 Aligned_cols=197 Identities=32% Similarity=0.534 Sum_probs=177.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.+|...+.||+|+||+||+|++. ++.+||||.+... ..+..+.+..|+.+|++++|||||.+++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 46777788999999999999975 5789999998764 45566678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC------CCeEEeeccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD------MNPKISDFGMAR 504 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~Dfgla~ 504 (671)
||.+|+|..++ +.++.+++.....++.|+|.||++||+++ ||||||||+||||+.. -.+||+|||+++
T Consensus 90 yC~gGDLs~yi---~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYI---RRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999 45567999999999999999999999998 9999999999999765 458999999999
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
.+.+... -...+|++.|||||+++.++|+.|+|+||+|+|+||+++|+.||+
T Consensus 164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 8864332 234799999999999999999999999999999999999999995
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=374.39 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=207.9
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccc---cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSS---CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
..|...+.||+|+|+.||+++. ..|+.||+|++.+ .+....+.+.+|+++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999997 7899999999975 23445667899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|+|++++|..++ +.++.+++.+++.+++||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999998 46778999999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
... ....||||.|+|||++.....+..+||||+||++|.|+.|++||+- ..+.+...+ .+. .+
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet--------k~vkety~~-Ik~------~~ 234 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET--------KTVKETYNK-IKL------NE 234 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc--------chHHHHHHH-HHh------cC
Confidence 333 3347999999999999988999999999999999999999999952 222222211 111 12
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..++...+. + ..+++..+|+.||++|||+++|+.
T Consensus 235 Y~~P~~ls~-~---A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 YSMPSHLSA-E---AKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccccccCH-H---HHHHHHHHhcCCcccCCCHHHHhc
Confidence 222222222 2 345666999999999999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=384.31 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=213.8
Q ss_pred hCCCCcccccCCCCcccEEEEEecC----CceEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.....+.++||.|.||+|++|.++- ...||||.|+. ..++.+.+|+.|..+|.++.||||++|.|+.......++
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3455678999999999999999752 34699999996 456677899999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|.|||++|+|+.+|.. +.+.+++.++..++++||.||.||-+.+ +|||||.++|||++.+..+|++||||+|.+.
T Consensus 708 iTEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred EhhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999964 4466999999999999999999999988 9999999999999999999999999999875
Q ss_pred CCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 508 GSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 508 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
++.... .+..-.=+.+|.|||.+..++++.+||||||||+|||.++ |.+||...... +..
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------------------dVI 844 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------------------DVI 844 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH------------------HHH
Confidence 544221 2222223468999999999999999999999999999988 99998643221 122
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
..++..++-..+++....|.+|++.|||.|-.+||.+.+|+.+|++.
T Consensus 845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 22232233333556667799999999999999999999999998763
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=341.93 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=207.7
Q ss_pred CCCcccccCCCCcccEEEEE-ecCCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeE-EEcCCe-eeEEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGF-CVDGDE-KLLVY 429 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~-~~~~~~-~~lv~ 429 (671)
+|++.++||+|.||+|||+. +.+|..||.|.++- .+.+..+++..|+.+|++|+|||||+++++ +.++.+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46778899999999999998 46899999998873 345667789999999999999999999984 334444 78999
Q ss_pred eccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCC-CCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 430 EFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDS-RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 430 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~-~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||+..|+|..++... +.++.+++..+|+++.|++.||.++|.+- +.-|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999998653 34567999999999999999999999842 1239999999999999999999999999999987
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
+..... ...+|||.||+||.+.+..|+.||||||+||++|||..-+.||. ..++.....+. ..++...
T Consensus 180 s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~--------g~n~~~L~~KI-~qgd~~~- 247 (375)
T KOG0591|consen 180 SKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY--------GDNLLSLCKKI-EQGDYPP- 247 (375)
T ss_pred chhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc--------cccHHHHHHHH-HcCCCCC-
Confidence 654432 23699999999999999999999999999999999999999994 33565554333 2332211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+.++ .....+.+|+..|+..||+.||+...+++.+.+
T Consensus 248 ----~p~~---~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 ----LPDE---HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----CcHH---HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111 122356677789999999999997666665554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=352.07 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=197.1
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchh-------chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQ-------GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
.+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.... ......+|+++|++|+|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 34577789999999999999985 57999999999752211 12235799999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC---CCeEEeecc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD---MNPKISDFG 501 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfg 501 (671)
.|+||||++||+|-+.+. .++.+.+..-..+++|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999988884 3455777777889999999999999999 9999999999999765 789999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY---SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL 578 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~ 578 (671)
+++...... .....|||+.|.|||++.++.+ ..|.|+||+||+||-+++|.+||...... ..+. +.
T Consensus 325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~sl~----eQ 393 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PSLK----EQ 393 (475)
T ss_pred hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----ccHH----HH
Confidence 999875332 2345799999999999987643 34889999999999999999999643321 1111 12
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...|+... .+. ...+--++.++++.++|..||++|||+.|+++
T Consensus 394 I~~G~y~f--~p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 394 ILKGRYAF--GPL----QWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HhcCcccc--cCh----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 22222211 010 11122234566777999999999999999985
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=342.76 Aligned_cols=243 Identities=26% Similarity=0.334 Sum_probs=200.9
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
..++|++.++||+|+||+|+.++.. +++.+|+|++++.. ..+.+...+|..+|.+++||.||+++..|++.+.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3467889999999999999999864 58899999997632 3445678899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|+||+.||.|..+| +..+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++..-
T Consensus 103 Vld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 99999999999998 55677999999999999999999999998 9999999999999999999999999998644
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.... .+...+||+.|||||++....|+..+|+||||+++|||++|.+||. ..+...+..+..+.. .
T Consensus 177 ~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~--------~~~~~~~~~~I~~~k-~--- 242 (357)
T KOG0598|consen 177 KDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY--------AEDVKKMYDKILKGK-L--- 242 (357)
T ss_pred cCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc--------CccHHHHHHHHhcCc-C---
Confidence 3322 2344799999999999999999999999999999999999999994 344444443333322 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP 620 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 620 (671)
...+.....+ ..+++...++.||++|-
T Consensus 243 ---~~~p~~ls~~---ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 ---PLPPGYLSEE---ARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCccCCHH---HHHHHHHHhccCHHHhc
Confidence 1112212233 44556689999999995
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=359.31 Aligned_cols=271 Identities=27% Similarity=0.436 Sum_probs=212.5
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
..++.++..+.+...+.||+|+||+||+|.+. ..||||++.. ......+.|++|+.++++-+|.||+-+.|+|.+.
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34555555566667889999999999999994 3699999974 3344667899999999999999999999999887
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
.. .+|+.+|++.+|..+|+..+ ..++..+.+.|++||++||.|||.++ |||||||.+||+|+++++|||+||||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 77 99999999999999997644 45899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAME---GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
+..-..-..........|...|||||+++. .+|++.+||||||+++|||++|..||.....+ +. .|
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--------qI---if 603 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--------QI---IF 603 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--------he---EE
Confidence 976443333333344567889999999965 47999999999999999999999999732211 11 12
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCC
Q 005893 580 NEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLC 637 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~ 637 (671)
.-|+-.-..|......-.+. .+.+|+..||..++++||.+.+|+.+|+.....++
T Consensus 604 mVGrG~l~pd~s~~~s~~pk---~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 604 MVGRGYLMPDLSKIRSNCPK---AMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred EecccccCccchhhhccCHH---HHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 22322222222222222233 35566669999999999999999998877654443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=348.70 Aligned_cols=267 Identities=25% Similarity=0.392 Sum_probs=217.8
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhc-hHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG-NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
...+...+.++||+|.||+|.......+..||||+++...... ..+|.+|+++|.+|+|||||+++|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 4445567789999999999999999888999999999755444 478999999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|||++|+|..++....- ..+.-....+|+.||+.||+||.+.+ +|||||.++|+|+|.++++||+|||++|.+...
T Consensus 615 EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999954321 22455667789999999999999988 999999999999999999999999999988777
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT--GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
++.....+.+-+++|||||.+..++++.++|||+||+++||+++ ..+||+... .+..++..-..+..+.....
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt-----~e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT-----DEQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh-----HHHHHHhhhhhcCCCCccee
Confidence 77776667788899999999999999999999999999999865 677875432 22333433333333322111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+ .. ++-....+.++++.||..+-++||+.++|...|+..
T Consensus 766 l---~~---P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 L---SR---PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred c---cC---CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 11 112233466899999999999999999999998764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=379.40 Aligned_cols=260 Identities=33% Similarity=0.529 Sum_probs=211.5
Q ss_pred hCCCCcccccCCCCcccEEEEEecC--Cc----eEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD--GK----EIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
..+.+..+.||+|.||.||+|...+ |. .||||.+++ .+.+...+|.+|..+|++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3445567889999999999999743 33 499999986 4567778999999999999999999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCC----CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 426 LLVYEFMPNSSLDAILFDPRK----RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
+|++|||++|+|..+|.+.+. ...++..+.+.++.|||+|+.||++++ +|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999976532 445899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
|++.+...+......+..-...|||||.+..+.++.|+|||||||++||++| |..||+..... .+ ...+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-----~v----~~~~~ 918 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-----EV----LLDVL 918 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-----HH----HHHHH
Confidence 9996665555544443344568999999999999999999999999999999 88898643221 11 12122
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
++- .+++ ..+.+ .++.+++..||+.+|++||++..|++.++...
T Consensus 919 ~gg---RL~~---P~~CP---~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 919 EGG---RLDP---PSYCP---EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred hCC---ccCC---CCCCC---hHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 222 1111 22223 35668889999999999999999999777653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=348.39 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=211.2
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
..|....+||+|..|.||.+.. .+++.||||++........+-+.+|+.+|+..+|+|||.++..+...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4566678999999999999984 578899999998766666777899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++.. ..+++.++..|+++++.||+|||.++ |+|||||.+|||++.+|.+||+|||++..+...+..
T Consensus 353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999999843 33899999999999999999999998 999999999999999999999999999987665543
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
....+||+.|||||+.....|++|.||||||++++||+-|++|| -.++.++..|.....|.+.--..
T Consensus 426 --R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPY--------lnE~PlrAlyLIa~ng~P~lk~~--- 492 (550)
T KOG0578|consen 426 --RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPY--------LNENPLRALYLIATNGTPKLKNP--- 492 (550)
T ss_pred --cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCc--------cCCChHHHHHHHhhcCCCCcCCc---
Confidence 34469999999999999999999999999999999999999998 33455666666655555422111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+..++ + +.++..+||+.|+++||++.|+++
T Consensus 493 -~klS~-~---~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 -EKLSP-E---LKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -cccCH-H---HHHHHHHHhhcchhcCCCHHHHhc
Confidence 11222 3 445556999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.49 Aligned_cols=262 Identities=29% Similarity=0.425 Sum_probs=203.4
Q ss_pred HHhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG 422 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 422 (671)
+..++|++.++||+|+||.||++.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3556788899999999999999974 235689999997533 23345789999999999 899999999988765
Q ss_pred C-eeeEEEeccCCCchhhhhcCCCC-------------------------------------------------------
Q 005893 423 D-EKLLVYEFMPNSSLDAILFDPRK------------------------------------------------------- 446 (671)
Q Consensus 423 ~-~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 446 (671)
+ ..++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4 57899999999999998854211
Q ss_pred ----CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccC
Q 005893 447 ----RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY 522 (671)
Q Consensus 447 ----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~ 522 (671)
...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...............++.
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 134788899999999999999999988 9999999999999999999999999998654332222222345667
Q ss_pred CccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHH
Q 005893 523 GYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEF 601 (671)
Q Consensus 523 ~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 601 (671)
.|+|||++.+..++.++||||||+++|||++ |+.||...... .........+... ......+
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~~~~-----~~~~~~~---- 303 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--------EEFCQRLKDGTRM-----RAPENAT---- 303 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--------HHHHHHHhcCCCC-----CCCCCCC----
Confidence 8999999999999999999999999999997 99998642211 1111222222211 1112222
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 602 LRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 602 ~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
..+.+++.+||+.||++|||+.||+++|+..
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2467888899999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=333.10 Aligned_cols=265 Identities=28% Similarity=0.376 Sum_probs=199.2
Q ss_pred CcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhh--cCCCCeeeEeeEEEcCC----eeeEEEe
Q 005893 357 SDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILK--LQHKNLVKLLGFCVDGD----EKLLVYE 430 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lv~e 430 (671)
+..++||+|+||.||||.+. ++.||||++.. ++.+.|.+|-++... ++|+||+++++.-.... +.+||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34578999999999999994 59999999975 344567777777664 68999999999877655 7899999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC------CCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED------SRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
|.++|+|.++| +...++|....+|+..|++||+|||+. .+++|+|||||++||||.+|+++.|+||||+.
T Consensus 289 fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 99999999999 456799999999999999999999975 36789999999999999999999999999999
Q ss_pred cccCCCCccccccccccCCccchhhhccC-CCC-----cchhhHHHHHHHHHHHhCCCCCCCCCCCC----------CCC
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYS-----IKSDVFSFGVLLIEIITGRRNTGFNQSRG----------ATA 568 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-----~ksDVwSlGvil~elltG~~p~~~~~~~~----------~~~ 568 (671)
.+........+...+||.+|||||++.+. .+. .+.||||+|.|||||++.-..... .... +..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhcCC
Confidence 98876665555567999999999998653 222 368999999999999996543321 0000 011
Q ss_pred CCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCC
Q 005893 569 PNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETI 634 (671)
Q Consensus 569 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~ 634 (671)
..+-+...-..++.....+-+.... ...+.-+.+.+..||..||+-|-|+.=|.+.+.....
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 1111111111112111111111111 1335567788889999999999999998888776543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=331.24 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=205.3
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
..+.|+...+||.|..++||+|+. +.+..||||++.- ....+.+.+.+|+..+..++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 345688889999999999999995 5679999999863 23334678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
.||.+|++.++++..- ...+++..+..|++++++||.|||++| -||||||+.||||+++|.+||+|||.+-.+...
T Consensus 104 pfMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999986532 334899999999999999999999998 999999999999999999999999988765543
Q ss_pred CCcc--ccccccccCCccchhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 510 EGEV--NTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 510 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.... .....+||+.|||||++++. .|+.|+||||||++..||.+|..||....+ .+.....+....+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--------mkvLl~tLqn~pp- 250 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--------MKVLLLTLQNDPP- 250 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--------HHHHHHHhcCCCC-
Confidence 3222 11457999999999997654 589999999999999999999999964321 1222222222211
Q ss_pred ccccccccCCCCHHH----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 586 DLIDPLLTDTCSPDE----FLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~----~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...- ...+.++ -+.+.+++-.|++.||++|||++++++
T Consensus 251 ~~~t----~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 251 TLLT----SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred Cccc----ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1111 1112222 125778888999999999999999864
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=340.15 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=208.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccc---cchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSS---CSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 426 (671)
..++|...+.||+|+|++|++++. ..++++|||++.+ ..++..+.+..|-+.|.+| .||.|++|+..|+++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 346788899999999999999995 4689999999975 2344556788899999999 8999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+|+||.++|+|.++|. +-+.+++...+.++.+|+.||+|||+.| ||||||||+|||||+++++||.|||-++.+
T Consensus 151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999994 4577999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCc---------ccc--ccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 507 AGSEGE---------VNT--ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 507 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
.+.... ... ..++||..|.+||++..+..+..+|+|+||||||+|+.|++||... .+.+.+.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-------NeyliFq 297 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-------NEYLIFQ 297 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-------cHHHHHH
Confidence 654322 111 3479999999999999999999999999999999999999999532 2222222
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.-+- ++-.+...+++ ...+|+.+.|..||.+|+|.++|.+
T Consensus 298 kI~~--------l~y~fp~~fp~----~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 298 KIQA--------LDYEFPEGFPE----DARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHH--------hcccCCCCCCH----HHHHHHHHHHccCccccccHHHHhh
Confidence 1111 23334444443 3556677999999999999999987
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=334.88 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=199.0
Q ss_pred CCCCcccccCCCCcccEEEEEecC-CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC--eeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e 430 (671)
.++...+.||+|.||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+++|...... ...++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 345667899999999999999754 8999999987653333567899999999999999999999855444 5889999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeeccccccccCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIFAGS 509 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~ 509 (671)
|+++|+|.+++..... .+++..+..+.+||++||.|||+++ |+|+||||.|||++. ++.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999954322 6999999999999999999999998 999999999999999 799999999999876541
Q ss_pred -CCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 510 -EGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 510 -~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
..........||+.|||||++.++.. ..++|||||||++.||+||+.||... .....+......+..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~---- 240 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDS---- 240 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCC----
Confidence 11122334789999999999986533 35999999999999999999999632 112222222222221
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
-|.+....+. + ..+++.+|++.+|++|||++|+++.-
T Consensus 241 -~P~ip~~ls~-~---a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 241 -LPEIPDSLSD-E---AKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -CCCCCcccCH-H---HHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1223333333 2 44556699999999999999999743
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=350.16 Aligned_cols=264 Identities=30% Similarity=0.418 Sum_probs=207.7
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecC--C--ce-EEEEEccc---cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSD--G--KE-IAVKRLSS---CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
..+++....++||+|+||.||+|.+.. + .. ||||..+. .......+|.+|.++|++++|||||+++|++...
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 344444556899999999999999742 2 23 89999874 3456678899999999999999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
..+++|||+++||+|+++|.. ..+.++..+++.++.+.|.||+|||+++ +|||||.++|+|++.++.+||+||||
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccc
Confidence 999999999999999999953 2336999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
++.-. ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..||... ...+...+....
T Consensus 309 s~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--------~~~~v~~kI~~~ 378 (474)
T KOG0194|consen 309 SRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--------KNYEVKAKIVKN 378 (474)
T ss_pred ccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--------CHHHHHHHHHhc
Confidence 87543 11111112245678999999999999999999999999999999 88888432 222322222233
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCC
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQ 638 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~ 638 (671)
+..... ....+.++. .++..||+.+|++||+|.++.+.|+........
T Consensus 379 ~~r~~~------~~~~p~~~~---~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 379 GYRMPI------PSKTPKELA---KVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CccCCC------CCCCHHHHH---HHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 222111 123444444 455599999999999999999999876555444
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=320.08 Aligned_cols=261 Identities=22% Similarity=0.326 Sum_probs=201.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
+.|+...++|+|+||.|||++.+ +|+.||||++....+ .-.+-.++|+++|++|+|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999975 599999999975332 223456899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|++..-|+++- +....++...+.+++.|++.|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+....
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 99988877764 34556888999999999999999999998 9999999999999999999999999999886421
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH----------HHHH
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA----------WHLW 579 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~----------~~~~ 579 (671)
...+..+.|..|.|||.+.+ .+|+...|||++||++.||++|.+-|+..+.. ..+.... .+.+
T Consensus 156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi----DQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI----DQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH----HHHHHHHHHHcccCHHHHHHh
Confidence 12334688999999999987 68999999999999999999999888643321 1111111 1111
Q ss_pred hcCCcc-cccccc------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNAL-DLIDPL------LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~~-~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...... .+.-|. +...+ +.-..-+++++..|++.||++|++-+|++.
T Consensus 230 ~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111111 111111 11111 122235788999999999999999999863
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.52 Aligned_cols=265 Identities=26% Similarity=0.414 Sum_probs=202.1
Q ss_pred hCCCCcccccCCCCcccEEEEEecC-----------------CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD-----------------GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVK 414 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 414 (671)
.++|...++||+|+||.||++.+.+ +..||+|++.... .....++.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3567888999999999999998532 3369999987643 334567899999999999999999
Q ss_pred EeeEEEcCCeeeEEEeccCCCchhhhhcCCC----------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCcee
Q 005893 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPR----------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478 (671)
Q Consensus 415 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~iv 478 (671)
+++++.+.+..++||||+++++|.+++.... ....++|..+++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885321 1234788999999999999999999988 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhC--CC
Q 005893 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG--RR 556 (671)
Q Consensus 479 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG--~~ 556 (671)
||||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865443332223334567889999999888999999999999999999975 44
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 557 NTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 557 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
|+.... .................. ........++ ..+.+++.+||+.+|++|||+.||.++|++
T Consensus 241 p~~~~~-----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELT-----DEQVIENAGEFFRDQGRQ--VYLFRPPPCP----QGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCC-----HHHHHHHHHHHhhhcccc--ccccCCCCCC----HHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 553211 112222222222111110 0000111222 346788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=337.49 Aligned_cols=264 Identities=27% Similarity=0.392 Sum_probs=219.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|...+.||+|.||.||||+.+ +.+.||+|.+.+. .+++...+.+|++++++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777889999999999999964 6789999998753 34556678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+.+ +|..+| ...+.++++.+..|+.++..||.|||+++ |+|||+||+|||++.++.+|++|||+++....+.
T Consensus 82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 999999 45667999999999999999999999988 9999999999999999999999999999876543
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ..+.+.|||.|||||+..+++|+..+|.||+|||+||+.+|++|| ....+.+.+.....++..
T Consensus 155 ~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF--------~a~si~~Lv~~I~~d~v~------ 218 (808)
T KOG0597|consen 155 S--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF--------YARSITQLVKSILKDPVK------ 218 (808)
T ss_pred e--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc--------hHHHHHHHHHHHhcCCCC------
Confidence 2 334579999999999999999999999999999999999999999 333444544444333211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCCCCCCCCCCCCccc
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGETITLCQPQKPAFS 645 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~~~~~~~p~~p~~~ 645 (671)
.+...-..++++....++.||..|.|-.+++. ++++.......|..|+|.
T Consensus 219 -----~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~ 270 (808)
T KOG0597|consen 219 -----PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFD 270 (808)
T ss_pred -----CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhccccccccc
Confidence 11222334777777999999999999999876 556655556677777765
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=329.62 Aligned_cols=245 Identities=21% Similarity=0.321 Sum_probs=195.0
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhc---hHHHHHHHHHHhhcCCCCeeeEeeEEEc----CCeeeEEEec
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG---NAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVYEF 431 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~ 431 (671)
...||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+.++.+++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68999999997643322 4568899999999999999999999877 3467899999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
+++|+|.+++.. .+.+++...++++.|++.||.|||+. + ++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999999843 45689999999999999999999984 5 8899999999999999999999999988653321
Q ss_pred CccccccccccCCccchhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAME--GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+........+..
T Consensus 178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~---- 240 (283)
T PHA02988 178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------TKEIYDLIINKNNS---- 240 (283)
T ss_pred -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcCCC----
Confidence 12467889999999876 689999999999999999999999995321 11111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
..+...++ + .+.+++.+||+.||++|||++||++.|+..
T Consensus 241 -~~~~~~~~-~---~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 241 -LKLPLDCP-L---EIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -CCCCCcCc-H---HHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11111222 2 356777799999999999999999999753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.96 Aligned_cols=253 Identities=31% Similarity=0.512 Sum_probs=203.5
Q ss_pred ceechhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc
Q 005893 342 FYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421 (671)
Q Consensus 342 ~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 421 (671)
+.+.+++|.. ++.||.|+.|.||+|++ .++.||||+++...+ .+|+-|++|+|+||+.+.|+|..
T Consensus 119 WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 119 WEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred ccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecC
Confidence 4455555543 57799999999999999 478999998875433 46778999999999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
....+||||||..|.|..+| +....+.......|..+||.||.|||.+. |||||||.=||||..+..+||+|||
T Consensus 184 sPcyCIiMEfCa~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred CceeEEeeeccccccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEecccc
Confidence 99999999999999999999 45566888889999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
-++...... ....++||-.|||||++.+.+.++|.||||||||||||+||.-||...... . ..|.-
T Consensus 258 TS~e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--------A---IIwGV 323 (904)
T KOG4721|consen 258 TSKELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--------A---IIWGV 323 (904)
T ss_pred chHhhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--------e---eEEec
Confidence 988765432 223468999999999999999999999999999999999999998643221 0 11111
Q ss_pred C-CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 582 G-NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 582 ~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
| +.+. .....-.|+.++- ++.+||+..|.+||++++++..|+-...++
T Consensus 324 GsNsL~----LpvPstcP~Gfkl---L~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 324 GSNSLH----LPVPSTCPDGFKL---LLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred cCCccc----ccCcccCchHHHH---HHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 1 1111 1112223444444 455999999999999999999998654443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=382.20 Aligned_cols=260 Identities=24% Similarity=0.476 Sum_probs=213.4
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
..|...++||+|+||.||+|+. .++..||||+++...... ..|+..+++++|||||+++|++.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999997 578999999987543222 35688899999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++. .++|..+.+|+.||++||+|||....++|+||||||+||+++.++..++. ||........
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999984 28999999999999999999996645569999999999999999988875 6654432211
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
....+++.|+|||++.+..++.|+|||||||++|||+||+.|++... .....+.+|++...........+|+.+
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF---GVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc---CCCCcHHHHHHHhcCccchhheeCccc
Confidence 12367899999999999999999999999999999999999985322 134556677665555555556677766
Q ss_pred cC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 593 TD--TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 593 ~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
.. ....++..++.+++.+||+.+|++||||+||+++|+...
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 44 334567778999999999999999999999999998653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=346.78 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=202.6
Q ss_pred HhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCC
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 423 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 423 (671)
..++|+..+.||+|+||.||+++. .++..||||+++... ......+.+|+.++..+ +||||+++++++....
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788899999999999999973 245689999997532 33445688999999999 8999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCCC---------------------------------------------------------
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRK--------------------------------------------------------- 446 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 446 (671)
..++||||+++|+|.+++.....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999988853211
Q ss_pred ---------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 447 ---------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 447 ---------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
...+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 124788999999999999999999988 99999999999999999999999999986544332
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...++....+....
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~~---- 337 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--------SKFYKMIKEGYRML---- 337 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--------HHHHHHHHhCccCC----
Confidence 222222345678999999999999999999999999999998 88887532111 11122222221110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
. ....+. .+.+++.+||+.||++||++.||+++|+.
T Consensus 338 -~-~~~~~~---~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 338 -S-PECAPS---EMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred -C-CCCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1 111222 46678889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.08 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=199.7
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 427 (671)
.+.|+..++||+|.||.|||++. .+|+.||+|+++... +.......+||.+|++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 34567778899999999999995 579999999987543 34455678999999999999999999999877 67899
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|+|||+. +|.-++.. ..-.|+..++..+++|++.||.|+|..+ |+|||||.+|||||.+|.+||+||||++.+.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999975 67666632 3445999999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC---
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN--- 583 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~--- 583 (671)
.......+. .+-|..|.|||++.+. .|+.+.|+||.||||.||+.|++.+.... ....+.-+.++.....
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t-----EveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT-----EVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc-----HHHHHHHHHHHhCCCChhc
Confidence 766554443 4668999999998874 79999999999999999999999885322 1111222222211110
Q ss_pred c-------ccccccccc-CCCCHHH----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 A-------LDLIDPLLT-DTCSPDE----FLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~-------~~~~d~~l~-~~~~~~~----~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
| ...+.+.-. ...-.+. ....++++..+|..||++|.|+.++++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 011111100 0000011 123567777899999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=300.80 Aligned_cols=262 Identities=25% Similarity=0.357 Sum_probs=203.9
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchh--chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQ--GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.+|...++||+|.||.||+|+. .+|+.||||+++..... -.....+|+..|++++|+||+.++++|-+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 3567788999999999999995 57999999999754322 24467899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
||+ .+|+.++.+ +...++..++..++.++++||+|||++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 689999864 4566999999999999999999999998 9999999999999999999999999999887654
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc---cc
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA---LD 586 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~---~~ 586 (671)
.... ..+-|..|.|||++.+ ..|+...|+||.|||+.||+-|.+-|... .+.+.+....+.+..... .+
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~-----sDidQL~~If~~LGTP~~~~WP~ 228 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD-----SDIDQLSKIFRALGTPTPDQWPE 228 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC-----chHHHHHHHHHHcCCCCcccCcc
Confidence 3322 2377899999998876 57999999999999999999988766422 222222223333322221 11
Q ss_pred c---cc--------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 587 L---ID--------PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 587 ~---~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
+ -| +......-+......++++..++..||.+|+|++|.+++
T Consensus 229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1 11 000011222233456788889999999999999999853
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.54 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=202.9
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD 421 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 421 (671)
....++|+..+.||+|+||.||+++.. ++..||+|+++... ......+.+|+.+++.+ +|+||+++++++..
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344567888999999999999998742 34579999997533 33345688999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCC--------------------------------------------------------
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPR-------------------------------------------------------- 445 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 445 (671)
....++||||+++|+|.+++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 999999999999999998874311
Q ss_pred -----------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 446 -----------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 446 -----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
....+++..+++++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 1124788899999999999999999988 99999999999999999999999999986543322222
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...+.....+. .....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--------~~~~~~~~~~~-----~~~~~ 337 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--------SKFYKMVKRGY-----QMSRP 337 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--------HHHHHHHHccc-----CccCC
Confidence 222345678999999998999999999999999999997 99998542211 11112222211 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+ ..+.+++.+||+.+|++||++.+|+++|+.
T Consensus 338 ~~~~----~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 338 DFAP----PEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 1122 236677789999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.03 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=202.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc----ch-hchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC----SE-QGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDE 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~ 424 (671)
...+|...+.||+|.||.|+.|.. .++..||+|++.+. .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456788899999999999999985 46899999977653 11 23446778999999998 9999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeecccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMA 503 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla 503 (671)
.++||||+.+|+|.+++.. .+.+.+.....+++|++.|++|||+++ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999943 566888999999999999999999998 9999999999999999 99999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGL-YS-IKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
........ .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+. .+.....++ ...
T Consensus 169 ~~~~~~~~--~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--------~~~~~l~~k-i~~ 237 (370)
T KOG0583|consen 169 AISPGEDG--LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--------SNVPNLYRK-IRK 237 (370)
T ss_pred cccCCCCC--cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------ccHHHHHHH-Hhc
Confidence 97642222 233469999999999999877 75 789999999999999999999964 222232222 222
Q ss_pred CCccccccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDLIDPLLTDTC-SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.. .+.... ++ .+..++.+|++.||.+|+|+.||++
T Consensus 238 ~~~------~~p~~~~S~----~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 GEF------KIPSYLLSP----EARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCc------cCCCCcCCH----HHHHHHHHHcCCCcccCCCHHHHhh
Confidence 211 111112 22 3667777999999999999999983
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.12 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=201.0
Q ss_pred hCCCCcccccCCCCcccEEEEEec----CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... ......+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456888899999999999999863 35689999998643 3334578899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+||+++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999853 2346899999999999999999999988 9999999999999999999999999876532
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
.... .......++..|+|||.+..+.++.++||||||+++||+++ |+.||..... .... +....+..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~-~~~~~~~~-- 226 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVI-KAVEDGFR-- 226 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHH-HHHHCCCC--
Confidence 2111 11112345678999999999999999999999999999875 9999853211 1111 11112111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
......++ ..+.+++..||+.+|++||+++||.+.|+.
T Consensus 227 ---~~~~~~~~----~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 ---LPAPRNCP----NLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred ---CCCCCCCC----HHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11112222 346778889999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.59 Aligned_cols=249 Identities=35% Similarity=0.570 Sum_probs=192.5
Q ss_pred ccccCCCCcccEEEEEec-----CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 359 SNMLGQGGFGPVYKGVLS-----DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.+.||.|.||.||+|.+. .+..|+||.++.. .....+.+.+|++.+.+++||||++++|++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999986 2568999999753 3344678999999999999999999999999888899999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.++|... ....+++..++.|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||++.........
T Consensus 84 ~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 84 PGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999999653 3456999999999999999999999988 999999999999999999999999999876333222
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
...........|+|||.+....++.++||||||+++|||++ |+.|+... ......... .++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~-~~~~~~~----- 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKL-KQGQRLP----- 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHH-HTTEETT-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-cccccce-----
Confidence 22333456778999999999999999999999999999999 67887422 222222222 2222211
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
....++. .+.+++..||+.+|++||++++|++.|
T Consensus 226 ~~~~~~~----~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPK----DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBH----HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhH----HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112222 366778899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=325.37 Aligned_cols=208 Identities=24% Similarity=0.335 Sum_probs=180.6
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
.......++|+.+.+||+|+||.||+++.+ +|..+|+|++++.. ......+..|-.+|....+|+||+++..|++.
T Consensus 134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 334556788999999999999999999964 69999999998643 34456788999999999999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
+.+||||||++||++..+| ...+.|++..+...+.+++.|+.-||+.| +|||||||+|+|||..|++||+||||
T Consensus 214 ~~LYLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred CeeEEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccc
Confidence 9999999999999999999 56778999999999999999999999999 99999999999999999999999999
Q ss_pred cccccC----------------------CCCcc----cc-------------------ccccccCCccchhhhccCCCCc
Q 005893 503 ARIFAG----------------------SEGEV----NT-------------------ARIVGTYGYMAPEYAMEGLYSI 537 (671)
Q Consensus 503 a~~~~~----------------------~~~~~----~~-------------------~~~~gt~~y~aPE~~~~~~~s~ 537 (671)
+..+.. .+... .. ...+|||.|||||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 863321 00000 00 0158999999999999999999
Q ss_pred chhhHHHHHHHHHHHhCCCCCCC
Q 005893 538 KSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 538 ksDVwSlGvil~elltG~~p~~~ 560 (671)
.+|+||||||+|||+.|.+||..
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s 390 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCS 390 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999953
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=328.89 Aligned_cols=260 Identities=26% Similarity=0.348 Sum_probs=201.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchh-chHHHHHHHHHHhhcC-CCCeeeEeeEEEcCC-eeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD-EKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~l 427 (671)
..++|...++||.|.||.||+|+. .+|..||||++++.-.. +.-.=.+|+..|++|+ |||||++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 345788889999999999999995 46889999999763322 2222468999999998 999999999999988 8999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|||||+ .+|.+++.+. +..+++..+..|+.||++||+|+|++| +.|||+||+|||+..+..+||+|||+||...
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 5788888653 778999999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCccccccccccCCccchhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH---HhcCC
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL---WNEGN 583 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~---~~~~~ 583 (671)
.... .+..+.|..|+|||++. .+-|+.+.|+|++|||++||.+-++-|+.... .+..|+. +....
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE--------~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE--------IDQIYKICEVLGTPD 230 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH--------HHHHHHHHHHhCCCc
Confidence 5432 34468899999999875 57899999999999999999999988853321 1111111 11111
Q ss_pred cccc---------cc---ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 584 ALDL---------ID---PLLTD----TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 584 ~~~~---------~d---~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
..+. +. +...+ ..-+.....+++++..|++.||++|||++|.+++
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000 00 00000 1112234457888889999999999999999873
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=325.62 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=204.0
Q ss_pred CCCCcccccCCCCcccEEEEEecC------CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSD------GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
++|+..+.||+|+||.||+|.... ...|++|.++... ......+.+|+..+.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778999999999999998642 2579999987533 233456899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC
Q 005893 427 LVYEFMPNSSLDAILFDPRK-------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 493 (671)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998854211 145889999999999999999999988 99999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHH
Q 005893 494 NPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLL 572 (671)
Q Consensus 494 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~ 572 (671)
.+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||..... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999986544332222333466788999999998999999999999999999998 9998853211 1
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 573 AYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+ ....+..+.... ....++ ..+.+++.+||+.+|++||+++||++.|++
T Consensus 234 ~-~~~~i~~~~~~~-----~~~~~~----~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 E-VIEMIRSRQLLP-----CPEDCP----ARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred H-HHHHHHcCCcCC-----CcccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1 122222222211 112223 346788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=302.77 Aligned_cols=196 Identities=33% Similarity=0.423 Sum_probs=178.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||.|+||.|.+++.+ +|..+|+|++++.. -+..+...+|..+|+.+.||.++++.+.+.+....+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46778899999999999999965 57889999997633 344566889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||.++|-|..+| ++.+.+++..++-++.||+.||+|||+.+ |++|||||+|||||.+|.+||.|||+++.....
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999 56677999999999999999999999998 999999999999999999999999999976443
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
+-..||||.|+|||++....+...+|.|+|||++|||+.|..||..
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 4457999999999999999999999999999999999999999964
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=326.16 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=203.7
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.|...+.||+|.||.||||+.. .++.||+|++.- ..+...+++.+|+.++.+++++||.+++|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4566688999999999999964 688999999974 34455678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
.+|++.+.| +....+++....-++++++.||.|||.++ .+|||||+.|||+.++|.+||+|||++-.+......
T Consensus 94 ~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 999999998 34445578888889999999999999998 999999999999999999999999999877655443
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
. ...+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+. ... --+.+-.-|.+
T Consensus 168 r--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvl------flIpk~~PP~L 231 (467)
T KOG0201|consen 168 R--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVL------FLIPKSAPPRL 231 (467)
T ss_pred c--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEE------EeccCCCCCcc
Confidence 3 4579999999999999889999999999999999999999998643321 000 00111122344
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.+.+. +.+++..|++.||+.||++.++++
T Consensus 232 ~~~~S~~----~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 232 DGDFSPP----FKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccCHH----HHHHHHHHhhcCcccCcCHHHHhh
Confidence 4444433 667777999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=320.75 Aligned_cols=256 Identities=30% Similarity=0.421 Sum_probs=204.3
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..++|+..+.||+|++|.||++...+++.||+|.++... ....++.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 446688889999999999999998778899999987543 3356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999985422 346899999999999999999999988 99999999999999999999999999987653221
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. .......+..|+|||.+....++.++||||||+++|||++ |+.||.... ... ...........
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~-~~~~~~~~~~~----- 223 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--------NAE-VLQQVDQGYRM----- 223 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--------HHH-HHHHHHcCCCC-----
Confidence 1 1111233457999999988899999999999999999999 998884221 111 11111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.. +......+.+++.+|++.+|++||++.++++.|++
T Consensus 224 ~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PC----PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CC----CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01 11122457788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.53 Aligned_cols=256 Identities=30% Similarity=0.473 Sum_probs=207.7
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
...+|+..++||+|+||.||+|...+++.+++|++.........++.+|+.+++.++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34567888999999999999999888999999999876665667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++... ....+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999653 3456899999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. .....++..|++||.+..+.++.++||||||+++|+|++ |+.||.... ....... ...+.. .
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~~~~~~~----~~~~~~-----~ 223 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----NHEVYDQ----ITAGYR-----M 223 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----HHHHHHH----HHhCCc-----C
Confidence 1 112345678999999988899999999999999999998 888885321 1111111 111111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
......+ ..+.+++.+||+.+|++|||+.++++.|++
T Consensus 224 ~~~~~~~----~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCP----QEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1111222 346788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=324.20 Aligned_cols=257 Identities=30% Similarity=0.485 Sum_probs=203.6
Q ss_pred CCCCcccccCCCCcccEEEEEecC------CceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSD------GKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
++|.+.+.||+|+||.||+|...+ ++.||||+++..... ....+.+|+.++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998633 478999999765443 4568999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 427 LVYEFMPNSSLDAILFDPR-----------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999985421 2345889999999999999999999988 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~ 574 (671)
||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |+.||..... .....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-----~~~~~- 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-----EEVIE- 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH-
Confidence 9999999876533322222223355788999999999999999999999999999998 9999853211 11111
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
....+.... .....+ ..+.+++.+||+.||++||++.||++.|+.
T Consensus 236 ---~~~~~~~~~-----~~~~~~----~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 ---CITQGRLLQ-----RPRTCP----SEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ---HHHcCCcCC-----CCCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 112222111 111222 236678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=324.03 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=202.7
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD 423 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 423 (671)
+..++|+..+.||+|+||.||+|... ++..||+|++.... .....++.+|+.+++.++||||+++++++..+.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35677899999999999999998753 24679999986432 234456889999999999999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCCC-------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeE
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRK-------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 496 (671)
..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence 99999999999999999854221 234688899999999999999999987 99999999999999999999
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~ 575 (671)
|+|||+++...............++..|+|||.+..+.++.++||||||+++|||++ |..||.... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~- 230 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQV- 230 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHH-
Confidence 999999876543332222222355778999999998899999999999999999999 688874321 1111
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.+....+.... +....+ ..+.+++.+|++.+|++|||+.|++++|++
T Consensus 231 ~~~~~~~~~~~-----~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 231 LRFVMEGGLLD-----KPDNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHHcCCcCC-----CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11111221111 111222 246778889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.73 Aligned_cols=252 Identities=29% Similarity=0.423 Sum_probs=200.6
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
++|+..+.||+|+||.||++.+.++..+|+|.++.. ......+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 347778899999999999999988889999988643 2334578899999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+|+|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999988532 245899999999999999999999988 999999999999999999999999998765332221
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......++..|+|||.+....++.++||||||+++|||++ |+.||... ...+..... ..+... ..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~--------~~~~~~~~i-~~~~~~--~~~-- 223 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK--------SNYEVVEMI-SRGFRL--YRP-- 223 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHH-HCCCCC--CCC--
Confidence 1122345668999999988889999999999999999999 88888432 112222221 111111 011
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
... ...+.+++.+||+.+|++||++.|+++.|.
T Consensus 224 --~~~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 224 --KLA---SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCC---CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111 124678888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=336.73 Aligned_cols=262 Identities=25% Similarity=0.379 Sum_probs=204.6
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcC-CCCeeeEeeEEEc
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVD 421 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 421 (671)
....++|.+.++||+|+||.||+|+.. .+..||||+++... ....+.+.+|+.+++++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 344567888999999999999999852 23469999997533 333457899999999996 9999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCC--------------------------------------------------------
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPR-------------------------------------------------------- 445 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 445 (671)
....++||||+++|+|.+++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999998875321
Q ss_pred -------------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEE
Q 005893 446 -------------------------------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488 (671)
Q Consensus 446 -------------------------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIl 488 (671)
....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 0134788889999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGAT 567 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 567 (671)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--- 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--- 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---
Confidence 99999999999999986544333222333456788999999988899999999999999999997 88888532111
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+.....+... ......+ ..+.+++.+||+.+|++||++.+|+++|+.
T Consensus 347 -----~~~~~~~~~~~~~-----~~~~~~~----~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 347 -----STFYNKIKSGYRM-----AKPDHAT----QEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred -----HHHHHHHhcCCCC-----CCCccCC----HHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 1111122222111 1111222 346788889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.50 Aligned_cols=250 Identities=26% Similarity=0.320 Sum_probs=197.3
Q ss_pred CCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
|+..+.||+|+||.||++.. .+|+.||+|++.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999986 478999999986432 22334578899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++|+|..++.. .....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999999888753 23345899999999999999999999988 99999999999999999999999999986533221
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... .............. ..
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~------~~ 223 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKEDQ------EE 223 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhccc------cc
Confidence 22357899999999999999999999999999999999999999643211 11111111111110 01
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
+....+. .+.+++.+||+.||++||+ ++|+++
T Consensus 224 ~~~~~s~----~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSE----DAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCH----HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1122232 3567777999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=320.21 Aligned_cols=255 Identities=30% Similarity=0.453 Sum_probs=204.4
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++.+......+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45688889999999999999998888899999987533 33567899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~-~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999998854 23456889999999999999999999987 999999999999999999999999999875432221
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......++..|+|||.+..+.++.++||||||+++|||++ |+.||.... ..... .....+... +
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--------~~~~~-~~~~~~~~~----~- 224 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--------NSDVM-SALQRGYRM----P- 224 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--------HHHHH-HHHHcCCCC----C-
Confidence 1222345678999999988889999999999999999998 999985321 11111 111111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+ ..+.+++.+|++.+|++||+++++.++|+.
T Consensus 225 ~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCP----DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCC----HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111222 236778889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=325.64 Aligned_cols=260 Identities=29% Similarity=0.443 Sum_probs=207.6
Q ss_pred CCCCcccccCCCCcccEEEEEec------CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.+|...+.||+|+||.||++... ++..+++|.++.........+.+|+..+++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45677789999999999999742 345699999887666666779999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC
Q 005893 428 VYEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN 494 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 494 (671)
||||+++++|.+++.... ..+.+++..++.++.||+.||+|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985421 2245899999999999999999999998 999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHH
Q 005893 495 PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLA 573 (671)
Q Consensus 495 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~ 573 (671)
++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~ 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------TE 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence 99999999976543322222233456788999999998899999999999999999999 9998753211 11
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCC
Q 005893 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETI 634 (671)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~ 634 (671)
.+.....+...+. .... ...+.+++.+||+.+|++||++++|+++|+....
T Consensus 234 -~~~~~~~~~~~~~-----~~~~----~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 -VIECITQGRVLER-----PRVC----PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred -HHHHHhCCCCCCC-----CccC----CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1222223222211 1112 2346788889999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.59 Aligned_cols=245 Identities=22% Similarity=0.242 Sum_probs=198.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999975 68899999986422 233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999998865332
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||.... ..... +....+..
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~-~~i~~~~~----- 215 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIY-EKILAGKL----- 215 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHH-HHHHhCCc-----
Confidence 123578999999999998889999999999999999999999985321 11111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVVM 628 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~~ 628 (671)
.+....++ .+.+++.+||+.||++||+ ++|+++.
T Consensus 216 -~~~~~~~~----~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -EFPRHLDL----YAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCCccCCH----HHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11122222 3567778999999999995 8888753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.33 Aligned_cols=256 Identities=27% Similarity=0.473 Sum_probs=200.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCc----eEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGK----EIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
..+|+..+.||+|+||.||+|++. +++ .||+|+++... .....++.+|+.+++.++||||++++|++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 356888999999999999999864 333 38999987533 34456788999999999999999999998764 567
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+++||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998853 2345889999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+. ......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~-~~~~~~~~~~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEI-SSILEKGERL 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHH-HHHHhCCCCC
Confidence 54333222222344678999999999999999999999999999998 999885321 1111 1111221110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....++ ..+.+++.+||+.+|++||++.+++..|...
T Consensus 231 -----~~~~~~~----~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 -----PQPPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred -----CCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011222 2467888899999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.86 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=201.8
Q ss_pred CCCCcccccCCCCcccEEEEEe-----cCCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-----SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
++|+..+.||+|+||.||+|.+ .+++.|++|.++... ......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999984 245789999997533 3344678899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCC--------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC
Q 005893 428 VYEFMPNSSLDAILFDPR--------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 493 (671)
+|||+++++|.+++.... ....+++...+.++.||+.||.|||+.+ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999884221 1235889999999999999999999988 99999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHH
Q 005893 494 NPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLL 572 (671)
Q Consensus 494 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~ 572 (671)
.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..||.... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--------~~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--------NQ 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HH
Confidence 999999999987544332222333456778999999988889999999999999999998 888874211 11
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 573 AYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
. ............ ....+++ .+.+++.+||+.+|++||++.+|.++|..
T Consensus 234 ~-~~~~~~~~~~~~-----~~~~~~~----~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 E-VIEMVRKRQLLP-----CSEDCPP----RMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H-HHHHHHcCCcCC-----CCCCCCH----HHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1 111222221111 1122232 36677789999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.93 Aligned_cols=199 Identities=27% Similarity=0.378 Sum_probs=174.1
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||+++.. ++..+|+|.+... .......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467889999999999999999975 5788999998753 23345578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|.+++. ....+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999984 3446889999999999999999999853 39999999999999999999999999987653321
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 2235789999999999988999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=313.38 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=201.2
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhh--cCCCCeeeEeeEEEcCC----e
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILK--LQHKNLVKLLGFCVDGD----E 424 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~----~ 424 (671)
...+.....+.||+|+||+||+|.+ .|..||||++....+. .+.+|.++.+. |+|+||+.+++.-..+. +
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3445667788999999999999999 5889999999875554 44577777764 69999999998765443 5
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-----CCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-----DSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
++||.+|++.|||.++|. +..++....++++..+|.||++||- +|++.|.|||||++|||+..++.+.|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 789999999999999993 4679999999999999999999994 5789999999999999999999999999
Q ss_pred ccccccccCCCCcc--ccccccccCCccchhhhccCC----C--CcchhhHHHHHHHHHHHhCC----------CCCCCC
Q 005893 500 FGMARIFAGSEGEV--NTARIVGTYGYMAPEYAMEGL----Y--SIKSDVFSFGVLLIEIITGR----------RNTGFN 561 (671)
Q Consensus 500 fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~----~--s~ksDVwSlGvil~elltG~----------~p~~~~ 561 (671)
+||+-......... .....+||.+|||||++.+.- + -..+||||||.|+||+...- .||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99998876653332 334569999999999986532 2 13699999999999997522 344322
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 562 QSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDT-CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 562 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
-+.++..++.. +---.+-+.|.+... .+.+.+..+.+++..||..||+-|-|+--+.+.|.+..
T Consensus 440 Vp~DPs~eeMr--------kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 440 VPSDPSFEEMR--------KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCCCCCHHHHh--------cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 11111111110 000011122333322 23466778899999999999999999998888887644
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=323.53 Aligned_cols=260 Identities=29% Similarity=0.450 Sum_probs=206.7
Q ss_pred hCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
.++|.+.+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 456888899999999999999842 34568999998766666678999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCC----------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeE
Q 005893 427 LVYEFMPNSSLDAILFDPR----------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 496 (671)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999885321 2235899999999999999999999988 99999999999999999999
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~ 575 (671)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--------~~~~- 231 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEV- 231 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHH-
Confidence 999999986543322222223455778999999988889999999999999999998 888874321 1111
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
......+.... .....+. .+.+++.+||+.+|.+|||+.||...|+...
T Consensus 232 ~~~i~~~~~~~-----~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 232 IECITQGRVLQ-----RPRTCPK----EVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHHHcCCcCC-----CCCCCCH----HHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11222222111 1122232 3778888999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.12 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=203.5
Q ss_pred hCCCCcccccCCCCcccEEEEEecC----CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.++|+..+.||+|+||.||+|.+.. ...||||.++... .....++.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568889999999999999999742 3579999987533 3345578899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
+|||+++++|.+++.. ..+.+++..+++++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999853 2346899999999999999999999987 9999999999999999999999999998775
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..+ ......+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~----~~~~~~~~~~~ 228 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDV----IKAVEDGYRLP 228 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHH----HHHHHcCCCCC
Confidence 3332222223345678999999998899999999999999999998 9988743211 111 11111111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..... ...+.+++.+||+.+|++||+++||+++|+.
T Consensus 229 -----~~~~~----~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 229 -----PPMDC----PSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred -----CCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 01112 2346788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=331.44 Aligned_cols=260 Identities=28% Similarity=0.400 Sum_probs=201.9
Q ss_pred HhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC-
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG- 422 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 422 (671)
..++|++.+.||+|+||.||+|... +++.||+|+++... ......+..|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 4457888999999999999999742 34789999987533 23345678899999999 899999999988754
Q ss_pred CeeeEEEeccCCCchhhhhcCCCC--------------------------------------------------------
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRK-------------------------------------------------------- 446 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 446 (671)
...++++||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 467899999999999988853211
Q ss_pred --CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCc
Q 005893 447 --RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY 524 (671)
Q Consensus 447 --~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 524 (671)
...++|..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 136899999999999999999999988 999999999999999999999999999876443332223334567789
Q ss_pred cchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHH
Q 005893 525 MAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLR 603 (671)
Q Consensus 525 ~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 603 (671)
+|||++.+..++.++|||||||++|||++ |+.||...... +..+.....+... ...... ...
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~-----~~~~~~----~~~ 304 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRM-----RAPEYA----TPE 304 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCC-----CCCccC----CHH
Confidence 99999999999999999999999999998 99988532111 1111122222111 111112 234
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 604 YIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 604 l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+.+++.+||+.+|++||++.||+++|+.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 7788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.73 Aligned_cols=253 Identities=22% Similarity=0.265 Sum_probs=199.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+++.. +++.||||+++... ......+.+|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999975 58899999997532 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999984 3456889999999999999999999998 99999999999999999999999999876533
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.. ...... ...+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~-~~i~~~--~~~~~ 218 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETW-ENLKYW--KETLQ 218 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHH-HHHHhc--ccccc
Confidence 12335789999999999988999999999999999999999999853221 1111 111110 00011
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
..............+.+++.+|++.+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000112235677779999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.80 Aligned_cols=241 Identities=24% Similarity=0.243 Sum_probs=193.2
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
+.||+|+||.||++... +|+.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 68899999987532 233456788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccc
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 515 (671)
+|..++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 9988884 3456899999999999999999999998 9999999999999999999999999987532221 122
Q ss_pred ccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCC
Q 005893 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDT 595 (671)
Q Consensus 516 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 595 (671)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........ ..+. ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~-~~~~------~~~p~~ 217 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELI-LMEE------IRFPRT 217 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHH-HcCC------CCCCCC
Confidence 34579999999999999999999999999999999999999985321 11111111 1111 112222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 596 CSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 596 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.++ .+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~----~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSP----EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCH----HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 333 356777799999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=337.91 Aligned_cols=250 Identities=31% Similarity=0.456 Sum_probs=206.5
Q ss_pred cccccCCCCcccEEEEEe-cCCc----eEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 358 DSNMLGQGGFGPVYKGVL-SDGK----EIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..++||+|+||+||||.+ ++|+ +||+|++.. ...+...++.+|+.+|.+|+|||+++++|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 468999999999999996 4443 689999875 34455678999999999999999999999998776 7899999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
|+.|+|.++++. .+..+-....+.|..|||+||.|||++. ++||||..+||||.+-..+||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999965 4555888899999999999999999887 99999999999999999999999999999887766
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
........-.+.|||-|.+....|+.++|||||||++||++| |..|+.....+ + +...+++|+.
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----e----I~dlle~geR------ 918 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----E----IPDLLEKGER------ 918 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----H----hhHHHhcccc------
Confidence 655555566788999999999999999999999999999999 88888643322 1 1222233322
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
-..++....++..++.+||..|+..||+++++...+.+
T Consensus 919 ---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 919 ---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 12234444567788899999999999999999876654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.34 Aligned_cols=241 Identities=22% Similarity=0.278 Sum_probs=191.3
Q ss_pred cCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
||+|+||.||++... +++.||+|+++.. .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 5789999998642 233445678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 99884 3456899999999999999999999988 99999999999999999999999999875432221 2234
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||... ............ .. .+....+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--------~~~~~~~~~~~~-~~------~~~~~~~ 217 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--------NVNEMYRKILQE-PL------RFPDGFD 217 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC--------CHHHHHHHHHcC-CC------CCCCcCC
Confidence 57899999999999999999999999999999999999998532 222222222211 11 1112222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
+ .+.+++.+||+.||++||+..++.+.|
T Consensus 218 ~----~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 R----DAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred H----HHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 2 356777799999999998654444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.92 Aligned_cols=244 Identities=27% Similarity=0.378 Sum_probs=203.0
Q ss_pred CCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
|+..+.||+|+-|.|..|++ .+|+.+|||++.+.. ......+.+|+.+|+-+.|||++++++++.+..++|||.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 55578899999999999996 579999999997542 22344588999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++|-|.+++ ..++.+++.++.+++.||+.|+.|+|..+ |+||||||+|+|||.+.++||+|||+|-.-.++.
T Consensus 94 v~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 94 VPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred cCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 9999999998 45678999999999999999999999998 9999999999999999999999999998654432
Q ss_pred ccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
.....||.++|.+||++++.+| +.++||||.|||||.|+||+.||+ +.++.....+. ..|.. +
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------DdNir~LLlKV-~~G~f-~---- 230 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------DDNIRVLLLKV-QRGVF-E---- 230 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------CccHHHHHHHH-HcCcc-c----
Confidence 2234699999999999999998 579999999999999999999995 33444433222 22221 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+...++++ +.+++.+|+..||++|.|++||.+
T Consensus 231 -MPs~Is~e----aQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 231 -MPSNISSE----AQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -CCCcCCHH----HHHHHHHHhccCccccccHHHHhh
Confidence 12334444 556677999999999999999987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=314.19 Aligned_cols=247 Identities=23% Similarity=0.356 Sum_probs=206.1
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.+|++.+.||+|.||.|-++.. ..|+.||||.+++. ++++...+.+|+++|..|+||||+.++.+|.+.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999985 67999999999763 4566667899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||..+|.|.+++ ..++.+++.+.+.+++||..|+.|+|+++ ++|||||.+|||||.++++||+||||+..+...
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 45667999999999999999999999987 999999999999999999999999999887544
Q ss_pred CCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. ...+||++.|.+||++.+.+| .+..|-|||||+||.|+.|..||+..+ .-..+. ....|...+-
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvr-QIs~GaYrEP- 273 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVR-QISRGAYREP- 273 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHH-HhhcccccCC-
Confidence 32 345799999999999999888 589999999999999999999996321 112222 2223322221
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
+......-++.||+..||++|.|+.+|...+
T Consensus 274 ----------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ----------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1122244567799999999999999998754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.82 Aligned_cols=252 Identities=27% Similarity=0.400 Sum_probs=200.0
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
++|...+.||+|+||.||++...++..+|+|.++... ....++.+|+.++.+++||||+++++++......+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3467778999999999999998777789999987532 334678999999999999999999999998888999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|.+++... ...+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++....... .
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 99999988532 236899999999999999999999988 99999999999999999999999999876543321 1
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......++..|++||.+....++.++||||||+++|||++ |+.||..... .... .....+... ..
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~-~~~~~~~~~-----~~ 222 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETV-EKVSQGLRL-----YR 222 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHH-HHHhcCCCC-----CC
Confidence 1112345678999999988889999999999999999999 9988853211 1111 111111111 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
.... ...+.+++.+||+.+|++||++.+|++.|+
T Consensus 223 ~~~~----~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLA----SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111 235678888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=314.25 Aligned_cols=248 Identities=29% Similarity=0.380 Sum_probs=194.1
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
+.||+|+||.||+++.. +++.||+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999974 6889999988643 233456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999843 2345899999999999999999999988 99999999999999999999999999876433211111111
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTC 596 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (671)
...+..|+|||.+..+.++.++||||||+++|||++ |..|+..... .. .......... .......
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~~~~~-----~~~~~~~ 221 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIEQGVR-----LPCPELC 221 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHHcCCC-----CCCcccC
Confidence 223457999999998899999999999999999998 8888743211 11 1111111111 0111112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 597 SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 597 ~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
...+.+++.+|++.+|++|||+.||.++|+
T Consensus 222 ----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 ----PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 234677888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=341.29 Aligned_cols=262 Identities=26% Similarity=0.300 Sum_probs=205.8
Q ss_pred hhhHHHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 346 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
..+.....++|.+.+.||+|+||.||++.. .+|+.||||++... .......+.+|+..+..++|+||+++...+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 344455667899999999999999999985 46899999998643 344456788999999999999999998876543
Q ss_pred C--------eeeEEEeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC
Q 005893 423 D--------EKLLVYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493 (671)
Q Consensus 423 ~--------~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 493 (671)
+ ..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 2 257999999999999988642 23456899999999999999999999988 99999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHH
Q 005893 494 NPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLA 573 (671)
Q Consensus 494 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~ 573 (671)
.+||+|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||... ....
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------~~~~ 252 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------NMEE 252 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------CHHH
Confidence 99999999998765433222233467999999999999999999999999999999999999998532 2222
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
..... ..+... .+....++ .+.+++..||+.+|++||++.++++.
T Consensus 253 ~~~~~-~~~~~~-----~~~~~~~~----~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 VMHKT-LAGRYD-----PLPPSISP----EMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHH-hcCCCC-----CCCCCCCH----HHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22111 111111 12222333 36677889999999999999999763
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.62 Aligned_cols=254 Identities=29% Similarity=0.427 Sum_probs=202.3
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.+|...+.||+|+||.||++... .++.|++|+++.. .....++.+|+.+++.++|+||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45777889999999999999975 5889999998753 334567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999998854 23456899999999999999999999988 999999999999999999999999998865433211
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+... ...+ .+.....+.. ..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~--------~~~~-~~~~~~~~~~-----~~ 225 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------DLSQ-VYELLEKGYR-----ME 225 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC--------CHHH-HHHHHHCCCC-----CC
Confidence 1112234568999999988899999999999999999998 88887422 1111 1222222111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+ ..+.+++.+||+.+|++||++.+++++|+.
T Consensus 226 ~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 226 RPEGCP----PKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 112223 236677889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.95 Aligned_cols=244 Identities=25% Similarity=0.294 Sum_probs=197.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56788899999999999999975 58899999986432 233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999884 3456888999999999999999999998 999999999999999999999999999865332
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
. ....||+.|+|||++.+..++.++||||||+++|||++|+.||... ..... ++....+..
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~-~~~i~~~~~----- 232 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--------TPFRI-YEKILAGRL----- 232 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC--------CHHHH-HHHHhcCCc-----
Confidence 2 2357899999999999989999999999999999999999998532 11111 122222211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
.+....+. .+.+++.+||+.||++||+ +++++.
T Consensus 233 -~~p~~~~~----~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 -KFPNWFDG----RARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -CCCCCCCH----HHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111222 3567778999999999997 677764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.17 Aligned_cols=258 Identities=30% Similarity=0.479 Sum_probs=200.8
Q ss_pred HhCCCCcccccCCCCcccEEEEEecC------CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSD------GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
.+++|...+.||+|++|.||+|.+.+ +..|++|.+.... ......+.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 45678889999999999999999753 5679999887433 3344578999999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCC----CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC---CeEE
Q 005893 425 KLLVYEFMPNSSLDAILFDPRK----RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM---NPKI 497 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 497 (671)
.++||||+++++|.+++..... ...+++..+++++.||+.||.|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999854321 235899999999999999999999988 99999999999998754 5999
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHH
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
+|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~~~~~--- 232 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----QEVME--- 232 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH---
Confidence 99999987633322221222334567999999998999999999999999999997 9988853211 11111
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
........ ......+ ..+.+++.+|++.+|++||++.+|++.|+
T Consensus 233 -~~~~~~~~-----~~~~~~~----~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 -FVTGGGRL-----DPPKGCP----GPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -HHHcCCcC-----CCCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111 1112222 34667888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=338.83 Aligned_cols=251 Identities=21% Similarity=0.228 Sum_probs=201.3
Q ss_pred CCcccccCCCCcccEEEEEec-C-CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-D-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
|...+.||+|+||.||++... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777899999999999999854 3 57889998765555555678899999999999999999999999999999999999
Q ss_pred CCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 434 NSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 434 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
+|+|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999887542 23456889999999999999999999988 999999999999999999999999999876543322
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......+||+.|+|||++.+..++.++||||||+++|||++|+.||... .......... .+... + +
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~--------~~~~~~~~~~-~~~~~----~-~ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP--------SQREIMQQVL-YGKYD----P-F 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHH-hCCCC----C-C
Confidence 2233467999999999999999999999999999999999999998532 1112111111 11111 1 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+ ..+.+++..||+.+|++||++.+++.
T Consensus 292 ~~~~s----~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVS----SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCC----HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11222 23667788999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.15 Aligned_cols=257 Identities=30% Similarity=0.419 Sum_probs=202.0
Q ss_pred CCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
+|+..+.||+|+||.||+|... ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 23578999887543 3345678899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCC---------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCc
Q 005893 428 VYEFMPNSSLDAILFDPR---------------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASN 486 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~N 486 (671)
++||+++++|.+++...+ ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875321 1235889999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 005893 487 VLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRG 565 (671)
Q Consensus 487 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~ 565 (671)
|++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--- 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--- 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence 9999999999999999986544332222223355678999999988889999999999999999998 998884321
Q ss_pred CCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 566 ATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
. ...+.....+.. .......+ ..+.+++.+||+.+|++||++.|+++.|+..
T Consensus 235 -----~-~~~~~~~~~~~~-----~~~~~~~~----~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 235 -----P-ERLFNLLKTGYR-----MERPENCS----EEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -----H-HHHHHHHhCCCC-----CCCCCCCC----HHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1 112222222211 11112222 3477888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.32 Aligned_cols=261 Identities=27% Similarity=0.411 Sum_probs=206.4
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecC-----CceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc-CC
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSD-----GKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD-GD 423 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~ 423 (671)
+..++|+..+.||+|+||.||+|...+ +..|++|+++.. .......+.+|+.++++++|+||+++++++.. +.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 345678889999999999999999765 688999998753 33445678899999999999999999998876 46
Q ss_pred eeeEEEeccCCCchhhhhcCCCCC-----CCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEe
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKR-----GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKIS 498 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 498 (671)
..++++||+++++|.+++...... ..+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEEC
Confidence 788999999999999998543322 56899999999999999999999987 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 499 DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 499 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
|||+++.+...+.........++..|+|||.+.+..++.++||||||+++||+++ |+.||.... ..... .
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~-~ 230 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--------PFEMA-A 230 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--------HHHHH-H
Confidence 9999987654443322233456778999999988889999999999999999999 999985321 11211 1
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
....+... .....++ ..+.+++.+||+.+|++|||+.||+++|+..
T Consensus 231 ~~~~~~~~-----~~~~~~~----~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 231 YLKDGYRL-----AQPINCP----DELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred HHHcCCCC-----CCCCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 22222110 0111222 2367788899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.56 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=200.3
Q ss_pred CCCcccccCCCCcccEEEEEec------CCceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
+|...+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556788999999999999863 2478999999754332 34568899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCC-------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC
Q 005893 428 VYEFMPNSSLDAILFDP-------------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN 494 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 494 (671)
++||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||.||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999987421 11235888999999999999999999988 999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHH
Q 005893 495 PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLA 573 (671)
Q Consensus 495 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~ 573 (671)
+||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |..|+... ...+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~--------~~~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--------CHHH
Confidence 99999999886544332222233456788999999988899999999999999999998 77777421 1111
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
. ......+... .....++. .+.+++..||+.+|++||++.||++.|+.
T Consensus 235 ~-~~~i~~~~~~-----~~~~~~~~----~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 V-IEMIRNRQVL-----PCPDDCPA----WVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHHHHcCCcC-----CCCCCCCH----HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1222222211 11222332 36678889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=317.96 Aligned_cols=254 Identities=29% Similarity=0.448 Sum_probs=198.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCc----eEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGK----EIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
++|+..+.||+|+||.||+|++. +++ .+++|.+.... .....++..|+..+.+++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45777899999999999999963 344 47888876433 233457788888999999999999999875 455788
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
++||+++|+|.+++.. ..+.+++..++.|+.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999853 3456899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
............++..|++||.+.++.++.++||||||+++|||++ |+.||..... .. ....+.++....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~-~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--------HE-VPDLLEKGERLA 231 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH-HHHHHHCCCcCC
Confidence 4433223334567788999999998999999999999999999998 9988853211 11 111222222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.+ ..++ ..+.+++.+||+.+|++|||+.|+++.|..
T Consensus 232 --~~---~~~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 232 --QP---QICT----IDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred --CC---CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11 1122 235667889999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.96 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=198.6
Q ss_pred CCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+|++.+.||+|+||.||++.+.++..+|+|++.... .....+.+|+.++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 467788999999999999998777789999986532 2345688899999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
++|.+++... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++........ .
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 9999998532 336899999999999999999999988 999999999999999999999999998765432211 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... .+... ....+. .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~-~~~~~~-----~~~~~ 223 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVE-SVSAGY-----RLYRP 223 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHH-HHHcCC-----cCCCC
Confidence 111233457999999998899999999999999999999 7888853211 11111 111111 11111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
...+ ..+.+++.+||+.+|++|||+.||+++|.
T Consensus 224 ~~~~----~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 224 KLAP----TEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1222 24778888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.89 Aligned_cols=262 Identities=28% Similarity=0.405 Sum_probs=205.4
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEE
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCV 420 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 420 (671)
++...++|+..+.||+|+||.||++... +...+|+|.+... ......++.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3345567888899999999999999864 2357999998753 334455788999999999 8999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCC-------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcE
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDP-------------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NI 487 (671)
.....+++|||+++|+|..++... .....+++..+++++.|++.||.|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999998532 23456899999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005893 488 LLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGA 566 (671)
Q Consensus 488 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 566 (671)
++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 239 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 239 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC----
Confidence 999999999999999987644332222222345678999999988899999999999999999998 888874221
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..+ ..+....+...+ .+......+.+++.+|++.+|++|||+.||++.|+.
T Consensus 240 ----~~~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 240 ----VEE-LFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred ----HHH-HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 111 112222221111 111122347788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=318.29 Aligned_cols=263 Identities=21% Similarity=0.275 Sum_probs=198.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|++.+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999975 57889999987532 2334567899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|++++++..+. .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99998877654 23456899999999999999999999988 9999999999999999999999999998754322
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH----------HHHHH-
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY----------AWHLW- 579 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~----------~~~~~- 579 (671)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||...... ..+... .++.+
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI----DQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhCCCCHHHHHhhh
Confidence 11 222357899999999999888999999999999999999999998642211 001000 00000
Q ss_pred hcCCccccccccccCCC------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNALDLIDPLLTDTC------SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~------~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..........+...... .......+.+++.+|++.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 01000000001000000 0001124778888999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.30 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=198.8
Q ss_pred CCcccccCCCCcccEEEEEecC----CceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe-----
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----- 424 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 424 (671)
|++.+.||+|+||.||+|.... +..||+|+++.. .......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 367999998743 23345678999999999999999999999876554
Q ss_pred -eeEEEeccCCCchhhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 425 -KLLVYEFMPNSSLDAILFDPR---KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 425 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
.++++||+++++|..++...+ ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999885432 2346899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
|+++...............++..|+|||.+....++.++||||||+++|||++ |..||.... ...+... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~~~~~~----~ 228 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NHEIYDY----L 228 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHH----H
Confidence 99987654332222222345678999999988889999999999999999999 888874321 1111111 1
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 580 NEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..+... .....+ ...+.+++.+||+.||++||++.||++.|+.
T Consensus 229 ~~~~~~-----~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 229 RHGNRL-----KQPEDC----LDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred HcCCCC-----CCCcCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 121111 111222 2347788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=318.42 Aligned_cols=266 Identities=27% Similarity=0.373 Sum_probs=198.0
Q ss_pred CCcccccCCCCcccEEEEEe-----cCCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeE
Q 005893 356 FSDSNMLGQGGFGPVYKGVL-----SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 427 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 427 (671)
|+..+.||+|+||+||++.. .+++.||+|.++... ......+.+|+.++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 357789999987543 23456788999999999999999999988754 35789
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999842 34899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ..................+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK---FEEMIGPKQGQMTVVRLIE 235 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch---hhhhhcccccccchhhhhh
Confidence 332211 111234566799999998888999999999999999999999997543211 0011110000000011111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.++.......+......+.+++..||+.+|++|||+++|+++|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 111111111111122346778889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=312.47 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=193.8
Q ss_pred ccCCCCcccEEEEEe---cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 361 MLGQGGFGPVYKGVL---SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~---~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
.||+|+||.||+|.+ .+++.+|+|+++... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 357889999986432 234567899999999999999999999875 45678999999999
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc-c
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-N 514 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~ 514 (671)
+|.+++. ..+.+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++......... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999984 3346899999999999999999999988 9999999999999999999999999998764433221 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
.....++..|+|||.+....++.++||||||+++|||++ |+.||.... ..... .....+... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--------~~~~~-~~i~~~~~~-----~~~ 220 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--------GNEVT-QMIESGERM-----ECP 220 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHCCCCC-----CCC
Confidence 122344678999999988889999999999999999998 999985321 11111 122222211 112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...++ .+.+++.+||+.||++||++.+|++.|++
T Consensus 221 ~~~~~----~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPP----EMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCH----HHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 22333 36678889999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=315.57 Aligned_cols=265 Identities=27% Similarity=0.395 Sum_probs=203.9
Q ss_pred hCCCCcccccCCCCcccEEEEEecC-----------------CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD-----------------GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVK 414 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 414 (671)
..+|+..+.||+|+||.||++...+ +..||+|.+.... ......+.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4568889999999999999988642 2458999987543 344567899999999999999999
Q ss_pred EeeEEEcCCeeeEEEeccCCCchhhhhcCCC--------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCc
Q 005893 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPR--------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASN 486 (671)
Q Consensus 415 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~N 486 (671)
+++++..++..++++||+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999985432 1236899999999999999999999988 9999999999
Q ss_pred EEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCC
Q 005893 487 VLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT--GRRNTGFNQSR 564 (671)
Q Consensus 487 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~ 564 (671)
|+++.++.++|+|||+++...............++..|+|||.+..+.++.++||||||+++|||++ |..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 9999999999999999886544332222334456788999999988899999999999999999998 555653211
Q ss_pred CCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 565 GATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 565 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...........+..+....... .++.....+.+++.+|++.+|++|||+.||++.|+.
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 ---DQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---hHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1122222222221111111111 011112357788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.96 Aligned_cols=261 Identities=29% Similarity=0.442 Sum_probs=212.5
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEecC-CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
++++....+....++||-|.||.||.|.|+. .-.||||.|+.. ....++|..|..+|+.++|||+|+++|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444445556667899999999999999864 568999999864 45677999999999999999999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
|||+|||..|+|.++|.+. ++..++-..++.++.||..||+||..++ +|||||..+|+|+.++..+||+||||++.
T Consensus 339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999653 4556777888999999999999999988 99999999999999999999999999998
Q ss_pred ccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
+..+.+.. .....-.+.|.|||.+....++.|+|||+|||+||||.| |-.||.. .++. .++.++.++-.
T Consensus 415 MtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG--------idlS-qVY~LLEkgyR 484 (1157)
T KOG4278|consen 415 MTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG--------IDLS-QVYGLLEKGYR 484 (1157)
T ss_pred hcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC--------ccHH-HHHHHHhcccc
Confidence 76654332 223445788999999999999999999999999999998 7777632 2222 23444444433
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.+- ...|++ ++.++++.||+.+|++||++.|+-+.++.
T Consensus 485 M~~-----PeGCPp----kVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 485 MDG-----PEGCPP----KVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred ccC-----CCCCCH----HHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 221 123333 47788899999999999999998776653
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=322.37 Aligned_cols=245 Identities=23% Similarity=0.284 Sum_probs=192.2
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||++... +++.||+|+++.. .......+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 5789999998753 223345577888888776 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ..+.+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 99988873 3456899999999999999999999998 99999999999999999999999999875322211 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...............+.++....... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p~ 226 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCCC
Confidence 2345789999999999999999999999999999999999999964332222222333333333322221 1222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
..+. .+.+++.+||+.||++||+.
T Consensus 227 ~~~~----~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 SLSV----KAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCH----HHHHHHHHHhcCCHHHcCCC
Confidence 2222 35677789999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.72 Aligned_cols=241 Identities=24% Similarity=0.261 Sum_probs=192.3
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
+.||+|+||.||++... +|+.||+|+++.. .......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 6899999998753 2233456778999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccc
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 515 (671)
+|..++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 9988874 3456899999999999999999999998 99999999999999999999999999875322221 12
Q ss_pred ccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCC
Q 005893 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDT 595 (671)
Q Consensus 516 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 595 (671)
....||+.|+|||++.++.++.++||||||+++|||++|+.||.... ........... . ..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~~-~------~~~p~~ 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILME-E------IRFPRT 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcC-C------CCCCCC
Confidence 23578999999999998999999999999999999999999985321 11111111111 1 112223
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 596 CSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 596 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.++ .+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~----~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSP----EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCH----HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 333 355677799999999998 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.78 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=207.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe-eeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lv~ 429 (671)
++|...+++|+|+||.++..+.+ +++.+++|.+.- .++.......+|+.++++++|||||.+++.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778899999999999998864 577899998863 344455578899999999999999999999999988 89999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
+|++||+|.+.+.. ++...+++..++.|+.||+.|+.|||++. |+|||||+.||+++.+..+||+|||+++.+.+.
T Consensus 84 ~Y~eGg~l~~~i~~-~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKE-QKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHH-HhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999965 33577999999999999999999999877 999999999999999999999999999998776
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.... ....||+.||.||++.+.+|..|+|||||||++|||++-+++|.- .+....+.+..... +.
T Consensus 160 ~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a--------~~m~~Li~ki~~~~-----~~ 224 (426)
T KOG0589|consen 160 DSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA--------SNMSELILKINRGL-----YS 224 (426)
T ss_pred hhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc--------cchHHHHHHHhhcc-----CC
Confidence 5332 336899999999999999999999999999999999999999843 33333333322221 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
| + +......+..++..|++.+|+.||++.+++.+
T Consensus 225 P-l----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 P-L----PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C-C----CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 1 22223346677779999999999999999864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=322.14 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=196.4
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
++||+|+||.||++... +++.||+|+++.. .......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999975 6889999999753 223345678899999888 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 99988873 3456999999999999999999999998 99999999999999999999999999874322111 2
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+..............+..+....... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~ 226 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPR 226 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCC
Confidence 2345789999999999999999999999999999999999999975332221222233333333333221 1222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPT------MSSVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt------~~ev~~ 627 (671)
..+. .+.+++.+|++.||++||+ ++++++
T Consensus 227 ~~~~----~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 227 SLSV----KASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCH----HHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 2332 3567777999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.04 Aligned_cols=200 Identities=29% Similarity=0.409 Sum_probs=173.7
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
..++|+..++||+|+||.||++... ++..+|+|++... .......+.+|+.++++++|+||+++++++...+..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3578999999999999999999975 5788999988753 2334457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++. ..+.+++..+..++.|++.||.|||+.. +|+||||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 83 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999984 3456889999999999999999999742 3999999999999999999999999998755322
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
. .....|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 1 1234688999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=312.80 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=200.6
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.++|++.+.||+|+||.||++...++..+|+|.++.... ....+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 456788899999999999999988888999999875432 3457899999999999999999999875 45678999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999998542 2345899999999999999999999988 999999999999999999999999999865432211
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......++..|+|||.+....++.++||||||+++|||++ |+.||.... ..+..... ..+.. ..
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~~-----~~ 223 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--------NREVLEQV-ERGYR-----MP 223 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHH-HcCCC-----CC
Confidence 1122345668999999988889999999999999999999 888885321 11111111 11111 01
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..... ...+.+++.+|++.+|++|||+.++.++|+.
T Consensus 224 ~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDC----PISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcC----CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122 2347788889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=317.72 Aligned_cols=257 Identities=29% Similarity=0.445 Sum_probs=203.0
Q ss_pred hCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
.++|...++||+|+||.||++... ++..+++|.++.........+.+|++++..++|+||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 356777899999999999999742 35689999988766666778999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCC------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC
Q 005893 427 LVYEFMPNSSLDAILFDPRK------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN 494 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 494 (671)
+++||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ ++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence 99999999999999854221 135889999999999999999999988 999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHH
Q 005893 495 PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLA 573 (671)
Q Consensus 495 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~ 573 (671)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~ 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TE 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HH
Confidence 99999999876543322222222345678999999998899999999999999999998 8888742211 11
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
.... ...+... .....+++ .+.+++.+||+.+|++||++.||.+.|+
T Consensus 233 ~~~~-~~~~~~~-----~~~~~~~~----~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 AIEC-ITQGREL-----ERPRTCPP----EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHH-HHcCccC-----CCCCCCCH----HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111 1111111 11122333 3667888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=322.53 Aligned_cols=242 Identities=24% Similarity=0.245 Sum_probs=193.6
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 6889999999753 2334456788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccc
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 515 (671)
+|..++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 9988874 3456899999999999999999999988 99999999999999999999999999875322211 22
Q ss_pred ccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCC
Q 005893 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDT 595 (671)
Q Consensus 516 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 595 (671)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......... .+ +..+...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--------~~~~~~~~~-~~------~~~~p~~ 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELIL-ME------DIKFPRT 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--------HHHHHHHhc-cC------CccCCCC
Confidence 33579999999999998899999999999999999999999985321 111111111 11 1112223
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 005893 596 CSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVVM 628 (671)
Q Consensus 596 ~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~~ 628 (671)
.++ .+.+++.+||+.||++|| ++.|+++.
T Consensus 218 ~~~----~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSA----DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCH----HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 333 356777799999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=318.34 Aligned_cols=200 Identities=27% Similarity=0.389 Sum_probs=168.5
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch-hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||++... +++.||||+++.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999975 688999999875332 223457789999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|++ ++|.+++.. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666632 3355889999999999999999999998 9999999999999999999999999987543221
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1223467899999998865 4588999999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=318.87 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=199.4
Q ss_pred hCCCCcccccCCCCcccEEEEEecC---------------CceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD---------------GKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLL 416 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~ 416 (671)
.++|++.+.||+|+||.||++...+ ...||+|.++.. .......+.+|++++.+++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987532 225899998753 333445789999999999999999999
Q ss_pred eEEEcCCeeeEEEeccCCCchhhhhcCCC---------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcE
Q 005893 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPR---------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487 (671)
Q Consensus 417 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NI 487 (671)
+++......++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999885321 1124788999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 005893 488 LLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT--GRRNTGFNQSRG 565 (671)
Q Consensus 488 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~~ 565 (671)
++++++.+||+|||+++...............++..|+|||.+..+.++.++||||||+++|||++ |..||....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~--- 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS--- 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC---
Confidence 999999999999999876543322222223355678999999998899999999999999999998 445553221
Q ss_pred CCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 566 ATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
...........+........ .......+ ..+.+++.+||+.+|++||++.+|+++|+
T Consensus 238 --~~~~~~~~~~~~~~~~~~~~--~~~~~~~~----~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 --DEQVIENTGEFFRNQGRQIY--LSQTPLCP----SPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred --hHHHHHHHHHhhhhcccccc--CCCCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111111111100000 00111122 34778888999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=314.26 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=195.8
Q ss_pred CcccccCCCCcccEEEEEecCC-c--eEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC------Cee
Q 005893 357 SDSNMLGQGGFGPVYKGVLSDG-K--EIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEK 425 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~~g-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 425 (671)
.+.+.||+|+||.||+|.+.+. . .+|+|.++.. .......+.+|+.+++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 4568899999999999997543 2 5899988753 344456788999999999999999999987542 245
Q ss_pred eEEEeccCCCchhhhhcCC---CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 426 LLVYEFMPNSSLDAILFDP---RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
++++||+++|+|..++... .....+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 12345899999999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
++...............+++.|++||.+....++.++||||||+++|||++ |+.||.... ... .+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~-~~~~~~~ 229 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--------NSE-IYDYLRQ 229 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--------HHH-HHHHHHc
Confidence 987643322111222345678999999998899999999999999999999 788875321 111 1222222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+.... ....++ ..+.+++.+||+.+|++|||+.||++.|+.
T Consensus 230 ~~~~~-----~~~~~~----~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 230 GNRLK-----QPPDCL----DGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCC-----CCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 22111 111222 236688889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=324.43 Aligned_cols=263 Identities=24% Similarity=0.277 Sum_probs=205.4
Q ss_pred hCCCCcccccCCCCcccEEEEEecC--CceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD--GKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.++|+..+.||+|+||.||+|...+ +..||+|++... .......+.+|+.++..++||||+++++++.++...++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468888999999999999998643 368999998642 22344568899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999984 3456899999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... .+....+..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--------~~~~-~~~i~~~~~--- 245 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--------PLLI-YQKILEGII--- 245 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--------HHHH-HHHHhcCCC---
Confidence 22 223578999999999998889999999999999999999999995321 1111 111222211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH--hcCC------CCCCCCCCCCccc
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVVM--LQGE------TITLCQPQKPAFS 645 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~~--L~~~------~~~~~~p~~p~~~ 645 (671)
.+....++ .+.+++.+|++.+|++|+ +++|+++. +++. ...+..|..|.+.
T Consensus 246 ---~~p~~~~~----~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 246 ---YFPKFLDN----NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred ---CCCCCCCH----HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 11122222 255777799999999995 89998764 2221 1234556666653
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.88 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=200.2
Q ss_pred CCCCcccccCCCCcccEEEEEe-----cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Ceee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-----SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 426 (671)
.+|++.+.||+|+||.||++.. .++..||+|++..........+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999974 25789999999876666677899999999999999999999987543 4578
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+|+||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999853 2345899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC-----CC--CCCCHHHHHHHH
Q 005893 507 AGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR-----GA--TAPNLLAYAWHL 578 (671)
Q Consensus 507 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~-----~~--~~~~l~~~~~~~ 578 (671)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..++...... +. ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4432211 111123445699999998889999999999999999999987765322110 00 000000111111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+... .....++ ..+.+++.+||+.+|++|||+.||++.|+.
T Consensus 239 ~~~~~~~-----~~~~~~~----~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 239 LKNNGRL-----PAPPGCP----AEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HhcCCcC-----CCCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 1111000 0111222 347788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.05 Aligned_cols=193 Identities=22% Similarity=0.306 Sum_probs=166.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..+|+..+.||+|+||.||++... +++.||+|.... ..+.+|+.++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999864 688999997542 3467899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+. ++|..++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 95 67877773 3345889999999999999999999988 99999999999999999999999999875332211
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
.......||+.|+|||++....++.++||||||+++|||++|+.|+-
T Consensus 238 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 238 -NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred -cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 11223579999999999999999999999999999999999998763
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=312.10 Aligned_cols=254 Identities=26% Similarity=0.328 Sum_probs=198.1
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--------------hchHHHHHHHHHHhhcCCCCeeeEe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--------------QGNAEFTNEVLLILKLQHKNLVKLL 416 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~ 416 (671)
.-+.|+..+.||+|.||.|-++... +++.||||++.+... ...+...+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3467888999999999999999964 689999999864211 1235788999999999999999999
Q ss_pred eEEEcC--CeeeEEEeccCCCchhhhhcCCCCCCC-CChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC
Q 005893 417 GFCVDG--DEKLLVYEFMPNSSLDAILFDPRKRGL-LCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493 (671)
Q Consensus 417 g~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 493 (671)
.+..+. +..|||+|||..|.+... ...+. ++..+++++++++..||+|||.++ ||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 998764 468999999998887543 23334 999999999999999999999998 99999999999999999
Q ss_pred CeEEeeccccccccCCC---CccccccccccCCccchhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005893 494 NPKISDFGMARIFAGSE---GEVNTARIVGTYGYMAPEYAMEGL----YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGA 566 (671)
Q Consensus 494 ~~kl~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~~~ 566 (671)
++||+|||.+..+.... ........+|||.|+|||....+. .+.+.||||+||+||-|+.|+.||-
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~------- 320 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF------- 320 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-------
Confidence 99999999998763321 111223479999999999987743 3568999999999999999999993
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
.......-.+. +...|.-...+++.+.+.++++++|+.||+.|.++.+|....
T Consensus 321 -~~~~~~l~~KI---------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 321 -DDFELELFDKI---------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -cchHHHHHHHH---------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 22222221111 111111111234556677888899999999999999997644
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.87 Aligned_cols=259 Identities=30% Similarity=0.469 Sum_probs=204.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEecC------CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSD------GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
..++|...+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.++..++|+||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34578888999999999999998642 3689999987543 3345578899999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCC-------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEE
Q 005893 425 KLLVYEFMPNSSLDAILFDPR-------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI 497 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 497 (671)
.++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999985422 2235789999999999999999999988 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHH
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||.... ...+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~~~~~---- 231 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-----NEEVL---- 231 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-----HHHHH----
Confidence 99999886544332222233456788999999988889999999999999999998 888884321 11111
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+....+.... +...+ ...+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 232 ~~~~~~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 KFVIDGGHLD-----LPENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHhcCCCCC-----CCCCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1122221111 11222 2346678889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=323.35 Aligned_cols=261 Identities=21% Similarity=0.334 Sum_probs=192.4
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----eee
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 426 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 426 (671)
+|+..++||+|+||.||+|+.. +|+.||||+++.. .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999964 6899999998742 2233456889999999999999999999886433 478
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888773 3446899999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCCc-cccccccccCCccchhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH------
Q 005893 507 AGSEGE-VNTARIVGTYGYMAPEYAME--GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH------ 577 (671)
Q Consensus 507 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~------ 577 (671)
...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ........
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~ 228 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV-----HQLDLITDLLGTPS 228 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH-----HHHHHHHHHhCCCC
Confidence 332211 12233578999999999865 67899999999999999999999998532210 00110000
Q ss_pred -----HHhcCCcccccc---ccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 578 -----LWNEGNALDLID---PLLTDTC---SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 578 -----~~~~~~~~~~~d---~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+......+.+. +...... .+.....+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000000 0000000 0001123567888999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.97 Aligned_cols=241 Identities=24% Similarity=0.331 Sum_probs=192.2
Q ss_pred cccCCCCcccEEEEEe----cCCceEEEEEccccc----hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 360 NMLGQGGFGPVYKGVL----SDGKEIAVKRLSSCS----EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+.||+|+||.||++.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357889999987522 23344678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++. ..+.+.+..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999883 3456788889999999999999999988 99999999999999999999999999875432221
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ......... .+.. .
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~-~~~~------~ 218 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKIL-KGKL------N 218 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCCC------C
Confidence 1223578999999999988889999999999999999999999985321 112221211 1111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
+....++ .+.+++.+||+.+|++|| ++.++++
T Consensus 219 ~~~~~~~----~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 LPPYLTP----EARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCH----HHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1222222 356777899999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.72 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=200.2
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
..+|.+.++||+|+||.||+|...++..||+|+++... .....+.+|+.+++.++||||+++++.+. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688889999999999999998777789999997533 23457889999999999999999999874 45678999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998532 2345799999999999999999999988 999999999999999999999999999765433221
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......++..|+|||......++.++||||||+++|||++ |+.||..... .. .......+.. ..
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~-~~~~~~~~~~-----~~ 223 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------RE-VLDQVERGYR-----MP 223 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HH-HHHHHhcCCC-----CC
Confidence 1122346678999999988899999999999999999999 7878753211 11 1111111110 01
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.+.+....+.+++.+|++.+|++||++.+++++|+.
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ----CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 112223457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.71 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=198.7
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCe
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 424 (671)
...-++|...++||+|.||+|+++.++ +++.+|||++++.. ..+.+..+.|.+++.-. +||.++.++..|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999975 57889999998743 34455677787777766 69999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.+.||||+.||++..+ +..+.+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999995443 35567999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
...... ..+..++||+.|||||++.+..|+...|+|+|||+||||+.|+.||.... .+++.+... .
T Consensus 517 e~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-----Eee~FdsI~----~--- 582 (694)
T KOG0694|consen 517 EGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-----EEEVFDSIV----N--- 582 (694)
T ss_pred ccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHh----c---
Confidence 644322 24567899999999999999999999999999999999999999996332 222222210 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
.|+......+ .+.+.|+.+.+..+|++|--+
T Consensus 583 ---d~~~yP~~ls----~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 ---DEVRYPRFLS----KEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---CCCCCCCccc----HHHHHHHHHHhccCcccccCC
Confidence 1122222222 336677779999999999877
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.71 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=202.9
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcC-CCCeeeEeeEEE
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQ-HKNLVKLLGFCV 420 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~ 420 (671)
.+...++|...+.||+|+||.||++++. .++.||||+++... ......+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344556777899999999999999863 34689999997543 223446889999999997 999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCC-------------------------------------------------------
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPR------------------------------------------------------- 445 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------------- 445 (671)
.....++|+||+++|+|.++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999885421
Q ss_pred ----------------------------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 005893 446 ----------------------------------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKAS 485 (671)
Q Consensus 446 ----------------------------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~ 485 (671)
....+++..++.++.||+.||.|||+.+ ++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1124778888999999999999999987 999999999
Q ss_pred cEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 005893 486 NVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSR 564 (671)
Q Consensus 486 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~ 564 (671)
|||+++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999986543322222223456788999999988889999999999999999998 8888753221
Q ss_pred CCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 565 GATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 565 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..........+... ......+ ..+.+++..||+.+|++||+++||++.|+.
T Consensus 348 -------~~~~~~~~~~~~~~-----~~p~~~~----~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 348 -------NEQFYNAIKRGYRM-----AKPAHAS----DEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred -------hHHHHHHHHcCCCC-----CCCCCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11111222222111 0111122 246677779999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.34 Aligned_cols=261 Identities=23% Similarity=0.299 Sum_probs=194.8
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999865 68899999987432 22344678999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 88887743 2345788999999999999999999988 99999999999999999999999999876433221
Q ss_pred ccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC-------
Q 005893 512 EVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN------- 583 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~------- 583 (671)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ........+......
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-----KEELHLIFRLLGTPTEETWPGI 231 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHHhhcc
Confidence 1223467899999998865 5689999999999999999999999853221 111111111111000
Q ss_pred -----ccccccccccCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 -----ALDLIDPLLTDTC----SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 -----~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
......+...... .+......++++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000001000000 0001123567888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=307.41 Aligned_cols=254 Identities=28% Similarity=0.385 Sum_probs=191.6
Q ss_pred cccCCCCcccEEEEEecC---CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 360 NMLGQGGFGPVYKGVLSD---GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
+.||+|+||.||+|...+ +..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 359999999999998643 4579999887543 233457889999999999999999999999988999999999999
Q ss_pred chhhhhcCCC--CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 436 SLDAILFDPR--KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 436 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2235677888899999999999999988 9999999999999999999999999987544333222
Q ss_pred ccccccccCCccchhhhccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 514 NTARIVGTYGYMAPEYAMEG-------LYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
......++..|+|||++... .++.++||||||+++|||++ |+.||..... ...... .. .+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~~~---~~-~~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVLTY---TV-REQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHH---Hh-hcccC
Confidence 22334677889999988542 35789999999999999996 9999853221 111111 11 11112
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
...++.+.... ++ .+.+++..|+ .+|++|||++||++.|+
T Consensus 229 ~~~~~~~~~~~-~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKLPL-SD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCCCC-Ch---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 22223322222 22 2455666898 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=317.08 Aligned_cols=261 Identities=29% Similarity=0.437 Sum_probs=202.5
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD 423 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 423 (671)
+..++|++.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+..++.++||||+++++++....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35677889999999999999999753 24579999886433 233446788999999999999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCC-------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeE
Q 005893 424 EKLLVYEFMPNSSLDAILFDPR-------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 496 (671)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++ |+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 9999999999999999985422 1244677888999999999999999988 99999999999999999999
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~ 575 (671)
|+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||.... ..+..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~~ 231 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQVL 231 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH
Confidence 999999886543332222222345678999999998899999999999999999999 777874221 11111
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....+.... ..... ...+.+++.+|++.+|++|||+.++++.|++.
T Consensus 232 -~~~~~~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 -KFVMDGGYLD-----QPDNC----PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -HHHHcCCCCC-----CCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111111111 11112 23477888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=296.07 Aligned_cols=269 Identities=23% Similarity=0.267 Sum_probs=209.4
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEE-ecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC--
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-- 423 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-- 423 (671)
.++.+..++|.+.+.||+|||+-||.++ ..+++.+|+|++.-...++.+...+|++..++++|||+++++++...+.
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 3445567889999999999999999998 5678899999998777778888999999999999999999998876544
Q ss_pred ---eeeEEEeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 424 ---EKLLVYEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 424 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
..||+++|...|+|.+.+.... +...+++.+.+.|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEe
Confidence 4899999999999998886533 4457999999999999999999999986 5799999999999999999999999
Q ss_pred ccccccccCC---C-Ccc---ccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 005893 500 FGMARIFAGS---E-GEV---NTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP 569 (671)
Q Consensus 500 fgla~~~~~~---~-~~~---~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~ 569 (671)
||.+....-. . ... .......|..|.|||.+. +...++++|||||||+||+|+.|..||+..-..|+...
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9988753211 0 000 111235688899999884 34578999999999999999999999974322221110
Q ss_pred CHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 570 NLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 570 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+.+.-.-.....+.+++++.+|++.||.+||++.|++..++.
T Consensus 253 ---------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 253 ---------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred ---------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 01111111000001133457888889999999999999999998865
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.67 Aligned_cols=246 Identities=27% Similarity=0.411 Sum_probs=189.8
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+|+..++||+|+||.||+++.. +++.||||++.... ......+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556788999999999999964 68999999986532 333457889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.... ..++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986432 3567778899999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCCccchhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 513 VNTARIVGTYGYMAPEYAME-----GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||..... ............. ..
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~-~~--- 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMS-QP--- 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhcc-CC---
Confidence 1123578999999998743 2345689999999999999999999963221 1111111111111 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+......+ ..+.+++.+||+.||++||++.||++
T Consensus 294 --~~~~~~~~----~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 --PEAPATAS----REFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --CCCCCccC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111222 24667788999999999999999986
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=310.71 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=202.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..++|+..++||+|+||.||++...+++.||+|.+.... .....+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 346788889999999999999998889999999987543 33467899999999999999999999864 4568999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. .....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKT-PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999998854 23456899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||.... ..+... ....+....
T Consensus 158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~~-~~~~~~~~~---- 223 (260)
T cd05067 158 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--------NPEVIQ-NLERGYRMP---- 223 (260)
T ss_pred c-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--------hHHHHH-HHHcCCCCC----
Confidence 1 1122345678999999988889999999999999999999 999985321 111111 111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+ ..+.+++.+|++.+|++||+++++..+|+.
T Consensus 224 -~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -RPDNCP----EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCC----HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111222 246778889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.13 Aligned_cols=261 Identities=22% Similarity=0.315 Sum_probs=190.1
Q ss_pred CCCCcccccCCCCcccEEEEEec--CCceEEEEEccccc--hhchHHHHHHHHHHhhc---CCCCeeeEeeEEEc-----
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS--DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKL---QHKNLVKLLGFCVD----- 421 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----- 421 (671)
++|++.+.||+|+||.||+++.. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46789999986432 22233556677776665 69999999999862
Q ss_pred CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
....++||||++ ++|.+++.. .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 688888753 22345899999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
+++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ............
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-----~~~~~i~~~~~~ 227 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-----DQLGKILDVIGL 227 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHHhCC
Confidence 99865432 1223457899999999998889999999999999999999999998643211 111111111000
Q ss_pred C---Cccc---cccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 G---NALD---LIDPLLTD-------TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~---~~~~---~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. .+.. .....+.. ...++....+.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000 00000000 000111224568888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.88 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=204.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+|+.. +++.||||.++.. .......+.+|+++++.++||||+++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888999999999999999964 6889999987542 2333456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875322 3455889999999999999999999988 99999999999999999999999999886543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+.... ......... ......
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~-~~~~~~---- 225 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQK-IEQCDY---- 225 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHH-HhcCCC----
Confidence 221 1123467889999999988889999999999999999999999984321 111222211 111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+.+ ........+.+++.+||+.+|++||++.||++.|+..
T Consensus 226 -~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 -PPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 111 1112224467888899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=320.45 Aligned_cols=259 Identities=29% Similarity=0.398 Sum_probs=201.5
Q ss_pred hCCCCcccccCCCCcccEEEEEec--------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS--------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG 422 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 422 (671)
.++|.+.+.||+|+||.||++... ++..+|+|.++.. ......++.+|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 456888999999999999999752 2346999999753 234456788999999999 799999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRK-------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL 489 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll 489 (671)
...++||||+++++|.+++..... ...+++..+++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999864321 235899999999999999999999987 9999999999999
Q ss_pred cCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 005893 490 DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATA 568 (671)
Q Consensus 490 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~ 568 (671)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~------- 246 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------- 246 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-------
Confidence 9999999999999876543222111222234568999999988889999999999999999998 88887422
Q ss_pred CCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 569 PNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 569 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
...+.. .....+...+ ..... ...+.+++..|++.+|++||++.||++.|+..
T Consensus 247 -~~~~~~-~~~~~~~~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 247 -PVEELF-KLLKEGHRMD-----KPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -CHHHHH-HHHHcCCCCC-----CCCcC----CHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 1122221111 11112 23466778899999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.29 Aligned_cols=256 Identities=30% Similarity=0.444 Sum_probs=203.8
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..++|.+.+.||+|+||.||++..++++.|+||.+.... ....++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 456788899999999999999998888899999987533 3456789999999999999999999999988899999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~i~~-~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999854 22346899999999999999999999988 99999999999999999999999999886543211
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ........ ..+. ..
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~-~~~~-----~~ 223 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQV-ERGY-----RM 223 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-HcCC-----CC
Confidence 11112234568999999998889999999999999999999 999884221 11111111 1110 00
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...... ...+.+++.+|++.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNC----PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111112 2346778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.84 Aligned_cols=200 Identities=27% Similarity=0.374 Sum_probs=173.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||+||++... +++.||||+++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999864 58899999997532 223456788999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCc---------------------------------cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 005893 510 EGE---------------------------------VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556 (671)
Q Consensus 510 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~ 556 (671)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCC
Q 005893 557 NTG 559 (671)
Q Consensus 557 p~~ 559 (671)
||.
T Consensus 235 Pf~ 237 (363)
T cd05628 235 PFC 237 (363)
T ss_pred CCC
Confidence 995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=326.22 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=195.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||+++.. +|+.||||+++... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999975 68899999997532 233456788999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCcc------------------------------------ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh
Q 005893 510 EGEV------------------------------------NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553 (671)
Q Consensus 510 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt 553 (671)
.... .....+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0012469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 005893 554 GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT---MSSVVV 627 (671)
Q Consensus 554 G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt---~~ev~~ 627 (671)
|+.||.... ................. ... ...+ ++ +.+++.+|+. +|++|++ +.|+++
T Consensus 235 G~~Pf~~~~--------~~~~~~~i~~~~~~~~~-~~~--~~~s-~~---~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDN--------PQETYRKIINWKETLQF-PDE--VPLS-PE---AKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCC--------HHHHHHHHHcCCCccCC-CCC--CCCC-HH---HHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999995321 11111111111110000 000 0122 22 4455567886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.91 Aligned_cols=256 Identities=28% Similarity=0.496 Sum_probs=201.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCc---eEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGK---EIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~---~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.++|+..+.||+|+||.||+|+.. +++ .+++|.++.. .......+.+|++++.+++|+||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356778899999999999999975 233 6999998754 33445678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++++|.+++.. ..+.+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999853 3356899999999999999999999988 9999999999999999999999999988654
Q ss_pred CCCCccc-cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 508 GSEGEVN-TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 508 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
....... ......+..|+|||.+..+.++.++||||||+++|||++ |+.||.... ..... +....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------~~~~~-~~i~~~~~~ 229 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------NHEVM-KAINDGFRL 229 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------HHHHH-HHHhcCCCC
Confidence 3322111 111223457999999988889999999999999999998 999984321 11111 111211110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+. .... ...+.+++.+||+.+|++||++.+|++.|++
T Consensus 230 ----~~-~~~~----~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 230 ----PA-PMDC----PSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred ----CC-CCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 1112 2346788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=325.44 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=199.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|.+.+.||+|+||.||++... +|+.||||+++... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999975 68899999987532 234456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999999853 356899999999999999999999988 999999999999999999999999999865443
Q ss_pred C---------------------------CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005893 510 E---------------------------GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQ 562 (671)
Q Consensus 510 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~ 562 (671)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223578999999999999999999999999999999999999985322
Q ss_pred CCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 005893 563 SRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-MSSVVVM 628 (671)
Q Consensus 563 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-~~ev~~~ 628 (671)
......+....... ...+. ....++ .+.+++..|++ +|++||+ +.|+++.
T Consensus 235 --------~~~~~~~i~~~~~~--~~~p~-~~~~~~----~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 --------LQETYNKIINWKES--LRFPP-DPPVSP----EAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred --------HHHHHHHHhccCCc--ccCCC-CCCCCH----HHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111110000 00000 011222 35567778997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=318.00 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=198.5
Q ss_pred CCCCcccccCCCCcccEEEEEecC-Cc--eEEEEEccc-cchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSD-GK--EIAVKRLSS-CSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
++|++.+.||+|+||.||+|...+ +. .+++|.++. ........+.+|+.++.++ +||||+++++++......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999998753 33 478888874 2334456789999999999 799999999999999999999
Q ss_pred EeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 429 YEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999985322 1235889999999999999999999988 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~ 574 (671)
||+|||++...... ........+..|+|||.+....++.++||||||+++|||++ |+.||.... ....
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--------~~~~ 227 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--------CAEL 227 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHH
Confidence 99999998642211 11111223457999999988889999999999999999998 999984321 1111
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETI 634 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~ 634 (671)
......+. .......++ ..+.+++.+||+.+|.+||++.++++.|+....
T Consensus 228 -~~~~~~~~-----~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 228 -YEKLPQGY-----RMEKPRNCD----DEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred -HHHHhcCC-----CCCCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 111112222 236678889999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=307.00 Aligned_cols=254 Identities=26% Similarity=0.342 Sum_probs=189.6
Q ss_pred cccCCCCcccEEEEEecC---CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 360 NMLGQGGFGPVYKGVLSD---GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
+.||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999997543 3468888876432 333456889999999999999999999999999999999999999
Q ss_pred chhhhhcCCCC--CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 436 SLDAILFDPRK--RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 436 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+|.+++..... ....++...+.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999865332 234567888999999999999999988 9999999999999999999999999987543332222
Q ss_pred ccccccccCCccchhhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 514 NTARIVGTYGYMAPEYAME-------GLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
......++..|+|||+... ..++.++||||||+++|||++ |..||..... .+........+ ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~-~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVREQ-DI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhhcc-Cc
Confidence 2233456778999998743 356889999999999999999 7777743211 11111222221 22
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
+..++.+...++. .+.+++..|| .||++|||++||+++|.
T Consensus 229 ~~~~~~~~~~~~~----~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLKYSD----RWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccccCCH----HHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 2223333323332 2445666888 59999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.19 Aligned_cols=259 Identities=29% Similarity=0.450 Sum_probs=202.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
..++|+..+.||+|+||.||++... ++..||+|+++... .....++.+|+.++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3467888999999999999999863 46789999987533 3345678899999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCC-------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 005893 425 KLLVYEFMPNSSLDAILFDPR-------------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKAS 485 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~ 485 (671)
.++++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999985321 1234788999999999999999999988 999999999
Q ss_pred cEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCC
Q 005893 486 NVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSR 564 (671)
Q Consensus 486 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~ 564 (671)
||++++++.++|+|||+++................+..|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~--- 236 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM--- 236 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---
Confidence 99999999999999999876543322211222344667999999988899999999999999999998 87777321
Q ss_pred CCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 565 GATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 565 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+.. .....+.... .....+ ..+.+++.+|++.+|++|||+.||++.|+.
T Consensus 237 -----~~~~~~-~~~~~~~~~~-----~~~~~~----~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 237 -----AHEEVI-YYVRDGNVLS-----CPDNCP----LELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----CHHHHH-HHHhcCCCCC-----CCCCCC----HHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111 1222222211 111222 346778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.99 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=195.7
Q ss_pred CCCcccccCCCCcccEEEEEe----cCCceEEEEEccccc----hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCee
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL----SDGKEIAVKRLSSCS----EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 425 (671)
+|++.+.||+|+||.||++.. .+++.||+|++++.. ......+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 357899999986422 22345678899999999 599999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++|+|.+++. .++.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999884 3456899999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
....... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... ........... .
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~-~--- 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRIL-K--- 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHHh-c---
Confidence 5433222 22345799999999998765 4789999999999999999999999643211 11111111111 1
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.++.+....++ .+.+++.+||+.||++|| +++++++
T Consensus 226 ---~~~~~~~~~~~----~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ---CDPPFPSFIGP----EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCCCCCCCH----HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11222222333 255777799999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.10 Aligned_cols=247 Identities=28% Similarity=0.386 Sum_probs=196.1
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchh
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLD 438 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 438 (671)
++||+|+||.||+|...+++.+|+|.++... ......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888999999987543 233446889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccc
Q 005893 439 AILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518 (671)
Q Consensus 439 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 518 (671)
+++.. ....+++..++.++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++......... .....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 98843 2345889999999999999999999988 999999999999999999999999998754322111 11122
Q ss_pred cccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 519 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
.++..|+|||++..+.++.++||||||+++|||++ |..||.... ..... .....+... ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--------~~~~~-~~~~~~~~~-----~~~~~~- 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--------NQQAR-EQVEKGYRM-----SCPQKC- 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--------HHHHH-HHHHcCCCC-----CCCCCC-
Confidence 44567999999988899999999999999999998 888885321 11111 111111111 111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
...+.+++.+|++.+|++||++.|+++.|.
T Consensus 220 ---~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 ---PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 234778888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=319.42 Aligned_cols=260 Identities=27% Similarity=0.402 Sum_probs=203.2
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec--------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS--------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCV 420 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 420 (671)
...++|.+.+.||+|+||.||+++.. ++..||+|.+... .......+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34566788899999999999999741 2457999998753 234456789999999999 8999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcE
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRK-------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NI 487 (671)
.....++||||+++++|.+++...+. ...+++..++.++.||+.||.|||+++ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999864321 235888999999999999999999988 99999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005893 488 LLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGA 566 (671)
Q Consensus 488 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 566 (671)
++++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+...
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----- 243 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 243 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----
Confidence 999999999999999987644332222233455678999999988889999999999999999998 77776421
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+.. .....+.... ....++ ..+.+++.+||+.+|++||++.||++.|+.
T Consensus 244 ---~~~~~~-~~~~~~~~~~-----~~~~~~----~~~~~li~~cl~~~p~~Rps~~e~l~~l~~ 295 (304)
T cd05101 244 ---PVEELF-KLLKEGHRMD-----KPANCT----NELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295 (304)
T ss_pred ---CHHHHH-HHHHcCCcCC-----CCCCCC----HHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 122222 1222221111 111222 346677889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=307.42 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=205.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||+|... +|+.|++|.++.. .......+.+|++++++++|+|++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999976 7899999988632 2233567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
||+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999885432 3455899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ..+..... ....+...
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~-~~~~~~~~--- 226 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCK-KIEKCDYP--- 226 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHh-hhhcCCCC---
Confidence 3221 123467889999999988889999999999999999999999984321 11212111 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+ +.. ......+.+++.+||+.+|++||++.+|+++|++.
T Consensus 227 -~-~~~---~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 -P-LPA---DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred -C-CCh---hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 111 12223466788899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.90 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=203.3
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG 422 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 422 (671)
...++|...+.||+|+||.||++... .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34567888999999999999999742 34579999987543 33345789999999999 799999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
+..+++|||+++++|.+++... ....+++.++..++.||+.||.|||+++ |+|+||||+||+++.++.++|+|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999998542 2234899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
++...............++..|+|||.+....++.++||||||+++|||++ |+.||..... .....+....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--------~~~~~~~~~~ 259 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--------DSKFYKLIKE 259 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------hHHHHHHHHc
Confidence 986544322212222345778999999998899999999999999999998 9988753211 1111112222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+... ......+ ..+.+++.+|++.+|++|||+.||++.|+.
T Consensus 260 ~~~~-----~~~~~~~----~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 260 GYRM-----AQPEHAP----AEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred CCcC-----CCCCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 1110 0111112 246678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=313.16 Aligned_cols=240 Identities=25% Similarity=0.301 Sum_probs=187.3
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhh-cCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILK-LQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||++... +++.||+|+++... ......+..|..++.. .+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 57889999987532 2233445667667665 4899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99998884 3446899999999999999999999988 9999999999999999999999999997643322 12
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ......... ... +.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~-~~~------~~~~~ 217 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--------EDELFDSIL-NDR------PHFPR 217 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-cCC------CCCCC
Confidence 234578999999999998899999999999999999999999985321 111111111 111 11122
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMS-SVV 626 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~-ev~ 626 (671)
..+. .+.+++.+||+.+|++||++. +++
T Consensus 218 ~~~~----~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 218 WISK----EAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCH----HHHHHHHHHccCCHHHcCCChHHHH
Confidence 2222 355677799999999999975 454
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.02 Aligned_cols=250 Identities=31% Similarity=0.460 Sum_probs=201.9
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.++|+..+.||+|+||.||++... |+.||+|.++.... ...++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 456788899999999999999874 78999999986544 4567899999999999999999999999989999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRS-RGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999853 22336899999999999999999999988 99999999999999999999999999986532211
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
....+..|+|||.+..+.++.++||||||+++|||++ |+.||.... ... .......+...+
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~-~~~~~~~~~~~~----- 219 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKD-VVPHVEKGYRME----- 219 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--------HHH-HHHHHhcCCCCC-----
Confidence 2234567999999988899999999999999999997 998885321 111 111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+ ..+.+++.+|++.+|++||++.||+++|++
T Consensus 220 ~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCP----PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111222 346678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=287.17 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=202.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
-++|++.+.||+|.||.||.|+.+ ++-.||+|++.+. ..+-..++.+|+++-..|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 367888999999999999999965 5678999998652 223345788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
+||.++|.|...|.. +..+.+++.....++.|+|.||.|+|..+ +|||||||+|+|++.++..||+|||.+..-..
T Consensus 101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999998853 34566888999999999999999999987 99999999999999999999999999875432
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
......+||..|.+||...+..++.+.|+|++|++.||++.|.+||..... .-.++...+ .+..
T Consensus 177 ----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---------~etYkrI~k---~~~~ 240 (281)
T KOG0580|consen 177 ----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---------SETYKRIRK---VDLK 240 (281)
T ss_pred ----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------HHHHHHHHH---cccc
Confidence 123347999999999999999999999999999999999999999964321 111222222 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+| ...+.+ ..+++..|+..+|.+|.+..||+.
T Consensus 241 ~p---~~is~~----a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 241 FP---STISGG----AADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CC---cccChh----HHHHHHHHhccCccccccHHHHhh
Confidence 22 222322 556777999999999999999985
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.60 Aligned_cols=252 Identities=24% Similarity=0.337 Sum_probs=192.7
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.|+..+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999864 67899999996532 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999984 3456889999999999999999999988 9999999999999999999999999976432100
Q ss_pred C---------------------------------------------ccccccccccCCccchhhhccCCCCcchhhHHHH
Q 005893 511 G---------------------------------------------EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFG 545 (671)
Q Consensus 511 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG 545 (671)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001124799999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHH--ccccCCCCCCCHH
Q 005893 546 VLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLL--CVQEDAFDRPTMS 623 (671)
Q Consensus 546 vil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPt~~ 623 (671)
|++|||++|+.||..... ................ + .....+++ +.+++.+ |+..+|..||++.
T Consensus 236 ~il~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~--~-~~~~~s~~----~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP--------TETQLKVINWENTLHI--P-PQVKLSPE----AVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hHHHHHHhCCCCCcCCCH--------HHHHHHHHccccccCC--C-CCCCCCHH----HHHHHHHHccCcccccCCCCHH
Confidence 999999999999953221 1111111111100000 0 00122333 3344434 6677888899999
Q ss_pred HHHH
Q 005893 624 SVVV 627 (671)
Q Consensus 624 ev~~ 627 (671)
|++.
T Consensus 301 ~~l~ 304 (381)
T cd05626 301 DIKA 304 (381)
T ss_pred HHhc
Confidence 9987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.03 Aligned_cols=256 Identities=29% Similarity=0.448 Sum_probs=199.2
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCc----eEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGK----EIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
.++|+..++||+|+||.||+|.+. +|+ .||+|+++.. ......++.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356788899999999999999853 444 4899998753 33345678899999999999999999999875 4567
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+++||+++|+|.+++.. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999998853 2346899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.............++..|++||...+..++.++||||||+++|||++ |..||..... ..+. .....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~----~~~~~~~~~ 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIP----DLLEKGERL 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH----HHHHCCCcC
Confidence 44332222222345678999999988899999999999999999998 8888853211 1111 112222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
. .....+ ..+.+++..||+.||++||++.|++..|+..
T Consensus 231 ~-----~~~~~~----~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 231 P-----QPPICT----IDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred C-----CCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1 011122 3466788899999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.60 Aligned_cols=264 Identities=25% Similarity=0.386 Sum_probs=200.5
Q ss_pred hCCCCcccccCCCCcccEEEEEec-----------------CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-----------------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVK 414 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~ 414 (671)
.++|++.+.||+|+||.||++... ++..||+|+++.. ......++.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456888999999999999998532 2346899998753 3344567899999999999999999
Q ss_pred EeeEEEcCCeeeEEEeccCCCchhhhhcCCC--------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCc
Q 005893 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPR--------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASN 486 (671)
Q Consensus 415 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~N 486 (671)
+++++...+..+++|||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999885422 1234788899999999999999999998 9999999999
Q ss_pred EEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCC
Q 005893 487 VLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT--GRRNTGFNQSR 564 (671)
Q Consensus 487 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt--G~~p~~~~~~~ 564 (671)
|++++++.++|+|||+++.+.............++..|++||....+.++.++||||||+++|||++ |..|+....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-- 238 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC--
Confidence 9999999999999999986544332222223345678999999888899999999999999999998 566664221
Q ss_pred CCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 565 GATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 565 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
................... ..+. ...++ ..+.+++.+||+.||++||++.||++.|+
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 239 ---DEQVIENTGEFFRDQGRQV-YLPK-PALCP----DSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ---hHHHHHHHHHHHhhccccc-cCCC-CCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111111111100 0010 11122 34678888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=310.89 Aligned_cols=254 Identities=26% Similarity=0.447 Sum_probs=198.7
Q ss_pred CCCcccccCCCCcccEEEEEecC-C---ceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSD-G---KEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
+|+..+.||+|+||.||+|.... + ..||||.++.. ......+|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999999743 3 35999998754 3445568999999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++.. ..+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999853 2456899999999999999999999988 999999999999999999999999998765433
Q ss_pred CCcccccc-c--cccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 510 EGEVNTAR-I--VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 510 ~~~~~~~~-~--~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
........ . ..+..|+|||.+..+.++.++||||||+++|||++ |+.||..... ...... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~~----i~~~~-- 228 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINA----IEQDY-- 228 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHHH----HHcCC--
Confidence 22211111 1 12357999999998999999999999999999886 9998843211 111111 11110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.......++ ..+.+++..||+.+|++||++.+|+.+|+.
T Consensus 229 ---~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 ---RLPPPMDCP----TALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---cCCCcccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 000111222 336778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.63 Aligned_cols=250 Identities=35% Similarity=0.492 Sum_probs=201.8
Q ss_pred cccCCCCcccEEEEEecC----CceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLSD----GKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||++...+ +..|++|.++..... ....+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 788999999864433 366889999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCC------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 435 SSLDAILFDPRK------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 435 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865321 367999999999999999999999988 99999999999999999999999999987655
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
...........++..|+|||.+....++.++||||||+++|||++ |+.||.... .... +.....+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~-~~~~~~~~~~-- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEV-LEYLRKGYRL-- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHH-HHHHHcCCCC--
Confidence 433223334567889999999988889999999999999999999 688885431 1111 1222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
...... ...+.+++.+||+.+|++||++.|++..|+
T Consensus 227 ---~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ---PKPEYC----PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCccC----ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111122 234677888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.44 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=198.7
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++.+++||||+++++.+..++..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35688899999999999999996 46889999999765445556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++. ..+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999884 3456899999999999999999999988 99999999999999999999999999986533221
Q ss_pred ccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
......|+..|+|||.+. ...++.++||||||+++|||++|+.|+...... .... . ...... .
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~----~~~~----~-~~~~~~---~ 227 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RALF----L-MSKSNF---Q 227 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh----hhhe----e-eecCCC---C
Confidence 122346788999999874 345788999999999999999999998422111 0000 0 000000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
.+.+.. .......+.+++.+||+.+|++||++++|++.|
T Consensus 228 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 011110 001123466778899999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=316.41 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=190.4
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHH---hhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLI---LKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
|.+.+.||+|+||.||++... +++.||||+++... ......+..|+.++ ..++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999864 68899999997532 22334566666554 567899999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|..++. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988873 346899999999999999999999988 99999999999999999999999999875322
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ........ ..+..
T Consensus 154 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i-~~~~~---- 218 (324)
T cd05589 154 FGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSI-VNDEV---- 218 (324)
T ss_pred CCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-HhCCC----
Confidence 211 2234578999999999999899999999999999999999999985321 11111111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.+....++ .+.+++.+||+.||++|| ++.++++
T Consensus 219 --~~p~~~~~----~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 --RYPRFLSR----EAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCH----HHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11222332 356777899999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=307.69 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=203.5
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||++.. .+++.++||.+... ......++.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3577788999999999999996 47899999987642 2334457889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 23456899999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...... +.... ..
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~-----~~ 224 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLC-KKIEQ-----CD 224 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHh-hhhhc-----CC
Confidence 3211 1234688899999999888899999999999999999999999843211 111111 11111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.+.+... .....+.+++.+||+.+|++||||.+|.++++.
T Consensus 225 ~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 225 YPPLPSD---HYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCCCCcc---cccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111111 122346677789999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.31 Aligned_cols=241 Identities=22% Similarity=0.261 Sum_probs=190.9
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
++||+|+||.||+|+.. +++.||+|+++.. .......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 5789999998753 223345577888888866 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
++|...+. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 99998884 3456889999999999999999999998 99999999999999999999999999875432221 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ......... .+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~-~~~~------~~p~ 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESIL-HDDV------LYPV 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCCC------CCCC
Confidence 233578999999999998899999999999999999999999995322 111111111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRP-------TMSSVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-------t~~ev~~ 627 (671)
..+. .+.+++..|++.||++|| +++++++
T Consensus 218 ~~~~----~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 218 WLSK----EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCH----HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1222 356777799999999999 7888864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=306.35 Aligned_cols=249 Identities=27% Similarity=0.376 Sum_probs=201.1
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|++|.||++... +++.|++|.+.. ........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999975 688999999864 2344566789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998642 2456899999999999999999999987 99999999999999999999999999886644322
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
. .....|++.|+|||+..+..++.++||||||+++|||++|+.||.... -...... ...+... .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~~-----~ 220 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILK-IIRGVFP-----P 220 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHcCCCC-----C
Confidence 1 223467889999999999999999999999999999999999985322 1111111 1111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+...++ ..+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~----~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccC----HHHHHHHHHHccCCcccCcCHHHHhh
Confidence 111222 34678888999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=306.36 Aligned_cols=253 Identities=29% Similarity=0.410 Sum_probs=198.3
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
++|...+.||+|++|.||++...++..+|+|++.... .....+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577788999999999999998777789999886533 23456889999999999999999999875 456789999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999998542 3345889999999999999999999988 999999999999999999999999999765332211
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......++..|+|||......++.++||||||+++|||++ |+.||..... ... +.....+.. ...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~-~~~~~~~~~-----~~~ 224 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REV-LEQVERGYR-----MPC 224 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH-HHHHHcCCC-----CCC
Confidence 1112345678999999988899999999999999999999 8888853211 111 111111111 011
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+.+....+.+++.+||+.+|++||++++|+++|+.
T Consensus 225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 ----PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122346677889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.26 Aligned_cols=249 Identities=32% Similarity=0.424 Sum_probs=196.8
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchh
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLD 438 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 438 (671)
++||+|+||.||++...+++.|++|.++..... ....+.+|+.++++++|+||+++++++.+....++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998764333 4567899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccc
Q 005893 439 AILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518 (671)
Q Consensus 439 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 518 (671)
+++.. ....+++..++.++.+++.+|.|||+++ ++||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 98853 2345789999999999999999999988 999999999999999999999999998765422221111222
Q ss_pred cccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 519 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..+..|+|||.+.++.++.++||||||+++|||++ |..||..... ... ......+.. .......
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~-~~~~~~~~~-----~~~~~~~- 220 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQT-RERIESGYR-----MPAPQLC- 220 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHH-HHHHhcCCC-----CCCCccC-
Confidence 34567999999988899999999999999999999 7888743211 111 111111110 0011112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+.+++.+|++.+|++|||+.||++.|+.
T Consensus 221 ---~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 221 ---PEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ---CHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 2347778889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=306.27 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=192.7
Q ss_pred ccCCCCcccEEEEEec---CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCc
Q 005893 361 MLGQGGFGPVYKGVLS---DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSS 436 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 436 (671)
.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 35579999987643 333456899999999999999999999875 457789999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc-cc
Q 005893 437 LDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-NT 515 (671)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~ 515 (671)
|.+++.. ....+++..+++++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998853 3456899999999999999999999988 9999999999999999999999999998654332211 11
Q ss_pred ccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 516 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
....++..|+|||.+....++.++||||||+++|||++ |+.||.... ... .......+... ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~-~~~~~~~~~~~-----~~~~ 221 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--------GPE-VMSFIEQGKRL-----DCPA 221 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--------HHH-HHHHHHCCCCC-----CCCC
Confidence 12234578999999988889999999999999999996 999985321 111 11222222211 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
..+ ..+.+++..||+.+|++||++.+|.+.|+..
T Consensus 222 ~~~----~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECP----PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 222 3355777799999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.36 Aligned_cols=261 Identities=28% Similarity=0.419 Sum_probs=202.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEec--------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS--------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD 421 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 421 (671)
..++|.+.+.||+|+||.||++... ....+|+|.++.. ......++.+|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3456778899999999999999742 2457999998753 234456788999999999 69999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEE
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIl 488 (671)
....+++|||+++|+|.+++.... ....+++..+.+++.||+.||.|||+.+ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 889999999999999999985422 1245899999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGAT 567 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 567 (671)
+++++.+||+|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~----- 241 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP----- 241 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-----
Confidence 99999999999999986543322221222234567999999988899999999999999999999 888874221
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
... .......+...+ ....++ ..+.+++.+||+.+|++||++.|+++.|+...
T Consensus 242 ---~~~-~~~~~~~~~~~~-----~~~~~~----~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 242 ---VEE-LFKLLREGHRMD-----KPSNCT----HELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ---HHH-HHHHHHcCCCCC-----CCCCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111 111222221111 111222 24667888999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.74 Aligned_cols=238 Identities=24% Similarity=0.276 Sum_probs=189.8
Q ss_pred cccCCCCcccEEEEEe----cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 360 NMLGQGGFGPVYKGVL----SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|+.++.+++||||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999997532 2234457789999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+|+|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999999883 3456899999999999999999999998 99999999999999999999999999876433211
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
......|++.|+|||.+....++.++||||||+++|||++|+.||.... .......... ... .+.
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--------~~~~~~~i~~-~~~------~~p 218 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--------RKETMTMILK-AKL------GMP 218 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--------HHHHHHHHHc-CCC------CCC
Confidence 2233578999999999988889999999999999999999999985321 1111111111 111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSS 624 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~e 624 (671)
...++ .+.+++.+||+.||++||++.+
T Consensus 219 ~~~~~----~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSP----EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCH----HHHHHHHHHhhcCHhHcCCCCC
Confidence 22222 3557777999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.96 Aligned_cols=241 Identities=23% Similarity=0.252 Sum_probs=191.5
Q ss_pred cccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 360 NMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
+.||+|+||.||++.. .+|+.||+|+++.. .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999986 46889999998753 2233456788999999999999999999999999999999999999
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
+|..++. ..+.+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 9988874 34568999999999999999999997 56 99999999999999999999999999875332221 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ......... ... ..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~-~~~------~~~p~ 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELIL-MEE------IRFPR 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHh-cCC------CCCCC
Confidence 223578999999999999999999999999999999999999985321 111111111 111 11222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
..++ .+.+++.+|++.||++|| ++.++++
T Consensus 218 ~~~~----~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 218 TLSP----EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCH----HHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 2333 356677799999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.66 Aligned_cols=260 Identities=29% Similarity=0.420 Sum_probs=199.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC-
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG- 422 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~- 422 (671)
..++|+..+.||+|+||.||+|.. .+++.||||+++... ......+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346788899999999999999973 356789999997533 23345688999999999 789999999988754
Q ss_pred CeeeEEEeccCCCchhhhhcCCCC--------------------------------------------------------
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRK-------------------------------------------------------- 446 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 446 (671)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 457899999999999998853210
Q ss_pred --------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccc
Q 005893 447 --------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518 (671)
Q Consensus 447 --------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 518 (671)
...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 124788889999999999999999988 999999999999999999999999998865433222222223
Q ss_pred cccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 519 ~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
.++..|+|||.+....++.++||||||+++|||++ |..||...... ........++.... .....+
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-----~~~~~~ 308 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTRMR-----APDYTT 308 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------HHHHHHHhccCCCC-----CCCCCC
Confidence 45678999999988899999999999999999997 88888532111 11111122221111 111122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+ .+.+++..||+.+|++||++.||++.|+.
T Consensus 309 ~----~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 P----EMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred H----HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 2 36788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=334.57 Aligned_cols=260 Identities=25% Similarity=0.276 Sum_probs=207.0
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEecCC-ceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeE-EEc----
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLSDG-KEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGF-CVD---- 421 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~-~~~---- 421 (671)
+.+...++.+.++|.+|||+.||.+....+ .++|+|++-..++.....+.+|+++|++|+ |+|||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 445666778889999999999999998665 999999998778888899999999999996 9999999993 221
Q ss_pred --CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 422 --GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 422 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
..+.+|.||||.+|.|-+++......+ |++.++++|+.++++|+++||... ++|||||||-+||||..+++.||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 135689999999999999986533333 999999999999999999999985 7899999999999999999999999
Q ss_pred ccccccccCCC-Cccc------cccccccCCccchhhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 005893 500 FGMARIFAGSE-GEVN------TARIVGTYGYMAPEYA---MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP 569 (671)
Q Consensus 500 fgla~~~~~~~-~~~~------~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~ 569 (671)
||.+.--.... .... .-...-|+.|+|||.+ .+..+++|+|||+|||+||-|+....||+...
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------- 262 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------- 262 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence 99886432211 1100 0123578999999986 45689999999999999999999999996321
Q ss_pred CHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 570 NLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 570 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+++..+.-...+.....+.+||..||+.||++||++-+|++.+-.
T Consensus 263 --------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 263 --------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred --------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 112222222111124556678889999999999999999999886643
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.51 Aligned_cols=236 Identities=26% Similarity=0.294 Sum_probs=187.5
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||+++.. +++.||||+++.. .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999975 5789999998753 223345677888888876 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 99998884 3456899999999999999999999988 99999999999999999999999999875322211 2
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..... .....+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~-~~i~~~~~------~~~~ 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLF-EAILNDEV------VYPT 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHH-HHHhcCCC------CCCC
Confidence 233578999999999998899999999999999999999999995321 11211 11112111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
..+. .+.+++.+|++.||++||++
T Consensus 218 ~~~~----~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQ----DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCH----HHHHHHHHHcccCHHHCCCC
Confidence 2222 35677779999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=315.26 Aligned_cols=241 Identities=24% Similarity=0.263 Sum_probs=190.6
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCC-CCeeeEeeEEEcCCeeeEEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~ 429 (671)
+|+..+.||+|+||.||+|+.. +++.||||+++.. .......+..|..++..++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999975 5778999998753 22344567889999999876 46888999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999998884 3456889999999999999999999988 999999999999999999999999998753222
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........ ....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i-~~~~------ 217 (324)
T cd05587 155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSI-MEHN------ 217 (324)
T ss_pred CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHH-HcCC------
Confidence 11 1234578999999999999999999999999999999999999985321 11111111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
..+....+. .+.+++.+|++.||++||+.
T Consensus 218 ~~~~~~~~~----~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSK----EAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCH----HHHHHHHHHhhcCHHHcCCC
Confidence 111122232 35677789999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=302.58 Aligned_cols=249 Identities=31% Similarity=0.426 Sum_probs=197.1
Q ss_pred cccCCCCcccEEEEEecC--C--ceEEEEEccccch-hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLSD--G--KEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|++|.||+|.+.+ + ..||||.++.... .....+.+|+..+++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998743 3 3699999987554 556689999999999999999999999988 888999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc-
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV- 513 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 513 (671)
++|.+++..... ..+++...+.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865322 56899999999999999999999988 9999999999999999999999999998765432221
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......++..|+|||.+....++.++||||||+++|||++ |+.||... ...+............. .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~--------~~~~~~~~~~~~~~~~~-----~ 222 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL--------SGSQILKKIDKEGERLE-----R 222 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHHhcCCcCC-----C
Confidence 1223456788999999988899999999999999999999 99998422 11111111111111100 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
.... ...+.+++.+|++.+|++||++.||++.|.
T Consensus 223 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 PEAC----PQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CccC----CHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1112 234677888999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.49 Aligned_cols=246 Identities=26% Similarity=0.306 Sum_probs=192.5
Q ss_pred cCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
||+|+||+||++... +++.||+|++.... ......+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999864 68899999986432 22335677899999999999999999999999999999999999999
Q ss_pred hhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccc
Q 005893 438 DAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA 516 (671)
Q Consensus 438 ~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 516 (671)
..++... .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 8887532 23456899999999999999999999988 999999999999999999999999998765443221 22
Q ss_pred cccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCC
Q 005893 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTC 596 (671)
Q Consensus 517 ~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 596 (671)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ......+. ..+...+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~-~~~~~~~~------~~~~~~~ 224 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKEL-KQRILNDS------VTYPDKF 224 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHH-HHhhcccC------CCCcccC
Confidence 357899999999999999999999999999999999999998643211 011111 11110100 0111122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 597 SPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 597 ~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
+ ..+.+++..||+.||++|| +++++++
T Consensus 225 ~----~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 S----PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred C----HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2 2366777899999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.35 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=200.4
Q ss_pred CCCCcccccCCCCcccEEEEEec-C---CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-D---GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.+|++.+.||+|+||.||+|... + +..+|+|.++... ......+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999863 2 3379999987532 33456789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++.. ..+.+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999853 2346899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 509 SEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 509 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... ......++..|++||.+.++.++.++||||||+++||+++ |+.||...... .... ...++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----~~~~----~~~~~~~-- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----DVIK----AIEEGYR-- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----HHHH----HHhCCCc--
Confidence 32221 1112233568999999998899999999999999999887 99998532111 1111 1111110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.......+ ..+.+++.+|++.+|++||++.++++.|+.
T Consensus 228 ---~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 228 ---LPAPMDCP----AALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred ---CCCCCCCC----HHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 00111122 346688889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=322.76 Aligned_cols=254 Identities=22% Similarity=0.268 Sum_probs=197.1
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
...++|+..+.||+|+||.||+++.. +++.||+|+++.. .......+.+|+.+++.++||||+++++++.++...+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567888999999999999999875 5889999998642 2233445788999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998843 34788888899999999999999988 999999999999999999999999999865
Q ss_pred cCCCCccccccccccCCccchhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEG----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
..... .......||+.|+|||++... .++.++|||||||++|||++|+.||.... ............
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~ 263 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMDHK 263 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC
Confidence 43221 112335799999999998653 47899999999999999999999985321 111111121111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFD--RPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPt~~ev~~ 627 (671)
.....-+. ...+ ..+.+++..|++.+|++ ||++.|++.
T Consensus 264 ~~~~~~~~---~~~s----~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 264 NSLTFPDD---IEIS----KQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CcCCCCCc---CCCC----HHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11111000 0122 23556777999999988 999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.56 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=197.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||++... +|+.||+|+++... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999864 68899999997532 234456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999853 2356899999999999999999999998 999999999999999999999999999876443
Q ss_pred CCccccccccccCCccchhhhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAM------EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.... .............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~ 226 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--------SAKTYNNIMNFQR 226 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--------HHHHHHHHHcCCC
Confidence 222 222347899999999986 4567899999999999999999999985321 1111112211111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....-+ ....+ . .+.+++..|++ +|++||++.+++.
T Consensus 227 ~~~~~~---~~~~~-~---~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 FLKFPE---DPKVS-S---DFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ccCCCC---CCCCC-H---HHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 111100 01122 2 25566668997 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=309.93 Aligned_cols=251 Identities=26% Similarity=0.302 Sum_probs=197.2
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677899999999999999964 68899999986532 1223457789999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++|+|..++.. .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988753 23356899999999999999999999988 9999999999999999999999999988653322
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. .....|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ............... .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~------~ 222 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE-----KVKREEVERRVKEDQ------E 222 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch-----hhHHHHHHHHhhhcc------c
Confidence 1 1234789999999999988999999999999999999999999963221 111111111111110 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.....++ ..+.+++..||+.||++|| ++.++++
T Consensus 223 ~~~~~~~----~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 EYSEKFS----EAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCcccC----HHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1111222 3366788899999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.63 Aligned_cols=200 Identities=27% Similarity=0.354 Sum_probs=171.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|...+.||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888899999999999999864 68899999986432 233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999884 3456889999999999999999999998 999999999999999999999999998643211
Q ss_pred CCc------------c---------------------------------ccccccccCCccchhhhccCCCCcchhhHHH
Q 005893 510 EGE------------V---------------------------------NTARIVGTYGYMAPEYAMEGLYSIKSDVFSF 544 (671)
Q Consensus 510 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSl 544 (671)
... . .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCC
Q 005893 545 GVLLIEIITGRRNTG 559 (671)
Q Consensus 545 Gvil~elltG~~p~~ 559 (671)
||++|||++|+.||.
T Consensus 235 Gvil~elltG~~Pf~ 249 (377)
T cd05629 235 GAIMFECLIGWPPFC 249 (377)
T ss_pred chhhhhhhcCCCCCC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.36 Aligned_cols=261 Identities=28% Similarity=0.403 Sum_probs=202.6
Q ss_pred HhCCCCcccccCCCCcccEEEEEec--------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS--------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD 421 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 421 (671)
...+|.+.+.||+|+||.||++... ++..||+|.++.. ......++.+|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3456788899999999999999742 1236899988753 234456789999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEE
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIl 488 (671)
....++++||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence 999999999999999999985422 1235889999999999999999999988 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGAT 567 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 567 (671)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~------ 240 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI------ 240 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC------
Confidence 99999999999999986543322222222344567999999999999999999999999999998 88887422
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
...+.. .....+...+ .....+ ..+.+++.+||+.+|++||++.|+++.|+...
T Consensus 241 --~~~~~~-~~~~~~~~~~-----~~~~~~----~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 241 --PVEELF-KLLKEGHRMD-----KPANCT----HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred --CHHHHH-HHHHcCCCCC-----CCCCCC----HHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 122221 1222221111 111222 24667888999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=314.08 Aligned_cols=241 Identities=24% Similarity=0.253 Sum_probs=190.3
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 429 (671)
+|...+.||+|+||.||+++.. +++.||||+++... ......+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777899999999999999875 57799999987532 22334566777887777 6899999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999998884 3456899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.. ......||+.|+|||++....++.++|||||||++|||++|+.||.... ....... ......
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--------~~~~~~~-i~~~~~----- 218 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQS-IMEHNV----- 218 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--------HHHHHHH-HHhCCC-----
Confidence 21 2234578999999999999999999999999999999999999995321 1111111 111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
.+....+ ..+.+++.+|++.+|++|++.
T Consensus 219 -~~p~~~s----~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMS----KEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCC----HHHHHHHHHHcccCHHhcCCC
Confidence 1112222 236677889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.00 Aligned_cols=201 Identities=26% Similarity=0.370 Sum_probs=171.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+++.. +++.||||++.... ......+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999964 58899999986432 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999984 3456888999999999999999999988 999999999999999999999999997533110
Q ss_pred CC-----------------------------------------ccccccccccCCccchhhhccCCCCcchhhHHHHHHH
Q 005893 510 EG-----------------------------------------EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548 (671)
Q Consensus 510 ~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil 548 (671)
.. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 00 0001124799999999999998999999999999999
Q ss_pred HHHHhCCCCCCC
Q 005893 549 IEIITGRRNTGF 560 (671)
Q Consensus 549 ~elltG~~p~~~ 560 (671)
|||++|+.||..
T Consensus 235 yell~G~~Pf~~ 246 (376)
T cd05598 235 YEMLVGQPPFLA 246 (376)
T ss_pred eehhhCCCCCCC
Confidence 999999999953
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.43 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=198.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-----hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-----EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
++|+..+.||+|++|.||++... +++.|++|.+.... ......+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999864 68899999886422 1223568899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|+||+++++|.+++. ..+.+++.....++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999884 3456889999999999999999999988 9999999999999999999999999987654
Q ss_pred CCCCccc-cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVN-TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.... . ............
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~-~~~~~~~~~~~~--- 224 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-------A-MAAIFKIATQPT--- 224 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-------h-HHHHHHHhccCC---
Confidence 3221111 123467889999999998889999999999999999999999985221 1 111111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
...+....+ ..+.+++..||+.+|++|||+.|+++.
T Consensus 225 --~~~~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 --NPQLPSHVS----PDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCCccCC----HHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111222222 235677789999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=313.02 Aligned_cols=241 Identities=26% Similarity=0.266 Sum_probs=191.5
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||++... +++.||||+++... ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57899999997532 23345577888888887 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
++|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 99988874 3446899999999999999999999988 99999999999999999999999999875322221 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ..... ........ .+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~-~~i~~~~~------~~~~ 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELF-QSILEDEV------RYPR 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHH-HHHHcCCC------CCCC
Confidence 233578999999999999999999999999999999999999985321 11111 11111111 1112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTM-----SSVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~-----~ev~~ 627 (671)
..+. .+.+++.+||+.||++||++ .++++
T Consensus 218 ~~~~----~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSK----EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCH----HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 2222 35677779999999999999 88865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=312.83 Aligned_cols=240 Identities=26% Similarity=0.316 Sum_probs=188.3
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||++... +|+.||+|+++... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 58899999987532 22344566777777754 899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 99998884 3456889999999999999999999988 99999999999999999999999999875322111 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .... ++....+. +.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--------~~~~-~~~~~~~~------~~~~~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--------EDEL-FESIRVDT------PHYPR 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHH-HHHHHhCC------CCCCC
Confidence 234578999999999999999999999999999999999999985321 1111 11111111 11222
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMS-SVV 626 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~-ev~ 626 (671)
..+. .+.+++.+||+.||++||++. ++.
T Consensus 218 ~~~~----~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITK----ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCH----HHHHHHHHHccCCHHHcCCChHHHH
Confidence 2222 355777799999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.21 Aligned_cols=255 Identities=28% Similarity=0.460 Sum_probs=197.1
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCc--eEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGK--EIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 427 (671)
.++|++.+.||+|+||.||+|.+. ++. .+++|.++.. .......+.+|++++.++ +|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888899999999999999964 444 4688877643 334456788999999999 89999999999999999999
Q ss_pred EEeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC
Q 005893 428 VYEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN 494 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 494 (671)
|+||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999985422 1235889999999999999999999988 999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHH
Q 005893 495 PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLA 573 (671)
Q Consensus 495 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~ 573 (671)
+||+|||+++..... .......++..|+|||.+....++.++||||||+++|||+| |..||..... .+
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~ 231 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE 231 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HH
Confidence 999999998642111 11111234567999999988889999999999999999998 9998842211 11
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.. .....+...+ .....++ .+.+++.+||+.+|++||++.+++++|+.
T Consensus 232 ~~-~~~~~~~~~~-----~~~~~~~----~~~~li~~~l~~~p~~Rp~~~~il~~l~~ 279 (303)
T cd05088 232 LY-EKLPQGYRLE-----KPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNR 279 (303)
T ss_pred HH-HHHhcCCcCC-----CCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11 1111111000 1111222 36678889999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.90 Aligned_cols=241 Identities=24% Similarity=0.311 Sum_probs=188.7
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhh-cCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILK-LQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||+|... +++.||||+++... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 57889999987532 2233456677777776 4999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence 99999884 3456889999999999999999999988 99999999999999999999999999875322211 2
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... .... .+...... +.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~-~~~i~~~~------~~~~~ 217 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--------EEEL-FQSIRMDN------PCYPR 217 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--------HHHH-HHHHHhCC------CCCCc
Confidence 233578999999999998899999999999999999999999985321 1111 11111111 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMS-SVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~-ev~~ 627 (671)
..+ ..+.+++.+||+.+|++||++. ++.+
T Consensus 218 ~~~----~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLT----REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCC----HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 222 2356777899999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=304.09 Aligned_cols=248 Identities=33% Similarity=0.471 Sum_probs=194.1
Q ss_pred cccCCCCcccEEEEEec--C--CceEEEEEccccch-hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS--D--GKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~--~--g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
++||+|+||.||+|++. + +..+|+|.+..... ....++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 26899999875443 34557899999999999999999999876 4567999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc-
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV- 513 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 513 (671)
++|.+++.. ...+++..++.++.|++.||.|||..+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999853 336899999999999999999999988 9999999999999999999999999998664433221
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......++..|+|||.+....++.++||||||+++|||++ |+.||.... ..+. ......+.... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--------~~~~-~~~~~~~~~~~-----~ 219 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--------GAEV-IAMLESGERLP-----R 219 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--------HHHH-HHHHHcCCcCC-----C
Confidence 1112234567999999988899999999999999999998 999985321 1111 11122221111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
...++ ..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 220 ~~~~~----~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 220 PEECP----QEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11222 3466888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=298.98 Aligned_cols=263 Identities=24% Similarity=0.351 Sum_probs=198.4
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc-----CCe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD-----GDE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 424 (671)
...|...+.||+|+||.|+.+... +|+.||||++.. ......+...+|+.+|+.++|+||+.+++++.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555788999999999999964 689999999873 344556678899999999999999999999876 245
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.|+|+|+| +.+|..++ +.++.++......++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 79999999 68999998 34555899999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC----------CCCCCHHH
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG----------ATAPNLLA 573 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~----------~~~~~l~~ 573 (671)
...........+..+.|..|.|||++.. ..|+...||||.|||+.||++|+.-|....... ...+....
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8765422223345688999999998765 579999999999999999999999886443210 00000000
Q ss_pred H-----HHHHHhcCCcc--ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 574 Y-----AWHLWNEGNAL--DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 574 ~-----~~~~~~~~~~~--~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. ++...+.-... .-+...+ ...++ ..+++..+||..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~f-p~a~p----~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIF-PNANP----LAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHc-CCCCH----HHHHHHHHHhccCccccCCHHHHhc
Confidence 0 01111100000 0000111 12223 3567777999999999999999975
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.90 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=200.0
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.+|+..+.||+|+||.||+|+. .+++.|++|.+..........+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677888999999999999986 468899999987655555667889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999998842 34789999999999999999999988 999999999999999999999999998765432211
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....+++.|+|||.+....++.++||||||+++|||++|+.||..... ..........+.. .+
T Consensus 173 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~------~~ 236 (296)
T cd06654 173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTP------EL 236 (296)
T ss_pred --cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--------HHhHHHHhcCCCC------CC
Confidence 1234688899999999888899999999999999999999999853221 1111111111111 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. .+......+.+++.+||+.+|++||++.||++
T Consensus 237 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 Q--NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred C--CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 01111234667888999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.95 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=201.9
Q ss_pred CcccccCCCCcccEEEEEecC---Cc--eEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 357 SDSNMLGQGGFGPVYKGVLSD---GK--EIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~~---g~--~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
...++||+|.||.||+|++.+ |. .||||.-+. ....+.+.|..|..+|++++||||++++|+|.+ ...++|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 345789999999999999643 33 589998876 445557789999999999999999999999975 46899999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
.++.|-|..+|.. +...++......++.||..+|+|||+.. +|||||..+|||+....-+||+|||++|.+..+.
T Consensus 471 L~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999964 4455888999999999999999999987 9999999999999999999999999999887665
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
....+ ...-++.|||||.+.-.+++.++|||-|||.+|||+. |..||..... .+....++
T Consensus 546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN------------------sDVI~~iE 606 (974)
T KOG4257|consen 546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN------------------SDVIGHIE 606 (974)
T ss_pred hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc------------------cceEEEec
Confidence 55433 3455789999999999999999999999999999987 9999853221 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..-+-.+++.....+..++-+||..+|.+||+..|+...|+.
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 111112233333347788889999999999999999887754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=291.53 Aligned_cols=275 Identities=24% Similarity=0.311 Sum_probs=202.4
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhc--hHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQG--NAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 428 (671)
++|+..+.|++|.||.||+|+.+ +++.||+|+++...++. -..-.+|+.+|.+.+|||||.+..+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45778899999999999999974 68899999998543322 23467999999999999999999988754 468999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||++ -+|..++..- ...+...++.-++.|+++|++|||.+. |+|||||++|+|+...|.+||+|||+||.+..
T Consensus 156 Me~~E-hDLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHH-hhHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99996 4888888542 256889999999999999999999998 99999999999999999999999999998865
Q ss_pred CCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
... ..+..+-|..|.|||++.+. .|+...|+||+|||+.||+++++.|.... ..+.++...+. -|.+.+.
T Consensus 230 p~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s-----E~dQl~~If~l--lGtPte~ 300 (419)
T KOG0663|consen 230 PLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS-----EIDQLDKIFKL--LGTPSEA 300 (419)
T ss_pred Ccc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHHH--hCCCccc
Confidence 422 23446779999999998875 68999999999999999999998886332 11222222222 2222222
Q ss_pred cccccc----------CCCCHHHH----------HHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCccc
Q 005893 588 IDPLLT----------DTCSPDEF----------LRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFS 645 (671)
Q Consensus 588 ~d~~l~----------~~~~~~~~----------~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~~~ 645 (671)
+-|.+. ...+...+ ..-.++....+..||++|-|++|.++ .+--.+.|.|..|.++
T Consensus 301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~P~~~ 376 (419)
T KOG0663|consen 301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPIDPSMF 376 (419)
T ss_pred cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCChhhc
Confidence 221110 00011100 12234555788999999999999875 2222334455555554
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=303.86 Aligned_cols=248 Identities=30% Similarity=0.408 Sum_probs=196.8
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEE-cCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV-DGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~~ 432 (671)
++|+..+.||+|+||.||++.. .|..|++|.++... ....+.+|+.++++++|+|++++++++. .++..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4677889999999999999987 47889999987532 3457889999999999999999999765 445689999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. .....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999854 23345889999999999999999999988 9999999999999999999999999987543322
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
....++..|+|||++....++.++||||||+++|||++ |+.|+... .+...... ...+... .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~-~~~~~~~-----~ 219 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPR-VEKGYKM-----D 219 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH-HhcCCCC-----C
Confidence 12234567999999988889999999999999999998 99887422 22222211 1111111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+....+ ..+.+++.+|++.+|++|||+.++++.|+.
T Consensus 220 ~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCP----PVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112222 246678889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.81 Aligned_cols=200 Identities=25% Similarity=0.359 Sum_probs=170.9
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.|+..++||+|+||.||+++.. +++.||+|++.... ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999964 67899999987532 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998843 356888999999999999999999998 9999999999999999999999999975331100
Q ss_pred C---------------------------------------------ccccccccccCCccchhhhccCCCCcchhhHHHH
Q 005893 511 G---------------------------------------------EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFG 545 (671)
Q Consensus 511 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlG 545 (671)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001124799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 005893 546 VLLIEIITGRRNTGF 560 (671)
Q Consensus 546 vil~elltG~~p~~~ 560 (671)
|++|||++|+.||..
T Consensus 236 vil~elltG~~Pf~~ 250 (382)
T cd05625 236 VILYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999953
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=313.43 Aligned_cols=256 Identities=30% Similarity=0.498 Sum_probs=198.2
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCc----eEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGK----EIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
.++|+..+.||+|+||.||+|.+. +|. .||+|.+.... .....++.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356777889999999999999864 344 47889887533 23344688999999999999999999998754 467
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+++||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998853 2345889999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.............++..|++||.+.+..++.++||||||+++|||++ |+.||.... ... .......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--------~~~-~~~~~~~~~~~ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--------TRE-IPDLLEKGERL 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHH-HHHHHHCCCCC
Confidence 54332222223455778999999988899999999999999999998 888884321 111 11222222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
. ....++ ..+.+++..||..+|++||++.+|++.|+..
T Consensus 231 ~-----~~~~~~----~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 P-----QPPICT----IDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred C-----CCCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 011122 3467888899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=304.42 Aligned_cols=252 Identities=29% Similarity=0.453 Sum_probs=199.7
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
.+|+..+.||+|+||.||++.+.+++.+++|+++... .....+.+|+.++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3567778999999999999998778899999987532 234578899999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999998853 2345889999999999999999999988 9999999999999999999999999987654322111
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....++..|+|||.+.++.++.++||||||+++|||++ |+.||.... ........ .++. ....+.
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~-~~~~--~~~~~~- 224 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETI-NAGF--RLYKPR- 224 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHH-hCCC--CCCCCC-
Confidence 112234678999999988899999999999999999998 898885321 11111111 1110 111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
.. ...+.+++.+||+.+|++|||+.||+++|.
T Consensus 225 ---~~---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 ---LA---SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CC---CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11 234778888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=320.59 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=193.6
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----eee
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 426 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 426 (671)
+|+..+.||+|+||.||++.. .+|+.||||++... .......+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 46899999998653 2234457889999999999999999999998776 789
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+|+||+. ++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 56777663 3456899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH-------
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL------- 578 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~------- 578 (671)
...... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... .........
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-----QQLDLITDLLGTPSLE 227 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHHcCCCCHH
Confidence 433221 12234678899999998764 5799999999999999999999998643211 011111000
Q ss_pred ------------Hhc-CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 579 ------------WNE-GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 579 ------------~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.. ........... ....+....+.+++.+|++.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 000 00000000000 000111234677888999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.72 Aligned_cols=258 Identities=27% Similarity=0.362 Sum_probs=199.2
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
++.+++++.....||+|+||.||+|... ++..|++|.+..........+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3456677777789999999999999964 577899999887666666789999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeeccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIF 506 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~ 506 (671)
|+||+++++|.+++.........++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999854222212378888999999999999999988 999999999999986 679999999998765
Q ss_pred cCCCCccccccccccCCccchhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
..... ......++..|+|||++.... ++.++||||||+++|||++|+.|+...... . ...+......
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~--~~~~~~~~~~-- 228 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----Q--AAMFKVGMFK-- 228 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----h--hhHhhhhhhc--
Confidence 43221 122245788999999986643 789999999999999999999998532111 0 0011100000
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+.+....+ ..+.+++.+||+.+|++|||+.||++
T Consensus 229 ---~~~~~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ---IHPEIPESLS----AEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ---cCCCCCcccC----HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111111222 33667788999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=314.97 Aligned_cols=237 Identities=24% Similarity=0.270 Sum_probs=185.8
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHH-HHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||++... +|+.||+|++.... .....++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999975 68899999986432 122334455544 45778999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 99998884 3456889999999999999999999998 9999999999999999999999999987532221 12
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||... +..+...... .+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~--------~~~~~~~~i~-~~~~------~~~~ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------DTAEMYDNIL-NKPL------RLKP 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC--------CHHHHHHHHH-cCCC------CCCC
Confidence 23457899999999999999999999999999999999999998532 1222211211 1111 1112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMS 623 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ 623 (671)
..+ ..+.+++.+|++.||++||++.
T Consensus 218 ~~~----~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NIS----VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCC----HHHHHHHHHHhhcCHHhCCCCC
Confidence 222 2366777799999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=319.59 Aligned_cols=257 Identities=22% Similarity=0.274 Sum_probs=196.0
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
+....++|+..+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 4445678999999999999999999975 5788999998642 22334457889999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 9999999999999998842 24788899999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEG----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
....... .......||+.|+|||++... .++.++||||||+++|||++|+.||... ...........
T Consensus 191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~--------~~~~~~~~i~~ 261 (370)
T cd05621 191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD--------SLVGTYSKIMD 261 (370)
T ss_pred ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC--------CHHHHHHHHHh
Confidence 7543221 122345799999999998654 3789999999999999999999999532 11222122221
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFD--RPTMSSVVVM 628 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPt~~ev~~~ 628 (671)
.......-+. ... .+ .+.+++..|++.++.+ ||++.|+++.
T Consensus 262 ~~~~~~~p~~---~~~-s~---~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKNSLNFPED---VEI-SK---HAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcccCCCCc---ccC-CH---HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111000 011 12 2445566788755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=304.83 Aligned_cols=255 Identities=28% Similarity=0.438 Sum_probs=201.8
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..++|+..+.||+|+||.||++...++..+++|.++.. ......+.+|+.++++++|+||+++.+.+.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34568888999999999999999877888999988753 2345678899999999999999999999887 678999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHh-CCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999854 23446889999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ......++..|+|||++..+.++.++|+||||+++||+++ |+.||..... ..+ ......+....
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~----~~~~~~~~~~~---- 223 (260)
T cd05073 158 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEV----IRALERGYRMP---- 223 (260)
T ss_pred c-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHH----HHHHhCCCCCC----
Confidence 1 1222345677999999988889999999999999999999 8988853211 111 11112221111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..... ...+.+++.+|++.+|++||++.+|.++|+.
T Consensus 224 -~~~~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 -RPENC----PEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CcccC----CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122 2346788889999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=314.76 Aligned_cols=243 Identities=24% Similarity=0.287 Sum_probs=191.1
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||++... +++.||+|+++... ......+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999974 57889999997532 23345678899999888 699999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 99988873 3456999999999999999999999988 99999999999999999999999999875322111 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .........++....... .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~------~~p~ 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN--PDMNTEDYLFQVILEKPI------RIPR 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCC--cccccHHHHHHHHHhCCC------CCCC
Confidence 23457899999999999999999999999999999999999999643222 122222333333322211 1112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
..+. .+.+++.+||+.||++||++
T Consensus 225 ~~~~----~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FLSV----KASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCH----HHHHHHHHHhccCHHHcCCC
Confidence 2222 35577779999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.75 Aligned_cols=247 Identities=26% Similarity=0.294 Sum_probs=190.7
Q ss_pred cCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
||+|+||.||++... +|+.||+|++.... ......+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999864 58999999986422 12233456799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
..++.. .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYN-VGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 888753 23345889999999999999999999988 9999999999999999999999999987654322 1223
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...... ............ ... .. ....++
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~-~~~----~~-~~~~~~ 223 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK----VAKEELKRRTLE-DEV----KF-EHQNFT 223 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch----hhHHHHHHHhhc-ccc----cc-ccccCC
Confidence 46889999999999888999999999999999999999998632211 011111111111 111 00 011222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
. .+.+++.+||+.||++||++.|+++.+
T Consensus 224 ~----~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 224 E----ESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred H----HHHHHHHHHhccCHhhCCCCccchhhh
Confidence 2 356777799999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.88 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=195.5
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+|+..++||+|+||.||+++. .+++.||+|++... ......++.+|+.++.+++||||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577788999999999999986 46889999998643 2334457889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999986542 3678888999999999999999988 9999999999999999999999999987653321
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......... ..... .+....... +.+
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~-~~~~~~~~~-----~~~ 220 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQL-LQCIVDEDP-----PVL 220 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHH-HHHHhccCC-----CCC
Confidence 223578999999999998889999999999999999999999986432211011 11111 111111111 111
Q ss_pred c-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 593 T-DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 593 ~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
. ...+ ..+.+++.+|++.+|++||+++|+++.
T Consensus 221 ~~~~~~----~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVGQFS----EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCcCC----HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1 1122 236678889999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=305.38 Aligned_cols=248 Identities=28% Similarity=0.474 Sum_probs=191.9
Q ss_pred cccCCCCcccEEEEEecC-Cc--eEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLSD-GK--EIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||+|.+.+ +. .+++|.++.. .......+.+|+.++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999753 43 4788988753 234455788999999999 899999999999999999999999999
Q ss_pred CchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 435 SSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 435 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
++|.+++...+ ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999985422 1235889999999999999999999987 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
+++..... ........+..|+|||++....++.++||||||+++|||++ |+.||.... .... .....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------~~~~-~~~~~ 225 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL-YEKLP 225 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------HHHH-HHHHh
Confidence 98632211 11111233567999999988889999999999999999997 999984321 1111 11111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.+...+ .....+ ..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 226 ~~~~~~-----~~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 226 QGYRLE-----KPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred CCCCCC-----CCCcCC----HHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 111111 111122 246688889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=301.54 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=189.1
Q ss_pred ccCCCCcccEEEEEecCCc---eEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCc
Q 005893 361 MLGQGGFGPVYKGVLSDGK---EIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSS 436 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~~g~---~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 436 (671)
.||+|+||.||++...++. .+++|.++... ......+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999864433 45677665432 3445678999999999999999999999999999999999999999
Q ss_pred hhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccc
Q 005893 437 LDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515 (671)
Q Consensus 437 L~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 515 (671)
|.+++.... ....+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999986432 2334677778899999999999999987 999999999999999999999999997643222211222
Q ss_pred ccccccCCccchhhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 516 ARIVGTYGYMAPEYAME-------GLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 516 ~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
....++..|+|||++.. ..++.++||||||+++|||++ |..||.... ......... .+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~-~~~~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVI-KDQQVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH-hhccccc
Confidence 33567889999998743 245789999999999999997 466663211 111112222 2233344
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
.++.+...+++ .+.+++..|| .+|++||+++||++.|.
T Consensus 230 ~~~~~~~~~~~----~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPYSE----RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCCcH----HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 44544433333 3556667899 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.59 Aligned_cols=194 Identities=26% Similarity=0.299 Sum_probs=166.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|+.++++++|+|||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 446888999999999999999975 478899996432 2356899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+. ++|..++.. ....++|..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 677777643 2346999999999999999999999988 99999999999999999999999999987644332
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNT 558 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~ 558 (671)
........||..|+|||++.+..++.++|||||||++|||++|..++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 22223457999999999999999999999999999999999987654
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=306.50 Aligned_cols=251 Identities=33% Similarity=0.516 Sum_probs=195.3
Q ss_pred cccCCCCcccEEEEEecC-------CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 360 NMLGQGGFGPVYKGVLSD-------GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+.||+|+||.||+|+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2579999886533 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCC----CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-----CeEEeeccc
Q 005893 432 MPNSSLDAILFDPR----KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-----NPKISDFGM 502 (671)
Q Consensus 432 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~Dfgl 502 (671)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+. .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986422 2345889999999999999999999987 99999999999999877 899999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||.... ..+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--------~~~~~~~~-~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--------NQEVLQHV-TA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--------HHHHHHHH-hc
Confidence 876543332222223345678999999999999999999999999999998 999885321 11111111 11
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+... ...... ...+.+++.+||+.+|++||++.+|++.|+.
T Consensus 229 ~~~~-----~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 GGRL-----QKPENC----PDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcc-----CCcccc----hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1110 011112 2346678889999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.66 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=200.6
Q ss_pred hCCCCcccccCCCCcccEEEEEecC-CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|+..+.||+|+||.||++...+ ++.+++|.++.... ..++.+|++++++++|+||+++++++......++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3578889999999999999999764 78999999876433 56899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999843 3456899999999999999999999988 99999999999999999999999999886543321
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ........ +.
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~-~~~~~~~~-----~~ 218 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAI-FMIPNKPP-----PT 218 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhh-hhhccCCC-----CC
Confidence 122345788999999998889999999999999999999999998642211 000 00000000 01
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+. .+......+.+++.+||+.+|++|||++||++
T Consensus 219 ~~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LS--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CC--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 10 01111234677888999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.54 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=186.6
Q ss_pred cccCCCCcccEEEEEecC-------------CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 360 NMLGQGGFGPVYKGVLSD-------------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
+.||+|+||.||+|++.+ ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2258999887655555567889999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC-------eEEee
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN-------PKISD 499 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~D 499 (671)
+||||+++++|+.++.. ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988743 3345899999999999999999999988 999999999999987654 89999
Q ss_pred ccccccccCCCCccccccccccCCccchhhhc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 500 FGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEII-TGRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 500 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~ell-tG~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+.... .... ..
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~-~~ 220 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT--------LAEK-ER 220 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc--------hhHH-HH
Confidence 9998654322 2235778899999886 467899999999999999998 5777764221 1111 01
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
... +.. . +... . ...+.+++.+||+.||++||++.+|++.|+
T Consensus 221 ~~~-~~~-~-----~~~~-~---~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 FYE-GQC-M-----LVTP-S---CKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHh-cCc-c-----CCCC-C---hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111 110 0 0011 1 234667888999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.72 Aligned_cols=196 Identities=22% Similarity=0.301 Sum_probs=169.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec---CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS---DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
..+|.+.+.||+|+||.||++... .+..|++|.+.... ...+|+.++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 35689999886532 3468999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|++. ++|..++ .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 6777777 34456999999999999999999999998 999999999999999999999999999866544
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
..........||+.|+|||++....++.++|||||||++|||++|+.||..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 333333446799999999999989999999999999999999999999854
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=314.97 Aligned_cols=238 Identities=24% Similarity=0.272 Sum_probs=186.2
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHH-HHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||+++.. +|+.||+|++... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 6889999998643 1223344555554 46778999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99988873 3456899999999999999999999988 9999999999999999999999999987532221 12
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||... ...+...... .+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~--------~~~~~~~~~~-~~~~------~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR--------DVAEMYDNIL-HKPL------VLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC--------CHHHHHHHHH-cCCc------cCCC
Confidence 23457899999999999999999999999999999999999998532 1122211111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMSS 624 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~e 624 (671)
..+ ..+.+++.+|++.+|++||++.+
T Consensus 218 ~~~----~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 GAS----LTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCC----HHHHHHHHHHhccCHHhcCCCCC
Confidence 222 23567778999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.05 Aligned_cols=265 Identities=28% Similarity=0.427 Sum_probs=201.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-----CCceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEc--CCee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-----DGKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 425 (671)
+.|+..+.||+|+||.||++.+. +++.+|||+++..... ....+.+|+.+++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999863 3678999999864432 45679999999999999999999999887 5578
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHh--CccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999853 2335899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCC------CCCHHHHHHHH
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT------APNLLAYAWHL 578 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~------~~~l~~~~~~~ 578 (671)
........ ......++..|++||.+.+..++.++||||||+++|||++|+.|+......... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 65332211 111234456799999998889999999999999999999999887532211000 00001111111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
...+... .....+ ...+.+++.+||+.+|++|||+.||+++|+..
T Consensus 239 ~~~~~~~-----~~~~~~----~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERL-----PRPPSC----PDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcC-----CCCccC----CHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111110 001111 23477888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.26 Aligned_cols=241 Identities=23% Similarity=0.277 Sum_probs=186.0
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHH-HHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEV-LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||+++.. +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999975 57789999986422 12223344444 356778999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
++|..++. ..+.+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 99999884 3455788888899999999999999998 99999999999999999999999999875432221 2
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........... .. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~-~~------~~~~ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNK-PL------QLKP 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------HHHHHHHHHhC-Cc------CCCC
Confidence 234579999999999999999999999999999999999999985321 11211111111 11 1112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+. .+.+++.+|++.+|++||++.+.+.
T Consensus 218 ~~~~----~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 NITN----SARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCH----HHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2222 3556777999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=337.17 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=198.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.++||+|+||.||+|... +|+.||+|+++... ......+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888999999999999999975 58899999987532 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCC--------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 430 EFMPNSSLDAILFDPR--------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
||+++++|.+++.... ....+++..+++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885321 1234677888999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCc----------------cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005893 502 MARIFAGSEGE----------------VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565 (671)
Q Consensus 502 la~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~ 565 (671)
+++........ .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 99865211100 0112347999999999999999999999999999999999999998532111
Q ss_pred CCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhcC
Q 005893 566 ATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-TMSSVVVMLQG 631 (671)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-t~~ev~~~L~~ 631 (671)
.. ...... ....+. ......+ ..+.+++.+|++.||++|| +++++.+.|+.
T Consensus 238 ----ki---~~~~~i-~~P~~~---~p~~~iP----~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 ----KI---SYRDVI-LSPIEV---APYREIP----PFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred ----hh---hhhhhc-cChhhc---cccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 000000 000000 0001222 2366788899999999995 56667666554
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.67 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=197.4
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|...+.||+|+||.||++... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999864 68899999987655555566889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++. ..+.+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999884 3456899999999999999999999998 9999999999999999999999999987653321
Q ss_pred cccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 513 VNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.......|+..|+|||.+. .+.++.++||||||+++|||++|+.|+...... .. .+.............
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~----~~----~~~~~~~~~~~~~~~ 232 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RA----LFLMTKSNFQPPKLK 232 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch----hh----HHhhhccCCCCCccc
Confidence 1123357899999999874 456889999999999999999999987432111 01 111111110000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. ..++ ..+.+++.+|++.+|++||++++|++
T Consensus 233 ~~--~~~~----~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DK--MKWS----NSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc--CCCC----HHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0122 23567888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=301.26 Aligned_cols=251 Identities=31% Similarity=0.472 Sum_probs=197.3
Q ss_pred CCCcccccCCCCcccEEEEEecCCceEEEEEccccc------hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS------EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
+|...+.||+|+||.||+|...+++.+|+|.++... ......+.+|++++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999998889999999886422 12234688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
+||+++++|.+++. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999984 3345889999999999999999999988 99999999999999999999999999876432
Q ss_pred CCC----ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 509 SEG----EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 509 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
... ........|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ...... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-------~~~~~~-~~~~~~~- 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-------RLAAMF-YIGAHRG- 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-------hHHHHH-HhhhccC-
Confidence 111 111223468899999999988889999999999999999999999985321 111111 1100100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+.+...++ ..+.+++.+||+.+|++||++.|+++
T Consensus 226 ---~~~~~~~~~~----~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 ---LMPRLPDSFS----AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCCCCC----HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112222222 23567778999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=299.10 Aligned_cols=250 Identities=21% Similarity=0.312 Sum_probs=199.9
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+|+..+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..+...+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999864 6889999998642 3344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. .....+++...+.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++........
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99999888743 23445889999999999999999999988 999999999999999999999999998765432211
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....|++.|+|||++.+..++.++|+||||+++|+|++|+.||... +......... .+.... +
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~--------~~~~~~~~~~-~~~~~~-----~ 220 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--------SWKNLILKVC-QGSYKP-----L 220 (255)
T ss_pred --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC--------CHHHHHHHHh-cCCCCC-----C
Confidence 22356888999999998888999999999999999999999998532 2222222221 221111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
....+ ..+.+++.+||+.+|++||++.||+..
T Consensus 221 ~~~~~----~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYS----YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccC----HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11222 236677889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=309.80 Aligned_cols=264 Identities=26% Similarity=0.399 Sum_probs=200.7
Q ss_pred CCCCcccccCCCCcccEEEEEe-----cCCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Cee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-----SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 425 (671)
+.|++.+.||+|+||.||++.+ .++..||+|.++... ......+.+|+.+++.++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4467889999999999999974 357789999987543 33445789999999999999999999998875 567
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999843 2345899999999999999999999988 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC-----CC-CCCCHHHHHHHH
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR-----GA-TAPNLLAYAWHL 578 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~-----~~-~~~~l~~~~~~~ 578 (671)
........ ......++..|+|||.+.+..++.++||||||+++|||++++.|....... +. ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65433221 122345677899999998888999999999999999999987664321100 00 001111111111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+.... ....++ ..+.+++.+||+.+|++||++.++++.|+.
T Consensus 239 ~~~~~~~~-----~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 239 LEEGKRLP-----RPPNCP----EEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHcCccCC-----CCCCCC----HHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 22221111 111222 347788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.49 Aligned_cols=239 Identities=23% Similarity=0.356 Sum_probs=185.5
Q ss_pred ccCCCCcccEEEEEecC-------------------------CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeE
Q 005893 361 MLGQGGFGPVYKGVLSD-------------------------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 415 (671)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13589999876544445678889999999999999999
Q ss_pred eeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC--
Q 005893 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-- 493 (671)
Q Consensus 416 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 493 (671)
++++......++||||+++|+|..++.. ..+.+++..+..++.||++||+|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998853 3456889999999999999999999987 99999999999997643
Q ss_pred -----CeEEeeccccccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCCCC
Q 005893 494 -----NPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEII-TGRRNTGFNQSRGA 566 (671)
Q Consensus 494 -----~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~ell-tG~~p~~~~~~~~~ 566 (671)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-- 228 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence 3799999987643221 12356778999998865 56899999999999999995 688888532211
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
..... ..... .+..... ..+.+++.+||+.+|++||++.+|++.|+
T Consensus 229 ---~~~~~----~~~~~-------~~~~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 ---EKERF----YEKKH-------RLPEPSC----KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHH----HHhcc-------CCCCCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 11100 1111111 24677888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.26 Aligned_cols=259 Identities=23% Similarity=0.269 Sum_probs=197.6
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
..+....++|+..+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++.+.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556688999999999999999999975 5789999998642 223344578899999999999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
...++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 999999999999999998842 34788888999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEG----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL 578 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~ 578 (671)
++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||... +........
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i 259 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSKI 259 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC--------CHHHHHHHH
Confidence 987643221 122345799999999998653 3789999999999999999999999532 222222222
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFD--RPTMSSVVVM 628 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPt~~ev~~~ 628 (671)
..........+. ...+ . .+.+++..|++.++.+ ||++.|+++.
T Consensus 260 ~~~~~~~~~~~~---~~~s-~---~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 260 MNHKNSLTFPDD---NDIS-K---EAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HcCCCcccCCCc---CCCC-H---HHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 222111111110 1122 2 2456666888744433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=299.11 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=198.2
Q ss_pred CCCcccccCCCCcccEEEEEecC--CceEEEEEcccc----------chhchHHHHHHHHHHhh-cCCCCeeeEeeEEEc
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSD--GKEIAVKRLSSC----------SEQGNAEFTNEVLLILK-LQHKNLVKLLGFCVD 421 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~ 421 (671)
+|++.+.||+|+||.||++.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999754 678999987532 22233457788888875 799999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999887432 234568999999999999999999996 45 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 500 FGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 500 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
||++....... ......|+..|++||.+.++.++.++||||||+++|||++|+.||... .........
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~--------~~~~~~~~~- 225 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST--------NMLSLATKI- 225 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc--------CHHHHHHHH-
Confidence 99998654432 223456888999999999888999999999999999999999998422 112211111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 580 NEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
..+... +......+ ..+.+++.+||+.||++||++.||.++|+
T Consensus 226 ~~~~~~----~~~~~~~~----~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYE----PLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCC----cCCcccCC----HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 11111222 23667778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.88 Aligned_cols=196 Identities=29% Similarity=0.410 Sum_probs=170.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999864 5788999988653 233345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
+++++|.+++. ..+.+++..+..++.|+++||.|||+ .+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999984 33568899999999999999999997 45 9999999999999999999999999987543221
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 123468899999999988889999999999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=327.58 Aligned_cols=260 Identities=21% Similarity=0.311 Sum_probs=188.3
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--------
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 422 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 422 (671)
...+|+..+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4567999999999999999999974 68899999885432 2345799999999999999999887532
Q ss_pred CeeeEEEeccCCCchhhhhcC-CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeec
Q 005893 423 DEKLLVYEFMPNSSLDAILFD-PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDF 500 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Df 500 (671)
...++||||+++ +|.+++.. ......+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 56555432 234566899999999999999999999998 99999999999999664 7999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+... .+..
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i-~~~~ 287 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRI-IQVL 287 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHH-HHHh
Confidence 99987643322 1234679999999988654 6899999999999999999999998532211 111111 1111
Q ss_pred hcCC----------ccccccc-----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGN----------ALDLIDP-----LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~----------~~~~~d~-----~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... ..+..-+ .+...++......+.+++.+||+.||++|||+.|+++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 1000 0000000 0000011111234677888999999999999999984
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=303.48 Aligned_cols=249 Identities=26% Similarity=0.379 Sum_probs=196.1
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
|++.+.||+|+||.||++... ++..+++|.+..........+.+|+++++.++||||+++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456788999999999999975 4778899998766666667889999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
++|..++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 999888743 3456899999999999999999999988 99999999999999999999999999876432211 1
Q ss_pred cccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 515 TARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.....++..|+|||++. ...++.++|||||||++|||++|+.||.... ........... .......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~~~~~-~~~~~~~ 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKS-EPPTLAQ 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--------HHHHHHHHhhc-CCCCCCC
Confidence 22346889999999874 3457889999999999999999999985321 11111111111 1111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...++ ..+.+++.+||+.+|++||++.++++
T Consensus 231 ---~~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 ---PSRWS----SEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ---ccccC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11122 23667778999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=302.16 Aligned_cols=199 Identities=30% Similarity=0.438 Sum_probs=168.5
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|++|.||+|... +++.||+|+++... ......+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999975 68899999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
++ ++|.+++........+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688887754444467899999999999999999999988 99999999999999999999999999876533211
Q ss_pred ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 512 EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 11223568899999988654 57899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.55 Aligned_cols=255 Identities=29% Similarity=0.480 Sum_probs=200.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCc----eEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGK----EIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.+|+..+.||+|+||.||+|... +|. .+|+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56777899999999999999864 233 58999887543 3345678899999999999999999999987 78899
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|+||+++|+|.+++.. ....+++..++.++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999853 3345899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
............++..|+|||.+....++.++||||||+++||+++ |+.||.... ..+.. .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------~~~~~-~~~~~~~~~- 230 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------AVEIP-DLLEKGERL- 230 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------HHHHH-HHHhCCCCC-
Confidence 4332222222234568999999988899999999999999999999 999985321 11111 111221111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
......+ ..+.+++.+||..+|++||++.++++.|+..
T Consensus 231 ----~~~~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 ----PQPPICT----IDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred ----CCCCCCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111122 2366778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=297.43 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=189.4
Q ss_pred cccCCCCcccEEEEEec----CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc-CCeeeEEEeccC
Q 005893 360 NMLGQGGFGPVYKGVLS----DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEFMP 433 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~ 433 (671)
+.||+|+||.||+|.+. +...||+|.+... .......+.+|+.+++.++||||+++++++.. +...++++||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999863 2357999998643 33445678899999999999999999998764 456789999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999853 2334678888999999999999999987 9999999999999999999999999987653321111
Q ss_pred --ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 514 --NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG-RRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 514 --~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
......++..|+|||.+....++.++||||||+++|||++| ..|+... .......... .+.. .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--------~~~~~~~~~~-~~~~-----~ 221 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------DSFDITVYLL-QGRR-----L 221 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHHHHh-cCCC-----C
Confidence 11223456789999999888999999999999999999995 4455321 1122221111 1111 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
......+ ..+.+++..||+.+|++||++.||++.|+.
T Consensus 222 ~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 222 LQPEYCP----DPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CCCCcCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 1111122 246688889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=301.00 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=195.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC------C
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG------D 423 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~------~ 423 (671)
+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5567888899999999999999864 57889999986543 3445788999999998 799999999998753 3
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..+++|||+++++|.+++.. .....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 57899999999999998854 23346899999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL 578 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~ 578 (671)
........ ......|+..|+|||++. ...++.++||||||+++|||++|+.|+..... .......
T Consensus 159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~--------~~~~~~~ 228 (272)
T cd06637 159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------MRALFLI 228 (272)
T ss_pred eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH--------HHHHHHH
Confidence 76533221 123357889999999986 34578899999999999999999999853211 1111111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... ... ......++ ..+.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~~-~~~----~~~~~~~~----~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRN-PAP----RLKSKKWS----KKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcC-CCC----CCCCCCcC----HHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 111 11111222 23667778999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.16 Aligned_cols=246 Identities=30% Similarity=0.400 Sum_probs=200.7
Q ss_pred ccccCCCCcccEEEEEec--CCc--eEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 359 SNMLGQGGFGPVYKGVLS--DGK--EIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
.++||+|.||.|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 578999999999999985 344 6899999875544 56789999999999999999999999887 77889999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
.|+|.+.|+. ..+..|-...+..++.|||.||.||..+. +|||||..+|+||-....+||+||||.+.+..++...
T Consensus 194 lGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 194 LGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred cchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999976 56677888899999999999999999987 9999999999999999999999999999887765543
Q ss_pred cc-ccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 514 NT-ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 514 ~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
.. ....-...|+|||.+..+.++.++|||+|||+||||+| |+.||..- .-.+. ++.+|..
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--------~g~qI----------L~~iD~~ 331 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--------RGIQI----------LKNIDAG 331 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--------CHHHH----------HHhcccc
Confidence 32 22344668999999999999999999999999999999 78887421 11111 1222211
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
-+-..++...+++.++++.||..+|++|||+..|.+
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 111123334456778888999999999999999973
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.49 Aligned_cols=250 Identities=23% Similarity=0.399 Sum_probs=199.8
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..+|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788889999999999999996 47899999999765555556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998832 35788999999999999999999988 99999999999999999999999999876543322
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .........+.. .
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~--------~~~~~~~~~~~~------~ 234 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGTP------E 234 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--------hheeeeccCCCC------C
Confidence 1 12346788999999999888999999999999999999999998532211 000000111100 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+ ..+......+.+++.+||+.+|++||++.+|++
T Consensus 235 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 L--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 001111123567778999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=298.27 Aligned_cols=249 Identities=30% Similarity=0.474 Sum_probs=196.3
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccchh---------chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQ---------GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
+|.....||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 5789999988643221 12468899999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++++||+++++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999984 3456889999999999999999999988 9999999999999999999999999988
Q ss_pred cccCCCCcc----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 505 IFAGSEGEV----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 505 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
......... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... . ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~-~~~~~~~~- 225 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-------Q-LQAIFKIG- 225 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-------H-HHHHHHHh-
Confidence 764321111 1122457889999999988889999999999999999999999985321 1 11111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. ...+.+....+ ..+.+++.+||+.+|++||++.||++
T Consensus 226 ~-----~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 E-----NASPEIPSNIS----SEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred c-----cCCCcCCcccC----HHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1 11122222222 34567777999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=303.99 Aligned_cols=251 Identities=27% Similarity=0.383 Sum_probs=198.4
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+.|++.++||+|+||.||+|... +++.+++|.+..........+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999975 58899999998766666778899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|..++.. ....+++..++.++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 99999887743 2345899999999999999999999987 99999999999999999999999999875432211
Q ss_pred cccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 513 VNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
......++..|+|||++. ...++.++||||||+++|||++|+.|+.... ......+. ........
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~~-~~~~~~~~ 235 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKI-AKSEPPTL 235 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--------HHHHHHHH-hcCCCccC
Confidence 122346788999999874 3457889999999999999999999985321 11111111 11111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. ....++ ..+.+++.+||+.+|++||++.|+++
T Consensus 236 ~---~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 S---QPSKWS----MEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C---CCcccC----HHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 011222 23667888999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.08 Aligned_cols=237 Identities=23% Similarity=0.277 Sum_probs=184.8
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHH-HHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
++||+|+||.||+++.. +++.||+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999974 57899999986432 222334555554 57788999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
++|...+. ..+.+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 99988773 3456888889999999999999999988 99999999999999999999999999875322221 2
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||... +........... .. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~-~~------~~~~ 217 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------DVSQMYDNILHK-PL------QLPG 217 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC--------CHHHHHHHHhcC-CC------CCCC
Confidence 23457899999999999889999999999999999999999998532 222222222111 10 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMS 623 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ 623 (671)
. ....+.+++.+|++.+|++||+..
T Consensus 218 ~----~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 G----KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C----CCHHHHHHHHHHccCCHhhcCCCC
Confidence 1 223466788899999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=295.61 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=199.2
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEccccch--hchHHHHHHHHHHhhcCCCC-eeeEeeEEEcCC------e
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKN-LVKLLGFCVDGD------E 424 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~------~ 424 (671)
.|+..++||+|.||+||+|+. .+|+.||+|+++-..+ .-.....+|+.++++|+|+| ||++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455567799999999999995 4789999999875333 23345689999999999999 999999999877 7
Q ss_pred eeEEEeccCCCchhhhhcCCCCC-CCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKR-GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
.++|+||+ ..+|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+++|.+||+|||++
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 88999999 56888888543322 45777889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
+.+.-... .....++|..|.|||++.+. .|+...||||+|||+.||++++.-|+... .........+.+...
T Consensus 168 ra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s-----e~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 168 RAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS-----EIDQLFRIFRLLGTP 240 (323)
T ss_pred HHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc-----HHHHHHHHHHHcCCC
Confidence 97653222 13445789999999999876 79999999999999999999988886432 222333333333222
Q ss_pred C---ccccc---c--ccccCCC-----CHHH---HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 583 N---ALDLI---D--PLLTDTC-----SPDE---FLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 583 ~---~~~~~---d--~~l~~~~-----~~~~---~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
. |.... + ....... .... .....+++.+|++.+|++|.|++..+++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1 11111 1 1111100 0000 1256788889999999999999999875
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=309.27 Aligned_cols=241 Identities=24% Similarity=0.267 Sum_probs=189.7
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 429 (671)
+|+..+.||+|+||.||++... +|+.||+|+++... ......+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999864 68899999987532 233445778888888875 577888999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|..++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999998883 3456899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ......... ....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~-~~~~----- 218 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--------EDELFQSIM-EHNV----- 218 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hCCC-----
Confidence 21 1233568999999999998899999999999999999999999985321 111111111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
.+....+. .+.+++.+|++.+|++|++.
T Consensus 219 -~~p~~~~~----~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSK----EAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCH----HHHHHHHHHcccCHhhCCCC
Confidence 11122222 35677789999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=297.89 Aligned_cols=238 Identities=26% Similarity=0.418 Sum_probs=186.8
Q ss_pred cccCCCCcccEEEEEecCCc-----------eEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 360 NMLGQGGFGPVYKGVLSDGK-----------EIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
+.||+|+||.||+|.+.+.. .+++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999985432 5788887654333 5678999999999999999999999988 778999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-------CeEEeecc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-------NPKISDFG 501 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Dfg 501 (671)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998542 226899999999999999999999988 99999999999999887 79999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccC--CCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCCCCCCHHHHHHHH
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITG-RRNTGFNQSRGATAPNLLAYAWHL 578 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~~~l~~~~~~~ 578 (671)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+...... .. ...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~----~~~ 218 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EK----ERF 218 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hH----HHH
Confidence 9886533 1223566789999998776 789999999999999999994 6666432110 00 111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
+..... +. ......+.+++.+||+.+|++|||+.||++.|+
T Consensus 219 ~~~~~~-------~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQDQHR-------LP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhcCCC-------CC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111110 00 001145678888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.27 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=196.2
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++......++|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555678999999999999864 57889999987432 3445578999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|.+++. .+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 999998873 245889999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ... . ....+. .+.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~~---~-~~~~~~-----~~~~~ 222 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RVL---F-LIPKNS-----PPTLE 222 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hHH---h-hhhcCC-----CCCCC
Confidence 122346788999999999888999999999999999999999997532111 010 0 011111 11122
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... ...+.+++.+||+.+|++||++.||++
T Consensus 223 ~~~----~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQY----SKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccc----CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 222 234667888999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.07 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=201.6
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.||.++. .+++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999885 46889999987642 344556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999998542 2456899999999999999999999988 99999999999999999999999999986644332
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||... ...+...... .+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~-~~~~~~~---- 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT--------NPLNLVVKIV-QGNYTPV---- 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHH-cCCCCCC----
Confidence 122356889999999998888899999999999999999999998532 1222222221 2221111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
.... ...+.+++.+||+.+|++||++.|+++.+
T Consensus 222 -~~~~----~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 -VSVY----SSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -cccc----CHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1112 23366777799999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.60 Aligned_cols=247 Identities=26% Similarity=0.425 Sum_probs=199.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||.|++|.||+|... +++.|++|++.... ......+.+|+.++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778899999999999999965 68899999987533 34456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999999843 26899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....... ..... +.
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~-~~~~~-----~~ 217 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLI-PKNNP-----PS 217 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHHh-hhcCC-----CC
Confidence 22235678899999999988899999999999999999999999853221 1111111 11111 11
Q ss_pred ccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDT-CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+... ++. .+.+++.+||+.+|++|||++++++
T Consensus 218 ~~~~~~~~----~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGNKFSK----PFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CcccccCH----HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 222 3667788999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=298.70 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=201.4
Q ss_pred CCCCcccccCCCCcccEEEEEec------CCceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
++|+..+.||+|+||.||+++.. +.+.|++|.+...... ....+.+|+.++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788899999999999999863 3467999988764433 4567899999999999999999999999988999
Q ss_pred EEEeccCCCchhhhhcCCCCC------CCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 427 LVYEFMPNSSLDAILFDPRKR------GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
+||||+++++|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998643322 26899999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
|+++....... .......++..|++||.+.+...+.++||||||+++|||++ |..||..... .... ...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~-~~~ 231 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVL-NRL 231 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHH-HHH
Confidence 99875433221 12223456778999999988889999999999999999999 7778742211 1111 112
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 580 NEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..+.... .....++ ..+.+++.+||+.+|++||++.|++..|++
T Consensus 232 ~~~~~~~----~~~~~~~----~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 232 QAGKLEL----PVPEGCP----SRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred HcCCcCC----CCCCCCC----HHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 2222111 0111222 246678889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.63 Aligned_cols=258 Identities=27% Similarity=0.373 Sum_probs=201.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|++.+.||+|+||+||++... +|+.||+|++... .......+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356777899999999999999964 5889999987643 23445678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|+++++|..++. ..+.+++.....++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999873 34568999999999999999999997 35 999999999999999999999999998654222
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCC---CCCHHHHHHHHHhcCCccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT---APNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~---~~~l~~~~~~~~~~~~~~~ 586 (671)
. .....|+..|+|||.+.++.++.++||||||+++|||++|+.||......... ...+...........
T Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 1 22357899999999998889999999999999999999999999753322111 111122222211111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
.+.+... +....+.+++.+|++.||++|||+.||+++.
T Consensus 230 --~~~~~~~---~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 --PPRLPSS---DFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred --CCCCCch---hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0111111 1123466778899999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=300.30 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=198.7
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.|+..+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++.++|+||+++++.+.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667788999999999999975 5889999998743 2344567899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++. .+.+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999884 245888999999999999999999987 99999999999999999999999999976543321
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...... ... .
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~-~~~---------~ 217 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFLI-PKN---------N 217 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhhh-hcC---------C
Confidence 122346788999999998888999999999999999999999998532111 100000 011 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
...........+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111222334457788889999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.23 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=199.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|++.+.||+|+||.||++... +++.+|+|.++.........+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999974 5889999999866666667889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998843 2346899999999999999999999998 99999999999999999999999998875433221
Q ss_pred ccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 512 EVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
......+++.|++||.+. ...++.++||||||+++|||++|+.||.... ........ ..+....
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~~~ 227 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--------PMRVLLKI-LKSEPPT 227 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--------HHHHHHHH-hcCCCCC
Confidence 122356889999999875 3457789999999999999999999985321 11111111 1111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... ...++ ..+.+++..||+.+|++||++.+|++
T Consensus 228 ~~~---~~~~~----~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 LDQ---PSKWS----SSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred cCC---cccCC----HHHHHHHHHHhccChhhCcCHHHHhc
Confidence 100 01122 23567777999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=299.21 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=198.8
Q ss_pred hCCCCcccccCCCCcccEEEEEecC----CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.++|...+.||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3457778999999999999998643 2468999887544 4455678999999999999999999998875 45789
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999853 2335899999999999999999999988 9999999999999999999999999988654
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
...... .....++..|+|||.+....++.++||||||+++|||++ |+.||..... .+.... ...+...
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~-~~~~~~~- 227 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIGR-IENGERL- 227 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHH-HHcCCcC-
Confidence 432211 112234568999999988889999999999999999996 9999853211 111111 1121111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....++. .+.+++.+|+..+|++|||+.+++..|+..
T Consensus 228 ----~~~~~~~~----~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 228 ----PMPPNCPP----TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ----CCCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122232 366777899999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=309.42 Aligned_cols=200 Identities=25% Similarity=0.327 Sum_probs=171.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999964 5889999998642 2233456888999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999843 2345889999999999999999999998 999999999999999999999999998765433
Q ss_pred CCccccccccccCCccchhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAME-----GLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
... ......||+.|+|||++.. +.++.++|||||||++|||++|+.||.
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 221 1223468999999999863 457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=304.61 Aligned_cols=249 Identities=25% Similarity=0.447 Sum_probs=200.1
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.+|+..+.||.|++|.||++.. .+++.|++|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4588889999999999999985 478999999987655555667889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|..++. ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999999884 235899999999999999999999998 999999999999999999999999998765433221
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........... ..... .
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~~~-~~~~~---~ 237 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNG-TPELQ---N 237 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcC-CcccC---C
Confidence 2234688899999999888899999999999999999999999853221 11111111111 10100 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+++ .+.+++.+||+.+|++||++.+|+.
T Consensus 238 ~~~~~~----~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSP----IFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCH----HHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112222 3567778999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=296.92 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=201.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|+..+.||+|+||.||++... +++.+++|.+..........+.+|+.++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999974 57889999998655556678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 99999998843 2356899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccCCccchhhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEG---LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
......++..|+|||.+... .++.++||||||+++|||++|+.|+..... .......... .. ..
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--------~~~~~~~~~~-~~---~~ 223 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--------MRALFLISKS-NF---PP 223 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc-cC---CC
Confidence 11234678899999998776 889999999999999999999999853211 1111111111 00 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.+. ........+.+++.+||+.+|++|||+++|+.
T Consensus 224 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1110 11122345778888999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=298.69 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=195.7
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccch----------hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE----------QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD 423 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 423 (671)
+|...+.||+|+||.||+|... +|+.||+|.++.... ...+.+.+|+.++..++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4666789999999999999864 688999998753111 11245788999999999999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++|+||+++++|.+++.. .+.+++..+..++.||+.||.|||+++ ++||||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999999843 356899999999999999999999987 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccchhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
+...............++..|+|||.+.... ++.++||||||+++||+++|+.|+.... ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~ 227 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--------AIAAMFKLGNK 227 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--------hHHHHHHhhcc
Confidence 7654322222223356888999999987654 7899999999999999999999984221 11111111111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.....+.+.....+ ...+.+++..||+.+|++||++.+|++
T Consensus 228 -~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 -RSAPPIPPDVSMNL----SPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -ccCCcCCccccccC----CHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11111111111122 234667778999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.68 Aligned_cols=252 Identities=29% Similarity=0.443 Sum_probs=196.5
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchH--HHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNA--EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
|+..+.||+|+||+||+++.. +++.+|+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999975 4668999999865433322 3456999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++. ..+.+++..++.++.||++||.+||+.+ ++|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999985 4566899999999999999999999998 99999999999999999999999999876411 12
Q ss_pred cccccccccCCccchhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
.......++..|+|||.+. ....+.++||||+|+++|+|++|+.|+..... ........+.... ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-----~~~~~~~~~~~~~----~~~~~~ 223 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-----DDQLEIIEKILKR----PLPSSS 223 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-----HHHHHHHHHHHHT----HHHHHT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-----hhhhhhhhhcccc----cccccc
Confidence 2334467889999999998 78899999999999999999999999853210 0111111111000 000000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... .....+.+++..||+.||++||++.++++
T Consensus 224 ~~~~---~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSR---EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHT---TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccc---hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 01145778888999999999999999984
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=301.68 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=200.7
Q ss_pred echhhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEE-
Q 005893 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCV- 420 (671)
Q Consensus 344 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~- 420 (671)
+.++.+....++|++.+.||+|+||.||++... +++.+|+|+++... ....++.+|+.++.++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334556667889999999999999999999874 57899999886532 2235678899999999 7999999999885
Q ss_pred ----cCCeeeEEEeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 421 ----DGDEKLLVYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 421 ----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
.+...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345679999999999999887532 23456889999999999999999999987 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-----GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~ 570 (671)
||+|||+++........ .....|++.|+|||++.. ..++.++||||||+++|||++|+.|+......
T Consensus 164 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------ 235 (286)
T cd06638 164 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------ 235 (286)
T ss_pred EEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------
Confidence 99999998865432221 223468999999998753 45788999999999999999999998532210
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
..... ..........++ ..++ ..+.+++.+||+.+|++|||+.||++.
T Consensus 236 --~~~~~-~~~~~~~~~~~~---~~~~----~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 --RALFK-IPRNPPPTLHQP---ELWS----NEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --HHHhh-ccccCCCcccCC---CCcC----HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11001 111111111111 1111 246678889999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=296.20 Aligned_cols=257 Identities=28% Similarity=0.399 Sum_probs=202.4
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||.|+||.||+|... ++..+++|++.... ......+.+|+..++.++|+||+++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999964 67889999986432 33556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++........+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999864333356899999999999999999999988 99999999999999999999999999887654332
Q ss_pred cc--ccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 512 EV--NTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 512 ~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. ......|+..|++||.+... .++.++|+||||+++|||++|+.||...... ....+..... ... .
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~-~~~-~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQND-PPS-L 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCC-CCC-c
Confidence 21 12334688999999998877 7899999999999999999999998533211 1111111111 100 1
Q ss_pred cccc-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLL-TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... ...+ ...+.+++..||+.||++||++.||++
T Consensus 228 ~~~~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKY----SKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccc----cHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1100 0111 234667888999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=296.33 Aligned_cols=247 Identities=30% Similarity=0.455 Sum_probs=197.7
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-----hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-----EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
+|+..+.||+|++|.||+|... +++.|++|.+.... ......+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 78999999886432 23446788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
+||+++++|.+++. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999984 3345889999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccchhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.. ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.... -....+........
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--------~~~~~~~~~~~~~~--- 220 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSKEL--- 220 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--------HHHHHHHHHhcccC---
Confidence 32 123356788999999987766 8999999999999999999999985321 11111221111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.+....+ ..+.+++.+||+.+|++||++.++++
T Consensus 221 --~~~~~~~~----~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 --PPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCcCCCcC----HHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11111222 33667888999999999999999984
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=300.67 Aligned_cols=240 Identities=24% Similarity=0.394 Sum_probs=186.9
Q ss_pred cccCCCCcccEEEEEecC--------CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 360 NMLGQGGFGPVYKGVLSD--------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998632 235888888765555556788999999999999999999999998999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC--------eEEeecccc
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN--------PKISDFGMA 503 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~Dfgla 503 (671)
+++|+|..++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998532 336899999999999999999999988 999999999999987765 599999987
Q ss_pred ccccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGR-RNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~-~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
...... ....++..|+|||.+.+. .++.++||||||+++|||++|. .|+.... ..... .....
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--------~~~~~-~~~~~ 220 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--------SQKKL-QFYED 220 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--------HHHHH-HHHHc
Confidence 654321 224678889999998764 5799999999999999999985 4443211 01100 01111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
. ..+... ....+.+++.+||+.+|++|||++++++.|+
T Consensus 221 -~------~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 -R------HQLPAP----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -c------ccCCCC----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 011111 1234667888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=298.63 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=196.1
Q ss_pred CCcccccCCCCcccEEEEEec----CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 423 (671)
|.+.+.||+|+||.||+|.+. +++.||||+++.. .....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 3678999998753 3344567889999999999999999999886543
Q ss_pred eeeEEEeccCCCchhhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 424 EKLLVYEFMPNSSLDAILFDPR---KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
..++++||+++|+|..++.... +...+++...++++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988874322 2235788999999999999999999988 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.|+.... ...+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~~~~----~~ 228 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYN----YL 228 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHHHHH----HH
Confidence 99886544332222223345678999999988889999999999999999999 888874221 111111 11
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 580 NEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..+.... . ++.....+.+++.+|++.+|++||++.||++.|++
T Consensus 229 ~~~~~~~-----~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 229 IKGNRLK-----Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred HcCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1111111 0 11122357788889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=305.49 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=195.8
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999864 68899999986432 22234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999988853 22345889999999999999999999988 99999999999999999999999999876433221
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ............. ...
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~-----~~~~~~~~~~~~~------~~~ 223 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK-----IKREEVERLVKEV------QEE 223 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc-----chHHHHHhhhhhh------hhh
Confidence 12246899999999999999999999999999999999999999642211 0111111111110 011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
+...+++ .+.+++..||+.||++||| ++|+++
T Consensus 224 ~~~~~~~----~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSP----DARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCH----HHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1222332 3567777999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=302.25 Aligned_cols=250 Identities=26% Similarity=0.315 Sum_probs=195.0
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|+.+++.++|+||+++.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556788999999999999874 68899999986532 22234577899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999999887542 3346999999999999999999999988 99999999999999999999999999876432211
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
.....|+..|+|||.+.+..++.++|+||||+++|||++|+.||...... .............. ..
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-----~~~~~~~~~~~~~~------~~ 223 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-----VKREEVDRRVLETE------EV 223 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhhhccc------cc
Confidence 12347899999999998889999999999999999999999998532211 01111111111111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
.....++ .+.+++..|++.||++||+ +.+++.
T Consensus 224 ~~~~~~~----~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSE----EAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCH----HHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 1122232 3567778999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.06 Aligned_cols=196 Identities=29% Similarity=0.367 Sum_probs=165.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 423 (671)
.++|+..+.||+|+||.||++... +|+.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467999999999999999999864 5889999998643 2334456789999999999999999999987543
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 468999999764 544442 23788889999999999999999998 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 7543221 12335789999999999998999999999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.86 Aligned_cols=247 Identities=28% Similarity=0.448 Sum_probs=195.3
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
++|.+.+.||+|+||.||++.. +++.||+|.++... ....+.+|+.++.+++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577789999999999999976 67889999986532 235788999999999999999999998654 5789999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998542 2345889999999999999999999987 9999999999999999999999999987543211
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....+..|+|||.+.++.++.++|+||||+++|||++ |+.||.... ..... .....+...+ .
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~-~~~~~~~~~~-----~ 218 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------LKEVK-ECVEKGYRME-----P 218 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------HHHHH-HHHhCCCCCC-----C
Confidence 11234567999999988899999999999999999998 898885321 11211 1112211111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
....+ ..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 219 ~~~~~----~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCP----ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11222 346678889999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=297.96 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=188.1
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe-----eeEEE
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-----KLLVY 429 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~lv~ 429 (671)
|...+++|.|+||.||+|++. +++.||||+.-...+. -.+|+.+|++++|||||+++.+|..... ..+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 445688999999999999975 4689999987543332 2479999999999999999998875432 34899
Q ss_pred eccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeecccccccc
Q 005893 430 EFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFA 507 (671)
Q Consensus 430 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~ 507 (671)
|||+. +|..++... ..+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99975 677766532 23455777788889999999999999988 9999999999999976 999999999999886
Q ss_pred CCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc-
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL- 585 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~- 585 (671)
.++.... ..-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|...+ ..+.+....+.+......
T Consensus 178 ~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-----~~dQL~eIik~lG~Pt~e~ 249 (364)
T KOG0658|consen 178 KGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-----SVDQLVEIIKVLGTPTRED 249 (364)
T ss_pred cCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-----HHHHHHHHHHHhCCCCHHH
Confidence 6554322 345788999999876 579999999999999999999999886432 112222222222211111
Q ss_pred ---------ccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 586 ---------DLIDPLLTDT-----CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 586 ---------~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.-.+.+... .......+.++++.++++.+|.+|.++.|++.
T Consensus 250 I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 250 IKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1111111111 11111223667778999999999999999875
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=315.39 Aligned_cols=201 Identities=27% Similarity=0.374 Sum_probs=172.8
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999875 58899999987422 233456788999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999998754321
Q ss_pred CCc---------------------------------cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 005893 510 EGE---------------------------------VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556 (671)
Q Consensus 510 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~ 556 (671)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00112479999999999999999999999999999999999999
Q ss_pred CCCC
Q 005893 557 NTGF 560 (671)
Q Consensus 557 p~~~ 560 (671)
||..
T Consensus 235 Pf~~ 238 (360)
T cd05627 235 PFCS 238 (360)
T ss_pred CCCC
Confidence 9953
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=304.36 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=193.3
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|...+.||+|+||.||+|... +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999865 57889999987433 22334677899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++ +|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 77776643 2345889999999999999999999988 99999999999999999999999999876433221
Q ss_pred ccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc------
Q 005893 512 EVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA------ 584 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~------ 584 (671)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +......+.......
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCHHHHhhh
Confidence 1223467899999998865 46899999999999999999999998643211 111111111100000
Q ss_pred ---ccccc---ccc--------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 ---LDLID---PLL--------TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ---~~~~d---~~l--------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+..+ +.. ....+ ..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 233 SSNDEFKNYNFPKYKPQPLINHAPRLD----TEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred cchhhhhhhhcCccCCCchhhhccCCC----HHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 000 01112 23567888999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=284.54 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=198.1
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc-----hh---chHHHHHHHHHHhhc-CCCCeeeEeeEEEcCC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-----EQ---GNAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 423 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~---~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 423 (671)
.+|...+.||+|..+.|.+... .+|+++|+|++.... +. -.+.-..|+.+|+++ .||+|+++.+++....
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4567788899999999998886 468899999885321 11 123346799999998 7999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++|+|.|+.|-|.++| ...-.+++.+..+|++|+.+|+.|||..+ |+||||||+|||+|++.++||+|||++
T Consensus 97 F~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 999999999999999999 45667999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAME------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
..+.+.. .....||||+|+|||.+.- ..|+...|.|+.|||+|.|+.|.+||....+ + ...+
T Consensus 171 ~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------m--lMLR 238 (411)
T KOG0599|consen 171 CQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------M--LMLR 238 (411)
T ss_pred eccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------H--HHHH
Confidence 9876553 2345799999999998742 3578899999999999999999999842111 0 1122
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+..+|+.. +...-..+......+++.+|++.||.+|.|.+|+++
T Consensus 239 ~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 33333321 111111122234557777999999999999999875
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=304.59 Aligned_cols=252 Identities=26% Similarity=0.371 Sum_probs=197.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||+|+||.||++... +++.||+|.++.. .......+.+|+.++++++|+||+++++.+......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999975 6899999988643 334456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
+++++|..++........+++..+..++.|++.||.|||+. + |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999885433345789999999999999999999974 5 9999999999999999999999999987653221
Q ss_pred CccccccccccCCccchhhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEG------LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
.....++..|+|||.+... .++.++||||||+++|||++|+.||.... ......... ....+..
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~-~~~~~~~ 227 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-----YANIFAQLS-AIVDGDP 227 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-----hhhHHHHHH-HHhhcCC
Confidence 2234678899999988543 35889999999999999999999985321 111111111 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.+ +++....+.+++.+||+.+|++||++.+++.
T Consensus 228 -----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 -----PTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----CCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111 2222334667888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=292.78 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=197.3
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-CeeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e 430 (671)
+|+..+.||+|++|.||++... +++.|++|++... .......+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999964 5788999998642 234455688999999999999999999887644 45789999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|.+++.. .....+++.+++.++.|++.||.+||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~-~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKE-QKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999998854 23445899999999999999999999998 9999999999999999999999999998664332
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ......+++.|+|||.+.+..++.++||||||++++||++|+.||... +......... .+.. +
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--------~~~~~~~~~~-~~~~-----~ 220 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--------DMNSLVYRII-EGKL-----P 220 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHH-hcCC-----C
Confidence 2 122346789999999999999999999999999999999999998522 1222222221 2211 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.... ...+.+++.+|++.+|++||++.|+++
T Consensus 221 ~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDY----SPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCcccc----CHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111122 234677888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=297.21 Aligned_cols=251 Identities=35% Similarity=0.505 Sum_probs=198.0
Q ss_pred CCcccccCCCCcccEEEEEecC-----CceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSD-----GKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
|++.+.||+|+||.||++...+ +..||+|+++..... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999753 378999999765433 5668899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999985321 122899999999999999999999988 999999999999999999999999999876544
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
...... ...++..|+|||.+....++.++||||||++++||++ |+.|+... ...... +....+....
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~-~~~~~~~~~~-- 224 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVL-EYLKKGYRLP-- 224 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHH-HHHhcCCCCC--
Confidence 222211 2336789999999988889999999999999999998 77777431 111111 1111211111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
..... ...+.+++.+|+..+|++|||+.|++++|
T Consensus 225 ---~~~~~----~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 ---KPENC----PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCcC----CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112 23466788899999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.82 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=196.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|+..+.||+|+||.||+++.. +|+.||+|++.... ......+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999975 58899999986432 2233467899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|..++. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999999988763 3345899999999999999999999988 9999999999999999999999999998764432
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH----------HHH
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW----------HLW 579 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~----------~~~ 579 (671)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+..... ..+
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV----DQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCChHHhhhc
Confidence 1 1223457788999999865 56789999999999999999999998532211 01111000 000
Q ss_pred hcCCcc-ccccccccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNAL-DLIDPLLTDTCSP-----DEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~~-~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...... ....+......+. .....+.+++.+||+.+|++||++.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 0000000000000 11234678888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=306.23 Aligned_cols=197 Identities=26% Similarity=0.428 Sum_probs=159.6
Q ss_pred ccccCCCCcccEEEEEec---CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc--CCeeeEEEeccC
Q 005893 359 SNMLGQGGFGPVYKGVLS---DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP 433 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 433 (671)
.++||+|+||.||+++.. +++.||+|.+.... ....+.+|+.++++++||||+++++++.. +...++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 46789999987532 23457789999999999999999998864 345789999986
Q ss_pred CCchhhhhcCC------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE----cCCCCeEEeecccc
Q 005893 434 NSSLDAILFDP------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL----DYDMNPKISDFGMA 503 (671)
Q Consensus 434 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla 503 (671)
++|..++... .....+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4676665321 12235889999999999999999999998 9999999999999 45678999999999
Q ss_pred ccccCCCCc-cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005893 504 RIFAGSEGE-VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFN 561 (671)
Q Consensus 504 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~ 561 (671)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876433211 12334678999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.80 Aligned_cols=199 Identities=20% Similarity=0.265 Sum_probs=164.0
Q ss_pred cccccCCC--CcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 358 DSNMLGQG--GFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 358 ~~~~lg~G--~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
..++||+| +|++||++.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7889999986 46899999998753 2233456778999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+++.||+...........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999988532 2345899999999999999999999988 999999999999999999999999865433211110
Q ss_pred c-----ccccccccCCccchhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 513 V-----NTARIVGTYGYMAPEYAME--GLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 513 ~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
. ......++..|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 0 0112356778999999876 4589999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=296.06 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=191.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-----hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Cee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-----EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 425 (671)
.+|+..+.||+|+||.||++... +++.|++|++.... .+....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 58899999886421 22345688999999999999999999988753 567
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++++||+++++|.+++. ..+.+++...+.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999884 3345889999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCCC-ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 506 FAGSEG-EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 506 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.... ......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~--------~~~~~~~~~~~~-- 225 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--------AMAAIFKIATQP-- 225 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc--------hHHHHHHHhcCC--
Confidence 533211 111223457889999999988889999999999999999999999985321 111111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+.+....+ + .+..++ .||..+|++||+++||++
T Consensus 226 ---~~~~~~~~~~-~---~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 ---TNPQLPSHIS-E---HARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCCCCchhcC-H---HHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1112211111 2 233333 688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.92 Aligned_cols=257 Identities=19% Similarity=0.226 Sum_probs=199.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||++... .++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999975 57899999987543 233456789999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999984 3456899999999999999999999988 999999999999999999999999998742111
Q ss_pred CC-------------ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH
Q 005893 510 EG-------------EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 510 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~~ 226 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFG 226 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 00 001112467889999999988889999999999999999999999984221 111111
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.. ..+.. ..+......+. .+.+++.+||+.+|++||+..++.++|+..
T Consensus 227 ~~-~~~~~---~~~~~~~~~~~----~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 227 QV-ISDDI---EWPEGDEALPA----DAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HH-Hhccc---CCCCccccCCH----HHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 11 11111 11111112222 256777899999999999987777777653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=310.85 Aligned_cols=243 Identities=30% Similarity=0.436 Sum_probs=198.2
Q ss_pred CCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
|+..+.||.|+||.||.+.. .+.+.||||++.... ...+.++..|+..|.+++|||++.+.|++..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55667899999999999996 467889999997543 34467899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
|- |+-.+++.- .++++.+.++..|+.+.+.||+|||+++ .||||||+.||||.+.|.+||+|||.+....+.+
T Consensus 108 Cl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn- 180 (948)
T KOG0577|consen 108 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN- 180 (948)
T ss_pred Hh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence 94 565666532 3466888999999999999999999998 9999999999999999999999999987765443
Q ss_pred ccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.++|||.|||||++. .|.|+-|+||||||++-.||.-.++|. ...+.....+..-.+..
T Consensus 181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl--------FnMNAMSALYHIAQNes----- 242 (948)
T KOG0577|consen 181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--------FNMNAMSALYHIAQNES----- 242 (948)
T ss_pred -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc--------cCchHHHHHHHHHhcCC-----
Confidence 368999999999984 578999999999999999999999886 33344444444433322
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
|.|.. .+....+.+++..|++.-|.+|||..+++.
T Consensus 243 -PtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 -PTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 23332 233444666777999999999999998864
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=301.14 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=188.9
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhc---CCCCeeeEeeEEEcC-----C
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKL---QHKNLVKLLGFCVDG-----D 423 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 423 (671)
+|++.+.||+|+||.||++... +++.||+|.++.... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999875 688999999874321 1223456677776655 799999999988642 3
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++++||+++ +|..++.. .....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999974 78777743 22345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC-
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG- 582 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~- 582 (671)
+...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .............
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~ 227 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-----DQLGKIFDLIGLPP 227 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-----HHHHHHHHHhCCCC
Confidence 8654322 122346789999999999889999999999999999999999998532211 0111111110000
Q ss_pred --Ccc-------cccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 --NAL-------DLIDPLLT---DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 --~~~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+. ....+... ....++....+.+++.+|++.||++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000 0011112234678888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.16 Aligned_cols=244 Identities=31% Similarity=0.449 Sum_probs=201.6
Q ss_pred ccCCCCcccEEEEEecC-CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchhh
Q 005893 361 MLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDA 439 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 439 (671)
+||+|.||+||.|+..+ ...+|||.+.....+..+-+..|+.+.+.|+|.|||+++|.+.+++..-+.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999999754 55799999987777777789999999999999999999999999998889999999999999
Q ss_pred hhcCCCCCCCC--ChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeeccccccccCCCCccccc
Q 005893 440 ILFDPRKRGLL--CWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIFAGSEGEVNTA 516 (671)
Q Consensus 440 ~l~~~~~~~~l--~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 516 (671)
+|. .+.+++ .+...-...+||++||.|||++. |||||||-+|||++. .|.+||+|||-++.+..-. +-+.
T Consensus 662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE 734 (1226)
T KOG4279|consen 662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE 734 (1226)
T ss_pred HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence 995 456666 77788889999999999999998 999999999999974 6899999999998775432 3455
Q ss_pred cccccCCccchhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 517 RIVGTYGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 517 ~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.+.||..|||||++..++ |+..+|||||||++.||.||++||-....+ + ..+++-|-. ...+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--------q--AAMFkVGmy------KvHP 798 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--------Q--AAMFKVGMY------KVHP 798 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--------h--Hhhhhhcce------ecCC
Confidence 678999999999998774 889999999999999999999999533222 0 112222111 0112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+.+--.+....+++|+..+|.+||+++++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 334444556788999999999999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=312.20 Aligned_cols=197 Identities=27% Similarity=0.347 Sum_probs=165.6
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD----- 423 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 423 (671)
..++|+..+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3468999999999999999999864 5889999998753 2333456788999999999999999999886543
Q ss_pred -eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 424 -EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 424 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
..++||||+++ +|...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999975 5555542 24788999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 98643321 12235789999999999988999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=292.59 Aligned_cols=249 Identities=21% Similarity=0.352 Sum_probs=199.1
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.+|++... +|+.|++|++... ......++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 6889999998642 234455789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998853 22335789999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
. .....|++.|+|||.+.++.++.++|+||||++++||++|+.|+... +.......... +... .
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------~~~~~~~~~~~-~~~~-----~ 220 (256)
T cd08218 157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--------NMKNLVLKIIR-GSYP-----P 220 (256)
T ss_pred h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--------CHHHHHHHHhc-CCCC-----C
Confidence 1 12346788999999998888999999999999999999999998532 22222222211 1111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..... ...+.+++.+||+.+|++||++.||++
T Consensus 221 ~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHY----SYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccC----CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11122 234667888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.82 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=195.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|+..+.||+|+||.||++... +++.||+|++..... .....+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 588999999864322 234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|..+.. ....+++..++.++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988763 2344899999999999999999999988 9999999999999999999999999988654432
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH----------HHH
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW----------HLW 579 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~----------~~~ 579 (671)
. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ...+..... ..+
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCCchhhHHHh
Confidence 1 1223467889999999865 4578899999999999999999988853211 000000000 000
Q ss_pred hcCCcc-ccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNAL-DLIDPLLTDT-----CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~~-~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...... ....+..... ..+.....+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 0000000000 00111245778888999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.25 Aligned_cols=200 Identities=25% Similarity=0.333 Sum_probs=170.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..++||+|+||.||+++.. +++.+|+|++.+. .......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999975 4678999998642 1223345788999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999853 2345899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
.. .......||+.|+|||++. .+.++.++|||||||++|||++|+.||.
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 22 1223357999999999986 3468899999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=300.10 Aligned_cols=264 Identities=23% Similarity=0.325 Sum_probs=197.2
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccchh-----chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQ-----GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
+|+..+.||+|+||.||+|... +++.|+||+++..... ....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999964 6889999999754322 234567899999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+ +++|.+++.... ..+++..++.++.||++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999985322 36999999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC-----
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG----- 582 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~----- 582 (671)
.... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..+|..... ..............
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-----IDQLGKIFEALGTPTEENW 227 (298)
T ss_pred CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-----HHHHHHHHHHcCCCchhhh
Confidence 3211 122356788999998854 4678999999999999999999777643211 11111111000000
Q ss_pred ----CccccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hcC
Q 005893 583 ----NALDLIDPLLTDTCS-----PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM--LQG 631 (671)
Q Consensus 583 ----~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~--L~~ 631 (671)
..............+ ......+.+++.+||+.+|++|||+.||++. +++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 000000000001111 1123457788999999999999999999984 544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=310.84 Aligned_cols=193 Identities=24% Similarity=0.339 Sum_probs=164.1
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
....+|.+.+.||+|+||.||++... +++.||+|+.... ....|+.++++++|+||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999975 4678999975432 2346899999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|++. ++|..++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 577777643 3456899999999999999999999988 999999999999999999999999998753222
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNT 558 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~ 558 (671)
. ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 122356899999999999999999999999999999999865543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.00 Aligned_cols=244 Identities=23% Similarity=0.355 Sum_probs=194.6
Q ss_pred ccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 359 SNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
...||+|+||.||++... +++.||+|++..........+.+|+.++..++||||+++++++..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999864 6889999998754445556788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
..++. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........ ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 98773 245889999999999999999999988 99999999999999999999999999875533221 1223
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ....... +........ ......+
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--------~~~~~~~-~~~~~~~~~---~~~~~~~ 244 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--------PVQAMKR-LRDSPPPKL---KNAHKIS 244 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HhccCCCCc---cccCCCC
Confidence 568899999999988889999999999999999999999985321 1111111 111111000 0011122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+.+++..|++.+|++||+++||++
T Consensus 245 ----~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 245 ----PVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ----HHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 23567777999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.14 Aligned_cols=200 Identities=24% Similarity=0.316 Sum_probs=171.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+++.. +++.||+|++... .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999975 5788999998642 1223345788999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999853 2346889999999999999999999988 999999999999999999999999999765433
Q ss_pred CCccccccccccCCccchhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAME-----GLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
... ......||+.|+|||++.. +.++.++||||||+++|||++|+.||.
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 221 2223579999999999865 567899999999999999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.42 Aligned_cols=197 Identities=27% Similarity=0.433 Sum_probs=159.0
Q ss_pred ccccCCCCcccEEEEEec---CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc--CCeeeEEEeccC
Q 005893 359 SNMLGQGGFGPVYKGVLS---DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMP 433 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 433 (671)
..+||+|+||.||+++.. ++..||+|.++... ....+.+|+.++++++||||+++++++.. +...++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999964 35689999987532 23457889999999999999999999864 456789999987
Q ss_pred CCchhhhhcCC------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE----cCCCCeEEeecccc
Q 005893 434 NSSLDAILFDP------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL----DYDMNPKISDFGMA 503 (671)
Q Consensus 434 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla 503 (671)
+ +|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 665555311 12335889999999999999999999988 9999999999999 56689999999999
Q ss_pred ccccCCCCc-cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005893 504 RIFAGSEGE-VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFN 561 (671)
Q Consensus 504 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~ 561 (671)
+........ .......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876443221 12234578999999999876 45899999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=330.96 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=195.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Ceee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 426 (671)
..++|.+.+.||+|+||.||++... +++.||+|++... .......+..|+.++.+|+|||||++++++... ...+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4467889999999999999999975 5678999988642 334456788999999999999999999988653 4678
Q ss_pred EEEeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCC----CceeecCCCCCcEEEcCC---------
Q 005893 427 LVYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSR----LRIIHRDLKASNVLLDYD--------- 492 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~----~~ivH~Dlkp~NIll~~~--------- 492 (671)
|||||+++++|.++|... .....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.+
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999988542 223569999999999999999999998541 349999999999999642
Q ss_pred --------CCeEEeeccccccccCCCCccccccccccCCccchhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005893 493 --------MNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME--GLYSIKSDVFSFGVLLIEIITGRRNTGFNQ 562 (671)
Q Consensus 493 --------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~ 562 (671)
+.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~- 246 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA- 246 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC-
Confidence 348999999998653322 1223578999999999854 45889999999999999999999998532
Q ss_pred CCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 563 SRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 563 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....... ..+..+... .+ ...+ ..+.+++..||+.+|++||++.|++.
T Consensus 247 ------~~~~qli-~~lk~~p~l-----pi-~~~S----~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 ------NNFSQLI-SELKRGPDL-----PI-KGKS----KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ------CcHHHHH-HHHhcCCCC-----Cc-CCCC----HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1222222 122221110 00 1122 23667778999999999999999983
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.11 Aligned_cols=261 Identities=27% Similarity=0.370 Sum_probs=200.4
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG 422 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 422 (671)
....+..++++|+..+.||+|+||.||++... +++.+|+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455556788999999999999999999974 68899999986532 2245678899999998 899999999998754
Q ss_pred C-----eeeEEEeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeE
Q 005893 423 D-----EKLLVYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496 (671)
Q Consensus 423 ~-----~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 496 (671)
+ ..++|+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3 578999999999999987532 23456899999999999999999999987 99999999999999999999
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l 571 (671)
|+|||++......... .....|+..|+|||.+... .++.++||||||+++|||++|+.|+.... .
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~--------~ 238 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH--------P 238 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--------H
Confidence 9999998865432211 1234678899999987543 36889999999999999999999985321 1
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.....+. .........++ .. ....+.+++.+||+.+|++||++.|+++
T Consensus 239 ~~~~~~~-~~~~~~~~~~~---~~----~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 239 VKTLFKI-PRNPPPTLLHP---EK----WCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHHH-hcCCCCCCCcc---cc----cCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111111 11111111111 11 1234778888999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=321.42 Aligned_cols=201 Identities=23% Similarity=0.326 Sum_probs=163.2
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCC------CCeeeEeeEE
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH------KNLVKLLGFC 419 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~g~~ 419 (671)
+++...+++|++.++||+|+||+||++... +++.||||+++... ....++..|+.++.+++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 345556788999999999999999999864 57889999996532 223345667777777654 4588999988
Q ss_pred EcC-CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCC----
Q 005893 420 VDG-DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDM---- 493 (671)
Q Consensus 420 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~---- 493 (671)
... ...++|||++ +++|.+++. ..+.+++..+..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 765 4678899988 677777773 345689999999999999999999974 6 99999999999998765
Q ss_pred ------------CeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 494 ------------NPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 494 ------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 499999998754221 12346889999999999999999999999999999999999999964
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.52 Aligned_cols=196 Identities=28% Similarity=0.354 Sum_probs=165.5
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC------C
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 423 (671)
.++|+..+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467999999999999999999864 5889999998753 233345678999999999999999999987643 3
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 46899999975 5655552 23788899999999999999999988 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
+...... ......+|..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 8643321 12235789999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.13 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=194.4
Q ss_pred ccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 359 SNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
...||+|+||.||++... +++.||||.+..........+.+|+..+..++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999864 6889999998765555566789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
.+++.. +.+++..++.++.||+.||.|||+.+ |+||||||+||++++++.++|+|||++........ ....
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 177 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKS 177 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCce
Confidence 998732 34889999999999999999999988 99999999999999999999999999876433221 1223
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||.... ....... .... +.+.+....
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------~~~~~~~-~~~~-----~~~~~~~~~- 242 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--------PLQAMRR-IRDN-----LPPRVKDSH- 242 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHhc-----CCCcccccc-
Confidence 468899999999988889999999999999999999999985321 1111111 1111 111111100
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
.....+.+++.+|++.+|++|||++|+++.
T Consensus 243 -~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 -KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011235566779999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=292.65 Aligned_cols=250 Identities=26% Similarity=0.367 Sum_probs=192.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-----chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Cee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-----SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 425 (671)
++|+..+.||+|+||.||++... +++.|+||.+... .......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999999999999974 5889999987532 122345788899999999999999999988764 457
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
+++|||+++++|.+++. ..+.+++...++++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 79999999999999884 2345788899999999999999999988 99999999999999999999999999876
Q ss_pred ccCCCCc-cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 506 FAGSEGE-VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 506 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ..... .+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-------~~~~~-~~~~~~~-- 225 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE-------AMAAI-FKIATQP-- 225 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc-------hHHHH-HHHhcCC--
Confidence 5332111 11223468889999999988889999999999999999999999985321 11111 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+ ..+......+..++.+|+. +|++||+++||++
T Consensus 226 ---~~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ---TNP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CCC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011 1122223345666778884 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=301.27 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=193.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|...+.||+|+||.||++... +++.||+|.++... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45788899999999999999875 57899999986432 23334677899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
++ ++|..++.. ....+++..+..++.||+.||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 588887743 2345889999999999999999999988 99999999999999999999999999876432221
Q ss_pred ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH-----------HHHH
Q 005893 512 EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA-----------WHLW 579 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~-----------~~~~ 579 (671)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..... ....... |..+
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCChhhchhh
Confidence 11223568899999988654 578899999999999999999999863321 1111111 1110
Q ss_pred hcC-CccccccccccCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEG-NALDLIDPLLTDTC----SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~-~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... .....-.+.....+ .+.-...+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 00000001000000 0001123567888999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=298.19 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=197.9
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.||++... +++.|++|+++.. .......+.+|+.++++++|+||+++++++...+..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 6788899999999999999975 5789999998642 233346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
++++.+..++. ....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 82 VERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99888876652 3445899999999999999999999988 99999999999999999999999999887654432
Q ss_pred ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh----------
Q 005893 512 EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN---------- 580 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~---------- 580 (671)
. ......++..|+|||++... .++.++||||||+++|||++|+.||..... ....+....
T Consensus 156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 226 (288)
T cd07833 156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--------IDQLYLIQKCLGPLPPSHQ 226 (288)
T ss_pred c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCCCHHHh
Confidence 1 12235678899999999887 889999999999999999999998853211 111111100
Q ss_pred ----c-CCcc--cccccc----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 581 ----E-GNAL--DLIDPL----LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 581 ----~-~~~~--~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. .... +..+.. +...++......+.+++.+||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0 0000 000000 000011111345778888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=295.72 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=198.5
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc--CCeeeEEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVY 429 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ 429 (671)
+|+..+.||.|+||.||++... +++.|++|++... .....+.+.+|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999864 6789999998642 33445678899999999999999999998764 34578999
Q ss_pred eccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHH-----hCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 430 EFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLH-----EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 430 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
||+++++|.+++... .....+++..++.++.||+.||.||| +.+ ++|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988542 23457899999999999999999999 655 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
......... .....+++.|++||.+....++.++||||||+++|+|++|+.|+.... ..... +....+.
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~-~~~~~~~ 226 (265)
T cd08217 158 KILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLA-SKIKEGK 226 (265)
T ss_pred ccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHH-HHHhcCC
Confidence 876543321 223468899999999988889999999999999999999999986322 11111 1122221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
. +.+.. .....+.+++.+|++.+|++||++.+|++.
T Consensus 227 ~-----~~~~~----~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 F-----RRIPY----RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred C-----CCCcc----ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 11112 223457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=293.48 Aligned_cols=253 Identities=26% Similarity=0.441 Sum_probs=198.3
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc------hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS------EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
+|+..+.||+|++|.||++.. .+++.||+|+++... ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999986 568899999986432 1234578899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIF 506 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 506 (671)
|+||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999843 446889999999999999999999998 99999999999998776 5999999998766
Q ss_pred cCCCCcc--ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 507 AGSEGEV--NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 507 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
....... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ........+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~- 228 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASATT- 228 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhccCC-
Confidence 4432111 12234688899999999888899999999999999999999999853221 111111111111100
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+ ..+......+.+++.+|++.+|++||++.|++.
T Consensus 229 ----~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ----AP----SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ----CC----CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11 112222344777888999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=282.28 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=196.1
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcc--ccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLS--SCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++.|+..+.||+|.|+.||+... .+|+.+|+|++. +.+..+.+++.+|+.+.+.|+|||||++.....+....++|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 35677778999999999999875 579999999874 334457788999999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC---CCeEEeeccccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD---MNPKISDFGMARIF 506 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 506 (671)
|+|+|++|..-+. .+-..++..+-..++||+++|.|+|.++ |||||+||.|+++-+. --+||+|||++..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999865442 2345777788889999999999999998 9999999999999543 45899999999987
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... .....|||+|||||++...+|+..+|||+-|||||-|+.|.+||..... ..+ ++....+...
T Consensus 164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-----~rl----ye~I~~g~yd- 230 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRL----YEQIKAGAYD- 230 (355)
T ss_pred CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-----HHH----HHHHhccccC-
Confidence 63222 2236899999999999999999999999999999999999999964221 112 2222222210
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~ 626 (671)
+++.--+... ++ ..+++.+|+..||++|.|+.|.+
T Consensus 231 -~~~~~w~~is-~~---Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 231 -YPSPEWDTVT-PE---AKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred -CCCcccCcCC-HH---HHHHHHHHhccChhhhccHHHHh
Confidence 1111111222 23 44566699999999999999876
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.26 Aligned_cols=195 Identities=28% Similarity=0.412 Sum_probs=165.1
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC------C
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 423 (671)
.++|+..+.||+|+||.||++.. .+++.||||++.... ......+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 46788899999999999999986 467899999987532 22345677899999999999999999987643 3
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++++|++ +++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 94 ~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 468899988 788888763 345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 865332 223468999999999876 5689999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=293.87 Aligned_cols=252 Identities=30% Similarity=0.409 Sum_probs=199.9
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+|+..+.||+|++|.||++... +++.+++|++.... .....++.+|+.++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999975 58899999987543 344567889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
++++|.+++.... ..+++.....++.|++.||.|||+ .+ ++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999985322 568899999999999999999999 76 99999999999999999999999999875532211
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+..... ............... .. +.
T Consensus 157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-~~-----~~ 223 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---PPDGIFELLQYIVNE-PP-----PR 223 (265)
T ss_pred ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---ccccHHHHHHHHhcC-CC-----CC
Confidence 115678899999999888999999999999999999999999864322 112222222222111 11 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+... .....+.+++..||..+|++|||+.|++.
T Consensus 224 ~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 LPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111 01223667788999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.26 Aligned_cols=256 Identities=26% Similarity=0.359 Sum_probs=203.6
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEcc--ccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCC
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLS--SCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 423 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 423 (671)
+.+.+....|++.++||+||.+.||++...+.+.+|+|++. ..+.+...-|.+|+..|.+| .|.+||++++|-..++
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 34556677899999999999999999998888888988764 35566677799999999999 5999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
.+|+||||- .-+|..+|.. .......| .+..+..||+.++.++|+++ |||.||||-|+|+ -.|.+||+|||.+
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k-~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA 506 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKK-KKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIA 506 (677)
T ss_pred eEEEEeecc-cccHHHHHHh-ccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechh
Confidence 999999976 5789999854 22333445 67788899999999999998 9999999999998 5678999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCC-----------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHH
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGL-----------YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLL 572 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~ 572 (671)
.....+.........+||..||+||.+.... .++++||||+|||||+|+.|+.||.... +.
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~- 578 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQ- 578 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HH-
Confidence 9988887777667789999999999885432 5679999999999999999999996221 11
Q ss_pred HHHHHHHhcCCcccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 573 AYAWHLWNEGNALDLIDPLLT---DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
++ + +..+.||.-. ...++. ..+++++..||+.||++||++.||++
T Consensus 579 -~a-K------l~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 -IA-K------LHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HH-H------HHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11 1 1122232110 111111 12788889999999999999999985
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=294.38 Aligned_cols=260 Identities=26% Similarity=0.319 Sum_probs=198.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 429 (671)
++|...+.||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35778899999999999999974 57899999987532 23456789999999999999999999998654 3678999
Q ss_pred eccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
||+++++|.+++... .....+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876432 23455889999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. .....++..|++||.+.+..++.++||||||+++|||++|+.|+...... .....+... .........+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~-~~~~~~~~~~~ 229 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLS-YIVNMPNPELK 229 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHH-HHhcCCchhhc
Confidence 21 12345788899999999889999999999999999999999998754221 111112111 11111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+. ..... .....+.+++.+||+.+|++|||+.||++
T Consensus 230 ~~-~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 DE-PGNGI--KWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cC-CCCCC--chHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11 11000 11234678888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=291.47 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=198.6
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.||++... +++.|++|.++.... .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999864 688999999875433 3567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999984 3345889999999999999999999988 99999999999999999999999999887654332
Q ss_pred ccc--cccccccCCccchhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 512 EVN--TARIVGTYGYMAPEYAMEGL---YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 512 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
... .....++..|++||.+.... .+.++||||||+++|||++|+.||.... ......+.... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~-------~~~~~~~~~~~-~~--- 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------NEFQIMFHVGA-GH--- 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc-------chHHHHHHHhc-CC---
Confidence 211 12346788999999988766 8899999999999999999999985321 11111111111 11
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.+.... .....+.+++.+||+.+|++||++.|++.
T Consensus 224 --~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 --KPPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 00223567778999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=295.26 Aligned_cols=247 Identities=25% Similarity=0.439 Sum_probs=196.2
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc-chhchHHHHHHHHHHhhcC---CCCeeeEeeEEEcCCeeeEEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 429 (671)
.|+..+.||+|+||.||+|.. .+++.|++|.++.. ......++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999996 46889999998653 3344567889999999986 999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++.. +.+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998742 36899999999999999999999988 999999999999999999999999999876544
Q ss_pred CCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||..... ..... ..... .
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~-~~~~~-----~ 218 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMM-LIPKS-----K 218 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhh-ccccC-----C
Confidence 321 2234688899999988754 468999999999999999999999853211 11110 00011 1
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.+.... ....+.+++.+||+.+|++||++.|++.
T Consensus 219 ~~~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 PPRLEDNG---YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11121111 1234667788999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=296.40 Aligned_cols=261 Identities=25% Similarity=0.331 Sum_probs=197.2
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|++.+.||+|+||.||++... +|+.|++|++.... ......+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999974 68899999987533 33345788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+ +++|.+++... ...+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999988542 356999999999999999999999988 99999999999999999999999999887644322
Q ss_pred ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC-------
Q 005893 512 EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN------- 583 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~------- 583 (671)
.......++..|+|||.+.+. .++.++||||+|+++|||++|+.+|.... ................
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-----DIEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-----HHHHHHHHHHHcCCCChHHHhhc
Confidence 112235688999999988654 46899999999999999999977764221 1111111111111000
Q ss_pred -----cccccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 -----ALDLIDPLLT----DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 -----~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.....+.-. ....++....+.+++.+|++.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0000112245778888999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=307.46 Aligned_cols=239 Identities=23% Similarity=0.266 Sum_probs=183.3
Q ss_pred cCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc---CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
||+|+||.||+++.. +++.||||++.... ......+..|..++..+ +||||+++++.+.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999964 58899999986422 12233445566666654 799999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|..++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 99988884 3456899999999999999999999998 99999999999999999999999999875433221 1
Q ss_pred cccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 515 TARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
.....||+.|+|||.+.+. .++.++|||||||++|||++|+.||... +..+.. +....+.. .+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~--------~~~~~~-~~i~~~~~------~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE--------DTQQMY-RNIAFGKV------RFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC--------CHHHHH-HHHHcCCC------CCC
Confidence 2345799999999998764 4899999999999999999999998532 112211 12222111 111
Q ss_pred C-CCCHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 005893 594 D-TCSPDEFLRYIHIGLLCVQEDAFDRP----TMSSVVV 627 (671)
Q Consensus 594 ~-~~~~~~~~~l~~l~~~Cl~~~p~~RP----t~~ev~~ 627 (671)
. ..+ + .+.+++.+||+.||++|| ++.|+++
T Consensus 218 ~~~~~-~---~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLS-D---EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCC-H---HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1 122 2 245677799999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=289.48 Aligned_cols=252 Identities=28% Similarity=0.410 Sum_probs=203.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch-hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||+|++|.||+++.. +++.|++|++..... .....+.+|+..+.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999976 489999999876443 4456799999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
+++++|.+++.. ...+++..++.++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999843 3668999999999999999999999 87 9999999999999999999999999988764433
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
... ....++..|+|||.+....++.++||||||+++|||++|+.|+..... ....+...... .... +
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~-~~~~-----~ 221 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAIC-DGPP-----P 221 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHh-cCCC-----C
Confidence 221 234678899999999988999999999999999999999999854321 11222111111 1111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.... ....+.+++.+|++.+|++||++.|+++
T Consensus 222 ~~~~~~---~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 222 SLPAEE---FSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCccc---CCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111110 2234777888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.00 Aligned_cols=250 Identities=26% Similarity=0.310 Sum_probs=203.6
Q ss_pred hCCCCcccccCCCCcccEEEEEecC-CceEEEEEccccch---hchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSE---QGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 427 (671)
...|+..+.||+|.||.||+++.+. |+.+|+|++.+... .....+.+|+.+|+++. |||||.+.+.+.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 3567778899999999999999764 99999999976433 24468999999999998 9999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC----CCeEEeecccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD----MNPKISDFGMA 503 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla 503 (671)
|||++.+|.|.+.+... .+++..+..++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999988543 3999999999999999999999988 9999999999999643 57999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||...... .... ....++
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~----~~~~-----~i~~~~ 254 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF----EIFL-----AILRGD 254 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh----HHHH-----HHHcCC
Confidence 98765 22344579999999999999999999999999999999999999999643321 0111 222222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+ .+.....+......-+++..++..||.+|+|+.++++
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 2 1112222222333556667999999999999999998
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.29 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=199.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|...+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999864 67899999987554455567899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999998842 34789999999999999999999998 999999999999999999999999998765433221
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....+++.|++||.+..+.++.++||||||+++||+++|+.||...... .........+.. .+
T Consensus 172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--------~~~~~~~~~~~~------~~ 235 (293)
T cd06647 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------RALYLIATNGTP------EL 235 (293)
T ss_pred --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--------hheeehhcCCCC------CC
Confidence 12346788999999998888999999999999999999999999643211 000001111110 00
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
. .+......+.+++..||+.+|++||++.+++..
T Consensus 236 ~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 Q--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011112246677889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=288.70 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=197.0
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.||++... +++.+|+|.+... .......+.+|+.++++++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 6789999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~ 510 (671)
+++++|.+++.. .....+++..+..++.|++.||.|||+++ ++|+||+|+||+++++ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999854 22445899999999999999999999988 9999999999999865 468999999998654332
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. .....++..|+|||.+....++.++||||||+++|+|++|+.||.... ......... .+....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~~~-~~~~~~---- 220 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLKIM-SGTFAP---- 220 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHHHH-hcCCCC----
Confidence 1 223467889999999988889999999999999999999999985321 111111111 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+....++ .+.+++..||+.+|++|||+.|+++
T Consensus 221 -~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 -ISDRYSP----DLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -CCCCcCH----HHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112222 3667888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=298.13 Aligned_cols=253 Identities=21% Similarity=0.231 Sum_probs=197.8
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch---hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE---QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|++|.||++... +++.||+|.+..... .....+.+|++++..++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999975 488999999875332 24456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+.+++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998853 23456899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCcc---------------------------ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005893 510 EGEV---------------------------NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQ 562 (671)
Q Consensus 510 ~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~ 562 (671)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 1112467889999999998889999999999999999999999985322
Q ss_pred CCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 005893 563 SRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT----MSSVVV 627 (671)
Q Consensus 563 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt----~~ev~~ 627 (671)
. .......... .. .+... ......+.+++.+||+.+|++||+ +.|++.
T Consensus 237 ~--------~~~~~~~~~~-~~------~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 R--------DETFSNILKK-EV------TFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred h--------HHHHHHHhcC-Cc------cCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 1111111111 10 00000 002234677888999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=295.27 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=196.9
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+..+.+++||||+++++++..+...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 666788999999999999864 67899999886432 3344578899999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|..++. ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 999999883 245889999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+.... ....... ...+.. +.+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~-----~~~~ 222 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--------PMKVLFL-IPKNNP-----PTLE 222 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--------hHHHHHH-HhcCCC-----CCCC
Confidence 1223467889999999988889999999999999999999999985321 1111111 111111 1122
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
...+ ..+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~----~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYS----KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2222 336678889999999999999999983
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=297.76 Aligned_cols=258 Identities=27% Similarity=0.433 Sum_probs=197.9
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc-
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD- 421 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 421 (671)
++.++....+.|+..+.||+|+||.||+|... +++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555556778999999999999999999974 67899999886533 3345688899999998 79999999999863
Q ss_pred -----CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeE
Q 005893 422 -----GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496 (671)
Q Consensus 422 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 496 (671)
....+++|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 35678999999999999988542 2345788889999999999999999988 99999999999999999999
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l 571 (671)
|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||...... ...
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~----~~~ 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM----RAL 235 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH----hhh
Confidence 999999875532221 122356889999999875 346788999999999999999999998532110 000
Q ss_pred HHHHHHHHhcCCccccccccc-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 572 LAYAWHLWNEGNALDLIDPLL-TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... ... .+.+ ...++ ..+.+++.+||+.||++||++.||++
T Consensus 236 ----~~~~-~~~-----~~~~~~~~~~----~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ----FLIP-RNP-----PPKLKSKKWS----KKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----hhHh-hCC-----CCCCcccccC----HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 000 1111 11222 24677888999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=287.48 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=202.7
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeEEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVY 429 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 429 (671)
+|...+.||+|++|.||+|... +++.|++|++..... .....+.+|+.++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4667789999999999999976 688999999875442 4566789999999999999999999999988 8899999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999853 337999999999999999999999987 999999999999999999999999998876554
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
..........++..|++||.+.....+.++||||||+++++|++|+.||.... +.....++........
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~---- 223 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSSGEPP---- 223 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhccccCCCc----
Confidence 32111233567889999999988889999999999999999999999986432 2222222222111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+... ....+.+++.+|++.+|++||++.|++.
T Consensus 224 -~~~~~----~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 224 -EIPEH----LSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -CCCcc----cCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111 1334677888999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=294.53 Aligned_cols=199 Identities=28% Similarity=0.436 Sum_probs=167.5
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|++|.||+++.. +|+.|+||+++... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999874 68899999886432 22335788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+. ++|..++.. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 678887754 23456899999999999999999999988 99999999999999999999999999876533221
Q ss_pred ccccccccccCCccchhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||..
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 122235678899999876544 68899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.01 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=193.4
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch-hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||+|++|.||++... +++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999975 688999999865332 2234567899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++ +|.+++.. ....+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 984 88888753 2346889999999999999999999988 99999999999999999999999999875432111
Q ss_pred ccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc----
Q 005893 512 EVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD---- 586 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~---- 586 (671)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ........+..........
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD----VEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHhcCCCChhhhhhh
Confidence 1112346788999998865 4588999999999999999999999853221 0011111111111100000
Q ss_pred -----ccc--------ccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 -----LID--------PLLTDTC-SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 -----~~d--------~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... ..+.... .......+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000 0001145678888999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=288.41 Aligned_cols=266 Identities=24% Similarity=0.376 Sum_probs=219.5
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEee
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLG 417 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g 417 (671)
...++.+...++....++-+|.||.||+|++. +.+.|.+|.++. .++-....+..|..++..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 45567777788888899999999999999764 345788898875 44455667889999999999999999999
Q ss_pred EEEcC-CeeeEEEeccCCCchhhhhc-----CCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC
Q 005893 418 FCVDG-DEKLLVYEFMPNSSLDAILF-----DPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY 491 (671)
Q Consensus 418 ~~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 491 (671)
++.+. ...++++.++.-|+|..+|. +......++..+...++.|++.|++|||+++ +||.||..+|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 98765 45789999999999999997 4455566888888999999999999999998 999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005893 492 DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPN 570 (671)
Q Consensus 492 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 570 (671)
..++||+|=.++|.+.+.+.+........+..||+||.+.+..|+..+|||||||+||||+| |+.|+..-++
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------- 504 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------- 504 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------
Confidence 99999999999999999999887777778889999999999999999999999999999999 8988853221
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.+ ....+++|.... . .-+++. ++..++.-||...|++||+.++++.-|.+
T Consensus 505 -fE-m~~ylkdGyRla--Q---P~NCPD----eLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 505 -FE-MEHYLKDGYRLA--Q---PFNCPD----ELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -HH-HHHHHhccceec--C---CCCCcH----HHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11 223344443211 1 113333 36778889999999999999999988865
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=288.02 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=202.5
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
|.+.++||+|+||.|||++++ .|+.+|||.+.- +.+.+++..|+.++++-+.|++|+++|.+.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556789999999999999975 699999998865 34667899999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+..+++. ..++++++.++..+++..++||+|||... -||||||..||||+.+|.+||+|||.+..+... ...
T Consensus 113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAK 185 (502)
T KOG0574|consen 113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAK 185 (502)
T ss_pred CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HHh
Confidence 99999985 35677999999999999999999999876 899999999999999999999999999876432 223
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
...+.||+.|||||++..-.|..++||||||+...||..|++||..-++-... . +.....+ |.++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------F-MIPT~PP-----PTF~- 250 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------F-MIPTKPP-----PTFK- 250 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------E-eccCCCC-----CCCC-
Confidence 34578999999999999999999999999999999999999999754332100 0 0000011 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.+....+-+.+..|+-.+|++|-|+.++++
T Consensus 251 -KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 251 -KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 12223345667777999999999999988765
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=298.80 Aligned_cols=204 Identities=26% Similarity=0.408 Sum_probs=167.6
Q ss_pred CCCcccccCCCCcccEEEEEec---CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Ceee
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS---DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKL 426 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 426 (671)
.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999974 47899999997633 33345678899999999999999999999988 7889
Q ss_pred EEEeccCCCchhhhhcCC-CC-CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC----CCCeEEeec
Q 005893 427 LVYEFMPNSSLDAILFDP-RK-RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY----DMNPKISDF 500 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~-~~-~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 500 (671)
+||||+++ +|..++... .. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 555555322 22 236889999999999999999999988 999999999999999 899999999
Q ss_pred cccccccCCCC-ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 005893 501 GMARIFAGSEG-EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQ 562 (671)
Q Consensus 501 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~ 562 (671)
|+++....... ........++..|+|||.+.+. .++.++||||||++++||++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99886543322 1122335678899999988664 57899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.68 Aligned_cols=246 Identities=29% Similarity=0.419 Sum_probs=192.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
+.|+..+.||+|+||.||+|... +++.||+|++.... .....++.+|+++++.++||||+++.+++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999974 68899999986432 233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||++ |+|.+++.. ..+.+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 566565532 2346899999999999999999999988 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
....++..|+|||.+. .+.++.++||||||+++|||++|+.|+... +............ .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~--------~~~~~~~~~~~~~-~-- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQND-S-- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc--------cHHHHHHHHhcCC-C--
Confidence 1245788899999874 456889999999999999999999998422 1111111111111 1
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
+.+.. ......+.+++.+||+.+|++||++.+|+..
T Consensus 232 ---~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ---PTLSS---NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCCCc---hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11111 1122346778889999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=296.90 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=191.3
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.||+++.. +|+.|++|+++... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999974 68899999986422 22234677899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++ +|.+++.. ..+.+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 974 67666632 2456899999999999999999999988 99999999999999999999999999886533221
Q ss_pred ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC------c
Q 005893 512 EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN------A 584 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~------~ 584 (671)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+..... .........+...... .
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC----HHHHHHHHHHHhCCCChHHhHHh
Confidence 1 1224568899999988764 478999999999999999999988632111 1111111110000000 0
Q ss_pred ccccc----ccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLID----PLLTDTC-----SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d----~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+ +...... .+.-...+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 0000000 0111234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=292.56 Aligned_cols=250 Identities=27% Similarity=0.363 Sum_probs=190.3
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHH-HhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|++.+.||+|+||.||+++.. +|+.||+|+++... ......+..|+.. ++.++||||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999975 68999999987532 2233455566665 556789999999999999999999999
Q ss_pred ccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 431 FMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 431 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|++ ++|.+++... .....+++..++.++.||+.||.|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6787776432 2345689999999999999999999986 6 99999999999999999999999999886533
Q ss_pred CCCccccccccccCCccchhhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAME----GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
.. ......++..|+|||.+.. ..++.++|+||||+++|||++|+.||..... . ........ .+..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~-~~~~~~~~-~~~~ 225 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------P-FQQLKQVV-EEPS 225 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------C-HHHHHHHH-hcCC
Confidence 21 1122467889999998754 4568899999999999999999999853211 1 11111111 1111
Q ss_pred ccccccccc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLT-DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.+. ..++ ..+.+++.+||+.+|++||++.+|++
T Consensus 226 -----~~~~~~~~~----~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 -----PQLPAEKFS----PEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----CCCCccccC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1122 23667777999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.62 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=196.4
Q ss_pred CCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 356 FSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
|...+.||+|++|.||++.. .+++.+++|++..........+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999986 46889999998755545556788999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999998843 45889999999999999999999988 99999999999999999999999998875433221 1
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||... +........ ..........+ .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~--------~~~~~~~~~-~~~~~~~~~~~---~ 239 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--------PPLQAMKRI-RDNLPPKLKNL---H 239 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC--------CHHHHHHHH-HhcCCCCCccc---c
Confidence 22346889999999998888999999999999999999999998432 111111111 11111111000 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+ ..+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~----~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVS----PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCC----HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 122 34677888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.58 Aligned_cols=243 Identities=28% Similarity=0.342 Sum_probs=196.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999975 58899999986422 233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999984 3456899999999999999999999988 999999999999999999999999998875433
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||.... ... ..+....+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~-~~~~~~~~~~----- 215 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQ-IYEKILEGKV----- 215 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHH-HHHHHhcCCc-----
Confidence 223468899999999988888999999999999999999999985321 111 1111111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVV 626 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~ 626 (671)
.+....+ ..+.+++.+||+.+|++|| +++|++
T Consensus 216 -~~~~~~~----~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 216 -RFPSFFS----PDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -cCCccCC----HHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1112222 3456777899999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=287.68 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=197.5
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.||++... +|..+|+|.+... .......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999975 5789999998642 223445788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 510 (671)
+++++|.+++.. .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINR-QRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999998854 22335799999999999999999999988 99999999999999885 46999999988664332
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
.. .....|++.|+|||.+....++.++||||||+++|||++|+.|+... +..+....... +.. .+
T Consensus 157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~-~~~----~~ 221 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--------NLHQLVLKICQ-GYF----AP 221 (257)
T ss_pred cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHhc-ccC----CC
Confidence 11 12246888999999998888999999999999999999999998422 22222222211 111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+....+ ..+.+++.+|++.+|++|||+.||+.
T Consensus 222 -~~~~~~----~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 -ISPNFS----RDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCC----HHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111122 24667788999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=287.84 Aligned_cols=270 Identities=21% Similarity=0.235 Sum_probs=212.7
Q ss_pred CCCcccccCCCCcccEEEEEecC-CceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.|+..+.||.|.-|+||++.+.+ +..+|+|++.+.. .+.......|-++|+.++||.++.|++.+..++..+|+||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45557889999999999999864 5889999997632 3344567789999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC-
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS- 509 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~- 509 (671)
||+||+|..+++ .+..+.+++..++-++.+|+-||+|||-.| ||.|||||+||||.++|++-|+||.|+......
T Consensus 158 yCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999998874 366778999999999999999999999998 999999999999999999999999987532110
Q ss_pred --------------------------------CCc---------------------cccccccccCCccchhhhccCCCC
Q 005893 510 --------------------------------EGE---------------------VNTARIVGTYGYMAPEYAMEGLYS 536 (671)
Q Consensus 510 --------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~s 536 (671)
... ......+||-.|+|||++.+.-.+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 001125899999999999999999
Q ss_pred cchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCC
Q 005893 537 IKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDA 616 (671)
Q Consensus 537 ~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p 616 (671)
.++|+|+|||++|||+.|+-||...... +.+...+. + .. .+.+. ++-...+.+++...|..||
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~----~Tl~NIv~----~--~l-----~Fp~~--~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK----ETLRNIVG----Q--PL-----KFPEE--PEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCch----hhHHHHhc----C--CC-----cCCCC--CcchhHHHHHHHHHhccCh
Confidence 9999999999999999999999643321 12222111 1 11 11111 1223456678889999999
Q ss_pred CCCCC----HHHHHH--HhcCCCCCCCCCCCCccc
Q 005893 617 FDRPT----MSSVVV--MLQGETITLCQPQKPAFS 645 (671)
Q Consensus 617 ~~RPt----~~ev~~--~L~~~~~~~~~p~~p~~~ 645 (671)
++|-. +.||.+ ++++.++.+-.-.+|++.
T Consensus 377 ~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~i 411 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEI 411 (459)
T ss_pred hhhhccccchHHhhcCccccCCChhheeccCCCcC
Confidence 99998 899987 678888887666666664
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=286.83 Aligned_cols=249 Identities=30% Similarity=0.468 Sum_probs=200.7
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999975 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|.+++... ...+++..+..++.|++.+|.+||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999988532 256899999999999999999999987 99999999999999999999999999887654332
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
.....++..|++||.+.....+.++||||||+++++|++|+.|+.... ......... .........+.
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~~~~~~-- 221 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP--------PMKALFKIA-TNGPPGLRNPE-- 221 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc--------hHHHHHHHH-hcCCCCcCccc--
Confidence 234568889999999988889999999999999999999999985321 111111111 11111111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+ ...+.+++..||+.+|++|||+.|+++
T Consensus 222 -~~----~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 -KW----SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -cc----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01 234667788999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=294.38 Aligned_cols=265 Identities=23% Similarity=0.308 Sum_probs=194.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 428 (671)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999975 588999999874332 2223567899999999999999999998877 789999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
+||++ ++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 488887743 2236899999999999999999999988 99999999999999999999999999887654
Q ss_pred CCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHH-------HHHHHHHh
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLL-------AYAWHLWN 580 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~-------~~~~~~~~ 580 (671)
.... .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||....... ....+. ...|..+.
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhh
Confidence 3211 1224568889999988654 46899999999999999999999986322110 000000 00011110
Q ss_pred c------CCccccccccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 581 E------GNALDLIDPLLTDTCSPD-EFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 581 ~------~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. ..........+...++.. ....+.+++..||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000001011111111111 1234667888999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.22 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=200.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++.|+..+.||+|++|.||++... +++.|++|++..... ....+.+|+++++.++|+|++++++.+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4456777889999999999999986 688999999976443 45678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999985422 37999999999999999999999987 9999999999999999999999999887554322
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ......++..|++||.+.+..++.++||||||+++|+|++|+.|+..... ........ ........++
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~~~~~~ 239 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLIT-TKGIPPLKNP 239 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hcCCCCCcch
Confidence 1 11224578899999999888899999999999999999999999853211 11111111 1111111000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..++ ..+.+++.+|++.+|.+||++.+|++
T Consensus 240 ---~~~~----~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 ---EKWS----PEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---hhCC----HHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0112 34667888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=290.68 Aligned_cols=254 Identities=25% Similarity=0.399 Sum_probs=197.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCC------
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~------ 423 (671)
++++|+..+.||+|++|.||++... +++.+++|++..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 5678999999999999999999975 578899999875433 345789999999999 7999999999997644
Q ss_pred eeeEEEeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999999885422 2456899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAME-----GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
+........ ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||..... .....+
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~ 229 (275)
T cd06608 160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--------MRALFK 229 (275)
T ss_pred ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--------HHHHHH
Confidence 876533221 1223468889999998753 3467899999999999999999999853211 111111
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. ..+... .+. .+......+.+++.+||..||++|||+.||++
T Consensus 230 ~-~~~~~~-----~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 I-PRNPPP-----TLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred h-hccCCC-----CCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 111111 111 01112234667888999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=293.18 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=195.9
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccch-hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+|+..+.||+|++|.||+|+.. +|+.||||+++.... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5778899999999999999975 688999999875432 23456778999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++ +|.+++........+++..+..++.||+.||.|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78877754444456899999999999999999999988 99999999999999999999999999875533211
Q ss_pred cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC--------
Q 005893 513 VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN-------- 583 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~-------- 583 (671)
......++..|++||.+.+. .++.++||||||+++|||++|+.||...... ..............
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-----DQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHHhCCCChhhHHHHh
Confidence 11224568889999988654 5789999999999999999999998643211 11111111100000
Q ss_pred ccccccccccC-------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTD-------TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
........+.. ...+.....+.+++.+|++.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000 000111234678888999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.19 Aligned_cols=248 Identities=25% Similarity=0.405 Sum_probs=195.7
Q ss_pred ccccCCCCcccEEEEEec-CCceEEEEEcc--c--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe--eeEEEec
Q 005893 359 SNMLGQGGFGPVYKGVLS-DGKEIAVKRLS--S--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE--KLLVYEF 431 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e~ 431 (671)
..+||+|+|-+||||... +|.+||--.++ . .+....+.|..|+.+|+.|+||||++++..+.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467999999999999974 57777654332 1 234455789999999999999999999999998766 6789999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~ 510 (671)
+..|+|..|+. +.+.++...+..|++||++||.|||++. ++|||||||-+||+|+.+ |.+||+|+|||.......
T Consensus 125 ~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999984 4455788899999999999999999986 789999999999999865 899999999999865443
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ....|||.|||||... ..|.+..||||||+.++||+|+..||. .-.+..+ .++....|.....+.+
T Consensus 201 a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-------EC~n~AQ-IYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 201 A----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-------ECTNPAQ-IYKKVTSGIKPAALSK 267 (632)
T ss_pred c----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-------hhCCHHH-HHHHHHcCCCHHHhhc
Confidence 2 2368999999999876 789999999999999999999999985 2233333 3344444433322222
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGE 632 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~ 632 (671)
--.| + +.+++.+|+.. .++|||+.|++. +|...
T Consensus 268 ----V~dP-e---vr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 ----VKDP-E---VREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----cCCH-H---HHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1122 2 55677799998 999999999986 55543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=294.02 Aligned_cols=201 Identities=27% Similarity=0.427 Sum_probs=166.7
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++++|...+.||+|+||.||+|... +++.|++|+++... ......+.+|+.+++.++|+||+++.+++..+...++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3467888999999999999999864 68899999986533 222346788999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+. ++|..++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++++||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 566655532 2345788889999999999999999988 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 111 1223568899999988654 578899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=293.94 Aligned_cols=257 Identities=17% Similarity=0.164 Sum_probs=181.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEecC----CceEEEEEccccchhch-----------HHHHHHHHHHhhcCCCCeeeEe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSCSEQGN-----------AEFTNEVLLILKLQHKNLVKLL 416 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~ 416 (671)
..++|++.++||+|+||.||+|...+ +..+++|+......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 44678899999999999999999754 34566665432221110 1122333445667899999999
Q ss_pred eEEEcCC----eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC
Q 005893 417 GFCVDGD----EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD 492 (671)
Q Consensus 417 g~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 492 (671)
+++.... ..++++|++.. ++.+.+. .....++..+..|+.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9766544 33677777643 5555542 2233578888999999999999999988 9999999999999999
Q ss_pred CCeEEeeccccccccCCCCc-----cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 005893 493 MNPKISDFGMARIFAGSEGE-----VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT 567 (671)
Q Consensus 493 ~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 567 (671)
+.++|+|||+++.+...... .......||+.|+|||...+..++.++||||||+++|||++|+.||......
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--- 239 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--- 239 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc---
Confidence 99999999999876432211 1112246999999999999999999999999999999999999999643211
Q ss_pred CCCHHHHHH----HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 568 APNLLAYAW----HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 568 ~~~l~~~~~----~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
..+..... .....+.. ..... + ..+.+++..|++.+|++||++.++++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~-------~~~~~-~---~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 -GNLIHAAKCDFIKRLHEGKI-------KIKNA-N---KFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -hHHHHHhHHHHHHHhhhhhh-------ccCCC-C---HHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11111111 11111110 01112 2 33566777999999999999999998874
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.45 Aligned_cols=247 Identities=27% Similarity=0.294 Sum_probs=198.0
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
+|+..+.||.|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999975 58899999987532 2345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|..++.. ...+++..+..++.||++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999999843 357899999999999999999999988 9999999999999999999999999988654432
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........... . .+
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~--~----~~ 219 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET--A----DV 219 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc--c----cc
Confidence 122346788999999998888999999999999999999999998643221 11111111111 0 01
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM--SSVV 626 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~--~ev~ 626 (671)
......+ ..+.+++.+||+.+|++||+. +|++
T Consensus 220 ~~~~~~~----~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWS----TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCc----HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111122 446677889999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.53 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=192.0
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
|+..+.||+|++|.||+|... +|+.|++|++.... ......+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566788999999999999864 68999999986432 223356889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
+ ++|.+++... ....+++..++.++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 6888887432 2246899999999999999999999987 999999999999999999999999998765332211
Q ss_pred cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC---------
Q 005893 513 VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG--------- 582 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~--------- 582 (671)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+... .+.....
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~ 228 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRI-FRTLGTPDEDVWPGVT 228 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-HHHhCCCChHHhhhhh
Confidence 1223568889999987654 5789999999999999999999998532210 001110 0000000
Q ss_pred Ccccccc-------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NALDLID-------PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+... .... ...+.....+.+++.+|++.+|++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 229 SLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 0000 001111134678888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=292.66 Aligned_cols=262 Identities=26% Similarity=0.333 Sum_probs=191.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 427 (671)
.++|++.+.||+|+||.||++... +|+.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457888999999999999999974 589999999864322 2223466899999999999999999998765 45799
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++ +|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999964 78777743 2356899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC----
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG---- 582 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~---- 582 (671)
..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ..............
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-----IEQLDLIIQLLGTPNESI 232 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCChhh
Confidence 33211 122345788999998865 4578999999999999999999999853211 11111111110000
Q ss_pred -------Ccccccc---ccccC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 -------NALDLID---PLLTD--TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 -------~~~~~~d---~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.....+. ..+.. .........+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 00000 000001233567888999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.30 Aligned_cols=253 Identities=28% Similarity=0.412 Sum_probs=190.6
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999864 58899999987532 234557889999999996 99999999999999899999999
Q ss_pred cCCCchhhhhcC--CCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 432 MPNSSLDAILFD--PRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 432 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
+.. +|.++... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 54443211 12335689999999999999999999975 5 99999999999999999999999999876543
Q ss_pred CCCccccccccccCCccchhhhccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEG---LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
... .....|+..|+|||.+... .++.++||||||+++|||++|+.||.... .......+... +..
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~-~~~- 228 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVK-GDP- 228 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcC-CCC-
Confidence 221 1223678899999998766 68999999999999999999999985321 11121111111 111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.+...........+.+++.+||+.+|++|||+.||++
T Consensus 229 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 229 ----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred ----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111111112234677888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.50 Aligned_cols=260 Identities=23% Similarity=0.338 Sum_probs=194.1
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeEEEe
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLVYE 430 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 430 (671)
|++.+.||+|++|.||+++.. +++.+|+|++.... ......+.+|+.++++++|+|++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999975 58899999997642 33345688999999999999999999999988 78999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++ +|..++... ...+++..++.++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 888877432 246899999999999999999999988 9999999999999999999999999998765433
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC------
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN------ 583 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~------ 583 (671)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..............
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-----EQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchhhccc
Confidence 21 1223456788999997764 45789999999999999999999998532211 11111111000000
Q ss_pred -----------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 -----------ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 -----------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
........+...........+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000000001345788899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=320.32 Aligned_cols=264 Identities=29% Similarity=0.413 Sum_probs=208.8
Q ss_pred hHHHHhCCCCcccccCCCCcccEEEEEec----C----CceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEee
Q 005893 348 TLDVATSNFSDSNMLGQGGFGPVYKGVLS----D----GKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLG 417 (671)
Q Consensus 348 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g 417 (671)
.++...++..+.+.||+|.||.|++|... . ...||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 34445555566679999999999999853 1 357999999853 335667899999999998 7999999999
Q ss_pred EEEcCCeeeEEEeccCCCchhhhhcCCC-----CC--------CCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCC
Q 005893 418 FCVDGDEKLLVYEFMPNSSLDAILFDPR-----KR--------GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKA 484 (671)
Q Consensus 418 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp 484 (671)
+|.+.+..++|+||+..|+|..+|...+ .. ..++..+.+.++.|||.||+||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999997644 00 24889999999999999999999987 99999999
Q ss_pred CcEEEcCCCCeEEeeccccccccCCCCcccc-ccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 005893 485 SNVLLDYDMNPKISDFGMARIFAGSEGEVNT-ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQ 562 (671)
Q Consensus 485 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~ 562 (671)
+|||+.++..+||+|||+++........... ....-...|||||.+....|+.|+|||||||+||||+| |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999976554433211 11113457999999999999999999999999999999 888885311
Q ss_pred CCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 563 SRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 563 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..... ++.+++|...+. +....+ ++.++++.||+.+|++||+..|+++.|+.
T Consensus 527 -------~~~~l-~~~l~~G~r~~~------P~~c~~---eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 527 -------PTEEL-LEFLKEGNRMEQ------PEHCSD---EIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred -------cHHHH-HHHHhcCCCCCC------CCCCCH---HHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11122 445555544332 122223 35578889999999999999999999987
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=301.34 Aligned_cols=194 Identities=26% Similarity=0.375 Sum_probs=167.0
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC-C-----CCeeeEeeEEEcCCeeeE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-H-----KNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 427 (671)
+|++.++||+|.||.|-++.. .+++.||||+++..... ..+...|+.+|..|+ | -|+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999986 46899999999875432 345678999999996 4 489999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC--CCeEEeecccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD--MNPKISDFGMARI 505 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~ 505 (671)
|+|.+ ..+|.++|...+. ..++...++.|+.||+.||.+||+.+ |||+||||+||||.+. -.+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 5789999976443 45999999999999999999999998 9999999999999754 4799999999986
Q ss_pred ccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
....-. ...-+..|+|||++.+.+|+.+.|+||||||+.||++|.+-|.
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 432211 3455778999999999999999999999999999999987775
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=290.62 Aligned_cols=263 Identities=23% Similarity=0.304 Sum_probs=191.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCe-----
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDE----- 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~----- 424 (671)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888899999999999999974 68899999876432 22335678899999999 46999999999887665
Q ss_pred eeEEEeccCCCchhhhhcCCCC--CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeecc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRK--RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFG 501 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg 501 (671)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 78777753221 356899999999999999999999988 999999999999998 8999999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
+++.+...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+... ...+.
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~-~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHI-FKLLG 229 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHH-HHHhC
Confidence 98765332111 122356788999998865 4578999999999999999999999853211 0111110 00000
Q ss_pred cCCc---c---cccc----cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 581 EGNA---L---DLID----PLLT----DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 581 ~~~~---~---~~~d----~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... . +..+ +... ....+.....+.+++.+||+.||++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0 0000 0000 0000111234678888999999999999999884
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=291.28 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=199.9
Q ss_pred CCcccccCCCCcccEEEEEe-cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 356 FSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
|...+.||+|.|..|-++++ =+|..||||++.+.. ......+.+|++-|+.++|||||+++.+......+|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 55567899999999999884 379999999998643 333456889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE-cCCCCeEEeeccccccccCCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL-DYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
++|+|.++|.. ....+.+....+++.||+.|+.|+|+.. +|||||||+||.+ ..-|-+||.|||++..+.+.+.
T Consensus 100 D~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 100 DGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred CCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999854 3345899999999999999999999987 9999999999865 5668999999999987766542
Q ss_pred ccccccccccCCccchhhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYS-IKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
....||...|-|||++.+..|. ++.||||||||||.|++|+.||...... + .+.-++|-
T Consensus 175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----E-------------TLTmImDC 234 (864)
T KOG4717|consen 175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----E-------------TLTMIMDC 234 (864)
T ss_pred ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----h-------------hhhhhhcc
Confidence 3346999999999999998886 6899999999999999999999643211 1 11112222
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. ..+..--.++.+++..|++.||++|.+.+||+.
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 11 123333446888888999999999999999985
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=287.23 Aligned_cols=242 Identities=25% Similarity=0.325 Sum_probs=191.7
Q ss_pred cCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
||.|++|.||+++.. +++.+++|++.... ......+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999975 48899999986432 23345789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345899999999999999999999988 9999999999999999999999999998764432 1223
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..++..|++||.+....++.++|+||||+++|||++|+.|+..... +............. ........
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-----~~~~~~~~- 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNG-----KLEFPNYI- 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCC-----CCCCCccc-
Confidence 4678899999999888899999999999999999999999864321 11121111111000 01111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
...+.+++.+||+.+|++||+ +.|+++
T Consensus 220 ---~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 ---DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 234678888999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=285.49 Aligned_cols=247 Identities=24% Similarity=0.295 Sum_probs=194.9
Q ss_pred cCCCCcccEEEEEec-CCceEEEEEccccch---hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE---QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
||+|+||.||+++.. +|+.+++|++..... .....+.+|++++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 489999999875332 3455788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC------
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG------ 511 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~------ 511 (671)
.+++.. .+.+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999843 336899999999999999999999988 99999999999999999999999999876433321
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
........++..|++||.......+.++||||||+++|||++|+.||.... ........ ..+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~~------ 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNI-LNGKIE------ 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHH-hcCCcC------
Confidence 112233567889999999988889999999999999999999999985322 11111111 111110
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..... .....+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 220 ~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00000 012346678889999999999999777777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=280.01 Aligned_cols=247 Identities=31% Similarity=0.449 Sum_probs=199.5
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|++|.||+++.. +++.|++|.+..... .....+.+|++++.+++|+|++++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 578999999976543 4556789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998843 356899999999999999999999988 99999999999999999999999999987654332
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
. .....++..|++||.......+.++||||||+++|+|++|+.|+.... -....+...... .+.
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~------~~~ 218 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--------PMAALFRIVQDD------HPP 218 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhccC------CCC
Confidence 1 223467889999999988888999999999999999999999985221 111122221111 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+....+ ..+.+++.+|++.+|++||++.|++.
T Consensus 219 ~~~~~~----~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGIS----PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCC----HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 112222 23667788999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=297.17 Aligned_cols=197 Identities=29% Similarity=0.366 Sum_probs=166.1
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD----- 423 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 423 (671)
..++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999964 6889999998642 2333456778999999999999999999886443
Q ss_pred -eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 424 -EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 424 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
..++||||+. ++|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 4689999996 477776632 2888999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 986533221 2234678899999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.08 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=193.1
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----ee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 425 (671)
+++|++.+.||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46789999999999999999986 468999999987432 233456788999999999999999999876543 46
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++++||+++ +|..++. .+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999964 7766662 345899999999999999999999998 99999999999999999999999999886
Q ss_pred ccCCCCcc-ccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~~ 230 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTPS 230 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCC
Confidence 54322211 1123578899999998754 5689999999999999999999999853211 001111111111100
Q ss_pred ccc---cccc-------ccc--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 584 ALD---LIDP-------LLT--DTCS-----PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 584 ~~~---~~d~-------~l~--~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
..+ ..+. .+. ...+ +.....+.+++.+||+.+|++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000 000 0000 1112347788889999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=289.24 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=193.5
Q ss_pred ccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 359 SNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
..+||+|+||.||++... +++.||||++..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 357999999999999874 6889999998765555566789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
.+++.. ..+++.....++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 988732 34789999999999999999999988 99999999999999999999999999875543221 1223
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..++..|++||.+.+..++.++||||||+++|||++|+.||..... .... .......... +. .+ ...+
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~-~~~~~~~~~~-~~-~~-~~~~ 243 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAM-KMIRDNLPPK-LK-NL-HKVS 243 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHHhhCCcc-cC-Cc-ccCC
Confidence 4678899999999888899999999999999999999999853211 1111 1111111000 00 00 1122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+ .+.+++.+||+.+|.+||++.+|++
T Consensus 244 ~----~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 P----SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred H----HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 2 3567777999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=291.09 Aligned_cols=245 Identities=28% Similarity=0.420 Sum_probs=190.7
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
|...+.||+|+||.||+++.. ++..||+|++.... ......+.+|+.++++++|||++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566788999999999999964 68899999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 974 66666532 2445899999999999999999999988 999999999999999999999999988754322
Q ss_pred ccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
....++..|+|||.+. .+.++.++||||||+++|||++|+.|+... ............+..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~~~---- 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNESP---- 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHHhccCC----
Confidence 2346788999999874 457899999999999999999999997421 111111111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
..... .....+.+++.+||+.+|++||++.+|++.+
T Consensus 243 --~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 243 --TLQSN---EWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred --CCCCc---cccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 11111 1122366788899999999999999999744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=280.46 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=201.6
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|+..+.||+|+||.||++... +++.+++|++.... ......+.+|+++++.++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999975 58899999987543 24556788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885422 2467999999999999999999999988 9999999999999999999999999988654432
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ......|++.|+|||......++.++||||+|+++++|++|+.|+.... ......... .... +
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~-----~ 221 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKIL-KGQY-----P 221 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHh-cCCC-----C
Confidence 1 1223468889999999988889999999999999999999999985321 122221211 1111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+....+ ..+.+++.+||..+|++|||+.|+++
T Consensus 222 ~~~~~~~----~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYS----SELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCC----HHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111222 34667888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.35 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=183.9
Q ss_pred ccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHh---hcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 361 MLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLIL---KLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
.||+|+||.||++... +++.+|+|.+.... ......+.+|..++. ..+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999974 58899999886432 112223344444333 3479999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|..++. ..+.+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999998884 3456999999999999999999999988 9999999999999999999999999987543321
Q ss_pred ccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....|+..|+|||.+.. ..++.++||||||+++|||++|+.||...... .... ....... ....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~-~~~~~~~------~~~~~ 218 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHE-IDRMTLT------VNVEL 218 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CHHH-HHHHhhc------CCcCC
Confidence 123468999999998864 45899999999999999999999998643221 1111 1111100 11122
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVVM 628 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~~ 628 (671)
....+ ..+.+++..|++.||++|| +++|+++.
T Consensus 219 ~~~~~----~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFS----PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccC----HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 22223 2356777799999999999 59999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=282.43 Aligned_cols=245 Identities=22% Similarity=0.253 Sum_probs=187.9
Q ss_pred cccCCCCcccEEEEEec-CCceEEEEEccccch---hchHHHHHHHHHH-hhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE---QGNAEFTNEVLLI-LKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||++... +|+.||+|+++.... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999874 588999999875321 1222344554444 445899999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
++|.+++. ..+.+++..+..++.||+.||.|||+.+ ++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999984 3356889999999999999999999988 99999999999999999999999999875432
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
.....++..|++||.+.+..++.++||||||+++|||++|+.||.... ... .+.....+... .......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~-~~~~~~~~~~~--~~~~~~~ 218 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--------PDA-VFDNILSRRIN--WPEEVKE 218 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--------HHH-HHHHHHhcccC--CCCcccc
Confidence 123467889999999988888999999999999999999999985321 111 11111111110 0111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.++ ..+.+++.+||+.+|++||++.++.+.|+-
T Consensus 219 ~~~----~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 219 FCS----PEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred cCC----HHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 122 336678889999999999988877776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.16 Aligned_cols=248 Identities=27% Similarity=0.378 Sum_probs=199.8
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|++.+.||+|+||.||+++.. +++.+++|.+... ......++.+|+.++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999854 6789999998753 233455778999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
+++++|..++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999885422 2356899999999999999999999988 9999999999999999999999999998764431
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
.....++..|++||.+.+..++.++|+||||+++|||++|+.||.... ....... ...+...
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~~----- 219 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--------MQDLRYK-VQRGKYP----- 219 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HhcCCCC-----
Confidence 222457889999999998899999999999999999999999985321 1111111 1111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+......+.+++..|++.+|++||++.|+++
T Consensus 220 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111223345778888999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=286.59 Aligned_cols=257 Identities=21% Similarity=0.275 Sum_probs=188.6
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcC--CeeeEEEe
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDG--DEKLLVYE 430 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 430 (671)
|+..+.||+|+||.||++... +++.||+|+++... ........+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999864 68899999987532 222234557888898885 99999999999987 78899999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|++ ++|.+.+.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 466666643 2356899999999999999999999988 999999999999999 999999999998654332
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH-----------H
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH-----------L 578 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~-----------~ 578 (671)
.. ....++..|+|||.+.. +.++.++||||||+++|||++|+.||...... ........ .
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-----DQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-----HHHHHHHHHcCCCCHHHHHh
Confidence 11 22457889999997654 56789999999999999999999998532211 11111111 1
Q ss_pred HhcCCccccccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 579 WNEGNALDLIDPLLTD----TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...........+...+ ...+.....+.+++.+||+.+|++||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1111100000000000 000122346788889999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.24 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=193.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC--Ceee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG--DEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~--~~~~ 426 (671)
.++|+..+.||+|+||.||+|... +++.+|+|++... .......+..|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 456888899999999999999975 5789999988542 223345677899999999 999999999998654 3579
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||++ ++|..++.. +.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 588887732 26889999999999999999999988 999999999999999999999999999866
Q ss_pred cCCCCc---cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH----
Q 005893 507 AGSEGE---VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL---- 578 (671)
Q Consensus 507 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~---- 578 (671)
...... .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~ 232 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-----NQLEKIIEVIGPP 232 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCC
Confidence 443321 12233568899999998755 46789999999999999999999998532211 111000000
Q ss_pred -------HhcCCccccccccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 579 -------WNEGNALDLIDPLLTD------TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 579 -------~~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
+......++++..... ...+.....+.+++.+||+.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000011100000 0000112347788889999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=288.17 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=190.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|+..+.||+|.+|.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999975 68899999986432 2233568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeeccccccccCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIFAGS 509 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~ 509 (671)
|++ ++|..++.. .....+++.....++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 467666632 22334678888899999999999999987 999999999999985 567999999999764332
Q ss_pred CCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. ......+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||...... ..+.. .......+ .....
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~-~~~~~~~~-~~~~~ 228 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFK-IFRILGTP-NEETW 228 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHHHhCCC-Chhhc
Confidence 11 1122456889999998865 45789999999999999999999998542211 01111 00000000 00000
Q ss_pred -------c-----ccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 -------D-----PLLTDT----CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 -------d-----~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+ +..... ..+.....+.+++.+|++.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000 00111233678888999999999999999985
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=286.62 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=194.6
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
|+..+.||+|++|.||++... +++.+++|+++.... .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999975 688999999875332 23457888999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++ +|..++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 77777643 2356899999999999999999999988 99999999999999999999999999887654331
Q ss_pred cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC---ccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN---ALDLI 588 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~ 588 (671)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... +........+..+. +....
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-----DQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCchHhcccch
Confidence 11224577889999998776 7899999999999999999999988532211 01000000000000 00000
Q ss_pred c------cccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 D------PLLT-------DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d------~~l~-------~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+ ..+. ....++-...+.+++..||+.||.+||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0000 0011122345778889999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=289.56 Aligned_cols=260 Identities=20% Similarity=0.196 Sum_probs=188.2
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCc
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSS 436 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 436 (671)
.+.+|.|+++.|+++.. +++.||||+++.. .......+.+|+.+++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455555655565555 6899999998753 34455679999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc----
Q 005893 437 LDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE---- 512 (671)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~---- 512 (671)
|.+++... ....+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+.........
T Consensus 86 l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99998542 2345888999999999999999999988 999999999999999999999999988755332111
Q ss_pred -cccccccccCCccchhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH----Hh-----
Q 005893 513 -VNTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL----WN----- 580 (671)
Q Consensus 513 -~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~----~~----- 580 (671)
.......++..|+|||++... .++.++||||||+++|||++|+.||...... ..+.+..... +.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCchh
Confidence 111234567789999998663 5889999999999999999999998642211 0111100000 00
Q ss_pred --cCCccc----ccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 581 --EGNALD----LIDPLLT----DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 581 --~~~~~~----~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...... ..++... ..........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000 0000000 0011112235678888999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=316.20 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=186.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 422 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 422 (671)
..+|++.+.||+|+||.|||++.+ ||+.+|||++.-. +.+....+.+|+..+++|+|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 356788889999999999999976 8999999998743 444556788999999999999999987533210
Q ss_pred --------------------------------------------------------------------------------
Q 005893 423 -------------------------------------------------------------------------------- 422 (671)
Q Consensus 423 -------------------------------------------------------------------------------- 422 (671)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh
Q 005893 423 -------------------------------DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471 (671)
Q Consensus 423 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~ 471 (671)
..+|+-||||+..+|.+++.+..-.. .-...++++++|++||.|+|+
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHh
Confidence 01356788888888888774322111 356778999999999999999
Q ss_pred CCCCceeecCCCCCcEEEcCCCCeEEeecccccccc----C------------CCCccccccccccCCccchhhhccC--
Q 005893 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA----G------------SEGEVNTARIVGTYGYMAPEYAMEG-- 533 (671)
Q Consensus 472 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~-- 533 (671)
++ ||||||||.||+||++..+||+|||++.... . .......+..+||..|+|||++.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 98 9999999999999999999999999998621 0 0011123446899999999999764
Q ss_pred -CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHcc
Q 005893 534 -LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCV 612 (671)
Q Consensus 534 -~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 612 (671)
+|+.|.|+||||||++||+. ||+-. .+... ....++++.+..- +.+ ..++...-..++.+++
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~Ts-------MERa~-iL~~LR~g~iP~~--~~f----~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTS-------MERAS-ILTNLRKGSIPEP--ADF----FDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCch-------HHHHH-HHHhcccCCCCCC--ccc----ccccchHHHHHHHHHh
Confidence 49999999999999999996 45421 11111 1223334443332 111 1222223346777999
Q ss_pred ccCCCCCCCHHHHHH
Q 005893 613 QEDAFDRPTMSSVVV 627 (671)
Q Consensus 613 ~~~p~~RPt~~ev~~ 627 (671)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999983
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.49 Aligned_cols=197 Identities=23% Similarity=0.312 Sum_probs=160.4
Q ss_pred cccCCC--CcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQG--GFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
..||+| +||+||++... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356776 89999999864 7899999998643 233346788999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc-
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV- 513 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 513 (671)
++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.++++||+............
T Consensus 84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999988542 2335889999999999999999999988 9999999999999999999999998654332211110
Q ss_pred ----ccccccccCCccchhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 514 ----NTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 514 ----~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01112345679999998764 478999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=298.94 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=199.3
Q ss_pred CCcccccCCCCcccEEEEEecCC-ceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSDG-KEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
|.+...||.|+||.||+++.++. -..|.|++.-.++...+++.-|+++|...+||+||++++.+..++.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 44567799999999999997653 44577888777777888999999999999999999999999999999999999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|..+.++.. -...|.+.++..+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+-.... ....
T Consensus 114 GAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk 186 (1187)
T KOG0579|consen 114 GAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK 186 (1187)
T ss_pred chHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence 999988753 3456999999999999999999999998 99999999999999999999999998754221 1122
Q ss_pred cccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 515 TARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
...+.|||.|||||+.+ ..+|+.++||||||++|.||..+.+|-. ..+......+..+. .+..++.
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh--------elnpMRVllKiaKS-ePPTLlq 257 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH--------ELNPMRVLLKIAKS-EPPTLLQ 257 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc--------ccchHHHHHHHhhc-CCCcccC
Confidence 34578999999999864 5689999999999999999999998863 22333333232222 2222222
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
| . .....+.++...|+..||..||++.++++
T Consensus 258 P----S---~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 P----S---HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred c----c---hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2 1 22234556667999999999999999875
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=285.98 Aligned_cols=256 Identities=24% Similarity=0.293 Sum_probs=198.3
Q ss_pred CCCcccccCCCCcccEEEEEe----cCCceEEEEEccccc----hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCee
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL----SDGKEIAVKRLSSCS----EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 425 (671)
+|+..+.||+|++|.||+++. .+++.||||+++... ......+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999884 356789999987432 22334678999999999 699999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++++|.+++. ....+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999884 3356889999999999999999999987 99999999999999999999999999886
Q ss_pred ccCCCCccccccccccCCccchhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
........ .....|+..|++||.+.+.. .+.++||||||+++|||++|+.||...... .............
T Consensus 155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~-- 227 (288)
T cd05583 155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKS-- 227 (288)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHcc--
Confidence 54432221 22346889999999987655 788999999999999999999998532211 1111111111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.+......++ .+.+++.+||+.+|++|||+.++.+.|+-.
T Consensus 228 -----~~~~~~~~~~----~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 -----KPPFPKTMSA----EARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----CCCCCcccCH----HHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1111122222 356777899999999999999998888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=287.58 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=190.9
Q ss_pred HhCCCCcccccCCCCcccEEEEEecC-CceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
..++|++.+.||+|+||.||++...+ ++.||||.++... .....++..|+.++.++ .|+||+++++++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34567888999999999999999864 8899999987532 22344566777777766 499999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|||++ ++|..++.. ....+++..+..++.||+.||.|||+ .+ |+||||+|+||++++++.+||+|||++..+.
T Consensus 93 ~e~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 467666533 23468999999999999999999997 45 9999999999999999999999999987654
Q ss_pred CCCCccccccccccCCccchhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGL----YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
..... ....++..|+|||.+.... ++.++||||||+++|||++|+.||..... ..+...+.....
T Consensus 167 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~- 235 (296)
T cd06618 167 DSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQEE- 235 (296)
T ss_pred CCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHHHhcCC-
Confidence 32221 2235778899999986543 78999999999999999999999853211 111111111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
.... .. ...++ ..+.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~-~~--~~~~~----~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 236 PPSL-PP--NEGFS----PDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCCC-CC--CCCCC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1110 00 00122 246778889999999999999999853
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=286.18 Aligned_cols=244 Identities=28% Similarity=0.359 Sum_probs=188.8
Q ss_pred cCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
||+|+||+||++... +|+.|++|.+.... ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999864 68899999986432 22334567899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
.+++... ....+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 9988542 2246899999999999999999999988 9999999999999999999999999987653321 1123
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..++..|++||.+.++.++.++||||||+++|+|++|+.||...... ...... ...... ....+....+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-----~~~~~~--~~~~~~~~~~ 222 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEK----VEKEEL-----KRRTLE--MAVEYPDKFS 222 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccc----ccHHHH-----Hhcccc--ccccCCccCC
Confidence 45778999999998888999999999999999999999998543221 011111 010000 0111112222
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
+ .+.+++.+||+.+|++|| ++.+++.
T Consensus 223 ~----~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 223 P----EAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred H----HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 2 366777899999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=280.16 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=192.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-----chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Cee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-----SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 425 (671)
.+|...+.||+|+||.||++... +++.|++|++... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999964 5889999987421 223445788999999999999999999998764 457
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++++||+++++|.+++. ..+.+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999884 3345889999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCC-ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 506 FAGSEG-EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 506 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.... ......+.... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~ 226 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--------AMAAIFKIATQ-PT 226 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--------HHHHHHHHHcC-CC
Confidence 532111 111123468899999999988889999999999999999999999985321 11111111111 11
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.+....+ ..+.+++..|++ +|..||+..+++.
T Consensus 227 ----~~~~p~~~~----~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 ----KPMLPDGVS----DACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----CCCCCcccC----HHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111222222 235566679998 5799999998774
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.41 Aligned_cols=263 Identities=23% Similarity=0.339 Sum_probs=194.2
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----CCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 425 (671)
.++|+..+.||+|+||.||++... +|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888999999999999999964 68999999987532 2334567789999999999999999998763 3457
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++|+||+. ++|..++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 68888873 3455999999999999999999999988 99999999999999999999999999876
Q ss_pred ccCCCCcc--ccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH---
Q 005893 506 FAGSEGEV--NTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW--- 579 (671)
Q Consensus 506 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~--- 579 (671)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g~~ 231 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLGSP 231 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhCCC
Confidence 54332211 1123478889999998865 46889999999999999999999998532110 0000000000
Q ss_pred --------hcCCcccccccc-ccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 --------NEGNALDLIDPL-LTDTCS-----PDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 --------~~~~~~~~~d~~-l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
......+..+.. ...... +.....+.+++.+|++.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000000000000 000000 112345778888999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=286.16 Aligned_cols=264 Identities=25% Similarity=0.332 Sum_probs=193.5
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC----
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD---- 423 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---- 423 (671)
...++|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45578889999999999999999975 58899999987532 223346778999999999999999999987655
Q ss_pred ------eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEE
Q 005893 424 ------EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI 497 (671)
Q Consensus 424 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 497 (671)
..++|+||+++ +|...+.. ....+++..++.++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68899999986 56555532 2346899999999999999999999988 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
+|||++.......... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ........
T Consensus 158 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~~ 231 (302)
T cd07864 158 ADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELIS 231 (302)
T ss_pred CcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHH
Confidence 9999998664433211 122345778999998764 4578999999999999999999999853211 11111111
Q ss_pred HHHhcCCc---ccc--------ccc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 577 HLWNEGNA---LDL--------IDP------LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 577 ~~~~~~~~---~~~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+....... .++ .++ ....... .....+.+++..||+.+|++||++.+|+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111100 000 000 0000000 01234678888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.15 Aligned_cols=245 Identities=25% Similarity=0.331 Sum_probs=200.1
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
...|.+.+.||+|.|+.|..++.. ++.+||||.+.+.. ......+.+|+++|..|+|||||+++.+......+++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456788899999999999999964 68999999997632 233345889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||..+|.+.+++. +.+.+....+..++.|+.++++|||+++ |+|||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999994 4455666888999999999999999998 999999999999999999999999999887532
Q ss_pred CCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
......+|++.|.|||++.+..| ++++|+||+|+++|.|+.|..||+... +.++-
T Consensus 209 ---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---------------------lk~Lr 264 (596)
T KOG0586|consen 209 ---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---------------------LKELR 264 (596)
T ss_pred ---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---------------------ccccc
Confidence 22345799999999999988776 689999999999999999999996321 11122
Q ss_pred cccccCCCCHH--HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~--~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
++.+.+.+--. -..++-+++.+.+-.+|.+|++++++.+
T Consensus 265 ~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 265 PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 22222211110 1123557777999999999999999975
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=285.68 Aligned_cols=249 Identities=26% Similarity=0.333 Sum_probs=198.8
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv 428 (671)
++|...+.||+|+||.||+++.. +++.|++|++... .......+.+|+.++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999975 6899999998652 2333457889999999998 99999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++. ..+.+++..++.|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999984 3447999999999999999999999988 99999999999999999999999999886544
Q ss_pred CCCc------------------cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005893 509 SEGE------------------VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570 (671)
Q Consensus 509 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~ 570 (671)
.... .......++..|++||.......+.++||||||++++++++|+.|+.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~ 227 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-------E 227 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-------H
Confidence 3221 11223467889999999988889999999999999999999999985321 1
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM----SSVVV 627 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~----~ev~~ 627 (671)
. ....... . ....+.... ...+.+++.+||+.+|++||++ +++++
T Consensus 228 ~-~~~~~~~-~------~~~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 Y-LTFQKIL-K------LEYSFPPNF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H-HHHHHHH-h------cCCCCCCcc----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 1111111 1 011111122 2346788889999999999999 77663
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=282.35 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=190.1
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhc---CCCCeeeEeeEEEcCCe-----
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKL---QHKNLVKLLGFCVDGDE----- 424 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 424 (671)
|++.+.||+|+||.||+++.. +++.||+|+++.... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566788999999999999986 489999999974322 2233566787777665 69999999999988776
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.+++|||+++ +|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999974 788877432 2235899999999999999999999988 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 227 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-----DQLDKIFDVIGLPSE 227 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-----HHHHHHHHHcCCCCh
Confidence 7543321 12235788899999999889999999999999999999999888532211 111111110000000
Q ss_pred ----------ccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 ----------LDLIDPLLT---DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ----------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
......... ....++-...+.+++.+||+.||++||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 228 EEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 0111122345678888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.33 Aligned_cols=261 Identities=23% Similarity=0.330 Sum_probs=193.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----e
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----E 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 424 (671)
.++|.+.+.||+|+||.||+++.. +++.||||.++.. .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 356888999999999999999864 6889999998643 2233456778999999999999999999876543 4
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++|+||+. ++|.+++. ..+.+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 789999996 67877773 3456999999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh---
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN--- 580 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~--- 580 (671)
....... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ............
T Consensus 157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~ 229 (337)
T cd07858 157 TTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPS 229 (337)
T ss_pred ccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 6543321 1123467889999998865 4689999999999999999999999853211 011111111000
Q ss_pred --------cCCccccc-------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 581 --------EGNALDLI-------DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 581 --------~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
.+...+.+ +..+.. ..+.....+.+++.+||+.+|++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 000000 001122346788889999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=289.85 Aligned_cols=264 Identities=25% Similarity=0.336 Sum_probs=190.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 423 (671)
.++|+..+.||+|+||.||+++.. +++.+++|++..... .....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467888999999999999999964 688999998864322 22345678999999999999999999876543
Q ss_pred --eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 424 --EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 424 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
..++|+||+.+ +|...+.. ....+++..+..++.||++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999975 56555532 2346999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCcc---------ccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCH
Q 005893 502 MARIFAGSEGEV---------NTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571 (671)
Q Consensus 502 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l 571 (671)
+++......... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-----~~ 235 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-----DQ 235 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-----HH
Confidence 998654322111 11234678889999987654 5889999999999999999999998532211 11
Q ss_pred HHHHHHHHhcCCc---------cccccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 572 LAYAWHLWNEGNA---------LDLIDPLLTDTCS-------PDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 572 ~~~~~~~~~~~~~---------~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+........ ....+.......+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111111110000 0000000000000 011145778889999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=282.06 Aligned_cols=241 Identities=26% Similarity=0.333 Sum_probs=183.9
Q ss_pred ccCCCCcccEEEEEec-CCceEEEEEccccch---hchHHHHHHHHH---HhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 361 MLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE---QGNAEFTNEVLL---ILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
.||+|+||.||++... +++.||+|.+..... .....+..|..+ +....||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 588999999864321 112223444433 344579999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|..++. ..+.+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++..+....
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999998883 3456999999999999999999999988 9999999999999999999999999987653322
Q ss_pred ccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...... ..... ...... ....+
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~------~~~~~ 218 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEI-DRMTLT------MAVEL 218 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHH-HHHhhc------cCCCC
Confidence 1234689999999998755 6899999999999999999999998643221 11111 111111 11112
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
....+ ..+.+++.+|++.+|++|| ++.++++
T Consensus 219 ~~~~s----~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCC----HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 22222 2366777799999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.62 Aligned_cols=251 Identities=24% Similarity=0.280 Sum_probs=193.8
Q ss_pred CCCcccccCCCCcccEEEEEe----cCCceEEEEEccccc----hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCee
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL----SDGKEIAVKRLSSCS----EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 425 (671)
+|+..+.||+|+||.||++.. .+|+.||+|+++... ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 368899999987532 22345678899999999 699999999999998899
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++|+||+++++|.+++. ....+++..+..++.|+++||.|||+.+ ++||||+|+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999884 3456889999999999999999999988 99999999999999999999999999886
Q ss_pred ccCCCCccccccccccCCccchhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
....... ......|+..|+|||.+... .++.++||||||+++|||++|+.|+..... ...............
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccC-
Confidence 5433211 12235688999999998653 467899999999999999999999864221 112222222221111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
+......+ ..+.+++.+||+.+|++|| ++.+++.
T Consensus 229 ------~~~~~~~~----~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ------PPYPQEMS----ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------CCCCccCC----HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11111222 2356777899999999997 6677764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=286.17 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=190.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe------
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------ 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 424 (671)
++|+..+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888899999999999999974 68899999886432 2223356789999999999999999999876543
Q ss_pred --eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 425 --KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 425 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
.++||||+.+ +|..++.. ....+++.+++.++.||+.||.|||+++ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4899999964 77776632 2345899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 503 ARIFAGSEGE--VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 503 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
+......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~~~~ 240 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLISQLC 240 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHh
Confidence 9865433221 112234678889999988654 478899999999999999999998853221 11111111111
Q ss_pred hc--------CCcccccccc-ccCCC---CH------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NE--------GNALDLIDPL-LTDTC---SP------DEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~--------~~~~~~~d~~-l~~~~---~~------~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. ....+..+.. +.... .+ .+...+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0000000000 00000 00 01124567888999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.33 Aligned_cols=200 Identities=32% Similarity=0.456 Sum_probs=173.4
Q ss_pred CCcccccCCCCcccEEEEEe-cCCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------eeeE
Q 005893 356 FSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------EKLL 427 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 427 (671)
+...+.||+|+||.||+|+. .+|+.||||.++... ....+...+|++++++|+|+|||+++++-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 34457899999999999995 579999999998633 344567889999999999999999998865443 4679
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc--CCC--CeEEeecccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD--YDM--NPKISDFGMA 503 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~Dfgla 503 (671)
|||||.+|||...|.++.+...|++.+.+.++.++..||.|||+++ |+||||||.||++- ++| --||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999999888889999999999999999999999998 99999999999983 333 4799999999
Q ss_pred ccccCCCCccccccccccCCccchhhhc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGRRNTGFN 561 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~p~~~~ 561 (671)
+.+..+. .....+||..|.+||.+. ++.|+..+|.|||||++||.+||..||...
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9876554 234479999999999998 488999999999999999999999999643
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=308.52 Aligned_cols=199 Identities=22% Similarity=0.370 Sum_probs=156.9
Q ss_pred hCCCCcccccCCCCcccEEEEEecC--CceEEEE------------------EccccchhchHHHHHHHHHHhhcCCCCe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD--GKEIAVK------------------RLSSCSEQGNAEFTNEVLLILKLQHKNL 412 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~ni 412 (671)
.++|++.+.||+|+||+||++.... +...++| .+. ........+.+|+.++++++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence 4679999999999999999987532 2222222 111 112234568899999999999999
Q ss_pred eeEeeEEEcCCeeeEEEeccCCCchhhhhcCCC--CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc
Q 005893 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPR--KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD 490 (671)
Q Consensus 413 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~ 490 (671)
+++++++...+..++|+|++. ++|..++.... ............|+.||+.||.|||+++ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 45655553321 1222345667789999999999999988 99999999999999
Q ss_pred CCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 005893 491 YDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRN 557 (671)
Q Consensus 491 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 557 (671)
.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999876433221 12235799999999999999999999999999999999998754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=285.25 Aligned_cols=243 Identities=28% Similarity=0.418 Sum_probs=188.6
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
|...+.||+|+||.||+|+.. +++.|++|++.... ......+.+|+.++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 68899999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+. ++|.+++.. ....+++..++.++.||+.+|.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 566666532 3446899999999999999999999988 99999999999999999999999998764321
Q ss_pred ccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.....|+..|+|||.+. .+.++.++||||||+++|||++|+.|+... +............ .....
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~--------~~~~~~~~~~~~~-~~~~~ 241 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQND-SPTLQ 241 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhcC-CCCCC
Confidence 12346788999999974 456889999999999999999999997432 1112222221111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...++ ..+.+++.+||+.+|++||++.+++.
T Consensus 242 ----~~~~~----~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 ----SNEWT----DSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ----ccccC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11112 23567777999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.68 Aligned_cols=202 Identities=30% Similarity=0.397 Sum_probs=178.7
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
..+.|..-++||+|+||.||-.+.. +|+-+|.|.+.+. ..+......+|-.+|.+++.+.||.+-..+.+.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 3456888899999999999999864 6999999998642 23445567899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|+..|.||+|.-+|++. ....+++..++-.+.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999999763 3467999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
..+... ..+||.+|||||++.++.|+...|.|||||+||||+.|+-||..
T Consensus 339 ~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 339 EGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred CCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 654332 23899999999999999999999999999999999999999964
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=278.88 Aligned_cols=243 Identities=21% Similarity=0.261 Sum_probs=184.6
Q ss_pred hCCCCccccc--CCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNML--GQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|++.+.+ |+|+||.||++... ++..+|+|.+....... .|+.....+ +||||+++++.+...+..++|
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv 87 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI 87 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence 3556666665 99999999999864 67889999986532111 122222222 799999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeecccccccc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIFA 507 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~ 507 (671)
|||+++++|.+++.. ...+++..+..++.||++||.|||+.+ ++||||||+||+++.++ .++|+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 88 MDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred EEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 999999999999843 347999999999999999999999988 99999999999999998 99999999987653
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.. ....++..|+|||.+....++.++||||||+++|||++|+.||...... ......+.... .....
T Consensus 162 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~---~~~~~- 228 (267)
T PHA03390 162 TP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---ELDLESLLKRQ---QKKLP- 228 (267)
T ss_pred CC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---hhhHHHHHHhh---cccCC-
Confidence 22 1236788999999999889999999999999999999999998632211 11122221111 11001
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-MSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-~~ev~~ 627 (671)
.....++ .+.+++..||+.+|++||+ ++|+++
T Consensus 229 ----~~~~~~~----~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 ----FIKNVSK----NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cccccCH----HHHHHHHHHhccChhhCCchHHHHhc
Confidence 1112222 3667778999999999996 688873
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=265.84 Aligned_cols=244 Identities=30% Similarity=0.464 Sum_probs=190.6
Q ss_pred ccccCCCCcccEEEEEec-CCceEEEEEccccch-hchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 359 SNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-QGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
...||.|..|.||+.... +|..+|||.+.+... ...+.+...++++.+- ..|.||+.+|+|..+...++.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 566999999999999975 588999999986543 3345667777776655 4899999999999999999999998 45
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccc
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 515 (671)
.++.++. +-.+++++..+-++...+.+||.||.++. +|+|||+||+|||+|+.|++||+|||++..+..+..+
T Consensus 176 C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--- 248 (391)
T KOG0983|consen 176 CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--- 248 (391)
T ss_pred HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc---
Confidence 6677664 34556888888899999999999998754 6999999999999999999999999999877655433
Q ss_pred ccccccCCccchhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 516 ARIVGTYGYMAPEYAME---GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 516 ~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
++..|.+.|||||.+.- ..|+.++||||||+.++||.||+.||..-..+ + +..-+.+.+.. |.|
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td------F-e~ltkvln~eP------P~L 315 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD------F-EVLTKVLNEEP------PLL 315 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc------H-HHHHHHHhcCC------CCC
Confidence 34578899999999854 46889999999999999999999999643221 1 11112222211 223
Q ss_pred cC--CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TD--TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+ .++++ +.+++..|++.|+.+||...++++
T Consensus 316 ~~~~gFSp~----F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 PGHMGFSPD----FQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CcccCcCHH----HHHHHHHHhhcCcccCcchHHHhc
Confidence 22 24444 667777999999999999999885
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.81 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=191.1
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD----- 423 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----- 423 (671)
..++|+..+.||+|+||.||++.. .+++.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456798999999999999999985 46889999998642 2223456789999999999999999999987654
Q ss_pred -eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 424 -EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 424 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
..++||||+ +++|..++. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 348999999 778888773 245899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH-------
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY------- 574 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~------- 574 (671)
+...... .....+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||...... ..+...
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~ 235 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL----DQLMEIMKVTGTP 235 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCC
Confidence 8764322 123466889999998876 45889999999999999999999998532110 000000
Q ss_pred ---HHHHHhcCCcccccc--ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 575 ---AWHLWNEGNALDLID--PLLTD----TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 575 ---~~~~~~~~~~~~~~d--~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+..+........+. +.+.. ...+.....+.+++.+|++.||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000000 00000 000011123678888999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=284.65 Aligned_cols=264 Identities=25% Similarity=0.299 Sum_probs=191.8
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccch-hchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEecc
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
|++.+.||+|++|.||+|+.. +++.|+||++..... .......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566788999999999999975 478899999865322 22334567899999998 999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
+++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 78888877432 2346899999999999999999999988 99999999999999999999999999876543221
Q ss_pred cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CCCHHHHHHHHHhcCC
Q 005893 513 VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT--------APNLLAYAWHLWNEGN 583 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~--------~~~l~~~~~~~~~~~~ 583 (671)
.....++..|+|||.+.. ..++.++|+||||+++|||++|+.||......... ...-..|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 122457889999998754 45789999999999999999999988543211000 0000000000000000
Q ss_pred cccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLT---DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+..... ....+.....+.+++.+||+.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 0000111245778899999999999999999985
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=290.53 Aligned_cols=261 Identities=24% Similarity=0.328 Sum_probs=191.4
Q ss_pred CCC-cccccCCCCcccEEEEEec-CCceEEEEEccccchhc--------------hHHHHHHHHHHhhcCCCCeeeEeeE
Q 005893 355 NFS-DSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQG--------------NAEFTNEVLLILKLQHKNLVKLLGF 418 (671)
Q Consensus 355 ~~~-~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g~ 418 (671)
+|. ..+.||+|+||.||++... +++.||||+++...... ...+.+|+.++..++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 343 3467999999999999964 68899999986432211 1246789999999999999999999
Q ss_pred EEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEe
Q 005893 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKIS 498 (671)
Q Consensus 419 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 498 (671)
+..++..++||||++ ++|.+++. ....+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 999999999999997 68888873 3445899999999999999999999988 9999999999999999999999
Q ss_pred eccccccccCCCC------------ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005893 499 DFGMARIFAGSEG------------EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565 (671)
Q Consensus 499 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~ 565 (671)
|||+++....... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-- 239 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE-- 239 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 9999986541110 1111223567889999998764 468999999999999999999999863321
Q ss_pred CCCCCHHHHHHHHHhcCCcc---cc--------ccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 566 ATAPNLLAYAWHLWNEGNAL---DL--------IDPLLTD---TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~---~~--------~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
................. .. ..+.... ...+.....+.+++..|++.+|++||+++|++.
T Consensus 240 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 ---IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ---HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111111111000 00 0000000 000111234678888999999999999999996
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=281.50 Aligned_cols=259 Identities=26% Similarity=0.340 Sum_probs=194.3
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
|+..+.||+|.+|.||+|+.. +++.|++|++.... ......+..|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999975 58999999987643 333456788999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
+ ++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 5899988532 246999999999999999999999988 99999999999999999999999999886543321
Q ss_pred cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH-----------HHHHHh
Q 005893 513 VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY-----------AWHLWN 580 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~-----------~~~~~~ 580 (671)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ..... .|..+.
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-----DQLFKIFQILGTPTEESWPGVT 227 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHHHhCCCcHHHHHhhc
Confidence 12223457789999998776 7899999999999999999999888532211 00000 011000
Q ss_pred cCC-ccccccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 581 EGN-ALDLIDPLLTD---TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 581 ~~~-~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.-. ........... ...+.....+.+++..||+.+|++||++.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 00000000000 000111335788888999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=321.23 Aligned_cols=257 Identities=27% Similarity=0.400 Sum_probs=198.9
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
+..-+-+++-..+||.|.||.||.++. ++|.-.|+|.++- ...+....+.+|+.++..++|||+|+++|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 344455677788999999999999995 5688899998763 3344456788999999999999999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
+|.||||++|+|.+++. .....++........|++.|+.|||++| ||||||||.||+|+.+|-+|++|||.+..
T Consensus 1310 ~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999984 3344666666778899999999999999 99999999999999999999999999987
Q ss_pred ccCCCCc--cccccccccCCccchhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 506 FAGSEGE--VNTARIVGTYGYMAPEYAMEGL---YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 506 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
..+.... .......||+.|||||++.+.. ...++||||+|||++||+||++||...+.+ ....++. .
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V-~ 1455 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHV-A 1455 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHH-h
Confidence 7654211 1223468999999999996543 456899999999999999999999643322 1222221 1
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
.|.. |.++...++ +- .+.+..|++.||++|.++.|+++.
T Consensus 1456 ~gh~-----Pq~P~~ls~-~g---~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGHK-----PQIPERLSS-EG---RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccCC-----CCCchhhhH-hH---HHHHHHHHhcCchhhhHHHHHHHh
Confidence 2211 222222222 22 344458999999999999888763
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=290.07 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=191.3
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC----------
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG---------- 422 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------- 422 (671)
.+|...+.||+|+||.||+|... +|+.||+|++..........+.+|+.++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999974 6889999998765555566788999999999999999999776543
Q ss_pred ----CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-CCCCeEE
Q 005893 423 ----DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-YDMNPKI 497 (671)
Q Consensus 423 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 497 (671)
...++|+||++ ++|.+++. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34689999997 58877763 235889999999999999999999988 99999999999997 4567899
Q ss_pred eeccccccccCCCCcc-ccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 498 SDFGMARIFAGSEGEV-NTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
+|||+++......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... .......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~----~~~~~~~ 232 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL----EQMQLIL 232 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH
Confidence 9999987653321111 1122357889999998754 46788999999999999999999998532110 0000000
Q ss_pred HH----------HHhcCCccccccccccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcC
Q 005893 576 WH----------LWNEGNALDLIDPLLTDTCSP-----DEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQG 631 (671)
Q Consensus 576 ~~----------~~~~~~~~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~ 631 (671)
.. ...................+. .....+.+++.+|++.||++|||++|++. .++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 000000000000000000000 11134678888999999999999999984 4543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=284.30 Aligned_cols=244 Identities=30% Similarity=0.435 Sum_probs=189.3
Q ss_pred CCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
|+..+.||+|+||.||+|+.. +++.+++|.+... ......++.+|+.+++.++|+|++++++++......++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 566788999999999999964 5788999988632 223345678899999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 97 CL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred cC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 96 577666632 2345889999999999999999999987 999999999999999999999999998765332
Q ss_pred ccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
....++..|+|||.+. .+.++.++||||||+++|||++|+.|+.... -....... ..+..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~-~~~~~---- 231 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHI-AQNES---- 231 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--------HHHHHHHH-hhcCC----
Confidence 2346788999999874 3567889999999999999999999974321 11111111 11111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
+..... .....+.+++.+||+.+|++||++.+|++.
T Consensus 232 -~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 -PALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -CCcCcc---cccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 111111 112335677789999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=288.30 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=196.2
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----eee
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKL 426 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 426 (671)
+|++.+.||+|++|.||+++.. +++.|+||++.... ......+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999975 48899999987643 334457889999999999999999999988775 789
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
++|||++ ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 57888874 3347999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCc-cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH-----
Q 005893 507 AGSEGE-VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW----- 579 (671)
Q Consensus 507 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~----- 579 (671)
...... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~ 228 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTPSE 228 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCCCh
Confidence 443210 112234678899999999887 7899999999999999999999998533210 0000000000
Q ss_pred ------hcCCccccccccc-cCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 ------NEGNALDLIDPLL-TDT-----CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ------~~~~~~~~~d~~l-~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
......+.+...- ... ..+.....+.+++.+||+.+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0000000000000 000 00111234678888999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=286.68 Aligned_cols=201 Identities=29% Similarity=0.419 Sum_probs=167.3
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG- 422 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~- 422 (671)
.++....++|+..+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 44556778899999999999999999985 468899999987532 22345678899999999999999999988643
Q ss_pred -----CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEE
Q 005893 423 -----DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI 497 (671)
Q Consensus 423 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 497 (671)
...+++++++ +++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 2356778776 788888773 235899999999999999999999988 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999998754321 123467889999998866 5688999999999999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=277.37 Aligned_cols=249 Identities=27% Similarity=0.365 Sum_probs=192.0
Q ss_pred CCCcccccCCCCcccEEEEEecC-CceEEEEEcccc-----chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSC-----SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
+|.+.+.||+|+||.||++.... +..+++|+++.. ......++..|+.++.+++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778999999999999998643 445666665531 222334567889999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 429 YEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
+||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888542 23456999999999999999999999988 999999999999975 569999999987654
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
..... .....|++.|+|||.+....++.++|+||||+++|+|++|..|+... .......... .+.
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--------~~~~~~~~~~-~~~---- 221 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--------NFLSVVLRIV-EGP---- 221 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHHHHH-cCC----
Confidence 33221 22346788999999998888899999999999999999999998421 1222221111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.+.. .....+.+++.+||+.+|++||++.|+++
T Consensus 222 -~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 -TPSLPE----TYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCcc----hhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111111 22234667888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=288.24 Aligned_cols=258 Identities=25% Similarity=0.353 Sum_probs=190.5
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 423 (671)
.++|...+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888999999999999999964 68999999986432 222346789999999999999999999987543
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 666554 235889999999999999999999988 999999999999999999999999998
Q ss_pred ccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc-
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE- 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~- 581 (671)
+..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .......+..
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--------~~~~~~~~~~~ 231 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVT 231 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhc
Confidence 754221 123467888999999876 4689999999999999999999999853211 1111111110
Q ss_pred C-Cc------------ccccc--ccc-cCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hcCC
Q 005893 582 G-NA------------LDLID--PLL-TDTC---SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM--LQGE 632 (671)
Q Consensus 582 ~-~~------------~~~~d--~~l-~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~--L~~~ 632 (671)
+ .. ...+. +.. .... .+.....+.+++..||+.||++||+++|++.. ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 0 00 00000 000 0000 00112346788889999999999999999853 5443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=284.62 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=192.9
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc-CCeee
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKL 426 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 426 (671)
..+++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.++.+++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35778999999999999999999854 7889999988642 22234567899999999999999999999875 45788
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+++||+ +++|..++. ...+++.....++.|+++||.|||+.+ |+||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 568888773 235788888899999999999999988 999999999999999999999999998754
Q ss_pred cCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH----------
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA---------- 575 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~---------- 575 (671)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ......
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~-----~~~~~~~~~~~~~~~~ 228 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-----NQFSIITDLLGTPPDD 228 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHH
Confidence 221 122456888999998765 56899999999999999999999998532210 000000
Q ss_pred -HHHHhcCCcccccccc-ccCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 576 -WHLWNEGNALDLIDPL-LTDTCSPD-----EFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 576 -~~~~~~~~~~~~~d~~-l~~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
+..+..+...+.+... .....+.. ....+.+++.+|++.+|++||++.|++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 229 VINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000001111111000 00011111 12357788889999999999999999753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=284.69 Aligned_cols=199 Identities=28% Similarity=0.393 Sum_probs=162.3
Q ss_pred CCCcccccCCCCcccEEEEEec-C--CceEEEEEccccc--hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC----Ce
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-D--GKEIAVKRLSSCS--EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG----DE 424 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 424 (671)
+|+..+.||+|+||.||++... + ++.||+|+++... ......+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999964 3 6789999987422 22345678899999999 599999999875432 34
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++++||+. ++|..++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889886 68888773 3456899999999999999999999988 9999999999999999999999999998
Q ss_pred cccCCCCc--cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 505 IFAGSEGE--VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 505 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
........ .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 65432211 11233578999999998765 4689999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=287.64 Aligned_cols=258 Identities=26% Similarity=0.343 Sum_probs=192.1
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe----
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE---- 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---- 424 (671)
..++|+..+.||+|++|.||+|... +++.||+|++... .......+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888999999999999999975 5789999998642 22334567789999999999999999988776554
Q ss_pred --eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 425 --KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 425 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 78999998 6789888742 45899999999999999999999988 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH--
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW-- 579 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~-- 579 (671)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..........
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-----~~~~~i~~~~~~ 234 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-----DQLKRIMNLVGT 234 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHhcCC
Confidence 8765332 223467888999998865 36789999999999999999999998532110 0000000000
Q ss_pred ---------hcCCccccccccc---cCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 ---------NEGNALDLIDPLL---TDTC---SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ---------~~~~~~~~~d~~l---~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
........+.... .... .......+.+++.+|++.+|++|||+.||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000000 0000 0011235778888999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=269.27 Aligned_cols=236 Identities=27% Similarity=0.305 Sum_probs=189.0
Q ss_pred cCCCCcccEEEEEec-CCceEEEEEccccch---hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 362 LGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE---QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
||+|+||.||++... +++.+++|++..... .....+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 588999999875332 2345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 999843 346899999999999999999999987 99999999999999999999999999876544321 1233
Q ss_pred ccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
..++..|++||...+...+.++|+||||+++|||++|+.||..... ......... .. ..+....
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~------~~~~~~~- 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-DP------LRFPEFL- 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-CC------CCCCCCC-
Confidence 5678899999999888889999999999999999999999853211 111111111 10 1111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHH
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSS 624 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~e 624 (671)
...+.+++.+||..||++||++.+
T Consensus 217 ---~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 ---SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CHHHHHHHHHHhcCCHhhCCCccc
Confidence 234667888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=305.35 Aligned_cols=277 Identities=25% Similarity=0.293 Sum_probs=213.2
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccc---cchhchHHHHHHHHHHhhcCCCCeeeEeeEEE
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS---CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 420 (671)
...+++...++|.+.++||+|+||.|..++.+ +++.||+|++.+ ....+..-|..|-.+|..-+.+.|+.+...|+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 34566777789999999999999999999974 588999999976 33344556889999999999999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
++..+|+|||||+||+|-.++.. -..+++..+..++..|.-||.-||+.| +|||||||+|||||..|++||+||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred CccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999843 336888889999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAME-----GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
|.+-.+.. ++.......+|||.|++||++.. +.|++.+|+||+||++|||+.|.-|| ..+.++..-
T Consensus 220 GsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF--------YadslveTY 290 (1317)
T KOG0612|consen 220 GSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF--------YADSLVETY 290 (1317)
T ss_pred hhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc--------hHHHHHHHH
Confidence 98876543 34445556799999999999853 57899999999999999999999999 344444443
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH--HhcCCCCCCCCCCCCcc
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT---MSSVVV--MLQGETITLCQPQKPAF 644 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt---~~ev~~--~L~~~~~~~~~p~~p~~ 644 (671)
.+.....+...+-+... -.++...+++ .-+ -+|+.|-. ++++.. ++++..+.-=....|+|
T Consensus 291 ~KIm~hk~~l~FP~~~~----VSeeakdLI~---~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~ 356 (1317)
T KOG0612|consen 291 GKIMNHKESLSFPDETD----VSEEAKDLIE---ALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPV 356 (1317)
T ss_pred HHHhchhhhcCCCcccc----cCHHHHHHHH---HHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCC
Confidence 33333322222221111 2344555554 333 37778877 888875 45555543333333444
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=302.64 Aligned_cols=145 Identities=24% Similarity=0.372 Sum_probs=129.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|.+.++||+|+||.||++... +++.||||+++... ......+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999999999999975 68899999987532 233457889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
||+++++|.+++.. .+.+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999843 345889999999999999999999987 9999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=264.49 Aligned_cols=242 Identities=26% Similarity=0.277 Sum_probs=193.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
..++|+..++||+|.||.|-.++- .+|+.+|+|++++.. ......-..|-++|+.-+||.+..+...|+..+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 447788899999999999999985 478999999998643 2333445678899999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||..||.|..+|. ....+++...+-.-.+|+.||.|||+++ ||.||||.+|.|||.+|++||.|||+++.-.
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999988773 3456888888888999999999999988 9999999999999999999999999998532
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.. ...+...||||.|+|||++....|....|+|.+||++|||++|+.||..... +.+.+.. ..+
T Consensus 320 ~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----~kLFeLI----l~e----- 383 (516)
T KOG0690|consen 320 KY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----EKLFELI----LME----- 383 (516)
T ss_pred cc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----hHHHHHH----Hhh-----
Confidence 22 2234568999999999999999999999999999999999999999954321 1222221 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP 620 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 620 (671)
|-.+.....++ .+ .+.--.+..||.+|.
T Consensus 384 -d~kFPr~ls~e-Ak---tLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 -DLKFPRTLSPE-AK---TLLSGLLKKDPKKRL 411 (516)
T ss_pred -hccCCccCCHH-HH---HHHHHHhhcChHhhc
Confidence 12233344444 33 334467889999994
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=259.90 Aligned_cols=256 Identities=25% Similarity=0.318 Sum_probs=192.2
Q ss_pred cccCCCCcccEEEEE-ecCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 360 NMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
+.||+|+|+.|-.++ +.+|.++|||++.+.....+..+.+|++++..- .|+||++++.+|.++...|||||-|.||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999988 578999999999887777778899999999987 599999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC---CeEEeecccccccc--CCC--
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM---NPKISDFGMARIFA--GSE-- 510 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~--~~~-- 510 (671)
...| ++++.+++.++.++.++|+.||.|||.+| |.||||||+|||-.+.. -+||+||.|..-.. ++-
T Consensus 164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 8888 56778999999999999999999999998 99999999999997654 48999998875322 111
Q ss_pred -CccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC--CCCCCHH----HHHHHH
Q 005893 511 -GEVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG--ATAPNLL----AYAWHL 578 (671)
Q Consensus 511 -~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~--~~~~~l~----~~~~~~ 578 (671)
..+.....+|+..|||||+.. ...|+.++|.||||||+|-|++|..||......+ =...+.. +.....
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence 112223468999999999762 2468899999999999999999999996432110 0011111 111222
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+|.. ++-|+. ...-.++.+ +++...+..++.+|-++.+++.
T Consensus 318 IQEGkY-eFPdkd--WahIS~eak---dlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEGKY-EFPDKD--WAHISSEAK---DLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhccCC-cCChhh--hHHhhHHHH---HHHHHHHhccHHhhhhhhhccC
Confidence 223222 111110 000122333 4444667799999999988876
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=289.31 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=208.6
Q ss_pred echhhHHHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc
Q 005893 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD 421 (671)
Q Consensus 344 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 421 (671)
++++.+-..++-|++.++||.|.+|.||+++. ++++.+|+|++.... ...++++.|.++++.+ .|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 34455555667788999999999999999995 578889999887643 3445788899999988 79999999999873
Q ss_pred -----CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeE
Q 005893 422 -----GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496 (671)
Q Consensus 422 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 496 (671)
++++|||||||.+|+..+++.... ...+.|..+..|+++++.||.+||.+. ++|||||-.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 568999999999999999997654 667999999999999999999999987 99999999999999999999
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l 571 (671)
|.|||++..+...-. ......||+.|||||++.-. .|+.++|+||||++..||--|.+|+-..++.
T Consensus 164 LvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------- 234 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------- 234 (953)
T ss_pred Eeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------
Confidence 999999987654332 33446899999999998543 4778999999999999999999998543321
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.......+.+ ...-..+....+++.+.+..|+..|-++||++.++++
T Consensus 235 -raLF~IpRNP--------PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 235 -RALFLIPRNP--------PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -hhhccCCCCC--------CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111111111 1111223455667888888999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=266.98 Aligned_cols=220 Identities=21% Similarity=0.166 Sum_probs=173.4
Q ss_pred CCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchhhhhcC
Q 005893 365 GGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFD 443 (671)
Q Consensus 365 G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 443 (671)
|.+|.||++... +++.+|+|+++... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999964 68899999987643 233455555666899999999999999999999999999999998843
Q ss_pred CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCC
Q 005893 444 PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523 (671)
Q Consensus 444 ~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 523 (671)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++|||++...... .....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcc
Confidence 345899999999999999999999988 999999999999999999999999987654332 112345677
Q ss_pred ccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHH
Q 005893 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLR 603 (671)
Q Consensus 524 y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 603 (671)
|+|||....+.++.++||||+|+++|||++|+.|+...... .... ....+....+ ..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------------~~~~-----~~~~~~~~~~----~~ 204 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------------INTH-----TTLNIPEWVS----EE 204 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------------cccc-----cccCCcccCC----HH
Confidence 99999998888999999999999999999999876432111 0000 0001112222 23
Q ss_pred HHHHHHHccccCCCCCCCHH
Q 005893 604 YIHIGLLCVQEDAFDRPTMS 623 (671)
Q Consensus 604 l~~l~~~Cl~~~p~~RPt~~ 623 (671)
+.+++.+|++.||++||++.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHccCCHHHhcCCC
Confidence 56777899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-33 Score=263.54 Aligned_cols=255 Identities=29% Similarity=0.362 Sum_probs=191.3
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+.+....||.|.||+|+|-.+ +.|+..|||+++... +++..++..|.+...+- +.||||+++|.+..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 344456799999999999876 469999999998643 46667788888877665 799999999999999999999999
Q ss_pred cCCCchhhhhcC--CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 432 MPNSSLDAILFD--PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 432 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|+ .+|+.+... .-....+++..+-.|..-...||.||.+.- .|||||+||+|||||..|.+||+|||.+..+.++
T Consensus 145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 94 667665321 123445788888888888999999998753 5999999999999999999999999998766443
Q ss_pred CCccccccccccCCccchhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
- ..+...|...|||||.+... .|+.+|||||||++|+|+.||+.|+.-+.+ +.+...+.. .|.+..+
T Consensus 222 i---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv-~gdpp~l 290 (361)
T KOG1006|consen 222 I---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVV-IGDPPIL 290 (361)
T ss_pred H---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHH-cCCCCee
Confidence 2 22345788889999988543 489999999999999999999999864332 222222222 2222222
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+.- ..+.-..+...+-.|+..|-.+||...++.+
T Consensus 291 ~~~~~----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKE----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCccc----ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11111 1112234666677999999999999999875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=256.81 Aligned_cols=203 Identities=28% Similarity=0.428 Sum_probs=167.4
Q ss_pred CCCCcccccCCCCcccEEEEEec---C--CceEEEEEccccchh--chHHHHHHHHHHhhcCCCCeeeEeeEEEc-CCee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS---D--GKEIAVKRLSSCSEQ--GNAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~---~--g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 425 (671)
..|+....||+|.||.|||+.-. + .+.+|||+++..+.. -.....+|+.++++++|||++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35777889999999999999642 2 237999999754322 12356789999999999999999999987 6778
Q ss_pred eEEEeccCCCchhhhhcC--CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC----CCeEEee
Q 005893 426 LLVYEFMPNSSLDAILFD--PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD----MNPKISD 499 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 499 (671)
+|++||.+. +|..+++. ....+.++...+..|+.||+.|+.|||++- |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999975 66666643 223457899999999999999999999998 9999999999999877 9999999
Q ss_pred ccccccccCCCCcc-ccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 500 FGMARIFAGSEGEV-NTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 500 fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
||++|.+.+.-... ....++-|..|.|||++.+. .||.+.|||+.|||+.||+|-++-|..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999886643332 44567889999999998874 699999999999999999998877653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=281.09 Aligned_cols=239 Identities=27% Similarity=0.336 Sum_probs=186.8
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 430 (671)
+..|.....+|.|+|+.|..+.. .+++..++|++.+... +-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 56677788899999999999985 4688999999976522 223566666555 79999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE-cCCCCeEEeeccccccccCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL-DYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~~ 509 (671)
.+.++-|.+.+. ..+.+. .++..|+.+|+.++.|||+++ ++||||||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999987766652 233343 777789999999999999998 9999999999999 58899999999999876544
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
....+-|..|.|||++....|++++|+||||++||+|++|+.||...... .++. .....+...
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----~ei~----~~i~~~~~s---- 532 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----IEIH----TRIQMPKFS---- 532 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----HHHH----HhhcCCccc----
Confidence 22246688999999999999999999999999999999999998643221 1111 111222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..-.++.+ +++.+||+.||.+||+|.++..
T Consensus 533 -----~~vS~~AK---dLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 -----ECVSDEAK---DLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -----cccCHHHH---HHHHHhccCChhhCcChhhhcc
Confidence 12234444 4455999999999999999974
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=255.85 Aligned_cols=248 Identities=23% Similarity=0.243 Sum_probs=189.7
Q ss_pred hCCCCc-ccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC----Cee
Q 005893 353 TSNFSD-SNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG----DEK 425 (671)
Q Consensus 353 ~~~~~~-~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~----~~~ 425 (671)
+++|.+ .++||-|-.|.|-....+ +++.+|+|+|.... ...+|+++.-.. .|||||.+++++.+. ..+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 344544 368999999999998864 68899999997532 345777776554 799999999998753 457
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEEeeccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISDFGM 502 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgl 502 (671)
++|||.|+||.|...+.+ +....+++.++-.|++||..|+.|||+.+ |.||||||+|+|... +-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 899999999999888854 45566999999999999999999999998 999999999999965 45699999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
++.-... ......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||-...-. .+..-.+...+.|
T Consensus 211 AK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-----aispgMk~rI~~g 282 (400)
T KOG0604|consen 211 AKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKRRIRTG 282 (400)
T ss_pred ccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc-----cCChhHHhHhhcc
Confidence 9864432 2233468899999999999999999999999999999999999998533211 1111112222222
Q ss_pred CccccccccccCCCCHHH----HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NALDLIDPLLTDTCSPDE----FLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~----~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. +++.+| .+...+++...|..+|++|-|+.|++.
T Consensus 283 qy----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QY----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred Cc----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 21 122222 223456667889999999999999985
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=274.75 Aligned_cols=193 Identities=31% Similarity=0.479 Sum_probs=168.5
Q ss_pred ccccCCCCcccEEEEEe-cCCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 359 SNMLGQGGFGPVYKGVL-SDGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
.++||+|.||+||-|+. ++|+.||||++.+ ...+....+.+|+.+|++++||.||.+.-.|+..+..++|||-+.|-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999996 5799999999875 23445578999999999999999999999999999999999999655
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC---CCeEEeeccccccccCCCCc
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD---MNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 512 (671)
-|+-+|. ...+.+++.....++.||+.||.|||.++ |+|.||||+||||.+. -++||+|||++|...+....
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 5555553 34556888888889999999999999998 9999999999999654 57999999999998765433
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
...+||+.|+|||++.++.|...-|+||.|||+|--++|..||.
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 34699999999999999999999999999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=257.43 Aligned_cols=238 Identities=30% Similarity=0.387 Sum_probs=190.3
Q ss_pred CcccEEEEEec-CCceEEEEEccccchhc-hHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchhhhhcC
Q 005893 366 GFGPVYKGVLS-DGKEIAVKRLSSCSEQG-NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFD 443 (671)
Q Consensus 366 ~~g~Vy~~~~~-~g~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 443 (671)
+||.||+++.. +|+.+++|++....... ...+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999986 48999999997654444 67899999999999999999999999999999999999999999998843
Q ss_pred CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCC
Q 005893 444 PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523 (671)
Q Consensus 444 ~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 523 (671)
...+++..++.++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 223889999999999999999999987 9999999999999999999999999998765432 2233567889
Q ss_pred ccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHH
Q 005893 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLR 603 (671)
Q Consensus 524 y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 603 (671)
|++||.+....++.++||||||+++++|++|..|+.... ... ........+..... .. .. .....
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~~~-~~~~~~~~~~~~~~-~~---~~---~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------QLL-ELFKKIGKPKPPFP-PP---EW---KISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHH-HHHHHHhccCCCCc-cc---cc---cCCHH
Confidence 999999988889999999999999999999999985321 111 11122222111100 00 00 01235
Q ss_pred HHHHHHHccccCCCCCCCHHHHHH
Q 005893 604 YIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 604 l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 778888999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=268.13 Aligned_cols=257 Identities=28% Similarity=0.371 Sum_probs=195.7
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccch-------hchHHHHHHHHHHhhcCCCCeeeEeeEEEc-C
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSE-------QGNAEFTNEVLLILKLQHKNLVKLLGFCVD-G 422 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~ 422 (671)
..++|-.+++||+|+|+.|||+.. ...+.||+|+-.-... .-.+...+|.++.+.|.||.||++++++.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 345666778999999999999984 5678899997542211 112346789999999999999999999874 5
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEEee
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISD 499 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~D 499 (671)
+..+-|+||++|.+|+.+| ...+.+++.+++.|+.||+.||.||.+.. ++|||-||||.||||-+ -|.+||.|
T Consensus 541 dsFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 5678899999999999999 45667999999999999999999999874 78999999999999954 47899999
Q ss_pred ccccccccCCCCc-----cccccccccCCccchhhhccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005893 500 FGMARIFAGSEGE-----VNTARIVGTYGYMAPEYAMEG----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570 (671)
Q Consensus 500 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~ 570 (671)
|||++.+..+... ..+....||..|++||.+.-+ ..+.|.||||.|||+|..+.|+.||+.....
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ------ 690 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ------ 690 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH------
Confidence 9999987654332 345567899999999988544 5788999999999999999999999864432
Q ss_pred HHHHHHHHHhcCCccccccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTC-SPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~ 626 (671)
...+....+...-.-.+.... -..+.. .++.+||+..-++|....++.
T Consensus 691 -----QdILqeNTIlkAtEVqFP~KPvVsseAk---aFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 691 -----QDILQENTILKATEVQFPPKPVVSSEAK---AFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----HHHHhhhchhcceeccCCCCCccCHHHH---HHHHHHHHhhhhhhhhHHHHc
Confidence 122223333332222222111 112333 455599999999998766654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=288.58 Aligned_cols=259 Identities=18% Similarity=0.192 Sum_probs=166.6
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-C----CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeE------EE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-D----GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF------CV 420 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~------~~ 420 (671)
..++|+..+.||+|+||.||+|++. + +..||||++...... +...+| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4577899999999999999999975 4 689999988653221 111111 1222222222222211 24
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCCC-----------------CCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRKR-----------------GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLK 483 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlk 483 (671)
.+...++|+||+++++|.+++...... .......+..++.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 556789999999999999888532110 01123345679999999999999988 9999999
Q ss_pred CCcEEEcC-CCCeEEeeccccccccCCCCccccccccccCCccchhhhccC----------------------CCCcchh
Q 005893 484 ASNVLLDY-DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG----------------------LYSIKSD 540 (671)
Q Consensus 484 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD 540 (671)
|+|||+++ ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 589999999999865433222 22345789999999965322 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc----cccccccccCC----C--CHHHHHHHHHHHHH
Q 005893 541 VFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA----LDLIDPLLTDT----C--SPDEFLRYIHIGLL 610 (671)
Q Consensus 541 VwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~----~~~~d~~l~~~----~--~~~~~~~l~~l~~~ 610 (671)
||||||++|||+++..+.+. .+..+.......+.. ...+.+....+ + .........+++.+
T Consensus 362 VwSlGviL~el~~~~~~~~~---------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~ 432 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS---------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS 432 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch---------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence 99999999999997665421 111111111111100 00011110000 0 00011124478889
Q ss_pred ccccCCCCCCCHHHHHH
Q 005893 611 CVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 611 Cl~~~p~~RPt~~ev~~ 627 (671)
|++.||++|||+.|+++
T Consensus 433 mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 433 MMRFKGRQRISAKAALA 449 (566)
T ss_pred HccCCcccCCCHHHHhC
Confidence 99999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=269.45 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=195.8
Q ss_pred echhhHHHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEE
Q 005893 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFC 419 (671)
Q Consensus 344 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 419 (671)
+.++.-+....-|..++.||-|+||+|.++.. ++...+|+|.|++.+ .......+.|.+||.+.+.+.||+|+..|
T Consensus 619 iRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF 698 (1034)
T KOG0608|consen 619 IRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF 698 (1034)
T ss_pred HHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence 33444444445577789999999999999985 456679999998643 34456788999999999999999999999
Q ss_pred EcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 420 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
.+.+.+|+||+|++||++-.+| -.-+.+.+..++..+.++..|+++.|+.| +|||||||+|||||.+|++||.|
T Consensus 699 QDkdnLYFVMdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 699 QDKDNLYFVMDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred ccCCceEEEEeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeee
Confidence 9999999999999999998888 34667889999999999999999999988 99999999999999999999999
Q ss_pred ccccccccC--------CCCccc---------------------------c-----ccccccCCccchhhhccCCCCcch
Q 005893 500 FGMARIFAG--------SEGEVN---------------------------T-----ARIVGTYGYMAPEYAMEGLYSIKS 539 (671)
Q Consensus 500 fgla~~~~~--------~~~~~~---------------------------~-----~~~~gt~~y~aPE~~~~~~~s~ks 539 (671)
|||+.-+.- ...+.. . ...+||+.|+|||++....++..+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 999864321 000000 0 014799999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 005893 540 DVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDR 619 (671)
Q Consensus 540 DVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R 619 (671)
|+||.|||||||+.|+.||-.....+ ....+. +|...++-...++.+++....+.+ +|. ++++|
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~-tq~kv~----------nw~~~l~~~~~~~ls~e~~~li~k---Lc~--sad~R 916 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGE-TQYKVI----------NWRNFLHIPYQGNLSKEALDLIQK---LCC--SADSR 916 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCc-ceeeee----------ehhhccccccccccCHHHHHHHHH---Hhc--Chhhh
Confidence 99999999999999999996544332 111121 233344444455666665544333 454 44455
Q ss_pred C
Q 005893 620 P 620 (671)
Q Consensus 620 P 620 (671)
.
T Consensus 917 L 917 (1034)
T KOG0608|consen 917 L 917 (1034)
T ss_pred h
Confidence 3
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=261.30 Aligned_cols=271 Identities=25% Similarity=0.285 Sum_probs=200.0
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch---hchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE---QGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 426 (671)
...+|....+||+|+||.|-++..+ +.+.+|||++++... .+.+--+.|-++|... +-|.++++..+++.-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 3456888899999999999999865 456799999986322 1222234566666655 6789999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+.+|+|--.+ +.-+.+.+..+.-.+.+||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.-
T Consensus 427 FVMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eEEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999997666 55666888889999999999999999998 999999999999999999999999999853
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
.-. ...+...+||+.|+|||++..++|+..+|+|||||+||||+.|+.||+.. +..++.+.. .+.+.
T Consensus 501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-----DE~elF~aI----~ehnv-- 567 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-----DEDELFQAI----MEHNV-- 567 (683)
T ss_pred ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHH----HHccC--
Confidence 222 23455689999999999999999999999999999999999999999643 223333332 22211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCC----HH-HHHH--Hh------cCCCCCCCCCCCCccccccC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT----MS-SVVV--ML------QGETITLCQPQKPAFSFGRV 649 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt----~~-ev~~--~L------~~~~~~~~~p~~p~~~~~~~ 649 (671)
......+.+ .+.|...-+..+|.+|.- -+ +|.+ ++ +-+.-++++|-+|..-.++.
T Consensus 568 ----syPKslSkE----Av~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~ 635 (683)
T KOG0696|consen 568 ----SYPKSLSKE----AVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRD 635 (683)
T ss_pred ----cCcccccHH----HHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCc
Confidence 111222333 445555677788888832 22 1211 01 11244577777777744433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=275.40 Aligned_cols=263 Identities=19% Similarity=0.258 Sum_probs=177.6
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-----------------cCCceEEEEEccccchhchHH--------------HHHH
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-----------------SDGKEIAVKRLSSCSEQGNAE--------------FTNE 400 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~l~~~~~~~~~~--------------~~~E 400 (671)
..++|++.++||+|+||.||+|.+ .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 235679999986533222222 3347
Q ss_pred HHHHhhcCCCCe-----eeEeeEEEc--------CCeeeEEEeccCCCchhhhhcCCCC---------------------
Q 005893 401 VLLILKLQHKNL-----VKLLGFCVD--------GDEKLLVYEFMPNSSLDAILFDPRK--------------------- 446 (671)
Q Consensus 401 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------- 446 (671)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 677777753 3467999999999999998863211
Q ss_pred CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccc
Q 005893 447 RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMA 526 (671)
Q Consensus 447 ~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 526 (671)
...++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123577888999999999999999987 99999999999999999999999999976433221 11122345789999
Q ss_pred hhhhccCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCCCCCCC---CCCCCHHHHHHHHHh
Q 005893 527 PEYAMEGLY----------------------SIKSDVFSFGVLLIEIITGRR-NTGFNQSRG---ATAPNLLAYAWHLWN 580 (671)
Q Consensus 527 PE~~~~~~~----------------------s~ksDVwSlGvil~elltG~~-p~~~~~~~~---~~~~~l~~~~~~~~~ 580 (671)
||.+..... ..+.||||+||+++||++|.. |+.....-. ....+. ...|+.+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~-~~~~r~~~ 457 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDND-LNRWRMYK 457 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccch-HHHHHhhc
Confidence 998754321 135799999999999999875 553211000 000001 11122222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDA---FDRPTMSSVVV 627 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPt~~ev~~ 627 (671)
.... +-...+..+ + ...+++.+++..+| .+|+|++|+++
T Consensus 458 ~~~~----~~~~~d~~s-~---~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKY----DFSLLDRNK-E---AGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCC----CcccccccC-h---HHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 2221 111111112 2 24556667877655 78999999984
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=279.55 Aligned_cols=245 Identities=29% Similarity=0.429 Sum_probs=186.2
Q ss_pred CCcccccCCCCccc-EEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 356 FSDSNMLGQGGFGP-VYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 356 ~~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
|...+++|.|+-|+ ||+|.+ +|++||||++-... ..-..+|+..|+.- +|||||++++.-.+++..|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 55567899999876 799999 68899999886422 23457899999876 7999999999988999999999999
Q ss_pred CCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---C--CCeEEeecccccccc
Q 005893 434 NSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---D--MNPKISDFGMARIFA 507 (671)
Q Consensus 434 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~Dfgla~~~~ 507 (671)
..+|++++... .......-...+.+..|+++||++||+.+ ||||||||.||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 57899998653 11111111445678899999999999987 999999999999975 2 579999999999887
Q ss_pred CCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 508 GSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG-RRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 508 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.+.... ......||.+|+|||++....-+...||||+||++|..++| ++||+..-..+ .++ +....-.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---~NI-------l~~~~~L 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---ANI-------LTGNYTL 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---hhh-------hcCccce
Confidence 765443 34557899999999999998888899999999999999995 99997533221 011 1111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~ 626 (671)
..+.+ .+++ ...+++..|+..+|..||++.+|+
T Consensus 733 ~~L~~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 733 VHLEP------LPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred eeecc------CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11111 1111 345667799999999999999997
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=233.54 Aligned_cols=215 Identities=29% Similarity=0.421 Sum_probs=175.1
Q ss_pred eechhhHHHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc-chhchHHHHHHHHHHhh-cCCCCeeeEeeEE
Q 005893 343 YIDLETLDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC-SEQGNAEFTNEVLLILK-LQHKNLVKLLGFC 419 (671)
Q Consensus 343 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~ 419 (671)
++....+++..++......||+|++|.|-+-++ .+|+..|+|+++.. ..+..+...+|+.+..+ ...|.+|.++|..
T Consensus 35 ~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 35 YIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred EEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence 444555666677777788899999999988875 58999999999753 34555677888888765 4799999999999
Q ss_pred EcCCeeeEEEeccCCCchhhhhcC-CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEe
Q 005893 420 VDGDEKLLVYEFMPNSSLDAILFD-PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKIS 498 (671)
Q Consensus 420 ~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 498 (671)
..+...++.||.| ..+|+.+-.+ ....+.+++..+-+|+..|..||.|||++- .+||||+||+|||++.+|++||+
T Consensus 115 ~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 115 FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEc
Confidence 9999999999999 4677776533 235667899999999999999999999863 69999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccchhhhcc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 005893 499 DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME----GLYSIKSDVFSFGVLLIEIITGRRNTGFNQS 563 (671)
Q Consensus 499 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVwSlGvil~elltG~~p~~~~~~ 563 (671)
|||.+..+.++-. .+...|...|||||.+.. ..|+.|+||||||+.+.||.+++.|++.+..
T Consensus 192 DFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 192 DFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred ccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 9999987654321 122356778999998743 3689999999999999999999999976543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=226.07 Aligned_cols=197 Identities=27% Similarity=0.414 Sum_probs=164.1
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+|...++||+|.||+|+|++.. +++.||+|+++- .++.-.....+|+-++++++|+|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4556688999999999999964 578899998863 3333345678999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+. .+|..+.. .-++.++.+....++.|+++||.|+|+++ +.||||||.|.||+.+|+.|++|||+++.+.-.-
T Consensus 83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 94 57777763 34566899999999999999999999998 9999999999999999999999999999764321
Q ss_pred ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHh-CCCCCC
Q 005893 512 EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIIT-GRRNTG 559 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~ellt-G~~p~~ 559 (671)
. -....+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |++.|+
T Consensus 156 r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 1 12223568899999998765 58999999999999999987 555553
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=254.63 Aligned_cols=260 Identities=21% Similarity=0.268 Sum_probs=195.8
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcC-C-C----CeeeEeeEEEcCCe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-H-K----NLVKLLGFCVDGDE 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~g~~~~~~~ 424 (671)
.+++|.+...+|+|.||.|-+.... .+..||||+++.... -.+..+-|+++++++. + | -+|.+.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 4788999999999999999999864 468899999986433 2345677999999993 2 2 37888899999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-------------
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY------------- 491 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~------------- 491 (671)
.++|+|.+ |-++.++|.. .+-.+++...++.|+.|++++++|||+.+ ++|-||||+|||+-+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 5688888854 34456889999999999999999999998 999999999999821
Q ss_pred -------CCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 005893 492 -------DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR 564 (671)
Q Consensus 492 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~ 564 (671)
+..+||+|||.++...... ..++.|..|.|||++.+-.++..+||||+||||.|+.||...|.....
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen- 314 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN- 314 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc-
Confidence 3458999999988643322 346789999999999999999999999999999999999988753321
Q ss_pred CCCCCCHHHH-----------------HHHHHhcCCcc--c---------ccccc--cc--CCCCHHHHHHHHHHHHHcc
Q 005893 565 GATAPNLLAY-----------------AWHLWNEGNAL--D---------LIDPL--LT--DTCSPDEFLRYIHIGLLCV 612 (671)
Q Consensus 565 ~~~~~~l~~~-----------------~~~~~~~~~~~--~---------~~d~~--l~--~~~~~~~~~~l~~l~~~Cl 612 (671)
.+.+ .. ..+....+.+. + ..++. +. -.....+...+.+++..++
T Consensus 315 ---~EHL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 315 ---LEHL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred ---HHHH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 1111 00 11111111000 0 00000 00 0112345667999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 005893 613 QEDAFDRPTMSSVVV 627 (671)
Q Consensus 613 ~~~p~~RPt~~ev~~ 627 (671)
..||.+|+|+.|++.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999884
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=265.58 Aligned_cols=242 Identities=25% Similarity=0.317 Sum_probs=195.1
Q ss_pred CCCCcccccCCCCcccEEEEEecCCc-eEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGK-EIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.+++....||-|+||.|-++..++.. .+|+|++++. ..+..+.+..|-.+|.+.+.|.||+++.-|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34455677999999999999875433 4899988752 3445567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|-|-||.|..+| +.++.++.....-++..+.+|++|||.++ ||.|||||+|.+||.+|-+||.|||+++.+...
T Consensus 500 EaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999 66788999999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
. .+-.++||+.|.|||++.+...+..+|.||||+++|||++|++||...++ ...+ ....+| +|
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-------mktY--n~ILkG-----id 636 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-------MKTY--NLILKG-----ID 636 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-------HHHH--HHHHhh-----hh
Confidence 3 34458999999999999999999999999999999999999999964322 1111 111111 22
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt 621 (671)
.. .++....+...++++.....+|.+|.-
T Consensus 637 ~i---~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KI---EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hh---hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11 111122233456666777899999976
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=243.44 Aligned_cols=221 Identities=24% Similarity=0.313 Sum_probs=181.3
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 426 (671)
.-++|....+||+|+|.+|-.+++. +.+.+|+|++++. ...+......|-.+..+. +||.+|-+..+|+.+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 3456888899999999999999874 5788999999752 233444456666666665 8999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+|.||+++|+|--.+ +....++++.++-...+|.-||.|||+.| ||.||||..|+|+|..|++||.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999996555 55566899999999999999999999998 999999999999999999999999999853
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
-... -.+...+||+.|.|||++.+..|....|+|+|||+++||+.|+.||+..... ....+-.++..+...+
T Consensus 402 l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-n~d~ntedylfqvile 473 (593)
T KOG0695|consen 402 LGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-NPDMNTEDYLFQVILE 473 (593)
T ss_pred CCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-CcccchhHHHHHHHhh
Confidence 2221 2345689999999999999999999999999999999999999999864422 2344555555554444
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=243.43 Aligned_cols=199 Identities=29% Similarity=0.478 Sum_probs=161.3
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--------C
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--------D 423 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--------~ 423 (671)
.|+...+||+|.||+||+++.. +|+.||+|+.-- ..+.--....+|+.+|..|+|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3455678999999999999864 578889987542 2223334568999999999999999999888642 2
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++|+.+++ -+|..+|.+. ...++..++.+.+.++..||.|+|... |+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 3689999996 4777777432 244888999999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCc--cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 504 RIFAGSEGE--VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 504 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
+.+...+.. ...+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||+||.+-+.
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 887654322 22334566899999998876 579999999999999999999987664
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=229.97 Aligned_cols=202 Identities=22% Similarity=0.436 Sum_probs=167.6
Q ss_pred eechhhHHHH---hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEee
Q 005893 343 YIDLETLDVA---TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLG 417 (671)
Q Consensus 343 ~~~~~~l~~~---~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g 417 (671)
++++|...+. .++|++.+++|+|.+++|+.|+. .+.+.++||++++... +.+.+|+.+|++|. ||||+++++
T Consensus 24 YWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~D 100 (338)
T KOG0668|consen 24 YWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLD 100 (338)
T ss_pred hcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhh
Confidence 4555544433 36789999999999999999994 5788999999987543 46789999999996 999999999
Q ss_pred EEEcCCe--eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CC
Q 005893 418 FCVDGDE--KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MN 494 (671)
Q Consensus 418 ~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 494 (671)
+..+... ..||+||+.+.+...+. ..++...+...+.+++.||.|+|+.| |.|||+||.|+++|.. -.
T Consensus 101 iV~Dp~SktpaLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 101 IVKDPESKTPSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred hhcCccccCchhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhce
Confidence 9887654 46999999999887764 33777788899999999999999998 9999999999999865 67
Q ss_pred eEEeeccccccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 495 PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 495 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
++|+|+|++..+-+.... ...+.+..|..||++.. +.|+..-|+|||||++.+|+..+.||-
T Consensus 172 LrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred eeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 999999999876554322 22355677899998865 568889999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-27 Score=231.58 Aligned_cols=211 Identities=36% Similarity=0.577 Sum_probs=181.9
Q ss_pred cCCCCcccEEEEEecC-CceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchhh
Q 005893 362 LGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDA 439 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 439 (671)
||+|.+|.||++...+ ++.+++|++...... ....+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999854 899999999865432 34678999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeeccccccccCCCCccccccc
Q 005893 440 ILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIFAGSEGEVNTARI 518 (671)
Q Consensus 440 ~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 518 (671)
++.... ..+++..++.++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985322 46889999999999999999999997 999999999999999 89999999999886544321 12234
Q ss_pred cccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCC
Q 005893 519 VGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCS 597 (671)
Q Consensus 519 ~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 597 (671)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 577889999998877 788999999999999998
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 005893 598 PDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629 (671)
Q Consensus 598 ~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L 629 (671)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3466788899999999999999998643
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=236.20 Aligned_cols=194 Identities=27% Similarity=0.431 Sum_probs=160.8
Q ss_pred cccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-----eeeEEE
Q 005893 358 DSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-----EKLLVY 429 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~ 429 (671)
..+.||-|+||.||.... .+|+.|++|++... .-...+.+-+|+.+|..++|.|++..+++..... +.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 357899999999999986 47999999998642 1223456789999999999999999988876543 467889
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|.| ..+|..++. ....++...+.-+..||++||.|||+.+ |.||||||.|.|++++-.+||+|||+++....+
T Consensus 137 ELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 137 ELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 988 568888774 4456788888889999999999999998 999999999999999999999999999976554
Q ss_pred CCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
+... .+..+-|..|.|||++++. .|+...||||.|||+.||+..+..|.
T Consensus 210 ~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 210 DRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 4333 3345668899999999874 69999999999999999998777664
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=227.20 Aligned_cols=198 Identities=33% Similarity=0.466 Sum_probs=170.7
Q ss_pred CCcccccCCCCcccEEEEEecC-CceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
|...+.||+|++|.||++...+ ++.+++|.+...... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556889999999999999865 889999999865444 56788999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+++|.+++.... ..+++.....++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 999999985322 11889999999999999999999987 999999999999999999999999999876544211
Q ss_pred ccccccccCCccchhhh-ccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 514 NTARIVGTYGYMAPEYA-MEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
......++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 12234677889999998 66678889999999999999999999994
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=246.70 Aligned_cols=195 Identities=27% Similarity=0.395 Sum_probs=164.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--------hchHHHHHHHHHHhhcC---CCCeeeEeeEEEc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--------QGNAEFTNEVLLILKLQ---HKNLVKLLGFCVD 421 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~ 421 (671)
.+|...+.+|+|+||.|+.++++ +..+|+||.+.+... ...-.+-.|+.+|..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45788899999999999999975 467899998865321 11123567999999997 9999999999999
Q ss_pred CCeeeEEEeccC-CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 422 GDEKLLVYEFMP-NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 422 ~~~~~lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
++..+|+||-.. +-+|.+++ .....+++.+...|++||+.|+++||+++ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999764 55777777 44556999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCC
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNT 558 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~ 558 (671)
|.+-...+.. ...++||.+|.|||++.+.+| ...-|||++|++||.++....||
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 9987654332 334789999999999998887 45689999999999999887776
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-27 Score=248.96 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=198.0
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|+..+.+|.|.||.|||++. ..++..|+|+++-....+..-+.+|+.+++.-+|||||.++|-+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 35677788999999999999996 46889999999876666677788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+.+|+|++.- ...+++++.++...+++.++||+|||+.+ -+|||||-.|||+++.+.+|++|||.+-.+...-
T Consensus 94 cgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence 9999999976 45678999999999999999999999998 8999999999999999999999999876543211
Q ss_pred ccccccccccCCccchhhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 512 EVNTARIVGTYGYMAPEYA---MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.....+.||+.|||||+. ..+.|..++|||++|+...|+---++|.-.. ...+..+-+-+. ..
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl--------hpmr~l~LmTkS-----~~ 232 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL--------HPMRALFLMTKS-----GF 232 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc--------chHHHHHHhhcc-----CC
Confidence 122346899999999987 4567999999999999999987766653211 111111111111 11
Q ss_pred c-ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005893 589 D-PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626 (671)
Q Consensus 589 d-~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~ 626 (671)
+ +.+.+. ......+.+++..|+-.+|++||+++.++
T Consensus 233 qpp~lkDk--~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 233 QPPTLKDK--TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCCcccCC--ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 2 122211 12233477888899999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=225.39 Aligned_cols=193 Identities=30% Similarity=0.372 Sum_probs=157.9
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------e
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------E 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------~ 424 (671)
.+|...+.+|.|.- .|-.+.. -.+++||+|++... .........+|...+..++|+||++++.++.-.. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 5554443 25889999987542 2344566789999999999999999999987543 4
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++|||+|. .+|..++. -.++-..+..|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 689999994 67777764 23666778899999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
.-... ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+--|.
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 64332 23344678899999999998889999999999999999999998775
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=225.93 Aligned_cols=132 Identities=27% Similarity=0.376 Sum_probs=107.7
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC-----C---CCeeeEeeEEEc--
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-----H---KNLVKLLGFCVD-- 421 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~g~~~~-- 421 (671)
..+|...++||-|.|++||++.. .+.+.||+|+.+.... -.+....||++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 46788999999999999999986 4567899999986432 2345678999999883 3 369999999985
Q ss_pred --CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE
Q 005893 422 --GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL 489 (671)
Q Consensus 422 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll 489 (671)
+.+.++|+|++ |-+|..+|... .-+.++...+.+|++||+.||.|||.+. +|||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999999 55666666432 3345889999999999999999999976 69999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=230.69 Aligned_cols=208 Identities=21% Similarity=0.244 Sum_probs=174.3
Q ss_pred echhhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcC------CCCeeeEe
Q 005893 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ------HKNLVKLL 416 (671)
Q Consensus 344 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~ 416 (671)
+.+.--+....+|.+....|+|-|++|-+|... -|+.||||++..... -.+.=+.|+++|.+|+ -.|+++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 333444566788999999999999999999864 478999999986432 2223467999999995 35899999
Q ss_pred eEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCe
Q 005893 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNP 495 (671)
Q Consensus 417 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~ 495 (671)
..|...++++||+|-+ ..+|.++|.....+-.|....+..++.|+.-||..|...+ |+|.||||.|||+++. ..+
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence 9999999999999987 5789999987777777999999999999999999999988 9999999999999876 568
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
||||||.|.....++- +...-+..|.|||++.+-+|+...|+||.||.||||.||+..|+.
T Consensus 577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 9999999876544432 223345679999999999999999999999999999999998863
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=263.04 Aligned_cols=196 Identities=19% Similarity=0.215 Sum_probs=136.6
Q ss_pred hcCC-CCeeeEeeEEE-------cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCce
Q 005893 406 KLQH-KNLVKLLGFCV-------DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477 (671)
Q Consensus 406 ~l~H-~niv~l~g~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~i 477 (671)
.++| .||+++++++. +....++++||+ +++|.++|.. ....+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3455 57777777762 233567788887 6699999853 2345999999999999999999999988 9
Q ss_pred eecCCCCCcEEEcC-------------------CCCeEEeeccccccccCCCC--------------ccccccccccCCc
Q 005893 478 IHRDLKASNVLLDY-------------------DMNPKISDFGMARIFAGSEG--------------EVNTARIVGTYGY 524 (671)
Q Consensus 478 vH~Dlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y 524 (671)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566666666654211000 0001124678899
Q ss_pred cchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHH
Q 005893 525 MAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRY 604 (671)
Q Consensus 525 ~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 604 (671)
||||++.+..++.++|||||||+||||++|..|+... ..... .+... .+.+.. .......
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-------~~~~~----~~~~~----~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-------SRTMS----SLRHR----VLPPQI-----LLNWPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-------HHHHH----HHHHh----hcChhh-----hhcCHHH
Confidence 9999999999999999999999999999988775311 00000 01000 011110 1112234
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 005893 605 IHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 605 ~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..++.+||+.+|.+||+|.||++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhh
Confidence 57778999999999999999975
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-25 Score=221.91 Aligned_cols=201 Identities=24% Similarity=0.420 Sum_probs=166.2
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec----CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCC
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 423 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 423 (671)
+....+.|...++||+|.|++||++++. ....||+|.+...+. ...+.+|+++|..+ .+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445567888999999999999999864 356899999876543 34588999999999 5999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeeccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGM 502 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgl 502 (671)
...+|+||++.....++... ++...+...++.+..||.++|.+| ||||||||+|+|.+.. +.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999888743 668888999999999999999998 9999999999999854 6789999999
Q ss_pred cccccCCC------C-------c--------------------c---------ccccccccCCccchhhhcc-CCCCcch
Q 005893 503 ARIFAGSE------G-------E--------------------V---------NTARIVGTYGYMAPEYAME-GLYSIKS 539 (671)
Q Consensus 503 a~~~~~~~------~-------~--------------------~---------~~~~~~gt~~y~aPE~~~~-~~~s~ks 539 (671)
+......+ . . . ......||++|.|||++.. +..+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211100 0 0 0 0012469999999999865 5679999
Q ss_pred hhHHHHHHHHHHHhCCCCCCC
Q 005893 540 DVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 540 DVwSlGvil~elltG~~p~~~ 560 (671)
||||-|||++-+++++.||-.
T Consensus 260 Diws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred ceeeccceeehhhcccccccc
Confidence 999999999999999999854
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-24 Score=204.35 Aligned_cols=165 Identities=21% Similarity=0.198 Sum_probs=122.3
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 514 (671)
|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688888843 2446999999999999999999999864 999999999999999 99987654321
Q ss_pred cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 515 ~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
..|++.|||||++.+..++.++||||||+++|||++|+.||..... ............... ++. .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~---~~~--~ 128 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGMPAD---DPR--D 128 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHhccC---Ccc--c
Confidence 2578999999999999999999999999999999999999853221 111111111110000 000 0
Q ss_pred CCCHHHHH---HHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 595 TCSPDEFL---RYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 595 ~~~~~~~~---~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+.... .+.+++.+||+.+|++||++.|+++.+..
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 01122222 47888999999999999999999987753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=204.31 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=176.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeE-EEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGF-CVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lv~e 430 (671)
+.|.+.+.||+|.||.+-++.++ +.+.+++|-+.... ....+|.+|..---.| .|.||+.-+++ |+..+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 46788899999999999999975 56789999887532 3456788887765556 69999987765 455566778999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE-c-CCCCeEEeeccccccccC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL-D-YDMNPKISDFGMARIFAG 508 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll-~-~~~~~kl~Dfgla~~~~~ 508 (671)
|++.|+|..-+.. ..+.+....+++.|++.||.|+|+++ +||||||.+|||| + +..++||+|||+.+..+.
T Consensus 103 ~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999887732 44777788899999999999999998 9999999999999 3 345899999999875322
Q ss_pred CCCccccccccccCCccchhhhccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEG-----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
. .....-+..|.+||..... ...+.+|||.||++++.++||+.||.-. ...+..-|.|..|..+.
T Consensus 176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-----~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-----SIMDKPYWEWEQWLKRK 245 (378)
T ss_pred e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-----hccCchHHHHHHHhccc
Confidence 1 1122335679999976543 2467899999999999999999999622 22233334455555544
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+-+ .+ ..+.+. ++++-.+-+..++++|=-..++..
T Consensus 246 ~~~~P~-~F-~~fs~~----a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 246 NPALPK-KF-NPFSEK----ALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred CccCch-hh-cccCHH----HHHHHHHhcCCcccccchhHHHHH
Confidence 332111 11 112222 333344667777777744444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=214.81 Aligned_cols=169 Identities=20% Similarity=0.235 Sum_probs=130.7
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec--CCceEEEEEcccc-----chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS--DGKEIAVKRLSSC-----SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 421 (671)
.....++|...+.||+|+||+||++... +++.||||++... .......+.+|++++++++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3445678999999999999999999864 5777899987532 12234568999999999999999853322
Q ss_pred CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCC-CCCcEEEcCCCCeEEeec
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDL-KASNVLLDYDMNPKISDF 500 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Df 500 (671)
....++||||+++++|.... ..+ ...++.|++++|.|||+.+ |+|||| ||+|||++.++++||+||
T Consensus 90 ~~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred cCCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 24579999999999996321 111 1467889999999999988 999999 999999999999999999
Q ss_pred cccccccCCCCcc------ccccccccCCccchhhhccC
Q 005893 501 GMARIFAGSEGEV------NTARIVGTYGYMAPEYAMEG 533 (671)
Q Consensus 501 gla~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~ 533 (671)
|+++.+....... ......+++.|+|||.+...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999765432111 11356788999999988543
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=181.49 Aligned_cols=101 Identities=32% Similarity=0.635 Sum_probs=78.5
Q ss_pred CCCCC-CCCCCC-CCCchHHHHHHHHHHHHhhhcccC---CccccccCCCCCcEEEEEeccCCCChhhhHHHHHHHHHHH
Q 005893 34 YNTCS-SSAADS-GHAGAIYSNLKKVLISLALNASAA---KFSDASSGNDSDRVYGLYMCLNYISNDTCNNCITTATQDI 108 (671)
Q Consensus 34 ~~~C~-~~~~~~-~~~s~~~~nl~~~~~~l~~~~~~~---~f~~~~~g~~~~~v~g~~~Cr~d~~~~~C~~C~~~a~~~~ 108 (671)
|+.|+ +..++| +++++|++||+.||+.|+.+++.+ +|+++..|.++++|||++||++|+++++|..||+.|+..+
T Consensus 1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~ 80 (106)
T PF01657_consen 1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANI 80 (106)
T ss_dssp ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCH
T ss_pred CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHH
Confidence 67899 544677 578889999999999999998764 7999988999999999999999999999999999999999
Q ss_pred HhhCCCCccceEEccceEeeeccccc
Q 005893 109 TKLCPNKTDAIVWEEVCQLRYAYGNF 134 (671)
Q Consensus 109 ~~~C~~~~~a~~~~~~C~~ry~~~~f 134 (671)
...|++.++|+||++.|+|||++++|
T Consensus 81 ~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 81 SSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHhCCCCceEEEECCCEEEEEECCCC
Confidence 99999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=200.64 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=183.7
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
-+|.+...|+.|+|+++ |..+++|++.- .+.....+|..|.-.|+-+.||||++++|.|.......++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 45889999999999995 45677787753 3334445788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 517 (671)
..+|+. ...-.++-.++.+++.+||+|++|||+..+ -|.---|.++.+++|++.+++|+-=. .+.... ...
T Consensus 275 ynvlhe-~t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad-~kfsfq------e~g 345 (448)
T KOG0195|consen 275 YNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMAD-TKFSFQ------EVG 345 (448)
T ss_pred HHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheeccc-ceeeee------ccc
Confidence 999975 444567888999999999999999999862 24444689999999999998875211 111100 111
Q ss_pred ccccCCccchhhhccCCCC---cchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccC
Q 005893 518 IVGTYGYMAPEYAMEGLYS---IKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD 594 (671)
Q Consensus 518 ~~gt~~y~aPE~~~~~~~s---~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 594 (671)
..-.+.||+||.+...+-+ ..+|+|||.+++|||.|...||...+..+ .-. + -..|-+...+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme----cgm----k-----ialeglrv~i-- 410 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME----CGM----K-----IALEGLRVHI-- 410 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh----hhh----h-----hhhccccccC--
Confidence 2346789999999876543 57999999999999999999997543321 111 1 1122233333
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 595 TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 595 ~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+|.....+.+++.-|+.+||.+||.+..|+-.|++
T Consensus 411 --ppgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 411 --PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred --CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 33333446677779999999999999999988875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=205.99 Aligned_cols=260 Identities=21% Similarity=0.271 Sum_probs=191.7
Q ss_pred CCCcccccCCCCcccEEEEEecCC--ceEEEEEccccchhchHHHHHHHHHHhhcCC----CCeeeEeeEE-EcCCeeeE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSDG--KEIAVKRLSSCSEQGNAEFTNEVLLILKLQH----KNLVKLLGFC-VDGDEKLL 427 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 427 (671)
+|.+.++||+|+||.||++...+. ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999997553 4789888765433333367788888888863 5888888888 46778899
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-----CCeEEeeccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-----MNPKISDFGM 502 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfgl 502 (671)
||+.+ +.+|.++..... .+.++..+.++|+.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99977 889999774433 567999999999999999999999998 9999999999999765 4699999999
Q ss_pred cc--cccCCCCc----cc--cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH
Q 005893 503 AR--IFAGSEGE----VN--TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 503 a~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~ 574 (671)
++ .+...... .. .....||..|.++....+...+.+.|+||++.++.|++.|..||...... ......
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~----~~~~~~ 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT----DLKSKF 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc----chHHHH
Confidence 99 43322221 11 12356999999999999999999999999999999999999998532211 011111
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
. +.... ..... .....+.++..+.+ .+-..+..++|....+...|+...
T Consensus 250 ~-~~~~~----~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 E-KDPRK----LLTDR--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred H-HHhhh----hcccc--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHH
Confidence 1 11000 11111 12334455554444 444478999999999999876543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.3e-20 Score=192.23 Aligned_cols=261 Identities=29% Similarity=0.386 Sum_probs=194.8
Q ss_pred CCcccccCCCCcccEEEEEecCCceEEEEEccccchh---chHHHHHHHHHHhhcCCC-CeeeEeeEEEcCCeeeEEEec
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ---GNAEFTNEVLLILKLQHK-NLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~ 431 (671)
|...+.||.|.||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999986 78999998754332 366789999999999988 799999999777778999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~ 510 (671)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976633211136888999999999999999999998 99999999999999988 79999999998655443
Q ss_pred Ccc----ccccccccCCccchhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 511 GEV----NTARIVGTYGYMAPEYAME---GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 511 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
... ......|+..|++||.+.. .......|+||+|++++++++|..|+...... ......+.......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~ 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----SATSQTLKIILELP 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----ccHHHHHHHHHhcC
Confidence 321 2345689999999999987 57899999999999999999999996433210 01111122211111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. .................+.+++..|+..+|..|.++.+...
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 11 00001111100112245667777999999999999998775
|
|
| >PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=169.92 Aligned_cols=101 Identities=41% Similarity=0.712 Sum_probs=77.6
Q ss_pred cccC---CCCC-CchhhHHHHHHHHHHHHHhhhcCCCCccccccccccCCCCCcEEEEEeeecCCChhcHHHHHHHHHHH
Q 005893 145 PKYN---RKNI-SEPERYRSVVNNTLNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIAD 220 (671)
Q Consensus 145 ~~~~---~~~~-~~~~~f~~~l~~ll~~l~~~aa~~~~~~~~a~g~~~~~~~~~vyglaqC~~Dls~~~C~~CL~~a~~~ 220 (671)
..|+ .+++ ++++.|.++++.+|..|...|+... ..+|++++.+ .+++++|||+||++||++.||+.||+.++.+
T Consensus 2 ~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~-~~~f~~~~~~-~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~ 79 (106)
T PF01657_consen 2 HFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSS-SKGFATGSAG-SGPDTVYGLAQCRGDLSPSDCRACLADAVAN 79 (106)
T ss_dssp --E---SSB----TT-THHHHHHHHHHHHHHHGGGTT--TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred CcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhcc-ccCcEEeecC-CCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence 3455 3444 4566699999999999999988653 4689999874 6788999999999999999999999999999
Q ss_pred hhhhcCCCcCcEEeccceeEEeeecee
Q 005893 221 ILSCCYFSRGARLLSRSCYLRYELYAF 247 (671)
Q Consensus 221 ~~~~c~~~~g~~v~~~~C~lry~~~~f 247 (671)
++.+|+.++||+|++++|+||||+++|
T Consensus 80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F 106 (106)
T PF01657_consen 80 ISSCCPGSRGGRVWYDSCFLRYENYPF 106 (106)
T ss_dssp HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred HHHhCCCCceEEEECCCEEEEEECCCC
Confidence 999999999999999999999999998
|
The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-21 Score=216.55 Aligned_cols=254 Identities=24% Similarity=0.299 Sum_probs=183.1
Q ss_pred CcccccCCCCcccEEEEEec-CCceEEEEEcc----c-cchhch-HHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 357 SDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLS----S-CSEQGN-AEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~----~-~~~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
....++|.|.+|.|+..... .....+.|.++ . ..+... ..+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34678999999977776632 33334444332 1 111111 12556777777889999988887777776666669
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++ +|..++. ....+...++..+++|+..|+.|||+.| |.|||||++|+++..++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9988883 3346888889999999999999999998 999999999999999999999999999876554
Q ss_pred CCc--cccccccccCCccchhhhccCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 510 EGE--VNTARIVGTYGYMAPEYAMEGLYSI-KSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 510 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
... ......+|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......+... .... .. ....
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~----~~-~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNN----YS-DQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhc----cc-cccc
Confidence 333 3445578999999999999999876 5899999999999999999997654432111 0000 00 0000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... ..............++..+++.+|.+|-|+++|++
T Consensus 546 ~~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 00111222345678888999999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=183.65 Aligned_cols=173 Identities=15% Similarity=0.184 Sum_probs=134.6
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchH---------HHHHHHHHHhhcCCCCeeeEeeEEEc
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNA---------EFTNEVLLILKLQHKNLVKLLGFCVD 421 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~H~niv~l~g~~~~ 421 (671)
...++|...++||.|+||.||.... +++.+|||++++....... .+.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4568899999999999999999655 6778999999753322222 26789999999999999999888664
Q ss_pred C--------CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC
Q 005893 422 G--------DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493 (671)
Q Consensus 422 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 493 (671)
. ...+|+|||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 34789999999999987631 222 34569999999999998 99999999999999988
Q ss_pred CeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh
Q 005893 494 NPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553 (671)
Q Consensus 494 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt 553 (671)
++|+|||.......... ...+.....+..++|+|+||+.+.-+..
T Consensus 173 -i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHHH
Confidence 99999998765422111 0114455667789999999999876553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.2e-20 Score=173.04 Aligned_cols=259 Identities=20% Similarity=0.316 Sum_probs=188.7
Q ss_pred hCCCCcccccCCCCcccEEEEE-ecCCceEEEEEccccchhchHHHHHHHHHHhhcCC-CCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 430 (671)
..+|...++||.|+||.+|.|. ..+|.+||||+-+.... ..++..|..+...|+| ..|..+..+..+.....+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4578889999999999999998 46899999998765322 3357788888888865 678888888888888999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC---CCeEEeecccccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD---MNPKISDFGMARIFA 507 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~ 507 (671)
.+ +-+|++++.-... .++..+++-++-|++.-++|+|.++ +|||||||+|+|..-+ .++.++|||+++.+.
T Consensus 92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 7899988754333 3888899999999999999999998 9999999999999644 568999999999876
Q ss_pred CCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 508 GSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 508 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
...... ......||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||..-... . ....++...+.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-----t-k~QKyEkI~Ek 239 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-----T-KKQKYEKISEK 239 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-----h-HHHHHHHHHHh
Confidence 543321 223467999999988777778899999999999999999999999642211 0 11111222222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
...-.+.. |...+ |.|+...+. -|-...-++-|...=+-+++.
T Consensus 240 K~s~~ie~-LC~G~-P~EF~myl~---Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 240 KMSTPIEV-LCKGF-PAEFAMYLN---YCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred hcCCCHHH-HhCCC-cHHHHHHHH---HHhhcCCCCCCcHHHHHHHHH
Confidence 22211221 22233 334443444 566666677777665555444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-20 Score=178.71 Aligned_cols=139 Identities=19% Similarity=0.206 Sum_probs=107.9
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchh--c-------h-----------------HHHHHHHHHHhhcCCCCe
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ--G-------N-----------------AEFTNEVLLILKLQHKNL 412 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~H~ni 412 (671)
...||+|+||.||+|...+|+.||||+++..... . . .....|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999999753210 1 0 122459999999988776
Q ss_pred eeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH-HhCCCCceeecCCCCCcEEEcC
Q 005893 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL-HEDSRLRIIHRDLKASNVLLDY 491 (671)
Q Consensus 413 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~~~ivH~Dlkp~NIll~~ 491 (671)
.....+.. ...++||||++++++...+. ....+++.....++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 43332222 23489999999887765432 234688999999999999999999 6877 99999999999998
Q ss_pred CCCeEEeeccccccc
Q 005893 492 DMNPKISDFGMARIF 506 (671)
Q Consensus 492 ~~~~kl~Dfgla~~~ 506 (671)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3e-20 Score=198.07 Aligned_cols=218 Identities=23% Similarity=0.333 Sum_probs=162.7
Q ss_pred HhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 005893 404 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLK 483 (671)
Q Consensus 404 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlk 483 (671)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+.. ....++|.....++++|+.||.|||... -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999964 4456999999999999999999999864 23999999
Q ss_pred CCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccC-------CCCcchhhHHHHHHHHHHHhCCC
Q 005893 484 ASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-------LYSIKSDVFSFGVLLIEIITGRR 556 (671)
Q Consensus 484 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVwSlGvil~elltG~~ 556 (671)
++|+++|..+.+||+|||+.................-...|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998776431111111112234579999998663 14678999999999999999999
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 557 NTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 557 p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
||+........ .++...+.+ .....+.|.+.... +....++.++..||.++|++||++++|-..++...
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCCh-HHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99864443222 223332221 11122222222110 11225778888999999999999999998887644
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=177.16 Aligned_cols=199 Identities=21% Similarity=0.321 Sum_probs=166.2
Q ss_pred CCCCcccccCCCCcccEEEEE-ecCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
-+|.+.++||+|.||..+.|+ +-+++.||||.-...+ ...++..|.+..+.| ..++|...+.+-..+....||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468889999999999999998 4589999999654332 234678888888888 568999988888888888999998
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-----CCeEEeeccccccc
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-----MNPKISDFGMARIF 506 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~Dfgla~~~ 506 (671)
+ |-+|+++..-+. ..++..++.-++.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+++.+
T Consensus 106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 788988764322 34899999999999999999999998 9999999999999643 35899999999987
Q ss_pred cCCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 507 AGSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 507 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
....... ......||.+||+-....+...+.+.|+-|||-+++..+-|..||..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 6654332 12235799999999999999999999999999999999999999964
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=6e-21 Score=212.07 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=181.3
Q ss_pred CCCcccccCCCCcccEEEEEecCCceEEEEEccccc-hhchHHHHHHHHHHh--hcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS-EQGNAEFTNEVLLIL--KLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++...+.||+++|=+|.+++.++|. |+||++-+.. .-....|.++++-++ .++|||.+++..+-.....-|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999998886 9999986533 444555666555554 35899999998887777777888888
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc-CCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA-GSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~-~~~ 510 (671)
..+ +|.+.| ..+..+...+..-|+.|++.||..+|..+ |+|||||.+||||+...-+.|+||...+... +.+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 854 565555 45666888888899999999999999998 9999999999999999999999998765322 111
Q ss_pred Cccccc----cccccCCccchhhhccC-----------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHH
Q 005893 511 GEVNTA----RIVGTYGYMAPEYAMEG-----------LYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 511 ~~~~~~----~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~ 574 (671)
...... ....-..|+|||.+... ..+++-||||+||++.||++ |+++|... .+..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--------QL~aY 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--------QLLAY 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH--------HHHhH
Confidence 111111 12233469999987541 16788999999999999998 78888532 22222
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
+.+. .......|. .. +-..+.++++.|++.||++|-++++.++.-++..
T Consensus 248 -----r~~~-~~~~e~~Le-~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 248 -----RSGN-ADDPEQLLE-KI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred -----hccC-ccCHHHHHH-hC---cCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1211 000000110 00 0014678999999999999999999998766543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=172.76 Aligned_cols=141 Identities=22% Similarity=0.236 Sum_probs=110.7
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchh---------------------c-----hHHHHHHHHHHhhcCCCCe
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ---------------------G-----NAEFTNEVLLILKLQHKNL 412 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~---------------------~-----~~~~~~E~~~l~~l~H~ni 412 (671)
...||+|++|.||+|...+|+.||||+++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998753210 0 1124578999999999987
Q ss_pred eeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcC
Q 005893 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDY 491 (671)
Q Consensus 413 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~ 491 (671)
.....+... ..+|||||++++++..... ....++......++.|++.++.+||+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544444332 3489999999886543321 22457788899999999999999999 87 99999999999999
Q ss_pred CCCeEEeeccccccccC
Q 005893 492 DMNPKISDFGMARIFAG 508 (671)
Q Consensus 492 ~~~~kl~Dfgla~~~~~ 508 (671)
+++++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.7e-18 Score=162.25 Aligned_cols=185 Identities=18% Similarity=0.128 Sum_probs=138.6
Q ss_pred CcccccCCCCcccEEEEEecCCceEEEEEccccchh----chHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEec
Q 005893 357 SDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ----GNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.....|++|+||+||.+.- .+.+++.+.+...... ....+.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997665 6778888877653321 1224789999999995 5889999886 456999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCC-CCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDL-KASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
+.+.+|...+. . ....++.|++.+|.++|+++ |+|||| ||.|||+++++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998865431 1 11357789999999999998 999999 7999999999999999999998644322
Q ss_pred Cc------cc-----cccccccCCccchhhhccC-CCC-cchhhHHHHHHHHHHHhCCCCCC
Q 005893 511 GE------VN-----TARIVGTYGYMAPEYAMEG-LYS-IKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 511 ~~------~~-----~~~~~gt~~y~aPE~~~~~-~~s-~ksDVwSlGvil~elltG~~p~~ 559 (671)
.. .+ ......++.|++|+...-- ..+ ...+.++.|.-+|.++|+..+.-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 11 00 0112467889999754322 233 67799999999999999887753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-19 Score=203.54 Aligned_cols=201 Identities=19% Similarity=0.231 Sum_probs=160.4
Q ss_pred hHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcC---CCCeeeEeeEEEcCCe
Q 005893 348 TLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDE 424 (671)
Q Consensus 348 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~ 424 (671)
++++....|.+.+.||+|+||.||+|...+|+.||+|+-+.....+ |+-=..++.+|+ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4556677889999999999999999998889999999987755432 222223333343 2334445555556677
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-------CCCCeEE
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-------YDMNPKI 497 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl 497 (671)
.+||+||.+.|+|.+++. ..+.++|...+.++.||++.++.||..+ |||+||||+|+||. +...++|
T Consensus 769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 899999999999999984 6777999999999999999999999998 99999999999993 2345899
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRN 557 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 557 (671)
+|||.+-.+.--.........++|-.+-.+|...+.+++.+.|.|.|+-+++-|+.|+..
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999988654322222334456888899999999999999999999999999999999864
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=171.85 Aligned_cols=230 Identities=20% Similarity=0.290 Sum_probs=145.4
Q ss_pred cccccCCCCcccEEEEEec-CCceEEEEEccc---cchhchHHHHHHHHHHhhcCC----------CCeeeEeeEEE---
Q 005893 358 DSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSS---CSEQGNAEFTNEVLLILKLQH----------KNLVKLLGFCV--- 420 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~--- 420 (671)
..+.||.|+++.||.++.. +|+++|||++.. ......+++++|...+..+.+ -.++.-++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3578999999999999985 589999998753 333456677777766666432 12222222221
Q ss_pred ------cCC--------eeeEEEeccCCCchhhhhcC----CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Q 005893 421 ------DGD--------EKLLVYEFMPNSSLDAILFD----PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDL 482 (671)
Q Consensus 421 ------~~~--------~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dl 482 (671)
... ..+++|+-+ .++|..++.. .+....+....++.+..|+++.+++||..| ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 111 235677766 6788777531 111223445566788899999999999998 999999
Q ss_pred CCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccC--------CCCcchhhHHHHHHHHHHHhC
Q 005893 483 KASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG--------LYSIKSDVFSFGVLLIEIITG 554 (671)
Q Consensus 483 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDVwSlGvil~elltG 554 (671)
+|+|++++.+|.++|+||+........- .. ...+..|.+||..... .++.+.|.|+||+++|.|.+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY----RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE----EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee----ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999998776532211 11 2345779999977442 478899999999999999999
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 005893 555 RRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDR 619 (671)
Q Consensus 555 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R 619 (671)
+.||+.......... .+ ..|. +-.+.+..++..+++.||++|
T Consensus 247 ~lPf~~~~~~~~~~~---------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW---------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG---------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc---------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999986543321110 11 2233 334445566679999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.8e-18 Score=163.20 Aligned_cols=136 Identities=18% Similarity=0.259 Sum_probs=105.6
Q ss_pred CcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc-----CCCCeeeEeeEEEcCC---e-eeE
Q 005893 357 SDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-----QHKNLVKLLGFCVDGD---E-KLL 427 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 427 (671)
...+.||+|+||.||. .++....+||++..........+.+|+.++..+ .||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433333479988764444556789999999999 5799999999998874 2 237
Q ss_pred EEec--cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHH-HHHHhCCCCceeecCCCCCcEEEcC----CCCeEEeec
Q 005893 428 VYEF--MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGI-LYLHEDSRLRIIHRDLKASNVLLDY----DMNPKISDF 500 (671)
Q Consensus 428 v~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 500 (671)
|+|| +++++|.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. +++++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 558999999943 235544 35678888777 9999998 999999999999973 348999995
Q ss_pred ccc
Q 005893 501 GMA 503 (671)
Q Consensus 501 gla 503 (671)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-18 Score=184.75 Aligned_cols=185 Identities=28% Similarity=0.339 Sum_probs=154.2
Q ss_pred ccCCCCcccEEEEEe----cCCceEEEEEccccchh--chHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 361 MLGQGGFGPVYKGVL----SDGKEIAVKRLSSCSEQ--GNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
++|+|.||.|+.... +.|.-+|+|++++.... .......|..++...+ ||.+|++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997652 35778999998754322 1224556778888886 9999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+|.|...+ .+...++..........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 99987776 34455677777778888999999999998 9999999999999999999999999998654332
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
..+||..|||||++. .....+|.||||++++||+||..||.
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 128999999999987 56789999999999999999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=157.60 Aligned_cols=134 Identities=19% Similarity=0.298 Sum_probs=112.7
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccch--------hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE--------QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+.||+|++|.||+|.. +|..+++|+...... .....+.+|+.++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 677899998653221 1123577899999999999988777777777888999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988421 12 77899999999999999998 99999999999999 78999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=159.69 Aligned_cols=143 Identities=20% Similarity=0.213 Sum_probs=110.8
Q ss_pred CCCCcccccCCCCcccEEEEE--ecCCceEEEEEccccchh------------------------chHHHHHHHHHHhhc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGV--LSDGKEIAVKRLSSCSEQ------------------------GNAEFTNEVLLILKL 407 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 407 (671)
.-|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347888999999999999998 568999999998643210 012356899999999
Q ss_pred CCCC--eeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 005893 408 QHKN--LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKAS 485 (671)
Q Consensus 408 ~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~ 485 (671)
.+.+ +.+++++ ...++||||+++.+|..... ....+.......++.||+.+|.+||+.+ +++||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 7533 3444443 23589999999988866542 2234556667899999999999999875 4999999999
Q ss_pred cEEEcCCCCeEEeeccccccc
Q 005893 486 NVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 486 NIll~~~~~~kl~Dfgla~~~ 506 (671)
||+++ +++++|+|||++...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=154.62 Aligned_cols=144 Identities=22% Similarity=0.203 Sum_probs=111.4
Q ss_pred hHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccch----------------------hchHHHHHHHHHHh
Q 005893 348 TLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE----------------------QGNAEFTNEVLLIL 405 (671)
Q Consensus 348 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~ 405 (671)
++.....-|...+.||+|+||.||++...+|+.||||++..... .....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 34444444777899999999999999988899999998653210 01123567888999
Q ss_pred hcCCCC--eeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCC
Q 005893 406 KLQHKN--LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLK 483 (671)
Q Consensus 406 ~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlk 483 (671)
.+.|++ +...++ ....++||||+++++|..+... .....++.+++.++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 998874 444443 2455899999999998765420 234678899999999999987 9999999
Q ss_pred CCcEEEcCCCCeEEeecccccccc
Q 005893 484 ASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 484 p~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=154.05 Aligned_cols=130 Identities=22% Similarity=0.351 Sum_probs=106.0
Q ss_pred ccCCCCcccEEEEEecCCceEEEEEccccch--------hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 361 MLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE--------QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.||+|+||.||+|.+ +|..+++|+...... .....+.+|+.++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 578899998653211 11245778999999999887665555566667779999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++++|.+++... .. .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.+++.|||+++.
T Consensus 80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---HH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887321 10 78999999999999998 99999999999999 89999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-17 Score=172.35 Aligned_cols=124 Identities=29% Similarity=0.443 Sum_probs=109.4
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++.|+++...+|.++|...+.....++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 467899999999999999776667778999999999999999999 55 999999999999999999999999998
Q ss_pred ccccCCC----CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh
Q 005893 504 RIFAGSE----GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553 (671)
Q Consensus 504 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt 553 (671)
....... .....+...||..||+||.+.+..|+.|+|||+||++|+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7655443 1223455789999999999999999999999999999999997
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.8e-16 Score=175.25 Aligned_cols=136 Identities=21% Similarity=0.312 Sum_probs=110.9
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEc-ccc-c------hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRL-SSC-S------EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l-~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
..|...+.||+|+||.||+|.+.+. .+++|+. .+. . ......+.+|++++..++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445678999999999999988544 3444432 211 1 11234688999999999999999888888777788
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999998873 35678999999999999988 9999999999999 678999999999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.9e-16 Score=154.26 Aligned_cols=198 Identities=22% Similarity=0.254 Sum_probs=133.9
Q ss_pred CCCCeeeEeeEEEcC---------------------------CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHH
Q 005893 408 QHKNLVKLLGFCVDG---------------------------DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVN 460 (671)
Q Consensus 408 ~H~niv~l~g~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 460 (671)
+|||||++.++|.+. ..+|+||.-.+ .+|..++. ....+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 699999999887641 23567777663 46777773 23355666777899
Q ss_pred HHHHHHHHHHhCCCCceeecCCCCCcEEEc--CC--CCeEEeeccccccccCC----CCccccccccccCCccchhhhcc
Q 005893 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLD--YD--MNPKISDFGMARIFAGS----EGEVNTARIVGTYGYMAPEYAME 532 (671)
Q Consensus 461 qia~gL~~LH~~~~~~ivH~Dlkp~NIll~--~~--~~~kl~Dfgla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 532 (671)
|+++|+.|||+++ |.|||+|++|||+. +| -.+.|+|||.+-.-... ......-..-|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999994 33 35789999976432110 00111112356677899999865
Q ss_pred CC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHH
Q 005893 533 GL------YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIH 606 (671)
Q Consensus 533 ~~------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 606 (671)
.+ --.|+|.|+.|-+.||+++...||--.. +.+++. ....+---|.+.+.+++. +.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG------em~L~~-------r~Yqe~qLPalp~~vpp~----~rq 488 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG------EMLLDT-------RTYQESQLPALPSRVPPV----ARQ 488 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc------hheech-------hhhhhhhCCCCcccCChH----HHH
Confidence 33 2358999999999999999998884211 111111 011122224455555554 668
Q ss_pred HHHHccccCCCCCCCHHHHHHHhc
Q 005893 607 IGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 607 l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
++...++.||++||+..=....|+
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 888999999999999765555443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=1e-14 Score=134.74 Aligned_cols=135 Identities=22% Similarity=0.242 Sum_probs=114.3
Q ss_pred cccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCC--CCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 358 DSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+..+..++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999854 7899999876433 4578899999999976 58999998888878899999999988
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
.+..+ +......++.+++++|.+||.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4566778899999999999986545699999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=140.73 Aligned_cols=135 Identities=24% Similarity=0.308 Sum_probs=97.2
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchh--chHH----------------------HHHHHHHHhhcCCCC--e
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ--GNAE----------------------FTNEVLLILKLQHKN--L 412 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 412 (671)
.+.||+|+||.||++...+|+.||||+++..... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998643211 1111 135556666664432 4
Q ss_pred eeEeeEEEcCCeeeEEEeccCCCchhhh-hcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEc
Q 005893 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAI-LFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLD 490 (671)
Q Consensus 413 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~ 490 (671)
.+.++. ...++||||++++.+... +.... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 444433 245899999999554321 11100 11 5677899999999999999 76 99999999999999
Q ss_pred CCCCeEEeeccccccc
Q 005893 491 YDMNPKISDFGMARIF 506 (671)
Q Consensus 491 ~~~~~kl~Dfgla~~~ 506 (671)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.3e-15 Score=166.95 Aligned_cols=211 Identities=23% Similarity=0.292 Sum_probs=137.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..+|..++.|-.|+||.||..+++ ..+.+|+|+-+... -+.+ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc---cccccCCccee------------------
Confidence 356788899999999999999875 36778885432210 0011 22222233332
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
|+=...+ ..-+.++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++..-....
T Consensus 136 ---gDc~tll---k~~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 3333333 22233332 2378899999988 99999999999999999999999999875321110
Q ss_pred -------------ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH
Q 005893 512 -------------EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL 578 (671)
Q Consensus 512 -------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~ 578 (671)
.......+||+.|+|||++....|...+|+|++|+|+||.+-|+.||... ..+.|+..+...
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd-----tpeelfg~visd 273 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-----TPEELFGQVISD 273 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC-----CHHHHHhhhhhh
Confidence 01123469999999999999999999999999999999999999998533 223333322111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
...+.|- |.. .+ .|. ..++...++.+|..|--.
T Consensus 274 --~i~wpE~-dea----~p-~Ea---~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 274 --DIEWPEE-DEA----LP-PEA---QDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred --hcccccc-CcC----CC-HHH---HHHHHHHHHhChHhhccc
Confidence 1122222 222 22 333 344558889999999433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.9e-14 Score=140.97 Aligned_cols=135 Identities=21% Similarity=0.225 Sum_probs=104.3
Q ss_pred ccccC-CCCcccEEEEEecCCceEEEEEccccc-------------hhchHHHHHHHHHHhhcCCCCe--eeEeeEEEcC
Q 005893 359 SNMLG-QGGFGPVYKGVLSDGKEIAVKRLSSCS-------------EQGNAEFTNEVLLILKLQHKNL--VKLLGFCVDG 422 (671)
Q Consensus 359 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~ 422 (671)
...|| .|+.|+||+.... +..++||++.... ......+.+|+.++.+|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999884 7789999875311 1223457889999999998875 6677664433
Q ss_pred Ce----eeEEEeccCC-CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEE
Q 005893 423 DE----KLLVYEFMPN-SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI 497 (671)
Q Consensus 423 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 497 (671)
.. .++|+|++++ .+|.+++.. ..++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 22 2599999997 688888732 234433 3578999999999998 999999999999999999999
Q ss_pred eecccccc
Q 005893 498 SDFGMARI 505 (671)
Q Consensus 498 ~Dfgla~~ 505 (671)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.5e-15 Score=168.20 Aligned_cols=256 Identities=23% Similarity=0.302 Sum_probs=184.3
Q ss_pred CCCCcccccCCCCcccEEEEEecC--CceEEEEEccccc--hhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSD--GKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv 428 (671)
..|...+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345666779999999998887643 3456666665432 222334455777767775 99999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH-hCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH-EDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIF 506 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 506 (671)
.+|..++++...+.. ......+.......+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||++..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998877731 12224556667788999999999999 777 99999999999999999 9999999999987
Q ss_pred cC-CCCccccccccc-cCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 507 AG-SEGEVNTARIVG-TYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 507 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... ..... |.+..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~-----~~~~~ 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSS-----WKSNK 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---cccee-----ecccc
Confidence 76 444444445678 9999999998874 45778999999999999999999997654331 11111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.......-..... ..+++..+++..+|+.|.+.+++..
T Consensus 248 --~~~~~~~~~~~~~----~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 --GRFTQLPWNSISD----QAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --cccccCccccCCh----hhhhcccccccCCchhccccccccc
Confidence 0000011111111 2445555788899999999888763
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=6e-13 Score=144.62 Aligned_cols=141 Identities=22% Similarity=0.255 Sum_probs=100.4
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhch----------------------------------------HHHH
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGN----------------------------------------AEFT 398 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~----------------------------------------~~~~ 398 (671)
.+.||+|++|.||+|++.+|+.||||+.++...... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865321110 1244
Q ss_pred HHHHHHhhc----CCCCeeeEeeEEE-cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHH-HHHHHHhC
Q 005893 399 NEVLLILKL----QHKNLVKLLGFCV-DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK-GILYLHED 472 (671)
Q Consensus 399 ~E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-gL~~LH~~ 472 (671)
+|...+.++ +|.+-+.+-.++. .....+|||||++|++|.++...... .. .+..++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 555555554 2333344333333 24567999999999999887632111 12 23456666665 47888988
Q ss_pred CCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 473 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
+ ++|+|++|.||++++++++++.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.6e-13 Score=132.78 Aligned_cols=155 Identities=23% Similarity=0.305 Sum_probs=117.9
Q ss_pred HHHHhhcCCCCeeeEeeEEEcCC-----eeeEEEeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCC
Q 005893 401 VLLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSR 474 (671)
Q Consensus 401 ~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~ 474 (671)
...|-++.|.|||++..|+.+.. ...++.|||..|+|..+|...+ ..+.+....+.+|+.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 44455678999999999887543 4578999999999999997643 3445777888899999999999999975
Q ss_pred CceeecCCCCCcEEEcCCCCeEEeeccccccc--cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHH
Q 005893 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIF--AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEII 552 (671)
Q Consensus 475 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~--~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ell 552 (671)
++|+|+++.-+.|++..++-+||+--...... .............+.++|.+||.-...+.+..+|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 77999999999999999998888532111100 0001111122345678999999877777888999999999999998
Q ss_pred hCCC
Q 005893 553 TGRR 556 (671)
Q Consensus 553 tG~~ 556 (671)
-|.-
T Consensus 277 ilEi 280 (458)
T KOG1266|consen 277 ILEI 280 (458)
T ss_pred Hhee
Confidence 7764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=1e-11 Score=117.58 Aligned_cols=130 Identities=23% Similarity=0.165 Sum_probs=97.0
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeee-EeeEEEcCCeeeEEEeccCCCch
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVK-LLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
.+.|+.|.++.||++... ++.+++|+...... ....+..|+..+..+.+.++++ ++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999874 77899998765432 2234678999999886655554 44432 3346899999999887
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS--RLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.... . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5430 0 11245678999999999876 23469999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.9e-12 Score=134.93 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=176.9
Q ss_pred CCCCcccccCC--CCcccEEEEEe---cCCceEEEEEcccc--chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCee
Q 005893 354 SNFSDSNMLGQ--GGFGPVYKGVL---SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 425 (671)
..|.+.+.+|+ |.+|.||++.. .++..+|+|+-+.. .......-++|+...+++ .|+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999986 35788999984432 223333345677777777 599999988888889999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHH----HHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeec
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK----GILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDF 500 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 500 (671)
++-+|.+. .+|..+.+. ....++....+....+... ||.++|... ++|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999885 677776643 2333666777778888888 999999988 9999999999999999 88999999
Q ss_pred cccccccCCCCccc---cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 501 GMARIFAGSEGEVN---TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 501 gla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
|+...+........ ..+..|...|++||.. ++.++..+|+|++|.++.|..+|.......... .|.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----------~W~ 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS----------SWS 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC----------Ccc
Confidence 99987765542221 1233677789999965 567899999999999999999986654321100 122
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+... +..++....-..+.....++++.+|-.|++.+.+..
T Consensus 337 ~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 222211 111111111112334677899999999999887754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.8e-11 Score=133.09 Aligned_cols=144 Identities=19% Similarity=0.236 Sum_probs=94.4
Q ss_pred CCCCcccccCCCCcccEEEEEecC-CceEEEEEccccchhc----------------------------------hH---
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQG----------------------------------NA--- 395 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~----------------------------------~~--- 395 (671)
.+|+. +.||+|++|.||++++.+ |+.||||++++.-... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 789999999999999987 9999999997532110 01
Q ss_pred ---HHHHHHHHHhhc----CCCCeeeEeeEEEc-CCeeeEEEeccCCCchhhhhcCCCCC---CCCChHHHHHHHHHHHH
Q 005893 396 ---EFTNEVLLILKL----QHKNLVKLLGFCVD-GDEKLLVYEFMPNSSLDAILFDPRKR---GLLCWSKRINIVNGIVK 464 (671)
Q Consensus 396 ---~~~~E~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qia~ 464 (671)
++.+|...+.++ .+.+.+.+-.++.+ ....+|||||++|+.+.++-.-.... +.+.......++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 134444444444 24444444444433 45678999999999997742111111 11222222233333
Q ss_pred HHHHHHhCCCCceeecCCCCCcEEEcCCC----CeEEeeccccccccC
Q 005893 465 GILYLHEDSRLRIIHRDLKASNVLLDYDM----NPKISDFGMARIFAG 508 (671)
Q Consensus 465 gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~~ 508 (671)
++..| ++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34456 99999999999999888 999999999886644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3e-10 Score=122.91 Aligned_cols=168 Identities=17% Similarity=0.215 Sum_probs=125.5
Q ss_pred ecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHH
Q 005893 375 LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSK 454 (671)
Q Consensus 375 ~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 454 (671)
..++.+|.|...+...........+-+..|+.++||||++++..+...+..|||+|-+. -|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34788999998876555444557788899999999999999999999999999999873 45555532 23455
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCC
Q 005893 455 RINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL 534 (671)
Q Consensus 455 ~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 534 (671)
....+.||+.||.|||..+ .++|++|.-..|++++.|+.||++|.+........... ....--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCccc
Confidence 5667899999999999765 49999999999999999999999999876543222100 0111123466676543221
Q ss_pred CCcchhhHHHHHHHHHHHhCCC
Q 005893 535 YSIKSDVFSFGVLLIEIITGRR 556 (671)
Q Consensus 535 ~s~ksDVwSlGvil~elltG~~ 556 (671)
...|.|-||++++|++.|..
T Consensus 182 --~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred --cchhhhhHHHHHHHHhCccc
Confidence 45699999999999999943
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.6e-10 Score=107.47 Aligned_cols=135 Identities=17% Similarity=0.145 Sum_probs=97.3
Q ss_pred cccCCCCcccEEEEEecC-------CceEEEEEcccc-------------c---------hhchHHH----HHHHHHHhh
Q 005893 360 NMLGQGGFGPVYKGVLSD-------GKEIAVKRLSSC-------------S---------EQGNAEF----TNEVLLILK 406 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~-------------~---------~~~~~~~----~~E~~~l~~ 406 (671)
..||.|.-+.||.|...+ +..+|||+.+.. . ......+ ++|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 569999999999998643 478999986420 0 0012223 389999998
Q ss_pred cCC--CCeeeEeeEEEcCCeeeEEEeccCCCchhh-hhcCCCCCCCCChHHHHHHHHHHHHHHHHH-HhCCCCceeecCC
Q 005893 407 LQH--KNLVKLLGFCVDGDEKLLVYEFMPNSSLDA-ILFDPRKRGLLCWSKRINIVNGIVKGILYL-HEDSRLRIIHRDL 482 (671)
Q Consensus 407 l~H--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~gL~~L-H~~~~~~ivH~Dl 482 (671)
+.. -++.+.+++ ...+|||||+.+..+.. .+. ...++..+...+..+++.+|..| |+.+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 843 456666654 56789999997654421 221 12244456677889999999999 7877 999999
Q ss_pred CCCcEEEcCCCCeEEeeccccccc
Q 005893 483 KASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 483 kp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
++.||+++ ++.+.|+|||.+...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.5e-10 Score=109.60 Aligned_cols=142 Identities=19% Similarity=0.265 Sum_probs=109.9
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccch-hchHHHHHHHHHHhhcCC--CCeeeEeeEEEcCC---eeeEEEeccC
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQH--KNLVKLLGFCVDGD---EKLLVYEFMP 433 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lv~e~~~ 433 (671)
+.|+.|..+.||++...+|+.+++|....... .....+..|..+++.+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999765322 234568899999999865 34566777765532 5689999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS---------------------------------------- 473 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~---------------------------------------- 473 (671)
+.++...+.. ..++...+..++.++++.|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988775521 34677788888899999999998531
Q ss_pred -------------CCceeecCCCCCcEEEcC--CCCeEEeecccccc
Q 005893 474 -------------RLRIIHRDLKASNVLLDY--DMNPKISDFGMARI 505 (671)
Q Consensus 474 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~ 505 (671)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56689999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-09 Score=99.66 Aligned_cols=131 Identities=23% Similarity=0.326 Sum_probs=99.8
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEc-cccc---h----hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRL-SSCS---E----QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l-~~~~---~----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..+++|+-+.+|.+.+. |.++++|.= ++.- + -....-.+|..++.+++--.|.-.+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999999774 445666642 2211 1 1123356899999988766665555566788888999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 2567778888889999998 99999999999997665 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.6e-09 Score=98.17 Aligned_cols=143 Identities=22% Similarity=0.305 Sum_probs=104.9
Q ss_pred cccccCCCCcccEEEEEecCCceEEEEE-cccc-------chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 358 DSNMLGQGGFGPVYKGVLSDGKEIAVKR-LSSC-------SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~-l~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
....|-+|+-+.|+++.+ .|+...||. +.+. ..-.....++|++.+.+++--.|.-..-++.+.....|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457799999999999998 577777774 3221 1122345678999999887656655555677777889999
Q ss_pred eccCC-CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC---CeEEeecccccc
Q 005893 430 EFMPN-SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM---NPKISDFGMARI 505 (671)
Q Consensus 430 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~ 505 (671)
||+++ .++.+++...-.....+ .....++..|-+.+.-||.++ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 46777765432222222 233678889999999999998 99999999999997654 458999999865
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.8e-09 Score=109.11 Aligned_cols=169 Identities=21% Similarity=0.297 Sum_probs=128.5
Q ss_pred cccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----CCeeeEEEeccCC-Cchhhh
Q 005893 367 FGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVYEFMPN-SSLDAI 440 (671)
Q Consensus 367 ~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~~~ 440 (671)
-.+.||+.. .||..|++|++.....+.......-+++++++.|+|+|++..++.. +..+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788874 4899999999954333333234456889999999999999998873 3457899999985 466655
Q ss_pred hcCC------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 441 LFDP------------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 441 l~~~------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
-+.. ..+...++..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 4422 12234778899999999999999999998 88899999999999999999999998776654
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCC
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRN 557 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p 557 (671)
+.... +. --.+-|.=-||.+++.|.||...
T Consensus 446 d~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 43111 11 12356888999999999999765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.1e-10 Score=120.89 Aligned_cols=248 Identities=21% Similarity=0.195 Sum_probs=170.1
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEec--CCceEEEEEccccchhchHH--HHHHHHHHhhc-CCCCeeeEeeEEEcCCe
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLS--DGKEIAVKRLSSCSEQGNAE--FTNEVLLILKL-QHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~g~~~~~~~ 424 (671)
.....+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.+++.....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344567888999999999999997753 57789999887543322222 23566665555 58888887777777777
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeecccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMA 503 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla 503 (671)
.++--||++++++...+ .-...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||..
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccc
Confidence 88999999999887665 23344777888999999999999999887 9999999999999886 88899999987
Q ss_pred ccccCCCCccccccccccCCcc--chhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 504 RIFAGSEGEVNTARIVGTYGYM--APEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
..+.-... .....-+++ +++......+-.+.|++|||.-+.|.++|..-... ..+| ...+.
T Consensus 415 t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~----------~~~~--~~i~~ 477 (524)
T KOG0601|consen 415 TRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES----------GVQS--LTIRS 477 (524)
T ss_pred cccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCcc----------cccc--eeeec
Confidence 64221111 111222333 45555556788999999999999999998643210 0111 11111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
+.. +.+.+ ....+..+...++..++..||.+.++..+.+
T Consensus 478 ~~~-----p~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 478 GDT-----PNLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccc-----cCCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111 11111 1123344555788899999999888876544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.1e-08 Score=95.72 Aligned_cols=124 Identities=25% Similarity=0.315 Sum_probs=82.1
Q ss_pred EEEEEecCCceEEEEEccccc--------------h------------hchHHHHHHHHHHhhcCCC--CeeeEeeEEEc
Q 005893 370 VYKGVLSDGKEIAVKRLSSCS--------------E------------QGNAEFTNEVLLILKLQHK--NLVKLLGFCVD 421 (671)
Q Consensus 370 Vy~~~~~~g~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~ 421 (671)
||.|...+|..+|||+.+... . .......+|.+.|.++... ++.+++.+
T Consensus 2 Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--- 78 (188)
T PF01163_consen 2 VYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--- 78 (188)
T ss_dssp EEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE---
T ss_pred EEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE---
Confidence 899998899999999864210 0 0123467899999999765 45566544
Q ss_pred CCeeeEEEeccC--CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH-HHhCCCCceeecCCCCCcEEEcCCCCeEEe
Q 005893 422 GDEKLLVYEFMP--NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILY-LHEDSRLRIIHRDLKASNVLLDYDMNPKIS 498 (671)
Q Consensus 422 ~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 498 (671)
....|||||++ +..+..+... .++......++.+++..+.. +|..+ |+|+||.+.||+++++ .+.|+
T Consensus 79 -~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 -NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp -ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred -eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 24579999998 6555544321 11234456677888886555 56777 9999999999999988 99999
Q ss_pred eccccccc
Q 005893 499 DFGMARIF 506 (671)
Q Consensus 499 Dfgla~~~ 506 (671)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.4e-08 Score=99.20 Aligned_cols=139 Identities=17% Similarity=0.099 Sum_probs=97.9
Q ss_pred cCCCCcccEEEEEecCCceEEEEEccccchh-----------chHHHHHHHHHHhhcCCCC--eeeEeeEEEc-----CC
Q 005893 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ-----------GNAEFTNEVLLILKLQHKN--LVKLLGFCVD-----GD 423 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~-----~~ 423 (671)
+-+-....|.+..+ +|+.+.||+....... ....+.+|...+.++...+ ..+.+++... ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344667666 6788999976432211 1123778888888874333 3344555433 23
Q ss_pred eeeEEEeccCCC-chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-------CCCe
Q 005893 424 EKLLVYEFMPNS-SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-------DMNP 495 (671)
Q Consensus 424 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~ 495 (671)
..+||+|++++. +|.+++.+.. ....+...+..++.+++..+.-||+.| |+|+|++++|||++. +..+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 468999999986 8888874321 233556677889999999999999998 999999999999975 4789
Q ss_pred EEeecccccc
Q 005893 496 KISDFGMARI 505 (671)
Q Consensus 496 kl~Dfgla~~ 505 (671)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.1e-09 Score=118.26 Aligned_cols=204 Identities=20% Similarity=0.244 Sum_probs=139.8
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.-+.|.+.+-+-+|.++.++...-. .|...++|+.... ...+.+....+-.++-..+||-++....-+.-.....|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4466777788999999999877642 2433344433221 11111112222222222345655554444445667899
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
+++|..+++|...|+. .+..+..-....+..+..++++||... +.|+|++|.|++...++..++.||+......
T Consensus 882 ~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999888853 334555555566777888999999876 8999999999999999999999998332111
Q ss_pred ------CCC---------------C----c----cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005893 508 ------GSE---------------G----E----VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNT 558 (671)
Q Consensus 508 ------~~~---------------~----~----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~ 558 (671)
... . . .......||+.|.+||.+.+......+|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 000 0 0 0012357999999999999999999999999999999999999998
Q ss_pred CCC
Q 005893 559 GFN 561 (671)
Q Consensus 559 ~~~ 561 (671)
...
T Consensus 1036 na~ 1038 (1205)
T KOG0606|consen 1036 NAE 1038 (1205)
T ss_pred CCc
Confidence 643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.5e-07 Score=92.66 Aligned_cols=263 Identities=16% Similarity=0.161 Sum_probs=154.6
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeE----EE--cCCe-eeEEEe
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGF----CV--DGDE-KLLVYE 430 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~----~~--~~~~-~~lv~e 430 (671)
...||+|+-+.+|..- +-..-+.|+.......... +.+..|.+. .||-+-.-+.+ .. ++.. ..+.|+
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 4679999999999532 1112345766543332222 233444444 56543321111 11 1122 456777
Q ss_pred ccCCCchhhhhcC----CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 431 FMPNSSLDAILFD----PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 431 ~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
.+++.---..++. .+.-...+|...++.++.++.+.+-||..| .+-+|++++|+|+.+++.+.|.|=..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 7765422222222 233456899999999999999999999998 889999999999999999999986543332
Q ss_pred cCCCCccccccccccCCccchhhhccC-----CCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCCCCCCHHHHHHH-H-
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEG-----LYSIKSDVFSFGVLLIEIITG-RRNTGFNQSRGATAPNLLAYAWH-L- 578 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~~~~l~~~~~~-~- 578 (671)
. ........+|...|.+||.-.-+ .-+...|-|.||+++++++.| ++||......++....+...... .
T Consensus 168 ~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 168 A---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred c---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 1 11223346889999999975422 346789999999999999886 99997544333222222111100 0
Q ss_pred -HhcCCccccccccccCCCC----HHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHhcCCCCCCC
Q 005893 579 -WNEGNALDLIDPLLTDTCS----PDEFLRYIHIGLLCVQE--DAFDRPTMSSVVVMLQGETITLC 637 (671)
Q Consensus 579 -~~~~~~~~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~--~p~~RPt~~ev~~~L~~~~~~~~ 637 (671)
+....-.. ..+. ....+ +..+. -+..+|+.+ ++.-|||++-++..|.....++.
T Consensus 245 ~ya~~~~~g-~~p~-P~~~P~~~Lpp~vq---AlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 245 AYASDQRRG-LKPP-PRSIPLSMLPPDVQ---ALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eechhccCC-CCCC-CCCCChhhcCHHHH---HHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 00000000 0000 01111 22233 333467654 36689999999998876544443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.3e-07 Score=90.03 Aligned_cols=134 Identities=19% Similarity=0.241 Sum_probs=94.0
Q ss_pred CCcccccCCCCcccEEEEEecCCceEEEEEccc----------cch------------hchHHHHHHHHHHhhcCCC--C
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSS----------CSE------------QGNAEFTNEVLLILKLQHK--N 411 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~----------~~~------------~~~~~~~~E~~~l~~l~H~--n 411 (671)
..+...||.|.-+.||.|..++|.++|||.=+. ... -......+|.+.|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999995211 000 1123467899999998644 6
Q ss_pred eeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC
Q 005893 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY 491 (671)
Q Consensus 412 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 491 (671)
+.+.+++ +...+||||+++.-|...- ++....-.++..|+.-+..+-..| +||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666554 4568999999987665432 112222233444444444444555 999999999999999
Q ss_pred CCCeEEeeccccc
Q 005893 492 DMNPKISDFGMAR 504 (671)
Q Consensus 492 ~~~~kl~Dfgla~ 504 (671)
+|.+.++||-.+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.2e-06 Score=84.15 Aligned_cols=139 Identities=17% Similarity=0.120 Sum_probs=101.9
Q ss_pred cCCCCcccEEEEEecCCceEEEEEccccc------hhchHHHHHHHHHHhhcCC--CCeeeEeeEEEc----CCeeeEEE
Q 005893 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCS------EQGNAEFTNEVLLILKLQH--KNLVKLLGFCVD----GDEKLLVY 429 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~----~~~~~lv~ 429 (671)
-|+||-+-|++-.+ +|+.+-+|+-.... ......|.+|+..|.+|.. -.+.+.+..-.. ...-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46789999999777 45579999875211 3356789999999999853 234444422111 12357999
Q ss_pred eccCC-CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC--eEEeecccccc
Q 005893 430 EFMPN-SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN--PKISDFGMARI 505 (671)
Q Consensus 430 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~ 505 (671)
|-+++ .+|.+++.+ ......+...+..++.+++..+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~-~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQ-HAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhc-CCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 578888743 22334677778899999999999999998 999999999999986666 99999987654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.2e-07 Score=88.30 Aligned_cols=106 Identities=23% Similarity=0.272 Sum_probs=82.0
Q ss_pred hHHHHHHHHHHhhcCC--CCeeeEeeEEEcCC----eeeEEEeccCCC-chhhhhcCCCCCCCCChHHHHHHHHHHHHHH
Q 005893 394 NAEFTNEVLLILKLQH--KNLVKLLGFCVDGD----EKLLVYEFMPNS-SLDAILFDPRKRGLLCWSKRINIVNGIVKGI 466 (671)
Q Consensus 394 ~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL 466 (671)
.....+|...+..|.. -...+.+++..... ..++|+|++++. +|.+++... ..++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 3457788888887743 33445566655432 347999999874 798888431 2256667788999999999
Q ss_pred HHHHhCCCCceeecCCCCCcEEEcCCC---CeEEeecccccc
Q 005893 467 LYLHEDSRLRIIHRDLKASNVLLDYDM---NPKISDFGMARI 505 (671)
Q Consensus 467 ~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~ 505 (671)
.-||+.+ |+|+|++++|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999998 99999999999999887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.5e-07 Score=99.45 Aligned_cols=141 Identities=17% Similarity=0.216 Sum_probs=92.9
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhc----------------------------------------hHHHHH
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG----------------------------------------NAEFTN 399 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~----------------------------------------~~~~~~ 399 (671)
+.|+.++-|.||+|++++|+.||||+.++.-... .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999976532110 011334
Q ss_pred HHHHHhhc----CCCCeeeEeeEEE-cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHH-HHHHHhCC
Q 005893 400 EVLLILKL----QHKNLVKLLGFCV-DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG-ILYLHEDS 473 (671)
Q Consensus 400 E~~~l~~l----~H~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~g-L~~LH~~~ 473 (671)
|...+.++ ++..-+++-.++. -.....|+|||++|..+.++..-. ...++...+ +..++++ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k~i---a~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRKEL---AELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 44444444 2222233333443 356789999999999998874221 133443332 2222222 22333345
Q ss_pred CCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 474 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
++|.|.+|.||+++.++++.+.|||+...+.+
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.8e-08 Score=105.42 Aligned_cols=151 Identities=21% Similarity=0.351 Sum_probs=98.3
Q ss_pred HHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccc-------cccccccCCccchhhhcc
Q 005893 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN-------TARIVGTYGYMAPEYAME 532 (671)
Q Consensus 460 ~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 532 (671)
.+++.||.|+|... .+||++|.|++|.++.++..||+.|+++....+...... ..-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45569999999865 699999999999999999999999998765443211110 011234568999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHc
Q 005893 533 GLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLC 611 (671)
Q Consensus 533 ~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 611 (671)
...+.++|+||+|+++|.+.. |+.-+..... ...+.... ...+.--.....+.+. | +.+=+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-------~~~~~~~~----~~~~~~~~~~s~~~p~-e---l~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-------LLSYSFSR----NLLNAGAFGYSNNLPS-E---LRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCC-------cchhhhhh----cccccccccccccCcH-H---HHHHHHHH
Confidence 888999999999999999995 5544332111 11111110 0000000011122333 3 34444578
Q ss_pred cccCCCCCCCHHHHHH
Q 005893 612 VQEDAFDRPTMSSVVV 627 (671)
Q Consensus 612 l~~~p~~RPt~~ev~~ 627 (671)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8999999998877753
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.1e-06 Score=81.85 Aligned_cols=132 Identities=17% Similarity=0.186 Sum_probs=84.9
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCC--eeeEeeEEEcCCeeeEEEeccCCCc-
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMPNSS- 436 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gs- 436 (671)
..||+|..+.||+. .|..+++|...... ......+|.+++..+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999983 35578889887533 3345688999998886443 3566777777777789999999863
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHH---------------------------------------HHHh-CCCCc
Q 005893 437 LDAILFDPRKRGLLCWSKRINIVNGIVKGIL---------------------------------------YLHE-DSRLR 476 (671)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~---------------------------------------~LH~-~~~~~ 476 (671)
+...+.. +......++.++++.+. +|.. .....
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211110 00111111111222121 2211 12345
Q ss_pred eeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 477 IIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 477 ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.8e-06 Score=78.92 Aligned_cols=139 Identities=17% Similarity=0.179 Sum_probs=92.1
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHH---------HHHHHHHhhcCC---CCeeeEeeE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEF---------TNEVLLILKLQH---KNLVKLLGF 418 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~g~ 418 (671)
....+|...+++-......|.+-.. +|+.+++|..+......+..| .+.+..+.+++. .....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3457788888888888777877766 678999999876433322222 233333333322 222222222
Q ss_pred EE-----cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC
Q 005893 419 CV-----DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493 (671)
Q Consensus 419 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 493 (671)
.. -....+++|||++|..|.++.. ++. .+...+.+.+.-||+.| +.|+|.+|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 22 2234568999999988866531 222 24566778899999998 9999999999999855
Q ss_pred CeEEeecccccc
Q 005893 494 NPKISDFGMARI 505 (671)
Q Consensus 494 ~~kl~Dfgla~~ 505 (671)
.+++.||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999986553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.3e-05 Score=76.54 Aligned_cols=151 Identities=23% Similarity=0.260 Sum_probs=98.1
Q ss_pred hhhHHHHhCCCCccc---ccCCCCcccEEEEEecCCceEEEEEccccchh-------------------ch-----HHHH
Q 005893 346 LETLDVATSNFSDSN---MLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQ-------------------GN-----AEFT 398 (671)
Q Consensus 346 ~~~l~~~~~~~~~~~---~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~-------------------~~-----~~~~ 398 (671)
++.+....++..+.. .|..|.-+.||+|...++..+|||+++..... +. ....
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 444444444444443 46678888899999888999999998532111 00 1134
Q ss_pred HHHHHHhhcC--CCCeeeEeeEEEcCCeeeEEEeccCCCch-hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCC
Q 005893 399 NEVLLILKLQ--HKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475 (671)
Q Consensus 399 ~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~ 475 (671)
+|...|.++. +-.+.+.+++. ...|||||+....+ .-.|. .-.+...+...+..++++.+.-|-...
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 6777777663 34444445442 45799999965411 11121 111223356677788888888887733
Q ss_pred ceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 476 ~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
++||+||..-|||+. ++.+.|+|||.+....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999876543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.3e-05 Score=87.65 Aligned_cols=141 Identities=16% Similarity=0.226 Sum_probs=90.2
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhc-------------------------------------hHHHHHHHH
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG-------------------------------------NAEFTNEVL 402 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~ 402 (671)
+.||..+.|.||++++++|+.||||+-++.-+.. .-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6799999999999999999999999976532211 012444544
Q ss_pred HHhh----cCCCC---eeeEeeEEEc-CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCC
Q 005893 403 LILK----LQHKN---LVKLLGFCVD-GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474 (671)
Q Consensus 403 ~l~~----l~H~n---iv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~ 474 (671)
...+ ++|-+ -|.+-.++.+ .....|+||||+|..+.++-.- ....++...+..-+.++..-+-+ ..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf--~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIF--KTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHH--hcC-
Confidence 4433 34555 1223333332 3467899999999988776432 22234444333333322221222 234
Q ss_pred CceeecCCCCCcEEEcC----CCCeEEeecccccccc
Q 005893 475 LRIIHRDLKASNVLLDY----DMNPKISDFGMARIFA 507 (671)
Q Consensus 475 ~~ivH~Dlkp~NIll~~----~~~~kl~Dfgla~~~~ 507 (671)
++|.|=+|.||++.. ++.+.+.|||+.....
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6789999999987653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.8e-05 Score=77.28 Aligned_cols=142 Identities=20% Similarity=0.218 Sum_probs=83.3
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCC--CeeeEeeEEEcC---CeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHK--NLVKLLGFCVDG---DEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~---~~~~lv~e~~~~ 434 (671)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++...... ...+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568899999999999876 69999987654 3455677888888888433 345666544332 245789999999
Q ss_pred Cchhh----------------hh---cCC-CCCCCCChHH---------HHHH------------HHHHHH-HHHHHHh-
Q 005893 435 SSLDA----------------IL---FDP-RKRGLLCWSK---------RINI------------VNGIVK-GILYLHE- 471 (671)
Q Consensus 435 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qia~-gL~~LH~- 471 (671)
..+.. .+ +.. .....+.+.. .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88776 11 011 0111111110 0000 112222 3333332
Q ss_pred ---CCCCceeecCCCCCcEEEc-CCCCeEEeeccccc
Q 005893 472 ---DSRLRIIHRDLKASNVLLD-YDMNPKISDFGMAR 504 (671)
Q Consensus 472 ---~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~ 504 (671)
.....++|+|+.|+||+++ +++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2345699999999999999 56666799998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=5e-05 Score=76.45 Aligned_cols=139 Identities=15% Similarity=0.129 Sum_probs=84.2
Q ss_pred cCCCCc-ccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEeccCCCchhh
Q 005893 362 LGQGGF-GPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDA 439 (671)
Q Consensus 362 lg~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 439 (671)
|..|.. ..||+.... +..++||+..... ...+.+|+.++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 788998764 4788999876543 335678888888873 4445567777766667899999999987764
Q ss_pred hhc-------------------CCCC-CCCCC--hHHHHHHHH--------------------HHHHHHHHHHh----CC
Q 005893 440 ILF-------------------DPRK-RGLLC--WSKRINIVN--------------------GIVKGILYLHE----DS 473 (671)
Q Consensus 440 ~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------qia~gL~~LH~----~~ 473 (671)
... .... ...+. ......... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 321 1000 00111 000000000 01111122211 12
Q ss_pred CCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 474 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.+.++|+|+.|.|||++++....|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3569999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=6.6e-07 Score=96.71 Aligned_cols=188 Identities=18% Similarity=0.085 Sum_probs=132.2
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCC-eeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~e~ 431 (671)
+.-+...+-+++|++++++|.+-.-.+....+.+... ....-++++|.+++||| .+..++-+..+...++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 3334445668899999999987543344445554432 34567899999999999 66666666667778899999
Q ss_pred cCCC-chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 432 MPNS-SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 432 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
+..+ +-..... .....+...+...+.+.-++++++||+.. -+|+| ||+..+ ...+..||+....+....
T Consensus 316 ~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9877 2111110 11111333344456666778999999864 58888 777655 678999999887665433
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNT 558 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~ 558 (671)
......+++.|+|||+...+.+..+.|+|++|+-..++--|-+|-
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 233467899999999999999999999999998777777777664
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.00 E-value=2.8e-05 Score=74.63 Aligned_cols=104 Identities=24% Similarity=0.244 Sum_probs=82.6
Q ss_pred HHHHHHHhhcCC-CCeeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCc
Q 005893 398 TNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476 (671)
Q Consensus 398 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ 476 (671)
.+|..+++.+++ +++.+++|.| ..+++.||...+++...-..-..--..+|..+.+|+.++++.+.+|+......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468888998976 6999999998 45789999987765422100011223689999999999999999999865555
Q ss_pred eeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 477 IIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 477 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
+...|++++|+-+++++++|+.|.+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 89999999999999999999999986654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00012 Score=70.68 Aligned_cols=129 Identities=20% Similarity=0.294 Sum_probs=89.9
Q ss_pred cccccCCCCcccEEEEEecCCceEEEEEccccc----------------hhchHHHHHHHHHHhhcC------CCCeeeE
Q 005893 358 DSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS----------------EQGNAEFTNEVLLILKLQ------HKNLVKL 415 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l 415 (671)
....||+|+.-.||. +++.....||+..... .....+..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346799999999995 5566778899887644 122345566666555554 8899999
Q ss_pred eeEEEcCCeeeEEEeccCC------CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE
Q 005893 416 LGFCVDGDEKLLVYEFMPN------SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL 489 (671)
Q Consensus 416 ~g~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll 489 (671)
+|+..++....+|+|.+.+ -+|.+++. .+.++. ...+.+. +-..||-++. |+.+|++|.||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998743 24666662 333554 3334444 3445666665 9999999999999
Q ss_pred cCC---C-CeEEee
Q 005893 490 DYD---M-NPKISD 499 (671)
Q Consensus 490 ~~~---~-~~kl~D 499 (671)
... . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 543 2 567776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00014 Score=86.04 Aligned_cols=79 Identities=16% Similarity=0.362 Sum_probs=57.5
Q ss_pred ccccCCCCcccEEEEEecCC---ceEEEEEccccc-hhchHHHHHHHHHHhhcC-CCCe--eeEeeEEEcC---CeeeEE
Q 005893 359 SNMLGQGGFGPVYKGVLSDG---KEIAVKRLSSCS-EQGNAEFTNEVLLILKLQ-HKNL--VKLLGFCVDG---DEKLLV 428 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lv 428 (671)
.+.|+.|.+..+|+....++ ..+++|+..... ......+.+|..+++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999877554 467888765422 123346889999999995 6665 7778877664 357899
Q ss_pred EeccCCCch
Q 005893 429 YEFMPNSSL 437 (671)
Q Consensus 429 ~e~~~~gsL 437 (671)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.0003 Score=72.95 Aligned_cols=76 Identities=12% Similarity=0.112 Sum_probs=56.0
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCC---CCeeeEeeEEEcC---CeeeEEEecc
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH---KNLVKLLGFCVDG---DEKLLVYEFM 432 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~---~~~~lv~e~~ 432 (671)
.+.||.|..+.||+....++ .+++|..+.. .....+..|.+.++.|.. ..+.++++++..+ +..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 46799999999999876555 5777775431 123478899999988843 4677888877543 5689999999
Q ss_pred CCCch
Q 005893 433 PNSSL 437 (671)
Q Consensus 433 ~~gsL 437 (671)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00019 Score=71.82 Aligned_cols=73 Identities=16% Similarity=0.252 Sum_probs=44.9
Q ss_pred cccCCCCcc-cEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCC---CeeeEeeEEEcC---CeeeEEEecc
Q 005893 360 NMLGQGGFG-PVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHK---NLVKLLGFCVDG---DEKLLVYEFM 432 (671)
Q Consensus 360 ~~lg~G~~g-~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~---~~~~lv~e~~ 432 (671)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.+++..+... -+.+.++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457766666 48874 346788876542 2344688899999877532 233334333222 1347899999
Q ss_pred CCCchh
Q 005893 433 PNSSLD 438 (671)
Q Consensus 433 ~~gsL~ 438 (671)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00026 Score=70.77 Aligned_cols=140 Identities=20% Similarity=0.252 Sum_probs=81.5
Q ss_pred cccCCCCcccEEEEEecC--CceEEEEEccccchhchHHHHHHHHHHhhcCCCCee-eEeeEEEcCCeeeEEEeccCCCc
Q 005893 360 NMLGQGGFGPVYKGVLSD--GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFMPNSS 436 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~--g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gs 436 (671)
+.|..|-...+|+....+ ++.|++|+....... .....+|+.++..+...+++ ++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999988764 678999987653222 12345788888888544443 4443322 248999999876
Q ss_pred hhhh-----------------hcCCCCC--------CCCC-hHHHHHHHH----------------------HHHHHHHH
Q 005893 437 LDAI-----------------LFDPRKR--------GLLC-WSKRINIVN----------------------GIVKGILY 468 (671)
Q Consensus 437 L~~~-----------------l~~~~~~--------~~l~-~~~~~~i~~----------------------qia~gL~~ 468 (671)
+... ++..... .... |..+..+.. .+..-+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 0110100 1111 222212211 11111111
Q ss_pred H----HhC-CCCceeecCCCCCcEEEcC-CCCeEEeeccccc
Q 005893 469 L----HED-SRLRIIHRDLKASNVLLDY-DMNPKISDFGMAR 504 (671)
Q Consensus 469 L----H~~-~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~ 504 (671)
| ... ....++|+|+.+.|||+++ +..+.|+||..+.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 111 2346999999999999998 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00026 Score=71.83 Aligned_cols=139 Identities=16% Similarity=0.095 Sum_probs=79.1
Q ss_pred ccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCee-eEeeEEEcCCeeeEEEeccCCCchhh
Q 005893 361 MLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFMPNSSLDA 439 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gsL~~ 439 (671)
.+..|-.+.+|+... +++.+++|........-.....+|..+++.+....++ ++++.. ..++|+||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 355688889998874 5778899986543222112356788888888544333 334332 2468999999876542
Q ss_pred h-----------------hcCCC-CCCCCChHHH-HHHHHH---------HHHHHHHHHhC-----CCCceeecCCCCCc
Q 005893 440 I-----------------LFDPR-KRGLLCWSKR-INIVNG---------IVKGILYLHED-----SRLRIIHRDLKASN 486 (671)
Q Consensus 440 ~-----------------l~~~~-~~~~l~~~~~-~~i~~q---------ia~gL~~LH~~-----~~~~ivH~Dlkp~N 486 (671)
- |+... ....++.... .....+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 1111222111 111111 11112222111 13458999999999
Q ss_pred EEEcCCCCeEEeecccccc
Q 005893 487 VLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 487 Ill~~~~~~kl~Dfgla~~ 505 (671)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00026 Score=65.51 Aligned_cols=128 Identities=20% Similarity=0.221 Sum_probs=86.6
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCchh
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLD 438 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 438 (671)
.+.|++|.+|.||+|.+. |..+|+|+-+..+ ....+..|.++|..++-.++-+=+-.+ +..++.|||+.|-.|.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~L~ 100 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcchh
Confidence 577999999999999995 5589999876543 345688999999998876665433222 2334559999988887
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCC-CCcEEEcCCCCeEEeecccccc
Q 005893 439 AILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLK-ASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 439 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~Dfgla~~ 505 (671)
++-.. .+ .+.+..+++.---|...| |-|+.|. |..++|-.+..+.|+||..+..
T Consensus 101 ~~~~~------~~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIG------GD----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhc------cc----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 65411 01 123344555544444445 8899887 4544454555999999998763
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00019 Score=83.30 Aligned_cols=199 Identities=20% Similarity=0.221 Sum_probs=135.5
Q ss_pred hHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee----EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 005893 394 NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL----LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469 (671)
Q Consensus 394 ~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~L 469 (671)
......|.+.+.++.|+|++.+++|..+....- +..|++..-++...+ +..+.++....+.+..+..+||.|+
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHH
Confidence 344556777888899999999999887655433 345777777777766 4556688888999999999999999
Q ss_pred HhCCCCceeecCCCCC---cEEEcCCCCeEEe--eccccccccCCCCccccccccccCCccchhhhccCCCCc--chhhH
Q 005893 470 HEDSRLRIIHRDLKAS---NVLLDYDMNPKIS--DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSI--KSDVF 542 (671)
Q Consensus 470 H~~~~~~ivH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVw 542 (671)
|+.. ..|.-|..+ +.-.+..+...++ ||+..+.+........ ..-+..|.+||......... ..|+|
T Consensus 303 h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHH
Confidence 9985 556555554 4455666777777 8888776544332211 12345678888776665544 47999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 543 SFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 543 SlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
.+|.....+..|..+-..... +..+++.. ... .+......|...++++|+..
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~--------------------~~~~l~~~----~~~----~~~d~~~~~~~~~~~~Rl~~ 428 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAV--------------------PVSLLDVL----STS----ELLDALPKCLDEDSEERLSA 428 (1351)
T ss_pred HHHHHHhhhhhcCcccccccc--------------------hhhhhccc----cch----hhhhhhhhhcchhhhhccch
Confidence 999999999998765321110 11111111 111 23345568999999999999
Q ss_pred HHHHHHh
Q 005893 623 SSVVVML 629 (671)
Q Consensus 623 ~ev~~~L 629 (671)
.+++...
T Consensus 429 ~~ll~~~ 435 (1351)
T KOG1035|consen 429 LELLTHP 435 (1351)
T ss_pred hhhhhch
Confidence 9998754
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00064 Score=65.09 Aligned_cols=125 Identities=26% Similarity=0.409 Sum_probs=88.4
Q ss_pred CCCCcccccCCCCc-ccEEEEEecCCceEEEEEccc---c---------ch---------hchHHHHHHHHHHhhcC---
Q 005893 354 SNFSDSNMLGQGGF-GPVYKGVLSDGKEIAVKRLSS---C---------SE---------QGNAEFTNEVLLILKLQ--- 408 (671)
Q Consensus 354 ~~~~~~~~lg~G~~-g~Vy~~~~~~g~~vavK~l~~---~---------~~---------~~~~~~~~E~~~l~~l~--- 408 (671)
.+++..+.||.|.- |.|||+.. +|+.+|+|.++. . .. .-..-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 99999999 678999999421 0 00 11124778888877774
Q ss_pred CCCe--eeEeeEEEcCC------------------eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHH
Q 005893 409 HKNL--VKLLGFCVDGD------------------EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILY 468 (671)
Q Consensus 409 H~ni--v~l~g~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~ 468 (671)
+.++ |+.+||..-.. ...||.||.+... .+ ..+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4456 89999874221 1235666654332 11 22345677788899
Q ss_pred HHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 469 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
+|+.+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999986 5689999853
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0015 Score=69.77 Aligned_cols=74 Identities=16% Similarity=0.189 Sum_probs=52.1
Q ss_pred cccCCCCcccEEEEEecCC-ceEEEEEcccc-----c--hhchHHHHHHHHHHhhcC---CCCeeeEeeEEEcCCeeeEE
Q 005893 360 NMLGQGGFGPVYKGVLSDG-KEIAVKRLSSC-----S--EQGNAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~-----~--~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv 428 (671)
+.||.|.+..||++...+| +.|+||.-.+. . ......+..|.+.|..+. ..++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5689999999999998777 58999985421 1 123345667777777752 2456666666 44667899
Q ss_pred EeccCCC
Q 005893 429 YEFMPNS 435 (671)
Q Consensus 429 ~e~~~~g 435 (671)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0013 Score=68.17 Aligned_cols=142 Identities=16% Similarity=0.114 Sum_probs=85.1
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCC--eeeEeeE------EEcCCeeeEEEe
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYE 430 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e 430 (671)
.+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +.+++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456788888899998764 45789998765 23345677888888774332 3444331 122345689999
Q ss_pred ccCCCchhh----hh----------cC----CCC----CCCCChHHHH----------HHHHHHHHHHHHHHh----CCC
Q 005893 431 FMPNSSLDA----IL----------FD----PRK----RGLLCWSKRI----------NIVNGIVKGILYLHE----DSR 474 (671)
Q Consensus 431 ~~~~gsL~~----~l----------~~----~~~----~~~l~~~~~~----------~i~~qia~gL~~LH~----~~~ 474 (671)
|++|..+.. .. +. ... .....|.... .....+...+.++.+ ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 00 10 000 0112222211 011123334445443 123
Q ss_pred CceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 475 LRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 475 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
..++|+|+.|.||+++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 459999999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00013 Score=52.25 Aligned_cols=40 Identities=45% Similarity=0.688 Sum_probs=32.6
Q ss_pred CCCCCCCCCCCccccccCCCC-----CCC--CccccCceeeccccCC
Q 005893 632 ETITLCQPQKPAFSFGRVTDD-----DDN--NYCSVNGLTISDLSPR 671 (671)
Q Consensus 632 ~~~~~~~p~~p~~~~~~~~~~-----~~~--~~~~~~~~~~~~~~~~ 671 (671)
+...|++|.+|+|+.++...+ +.. ...|+|+||||.+++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 456899999999999988632 112 5789999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.002 Score=67.00 Aligned_cols=140 Identities=24% Similarity=0.308 Sum_probs=82.5
Q ss_pred cccCCCCcccEEEEEecC-------CceEEEEEccccchhchHHHHHHHHHHhhcCCCCee-eEeeEEEcCCeeeEEEec
Q 005893 360 NMLGQGGFGPVYKGVLSD-------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~ 431 (671)
+.|..|-...+|+....+ ++.+++|+...... ...+..+|.+++..+...++. ++++.+. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 345567777899888654 57899999765432 223557888888887543333 4455443 2468999
Q ss_pred cCCCchhhh-----------------hcCCCCCC------CC--ChHHHHH--------------------------HHH
Q 005893 432 MPNSSLDAI-----------------LFDPRKRG------LL--CWSKRIN--------------------------IVN 460 (671)
Q Consensus 432 ~~~gsL~~~-----------------l~~~~~~~------~l--~~~~~~~--------------------------i~~ 460 (671)
++|..+... ++...... .. -|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988766431 11110000 00 0111111 111
Q ss_pred HHHHHHHHHHh------CCCCceeecCCCCCcEEEcCC----CCeEEeeccccc
Q 005893 461 GIVKGILYLHE------DSRLRIIHRDLKASNVLLDYD----MNPKISDFGMAR 504 (671)
Q Consensus 461 qia~gL~~LH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~ 504 (671)
.+..-+..|.. ..+..++|+|+.+.||+++++ +.++++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 235579999999999999985 889999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0038 Score=65.18 Aligned_cols=143 Identities=20% Similarity=0.178 Sum_probs=81.2
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCC--eeeEeeE------EEcCCeeeEEEe
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYE 430 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e 430 (671)
.+.++.|....+|+....+| .+++|+..... ...++..|..++..|.... +.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677787889999876444 68889875422 1234556677776664222 3333331 112345689999
Q ss_pred ccCCCchhhh--------------hcCC-C---CC-----CCCChHHHHH------------HHHHHHHHHHHHHh----
Q 005893 431 FMPNSSLDAI--------------LFDP-R---KR-----GLLCWSKRIN------------IVNGIVKGILYLHE---- 471 (671)
Q Consensus 431 ~~~~gsL~~~--------------l~~~-~---~~-----~~l~~~~~~~------------i~~qia~gL~~LH~---- 471 (671)
|++|..+... ++.. . .. ..-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988653210 1110 0 00 0111211100 01123344555542
Q ss_pred CCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 472 ~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.-+..++|+|+++.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999988777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0062 Score=63.87 Aligned_cols=142 Identities=16% Similarity=0.182 Sum_probs=76.3
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCC--eeeEee------EEEcCCeeeEEEe
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN--LVKLLG------FCVDGDEKLLVYE 430 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g------~~~~~~~~~lv~e 430 (671)
.+.|+.|....+|+....+| .+++|++... ....+..|+..+..|...+ +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35577788889999887555 7899987622 2233444555555553211 223221 1122455789999
Q ss_pred ccCCCchhh-----------hh---cCC-C-------CCCCCCh-HHHHH------------HHHH-HHHHHHHHHhC--
Q 005893 431 FMPNSSLDA-----------IL---FDP-R-------KRGLLCW-SKRIN------------IVNG-IVKGILYLHED-- 472 (671)
Q Consensus 431 ~~~~gsL~~-----------~l---~~~-~-------~~~~l~~-~~~~~------------i~~q-ia~gL~~LH~~-- 472 (671)
|++|..+.. .| +.. + ....+.| ..... .+.+ +...+..+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 100 0 0001112 11111 1111 11122233211
Q ss_pred --CCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 473 --SRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 473 --~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
-+.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23469999999999999966556899999765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0087 Score=61.84 Aligned_cols=137 Identities=15% Similarity=0.244 Sum_probs=81.2
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEcc-ccchhchHHHHHHHHHHhhcCC--CCeeeEeeEEEcCC--eeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQH--KNLVKLLGFCVDGD--EKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lv~e~~~~ 434 (671)
+.+..|..-.+|.... ++++++++... ...........+|..+|+.+.- .-+...++.|.++. ..+.||+|+++
T Consensus 31 ~~~~~G~sn~t~~~~~-~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGD-TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEec-CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 3343344444454444 37788888321 1222334456778888877643 23345667777666 56899999988
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHH-HHHHHHHHHHH-------------------------------------------
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIV-NGIVKGILYLH------------------------------------------- 470 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~-~qia~gL~~LH------------------------------------------- 470 (671)
..+...+.... .. .+++ ..+++.|.-||
T Consensus 110 e~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 110 EVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred eeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 54332221100 00 1111 13344444444
Q ss_pred -------hC-----CCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 471 -------ED-----SRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 471 -------~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
.+ +++.++|+|+.+.||+++.+..+-|.||+++..
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 22 245799999999999999998899999998865
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0095 Score=61.02 Aligned_cols=31 Identities=26% Similarity=0.521 Sum_probs=25.5
Q ss_pred CceeecCCCCCcEEEcCCCC-eEEeecccccc
Q 005893 475 LRIIHRDLKASNVLLDYDMN-PKISDFGMARI 505 (671)
Q Consensus 475 ~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~ 505 (671)
..++|+|++|.||+++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999997753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0012 Score=66.77 Aligned_cols=134 Identities=17% Similarity=0.178 Sum_probs=91.7
Q ss_pred CCCcccccCCCCcccEEEEEecCCceEEEEEccc-----------------cchhc-----hHHHHHHHHHHhhcCC--C
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSS-----------------CSEQG-----NAEFTNEVLLILKLQH--K 410 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~-----------------~~~~~-----~~~~~~E~~~l~~l~H--~ 410 (671)
-+...+.||-|.-+-||.+...+|++.++|.=+- ..... +-...+|...|+.|.. -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3567899999999999999999999999984210 00111 1234567777777743 2
Q ss_pred CeeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc
Q 005893 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD 490 (671)
Q Consensus 411 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~ 490 (671)
-+.+.++ ....++|||++.+-.|..+- ...+... +...+..-+.-|..+| +||+|..--||+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 2333343 34568999999888875543 1222333 3334444456666677 99999999999999
Q ss_pred CCCCeEEeeccccc
Q 005893 491 YDMNPKISDFGMAR 504 (671)
Q Consensus 491 ~~~~~kl~Dfgla~ 504 (671)
++..++++||-..-
T Consensus 237 dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMV 250 (465)
T ss_pred cCCCEEEeechHhh
Confidence 99999999996543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.012 Score=62.32 Aligned_cols=140 Identities=21% Similarity=0.249 Sum_probs=81.1
Q ss_pred cccCCCCcccEEEEEecC-----CceEEEEEccccchhchHHHHHHHHHHhhcCCCCee-eEeeEEEcCCeeeEEEeccC
Q 005893 360 NMLGQGGFGPVYKGVLSD-----GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~ 433 (671)
..|-.|-...+|+....+ ++.|++|+......... .-.+|..++..+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557778889887532 36799998876443322 336788888888544444 445554322 5899998
Q ss_pred CCchhhh-----------------hcCCC--CCC-CCChHHHHHHHHHH-----------------HHHHHHH----Hh-
Q 005893 434 NSSLDAI-----------------LFDPR--KRG-LLCWSKRINIVNGI-----------------VKGILYL----HE- 471 (671)
Q Consensus 434 ~gsL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~qi-----------------a~gL~~L----H~- 471 (671)
+.+|... +|... ... ...|.+..++..++ ..-+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 11111 011 11233333332221 1112222 21
Q ss_pred CCCCceeecCCCCCcEEEcC-CCCeEEeeccccc
Q 005893 472 DSRLRIIHRDLKASNVLLDY-DMNPKISDFGMAR 504 (671)
Q Consensus 472 ~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~ 504 (671)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22346899999999999986 4689999998765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.013 Score=60.07 Aligned_cols=73 Identities=22% Similarity=0.292 Sum_probs=47.3
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc---CCCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
.+.|+.|....+|+.. .+++.+.||+-.. .....|..|.+-|+.| .--.+.+.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999877 5788999998762 2334677888888877 3445778888887777789999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.015 Score=60.10 Aligned_cols=140 Identities=21% Similarity=0.215 Sum_probs=95.3
Q ss_pred cccccCCCCcccEEEEEecCCceEEEEEcccc-------c---------------hhc----hHHHHHHHHHHhhcCCCC
Q 005893 358 DSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC-------S---------------EQG----NAEFTNEVLLILKLQHKN 411 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~-------~---------------~~~----~~~~~~E~~~l~~l~H~n 411 (671)
+...|..|.-+.||.+.-.+|..+|||+++-. . ... ......|++.|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34678889999999999999999999986420 0 000 112457888888886544
Q ss_pred eeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC
Q 005893 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY 491 (671)
Q Consensus 412 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 491 (671)
|.-..-+.. ....|||+|+..-. +-...-+...++...+..+-.|++.-|.-|.+.. ++||.||.--|+|+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH- 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence 332111111 13478999995322 1111123344677778888889999999888776 599999999999994
Q ss_pred CCCeEEeecccccc
Q 005893 492 DMNPKISDFGMARI 505 (671)
Q Consensus 492 ~~~~kl~Dfgla~~ 505 (671)
+|.+.|+|-+.+..
T Consensus 300 dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVE 313 (520)
T ss_pred CCEEEEEEcccccc
Confidence 56899999876654
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.072 Score=57.01 Aligned_cols=73 Identities=14% Similarity=0.149 Sum_probs=48.0
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEcccc----ch---hchHHHHHHHHHHhhcC---CCCeeeEeeEEEcCCeeeEE
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC----SE---QGNAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv 428 (671)
.+.||.|....||+... +++.++||+-... +. .....-..|...|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 35689999999999876 4567999976521 11 12223334455555542 346777887765 556889
Q ss_pred EeccCC
Q 005893 429 YEFMPN 434 (671)
Q Consensus 429 ~e~~~~ 434 (671)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.018 Score=56.36 Aligned_cols=30 Identities=37% Similarity=0.543 Sum_probs=21.4
Q ss_pred CceeecCCCCCcEEE-cCCCCeEEeeccccc
Q 005893 475 LRIIHRDLKASNVLL-DYDMNPKISDFGMAR 504 (671)
Q Consensus 475 ~~ivH~Dlkp~NIll-~~~~~~kl~Dfgla~ 504 (671)
..++|+||.+.|||+ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 358899999999999 888999999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.076 Score=55.96 Aligned_cols=140 Identities=16% Similarity=0.218 Sum_probs=79.2
Q ss_pred ccCCCCcccEEEEEecC----CceEEEEEccccchhchHHHHHHHHHHhhcCCCCee-eEeeEEEcCCeeeEEEeccCCC
Q 005893 361 MLGQGGFGPVYKGVLSD----GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~g 435 (671)
.|..|--..+|+....+ +..|++|+....... ...-.+|..+++.+...++. ++++++. . . +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~-G--~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-N-G--MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-C-c--EeehhhcCC
Confidence 45446677788876543 237999988664432 22346788888888655554 4555542 2 2 589999776
Q ss_pred chhhh-----------------hcCCC--CCC-CCChHHHHHHHHHH----------------------HHHHHHHH---
Q 005893 436 SLDAI-----------------LFDPR--KRG-LLCWSKRINIVNGI----------------------VKGILYLH--- 470 (671)
Q Consensus 436 sL~~~-----------------l~~~~--~~~-~l~~~~~~~i~~qi----------------------a~gL~~LH--- 470 (671)
.|..- ++... ... .--|....++..++ ..-+..+.
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 55221 11111 011 11233322222221 11111111
Q ss_pred -h-CCCCceeecCCCCCcEEEcC-CCCeEEeecccccc
Q 005893 471 -E-DSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARI 505 (671)
Q Consensus 471 -~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~ 505 (671)
. ..+..++|+|+.+.|||+++ ++.++++||..+..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 12345799999999999975 57899999998753
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.0034 Score=74.94 Aligned_cols=158 Identities=13% Similarity=-0.064 Sum_probs=110.3
Q ss_pred HHHHHHhhcCCCCeeeEeeEEEc--CCeeeEEEeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhC--C
Q 005893 399 NEVLLILKLQHKNLVKLLGFCVD--GDEKLLVYEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHED--S 473 (671)
Q Consensus 399 ~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~--~ 473 (671)
.|...+++..|+++.....-... ..+.+..++|+..|.+.+.|.... +...++..-......+......-.|.. +
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 34444555689988765544332 335688999999999988875432 333344444443333334455554543 2
Q ss_pred CCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh
Q 005893 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553 (671)
Q Consensus 474 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt 553 (671)
..-.+|++||+-|.+|..+.++|++++|+.+...+.... .....+++.|+.|++...-.++.++|+|..|+-+|+.--
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 345789999999999999999999999999843332221 223467888999999888899999999999999999887
Q ss_pred CCCCC
Q 005893 554 GRRNT 558 (671)
Q Consensus 554 G~~p~ 558 (671)
|..++
T Consensus 1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred ccHHH
Confidence 77654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.15 Score=53.36 Aligned_cols=140 Identities=23% Similarity=0.275 Sum_probs=82.6
Q ss_pred ccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCC---CCeee---Eee----EEEcCCeeeEEEe
Q 005893 361 MLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH---KNLVK---LLG----FCVDGDEKLLVYE 430 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~---l~g----~~~~~~~~~lv~e 430 (671)
.|.+ .-..+|+....+|+. ++|+.... ....++..|+..+..|.- +=.++ +-| ....+...+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556788888866666 88888765 445567778888877732 11112 111 1112236678999
Q ss_pred ccCCCchhh-hh--------------c----C-----CCCCCCCChHH-------------HHHHHHHHHHHHHHHHhC-
Q 005893 431 FMPNSSLDA-IL--------------F----D-----PRKRGLLCWSK-------------RINIVNGIVKGILYLHED- 472 (671)
Q Consensus 431 ~~~~gsL~~-~l--------------~----~-----~~~~~~l~~~~-------------~~~i~~qia~gL~~LH~~- 472 (671)
|++|..+.. .. + . ........|.. -.....++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 10 0 0 00111233431 011233444445555432
Q ss_pred ------CCCceeecCCCCCcEEEcCCCC-eEEeeccccc
Q 005893 473 ------SRLRIIHRDLKASNVLLDYDMN-PKISDFGMAR 504 (671)
Q Consensus 473 ------~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~ 504 (671)
....+||+|+.|.||+++++.. .-+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1123999999999999999885 8899999764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.11 Score=54.71 Aligned_cols=72 Identities=15% Similarity=0.203 Sum_probs=45.5
Q ss_pred ccCCCCcccEEEEEecCC-ceEEEEEcccc-------chhchHHHHHHHHHHhhcC--CCC-eeeEeeEEEcCCeeeEEE
Q 005893 361 MLGQGGFGPVYKGVLSDG-KEIAVKRLSSC-------SEQGNAEFTNEVLLILKLQ--HKN-LVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~~~~g-~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lv~ 429 (671)
.||.|....||++..++| +.|+||.-.+. -.-......-|.+.|.... -|. +.+++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999998654 68999974321 1222334445666665542 343 4444433 556667999
Q ss_pred eccCC
Q 005893 430 EFMPN 434 (671)
Q Consensus 430 e~~~~ 434 (671)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.2 Score=52.25 Aligned_cols=29 Identities=24% Similarity=0.308 Sum_probs=25.2
Q ss_pred CceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 475 LRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 475 ~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 46999999999999987 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.35 Score=50.81 Aligned_cols=71 Identities=17% Similarity=0.163 Sum_probs=44.4
Q ss_pred CCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCC--CeeeEe---e--EEEcCCeeeEEEeccCCCc
Q 005893 365 GGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHK--NLVKLL---G--FCVDGDEKLLVYEFMPNSS 436 (671)
Q Consensus 365 G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~---g--~~~~~~~~~lv~e~~~~gs 436 (671)
+.-..||+....+|+.+++|+.+.. .....++..|+..+..|... .++... | +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4456789988877888999987632 23455677788887776321 122211 1 1222445678999998764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.19 Score=52.33 Aligned_cols=31 Identities=26% Similarity=0.309 Sum_probs=27.7
Q ss_pred CCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 474 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
+..++|+|+.+.|||+++++.+.|+||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4469999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.28 Score=59.57 Aligned_cols=141 Identities=21% Similarity=0.266 Sum_probs=77.7
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc--C-----CCCeeeEe-e----EEEc-CC--e
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL--Q-----HKNLVKLL-G----FCVD-GD--E 424 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~-----H~niv~l~-g----~~~~-~~--~ 424 (671)
+.|+ |..-.+|+....+|+.+++|+...... ......|...+..| + -|.+++-. | .... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3454 456788988887888999999986432 23344455555544 2 23333321 1 1111 12 3
Q ss_pred eeEEEeccCCCchhhhh---------------------cC---CCCCCCCChHH-----------------HHHHHHHHH
Q 005893 425 KLLVYEFMPNSSLDAIL---------------------FD---PRKRGLLCWSK-----------------RINIVNGIV 463 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l---------------------~~---~~~~~~l~~~~-----------------~~~i~~qia 463 (671)
.+-+++|++|..+.+.. .+ ......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 46689999987765411 00 00011123321 122233333
Q ss_pred HHHH-----HHHhCCCCceeecCCCCCcEEEcCCC--CeE-Eeeccccc
Q 005893 464 KGIL-----YLHEDSRLRIIHRDLKASNVLLDYDM--NPK-ISDFGMAR 504 (671)
Q Consensus 464 ~gL~-----~LH~~~~~~ivH~Dlkp~NIll~~~~--~~k-l~Dfgla~ 504 (671)
+... .|.+ -+..+||+|+.+.|||++.+. ++. |+|||-+.
T Consensus 188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 3222 1222 134599999999999999875 555 99999765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.24 Score=51.51 Aligned_cols=106 Identities=15% Similarity=0.195 Sum_probs=70.2
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..+++|++. ++.+.. .+...|.+...++.+.+.-+.-+..+- +.-|||+.-.||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 346677765 455432 233568999999999888888887654 689999999999999 999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHH
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil 548 (671)
|...+. ..... ...--|-.+. |.-+.+=|||-+--.+
T Consensus 369 Rl~~~q-~~isy------~rldhp~lF~-G~dd~QFeIYrlMr~l 405 (488)
T COG5072 369 RLSYSQ-GIISY------NRLDHPDLFN-GVDDYQFEIYRLMRRL 405 (488)
T ss_pred ecccCC-ceeec------cccCchhhhc-CccceeeeHHHHHHHH
Confidence 953322 21111 1122344443 3335566777654433
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.15 Score=54.31 Aligned_cols=74 Identities=16% Similarity=0.168 Sum_probs=46.6
Q ss_pred ccccCCCCcccEEEEEecC-CceEEEEEccc---cc---hhchHHHHHHHHHHhhcC--CCC-eeeEeeEEEcCCeeeEE
Q 005893 359 SNMLGQGGFGPVYKGVLSD-GKEIAVKRLSS---CS---EQGNAEFTNEVLLILKLQ--HKN-LVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~---~~---~~~~~~~~~E~~~l~~l~--H~n-iv~l~g~~~~~~~~~lv 428 (671)
.+.||.|.-.-||++...+ ++.|+||.-.+ .. .-......-|.+.|+.+. -|. +.+++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3578999999999999743 56899997432 11 222344555666666542 343 4445543 55566788
Q ss_pred EeccCC
Q 005893 429 YEFMPN 434 (671)
Q Consensus 429 ~e~~~~ 434 (671)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.57 E-value=0.22 Score=49.99 Aligned_cols=75 Identities=20% Similarity=0.195 Sum_probs=54.0
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHH---HHHhhcCCCCeeeEeeEEEcCCeeeEEEecc-CCC
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEV---LLILKLQHKNLVKLLGFCVDGDEKLLVYEFM-PNS 435 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~-~~g 435 (671)
..+..|..+.|++++..+|.++++|+..+.... ..|. ..|+..+-...|+++..- .....|.+|.+ ++.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~-----~~E~~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~ 80 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEA-----EHEARGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGR 80 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccc-----hhhhhHHhHhheeCCCCceeeeccc--cccchhhhhhccCCC
Confidence 456779999999999999999999998754322 2232 446667778889988763 34567888888 555
Q ss_pred chhhhh
Q 005893 436 SLDAIL 441 (671)
Q Consensus 436 sL~~~l 441 (671)
+|.++.
T Consensus 81 ~L~~~~ 86 (253)
T PF04655_consen 81 SLASLP 86 (253)
T ss_pred chhhcc
Confidence 676554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.47 E-value=0.52 Score=46.03 Aligned_cols=73 Identities=21% Similarity=0.249 Sum_probs=49.3
Q ss_pred cCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc---CCCCeeeEeeEEEcCCeeeEEEeccCCCchh
Q 005893 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL---QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLD 438 (671)
Q Consensus 362 lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 438 (671)
+--|.--..|.... +.+++.||+-.. .....|..|+.-|..| +--++.+.+.+-......++|+||++-+.++
T Consensus 24 v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 44344444454433 567899997543 2234677787777666 3456777888877888999999999987665
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 671 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-54 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-45 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-40 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-24 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-24 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-23 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-22 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-22 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-22 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-21 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-21 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-21 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-21 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-21 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-21 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-21 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-21 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-21 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-21 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-19 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-19 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 8e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 9e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-18 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 6e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 8e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-15 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-15 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 9e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 8e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 426 bits (1098), Expect = e-146
Identities = 118/291 (40%), Positives = 169/291 (58%), Gaps = 3/291 (1%)
Query: 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGN-AEFTNEVLLI 404
L L VA+ NFS+ N+LG+GGFG VYKG L+DG +AVKRL QG +F EV +I
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 405 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRK-RGLLCWSKRINIVNGIV 463
H+NL++L GFC+ E+LLVY +M N S+ + L + + + L W KR I G
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
+G+ YLH+ +IIHRD+KA+N+LLD + + DFG+A++ + V T + GT G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGTIG 200
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583
++APEY G S K+DVF +GV+L+E+ITG+R + LL + L E
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETI 634
L+D L +E + I + LLC Q +RP MS VV ML+G+ +
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-144
Identities = 111/301 (36%), Positives = 156/301 (51%), Gaps = 21/301 (6%)
Query: 346 LETLDVATSNFSD------SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC----SEQGNA 395
L T+NF + N +G+GGFG VYKG + + +AVK+L++ +E+
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 396 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR 455
+F E+ ++ K QH+NLV+LLGF DGD+ LVY +MPN SL L L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
I G GI +LHE+ IHRD+K++N+LLD KISDFG+AR V T
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575
+RIVGT YMAPE + G + KSD++SFGV+L+EIITG ++ LL
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE----PQLLLDIK 247
Query: 576 WHLWNEGNAL-DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETI 634
+ +E + D ID + D + C+ E RP + V +LQ T
Sbjct: 248 EEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
Query: 635 T 635
+
Sbjct: 307 S 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-128
Identities = 104/288 (36%), Positives = 164/288 (56%), Gaps = 8/288 (2%)
Query: 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLIL 405
L L+ AT+NF ++G G FG VYKGVL DG ++A+KR + S QG EF E+ +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 406 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-LCWSKRINIVNGIVK 464
+H +LV L+GFC + +E +L+Y++M N +L L+ + + W +R+ I G +
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF-AGSEGEVNTARIVGTYG 523
G+ YLH + IIHRD+K+ N+LLD + PKI+DFG+++ + ++T + GT G
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGTLG 206
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583
Y+ PEY ++G + KSDV+SFGV+L E++ R QS NL +A N G
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI--VQSLPREMVNLAEWAVESHNNGQ 264
Query: 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631
++DP L D P+ ++ + C+ + DRP+M V+ L+
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 1e-95
Identities = 71/312 (22%), Positives = 126/312 (40%), Gaps = 36/312 (11%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLL 403
+ E L + + +G FG V+K L + +AVK +Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 404 ILKLQHKNLVKLLGFCVDGD----EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIV 459
+ ++H+N+++ +G G + L+ F SL L K ++ W++ +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 460 NGIVKGILYLHED-------SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512
+ +G+ YLHED + I HRD+K+ NVLL ++ I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 513 VNTARIVGTYGYMAPEYAMEGL-----YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT 567
+T VGT YMAPE + ++ D+++ G++L E+ + G
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD-----GPV 242
Query: 568 APNLLAYAWHLWNEGNALDL--------IDPLLTDTCSPDEFLR-YIHIGLLCVQEDAFD 618
+L + + + D+ P+L D + C DA
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 619 RPTMSSVVVMLQ 630
R + V +
Sbjct: 303 RLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-79
Identities = 72/336 (21%), Positives = 123/336 (36%), Gaps = 47/336 (13%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNE--V 401
+ N ++G+G +G VYKG L D + +AVK S + Q F NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 402 LLILKLQHKNLVKLLGFCVDGD-----EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI 456
+ ++H N+ + + E LLV E+ PN SL L W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 457 NIVNGIVKGILYLHED------SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS- 509
+ + + +G+ YLH + + I HRDL + NVL+ D ISDFG++ G+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 510 -----EGEVNTARIVGTYGYMAPEYAMEGL-------YSIKSDVFSFGVLLIEIITGRRN 557
E + VGT YMAPE + + D+++ G++ EI +
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 558 TGFNQSRGATAPNLLAYAWHLWNEGNALDLID--------PLLTDTCSPDEFLRYIHIGL 609
+ +A+ + N D+ P + +
Sbjct: 235 LFPG---ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 610 L--CVQEDAFDRPTMSSVVVMLQGETITLCQPQKPA 643
+ C +DA R T + + + + +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-64
Identities = 80/329 (24%), Positives = 142/329 (43%), Gaps = 41/329 (12%)
Query: 308 VRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGF 367
++ H + D + +G D D I L++ +G G F
Sbjct: 1 MKHHHHHHPMSDYDIPTTENLYFQGAMD---GDDMDIPWCDLNI-------KEKIGAGSF 50
Query: 368 GPVYKGVLSDGKEIAVKRL--SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425
G V++ G ++AVK L + EF EV ++ +L+H N+V +G
Sbjct: 51 GTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKAS 485
+V E++ SL +L R L +R+++ + KG+ YLH I+HR+LK+
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSP 168
Query: 486 NVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFG 545
N+L+D K+ DFG++R+ A + +A GT +MAPE + + KSDV+SFG
Sbjct: 169 NLLVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEKSDVYSFG 226
Query: 546 VLLIEIITGRRNTGFNQSRGATAP----NLLAYAWHLWNEGNALDLIDPLLTDTCSPDEF 601
V+L E+ T ++ P N + + L++ P +
Sbjct: 227 VILWELATLQQ------------PWGNLNPAQVVAAVGFKCKRLEI--P---RNL-NPQV 268
Query: 602 LRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
I C + + RP+ ++++ +L+
Sbjct: 269 AAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 9e-63
Identities = 71/288 (24%), Positives = 113/288 (39%), Gaps = 46/288 (15%)
Query: 362 LGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
LG+G FG K G+ + +K L E+ F EV ++ L+H N++K +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
+ E++ +L I+ + WS+R++ I G+ YLH + IIHR
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR------------IVGTYGYMAPE 528
DL + N L+ + N ++DFG+AR+ + + R +VG +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588
Y K DVFSFG++L EII A + +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVN------------------ADPDYLPRTMDFGL 234
Query: 589 D------PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ C P F + C D RP+ + L+
Sbjct: 235 NVRGFLDRYCPPNC-PPSFFPIT---VRCCDLDPEKRPSFVKLEHWLE 278
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-60
Identities = 78/289 (26%), Positives = 121/289 (41%), Gaps = 36/289 (12%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLL 403
ID + ++V ++G+G FG V K K++A+K++ S SE+ F E+
Sbjct: 5 IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQ 54
Query: 404 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIV 463
+ ++ H N+VKL G C++ LV E+ SL +L + ++
Sbjct: 55 LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMN-PKISDFGMARIFAGSEGEVNTARIVGTY 522
+G+ YLH +IHRDLK N+LL KI DFG A G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSA 167
Query: 523 GYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR-NTGFNQSRGATAPNLLAYAWHLWNE 581
+MAPE YS K DVFS+G++L E+IT R+ W + +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-------AFRIMWAV-HN 219
Query: 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
G LI P + C +D RP+M +V ++
Sbjct: 220 GTRPPLI-----KNL-PKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-60
Identities = 79/311 (25%), Positives = 135/311 (43%), Gaps = 53/311 (17%)
Query: 338 KAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNA- 395
K++ + ++ +G+GGFG V+KG + D +A+K L +G
Sbjct: 10 KSRLPTLADNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 396 ------EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL 449
EF EV ++ L H N+VKL G + +V EF+P L L D
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP-- 118
Query: 450 LCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-----YDMNPKISDFGMAR 504
+ WS ++ ++ I GI Y+ + I+HRDL++ N+ L + K++DFG+++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 505 IFAGSEGEVNTARIVGTYGYMAPE--YAMEGLYSIKSDVFSFGVLLIEIITGR---RNTG 559
S + ++G + +MAPE A E Y+ K+D +SF ++L I+TG
Sbjct: 178 QSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 560 FNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDR 619
+ + + + + EG + + C P R ++ LC D R
Sbjct: 233 YGK---------IKFINMIREEGLRPTIP-----EDCPP----RLRNVIELCWSGDPKKR 274
Query: 620 PTMSSVVVMLQ 630
P S +V L
Sbjct: 275 PHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 8e-60
Identities = 84/303 (27%), Positives = 132/303 (43%), Gaps = 53/303 (17%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNA----EFTN 399
ID L + ++G GGFG VY+ G E+AVK ++ +
Sbjct: 4 IDFAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQ 55
Query: 400 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIV 459
E L L+H N++ L G C+ LV EF L+ +L R + +N
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWA 111
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP--------KISDFGMARIFAGSEG 511
I +G+ YLH+++ + IIHRDLK+SN+L+ + KI+DFG+AR + +
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP-- 569
G Y +MAPE ++S SDV+S+GVLL E++TG P
Sbjct: 172 MSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------------PFR 215
Query: 570 --NLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627
+ LA A+ + AL + TC + + C D RP+ ++++
Sbjct: 216 GIDGLAVAYGVAMNKLALPIP-----STCPEP----FAKLMEDCWNPDPHSRPSFTNILD 266
Query: 628 MLQ 630
L
Sbjct: 267 QLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 1e-58
Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 45/298 (15%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRL--SSCSEQGNAEFTNEV 401
I + V +G G FG VYKG ++AVK L ++ + Q F NEV
Sbjct: 21 IPDGQITVG-------QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEV 71
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVN 460
++ K +H N++ +G+ +L +V ++ SSL L + K I+I
Sbjct: 72 GVLRKTRHVNILLFMGYSTA--PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIAR 127
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG 520
+G+ YLH IIHRDLK++N+ L D KI DFG+A + G ++ G
Sbjct: 128 QTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 521 TYGYMAPE---YAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP-----NLL 572
+ +MAPE YS +SDV++FG++L E++TG+ P N
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQL------------PYSNINNRD 232
Query: 573 AYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ +L + C + C+++ +RP+ ++ ++
Sbjct: 233 QIIEMVGR--GSLSPDLSKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 5e-58
Identities = 68/317 (21%), Positives = 124/317 (39%), Gaps = 52/317 (16%)
Query: 331 RGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRL--SS 388
+ + Q++ I E L++ ++G+G FG VY G E+A++ +
Sbjct: 17 KASQTSIFLQEWDIPFEQLEI-------GELIGKGRFGQVYHGRWHG--EVAIRLIDIER 67
Query: 389 CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG 448
+E F EV+ + +H+N+V +G C+ ++ +L +++ D +
Sbjct: 68 DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV- 126
Query: 449 LLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508
L +K I IVKG+ YLH I+H+DLK+ NV D + I+DFG+ I
Sbjct: 127 -LDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181
Query: 509 SEGEVNTARI---VGTYGYMAPE---------YAMEGLYSIKSDVFSFGVLLIEIITGR- 555
+ ++ G ++APE + +S SDVF+ G + E+
Sbjct: 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
Query: 556 --RNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQ 613
+ + P L+ E + L C
Sbjct: 242 PFKTQPAEAIIWQMGTGMK-----------------PNLSQIGMGKEISDIL---LFCWA 281
Query: 614 EDAFDRPTMSSVVVMLQ 630
+ +RPT + ++ ML+
Sbjct: 282 FEQEERPTFTKLMDMLE 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 9e-58
Identities = 65/299 (21%), Positives = 117/299 (39%), Gaps = 51/299 (17%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRL--SSCSEQGNAEFTNEV 401
ID + L+ L + G ++KG G +I VK L S + + +F E
Sbjct: 7 IDFKQLNF-------LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLL--VYEFMPNSSLDAILFDPRKRGLLCWSKRINIV 459
+ H N++ +LG C + +MP SL +L + ++ S+ +
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFA 117
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV 519
+ +G+ +LH L I L + +V++D DM +IS + F +
Sbjct: 118 LDMARGMAFLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------M 169
Query: 520 GTYGYMAPEYAMEG----LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP----NL 571
++APE A++ +D++SF VLL E++T P +
Sbjct: 170 YAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREV------------PFADLSN 216
Query: 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ + EG + P + SP + + I C+ ED RP +V +L+
Sbjct: 217 MEIGMKVALEG-----LRPTIPPGISP-HVSKLMKI---CMNEDPAKRPKFDMIVPILE 266
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-52
Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 44/300 (14%)
Query: 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNE--VLLILKLQHKNLVKLLG 417
+G+G +G V+ G G+++AVK + A + E + + ++H+N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 418 FCVDGDEK----LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+ G L+ ++ N SL L K L + + V G+ +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 474 RLR-----IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI--VGTYGYMA 526
I HRDLK+ N+L+ + I+D G+A F EV+ VGT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 527 PE------YAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580
PE I +D++SFG++L E+ S G L Y + +
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARR------CVSGGIVEEYQLPYHDLVPS 268
Query: 581 EGNALDLID--------PLLTDTCSPDEFLRYIHIGLL--CVQEDAFDRPTMSSVVVMLQ 630
+ + D+ + P + S DE LR + L+ C + R T V L
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-52
Identities = 64/300 (21%), Positives = 118/300 (39%), Gaps = 44/300 (14%)
Query: 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNE--VLLILKLQHKNLVKLLG 417
+G+G +G V++G G+ +AVK SS + + E + + L+H+N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 418 FCVDGDEK----LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+ L+ + SL L + L + IV I G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 474 RLR-----IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI--VGTYGYMA 526
I HRDLK+ N+L+ + I+D G+A + + S +++ VGT YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 527 PE------YAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580
PE + D+++FG++L E+ S G + + N
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR------MVSNGIVEDYKPPFYDVVPN 239
Query: 581 EGNALDLID--------PLLTDTCSPDEFLRYIHIGLL--CVQEDAFDRPTMSSVVVMLQ 630
+ + D+ P + + D L + L+ C ++ R T + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-50
Identities = 63/301 (20%), Positives = 119/301 (39%), Gaps = 46/301 (15%)
Query: 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNE--VLLILKLQHKNLVKLLG 417
+G+G FG V++G G+E+AVK SS + + E + + L+H+N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 418 FCVDGDEK----LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED- 472
+ LV ++ + SL L R + I + G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 473 ----SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI--VGTYGYMA 526
+ I HRDLK+ N+L+ + I+D G+A + ++ A VGT YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 527 PEYAMEGL-------YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579
PE ++ ++D+++ G++ EI G L Y +
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR------CSIGGIHEDYQLPYYDLVP 272
Query: 580 NEGNALDLID--------PLLTDTCSPDEFLRYIHIGLL--CVQEDAFDRPTMSSVVVML 629
++ + ++ P + + E LR + ++ C + R T + L
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTL 331
Query: 630 Q 630
Sbjct: 332 S 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-47
Identities = 73/281 (25%), Positives = 110/281 (39%), Gaps = 44/281 (15%)
Query: 362 LGQGGFGPVYKGVL-SDGKEIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
+G+G FG V+ G L +D +AVK + A+F E ++ + H N+V+L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRG-LLCWSKRINIVNGIVKGILYLHEDSRLRII 478
+V E + L R G L + +V G+ YL I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIK 538
HRDL A N L+ KISDFGM+R A + + APE G YS +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 539 SDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID-------P 590
SDV+SFG+LL E + G P Y + + ++ P
Sbjct: 296 SDVWSFGILLWETFSLGAS------------P----YPN--LSNQQTREFVEKGGRLPCP 337
Query: 591 LLTDTCSPDEFLRYIH-IGLLCVQEDAFDRPTMSSVVVMLQ 630
+ C + + C + RP+ S++ LQ
Sbjct: 338 ---ELCPDA-----VFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 5e-45
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 33/286 (11%)
Query: 362 LGQGGFGPVYKGVL-----SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
LG+G FG V + G+ +AVK+L +E+ +F E+ ++ LQH N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 417 GFCVDGDEK--LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
G C + L+ E++P SL L + + + K + + I KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT--- 132
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAME 532
R IHRDL N+L++ + KI DFG+ ++ + E + G + APE E
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK-EFFKVKEPGESPIFWYAPESLTE 191
Query: 533 GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592
+S+ SDV+SFGV+L E+ T + + + LI+ L
Sbjct: 192 SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-GQMIVF----HLIELLK 246
Query: 593 T-------DTCSPDEFLRYIH-IGLLCVQEDAFDRPTMSSVVVMLQ 630
D C + I+ I C + RP+ + + +
Sbjct: 247 NNGRLPRPDGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-45
Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 39/289 (13%)
Query: 362 LGQGGFGPVYKGVL-----SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
LG+G FG V + G+ +AVK+L +E+ +F E+ ++ LQH N+VK
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 417 GFCVDGDEK--LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
G C + L+ E++P SL L + + + K + + I KG+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT--- 163
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG-----YMAPEY 529
R IHRDL N+L++ + KI DFG+ ++ + V G + APE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPES 219
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589
E +S+ SDV+SFGV+L E+ T + + + LI+
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-GQMIVF----HLIE 274
Query: 590 PLLT-------DTCSPDEFLRYIH-IGLLCVQEDAFDRPTMSSVVVMLQ 630
L D C + I+ I C + RP+ + + +
Sbjct: 275 LLKNNGRLPRPDGCPDE-----IYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-44
Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 48/293 (16%)
Query: 362 LGQGGFGPVYKGVL-----SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
LG+G FG V + G +AVK+L +F E+ ++ L +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 417 GFCVDGDEK--LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
G + LV E++P+ L L R R L S+ + + I KG+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS--- 145
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG-----YMAPEY 529
R +HRDL A N+L++ + + KI+DFG+A++ + +V G + APE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPES 201
Query: 530 AMEGLYSIKSDVFSFGVLLIEIIT-GRR----NTGFNQSRGATAPNLLAYAWHLWNEGNA 584
+ ++S +SDV+SFGV+L E+ T + + F + G
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP-----------AL 250
Query: 585 LDLIDPLLT-------DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
L++ L C P E + + LC DRP+ S++ L
Sbjct: 251 SRLLELLEEGQRLPAPPAC-PAEV--H-ELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-44
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V G ++A+K + S EF E +++ L H+ LV+L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
++ E+M N L L R + + + + + + YL + +HRD
Sbjct: 91 QRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSIKS 539
L A N L++ K+SDFG++R + T+ + + PE M +S KS
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 540 DVFSFGVLLIEIIT-GRR 556
D+++FGVL+ EI + G+
Sbjct: 203 DIWAFGVLMWEIYSLGKM 220
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-44
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
+G G FG V+ G + ++A+K + + +F E +++KL H LV+L G C++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
LV EFM + L L +RGL + + + +G+ YL +IHRD
Sbjct: 75 QAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSIKS 539
L A N L+ + K+SDFGM R + T+ + +PE YS KS
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 540 DVFSFGVLLIEIIT-GRR 556
DV+SFGVL+ E+ + G+
Sbjct: 187 DVWSFGVLMWEVFSEGKI 204
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 81/317 (25%), Positives = 130/317 (41%), Gaps = 57/317 (17%)
Query: 334 DDDL--KAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKE----IAVKRL- 386
D L + +D I E + ++G+G FG VY G D + A+K L
Sbjct: 4 DSALLAEVKDVLIPHERVVT-----HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS 58
Query: 387 SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE-KLLVYEFMPNSSLDAILFDPR 445
Q F E LL+ L H N++ L+G + + ++ +M + L + P+
Sbjct: 59 RITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ 118
Query: 446 KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
+ I+ + +G+ YL + + +HRDL A N +LD K++DFG+AR
Sbjct: 119 RN--PTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173
Query: 506 FAGSEGEVNTARIVGTYG-----YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560
+ E + + + + A E ++ KSDV+SFGVLL E++T
Sbjct: 174 IL--DREYYSVQ-QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT------- 223
Query: 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT-------DTCSPDEFLRYIHIGLLCVQ 613
RGA P Y H+ DL L + C PD Y + C +
Sbjct: 224 ---RGAP-P----Y-RHIDPF----DLTHFLAQGRRLPQPEYC-PDSL--Y-QVMQQCWE 266
Query: 614 EDAFDRPTMSSVVVMLQ 630
D RPT +V ++
Sbjct: 267 ADPAVRPTFRVLVGEVE 283
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 23/208 (11%)
Query: 362 LGQGGFGPVYKGVLSDGKE-----IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
+G G FG VYKG+L +A+K L + +E+ +F E ++ + H N+++L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
G +++ E+M N +LD L K G + + ++ GI G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG------YMAPEY 529
+HRDL A N+L++ ++ K+SDFG++R+ T G + APE
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPEA 221
Query: 530 AMEGLYSIKSDVFSFGVLLIEIIT-GRR 556
++ SDV+SFG+++ E++T G R
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 35/287 (12%)
Query: 362 LGQGGFGPVYKGVL-----SDGKEIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V + G+++AVK L A+ E+ ++ L H+N+VK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 416 LGFCVDGDEK--LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
G C + L+ EF+P+ SL L P+ + + +++ I KG+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS-- 144
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAM 531
+ +HRDL A NVL++ + KI DFG+ + ++ E T + + APE M
Sbjct: 145 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 532 EGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590
+ + I SDV+SFGV L E++T ++ + + L++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDS---SPMALFLKMIGPTHGQMTVT----RLVNT 255
Query: 591 LLT-------DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
L C PDE Y + C + +R + +++ +
Sbjct: 256 LKEGKRLPCPPNC-PDEV--Y-QLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-43
Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 44/303 (14%)
Query: 362 LGQGGFGPVYKGVL---SDGKEI--AVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V +DG AVK L + Q + + E+ ++ L H++++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 416 LGFCVDGDEK--LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
G C D LV E++P SL L + + ++ + I +G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSI-GLAQLLLFAQQICEGMAYLHA-- 152
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG-----YMAPE 528
IHRDL A NVLLD D KI DFG+A+ V G + APE
Sbjct: 153 -QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPE 207
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587
E + SDV+SFGV L E++T + + +A + L
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQ-GQMTVL----RL 260
Query: 588 IDPLLT-------DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQ 640
+ L D C + + H+ C + +A RPT +++ +L+ Q Q
Sbjct: 261 TELLERGERLPRPDKCPAEVY----HLMKNCWETEASFRPTFENLIPILK-TVHEKYQGQ 315
Query: 641 KPA 643
P+
Sbjct: 316 APS 318
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 362 LGQGGFGPVYKGVL--SDGKEI--AVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
+G G G V G L +++ A+K L + +E+ +F +E ++ + H N+++L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G G ++V E+M N SLD L + + + ++ G+ G+ YL S L
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL---SDLG 171
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG------YMAPEYA 530
+HRDL A NVL+D ++ K+SDFG++R+ T G + APE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPEAI 226
Query: 531 MEGLYSIKSDVFSFGVLLIEIIT-GRR 556
+S SDV+SFGV++ E++ G R
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-43
Identities = 64/199 (32%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V G ++AVK + S EF E ++KL H LVK G C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRG-LLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
+V E++ N L L R G L S+ + + + +G+ +L + IHR
Sbjct: 75 EYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSIK 538
DL A N L+D D+ K+SDFGM R + + + + APE YS K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 539 SDVFSFGVLLIEIIT-GRR 556
SDV++FG+L+ E+ + G+
Sbjct: 186 SDVWAFGILMWEVFSLGKM 204
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 360 NMLGQGGFGPVYKGVLSDGKE-----IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLV 413
+LG G FG VYKG+ E +A+K L + S + N E +E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+LLG C+ L+ + MP L + + + + +N I KG+ YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG-----YMAPE 528
R++HRDL A NVL+ + KI+DFG+A++ E E + G +MA E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIIT-GRR 556
+ +Y+ +SDV+S+GV + E++T G +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-43
Identities = 83/313 (26%), Positives = 126/313 (40%), Gaps = 59/313 (18%)
Query: 338 KAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKE----IAVKRL-SSCSEQ 392
Q I +L V + ++G+G FG VY G L D AVK L
Sbjct: 14 AVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 68
Query: 393 GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMPNSSLDAILFDPRKRGLLC 451
++F E +++ H N++ LLG C+ + L V +M + L + +
Sbjct: 69 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 126
Query: 452 WSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSE 510
I + KG+ YL + +HRDL A N +LD K++DFG+AR ++
Sbjct: 127 VKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY---- 179
Query: 511 GEVNTARIVGTYG------YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR 564
+ + G +MA E ++ KSDV+SFGVLL E++T R
Sbjct: 180 -DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT----------R 228
Query: 565 GATAPNLLAYAWHLWNEGNALDLIDPLLT-------DTCSPDEFLRYIHIGLLCVQEDAF 617
GA P Y + D+ LL + C PD Y + L C A
Sbjct: 229 GAP-P----Y-PDVNTF----DITVYLLQGRRLLQPEYC-PDPL--Y-EVMLKCWHPKAE 274
Query: 618 DRPTMSSVVVMLQ 630
RP+ S +V +
Sbjct: 275 MRPSFSELVSRIS 287
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 362 LGQGGFGPVYKGVL--SDGKEI--AVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
+G G FG V G L KEI A+K L +E+ +F E ++ + H N+++L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRK-RGLLCWSKRINIVNGIVKGILYLHEDSRL 475
G ++V E+M N SLD+ L RK + + ++ GI G+ YL S +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT---YGYMAPEYAME 532
+HRDL A N+L++ ++ K+SDFG+ R+ T R G + +PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAY 224
Query: 533 GLYSIKSDVFSFGVLLIEIIT-GRR 556
++ SDV+S+G++L E+++ G R
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 57/297 (19%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V+ + +AVK L + +F E L+ LQH+++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR-------------INIVNGI 462
G C DGD ++V+E+M + L+ L ++ + ++I + I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI--VG 520
G++YL + +HRDL N L+ ++ KI DFGM+R +V + VG
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-------DVYSTDYYRVG 192
Query: 521 TYG-----YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQS--RGATAPNLLA 573
+ +M PE M ++ +SDV+SFGV+L EI T + + + ++
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT------YGKQPWFQLSNTEVIE 246
Query: 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+G L+ P C P E Y + L C Q + R + + +L
Sbjct: 247 CI----TQGRVLE--RP---RVC-PKEV--Y-DVMLGCWQREPQQRLNIKEIYKILH 290
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 362 LGQGGFGPVYKGVLSDGK-EIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
LG G +G VY+GV +AVK L + + EF E ++ +++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
++ EFM +L L + R + + + I + YL + IHR
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYL---EKKNFIHR 135
Query: 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSIK 538
DL A N L+ + K++DFG++R+ G+ TA + APE +SIK
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 539 SDVFSFGVLLIEIIT-GRR 556
SDV++FGVLL EI T G
Sbjct: 193 SDVWAFGVLLWEIATYGMS 211
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-42
Identities = 70/198 (35%), Positives = 106/198 (53%), Gaps = 12/198 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V+ G + ++AVK L S + F E L+ +LQH+ LV+L V
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYA-VVT 78
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
+ ++ E+M N SL L L +K +++ I +G+ ++ IHRD
Sbjct: 79 QEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFI---EERNYIHRD 134
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSIKS 539
L+A+N+L+ ++ KI+DFG+AR+ E TAR + APE G ++IKS
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 540 DVFSFGVLLIEIIT-GRR 556
DV+SFG+LL EI+T GR
Sbjct: 192 DVWSFGILLTEIVTHGRI 209
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-42
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 362 LGQGGFGPVYKGVLSDGK--------EIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
LGQG F ++KGV + E+ +K L + F ++ KL HK+LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
G CV GDE +LV EF+ SLD L + + + ++ + + + +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFL---E 130
Query: 474 RLRIIHRDLKASNVLLDYDMNP--------KISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+IH ++ A N+LL + + K+SD G++ + RI ++
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERI----PWV 184
Query: 526 APEYAMEG-LYSIKSDVFSFGVLLIEIIT-GRR 556
PE ++ +D +SFG L EI + G +
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 62/203 (30%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 362 LGQGGFGPVYKGVLSDGK---EIAVKRL--SSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
LG G FG V KG K +AVK L + E E ++ +L + +V+++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G C + + +LV E L+ L ++ + I +V+ + G+ YL
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EESN 137
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGL 534
+HRDL A NVLL KISDFG+++ E A+ G + + APE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-KAQTHGKWPVKWYAPECINYYK 196
Query: 535 YSIKSDVFSFGVLLIEIIT-GRR 556
+S KSDV+SFGVL+ E + G++
Sbjct: 197 FSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-42
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 362 LGQGGFGPVYKGVL-SDGKEI--AVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
LG G FG V +GV K+I A+K L + E E ++ +L + +V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
C + +LV E L L R+ + S +++ + G+ YL
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKNF 131
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGLY 535
+HRDL A NVLL KISDFG+++ + TAR G + + APE +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRKF 190
Query: 536 SIKSDVFSFGVLLIEIIT-GRR 556
S +SDV+S+GV + E ++ G++
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQK 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 9e-42
Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 20/200 (10%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G+G FG V G G ++AVK + + + Q F E ++ +L+H NLV+LLG V
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 421 DGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
+ L +V E+M SL L R R +L + + + + YL +H
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 140
Query: 480 RDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSI 537
RDL A NVL+ D K+SDFG+ + E ++ + G APE E +S
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 538 KSDVFSFGVLLIEIIT-GRR 556
KSDV+SFG+LL EI + GR
Sbjct: 194 KSDVWSFGILLWEIYSFGRV 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 35/217 (16%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG+G FG V+ + +AVK L SE +F E L+ LQH+++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAIL------------FDPRKRGLLCWSKRINIVNGIV 463
G C +G L+V+E+M + L+ L + G L + + + + +
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI--VGT 521
G++YL + L +HRDL N L+ + KI DFGM+R ++ + VG
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYSTDYYRVGG 218
Query: 522 YG-----YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+M PE + ++ +SDV+SFGV+L EI T
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 60/206 (29%), Positives = 84/206 (40%), Gaps = 19/206 (9%)
Query: 362 LGQGGFGPVYKGVL--SDGKEI--AVKRL---SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG G FG V +G GK + AVK L + +F EV + L H+NL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
L G + +V E P SL L + + +G+ YL
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYL---ES 139
Query: 475 LRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT---YGYMAPEYAM 531
R IHRDL A N+LL KI DFG+ R ++ + + APE
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESLK 197
Query: 532 EGLYSIKSDVFSFGVLLIEIIT-GRR 556
+S SD + FGV L E+ T G+
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-41
Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 20/200 (10%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G+G FG V G G ++AVK + + + Q F E ++ +L+H NLV+LLG V
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ---AFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 421 DGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
+ L +V E+M SL L R R +L + + + + YL +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFVH 312
Query: 480 RDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSI 537
RDL A NVL+ D K+SDFG+ + E ++ + G APE E +S
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 538 KSDVFSFGVLLIEIIT-GRR 556
KSDV+SFG+LL EI + GR
Sbjct: 366 KSDVWSFGILLWEIYSFGRV 385
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 76/302 (25%), Positives = 121/302 (40%), Gaps = 66/302 (21%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG+ FG VYKG L +A+K L EF +E +L +LQH N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAIL-------------FDPRKRGLLCWSKRINIVNG 461
LLG +++ + + L L D + L +++V
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I G+ YL S ++H+DL NVL+ +N KISD G+ R ++ ++
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD----YYKL-LG 188
Query: 522 YG-----YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYA 575
+MAPE M G +SI SD++S+GV+L E+ + G + P Y
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ------------P----Y- 231
Query: 576 WHLWNEGNALDLIDPLLT-------DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628
N+ D+++ + D C P Y + + C E RP +
Sbjct: 232 CGYSNQ----DVVEMIRNRQVLPCPDDC-PAWV--Y-ALMIECWNEFPSRRPRFKDIHSR 283
Query: 629 LQ 630
L+
Sbjct: 284 LR 285
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-41
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LG G FG V+ + ++AVK + S F E ++ LQH LVKL
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT- 253
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
+ ++ EFM SL L + K I+ I +G+ ++ + IHRD
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIHRD 309
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSIKS 539
L+A+N+L+ + KI+DFG+AR+ E TAR + APE G ++IKS
Sbjct: 310 LRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 540 DVFSFGVLLIEIIT-GRR 556
DV+SFG+LL+EI+T GR
Sbjct: 367 DVWSFGILLMEIVTYGRI 384
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-41
Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 362 LGQGGFGPVYKGVL-SDGKEIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
LG G +G VY+GV +AVK L E EF E ++ +++H NLV+LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV--EEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
++ EFM +L L + ++ + + + I + YL + IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL---EKKNFIH 341
Query: 480 RDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLYSI 537
R+L A N L+ + K++DFG++R+ G+ TA + APE +SI
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 538 KSDVFSFGVLLIEIIT 553
KSDV++FGVLL EI T
Sbjct: 399 KSDVWAFGVLLWEIAT 414
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 75/274 (27%), Positives = 119/274 (43%), Gaps = 43/274 (15%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
+LG+G +G VY G LS+ IA+K + + + E+ L L+HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
+ + E +P SL A+L I++G+ YLH++ +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 480 RDLKASNVLLD-YDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE---YAMEGLY 535
RD+K NVL++ Y KISDFG ++ AG T GT YMAPE G Y
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG-Y 202
Query: 536 SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH-LWNEGNALDLI-----D 589
+D++S G +IE+ TG+ P ++ L A+ +
Sbjct: 203 GKAADIWSLGCTIIEMATGKP------------P------FYELGEPQAAMFKVGMFKVH 244
Query: 590 PLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPT 621
P + ++ S + F+ C + D R
Sbjct: 245 PEIPESMSAEAKAFIL------KCFEPDPDKRAC 272
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 83/313 (26%), Positives = 131/313 (41%), Gaps = 59/313 (18%)
Query: 338 KAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVL--SDGKEI--AVKRL-SSCSEQ 392
Q I +L V + ++G+G FG VY G L +DGK+I AVK L
Sbjct: 78 AVQHVVIGPSSLIV-----HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132
Query: 393 GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL-VYEFMPNSSLDAILFDPRKRGLLC 451
++F E +++ H N++ LLG C+ + L V +M + L + +
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PT 190
Query: 452 WSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSE 510
I + KG+ +L + + +HRDL A N +LD K++DFG+AR ++
Sbjct: 191 VKDLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247
Query: 511 GEVNTARIVGTYG-----YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565
V+ T +MA E ++ KSDV+SFGVLL E++T RG
Sbjct: 248 DSVHN----KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT----------RG 293
Query: 566 ATAPNLLAYAWHLWNEGNALDLIDPLLT-------DTCSPDEFLRYIH-IGLLCVQEDAF 617
A P Y + D+ LL + C ++ + L C A
Sbjct: 294 AP-P----Y-PDVNTF----DITVYLLQGRRLLQPEYCPDP-----LYEVMLKCWHPKAE 338
Query: 618 DRPTMSSVVVMLQ 630
RP+ S +V +
Sbjct: 339 MRPSFSELVSRIS 351
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 60/277 (21%), Positives = 107/277 (38%), Gaps = 52/277 (18%)
Query: 360 NMLGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
+G+G FG V++ G + AVK RL + E++ L +V L
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLY 116
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G +G + E + SL ++ ++ G L + + + ++G+ YLH R
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---R 170
Query: 477 IIHRDLKASNVLLDYDMNP-KISDFGMARIFAGSEGEVNTAR---IVGTYGYMAPEYAME 532
I+H D+KA NVLL D + + DFG A + I GT +MAPE M
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 533 GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI---- 588
K D++S +++ ++ G P W + G I
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCH------------P------WTQYFRGPLCLKIASEP 272
Query: 589 --DPLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPT 621
+ +C+P + ++ ++++ R +
Sbjct: 273 PPIREIPPSCAPLTAQAIQ------EGLRKEPVHRAS 303
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 360 NMLGQGGFGPVYKGVLSDGKE-----IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLV 413
+LG G FG VYKG+ E +A+K L + S + N E +E ++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+LLG C+ L+ + MP L + + + + +N I KG+ YL
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYL---E 134
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG-----YMAPE 528
R++HRDL A NVL+ + KI+DFG+A++ E E + G +MA E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIIT-GRR 556
+ +Y+ +SDV+S+GV + E++T G +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 362 LGQGGFGPVYKGVL--SDGKEI--AVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
+G+G FG V++G+ + + A+K + S+ +F E L + + H ++VKL+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G + ++ E L + L ++ L + I + + YL R
Sbjct: 83 GVI-TENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL---ESKR 136
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY--GYMAPEYAMEGL 534
+HRD+ A NVL+ + K+ DFG++R E G +MAPE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 535 YSIKSDVFSFGVLLIEIIT-GRR 556
++ SDV+ FGV + EI+ G +
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVK 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-40
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 362 LGQGGFGPVYKGVL--SDGKEI--AVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
LG+G FG VY+GV G++I AVK C+ +F +E +++ L H ++VKL+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
G + + ++ E P L L R + L + I K + YL +
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYL---ESIN 133
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY------------ 524
+HRD+ N+L+ K+ DFG++R + Y
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-------------YYKASVTRLPIKW 180
Query: 525 MAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRR 556
M+PE ++ SDV+ F V + EI++ G++
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 362 LGQGGFGPVYKGVLSDGKE-----IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
LG G FG V+KGV E + +K + Q T+ +L I L H ++V+L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
LG C G LV +++P SL + RG L +N I KG+ YL
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYL---EEH 134
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG-----YMAPEYA 530
++HR+L A NVLL +++DFG+A + + ++ + +MA E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALESI 189
Query: 531 MEGLYSIKSDVFSFGVLLIEIIT-GRR 556
G Y+ +SDV+S+GV + E++T G
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 70/213 (32%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 362 LGQGGFGPVYKGVLSDGK------EIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG G FG VY+G +S ++AVK L CSEQ +F E L+I K H+N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPR----KRGLLCWSKRINIVNGIVKGILYLH 470
+G + + ++ E M L + L + R + L +++ I G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 471 EDSRLRIIHRDLKASNVLLDY---DMNPKISDFGMARIFAGSEGEVNTARI--VGTYGY- 524
IHRD+ A N LL KI DFGMAR ++ A G
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-------DIYRASYYRKGGCAML 207
Query: 525 ----MAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
M PE MEG+++ K+D +SFGVLL EI +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-40
Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LGQG FG VY+GV + +A+K + + S + EF NE ++ + ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAIL-------FDPRKRGLLCWSKRINIVNGIVKGIL 467
LLG G L++ E M L + L + SK I + I G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVGTYGY-- 524
YL+ + +HRDL A N ++ D KI DFGM R I+ E + R G G
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-----ETDYYR-KGGKGLLP 203
Query: 525 ---MAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
M+PE +G+++ SDV+SFGV+L EI T
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 80/298 (26%), Positives = 129/298 (43%), Gaps = 60/298 (20%)
Query: 360 NMLGQGGFGPVYKGVLSDGKE----IAVKRL--SSCSEQGNAEFTNEVLLILKLQHKNLV 413
+LG+G FG V +G L +AVK + + S++ EF +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 414 KLLGFCVDGD-----EKLLVYEFMPNSSLDAILFDPRKRG---LLCWSKRINIVNGIVKG 465
+LLG C++ + +++ FM L L R + + + I G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTA-----RIV 519
+ YL S +HRDL A N +L DM ++DFG+++ I++G +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-- 214
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579
++A E + +Y+ KSDV++FGV + EI T RG T P Y +
Sbjct: 215 ----WIAIESLADRVYTSKSDVWAFGVTMWEIAT----------RGMT-P----Y-PGVQ 254
Query: 580 NEGNALDLIDPLLT-------DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
N ++ D LL + C DE Y I C + D DRPT S + + L+
Sbjct: 255 NH----EMYDYLLHGHRLKQPEDC-LDEL--Y-EIMYSCWRTDPLDRPTFSVLRLQLE 304
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 360 NMLGQGGFGPVYKGVLSDGKE----IAVKRL--SSCSEQGNAEFTNEVLLILKLQHKNLV 413
MLG+G FG V + L +AVK L + EF E + + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 414 KLLGFCVDGDEK------LLVYEFMPNSSLDAILFDPR---KRGLLCWSKRINIVNGIVK 464
KL+G + K +++ FM + L A L R L + + I
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTA-----RI 518
G+ YL S IHRDL A N +L DM ++DFG++R I++G A +
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK- 204
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
++A E + LY++ SDV++FGV + EI+T
Sbjct: 205 -----WLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 84/296 (28%), Positives = 121/296 (40%), Gaps = 60/296 (20%)
Query: 362 LGQGGFGPVYKGVLSDGK------EIAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG G FG VY+G +S ++AVK L CSEQ +F E L+I K H+N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPR----KRGLLCWSKRINIVNGIVKGILYLH 470
+G + + ++ E M L + L + R + L +++ I G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 471 EDSRLRIIHRDLKASNVLLDY---DMNPKISDFGMAR-IFAGSEGEVNTARIVGTYGY-- 524
IHRD+ A N LL KI DFGMAR I+ R G
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-----RAGYYR-KGGCAMLP 249
Query: 525 ---MAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581
M PE MEG+++ K+D +SFGVLL EI + G P Y N+
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------LGYM-P----Y-PSKSNQ 293
Query: 582 GNALDLID-------PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
L+ + P C + I C Q DRP + ++ ++
Sbjct: 294 -EVLEFVTSGGRMDPP---KNCPGPVY----RIMTQCWQHQPEDRPNFAIILERIE 341
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-40
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 362 LGQGGFGPVYKGVLSDGKE---IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
LG G FG V +GV K+ +A+K L + E E ++ +L + +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
C + +LV E L L R+ + S +++ + G+ YL
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL---EEKNF 457
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY--MAPEYAMEGLY 535
+HR+L A NVLL KISDFG+++ + TAR G + APE +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRKF 516
Query: 536 SIKSDVFSFGVLLIEIIT-GRR 556
S +SDV+S+GV + E ++ G++
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQK 538
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 83/369 (22%), Positives = 140/369 (37%), Gaps = 58/369 (15%)
Query: 294 FFAAKKVARKRKGMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLD--- 350
K++ +R+ V + + + + D + A +L
Sbjct: 18 HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWE 77
Query: 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKE--------IAVKRL-SSCSEQGNAEFTNEV 401
+ LG+G FG V + +AVK L +E+ ++ +E+
Sbjct: 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137
Query: 402 LLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR----- 455
++ + +HKN++ LLG C ++ E+ +L L R G+
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 456 --------INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IF 506
++ + +G+ YL + + IHRDL A NVL+ + KI+DFG+AR I
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 507 AGSEGEVNTA-----RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFN 561
+ T + +MAPE + +Y+ +SDV+SFGVL+ EI T G +
Sbjct: 255 NIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT----LGGS 304
Query: 562 QSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621
G L EG+ +D P C +E Y + C RPT
Sbjct: 305 PYPGIPVEELFKLL----KEGHRMDK--P---ANC-TNEL--Y-MMMRDCWHAVPSQRPT 351
Query: 622 MSSVVVMLQ 630
+V L
Sbjct: 352 FKQLVEDLD 360
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-40
Identities = 60/276 (21%), Positives = 108/276 (39%), Gaps = 49/276 (17%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G F VYKG+ E+A + ++ F E ++ LQH N+V+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 419 CVDGDEK----LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
+ +LV E M + +L L ++ ++ + I+KG+ +LH +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 475 LRIIHRDLKASNVLLD-YDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
IIHRDLK N+ + + KI D G+A + S ++GT +MAPE E
Sbjct: 151 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEEK 205
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI----- 588
Y DV++FG+ ++E+ T Y + +
Sbjct: 206 -YDESVDVYAFGMCMLEMATSE------------------YPYSECQNAAQIYRRVTSGV 246
Query: 589 -DPLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPT 621
P+ E + C++++ +R +
Sbjct: 247 KPASFDKVAIPEVKEIIE------GCIRQNKDERYS 276
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 65/301 (21%)
Query: 360 NMLGQGGFGPVYKGVLSDGKE---IAVKRL-SSCSEQGNAEFTNEVLLILKL-QHKNLVK 414
+++G+G FG V K + A+KR+ S+ + +F E+ ++ KL H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAIL-------------FDPRKRGLLCWSKRINIVNG 461
LLG C L E+ P+ +L L L + ++
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
+ +G+ YL S+ + IHRDL A N+L+ + KI+DFG++R EV + T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKK---T 199
Query: 522 YG-----YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576
G +MA E +Y+ SDV+S+GVLL EI++ G T P Y
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------LGGT-P----Y-C 243
Query: 577 HLWNEGNALDLIDPLLT-------DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629
+ +L + L C DE Y + C +E ++RP+ + ++V L
Sbjct: 244 GMTCA----ELYEKLPQGYRLEKPLNC-DDEV--Y-DLMRQCWREKPYERPSFAQILVSL 295
Query: 630 Q 630
Sbjct: 296 N 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 63/279 (22%), Positives = 117/279 (41%), Gaps = 43/279 (15%)
Query: 361 MLGQGGFGPVYKGV-LSDG-----KEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVK 414
+G+G F VY+ L DG K++ + L + + E+ L+ +L H N++K
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQLNHPNVIK 96
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGILYLHEDS 473
++ +E +V E L ++ +K+ L + + + + ++H
Sbjct: 97 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
R++HRD+K +NV + K+ D G+ R F+ ++ +VGT YM+PE E
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHEN 211
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI----- 588
Y+ KSD++S G LL E+ + + N + I
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQS----------------PFYGDKMNLYSLCKKIEQCDY 255
Query: 589 DPLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPTMSSV 625
PL +D S + + + +C+ D RP ++ V
Sbjct: 256 PPLPSDHYSEELRQLVN------MCINPDPEKRPDVTYV 288
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 43/226 (19%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG+G FG V K K +AVK L + S + +E ++ ++ H +++K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------------- 461
L G C LL+ E+ SL L + RK G + +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 462 --------IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGE 512
I +G+ YL + ++++HRDL A N+L+ KISDFG++R ++
Sbjct: 151 DLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 513 VNTA-----RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+ + +MA E + +Y+ +SDV+SFGVLL EI+T
Sbjct: 208 KRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-39
Identities = 61/192 (31%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LGQG FG V+ G + +A+K L + F E ++ KL+H+ LV+L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
+ +V E+M SL L L + +++ I G+ Y+ R+ +HRD
Sbjct: 334 -EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 388
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDV 541
L+A+N+L+ ++ K++DFG+AR+ +E + APE A+ G ++IKSDV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDV 447
Query: 542 FSFGVLLIEIIT 553
+SFG+LL E+ T
Sbjct: 448 WSFGILLTELTT 459
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-39
Identities = 61/192 (31%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
LGQG FG V+ G + +A+K L + F E ++ KL+H+ LV+L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
+ +V E+M SL L L + +++ I G+ Y+ R+ +HRD
Sbjct: 251 -EPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRD 305
Query: 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDV 541
L+A+N+L+ ++ K++DFG+AR+ +E + APE A+ G ++IKSDV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDV 364
Query: 542 FSFGVLLIEIIT 553
+SFG+LL E+ T
Sbjct: 365 WSFGILLTELTT 376
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 43/226 (19%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRL-SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
+G+G FG V++ +AVK L S A+F E L+ + + N+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR------------------- 455
LLG C G L++E+M L+ L + S
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 456 --INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGE 512
+ I + G+ YL S + +HRDL N L+ +M KI+DFG++R I++ +
Sbjct: 175 EQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 513 VNTA-----RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+ R +M PE Y+ +SDV+++GV+L EI +
Sbjct: 232 ADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 77/298 (25%), Positives = 123/298 (41%), Gaps = 55/298 (18%)
Query: 362 LGQGGFGPVYKGVLSDGKE--------IAVKRL-SSCSEQGNAEFTNEVLLILKL-QHKN 411
LG+G FG V + +AVK L +E+ ++ +E+ ++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR-------------INI 458
++ LLG C ++ E+ +L L R G+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTA- 516
+ +G+ YL + + IHRDL A NVL+ + KI+DFG+AR I + T
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 517 ----RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLL 572
+ +MAPE + +Y+ +SDV+SFGVL+ EI T G + G L
Sbjct: 220 RLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTL----GGSPYPGIPVEELF 269
Query: 573 AYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
EG+ +D P C +E Y + C RPT +V L
Sbjct: 270 KLL----KEGHRMD--KP---ANC-TNEL--Y-MMMRDCWHAVPSQRPTFKQLVEDLD 314
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 347 ETLDVATSNFSDSNM--------LGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNA 395
+D+ T N +M +G+G FG DG++ +K +S S +
Sbjct: 9 SGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE 68
Query: 396 EFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR 455
E EV ++ ++H N+V+ + +V ++ L + + +K L +
Sbjct: 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQI 127
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
++ I + ++H+ +I+HRD+K+ N+ L D ++ DFG+AR+ +
Sbjct: 128 LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA 184
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
+GT Y++PE Y+ KSD+++ G +L E+ T +
Sbjct: 185 --CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-39
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRL-SSCSEQGNAEFTNEVLLILKL-QHKNLV 413
LG G FG V + + +AVK L S+ +E+ ++ L QH+N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSL-----------DAILFDPRKRGLLCWSKRINIVNGI 462
LLG C G L++ E+ L + ++ + +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNTARIVGT 521
+G+ +L + IHRD+ A NVLL KI DFG+AR I S V +
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-P 229
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+MAPE + +Y+++SDV+S+G+LL EI +
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 27/226 (11%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL 412
+F + ++G GGFG V+K DGK +KR+ + N + EV + KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILF---------------DPRKRGLLCWSKRIN 457
V G D + S LF + R+ L +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 458 IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517
+ I KG+ Y+H ++I+RDLK SN+ L KI DFG+ + + R
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTR 180
Query: 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQS 563
GT YM+PE Y + D+++ G++L E++ T F S
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD-TAFETS 225
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 59/227 (25%), Positives = 89/227 (39%), Gaps = 50/227 (22%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRL-SSCSEQGNAEFTNEVLLILKL-QHKNLV 413
LG G FG V + + +AVK L S +E+ ++ L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------------ 461
LLG C G L++ E+ L L R + + + +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 462 ---IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+ KG+ +L + IHRDL A N+LL + KI DFG+AR I
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD------------I 195
Query: 519 VGTYGY------------MAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
Y MAPE +Y+ +SDV+S+G+ L E+ +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 362 LGQGGFGPVYKGVL------SDGKEIAVKRL-SSCSEQGNAEFTNEVLLILKL-QHKNLV 413
LG+G FG V + + + +AVK L + + +E+ +++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 414 KLLGFCVDGDEKLLV-YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG----------- 461
LLG C L+V EF +L L R + ++
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 462 --IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR-IFAGSEGEVNT-AR 517
+ KG+ +L + + IHRDL A N+LL KI DFG+AR I+ + AR
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 518 I-VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
+ + +MAPE + +Y+I+SDV+SFGVLL EI +
Sbjct: 212 LPL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 55/243 (22%), Positives = 99/243 (40%), Gaps = 23/243 (9%)
Query: 328 QHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKR-- 385
H + + +++ V +S +G GG V++ + + A+K
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 386 LSSCSEQGNAEFTNEVLLILKLQHKNL--VKLLGFCVDGDEKLLVYEFMPNSSLDAILFD 443
L Q + NE+ + KLQ + ++L + + +V E N L++ L
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-- 118
Query: 444 PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503
+K+ + +R + +++ + +H+ I+H DLK +N L+ D K+ DFG+A
Sbjct: 119 -KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIA 173
Query: 504 RIFAGSEGEVNTARIVGTYGYMAPE-----------YAMEGLYSIKSDVFSFGVLLIEII 552
V VGT YM PE + S KSDV+S G +L +
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
Query: 553 TGR 555
G+
Sbjct: 234 YGK 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 36/220 (16%)
Query: 362 LGQGGFGPVYKGVLSDGK--------EIAVKRL-SSCSEQGNAEFTNEVLLILKL-QHKN 411
LG+G FG V ++AVK L S +E+ ++ +E+ ++ + +HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG---------- 461
++ LLG C ++ E+ +L L R GL +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 462 ---IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+ +G+ YL + + IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID-----YYK 248
Query: 519 VGTYG-----YMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
T G +MAPE + +Y+ +SDV+SFGVLL EI T
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 23/224 (10%)
Query: 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKR--LSSCSEQGNAEFTNEVLLI 404
E + V +S +G GG V++ + + A+K L Q + NE+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 405 LKLQHKNL--VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGI 462
KLQ + ++L + + +V E N L++ L +K+ + +R + +
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNM 117
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY 522
++ + +H+ I+H DLK +N L+ D K+ DFG+A V VGT
Sbjct: 118 LEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 523 GYMAPE-----------YAMEGLYSIKSDVFSFGVLLIEIITGR 555
YM PE + S KSDV+S G +L + G+
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-37
Identities = 60/279 (21%), Positives = 114/279 (40%), Gaps = 15/279 (5%)
Query: 286 LVVASTGYFFAAKKVARKRKGMVRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYID 345
LV +T F + +R ++ ++ + + + +D Y
Sbjct: 320 LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTM 379
Query: 346 LETLD--VATSNFSDSNMLGQGGFGPVYKGVL--SDGKEI--AVKRL-SSCSEQGNAEFT 398
T D + +G+G FG V++G+ + + A+K + S+ +F
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL 439
Query: 399 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINI 458
E L + + H ++VKL+G + + ++ E L + L ++ L + I
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLILY 496
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
+ + YL R +HRD+ A NVL+ + K+ DFG++R S +
Sbjct: 497 AYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRR 556
+ +MAPE ++ SDV+ FGV + EI+ G +
Sbjct: 554 L-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-37
Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 23/211 (10%)
Query: 360 NMLGQGGFGPVYKGVLSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKLQHKNL--VKL 415
+G GG V++ + + A+K L Q + NE+ + KLQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
+ + +V E N L++ L +K+ + +R + +++ + +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE------- 528
I+H DLK +N L+ D K+ DFG+A V VG YM PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 529 ----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
+ S KSDV+S G +L + G+
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 63/232 (27%), Positives = 92/232 (39%), Gaps = 55/232 (23%)
Query: 362 LGQGGFGPVYKGVLSDGKE------IAVKRL-SSCSEQGNAEFTNEVLLILKL-QHKNLV 413
LG G FG V + +AVK L +E+ ++ +L H+N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------------ 461
LLG C L++E+ L L R++ + N
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 462 --------IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513
+ KG+ +L +HRDL A NVL+ + KI DFG+AR
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD-------- 221
Query: 514 NTARIVGTYGY------------MAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
I+ Y MAPE EG+Y+IKSDV+S+G+LL EI +
Sbjct: 222 ----IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 57/256 (22%), Positives = 105/256 (41%), Gaps = 28/256 (10%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEV-LLILKLQHKNLV 413
+F ++LG G G + + D +++AVKR+ + + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+ D + + E + + + +K + I ++ G+ +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 474 RLRIIHRDLKASNVLL-----DYDMNPKISDFGMARIFAGSEGEVNTAR-IVGTYGYMAP 527
L I+HRDLK N+L+ + ISDFG+ + A + + GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 528 EY---AMEGLYSIKSDVFSFGVLLIEIITG-------RRNTGFNQSRGATAPNLLAYAWH 577
E + + D+FS G + +I+ N GA + + L H
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 578 LWNEGNALDLIDPLLT 593
A +LI+ ++
Sbjct: 256 EDVI--ARELIEKMIA 269
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 64/303 (21%), Positives = 101/303 (33%), Gaps = 50/303 (16%)
Query: 331 RGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVK--RLS 387
RG + Y +F + LG G +G V+K DG+ AVK
Sbjct: 34 RGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP 93
Query: 388 SCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRK 446
+ A EV K+ QH V+L +G L E S
Sbjct: 94 FRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHC----EA 149
Query: 447 RGLLCWSKRI-NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
G ++ + + + +LH ++H D+K +N+ L K+ DFG+
Sbjct: 150 WGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565
G+ G G YMAPE ++G Y +DVFS G+ ++E+
Sbjct: 207 L-GTAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACN----------- 251
Query: 566 ATAPNLLAYAWHLWNEGNALDLI-----DPLLTDTCSPD--EFLRYIHIGLLCVQEDAFD 618
L + G + P T S + L + ++ D
Sbjct: 252 ----------MELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV------MMLEPDPKL 295
Query: 619 RPT 621
R T
Sbjct: 296 RAT 298
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 60/204 (29%), Positives = 91/204 (44%), Gaps = 10/204 (4%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
+G G +G K SDGK + K S +E +EV L+ +L+H N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 418 FCVDGDEKLL--VYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGILYLHE--D 472
+D L V E+ L +++ K + + ++ + + H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
++HRDLK +NV LD N K+ DFG+ARI T VGT YM+PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR 190
Query: 533 GLYSIKSDVFSFGVLLIEIITGRR 556
Y+ KSD++S G LL E+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 37/231 (16%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN 411
S+F + +LGQG FG V K D + A+K++ +E+ + +EV+L+ L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 412 LVKLLGFCVDGDEKL-------------LVYEFMPNSSL-DAILFDPRKRGLLCWSKRI- 456
+V+ ++ + + E+ N +L D I L
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119
Query: 457 NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA 516
+ I++ + Y+H IIHRDLK N+ +D N KI DFG+A+ S +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 517 RI------------VGTYGYMAPE-YAMEGLYSIKSDVFSFGVLLIEIITG 554
+GT Y+A E G Y+ K D++S G++ E+I
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 64/222 (28%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 347 ETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRL-SSCSEQGNAEFTNEVLLI 404
+ D + D +G+G +G V K V G+ +AVKR+ S+ E+ + ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 405 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN------ 457
++ +V+ G + + E M ++S D K I
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGK 129
Query: 458 IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517
I VK + +L E+ L+IIHRD+K SN+LLD N K+ DFG++ S +
Sbjct: 130 ITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-- 185
Query: 518 IVGTYGYMAPE----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
G YMAPE A Y ++SDV+S G+ L E+ TGR
Sbjct: 186 -AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 27/224 (12%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQHKN 411
++F LG+GGFG V++ D A+KR+ E + EV + KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 412 LVKLLGFCVDGDE---------KLLVY---EFMPNSSLDAILFDPRKRGLLCWSKRINIV 459
+V+ ++ + K+ +Y + +L + S ++I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR-- 517
I + + +LH ++HRDLK SN+ D K+ DFG+ E E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 518 --------IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
VGT YM+PE YS K D+FS G++L E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 24/221 (10%)
Query: 348 TLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRL-SSCSEQGNAEFTNEVLLIL 405
+++V + LG+G +G V K + G+ +AVKR+ ++ + Q ++ + +
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 406 KL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN------I 458
+ V G + + E M ++SLD +G + I I
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKG-----QTIPEDILGKI 114
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
IVK + +LH S+L +IHRD+K SNVL++ K+ DFG++ V
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDID 169
Query: 519 VGTYGYMAPE----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
G YMAPE + YS+KSD++S G+ +IE+ R
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE-FTNEVLLILKLQHKNLVKLLGF 418
+LGQG V++G G A+K ++ S + E ++ KL HKN+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 419 CVDGDEKL--LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
+ + L+ EF P SL +L +P L S+ + ++ +V G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 477 IIHRDLKASNVLL----DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE---- 528
I+HR++K N++ D K++DFG AR E + GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYER 189
Query: 529 ----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
+ Y D++S GV TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 54/203 (26%), Positives = 107/203 (52%), Gaps = 10/203 (4%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN 411
++ +GQG G VY + ++ G+E+A+++++ + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+V L + GDE +V E++ SL ++ + + + ++ + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
+ ++IHRD+K+ N+LL D + K++DFG + + +T +VGT +MAPE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 532 EGLYSIKSDVFSFGVLLIEIITG 554
Y K D++S G++ IE+I G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLS-SCSEQGNAEFTNEV 401
+ ++ +F + LG G G V+K G +A K + + E+
Sbjct: 23 QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 82
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN---- 457
++ + +V G E + E M SLD +L K+ RI
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKA-----GRIPEQIL 133
Query: 458 --IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
+ ++KG+ YL E +I+HRD+K SN+L++ K+ DFG++ S N+
Sbjct: 134 GKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS 189
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
VGT YM+PE YS++SD++S G+ L+E+ GR
Sbjct: 190 --FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 60/300 (20%), Positives = 105/300 (35%), Gaps = 67/300 (22%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKR--LSSCSEQGNAEFTNEVLLILKL-Q 408
T+ F + +G G FG V+K V DG A+KR EV L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
H ++V+ + D L+ E+ SL DAI + R ++ +++ + +G+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNP-------------------KISDFGMARIFAG 508
Y+H ++H D+K SN+ + P KI D G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 509 SEGEVNTARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT 567
+ E +R ++A E E + K+D+F+ + ++
Sbjct: 187 PQVEEGDSR------FLANEVLQENYTHLPKADIFALALTVVCAAGAE------------ 228
Query: 568 APNLLAYAWHLWNEGNALDLID----PLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPT 621
L G+ I P + S + E L+ + + D RP+
Sbjct: 229 ---------PLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLK------VMIHPDPERRPS 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 19/224 (8%)
Query: 348 TLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILK 406
+ + ++ LG+GGF V L DG A+KR+ +Q E E +
Sbjct: 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRL 82
Query: 407 LQHKNLVKLLGFCVD----GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNG 461
H N+++L+ +C+ E L+ F +L + + +G +I ++ G
Sbjct: 83 FNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV-- 519
I +G+ +H HRDLK +N+LL + P + D G A +
Sbjct: 143 ICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 520 -----GTYGYMAPEYAMEGLYSI---KSDVFSFGVLLIEIITGR 555
T Y APE + + ++DV+S G +L ++ G
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE-FTNEVLLILKLQHKNLVKLLGF 418
+LGQG V++G G A+K ++ S + E ++ KL HKN+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 419 CVDGDEKL--LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
+ + L+ EF P SL +L +P L S+ + ++ +V G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NG 132
Query: 477 IIHRDLKASNVLL----DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE---- 528
I+HR++K N++ D K++DFG AR E + GT Y+ P+
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYER 189
Query: 529 ----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
+ Y D++S GV TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 54/203 (26%), Positives = 101/203 (49%), Gaps = 10/203 (4%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN 411
+G+G G V G+++AVK + +Q NEV+++ QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+V++ + G+E ++ EF+ +L I+ + L + + +++ + YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
+IHRD+K+ ++LL D K+SDFG + + + +VGT +MAPE
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVIS 214
Query: 532 EGLYSIKSDVFSFGVLLIEIITG 554
LY+ + D++S G+++IE++ G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 10/228 (4%)
Query: 328 QHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRL 386
+ V+ R+ + + F LG+G +G VYK + G+ +A+K++
Sbjct: 3 ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62
Query: 387 SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRK 446
E E E+ ++ + ++VK G + +V E+ S+ I+ +
Sbjct: 63 PV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLR 118
Query: 447 RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506
L + I+ +KG+ YLH R IHRD+KA N+LL+ + + K++DFG+A
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
+ + NT ++GT +MAPE E Y+ +D++S G+ IE+ G
Sbjct: 176 TDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 58/267 (21%), Positives = 93/267 (34%), Gaps = 43/267 (16%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEV-LLILKLQHKNLVKLLGFCV 420
LG G G V G+ +AVKR+ E+ LL H N+++
Sbjct: 23 LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSET 79
Query: 421 DGDEKLLVYEFMPNSSLDAIL---FDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
+ E + D + L I+++ I G+ +LH L+I
Sbjct: 80 TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKI 136
Query: 478 IHRDLKASNVLLD-------------YDMNPKISDFGMARIFAGSEG--EVNTARIVGTY 522
IHRDLK N+L+ ++ ISDFG+ + + N GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 523 GYMAPE-------YAMEGLYSIKSDVFSFGVLLIEIITG-------RRNTGFNQSRGATA 568
G+ APE + + D+FS G + I++ + + N RG
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRG--I 254
Query: 569 PNLLAYAWHLWNE--GNALDLIDPLLT 593
+L A DLI ++
Sbjct: 255 FSLDEMKCLHDRSLIAEATDLISQMID 281
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 57/238 (23%), Positives = 101/238 (42%), Gaps = 29/238 (12%)
Query: 332 GRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRL-SSC 389
G I + ++ + +G G G V+K G IAVK++ S
Sbjct: 4 GSSGKQTGYLT-IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 390 SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG 448
+++ N ++ ++LK +V+ G + + + E M + + + ++
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK---KRMQ 118
Query: 449 LLCWSKRIN------IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502
I + IVK + YL E +IHRD+K SN+LLD K+ DFG+
Sbjct: 119 -----GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGI 171
Query: 503 ARIFAGSEGEVNTARIVGTYGYMAPE-----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
+ + + + G YMAPE + Y I++DV+S G+ L+E+ TG+
Sbjct: 172 SGRLVDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-32
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 19/208 (9%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE-FTNEVLLILKLQHKNLVKLL-- 416
LG GGFG V + + G+++A+K+ N E + E+ ++ KL H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 417 ----GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
D LL E+ L L L +++ I + YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139
Query: 473 SRLRIIHRDLKASNVLLDY---DMNPKISDFGMARIFAGSEGEV-NTARIVGTYGYMAPE 528
RIIHRDLK N++L + KI D G A+ +GE+ VGT Y+APE
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF--VGTLQYLAPE 193
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITGRR 556
+ Y++ D +SFG L E ITG R
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 11/204 (5%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGN-AEFTNEVLLILKLQHK 410
F+ +G+G FG V+KG+ K +A+K + + + E+ ++ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
+ K G + + ++ E++ S +L + G L ++ I+ I+KG+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 136
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
+ + IHRD+KA+NVLL K++DFG+A ++ + NT VGT +MAPE
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 531 MEGLYSIKSDVFSFGVLLIEIITG 554
+ Y K+D++S G+ IE+ G
Sbjct: 192 KQSAYDSKADIWSLGITAIELARG 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 15/206 (7%)
Query: 356 FSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVK 414
+ LG G FG VYK G A K + + SE+ ++ E+ ++ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVNGIVKGILYLHEDS 473
LLG + ++ EF P ++DAI+ RGL +I + +++ + +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM-LELDRGLT--EPQIQVVCRQMLEALNFLHSK- 136
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE----- 528
RIIHRDLKA NVL+ + + +++DFG++ + + ++ +GT +MAPE
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 529 YAMEGLYSIKSDVFSFGVLLIEIITG 554
+ Y K+D++S G+ LIE+
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT---NEVLLILKLQ 408
FSD +G G FG VY + + + +A+K++S +Q N ++ EV + KL+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILY 468
H N ++ G + LV E+ S+ D + L + + +G ++G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAY 169
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
LH +IHRD+KA N+LL K+ DFG A N+ VGT +MAPE
Sbjct: 170 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--FVGTPYWMAPE 220
Query: 529 ---YAMEGLYSIKSDVFSFGVLLIEIITG 554
EG Y K DV+S G+ IE+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK-----RLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
+G+G F V + + G++ AVK + +S + E + L+H ++V+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 416 LGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRI--NIVNGIVKGILYLHED 472
L +V+EFM + L I+ R +S+ + + + I++ + Y H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIV--KRADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 473 SRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
IIHRD+K VLL + K+ FG+A S VGT +MAPE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMAPEV 204
Query: 530 AMEGLYSIKSDVFSFGVLL 548
Y DV+ GV+L
Sbjct: 205 VKREPYGKPVDVWGCGVIL 223
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
+G G V +++A+KR++ + E E+ + + H N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN------IVNGIVKGILYLHEDS 473
V DE LV + + S+ I+ +G S ++ I+ +++G+ YLH++
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGM-ARIFAGSEGEVNTAR--IVGTYGYMAPEYA 530
IHRD+KA N+LL D + +I+DFG+ A + G + N R VGT +MAPE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 531 MEGL-YSIKSDVFSFGVLLIEIITGR 555
+ Y K+D++SFG+ IE+ TG
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGA 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-30
Identities = 68/241 (28%), Positives = 103/241 (42%), Gaps = 23/241 (9%)
Query: 328 QHVRGRDDDLKAQDFYIDLET-LDVATSNFSD----SNMLGQGGFGPVYKGV-LSDGKEI 381
H GR++ D + + S+ LG G +G V E
Sbjct: 6 HHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVER 65
Query: 382 AVKRL--SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-D 438
A+K + +S S N++ EV ++ L H N++KL F D LV E L D
Sbjct: 66 AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 439 AILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNP 495
I+ R I+ ++ G+ YLH+ I+HRDLK N+LL + D
Sbjct: 126 EII----HRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALI 178
Query: 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
KI DFG++ +F + +GT Y+APE + Y K DV+S GV+L ++ G
Sbjct: 179 KIVDFGLSAVF--ENQKKMK-ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
Query: 556 R 556
Sbjct: 235 P 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 20/225 (8%)
Query: 343 YIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEV 401
IDL L F ++G G +G VYKG + G+ A+K + + E E+
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEI 71
Query: 402 LLILKL-QHKNLVKLLG-----FCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSK 454
++ K H+N+ G D++L LV EF S+ ++ K L
Sbjct: 72 NMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEW 130
Query: 455 RINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514
I I++G+ +LH+ ++IHRD+K NVLL + K+ DFG++ + G N
Sbjct: 131 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 515 TARIVGTYGYMAPE-----YAMEGLYSIKSDVFSFGVLLIEIITG 554
T +GT +MAPE + Y KSD++S G+ IE+ G
Sbjct: 188 T--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAE-FTNEVLLILKLQHKNLVKLL 416
LG+GGF ++ + A K + S + E + E+ + L H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
GF D D +V E SL + ++R L + + IV G YLH R R
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNR 161
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
+IHRDLK N+ L+ D+ KI DFG+A + GT Y+APE + +S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 219
Query: 537 IKSDVFSFGVLLIEIITGR 555
+ DV+S G ++ ++ G+
Sbjct: 220 FEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 12/199 (6%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAE-FTNEVLLILKLQHKNLVKLL 416
LG+GGF ++ + A K + S + E + E+ + L H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
GF D D +V E SL + ++R L + + IV G YLH R R
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH---RNR 135
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
+IHRDLK N+ L+ D+ KI DFG+A + GT Y+APE + +S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGHS 193
Query: 537 IKSDVFSFGVLLIEIITGR 555
+ DV+S G ++ ++ G+
Sbjct: 194 FEVDVWSIGCIMYTLLVGK 212
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
LG GG VY ++A+K + E+ F EV +L H+N+V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
+ D LV E++ +L + G L IN N I+ GI + H +RI
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMRI 132
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSI 537
+HRD+K N+L+D + KI DFG+A+ T ++GT Y +PE A
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191
Query: 538 KSDVFSFGVLLIEIITGRR 556
+D++S G++L E++ G
Sbjct: 192 CTDIYSIGIVLYEMLVGEP 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 44/225 (19%), Positives = 85/225 (37%), Gaps = 20/225 (8%)
Query: 345 DLETLDVATSNFSDSNMLGQG--GFGPVYKGV-LSDGKEIAVKR--LSSCSEQGNAEFTN 399
+ + + ++G+G V G+ + V+R L +CS +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 400 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI--N 457
E+ + H N+V + +E +V FM S ++ G+ ++
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM---NELAIAY 132
Query: 458 IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT-- 515
I+ G++K + Y+H +HR +KAS++L+ D +S
Sbjct: 133 ILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 516 ---ARIVGTYGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGR 555
V +++PE + L Y KSD++S G+ E+ G
Sbjct: 190 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 17/206 (8%)
Query: 353 TSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE-FTNEVLLILK 406
D LG G FG V+ S G E +K ++ Q E E+ ++
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76
Query: 407 LQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKG 465
L H N++K+ D +V E L + I+ + L ++ ++
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 466 ILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGTY 522
+ Y H ++H+DLK N+L KI DFG+A +F E +T GT
Sbjct: 137 LAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHSTN-AAGTA 190
Query: 523 GYMAPEYAMEGLYSIKSDVFSFGVLL 548
YMAPE + + K D++S GV++
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 29/234 (12%)
Query: 347 ETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLIL 405
+T+++ +L +GGF VY+ + G+E A+KRL S E+ N EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 406 KLQ-HKNLVKLLGFCVDGDEK--------LLVYEFMPNSSLDAILFDPRKRGLLCWSKRI 456
KL H N+V+ G E+ LL+ E ++ + RG L +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL 139
Query: 457 NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA 516
I + + ++H + IIHRDLK N+LL K+ DFG A + +A
Sbjct: 140 KIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 517 RI----------VGTYGYMAPEYAMEGLYS-----IKSDVFSFGVLLIEIITGR 555
+ T Y PE + LYS K D+++ G +L + +
Sbjct: 199 QRRALVEEEITRNTTPMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 353 TSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLLIL 405
F++ MLG+G FG V K +E AVK + +S + + EV L+
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 406 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVK 464
KL H N++KL D +V E L D I+ KR I+ +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFS 132
Query: 465 GILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
GI Y+H+ I+HRDLK N+LL + D + KI DFG++ F + +GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKD-RIGT 186
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLL 548
Y+APE + G Y K DV+S GV+L
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-29
Identities = 68/215 (31%), Positives = 100/215 (46%), Gaps = 22/215 (10%)
Query: 353 TSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLLIL 405
F++ MLG+G FG V K +E AVK + +S + + EV L+
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 406 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVK 464
KL H N++KL D +V E L D I+ KR I+ +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFS 132
Query: 465 GILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
GI Y+H+ I+HRDLK N+LL + D + KI DFG++ F + +GT
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMK-DRIGT 186
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
Y+APE + G Y K DV+S GV+L +++G
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 353 TSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLLIL 405
++ FSD LG+G F V + V + G E A K + S + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 406 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVK 464
KLQH N+V+L + LV++ + L + I+ R + + + I++
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILE 116
Query: 465 GILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I Y H I+HR+LK N+LL K++DFG+A ++ E GT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHG-FAGT 170
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLL 548
GY++PE + YS D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 30/235 (12%)
Query: 340 QDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS----------- 387
Y+ + + ++ LG G +G V + E A+K +
Sbjct: 23 PGMYVRKKEGKI-GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81
Query: 388 --SCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDP 444
E+ + E NE+ L+ L H N++KL D LV EF L + I+
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII--- 138
Query: 445 RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFG 501
R NI+ I+ GI YLH+ I+HRD+K N+LL + +N KI DFG
Sbjct: 139 -NRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
++ F S+ +GT Y+APE ++ Y+ K DV+S GV++ ++ G
Sbjct: 195 LSSFF--SKDYKLR-DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 68/231 (29%), Positives = 102/231 (44%), Gaps = 20/231 (8%)
Query: 333 RDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS---S 388
D ++ T + + +LG+G FG V G+E AVK +S
Sbjct: 6 MDHLHATPGMFVQHSTAIF-SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV 64
Query: 389 CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKR 447
+ EV L+ +L H N++KL F D LV E L D I+ R
Sbjct: 65 KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SR 120
Query: 448 GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMAR 504
I+ ++ GI Y+H+ +I+HRDLK N+LL D N +I DFG++
Sbjct: 121 KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
F + +GT Y+APE + G Y K DV+S GV+L +++G
Sbjct: 178 HF--EASKKMK-DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRL--SSCSEQGNAEFTNEVLL--------------IL 405
L QG F + D K A+K+ S ++ + +N + I+
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 406 K-LQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL-----FDPRKRGLLCWSKRINIV 459
++++ + G + DE ++YE+M N S+ D + I+
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV 519
++ Y+H + I HRD+K SN+L+D + K+SDFG + + ++ +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VDKKIKGS--R 211
Query: 520 GTYGYMAPE-YAMEGLYS-IKSDVFSFGVLLIEIITGR 555
GTY +M PE ++ E Y+ K D++S G+ L +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 352 ATSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVKRLS---------SCSEQGNAEF 397
+T F + +LG+G V + + KE AVK + ++
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 398 TNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKR 455
EV ++ K+ H N+++L LV++ M L D + ++ L +
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKET 126
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
I+ +++ I LH+ L I+HRDLK N+LLD DMN K++DFG + GE
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLR 181
Query: 516 ARIVGTYGYMAPE------YAMEGLYSIKSDVFSFGVLL 548
+ GT Y+APE Y + D++S GV++
Sbjct: 182 E-VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAE-FTNEVLLILKLQHKNLVKLLG 417
LG+G F VY+ + G E+A+K + + + G + NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDP--RKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
+ D + LV E N + + ++ + ++ I+ G+LYLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
I+HRDL SN+LL +MN KI+DFG+A + T + GT Y++PE A +
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAH 189
Query: 536 SIKSDVFSFGVLLIEIITGR 555
++SDV+S G + ++ GR
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 352 ATSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVKRLS--------SCSEQGNAEFT 398
A F +++G+G V + V + G E AVK + E+
Sbjct: 88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147
Query: 399 NEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRI 456
E ++ ++ H +++ L+ LV++ M L D + ++ L +
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETR 203
Query: 457 NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-NT 515
+I+ +++ + +LH I+HRDLK N+LLD +M ++SDFG + GE
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRE 258
Query: 516 ARIVGTYGYMAPE------YAMEGLYSIKSDVFSFGVLL 548
+ GT GY+APE Y + D+++ GV+L
Sbjct: 259 --LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 22/230 (9%), Positives = 51/230 (22%), Gaps = 43/230 (18%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRL---SSCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
L G V+ + ++ A+K + S +L ++ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 417 GFC--------------------------VDGDEKLLVYEFMP---NSSLDAILFDPRKR 447
LL+ + F R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 448 GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507
G + +++ L ++H N+ + D + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 508 GSEGEVNTARIVGTYGYMAPEYAM--EGLYSIKSDVFSFGVLLIEIITGR 555
G A Y E+ ++ + + G+ + +
Sbjct: 243 -KVGTRGPA-SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 353 TSNFSDS----NMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL 407
T+N + +LG G F V+ GK A+K + ++ NE+ ++ K+
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 408 QHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGI 466
+H+N+V L LV + + L D IL +RG+ ++ ++ +
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAV 119
Query: 467 LYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
YLHE I+HRDLK N+L + + I+DFG++++ G ++T GT G
Sbjct: 120 KYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMST--ACGTPG 172
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLL 548
Y+APE + YS D +S GV+
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 353 TSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL 407
+ F+D +G G + + + + E AVK + T E+ ++L+
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRY 72
Query: 408 -QHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKG 465
QH N++ L DG +V E M L D IL ++ + ++ I K
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKT 128
Query: 466 ILYLHEDSRLRIIHRDLKASNVLL-DYDMNP---KISDFGMARIFAGSEGEVNTARIVGT 521
+ YLH ++HRDLK SN+L D NP +I DFG A+ G + T T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYT 183
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLL 548
++APE Y D++S GVLL
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 33/222 (14%)
Query: 344 IDLETLDVATSNFSD-----SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEF 397
+ + + +D +LG G G V + G++ A+K L +
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA 68
Query: 398 TNEVLLILKLQ-HKNLVKLLGFCVDGDEK----LLVYEFMPNSSL-DAILFDPRKRGLLC 451
EV + ++V +L + L++ E M L I +RG
Sbjct: 69 RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQA 124
Query: 452 WSKRI--NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIF 506
+++R I+ I I +LH I HRD+K N+L + D K++DFG A+
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181
Query: 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
++ + T T Y+APE Y D++S GV++
Sbjct: 182 --TQNALQT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 16/192 (8%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G+G +G V V A K++ + F E+ ++ L H N+++L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 421 DGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
D + LV E L + ++ + + S I+ ++ + Y H+ L + H
Sbjct: 77 DNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHK---LNVAH 129
Query: 480 RDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS 536
RDLK N L D K+ DFG+A F G++ VGT Y++P+ +EGLY
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRT-KVGTPYYVSPQ-VLEGLYG 185
Query: 537 IKSDVFSFGVLL 548
+ D +S GV++
Sbjct: 186 PECDEWSAGVMM 197
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 30/234 (12%), Positives = 65/234 (27%), Gaps = 43/234 (18%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGN---AEFTNEVLLILKLQ-------- 408
+LGQ + G+ V + + EVL + L+
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 409 --------------HKNLVKLLGFCVDGDEKLLVYEF--MPNSS------LDAILFDPRK 446
K++ +D + ++ F P + +L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 447 RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506
L R+ + +++ + LH ++H L+ +++LD ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 260
Query: 507 AGSEGEVNTARIVGTYGYMAPE-----YAMEGLYSIKSDVFSFGVLLIEIITGR 555
G+ R A L + D ++ G+ + I
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 347 ETLDVATSNFSDS----NMLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTN 399
E + A++ FSD+ LG+G F V + V + G E A K + S + +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 400 EVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINI 458
E + KLQH N+V+L + LV++ + L + I+ R + +
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV----AREFYSEADASHC 133
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNT 515
+ I++ I Y H I+HR+LK N+LL K++DFG+A ++ E
Sbjct: 134 IQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWH 188
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
GT GY++PE + YS D+++ GV+L
Sbjct: 189 G-FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 42/254 (16%), Positives = 81/254 (31%), Gaps = 29/254 (11%)
Query: 360 NMLGQGGFGPVYKGVLSD------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
++LG+G F VY+ D ++ +K + T + + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSL-DAI-LFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
K + + +LV E +L +AI L+ ++ I+ ++ I +H+
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 472 DSRLRIIHRDLKASNVLL-----------DYDMNPKISDFGMARIFAGSEGEVNTARIVG 520
IIH D+K N +L D + D G +
Sbjct: 191 ---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 521 TYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH--L 578
T G+ E ++ + D F + ++ G N+ L H +
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDM 307
Query: 579 WNEGNALDLIDPLL 592
WN + +L
Sbjct: 308 WN-----EFFHVML 316
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 351 VATSNFSDS----NMLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLL 403
+ + F++ LG+G F V + V + G+E A + S + + + E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 404 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGI 462
L+H N+V+L + L+++ + L + I+ R + + + I
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQI 119
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIV 519
++ +L+ H+ + ++HR+LK N+LL K++DFG+A G +
Sbjct: 120 LEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FA 174
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
GT GY++PE + Y D+++ GV+L
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 13/201 (6%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE----FTNEVLLILKLQHKNLVKL 415
++G+GG G VY+ + +A+K +S + + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
F + + + L A+L R++G L + + IV I + H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA--- 153
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
HRD+K N+L+ D + DFG+A E VGT YMAPE E
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 536 SIKSDVFSFGVLLIEIITGRR 556
+ ++D+++ +L E +TG
Sbjct: 213 TYRADIYALTCVLYECLTGSP 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 353 TSNFSD-------SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLI 404
S F LG+G F K V + AVK +S E A E+ +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQKEITAL 59
Query: 405 LKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGI 462
+ H N+VKL D LV E + L + I K+ ++ I+ +
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKL 115
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIV 519
V + ++H+ + ++HRDLK N+L + ++ KI DFG AR+ + T
Sbjct: 116 VSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PC 170
Query: 520 GTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
T Y APE + Y D++S GV+L
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 354 SNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVK-----RLSSCSEQGNAE-FTNEVL 402
S D LG G F V K GKE A K RLSS + E EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 403 LILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNG 461
++ +++H N++ L + + +L+ E + L D + ++ L + +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA----EKESLTEDEATQFLKQ 116
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLL----DYDMNPKISDFGMARIFAGSEGEVNTAR 517
I+ G+ YLH RI H DLK N++L + K+ DFG+A E
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-EFKN-- 170
Query: 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
I GT ++APE +++D++S GV+
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 55/249 (22%), Positives = 98/249 (39%), Gaps = 17/249 (6%)
Query: 308 VRKQIQLHKIGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSD----SNMLG 363
+R H G + + D + + ++V + D LG
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 364 QGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422
G FG V++ V + G+ K +++ NE+ ++ +L H L+ L D
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 423 DEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481
E +L+ EF+ L D I + + ++ IN + +G+ ++HE I+H D
Sbjct: 121 YEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLD 174
Query: 482 LKASNVLLDYDMNP--KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKS 539
+K N++ + KI DFG+A E V T + APE +
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDE-IVKV--TTATAEFAAPEIVDREPVGFYT 231
Query: 540 DVFSFGVLL 548
D+++ GVL
Sbjct: 232 DMWAIGVLG 240
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 353 TSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVK----RLSSCSEQGN--AEFTNEV 401
D LG G F V K S G E A K R S S +G E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVN 460
++ ++ H N++ L + + +L+ E + L D + ++ L + + +
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIK 122
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLL----DYDMNPKISDFGMARIFAGSEGEVNTA 516
I+ G+ YLH +I H DLK N++L + K+ DFG+A +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
I GT ++APE +++D++S GV+
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 353 TSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVK----RLSSCSEQGN--AEFTNEV 401
N D LG G F V K S G + A K R + S +G + EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVN 460
++ ++QH N++ L + + +L+ E + L D + ++ L + +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLK 121
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLL----DYDMNPKISDFGMARIFAGSEGEVNTA 516
I+ G+ YLH L+I H DLK N++L KI DFG+A G
Sbjct: 122 QILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKN 176
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
I GT ++APE +++D++S GV+
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 27/237 (11%)
Query: 325 LRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSD-----SNMLGQGGFGPVYKGV-LSDG 378
+ + H DL ++ Y + NF++ S LG+G F V + + S G
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQ------SMENFNNFYILTSKELGRGKFAVVRQCISKSTG 54
Query: 379 KEIAVK--RLSSCSEQGNAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYEFMPNS 435
+E A K + + AE +E+ ++ + ++ L + E +L+ E+
Sbjct: 55 QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 436 SL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DY 491
+ L P ++ + I ++ I++G+ YLH+ I+H DLK N+LL
Sbjct: 115 EIFSLCL--PELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYP 169
Query: 492 DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
+ KI DFGM+R I+GT Y+APE + +D+++ G++
Sbjct: 170 LGDIKIVDFGMSRKI--GHACELRE-IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE----FTNEVLLILKLQHKNLVKL 415
+LG GG V+ L D +++AVK L + + F E L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 416 L--GFCVDGDEKLLVY---EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
G + L Y E++ +L I+ G + + I ++ + + + H
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-NTARIVGTYGYMAPEY 529
+ IIHRD+K +N+++ K+ DFG+AR A S V TA ++GT Y++PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGRR 556
A +SDV+S G +L E++TG
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 7e-27
Identities = 30/240 (12%), Positives = 66/240 (27%), Gaps = 54/240 (22%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSE---------------------------- 391
+LGQ + G+ V
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 392 QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK--LLVYEFMPNSSLDAI--LFD-PRK 446
+ + F L+ Q K ++++ D +Y M ++ L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 447 RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506
L R+ + +++ + LH ++H L+ +++LD ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 507 AGSEGEVNTARIVGTYGYMAPEY-----------AMEGLYSIKSDVFSFGVLLIEIITGR 555
+G + G+ PE L + D ++ G+++ I
Sbjct: 255 --RDGARVV--SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)
Query: 353 TSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVK----RLSSCSEQGN--AEFTNEV 401
D LG G F V K S G E A K R S S +G E EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVN 460
++ ++ H N++ L + + +L+ E + L D + ++ L + + +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIK 122
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP----KISDFGMARIFAGSEGEVNTA 516
I+ G+ YLH +I H DLK N++L P K+ DFG+A +G
Sbjct: 123 QILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN 177
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
I GT ++APE +++D++S GV+
Sbjct: 178 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 61/243 (25%), Positives = 113/243 (46%), Gaps = 35/243 (14%)
Query: 330 VRGRDDDLKA-QDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSS 388
+ DD K + D +T + +++ ++G G FG V++ L + E+A+K++
Sbjct: 15 LNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ 74
Query: 389 CSEQGNAEFTN-EVLLILKLQHKNLVKLLGF-----CVDGDEKL-LVYEFMPNSSLDAIL 441
+ F N E+ ++ ++H N+V L F + L LV E++P ++
Sbjct: 75 -----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRAS 128
Query: 442 FDPRKRGLLCWSKRINIVNG------IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495
K + + ++ +++ + Y+H + I HRD+K N+LLD
Sbjct: 129 RHYAKLK-----QTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGV 180
Query: 496 -KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEII 552
K+ DFG A+I GE N + I Y Y APE + G Y+ D++S G ++ E++
Sbjct: 181 LKLIDFGSAKIL--IAGEPNVSYICSRY-YRAPE-LIFGATNYTTNIDIWSTGCVMAELM 236
Query: 553 TGR 555
G+
Sbjct: 237 QGQ 239
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 17/210 (8%)
Query: 347 ETLDVATSNFSD----SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEV 401
+ +++ + D LG G FG V++ + G A K + + E E+
Sbjct: 146 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 205
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVN 460
+ L+H LV L D +E +++YEFM L + + + + + + +
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMR 262
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP--KISDFGMARIFAGSEGEVNTARI 518
+ KG+ ++HE +H DLK N++ + K+ DFG+ + V
Sbjct: 263 QVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-SVKV--T 316
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
GT + APE A +D++S GVL
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 58/248 (23%), Positives = 96/248 (38%), Gaps = 37/248 (14%)
Query: 317 IGDASKTGLRYQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-L 375
+ + + + D + + + S LG G G V
Sbjct: 108 LSLSRNKVFVFFDLTVDDQSVYPKAL----------RDEYIMSKTLGSGACGEVKLAFER 157
Query: 376 SDGKEIAVKRLS--------SCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427
K++A++ +S + E+ ++ KL H ++K+ F D ++ +
Sbjct: 158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYI 216
Query: 428 VYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASN 486
V E M L D ++ L + ++ + YLHE IIHRDLK N
Sbjct: 217 VLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPEN 269
Query: 487 VLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE---YAMEGLYSIKSD 540
VLL + D KI+DFG ++I E + + GT Y+APE Y+ D
Sbjct: 270 VLLSSQEEDCLIKITDFGHSKIL--GETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 541 VFSFGVLL 548
+S GV+L
Sbjct: 327 CWSLGVIL 334
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 39/204 (19%), Positives = 79/204 (38%), Gaps = 24/204 (11%)
Query: 361 MLGQGGFGPVYKGV--LSDGKEIAVKRLSSCSEQGNAE-FTNEVLLILKLQHKNLVKLLG 417
+ GG G +Y + +G+ + +K L + E + ++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 418 FCVDGDEKL-----LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
F D +V E++ SL L ++ I + I+ + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
+ +++ DLK N++L + K+ D G + GT G+ APE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIV-R 250
Query: 533 GLYSIKSDVFSFGVLLIEIITGRR 556
++ +D+++ G L +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLP 274
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 350 DVATSNFSD-----SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLL 403
D + F D ++LG+G V + L +E AVK + + EV +
Sbjct: 4 DSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEM 63
Query: 404 ILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRI--NIV 459
+ + Q H+N+++L+ F + D LV+E M S+ I KR +++ +V
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH----KRR--HFNELEASVVV 117
Query: 460 NGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTA 516
+ + +LH I HRDLK N+L + KI DF + + +
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 517 R-----IVGTYGYMAPE-----YAMEGLYSIKSDVFSFGVLL 548
G+ YMAPE +Y + D++S GV+L
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKN 411
+ +G+G +G VYK S G+ +A+KR+ +E T E+ L+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLD-AILFDPRKRGLL-----CWSKRINIVNGIVKG 465
+V L+ LV+EFM D + D K GL + ++ ++G
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME---KDLKKVLDENKTGLQDSQIKIYLYQL------LRG 131
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ + H+ RI+HRDLK N+L++ D K++DFG+AR F G T +V T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186
Query: 526 APEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
AP+ M YS D++S G + E+ITG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
S + +LG G FG V+K + G ++A K + + + E NE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
+L ++ +LV E++ L D I+ + L I + I +GI ++H+
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 473 SRLRIIHRDLKASNVLL-DYDMNP-KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
+ I+H DLK N+L + D KI DFG+AR + E ++ GT ++APE
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKV--NFGTPEFLAPEVV 260
Query: 531 MEGLYSIKSDVFSFGVLL 548
S +D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 41/191 (21%), Positives = 81/191 (42%), Gaps = 14/191 (7%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
LG+G FG V++ V S K K + E+ ++ +H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 421 DGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIH 479
+E ++++EF+ + + I L + ++ V+ + + + +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125
Query: 480 RDLKASNVLLDYDMNP--KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSI 537
D++ N++ + KI +FG AR + + Y APE + S
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-NFRL--LFTAPEYYAPEVHQHDVVST 182
Query: 538 KSDVFSFGVLL 548
+D++S G L+
Sbjct: 183 ATDMWSLGTLV 193
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 56/243 (23%), Positives = 83/243 (34%), Gaps = 52/243 (21%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK-----RLSSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
+GQG +G V + A+K ++ + + EV L+ KL H N+ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 416 LGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRI------------------ 456
D LV E L D + C +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 457 ------------------NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL--DYDMNPK 496
NI+ I + YLH I HRD+K N L + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIK 210
Query: 497 ISDFGMARIF-AGSEGEVNTAR-IVGTYGYMAPE--YAMEGLYSIKSDVFSFGVLLIEII 552
+ DFG+++ F + GE GT ++APE Y K D +S GVLL ++
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 553 TGR 555
G
Sbjct: 271 MGA 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 14/206 (6%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAE-FTNEVLLILKLQH 409
+F LG+G FG VY +A+K L + + G EV + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
N+++L G+ D L+ E+ P ++ L +K + + + + Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 125
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
H R+IHRD+K N+LL KI+DFG + S + GT Y+ PE
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTD--LCGTLDYLPPEM 178
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGR 555
++ K D++S GVL E + G+
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 58/267 (21%), Positives = 93/267 (34%), Gaps = 66/267 (24%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQHKN 411
++F +G+GGFG V++ D A+KR+ E + EV + KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 412 LVKLLGFCVDGD----EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI----------- 456
+V+ ++ ++ + ++ + S D L P R
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 457 NIVNGIVKGILY----------LHE--DSRLR---------------------------I 477
+ K LY L + + R +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA----------RIVGTYGYMAP 527
+HRDLK SN+ D K+ DFG+ E E VGT YM+P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITG 554
E YS K D+FS G++L E++
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS-------SCSEQGNAE-FTNEVLLILKLQHKNL 412
LG G G V K++A+K +S S E A E+ ++ KL H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+K+ F D ++ +V E M L D ++ L + ++ + YLHE
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 472 DSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEV-NTARIVGTYGYMAP 527
IIHRDLK NVLL + D KI+DFG ++I E + T + GT Y+AP
Sbjct: 133 ---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT--LCGTPTYLAP 185
Query: 528 E---YAMEGLYSIKSDVFSFGVLL 548
E Y+ D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 24/216 (11%)
Query: 352 ATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQ 408
++S F LG G + VYKG+ + G +A+K + SE+G T E+ L+ +L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-TPSTAIREISLMKELK 61
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPN---SSLDAILFDPRKRGLL-----CWSKRINIVN 460
H+N+V+L ++ LV+EFM N +D+ RGL + ++
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL---- 117
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG 520
++G+ + HE+ +I+HRDLK N+L++ K+ DFG+AR F G ++ +V
Sbjct: 118 --LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV- 170
Query: 521 TYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
T Y AP+ M YS D++S G +L E+ITG+
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 53/218 (24%), Positives = 88/218 (40%), Gaps = 32/218 (14%)
Query: 348 TLDVATSNFSD-----SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEV 401
L + + D S +LG G G V + ++ A+K L C + EV
Sbjct: 51 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREV 105
Query: 402 LLILKLQ-HKNLVKLLGFCVDGDEK----LLVYEFMPNSSL-DAILFDPRKRGLLCWSKR 455
L + ++V+++ + L+V E + L I RG +++R
Sbjct: 106 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTER 161
Query: 456 I--NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSE 510
I+ I + I YLH + I HRD+K N+L + K++DFG A+
Sbjct: 162 EASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
+ T T Y+APE Y D++S GV++
Sbjct: 219 S-LTT--PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 59/235 (25%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS-----------------SCSEQGNAEFTNEVLL 403
+G+G +G V +D A+K LS +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 404 --------ILK-LQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAI-----------LFD 443
ILK L H N+VKL E + + + D + + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL-------------VEVLDDPNEDHLYMVFELVNQGPVME 127
Query: 444 PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503
L + ++KGI YLH +IIHRD+K SN+L+ D + KI+DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 504 RIFAGSEGEVNTARIVGTYGYMAPE--YAMEGLYS-IKSDVFSFGVLLIEIITGR 555
F GS+ ++ VGT +MAPE ++S DV++ GV L + G+
Sbjct: 185 NEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKN 411
+ +G+G +G V+K + +A+KR+ + + E+ L+ +L+HKN
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 412 LVKLLGFCVDGDEKL-LVYEFMPNSSLD-AILFDPRKRGLL-----CWSKRINIVNGIVK 464
+V+L D+KL LV+EF D FD L + ++ +K
Sbjct: 63 IVRLHDVLH-SDKKLTLVFEFC---DQDLKKYFDSCNGDLDPEIVKSFLFQL------LK 112
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGY 524
G+ + H ++HRDLK N+L++ + K+++FG+AR F G +A +V T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167
Query: 525 MAPEYAM-EGLYSIKSDVFSFGVLLIEIITGRR 556
P+ LYS D++S G + E+ R
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKNL 412
+ +G+G +G VYK + G+ A+K++ E T E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLD-AILFDPRKRGLL-----CWSKRINIVNGIVKGI 466
VKL +LV+E + D L D + GL + ++ + GI
Sbjct: 63 VKLYDVIHTKKRLVLVFEHL---DQDLKKLLDVCEGGLESVTAKSFLLQL------LNGI 113
Query: 467 LYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMA 526
Y H+ R++HRDLK N+L++ + KI+DFG+AR F G T IV T Y A
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRA 168
Query: 527 PEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
P+ M YS D++S G + E++ G
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK-----RLSSCSEQGNAE-FTNEVLLILKLQHK--NL 412
LG GGFG VY G+ +SD +A+K R+S E N EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFD-PRKRGLLCWSKRINIVNGIVKGILYLHE 471
++LL + D +L+ E P D LFD +RG L + +++ + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCH- 166
Query: 472 DSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
++HRD+K N+L+D + K+ DFG + GT Y PE+
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDF--DGTRVYSPPEWI 220
Query: 531 MEGLYS-IKSDVFSFGVLLIEIITGR 555
Y + V+S G+LL +++ G
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE---FTN--EVLLILKL 407
+ + LG+G F VYK + + +A+K++ + T E+ L+ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 408 QHKNLVKLLGFCVDGDEKL-LVYEFMPNSSLD-AILFDPRKRGLL-----CWSKRINIVN 460
H N++ LL + LV++FM D ++ L +
Sbjct: 70 SHPNIIGLLD-AFGHKSNISLVFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMT---- 121
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG 520
++G+ YLH+ I+HRDLK +N+LLD + K++DFG+A+ F GS T ++V
Sbjct: 122 --LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV- 174
Query: 521 TYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
T Y APE +Y + D+++ G +L E++
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 39/222 (17%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTN-EVLLILKLQHK 410
+++D+ ++G G FG VY+ L D G+ +A+K++ + F N E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107
Query: 411 NLVKLLGFCVDGDEKL------LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK 464
N+V+L F EK LV +++P ++ + + + + VK
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRA-------KQTLPVIYVK 159
Query: 465 --------GILYLHEDSRLRIIHRDLKASNVLLDYDMNP-KISDFGMARIFAGSEGEVNT 515
+ Y+H I HRD+K N+LLD D K+ DFG A+ GE N
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNV 214
Query: 516 ARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITGR 555
+ I Y Y APE + G Y+ DV+S G +L E++ G+
Sbjct: 215 SYICSRY-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 17/214 (7%)
Query: 340 QDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT 398
D++ID D + F + LG+G VY+ K A+K L ++
Sbjct: 39 PDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR-- 96
Query: 399 NEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL-DAILFDPRKRGLLCWSKRIN 457
E+ ++L+L H N++KL E LV E + L D I+ ++G +
Sbjct: 97 TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAAD 152
Query: 458 IVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVN 514
V I++ + YLHE I+HRDLK N+L D KI+DFG+++I +
Sbjct: 153 AVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLM 207
Query: 515 TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLL 548
+ GT GY APE Y + D++S G++
Sbjct: 208 K-TVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLL---ILKL-----QH 409
+LG+GGFG V+ G L+D ++A+K + + + L +L H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFD-PRKRGLLCWSKRINIVNGIVKGILY 468
+++LL + + +LV E P + D LFD ++G L +V I +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNP-KISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
H ++HRD+K N+L+D K+ DFG + GT Y P
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDF--DGTRVYSPP 207
Query: 528 EYAMEGLYS-IKSDVFSFGVLLIEIITGR 555
E+ Y + + V+S G+LL +++ G
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 355 NFSDSNMLGQGGFGPVYKG-VLSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKN 411
+ + LG+G + VYKG +A+K + E+G A T EV L+ L+H N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHAN 61
Query: 412 LVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLL-----CWSKRINIVNGIVKG 465
+V L ++ L LV+E++ + L L D + + ++ ++G
Sbjct: 62 IVTLHDIIH-TEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQL------LRG 112
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ Y H +++HRDLK N+L++ K++DFG+AR + +V T Y
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYR 167
Query: 526 APEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
P+ + YS + D++ G + E+ TGR
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKNLVKLLGF 418
+G+G +G V K G+ +A+K+ + + E+ L+ +L+H+NLV LL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
C LV+EF+ ++ LD + GL + + I+ GI + H II
Sbjct: 93 CKKKKRWYLVFEFVDHTILD--DLELFPNGLDYQVVQ-KYLFQIINGIGFCHSH---NII 146
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-EGLYSI 537
HRD+K N+L+ K+ DFG AR + GEV + T Y APE + + Y
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRWYRAPELLVGDVKYGK 204
Query: 538 KSDVFSFGVLLIEIITGR 555
DV++ G L+ E+ G
Sbjct: 205 AVDVWAIGCLVTEMFMGE 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKNLVKLLGF 418
+G+G +G V+K G+ +A+K+ + + E+ ++ +L+H NLV LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
LV+E+ ++ L D +RG+ + +I ++ + + H + I
Sbjct: 71 FRRKRRLHLVFEYCDHTVLH--ELDRYQRGVPEHLVK-SITWQTLQAVNFCH---KHNCI 124
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-EGLYSI 537
HRD+K N+L+ K+ DFG AR+ + + T Y +PE + + Y
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRWYRSPELLVGDTQYGP 182
Query: 538 KSDVFSFGVLLIEIITGR 555
DV++ G + E+++G
Sbjct: 183 PVDVWAIGCVFAELLSGV 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 362 LGQGGFGPVYKGV---LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHKNLVKLL 416
+G+G +G VYK D K+ A+K++ E + E+ L+ +L+H N++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 84
Query: 417 GFCVD-GDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK--------GI 466
+ D K+ L++++ L I+ R ++ G+VK GI
Sbjct: 85 KVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPR--GMVKSLLYQILDGI 141
Query: 467 LYLHEDSRLRIIHRDLKASNVLLDYDMNP----KISDFGMARIFAGSEGEVNT--ARIVG 520
YLH + ++HRDLK +N+L+ + KI+D G AR+F S + +V
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLDPVVV 197
Query: 521 TYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
T+ Y APE + Y+ D+++ G + E++T
Sbjct: 198 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 24/203 (11%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRL-------SSCSEQGNAEFTNEVLLILK-LQHKNL 412
LG+G FG VY + +A+K L Q E I L+H N+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE-----IQSHLRHPNI 76
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
+++ + D L+ EF P L L +K G + + + + Y H
Sbjct: 77 LRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH-- 131
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
++IHRD+K N+L+ Y KI+DFG + T + GT Y+ PE
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--RRRT--MCGTLDYLPPEMIEG 186
Query: 533 GLYSIKSDVFSFGVLLIEIITGR 555
+ K D++ GVL E + G
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 28/216 (12%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHK 410
+ LG+G +G VYK + + +A+KR+ E+ T EV L+ +LQH+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL-----FDPRKRGLLCWSKRINIVNGIVKG 465
N+++L L++E+ + L + R + ++ G
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ--------LING 144
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNP-----KISDFGMARIFAGSEGEVNTARIVG 520
+ + H R +HRDLK N+LL KI DFG+AR F G T I+
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII- 199
Query: 521 TYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
T Y PE + YS D++S + E++
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 62/226 (27%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKL---- 407
F M GQG FG V G G +A+K++ + F N L I++
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-----DPRFRNRELQIMQDLAVL 76
Query: 408 QHKNLVKLL------GFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVN 460
H N+V+L G D L +V E++P +L + +R +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQV-------APPP 128
Query: 461 GIVK--------GILYLHEDSRLRIIHRDLKASNVLLDYDMNP-KISDFGMARIFAGSEG 511
++K I LH S + + HRD+K NVL++ K+ DFG A+ S
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL--SPS 185
Query: 512 EVNTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITGR 555
E N A I Y Y APE + G Y+ D++S G + E++ G
Sbjct: 186 EPNVAYICSRY-YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQHK 410
S + +GQG FG V+K G+++A+K++ +E+ T E+ ++ L+H+
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 411 NLVKLLGFCVDGDEKL--------LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGI 462
N+V L+ C LV++F L +L + + L K ++ +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIK--RVMQML 133
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN---TARIV 519
+ G+ Y+H + +I+HRD+KA+NVL+ D K++DFG+AR F+ ++ T R+V
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 520 GTYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGR 555
T Y PE + E Y D++ G ++ E+ T
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 56/205 (27%), Positives = 84/205 (40%), Gaps = 20/205 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK--------RLSSCSEQGNAEFTNEVLLILKLQHKNL 412
LG G FG V+ V KE+ VK + + T E+ ++ +++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFD-PRKRGLLCWSKRINIVNGIVKGILYLHE 471
+K+L + LV E S LD LF + L I +V + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKH-GSGLD--LFAFIDRHPRLDEPLASYIFRQLVSAVGYLR- 147
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
IIHRD+K N+++ D K+ DFG A T GT Y APE M
Sbjct: 148 --LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTF--CGTIEYCAPEVLM 202
Query: 532 EGLYS-IKSDVFSFGVLLIEIITGR 555
Y + +++S GV L ++
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 68/225 (30%), Positives = 98/225 (43%), Gaps = 30/225 (13%)
Query: 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT-NEV 401
LE + F D +LG+GGFG V+ + ++ A K+L+ ++ + E
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMP---------NSSLDAILFD-PRKRGLL 450
++ K+ + +V L + + L LV M N D F PR
Sbjct: 237 KILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295
Query: 451 CWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510
IV G+ +LH+ II+RDLK NVLLD D N +ISD G+A
Sbjct: 296 A---------QIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKA 341
Query: 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
G+ T GT G+MAPE + Y D F+ GV L E+I R
Sbjct: 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 352 ATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN-----EVLLIL 405
ATS + +G G +G VYK G +A+K + + G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 406 KLQ---HKNLVKLLGFCV----DGDEKL-LVYEFMPNSSLD-AILFDPRKRGLLCWSKRI 456
+L+ H N+V+L+ C D + K+ LV+E + D D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIK 123
Query: 457 NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA 516
+++ ++G+ +LH + I+HRDLK N+L+ K++DFG+ARI+ + + T
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY-SYQMAL-TP 178
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
+V T Y APE ++ Y+ D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-22
Identities = 56/215 (26%), Positives = 111/215 (51%), Gaps = 22/215 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKG--VLSDGKEIAVKRLSSCSEQGNAEFTN--EVLLILKLQ- 408
+ +G+G +G V+K + + G+ +A+KR+ + + + EV ++ L+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 409 --HKNLVKLL----GFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRI-NIVN 460
H N+V+L D + KL LV+E + + L L + G+ ++ I +++
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP--TETIKDMMF 127
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG 520
+++G+ +LH R++HRDLK N+L+ K++DFG+ARI+ + + T+ +V
Sbjct: 128 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMAL-TSVVV- 181
Query: 521 TYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
T Y APE ++ Y+ D++S G + E+ +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 13/215 (6%)
Query: 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT-NEV 401
LE V + F +LG+GGFG V + ++ A K+L ++ NE
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVN 460
++ K+ + +V L + + + L LV M L ++ + G
Sbjct: 236 QILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG 520
I G+ LH RI++RDLK N+LLD + +ISD G+A EG+ R VG
Sbjct: 295 -ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQTIKGR-VG 347
Query: 521 TYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
T GYMAPE Y+ D ++ G LL E+I G+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 61/217 (28%), Positives = 92/217 (42%), Gaps = 32/217 (14%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-------EQGNAEFTNEVLLIL 405
+F +LG+G F V + +E A+K L E +V+
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE--RDVMS-- 85
Query: 406 KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG--- 461
+L H VKL D DEKL + N L L RK G +
Sbjct: 86 RLDHPFFVKLYFTFQD-DEKLYFGLSYAKNGEL---LKYIRKIG------SFDETCTRFY 135
Query: 462 ---IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI 518
IV + YLH IIHRDLK N+LL+ DM+ +I+DFG A++ + +
Sbjct: 136 TAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 519 VGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
VGT Y++PE E SD+++ G ++ +++ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT-NE--VL-LILK 406
++FS ++G+GGFG VY +D ++ A+K L + NE +L L+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 407 LQHKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG 465
+V + + +KL + + M L + + G+ + I+ G
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL---HYHLSQHGVFSEADMRFYAAEIILG 304
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ ++H +++RDLK +N+LLD + +ISD G+A S+ + + VGT+GYM
Sbjct: 305 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHA--SVGTHGYM 357
Query: 526 APEYAMEGL-YSIKSDVFSFGVLLIEIITGR 555
APE +G+ Y +D FS G +L +++ G
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 35/210 (16%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK-----RLSSCSEQGNAEFTNEVLLILK-LQHKNLVK 414
LG+G +G V V + +AVK R C E E I K L H+N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENVVK 69
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IVKGILY 468
G +G+ + L E+ LFD + + + ++ G++Y
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGE----LFD-----RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA--GSEGEVNTARIVGTYGYMA 526
LH + I HRD+K N+LLD N KISDFG+A +F E +N GT Y+A
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVA 175
Query: 527 PEYAMEGLYS-IKSDVFSFGVLLIEIITGR 555
PE + DV+S G++L ++ G
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEF--TNEVLLILKLQHKNLVKLL 416
LG+G +G V + + AVK L N E E+ L+ +L+HKN+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL- 71
Query: 417 GFCVDGDE---KL-LVYEFMPNSSLDAILFD--PRKRGLLCWSKRINIVNGIVKGILYLH 470
V +E K+ +V E+ + + D P KR ++ G+ YLH
Sbjct: 72 -VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKR-FPVCQAH-GYFCQLIDGLEYLH 126
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF--AGSEGEVNTARIVGTYGYMAPE 528
I+H+D+K N+LL KIS G+A ++ T++ G+ + PE
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--GSPAFQPPE 181
Query: 529 YAM-EGLYS-IKSDVFSFGVLLIEIITGR 555
A +S K D++S GV L I TG
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G F V + G+E+A+K + + + + EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE- 81
Query: 419 CVDGDEKL-LVYEFMPNSSLDAILFD-PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476
++ ++ L L+ E+ + FD G + + + IV + Y H + R
Sbjct: 82 VIETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQYCH---QKR 134
Query: 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-NTARIVGTYGYMAPEYAMEGLY 535
I+HRDLKA N+LLD DMN KI+DFG + F + G + G Y APE Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAF--CGAPPYAAPELFQGKKY 190
Query: 536 S-IKSDVFSFGVLLIEIITGR 555
+ DV+S GV+L +++G
Sbjct: 191 DGPEVDVWSLGVILYTLVSGS 211
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 35/210 (16%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK-----RLSSCSEQGNAEFTNEVLLILK-LQHKNLVK 414
LG+G +G V V + +AVK R C E E I K L H+N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-----INKMLNHENVVK 69
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IVKGILY 468
G +G+ + L E+ LFD + + + ++ G++Y
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGE----LFD-----RIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA--GSEGEVNTARIVGTYGYMA 526
LH + I HRD+K N+LLD N KISDFG+A +F E +N GT Y+A
Sbjct: 121 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVA 175
Query: 527 PEYAMEGLYS-IKSDVFSFGVLLIEIITGR 555
PE + DV+S G++L ++ G
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 57/251 (22%), Positives = 102/251 (40%), Gaps = 57/251 (22%)
Query: 349 LDVATSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTN-EVLLILK 406
L+ ++ +S LG G FG V + + GK A+K++ + + N E+ ++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKV 56
Query: 407 LQHKNLVKLL-GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWS------KRINIV 459
L H N++KL+ F GDE+ + + + + K +N++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 460 -----------------NG--------------IVKGILYLHEDSRLRIIHRDLKASNVL 488
+G + + + ++H L I HRD+K N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLL 173
Query: 489 LDYDMNP-KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY---AMEGLYSIKSDVFSF 544
++ N K+ DFG A+ E + A I + Y APE A E Y+ D++S
Sbjct: 174 VNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATE--YTPSIDLWSI 228
Query: 545 GVLLIEIITGR 555
G + E+I G+
Sbjct: 229 GCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 43/223 (19%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTN---------EVL 402
+ + +G G G V + + +A+K+LS F N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 403 LILKLQHKNLVKLLG-FCVDGDEKL-----LVYEFMPNSSLDAI----LFDPRKRGLLCW 452
L+ + HKN++ LL F + +V E M ++L + L R LL
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSYLLY- 134
Query: 453 SKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512
++ GI +LH IIHRDLK SN+++ D KI DFG+AR +
Sbjct: 135 --------QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTS 180
Query: 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
V T Y APE + Y D++S G ++ E+I G
Sbjct: 181 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLLILKL-QHKNLVKLLG 417
LG G FG V G G ++AVK L + LKL +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IVKGILYLHE 471
+ +V E++ L FD +C R+ + I+ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGEL----FD-----YICKHGRVEEMEARRLFQQILSAVDYCH- 128
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-NTARIVGTYGYMAPEYA 530
R ++HRDLK NVLLD MN KI+DFG++ + S+GE T+ G+ Y APE
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS--CGSPNYAAPEVI 182
Query: 531 MEGLYS-IKSDVFSFGVLLIEIITGR 555
LY+ + D++S GV+L ++ G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 54/189 (28%), Positives = 77/189 (40%), Gaps = 29/189 (15%)
Query: 447 RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506
+ L I + KG+ +L + + IHRDL A N+LL KI DFG+AR
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGA 566
V +MAPE + +Y+I+SDV+SFGVLL EI + GA
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----------LGA 293
Query: 567 T-----APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621
+ + EG + P D +P+ + L C + RPT
Sbjct: 294 SPYPGVKIDEEFC--RRLKEGTRMR--AP---DYTTPEMY----QTMLDCWHGEPSQRPT 342
Query: 622 MSSVVVMLQ 630
S +V L
Sbjct: 343 FSELVEHLG 351
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 37/160 (23%), Positives = 59/160 (36%), Gaps = 19/160 (11%)
Query: 360 NMLGQGGFGPVYKGVL------SDGKEIAVKRL-SSCSEQGNAEFTNEVLLILKL-QHKN 411
LG+G FG V + + + +AVK L + + +E+ +++ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 412 LVKLLGFCVDGDEKLLV-YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
+V LLG C L+V EF +L L SKR V KG +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510
+ I DLK + + S F + + E
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 69/273 (25%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 338 KAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCS--EQGN 394
+ +D + L + ++ ++G+G FG V +++ A+K LS ++ +
Sbjct: 53 RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 112
Query: 395 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCW 452
+ F E I+ +V+L + D L +V E+MP L ++ +
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEK 168
Query: 453 SKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512
R +V + +H + IHRD+K N+LLD + K++DFG EG
Sbjct: 169 WARFYTAE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGM 223
Query: 513 VNTARIVGTYGYMAPE----YAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF-NQSRGAT 567
V VGT Y++PE +G Y + D +S GV L E++ G T F S T
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYADSLVGT 281
Query: 568 ------APNLLAYAWHLWNEGNALDLIDPLLTD 594
N L + A +LI LTD
Sbjct: 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTD 314
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 34/212 (16%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFTNEVLLILK-LQHKNLVKLL 416
+G+G FG V +D K++ A+K ++ C E+ + L I++ L+H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 417 GFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK--------GIL 467
+ +E + +V + + L R L + ++ VK +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDL---------RYHL--QQNVHFKEETVKLFICELVMALD 129
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YL RIIHRD+K N+LLD + I+DF +A + + GT YMAP
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 528 E---YAMEGLYSIKSDVFSFGVLLIEIITGRR 556
E YS D +S GV E++ GRR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 28/221 (12%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAE--FTN---------EV 401
S ++ + G +G V GV S+G +A+KR+ + G ++ E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 402 LLILKLQHKNLVKLLG-FCVDGDEKL----LVYEFMPNSSLDAILFDPRKRGLLCWSKRI 456
L+ H N++ L F + + LV E M + L ++ + ++ + I
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVI---HDQRIVISPQHI 136
Query: 457 N-IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
+ I+ G+ LHE ++HRDL N+LL + + I DF +AR N
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NK 190
Query: 516 ARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
V Y APE M+ ++ D++S G ++ E+ +
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 41/282 (14%)
Query: 338 KAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCS--EQGN 394
A+ F ++ + + +F ++G+G FG V L + ++ A+K L+ ++
Sbjct: 58 WAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE 117
Query: 395 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPN-------SSLDAILFDPR 445
E +L K + L + D L LV ++ S + L +
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM 176
Query: 446 KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
R L +V I +H+ L +HRD+K N+L+D + + +++DFG
Sbjct: 177 ARFYLA---------EMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 506 FAGSEGEVNTARIVGTYGYMAPE-----YAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560
+G V ++ VGT Y++PE +G Y + D +S GV + E++ G T F
Sbjct: 225 L-MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE--TPF 281
Query: 561 -NQSRGATAPNLLAYAWHL----WNEG---NALDLIDPLLTD 594
+S T ++ + NA DLI L+
Sbjct: 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS 323
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK-----RLSSCSEQGNAEFTNEVLLILKL-QHKNLVK 414
LG G FG V G G ++AVK ++ S G E+ LKL +H +++K
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQ-NLKLFRHPHIIK 80
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IVKGILY 468
L + +V E++ L FD +C + R++ I+ G+ Y
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGEL----FD-----YICKNGRLDEKESRRLFQQILSGVDY 131
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-NTARIVGTYGYMAP 527
H R ++HRDLK NVLLD MN KI+DFG++ + S+GE T+ G+ Y AP
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRTS--CGSPNYAAP 184
Query: 528 EYAMEGLYS-IKSDVFSFGVLLIEIITGR 555
E LY+ + D++S GV+L ++ G
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK-----RLSSCSEQGNAEFTNEVLLILKL-QHKNLVK 414
LG+G FG V +++A+K L E E+ LKL +H +++K
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REIS-YLKLLRHPHIIK 73
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAI----------LFD-PRKRGLLCWSKRINIVNGIV 463
L Y+ + + I LFD ++ + + I+
Sbjct: 74 L-------------YDVITTPT--DIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-NTARIVGTY 522
I Y H R +I+HRDLK N+LLD ++N KI+DFG++ I ++G T+ G+
Sbjct: 119 CAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTS--CGSP 171
Query: 523 GYMAPEYAMEGLYS-IKSDVFSFGVLLIEIITGR 555
Y APE LY+ + DV+S G++L ++ GR
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 64/284 (22%), Positives = 108/284 (38%), Gaps = 43/284 (15%)
Query: 338 KAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCS--EQGN 394
A+ + L+ + + +F ++G+G F V + ++ A+K ++ ++G
Sbjct: 45 WAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE 104
Query: 395 AEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKL-LVYEFMPN-------SSLDAILFDPR 445
E +L + + +L F + L LV E+ S +
Sbjct: 105 VSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM 163
Query: 446 KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
R L IV I +H L +HRD+K N+LLD + +++DFG
Sbjct: 164 ARFYLA---------EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211
Query: 506 FAGSEGEVNTARIVGTYGYMAPE-------YAMEGLYSIKSDVFSFGVLLIEIITGRRNT 558
++G V + VGT Y++PE G Y + D ++ GV E+ G+ T
Sbjct: 212 L-RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ--T 268
Query: 559 GF-NQSRGATAPNLLAYAWHL-------WNEGNALDLIDPLLTD 594
F S T ++ Y HL A D I LL
Sbjct: 269 PFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCP 312
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 8e-18
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 35/219 (15%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN---------EVL 402
+ + +G G G V + +A+K+LS F N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 403 LILKLQHKNLVKLL------GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI 456
L+ + HKN++ LL + + LV E M ++L ++ + L +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI-----QMELDHERMS 167
Query: 457 NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA 516
++ ++ GI +LH IIHRDLK SN+++ D KI DFG+AR + T
Sbjct: 168 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 222
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
V T Y APE + Y D++S G ++ E++ +
Sbjct: 223 Y-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 47/199 (23%), Positives = 76/199 (38%), Gaps = 48/199 (24%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFC 419
LG G G V + ++ A+K L C + EV L + Q ++V+++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 80
Query: 420 VDGDEK----LLVYEFMPNSSL-DAILFDPRKRGLLCWSKRI--NIVNGIVKGILYLHED 472
+ L+V E + L I RG +++R I+ I + I YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLHS- 135
Query: 473 SRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
+ I HRD+K N+L + K++DFG A E
Sbjct: 136 --INIAHRDVKPENLLYTSKRPNAILKLTDFG-----------------------FAKET 170
Query: 530 AMEGLYSIKSDVFSFGVLL 548
E Y D++S GV++
Sbjct: 171 TGEK-YDKSCDMWSLGVIM 188
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 56/224 (25%), Positives = 97/224 (43%), Gaps = 46/224 (20%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN---------EVL 402
+ +G G +G V + G+++A+K+LS F + E+L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS------RP-FQSEIFAKRAYRELL 75
Query: 403 LILKLQHKNLVKLL-----GFCVDGDEKL-LVYEFMPNSSLDAI----LFDPRKRGLLCW 452
L+ +QH+N++ LL + LV FM + L I + + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQ----- 129
Query: 453 SKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512
+V ++KG+ Y+H ++HRDLK N+ ++ D KI DFG+AR
Sbjct: 130 ----YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 513 VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
V T Y APE + Y+ D++S G ++ E++TG+
Sbjct: 183 Y-----VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 343 YIDLETLDVA---TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT 398
Y D E+ V ++ LG+G + V++ + +++ +++ VK L ++ +
Sbjct: 22 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 78
Query: 399 NEVLLILKLQ-HKNLVKLLGFCVDGDEK--LLVYEFMPNSSLDAI---LFDPRKRGLLCW 452
E+ ++ L+ N++ L D + LV+E + N+ + L D R +
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-- 136
Query: 453 SKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGSEG 511
I+K + Y H S I+HRD+K NV++D++ ++ D+G+A G
Sbjct: 137 -------YEILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPG 184
Query: 512 EVNTARIVGTYGYMAPE----YAMEGLYSIKSDVFSFGVLLIEIITGRR 556
+ R+ Y + PE Y M Y D++S G +L +I +
Sbjct: 185 QEYNVRVASRY-FKGPELLVDYQM---YDYSLDMWSLGCMLASMIFRKE 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 5e-17
Identities = 65/241 (26%), Positives = 109/241 (45%), Gaps = 42/241 (17%)
Query: 328 QHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVY---KGVLSDGKEI-AV 383
HV+ + F E L V LGQG FG V+ K SD +++ A+
Sbjct: 12 HHVKEGHEKADPSQF----ELLKV----------LGQGSFGKVFLVKKISGSDARQLYAM 57
Query: 384 KRLS--SCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNSSL--- 437
K L + + E +++++ H +VKL + + KL L+ +F+ L
Sbjct: 58 KVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTR 116
Query: 438 --DAILFD-PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN 494
++F + L + + +LH L II+RDLK N+LLD + +
Sbjct: 117 LSKEVMFTEEDVKFYLA---------ELALALDHLHS---LGIIYRDLKPENILLDEEGH 164
Query: 495 PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
K++DFG+++ E + + GT YMAPE ++ +D +SFGVL+ E++TG
Sbjct: 165 IKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222
Query: 555 R 555
Sbjct: 223 T 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 9e-17
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 25/206 (12%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT-NEVLLILKLQHKNLVKLL 416
+LG+G FG V A+K L + T E ++ +H L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 417 GFCVDGDEKL-LVYEFMPNSSL------DAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
+ ++L V E+ L + + + R R IV + YL
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA---------EIVSALDYL 264
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
H S +++RDLK N++LD D + KI+DFG+ + G + GT Y+APE
Sbjct: 265 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEV 320
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGR 555
+ Y D + GV++ E++ GR
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 53/212 (25%), Positives = 102/212 (48%), Gaps = 17/212 (8%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT-NEVLLILKLQHK 410
+++ + +G+G +G V + +A+K++S Q + T E+ ++L+ +H+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 411 NLVKLLG-FCVDGDEKL----LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG 465
N++ + E++ +V + M + L +L K L + I++G
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRG 140
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT-ARIVGTYGY 524
+ Y+H + ++HRDLK SN+LL+ + KI DFG+AR+ V T Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 525 MAPEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
APE + Y+ D++S G +L E+++ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 61/220 (27%), Positives = 98/220 (44%), Gaps = 37/220 (16%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN---------EVL 402
+ + D +G G +G V V G ++A+K+L F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY------RP-FQSELFAKRAYRELR 76
Query: 403 LILKLQHKNLVKLLG-FCVDGDEKL-----LVYEFMPNSSLDAILFDPRKRGLLCWSKRI 456
L+ ++H+N++ LL F D LV FM + L ++ K L +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM----KHEKLGEDRIQ 131
Query: 457 NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA 516
+V ++KG+ Y+H IIHRDLK N+ ++ D KI DFG+AR
Sbjct: 132 FLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--- 185
Query: 517 RIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
V T Y APE + Y+ D++S G ++ E+ITG+
Sbjct: 186 --VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.4 bits (203), Expect = 2e-16
Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 23/212 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLSSCSEQGNAEFTNEV--------LLI 404
++F+ +LG+G FG V E+ AVK L + ++V +L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK----KDVVIQDDDVECTMVEKRVLA 396
Query: 405 LKLQHKNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIV 463
L + L +L C ++L V E++ L ++ ++ G + I
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIA 452
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
G+ +L II+RDLK NV+LD + + KI+DFGM + V T GT
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPD 507
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE Y D ++FGVLL E++ G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 55/254 (21%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEV--------LL 403
+ +++G G +G V + + + +A+K++ F + + +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 404 ILK-LQHKNLVKLLGFCV----DGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRIN 457
IL L H ++VK+L + + ++L +V E S + R L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLF---RTPVYLTELHIKT 160
Query: 458 IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR 517
++ ++ G+ Y+H S I+HRDLK +N L++ D + K+ DFG+AR E +
Sbjct: 161 LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 518 IVGTYG-------------------------YMAPEYAM-EGLYSIKSDVFSFGVLLIEI 551
I Y APE + + Y+ DV+S G + E+
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 552 ITGRRNTGFNQSRG 565
+ + +
Sbjct: 278 LNMIKENVAYHADR 291
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I + +LH+ II+RDLK N++L++ + K++DFG+ + +T GT
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGT 184
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
YMAPE M ++ D +S G L+ +++TG
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 26/204 (12%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G G FG + +AVK + + E++ L+H N+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IVKGILYLHEDSR 474
++ E+ L ++ +C + R + ++ G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGEL----YE-----RICNAGRFSEDEARFFFQQLLSGVSYCH---S 134
Query: 475 LRIIHRDLKASNVLLD--YDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
++I HRDLK N LLD KI DFG ++ + + VGT Y+APE +
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKST--VGTPAYIAPEVLLR 191
Query: 533 GLYS-IKSDVFSFGVLLIEIITGR 555
Y +DV+S GV L ++ G
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGA 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 56/230 (24%), Positives = 104/230 (45%), Gaps = 44/230 (19%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTN---------EVL 402
S + D LG GG G V+ V +D K +A+K++ T+ E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 403 LILKLQHKNLVKLL--------------GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRG 448
+I +L H N+VK+ G + + +V E+M + L +L ++G
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL----EQG 115
Query: 449 LLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-YDMNPKISDFGMARIFA 507
L + +++G+ Y+H + ++HRDLK +N+ ++ D+ KI DFG+ARI
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 508 GSEGEVNT-ARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGR 555
+ + T Y +P + Y+ D+++ G + E++TG+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 24/219 (10%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT-NEVLLILKLQHK 410
+S+F ++LG+G +G V G+ +A+K++ + A T E+ ++ +H+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 411 NLVKLLG-FCVDGDEKL----LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG 465
N++ + D E ++ E M + L ++ +L + ++
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLSDDHIQYFIYQTLRA 124
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARI------- 518
+ LH + +IHRDLK SN+L++ + + K+ DFG+ARI S + +
Sbjct: 125 VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 519 -VGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
V T Y APE + YS DV+S G +L E+ R
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 61/208 (29%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT---NEVLLILKLQHKNLVK 414
+LG+G FG V E+ AVK L + + E T VL L + L +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPGKPPFLTQ 85
Query: 415 LLGFCVDGDEKL-LVYEFMPNSSL-----DAILFD-PRKRGLLCWSKRINIVNGIVKGIL 467
L C ++L V E++ L F P I G+
Sbjct: 86 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA---------EIAIGLF 135
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
+L II+RDLK NV+LD + + KI+DFGM + V T GT Y+AP
Sbjct: 136 FLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIAP 190
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGR 555
E Y D ++FGVLL E++ G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
IV + YLH +++RD+K N++LD D + KI+DFG+ + G GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 168
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE + Y D + GV++ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 29/208 (13%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT---NEVLLILKLQHKNLVK 414
+LG+G FG V + + ++ AVK L + + E T +L L H L +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS-LARNHPFLTQ 88
Query: 415 LLGFCVDGDEKL-LVYEFMPNSSL-----DAILFD-PRKRGLLCWSKRINIVNGIVKGIL 467
L C ++L V EF+ L + FD R R I+ ++
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA---------EIISALM 138
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
+LH+ II+RDLK NVLLD++ + K++DFGM + G V TA GT Y+AP
Sbjct: 139 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAP 193
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGR 555
E E LY D ++ GVLL E++ G
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 27/212 (12%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT-NEVLLILKLQH 409
F LG G FG V + A+K L + E T NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------IV 463
LVKL D +V E++ + + L R+ G R + + IV
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIG------RFSEPHARFYAAQIV 151
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
YLH L +I+RDLK N+L+D +++DFG A+ + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 203
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
+APE + Y+ D ++ GVL+ E+ G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I + YLHE II+RDLK NVLLD + + K++D+GM + G T+ GT
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 173
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE Y D ++ GVL+ E++ GR
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 29/208 (13%)
Query: 361 MLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT---NEVLLILKLQHKNLVK 414
++G+G FG V + AVK L + ++ + VLL ++H LV
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL-KNVKHPFLVG 103
Query: 415 LLGFCVDGDEKL-LVYEFMPNSSL-----DAILFD-PRKRGLLCWSKRINIVNGIVKGIL 467
L F +KL V +++ L F PR R I +
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA---------EIASALG 153
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YLH L I++RDLK N+LLD + ++DFG+ + E T+ GT Y+AP
Sbjct: 154 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAP 208
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGR 555
E + Y D + G +L E++ G
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 38/94 (40%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I+ G+ +LH I++RDLK N+LLD D + KI+DFGM + G+ T GT
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGT 181
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE + Y+ D +SFGVLL E++ G+
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 37/220 (16%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTN---------EVL 402
+ + + +G G +G V + G +AVK+LS F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 403 LILKLQHKNLVKLL-----GFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRI 456
L+ ++H+N++ LL ++ + LV M + L+ I+ K L
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQ 135
Query: 457 NIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA 516
++ I++G+ Y+H IIHRDLK SN+ ++ D KI DFG+AR A
Sbjct: 136 FLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY--- 189
Query: 517 RIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGR 555
V T Y APE + Y+ D++S G ++ E++TGR
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
I + YLHE II+RDLK NVLLD + + K++D+GM + G T+ GT
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGT 216
Query: 522 YGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE Y D ++ GVL+ E++ GR
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 24/201 (11%), Positives = 56/201 (27%), Gaps = 45/201 (22%)
Query: 362 LGQGGFGPVYKGVLSD---GKEIAVKRL---SSCSEQGNAEFTNEVLLILKLQHKNLVKL 415
G ++ + D +++A+ + + E + L + ++ + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
L L+V E++ SL + I + + H R
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAH---RA 148
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
+ S V + D G+V ++ M
Sbjct: 149 GVALSIDHPSRVRVSID------------------GDV----VLAYPATMPDA------- 179
Query: 536 SIKSDVFSFGVLLIEIITGRR 556
+ + D+ G L ++ R
Sbjct: 180 NPQDDIRGIGASLYALLVNRW 200
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 54/270 (20%), Positives = 104/270 (38%), Gaps = 55/270 (20%)
Query: 333 RDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSE 391
+ ++ ++ + V N+ +++G+G +G VY + K +A+K+++
Sbjct: 6 HHSSGRENLYFQGIKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN---- 60
Query: 392 QGNAEFTNEV--------LLILK-LQHKNLVKLLG-FCVDGDEKL----LVYEFMPNSSL 437
F + + + IL L+ +++L D K +V E S L
Sbjct: 61 --RM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDL 116
Query: 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI 497
+ + L I+ ++ G ++HE IIHRDLK +N LL+ D + K+
Sbjct: 117 KKLF---KTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKV 170
Query: 498 SDFGMARIFAGSEGEVNTARI--------------------VGTYGYMAPE---YAMEGL 534
DFG+AR + + V T Y APE
Sbjct: 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN-- 228
Query: 535 YSIKSDVFSFGVLLIEIITGRRNTGFNQSR 564
Y+ D++S G + E++ ++ + +
Sbjct: 229 YTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 35/96 (36%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
IV + +LH+ L II+RD+K N+LLD + + ++DFG+++ F E E GT
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223
Query: 522 YGYMAPEYAMEGLYSIKSDV--FSFGVLLIEIITGR 555
YMAP+ G V +S GVL+ E++TG
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 58/241 (24%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEV--------LL 403
+ LG+G +G V+K + G+ +AVK++ F N ++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 404 ILKL--QHKNLVKLLG-FCVDGDEKL-LVYEFMPNSSLDAI-----LFDPRKRGLLCWSK 454
IL H+N+V LL D D + LV+++M + L A+ L K+
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQ------- 112
Query: 455 RINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN 514
+V ++K I YLH S ++HRD+K SN+LL+ + + K++DFG++R F N
Sbjct: 113 --YVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 515 TARI-------------------VGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITG 554
+ V T Y APE + Y+ D++S G +L EI+ G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 555 R 555
+
Sbjct: 228 K 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEI-AVKRLS--SCSEQGNAEFT-NEVLLILKLQH 409
+F LG G FG V+ A+K L E T +E L++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 410 KNLVKLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG------I 462
++++ G D +++ ++ +++ L ++L RK R +
Sbjct: 66 PFIIRMWGTFQD-AQQIFMIMDYIEGGELFSLL---RKSQ------RFPNPVAKFYAAEV 115
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTY 522
+ YLH II+RDLK N+LLD + + KI+DFG A+ T + GT
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTP 167
Query: 523 GYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
Y+APE Y+ D +SFG+L+ E++ G
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 42/222 (18%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCS---EQGNAEFTNEVLLILK---------L 407
LG G F V+ + + +A+K + E E ++L + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEI--KLLQRVNDADNTKEDSM 83
Query: 408 QHKNLVKLLG-FCVDGDEKL---LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIV 463
+++KLL F G + +V+E + +L A++ RG+ + V I
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGI-----PLIYVKQIS 137
Query: 464 KGIL----YLHEDSRLRIIHRDLKASNVLLDYDMNP------KISDFGMARIFAGSEGEV 513
K +L Y+H R IIH D+K NVL++ +P KI+D G A E
Sbjct: 138 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEH 191
Query: 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
T I T Y +PE + + +D++S L+ E+ITG
Sbjct: 192 YTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 5e-11
Identities = 39/263 (14%), Positives = 78/263 (29%), Gaps = 67/263 (25%)
Query: 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRL--------SSCSEQGNAEFTNEVL 402
+ T +G+G FG V++ + D +A+K + + ++ E E++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 403 LILKLQ---------HKNLVKLLGFCV------------------------------DGD 423
+ +L + + L D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLK 483
+ +V EF + + L + +I++ + + LR HRDL
Sbjct: 136 QLFIVLEFEFGGI----DLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 484 ASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP--EYAMEGLYSIKSDV 541
NVLL K+ + + + G +Y + L V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 542 FSFGVLLIEIITGRRNTGFNQSR 564
F + ++ TG + F+ R
Sbjct: 239 FCDVSMDEDLFTGDGDYQFDIYR 261
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 55/245 (22%), Positives = 98/245 (40%), Gaps = 46/245 (18%)
Query: 332 GRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVK---RLS 387
G DDD ++ ++ + + +++G+G FG V K + + +A+K
Sbjct: 36 GYDDD----NYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK 91
Query: 388 SCSEQGNAEFTNEVLLILKLQ----HKNLVKLLGF-------CVDGDEKLLVYEFMPNSS 436
+ Q E +L ++ +V L C LV+E + + +
Sbjct: 92 AFLNQAQIEV--RLLELMNKHDTEMKYYIVHLKRHFMFRNHLC-------LVFEML-SYN 141
Query: 437 LDAILFDPRKRGLLCWSKRINIVNGIVKGIL----YLHEDSRLRIIHRDLKASNVLLDYD 492
L +L + RG+ +N+ + + +L L IIH DLK N+LL
Sbjct: 142 LYDLLRNTNFRGV-----SLNLTRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNP 195
Query: 493 MNP--KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIE 550
KI DFG + G+ I + Y +PE + Y + D++S G +L+E
Sbjct: 196 KRSAIKIVDFGSSCQ----LGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVE 250
Query: 551 IITGR 555
+ TG
Sbjct: 251 MHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 53/220 (24%), Positives = 88/220 (40%), Gaps = 52/220 (23%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQ----HKNL 412
++G+G FG V K + +A+K + + Q E +L L+ Q N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI--RILEHLRKQDKDNTMNV 161
Query: 413 VKLLGF-------CVDGDEKLLVYEFMPNSSLDAILFDPRK----RGLLCWSKRINIVNG 461
+ +L C + +E + + L++ K +G + +V
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSMN-----LYELIKKNKFQGF-----SLPLVRK 204
Query: 462 IVKGIL----YLHEDSRLRIIHRDLKASNVLLDYDMNP--KISDFGMARIFAGSEGEVNT 515
IL LH + RIIH DLK N+LL K+ DFG + E +
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVY 257
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
I + Y APE + Y + D++S G +L E++TG
Sbjct: 258 TYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 51/273 (18%), Positives = 93/273 (34%), Gaps = 80/273 (29%)
Query: 350 DVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ 408
D+ + LG G F V+ + K +A+K + S +E+ L+ ++
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVR 91
Query: 409 --------HKNLVKLLG-FCVDGDE---KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI 456
+ +V+LL F + G +V+E + L + +GL +
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGL-----PL 145
Query: 457 NIVNGIVKGIL----YLHEDSRLRIIHRDLKASNVLLDYD-------------------- 492
V I++ +L YLH ++ RIIH D+K N+LL +
Sbjct: 146 PCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAP 203
Query: 493 -----------------------------MNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
+ KI+D G A + + T
Sbjct: 204 PPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW-----VHKHFTEDIQTRQ 258
Query: 524 YMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
Y + E + Y+ +D++S + E+ TG
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 30/210 (14%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTN---EVLLILKLQHKNLV-KLL 416
+G G FG +Y G + +E+A+K E + E + LQ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKIYRILQGGTGIPNVR 69
Query: 417 GFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR--INIVNGIVKGILYLHEDSR 474
F V+GD +LV + + S D LF+ R L S + + + + ++ + ++H S
Sbjct: 70 WFGVEGDYNVLVMDLLGPSLED--LFNFCSRKL---SLKTVLMLADQMINRVEFVHSKS- 123
Query: 475 LRIIHRDLKASNVLLDYDMNPK---ISDFGMARIFAGSEGEV-----NTARIVGTYGYMA 526
+HRD+K N L+ I DFG+A+ + + + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 527 PEYAMEGL-YSIKSDVFSFGVLLIEIITGR 555
G+ S + D+ S G +L+ + G
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 45/204 (22%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G G FG +Y G ++ G+E+A+K ++ +++ +++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-GGVGIPTIRWCGA 75
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
+GD ++V E + SL+ LF+ R + + + ++ I Y+H + IHR
Sbjct: 76 EGDYNVMVMELL-GPSLED-LFNFCSRKFSL-KTVLLLADQMISRIEYIHSKN---FIHR 129
Query: 481 DLKASNVLLDYDMNPK---ISDFGMARIFAGSEGEV-----NTARIVGTYGYMAPEYAME 532
D+K N L+ I DFG+A+ + + + GT Y A
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINTHL 188
Query: 533 GL-YSIKSDVFSFGVLLIEIITGR 555
G+ S + D+ S G +L+ G
Sbjct: 189 GIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 45/217 (20%), Positives = 78/217 (35%), Gaps = 42/217 (19%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G G FG + G L + +A+K S L + ++ F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFGP 75
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR--INIVNGIVKGILYLHEDSRLRII 478
G +V E + SL+ LFD R S + + I ++ + Y+H + +I
Sbjct: 76 CGKYNAMVLELL-GPSLED-LFDLCDRTF---SLKTVLMIAIQLISRMEYVHSKN---LI 127
Query: 479 HRDLKASNVLLDYDMNPK-----ISDFGMARIFAGSEGEV-----NTARIVGTYGYMAPE 528
+RD+K N L+ N I DF +A+ + E + + GT YM
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM--- 184
Query: 529 YAMEGLYSI----------KSDVFSFGVLLIEIITGR 555
SI + D+ + G + + + G
Sbjct: 185 -------SINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 40/208 (19%), Positives = 80/208 (38%), Gaps = 24/208 (11%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
+G+G FG +++G L + +++A+K S+ +L + + F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA-GCTGIPNVYYFGQ 76
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR--INIVNGIVKGILYLHEDSRLRII 478
+G +LV + + S D L D R S + ++ + +HE S ++
Sbjct: 77 EGLHNVLVIDLLGPSLED--LLDLCGRKF---SVKTVAMAAKQMLARVQSIHEKS---LV 128
Query: 479 HRDLKASNVLLDYDMNPK-----ISDFGMARIFAGSEGEV-----NTARIVGTYGYMAPE 528
+RD+K N L+ + + DFGM + + + + GT Y
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY-MSI 187
Query: 529 YAMEGL-YSIKSDVFSFGVLLIEIITGR 555
G S + D+ + G + + + G
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 24/167 (14%), Positives = 60/167 (35%), Gaps = 27/167 (16%)
Query: 362 LGQGGFGPVYKGV---------LSDGKEIAVKRLSS----CSEQGNAEFTNEVLLILKLQ 408
+ G +Y+ ++ ++K + +EQ + + L + K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 409 HKNLVKLLGF-------CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG 461
LL + LV + SL + D + +L + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVACR 167
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI--SDFGMARIF 506
++ + +LHE+ +H ++ A N+ +D + ++ + +G A +
Sbjct: 168 LLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 46/237 (19%), Positives = 85/237 (35%), Gaps = 70/237 (29%)
Query: 361 MLGQGGFGPVYKGV--LSDGKEIAVK---RLSSCSEQGNAEFTNEVLLILKLQ----HKN 411
LG+G FG V + + ++A+K + E E VL +K +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEI--NVLKKIKEKDKENKFL 83
Query: 412 LVKLLGF-------CVDGDEKLLVYEFMPNSSLDAILFDPRK----RGLLCWSKRINIVN 460
V + + C + +E + + F+ K + + V
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELLGKN-----TFEFLKENNFQPY-----PLPHVR 126
Query: 461 GIVKGIL----YLHEDSRLRIIHRDLKASNVLL---DYDMNP----------------KI 497
+ + +LHE ++ H DLK N+L +++ ++
Sbjct: 127 HMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
+DFG A F + E +T + + Y PE +E ++ DV+S G +L E G
Sbjct: 184 ADFGSA-TF---DHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 35/170 (20%), Positives = 68/170 (40%), Gaps = 33/170 (19%)
Query: 362 LGQGGFGPVYKGVLSDGKEI------AVKRLSSCSEQGNAEFT-----NEVLLILKLQHK 410
+GQGGFG +Y ++ + + VK S + E + I K
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 411 NLVKLLGFC----------VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR--INI 458
+K LG + ++ + S L +++ + S++ + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRF---SRKTVLQL 157
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI--SDFGMARIF 506
I+ + Y+HE +H D+KASN+LL+Y ++ D+G+A +
Sbjct: 158 SLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 56/237 (23%), Positives = 90/237 (37%), Gaps = 70/237 (29%)
Query: 361 MLGQGGFGPVYKGV--LSDGKEIAVK---RLSSCSEQGNAEFTNEVLLILKLQ----HKN 411
LG+G FG V + + + G+ +AVK + E +E +VL L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEI--QVLEHLNTTDPNSTFR 78
Query: 412 LVKLLGF-------CVDGDEKLLVYEFMPNSSLDAILFDPRK----RGLLCWSKRINIVN 460
V++L + C +V+E + S +D K R++ +
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFELLGLS-----TYDFIKENGFLPF-----RLDHIR 121
Query: 461 GIVKGIL----YLHEDSRLRIIHRDLKASNVLL---DYDMNP----------------KI 497
+ I +LH ++ H DLK N+L DY K+
Sbjct: 122 KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG 554
DFG A + + E + + +V T Y APE + +S DV+S G +LIE G
Sbjct: 179 VDFGSA-TY---DDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 52/241 (21%), Positives = 92/241 (38%), Gaps = 74/241 (30%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVK---RLSSCSEQGNAEFTNEVLLILKLQH---KNLV 413
+G G FG V + + K AVK + + E ++L ++ N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEA--DILKKIQNDDINNNNIV 99
Query: 414 KLLGF-------CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRI--------NI 458
K G C L++E + S L++ ++ +
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGPS-----LYE-----IITRNNYNGFHIEDIKLY 142
Query: 459 VNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNP-------------------- 495
I+K + YL + + + H DLK N+LL ++ +
Sbjct: 143 CIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 496 --KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553
K+ DFG A F + + + + I+ T Y APE + + + SD++SFG +L E+ T
Sbjct: 200 GIKLIDFGCA-TF---KSDYHGS-IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
Query: 554 G 554
G
Sbjct: 255 G 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 29/167 (17%), Positives = 62/167 (37%), Gaps = 30/167 (17%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV------- 413
+G GGFG +Y + ++ A + Q N +E+ ++ K+ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 414 --------KLLGF----CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG 461
G + +V E + L I + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKST---VLQLGIR 159
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI--SDFGMARIF 506
++ + Y+HE+ +H D+KA+N+LL Y ++ +D+G++ +
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.92 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.91 | |
| 3a2e_A | 108 | Ginkbilobin-2; domain 26 unknown function (DUF26), | 99.9 | |
| 2e79_A | 108 | Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.88 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.34 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.75 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.26 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.1 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.0 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.85 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.83 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.17 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.03 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.93 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.03 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 81.61 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.96 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 80.53 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=438.67 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=212.4
Q ss_pred CCCCcccccCCCCcccEEEEEec------CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667789999999999999863 467899999988777777889999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCC----------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEE
Q 005893 428 VYEFMPNSSLDAILFDP----------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI 497 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 497 (671)
||||+++|+|.++|... .....++|.++++|+.||++||.|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999642 23456999999999999999999999988 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHH
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
+|||+++.....+.........||+.|||||++.++.|+.++|||||||++|||+| |+.||... ...+...
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~--------~~~~~~~ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL--------SNNEVIE 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--------CHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------CHHHHHH
Confidence 99999987655444334445679999999999999999999999999999999999 89999532 1222222
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
....+...+ ....+++ .+.+++.+||+.||++|||++||+++|++.
T Consensus 242 -~i~~~~~~~-----~p~~~~~----~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 242 -CITQGRVLQ-----RPRTCPQ----EVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp -HHHHTCCCC-----CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHcCCCCC-----CCccchH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222332211 1223343 366788899999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=440.44 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=205.6
Q ss_pred CCCCcccccCCCCcccEEEEEec------CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+.+|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 44566788999999999999864 477899999998777777889999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCC------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 428 VYEFMPNSSLDAILFDPR------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
||||+++|+|.+++.... ....++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999986532 2346999999999999999999999988 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~ 574 (671)
||+|||+++.....+.........||+.|||||++.+..++.++|||||||++|||+| |+.||... ...+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~--------~~~~~ 269 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL--------SNTEA 269 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS--------CHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC--------CHHHH
Confidence 9999999997755544444455689999999999999999999999999999999999 89998532 12222
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
. .....+... .....+++ .+.+++.+||+.||++|||++||+++|+...
T Consensus 270 ~-~~i~~g~~~-----~~p~~~~~----~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 270 I-DCITQGREL-----ERPRACPP----EVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp H-HHHHHTCCC-----CCCTTCCH----HHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred H-HHHHcCCCC-----CCcccccH----HHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 2 222222211 12233443 3667888999999999999999999998643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=434.85 Aligned_cols=266 Identities=28% Similarity=0.420 Sum_probs=204.0
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccc--cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSS--CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
..+++...++||+|+||+||+|++.+ .||||+++. ......+.|.+|+.++++++|||||+++|++.+ +..+|||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 34567778999999999999998753 699999874 334456789999999999999999999998864 5689999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.++|.. ....++|.+++.|+.|||.||+|||+++ ||||||||+||||++++++||+|||+++.....
T Consensus 111 Ey~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999964 3356999999999999999999999988 999999999999999999999999999876554
Q ss_pred CCccccccccccCCccchhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAME---GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
.........+||+.|||||++.. ++|+.++|||||||++|||+||+.||.... ... ........+....
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-------~~~-~~~~~~~~~~~~p 257 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-------NRD-QIIFMVGRGYASP 257 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHH-HHHHHHHTTCCCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-------hHH-HHHHHHhcCCCCC
Confidence 43334455789999999999863 468999999999999999999999995321 111 1222222221111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQ 638 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~ 638 (671)
.+ +.+...+++ .+.+++.+||+.||++||||.||++.|+...-+++.
T Consensus 258 ~~-~~~~~~~~~----~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 258 DL-SKLYKNCPK----AMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp CS-TTSCTTSCH----HHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred Cc-ccccccchH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 11 112223333 366788899999999999999999998765444443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-53 Score=435.79 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=208.9
Q ss_pred CCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
++..++||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445678999999999999862 46789999997543 34456899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 429 YEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
||||++|+|.++|.... ....++|.++++|+.|||+||+|||+++ ||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 99999999999996432 1346999999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~ 574 (671)
||+|||+++.....+.........||+.|||||++.++.++.++|||||||++|||+| |+.||... ...+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~--------~~~~~ 256 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY--------SNQDV 256 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--------CHHHH
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------CHHHH
Confidence 9999999987655444444455689999999999999999999999999999999999 89998532 11222
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
. .....+.... ....+++ .+.+++.+||+.||++|||++||++.|+.
T Consensus 257 ~-~~i~~~~~~~-----~p~~~~~----~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 257 V-EMIRNRQVLP-----CPDDCPA----WVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp H-HHHHTTCCCC-----CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H-HHHHcCCCCC-----CcccchH----HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 2 2223332221 1233443 36788889999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-51 Score=428.66 Aligned_cols=268 Identities=28% Similarity=0.399 Sum_probs=217.1
Q ss_pred echhhHHHHhCCCCcccccCCCCcccEEEEEecC------CceEEEEEccccc-hhchHHHHHHHHHHhhcCC-CCeeeE
Q 005893 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSD------GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQH-KNLVKL 415 (671)
Q Consensus 344 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l 415 (671)
++..++++..++|+..+.||+|+||+||+|.+.. ++.||||+++... ....+.|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3445566777889999999999999999998642 3579999997643 3445679999999999965 999999
Q ss_pred eeEEEcC-CeeeEEEeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecC
Q 005893 416 LGFCVDG-DEKLLVYEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481 (671)
Q Consensus 416 ~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~D 481 (671)
+|+|.+. +..+||||||++|+|.++|...+ ....++|.+++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 56899999999999999996422 1345899999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 005893 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGF 560 (671)
Q Consensus 482 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~ 560 (671)
|||+|||+++++.+||+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998766555545556789999999999999999999999999999999998 9999953
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 561 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
... .....+....+... .....+++ .+.+++.+||+.||++|||++||++.|+.
T Consensus 291 ~~~--------~~~~~~~i~~g~~~-----~~p~~~~~----~~~~li~~c~~~dP~~RPt~~eil~~L~~ 344 (353)
T 4ase_A 291 VKI--------DEEFCRRLKEGTRM-----RAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGN 344 (353)
T ss_dssp CCC--------SHHHHHHHHHTCCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCH--------HHHHHHHHHcCCCC-----CCCccCCH----HHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 221 11222333333221 12233343 36678889999999999999999998865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=421.70 Aligned_cols=250 Identities=21% Similarity=0.330 Sum_probs=201.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|++.+.||+|+||+||+++.. +|+.||||++... .....+.+.+|+.++++|+|||||++++++.+++..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999964 6899999998643 34456679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++|+|.++|.. ++...+++.+++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999853 33456789999999999999999999998 9999999999999999999999999998753221
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.. .+..+...+.... ...
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~--------~~~~~~~~~i~~~-~~~----- 243 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA--------GSMKNLVLKIISG-SFP----- 243 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHT-CCC-----
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC--------cCHHHHHHHHHcC-CCC-----
Confidence 122346899999999999999999999999999999999999999953 2333333333322 211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+...++++ +.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~s~~----~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 PVSLHYSYD----LRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCTTSCHH----HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccCCHH----HHHHHHHHccCChhHCcCHHHHhc
Confidence 122233433 667777999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=418.31 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=205.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
..|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45778899999999999999975 68999999997655555667899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++.. +.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+......
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999843 45999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||... +..+..... ..+.....-.
T Consensus 227 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i-~~~~~~~~~~--- 292 (346)
T 4fih_A 227 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMI-RDNLPPRLKN--- 292 (346)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHH-HHSSCCCCSC---
T ss_pred --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHH-HcCCCCCCCc---
Confidence 33468999999999999999999999999999999999999999532 222222222 2211111100
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+++ .+.+++.+||+.||++|||+.|+++
T Consensus 293 ~~~~s~----~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSP----SLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCH----HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 012233 3567777999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=412.33 Aligned_cols=247 Identities=25% Similarity=0.304 Sum_probs=207.3
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||+||+++. .+|+.||||++.+. .......+.+|+.++++++|||||++++++.+++..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4688899999999999999996 46899999999742 2334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. +.+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999994 4567999999999999999999999998 999999999999999999999999999987654
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.........+||+.|||||++.+..|+.++||||+||++|||++|+.||... +......+.. .+..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i~-~~~~----- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEGLIFAKII-KLEY----- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHH-HTCC-----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHH-cCCC-----
Confidence 4444445579999999999999999999999999999999999999999532 2222222222 2221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev 625 (671)
.+....+++ +.+++.+||+.||++|||++|+
T Consensus 252 -~~p~~~s~~----~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 252 -DFPEKFFPK----ARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp -CCCTTCCHH----HHHHHHHHSCSSGGGSTTSGGG
T ss_pred -CCCcccCHH----HHHHHHHHccCCHhHCcChHHH
Confidence 122334443 5677779999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=414.02 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=199.7
Q ss_pred CCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC----eeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~e 430 (671)
+|...++||+|+||+||+|++ +|+.||||+++..... ...++.|+..+.+++|||||+++|++.+.+ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 456678999999999999998 6899999999754322 223445666777899999999999998654 5789999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-----CCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED-----SRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
|+++|+|.++|.. ..++|..+++++.|++.||+|||++ ..++|+||||||+||||++++++||+|||+++.
T Consensus 82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 9999999999953 4589999999999999999999986 123599999999999999999999999999987
Q ss_pred ccCCCCcc--ccccccccCCccchhhhccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCC------CCH
Q 005893 506 FAGSEGEV--NTARIVGTYGYMAPEYAMEG------LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATA------PNL 571 (671)
Q Consensus 506 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~------~~l 571 (671)
........ .....+||+.|||||++.+. .++.++|||||||++|||+||+.|+.......... ...
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 65543322 22346899999999998654 46789999999999999999988775322211010 011
Q ss_pred HHHHHHHHhcCCccccccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 572 LAYAWHLWNEGNALDLIDPLLTDTC-SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+....+ .+++.+.... +.+....+.+++.+||+.||++||||.||++.|+.
T Consensus 238 ~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 294 (303)
T 3hmm_A 238 VEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 11112222111 1222222211 23455678899999999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=417.04 Aligned_cols=252 Identities=22% Similarity=0.273 Sum_probs=201.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+.|...++||+|+||.||+++.. +|+.||||+++.... ..+|+.++++++|||||++++++.+++..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999974 689999999975322 246999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccccCCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIFAGSEG 511 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~ 511 (671)
++|+|.++|. ..+.+++..+..++.||+.||+|||+++ |+||||||+||||+.++ ++||+|||+++.+.....
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999994 3456999999999999999999999998 99999999999999987 699999999997654322
Q ss_pred c---cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 512 E---VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 512 ~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||..... ..+.. +.........
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~---~i~~~~~~~~-- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-----GPLCL---KIASEPPPIR-- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-----SCCHH---HHHHSCCGGG--
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----HHHHH---HHHcCCCCch--
Confidence 1 122346899999999999999999999999999999999999999964321 12222 1122221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.+...++++ +.+++.+||+.||++|||+.||++.|...
T Consensus 277 --~~~~~~s~~----~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 --EIPPSCAPL----TAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --GSCTTSCHH----HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hcCccCCHH----HHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 122334433 56777799999999999999999887653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=403.42 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=195.8
Q ss_pred CcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----CCeeeEEE
Q 005893 357 SDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVY 429 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 429 (671)
+..++||+|+||+||+|... ++..||+|++... .....+.|.+|+.++++++|||||++++++.+ +...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999974 5889999998642 34445679999999999999999999999875 34578999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~ 508 (671)
||+++|+|.+++. ..+.+++..+..|+.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+++....
T Consensus 109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999994 3467999999999999999999999875 35999999999999984 79999999999986432
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
. .....+||+.|||||++. +.|+.++|||||||++|||+||+.||... .+... ..+....+....
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~-------~~~~~-~~~~i~~~~~~~-- 249 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQ-IYRRVTSGVKPA-- 249 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHH-HHHHHTTTCCCG--
T ss_pred C----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCC-------CcHHH-HHHHHHcCCCCC--
Confidence 2 223468999999999875 56999999999999999999999999522 12222 222233322211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+....+++ +.+++.+||+.||++|||++|+++
T Consensus 250 --~~~~~~~~~----~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 --SFDKVAIPE----VKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGCCCHH----HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHH----HHHHHHHHccCChhHCcCHHHHhc
Confidence 122223333 567778999999999999999985
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=419.36 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=206.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46888899999999999999974 68999999997655556667899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++.. +.+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++.+......
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999842 35999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||... +..+..... ........- .
T Consensus 304 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------~~~~~~~~i-~~~~~~~~~---~ 369 (423)
T 4fie_A 304 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--------PPLKAMKMI-RDNLPPRLK---N 369 (423)
T ss_dssp --BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHH-HHSCCCCCS---C
T ss_pred --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHH-HcCCCCCCc---c
Confidence 33468999999999999999999999999999999999999999522 222222222 221111110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...++++ +.+++.+||+.||++|||+.|+++
T Consensus 370 ~~~~s~~----~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPS----LKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHH----HHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHH----HHHHHHHHcCCChhHCcCHHHHhc
Confidence 1123333 567777999999999999999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=394.15 Aligned_cols=245 Identities=24% Similarity=0.376 Sum_probs=189.1
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||+||+++. .+|+.||||++++. .......+.+|+.++++++|||||++++++.+++..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999996 46899999999643 2233557899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+ +|+|.+++. .++.+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 678888884 3456999999999999999999999998 999999999999999999999999999875433
Q ss_pred CCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
. .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||... +...... ....+..
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~-~i~~~~~---- 229 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFK-NISNGVY---- 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHH-HHHHTCC----
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHH-HHHcCCC----
Confidence 2 1234689999999999988776 57999999999999999999999532 2222222 2222221
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+....+++ +.+++.+||+.||++|||++|+++
T Consensus 230 --~~p~~~s~~----~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 --TLPKFLSPG----AAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCCTTSCHH----HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCHH----HHHHHHHHccCChhHCcCHHHHHc
Confidence 122233433 567777999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=403.54 Aligned_cols=247 Identities=23% Similarity=0.275 Sum_probs=195.0
Q ss_pred CCCCcccccCCCCcccEEEEEec----CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
++|++.+.||+|+||+||+++.. +++.||||+++... ......+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46888999999999999999852 46789999997532 2334468899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++|+|.+++. +.+.+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999984 3457999999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
..... ....+||+.|||||++.+..|+.++|||||||++|||+||+.||... +..+....... +..
T Consensus 178 ~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~-~~~--- 243 (304)
T 3ubd_A 178 DHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--------DRKETMTMILK-AKL--- 243 (304)
T ss_dssp ---CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-CCC---
T ss_pred CCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc--------CHHHHHHHHHc-CCC---
Confidence 33222 23468999999999999999999999999999999999999999532 22232222222 211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
.+....+++ +.+++.+||+.||++||| ++|+++
T Consensus 244 ---~~p~~~s~~----~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 ---GMPQFLSPE----AQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CCCTTSCHH----HHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCCCcCCHH----HHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 122334443 567777999999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=395.34 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=187.4
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC---------
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD--------- 423 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--------- 423 (671)
+|++.+.||+|+||+||+++.. +|+.||||+++.. .+...+.+.+|+.++++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888899999999999999964 6899999998743 3344567899999999999999999999987544
Q ss_pred ---eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 424 ---EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 424 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
..++||||+++|+|.+++.........++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccC
Confidence 36899999999999999965444445677788999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCcc----------ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005893 501 GMARIFAGSEGEV----------NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570 (671)
Q Consensus 501 gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~ 570 (671)
|+++......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||... .+
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~~ 232 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------ME 232 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------HH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------cH
Confidence 9998765432211 1223589999999999999999999999999999999996 65311 01
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... ............ ..+....+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~-~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 RVRT-LTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 111122111110 1112223567888999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=385.32 Aligned_cols=285 Identities=36% Similarity=0.632 Sum_probs=245.4
Q ss_pred eechhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 343 YIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 343 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
.+++.++...+++|+..+.||+|+||.||+|+..+++.||||++..........+.+|+.++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 44556667788999999999999999999999888999999999876666677899999999999999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999986533 2345999999999999999999999988 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
+++...............||+.|+|||.+.++.++.++||||||+++|||++|+.||...... .......+.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 262 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNN 262 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhcccc
Confidence 998654433322333457899999999999999999999999999999999999999754433 345566666666667
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+.....+++.+.....++....+.+++.+||+.||++|||+.||++.|+..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 777778888877778888889999999999999999999999999999853
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=384.93 Aligned_cols=293 Identities=40% Similarity=0.667 Sum_probs=248.7
Q ss_pred ceechhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccch-hchHHHHHHHHHHhhcCCCCeeeEeeEEE
Q 005893 342 FYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKLLGFCV 420 (671)
Q Consensus 342 ~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 420 (671)
..+++.++....++|+..+.||+|+||.||++...+|+.||||++..... .....+.+|+.++.+++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 35678899999999999999999999999999988899999999975432 23336899999999999999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
.....++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+...++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999996543 344599999999999999999999998222399999999999999999999999
Q ss_pred ccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 500 FGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 500 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............+..+.....
T Consensus 178 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999876543322 223356999999999999999999999999999999999999999643333334556667766666
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCC
Q 005893 580 NEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETIT 635 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~ 635 (671)
.........+..+......+....+.+++.+||+.||++|||++||+++|++....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 67777778888888888889999999999999999999999999999999875433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=386.25 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=197.1
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC------Ce
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG------DE 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 424 (671)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .......+.+|+.+|++++|||||++++++... ..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5788999999999999999997 46999999999753 233455788999999999999999999997643 56
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.+|||||++ |+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 799999996 77888883 4567999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCC--ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 505 IFAGSEG--EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 505 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
.+..... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.... ..............
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-----~~~~l~~I~~~~g~ 281 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-----YVHQLQLIMMVLGT 281 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-----HHHHHHHHHHHHCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHhcCC
Confidence 7644321 1223346899999999998775 56999999999999999999999995321 11111111111111
Q ss_pred CCcccccc---------------c-------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDLID---------------P-------LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~~d---------------~-------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... +... + .+....++ .+.+++.+||+.||++|||+.|+++
T Consensus 282 p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 282 PSP-AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADR----QALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCG-GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCh-HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCH----HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 110 0000 0 00011222 3667888999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=372.00 Aligned_cols=197 Identities=23% Similarity=0.336 Sum_probs=169.3
Q ss_pred HhCCCCcccccCCCCcccEEEEEec----CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 426 (671)
..+.|++.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+.++..+ +|||||++++++.+.+..+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4577999999999999999999853 46789999987543 345678999999998 6999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeecccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARI 505 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~ 505 (671)
+||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999882 3899999999999999999999998 9999999999999877 7999999999986
Q ss_pred ccCCCCc--------------------------cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCC
Q 005893 506 FAGSEGE--------------------------VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNT 558 (671)
Q Consensus 506 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~ 558 (671)
....... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 5432211 011235799999999999775 5899999999999999999999998
Q ss_pred C
Q 005893 559 G 559 (671)
Q Consensus 559 ~ 559 (671)
.
T Consensus 248 ~ 248 (361)
T 4f9c_A 248 Y 248 (361)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=394.02 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=207.3
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|++.+.||+|+||.||+++.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+....+|||||+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57899999999999999999974 68999999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC--CCeEEeeccccccccCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD--MNPKISDFGMARIFAGSE 510 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~ 510 (671)
++|+|.++|.. ..+.+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999998843 3456999999999999999999999998 9999999999999854 899999999999875433
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||... +..+..... ...... +..
T Consensus 312 ~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~--------~~~~~~~~i-~~~~~~--~~~ 377 (573)
T 3uto_A 312 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNV-KSCDWN--MDD 377 (573)
T ss_dssp E---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHH-HTTCCC--CCS
T ss_pred c---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------CHHHHHHHH-HhCCCC--CCc
Confidence 2 23458999999999999999999999999999999999999999532 222222222 221110 111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.....++++ +.+++.+||+.||++|||+.|+++
T Consensus 378 ~~~~~~s~~----~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGISED----GKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSCHH----HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHH----HHHHHHHHccCChhHCcCHHHHhc
Confidence 111233333 567777999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=389.30 Aligned_cols=248 Identities=26% Similarity=0.319 Sum_probs=197.3
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHH---HHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFT---NEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~---~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
++|++.++||+|+||+||+++.. +|+.||||++++.. ......+. .++.++..++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57889999999999999999974 68999999996421 12222333 3456667789999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
|||||++||+|..+|. ..+.+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+++.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999994 3466999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.... ....+||+.|||||++.. ..|+.++|||||||++|||++|+.||..... .+......... ...
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-----~~~~~i~~~i~-~~~-- 410 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTL-TMA-- 410 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-----CCHHHHHHHHH-HCC--
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhhc-CCC--
Confidence 5432 234689999999999975 4799999999999999999999999953221 12222221221 111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
..+...++++ +.+++.+||+.||++|++ ++||.+
T Consensus 411 ----~~~p~~~S~~----a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 ----VELPDSFSPE----LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----CCCCTTSCHH----HHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----CCCCccCCHH----HHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1122334443 567777999999999998 677764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=355.51 Aligned_cols=281 Identities=38% Similarity=0.583 Sum_probs=229.0
Q ss_pred ceechhhHHHHhCCCCcc------cccCCCCcccEEEEEecCCceEEEEEcccc----chhchHHHHHHHHHHhhcCCCC
Q 005893 342 FYIDLETLDVATSNFSDS------NMLGQGGFGPVYKGVLSDGKEIAVKRLSSC----SEQGNAEFTNEVLLILKLQHKN 411 (671)
Q Consensus 342 ~~~~~~~l~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~n 411 (671)
..++++++...+++|... +.||+|+||.||+|.. +++.||||++... .......+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 456788899999999887 8999999999999987 6889999998642 2334567899999999999999
Q ss_pred eeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC
Q 005893 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY 491 (671)
Q Consensus 412 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 491 (671)
|+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+||++++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence 99999999999999999999999999999876555667999999999999999999999998 999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCH
Q 005893 492 DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571 (671)
Q Consensus 492 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l 571 (671)
++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... ..+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~ 243 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----QLL 243 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----SBT
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----HHH
Confidence 99999999999987654433333444678999999998754 5899999999999999999999999754322 122
Q ss_pred HHHHHHHHhc-CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 572 LAYAWHLWNE-GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 572 ~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
..+....... ....+.+++.+ ...+......+.+++..||+.||++|||+.||++.|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 2222222211 22233444444 234566677888999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=360.55 Aligned_cols=269 Identities=26% Similarity=0.415 Sum_probs=204.7
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
..+.+..++|++.+.||+|+||.||+++. +|+.||||++.... ......+.+|+.++++++||||+++++++.+...
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 34445567788899999999999999987 68899999987533 3445678999999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||+++|+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 9999999999999999965433345999999999999999999999875 349999999999999999999999999997
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..............
T Consensus 188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~ 257 (309)
T 3p86_A 188 LKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------PAQVVAAVGFKCKR 257 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------HHHHHHHHHHSCCC
T ss_pred cccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcCCC
Confidence 543322 12234578999999999999999999999999999999999999995321 12222111111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
..+...+++ .+.+++.+||+.||++|||+.||++.|+......
T Consensus 258 -----~~~~~~~~~----~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 258 -----LEIPRNLNP----QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp -----CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred -----CCCCccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 112223333 3667888999999999999999999998764433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=368.00 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=210.1
Q ss_pred HhCCCCcccccCCCCcccEEEEEec--------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS--------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD 421 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 421 (671)
..++|...+.||+|+||.||++... ++..||||+++.. .......+.+|+.+++++ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3467888899999999999999852 3457999999754 334556799999999999 89999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCCC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEE
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPRK-------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIl 488 (671)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999864321 245899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGAT 567 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 567 (671)
++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~----- 310 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----- 310 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence 99999999999999987655443333444567889999999999999999999999999999999 999986422
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
...+.. ....+... .....++. .+.+++.+||+.||++||++.||++.|+..
T Consensus 311 ~~~~~~----~~~~~~~~-----~~~~~~~~----~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 311 VEELFK----LLKEGHRM-----DKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp GGGHHH----HHHTTCCC-----CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHH----HHhcCCCC-----CCCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 112222 12222111 11222333 366788899999999999999999999753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.78 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=211.7
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|...+.||+|+||.||++... +++.||+|++..........+.+|+.++++++||||+++++++.++...++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 356777899999999999999974 6889999999877777778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999854 2456999999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccc------------cccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCC-CCHHHHHHHH
Q 005893 512 EVN------------TARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATA-PNLLAYAWHL 578 (671)
Q Consensus 512 ~~~------------~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~-~~l~~~~~~~ 578 (671)
... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.......... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~---- 239 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF---- 239 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----
Confidence 111 113579999999999999999999999999999999999999986543321111 111111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCC
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETIT 635 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~ 635 (671)
.+......+++ .+.+++.+||+.||++|||+.||++.|+.....
T Consensus 240 ---------~~~~~~~~~~~----~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 240 ---------LDRYCPPNCPP----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---------HHHTCCTTCCT----THHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------ccccCCCCCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111222232 366788899999999999999999999876433
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.56 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=205.7
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|+..+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35788899999999999999996 56899999999765555667789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999843 35899999999999999999999998 99999999999999999999999999987654332
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||... +...........+..... .
T Consensus 172 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~~~~~~~~~~~-~-- 238 (297)
T 3fxz_A 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGTPELQ-N-- 238 (297)
T ss_dssp C--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHHCSCCCS-C--
T ss_pred c--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhCCCCCCC-C--
Confidence 2 23457999999999999999999999999999999999999999532 222222222222211110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 239 -~~~~~----~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 -PEKLS----AIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp -GGGSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccccC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11122 23667788999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=350.95 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=209.3
Q ss_pred echhhHHHHhCC----------CCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCe
Q 005893 344 IDLETLDVATSN----------FSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL 412 (671)
Q Consensus 344 ~~~~~l~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni 412 (671)
++.+++..+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 455666655543 566778999999999999976 799999999987666667789999999999999999
Q ss_pred eeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC
Q 005893 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD 492 (671)
Q Consensus 413 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 492 (671)
+++++++...+..++||||+++++|.+++. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.+
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD 177 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence 999999999999999999999999999984 235899999999999999999999998 9999999999999999
Q ss_pred CCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHH
Q 005893 493 MNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLL 572 (671)
Q Consensus 493 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~ 572 (671)
+.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ...
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~--------~~~ 247 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD--------SPV 247 (321)
T ss_dssp CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHH
T ss_pred CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHH
Confidence 9999999999987644322 223457999999999999999999999999999999999999998532 112
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 573 AYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..... ........... ....++ .+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~-~~~~~~~~~~~---~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 248 QAMKR-LRDSPPPKLKN---SHKVSP----VLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHH-HHHSSCCCCTT---GGGSCH----HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHH-HhcCCCCCcCc---cccCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence 22212 22211111100 011222 3667777999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=359.64 Aligned_cols=268 Identities=24% Similarity=0.331 Sum_probs=206.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC----eeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 427 (671)
..++|+..++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.... ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3467888999999999999999885 7899999997543 33345667899999999999999999998754 3689
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC----------CCCceeecCCCCCcEEEcCCCCeEE
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED----------SRLRIIHRDLKASNVLLDYDMNPKI 497 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~----------~~~~ivH~Dlkp~NIll~~~~~~kl 497 (671)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 9999999999999843 3499999999999999999999988 6 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCC-----
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-----GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT----- 567 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~----- 567 (671)
+|||+++...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987665444333444689999999999876 35667899999999999999999998643322100
Q ss_pred ---CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 568 ---APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 568 ---~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
........ ...........+..... .......+.+++.+||+.||++|||+.||++.|+..
T Consensus 253 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 253 IGQHPSLEDMQ-EVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp HCSSCCHHHHH-HHHTTSCCCCCCCGGGG---SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCCchhhhh-hhhhcccCCCCcccccc---ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111111 11111111111111111 123445688888999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.39 Aligned_cols=269 Identities=28% Similarity=0.412 Sum_probs=214.6
Q ss_pred eechhhHHHHhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeee
Q 005893 343 YIDLETLDVATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVK 414 (671)
Q Consensus 343 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~ 414 (671)
.++...++...++|+..+.||+|+||.||++.+ .+++.||||+++.. .......+.+|+.++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 345566677788999999999999999999984 24578999999763 334456799999999999 8999999
Q ss_pred EeeEEEcCCe-eeEEEeccCCCchhhhhcCCCC-----------------------------------------------
Q 005893 415 LLGFCVDGDE-KLLVYEFMPNSSLDAILFDPRK----------------------------------------------- 446 (671)
Q Consensus 415 l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 446 (671)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987654 8899999999999999965332
Q ss_pred ----------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 447 ----------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 447 ----------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122899999999999999999999998 9999999999999999999999999998765544
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.........||+.|+|||++.+..++.++||||||+++|||++ |+.||...... .........+....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~~--- 316 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEGTRMR--- 316 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--------HHHHHHHHHTCCCC---
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--------HHHHHHHHcCCCCC---
Confidence 4444445678999999999999999999999999999999998 99998543211 11222222222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....++ .+.+++..||+.||++|||+.||++.|+.
T Consensus 317 --~~~~~~~----~l~~li~~~l~~dP~~Rps~~ell~~L~~ 352 (359)
T 3vhe_A 317 --APDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGN 352 (359)
T ss_dssp --CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCH----HHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 1122333 36678889999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=365.20 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=195.6
Q ss_pred HhCCCCcccccCCCCcccEEEEEec----CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
..++|++.+.||+|+||.||+|+.. ++..||||+++.. .......+.+|+.++.+++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3467889999999999999999864 4678999999754 3445567999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999953 3446999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 507 AGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 507 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
....... ......+++.|+|||.+....++.++||||||+++|||++ |+.||.... ..... .....+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------~~~~~-~~i~~~~~ 268 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------NQDVI-KAVDEGYR 268 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------HHHHH-HHHHTTEE
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHcCCC
Confidence 5432221 1222345778999999999999999999999999999998 999985321 11111 11111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
......++ ..+.+++.+||+.||++||++.||+++|+..
T Consensus 269 -----~~~~~~~~----~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 -----LPPPMDCP----AALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -----CCCCTTCB----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCcccc----HHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 00111222 3477888899999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.52 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=205.2
Q ss_pred hCCCCcccccCCCCcccEEEEEec----CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.++|.+.+.||+|+||.||+|.+. .+..||||+++.. .......+.+|+.++++++||||+++++++.+....++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456888899999999999999974 3446999999764 34455679999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999853 3356999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 508 GSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 508 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.... ....... ...+..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------~~~~~~~-~~~~~~- 272 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------NRDVISS-VEEGYR- 272 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHH-HHTTCC-
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------HHHHHHH-HHcCCC-
Confidence 432221 2223456788999999998999999999999999999999 999985321 1122111 122111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
......+++ .+.+++..||+.||++|||+.||+++|+..
T Consensus 273 ----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 273 ----LPAPMGCPH----ALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp ----CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCcCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111122333 366788899999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=351.40 Aligned_cols=247 Identities=26% Similarity=0.361 Sum_probs=203.3
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.++|...+.||+|+||.||++.. .+|+.||||++... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 35688899999999999999997 57899999998653 3344567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999843 356899999999999999999999998 999999999999999999999999999866443
Q ss_pred CCccccccccccCCccchhhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYS-IKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
. .....+||+.|+|||++.+..+. .++||||||+++|||++|+.||... +.......... +..
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~-~~~---- 231 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--------NLKELRERVLR-GKY---- 231 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-CCC----
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHh-CCC----
Confidence 2 23346899999999999888765 8999999999999999999999532 22332222222 211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+....++ .+.+++.+||+.||++|||++|+++
T Consensus 232 --~~p~~~s~----~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 --RIPFYMST----DCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCCTTSCH----HHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCCCCH----HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11122233 3567778999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=358.95 Aligned_cols=255 Identities=27% Similarity=0.497 Sum_probs=197.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCce----EEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKE----IAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
.++|+..+.||+|+||.||+|++. +++. ||+|.++.. .......+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 356888899999999999999964 4443 588888643 3345668999999999999999999999998754 78
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+|+||+++|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999854 3456999999999999999999999998 999999999999999999999999999877
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.. ....+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~----~~~~~~~~ 238 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISS----ILEKGERL 238 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHH----HHHTTCCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHH----HHHcCCCC
Confidence 65544433444567889999999999999999999999999999999 9999864321 12221 11121111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
. .....+ ..+.+++.+||+.||++||++.||++.|+.
T Consensus 239 ~-----~~~~~~----~~~~~li~~~l~~~p~~Rps~~ell~~l~~ 275 (327)
T 3poz_A 239 P-----QPPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSK 275 (327)
T ss_dssp C-----CCTTBC----HHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred C-----CCccCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 0 111222 347788889999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=370.64 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=206.6
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
...++|...+.||+|+||.||+|.+. +++.||||+++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34466788899999999999999986 68899999997543 23344688999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999853 2345899999999999999999999998 99999999999999999999999999986433
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
...........+++.|+|||.+..+.++.++||||||+++|||++ |+.||.... ..+ .......+...
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~--------~~~-~~~~~~~~~~~-- 334 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS--------NQQ-TREFVEKGGRL-- 334 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC--------HHH-HHHHHHTTCCC--
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHH-HHHHHHcCCCC--
Confidence 221111122345778999999999999999999999999999998 999985321 111 11222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....+++ .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 335 ---~~~~~~~~----~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 335 ---PCPELCPD----AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ---CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCH----HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11122332 366778899999999999999999999753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=354.71 Aligned_cols=268 Identities=27% Similarity=0.410 Sum_probs=213.7
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEE
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFC 419 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 419 (671)
..+....++|+..+.||+|+||.||++... +++.||||+++... ......+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344556788999999999999999999974 34789999997643 33456789999999999999999999999
Q ss_pred EcCCeeeEEEeccCCCchhhhhcCCCC---------------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCcee
Q 005893 420 VDGDEKLLVYEFMPNSSLDAILFDPRK---------------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478 (671)
Q Consensus 420 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~iv 478 (671)
.+.+..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ |+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 999999999999999999999864221 256999999999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCC
Q 005893 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRN 557 (671)
Q Consensus 479 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p 557 (671)
||||||+|||++.++.+||+|||+++...............+|+.|+|||.+....++.++||||||+++|||++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999986544332222334577899999999999999999999999999999999 9999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCC
Q 005893 558 TGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETIT 635 (671)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~ 635 (671)
|... ...... .....+... .+...+++ .+.+++.+||+.||++||++.||++.|+.....
T Consensus 277 ~~~~--------~~~~~~-~~~~~~~~~-----~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 277 YYGM--------AHEEVI-YYVRDGNIL-----ACPENCPL----ELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTS--------CHHHHH-HHHHTTCCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCC--------ChHHHH-HHHhCCCcC-----CCCCCCCH----HHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 8532 112222 222222221 11223333 366788899999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=353.51 Aligned_cols=261 Identities=30% Similarity=0.441 Sum_probs=211.0
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
+...++|.+.+.||+|+||.||++.. .+++.||||+++.. .......+.+|+.++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34556788899999999999999985 24578999999753 334456789999999999999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCC---------------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecC
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRK---------------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~D 481 (671)
+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence 999999999999999999865332 234899999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 005893 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGF 560 (671)
Q Consensus 482 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~ 560 (671)
|||+||++++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987655444333344567889999999999999999999999999999999 9999854
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 561 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
... ..+. .....+... .....+++ .+.+++.+||+.||++||++.||++.|+.
T Consensus 256 ~~~-----~~~~----~~~~~~~~~-----~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 256 IPP-----ERLF----NLLKTGHRM-----ERPDNCSE----EMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp CCG-----GGHH----HHHHTTCCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCH-----HHHH----HHhhcCCcC-----CCCccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 321 1222 222222111 11223333 36678889999999999999999999975
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=357.14 Aligned_cols=259 Identities=30% Similarity=0.447 Sum_probs=207.1
Q ss_pred hCCCCcccccCCCCcccEEEEEec------CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
.++|...+.||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 456888899999999999999953 4668999999753 344556789999999999999999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCC----CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC---CeEEe
Q 005893 426 LLVYEFMPNSSLDAILFDPR----KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM---NPKIS 498 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 498 (671)
++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986432 2245899999999999999999999998 99999999999999554 59999
Q ss_pred eccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 499 DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 499 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||... ........
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~--------~~~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK--------SNQEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC--------CHHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHH
Confidence 9999986543333333344578899999999999999999999999999999998 99998532 12222222
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
. ..+... .....++. .+.+++.+||+.||++|||+.||++.|+..
T Consensus 299 i-~~~~~~-----~~~~~~~~----~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 299 V-TSGGRM-----DPPKNCPG----PVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp H-HTTCCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HcCCCC-----CCCccCCH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2 222111 11122333 366788899999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.60 Aligned_cols=254 Identities=29% Similarity=0.430 Sum_probs=206.4
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.++|+..+.||+|+||.||++...+++.||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35677889999999999999999888999999997643 23457899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 99999999853 3456899999999999999999999998 99999999999999999999999999986543221
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
.......+++.|+|||.+....++.++||||||+++|||++ |+.||.... ....... ...+. ...
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~-~~~~~-----~~~ 227 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVED-ISTGF-----RLY 227 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHH-HHTTC-----CCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHH-HhcCc-----cCC
Confidence 12223456778999999999999999999999999999999 999985321 1222211 11211 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....++ .+.+++..||+.||++|||+.|+++.|+.
T Consensus 228 ~~~~~~~----~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 228 KPRLAST----HVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp CCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCcCCH----HHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 1112222 36677889999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.67 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=204.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 457888999999999999999964 6889999998542 233456789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999984 3456999999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||... .......+....... . .
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--------~~~~~~~~~~~~~~~-~-~ 232 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE--------TAVSIAIKHIQDSVP-N-V 232 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS--------CHHHHHHHHHSSCCC-C-H
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhhccCC-C-c
Confidence 321 1233457999999999999999999999999999999999999999532 222222222222111 1 1
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhcCCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-TMSSVVVMLQGET 633 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-t~~ev~~~L~~~~ 633 (671)
...+....++ .+.+++.+|++.||++|| +++++.+.|+...
T Consensus 233 ~~~~~~~~~~----~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 233 TTDVRKDIPQ----SLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHSCTTSCH----HHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred chhcccCCCH----HHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 1112223333 366788899999999998 9999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.70 Aligned_cols=267 Identities=28% Similarity=0.387 Sum_probs=210.3
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEE
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCV 420 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 420 (671)
.+...++|...+.||+|+||.||++.. .++..||||++... .......+.+|+.++.++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 344567889999999999999999996 24568999999753 334456789999999999 8999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCC--------------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeec
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRK--------------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~ 480 (671)
..+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 99999999999999999999965332 134899999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCC
Q 005893 481 DLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTG 559 (671)
Q Consensus 481 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~ 559 (671)
||||+|||++.++.+||+|||++................||+.|+|||.+.++.++.++||||||+++|||+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999987655444333444577889999999999999999999999999999998 999985
Q ss_pred CCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCC
Q 005893 560 FNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETIT 635 (671)
Q Consensus 560 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~ 635 (671)
..... .........+.. .......++ .+.+++.+||+.||++|||+.||++.|+.....
T Consensus 277 ~~~~~--------~~~~~~~~~~~~-----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVD--------ANFYKLIQNGFK-----MDQPFYATE----EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCS--------HHHHHHHHTTCC-----CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcH--------HHHHHHHhcCCC-----CCCCCCCCH----HHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 43211 111222222211 111122232 366778899999999999999999999875433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.30 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=200.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch-hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57888999999999999999975 788999999864332 2335688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999984 3456999999999999999999999998 99999999999999999999999999987654333
Q ss_pred ccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... .... ..+...... ..+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~---~~~~~~~~~--~~~ 230 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQEY---SDWKEKKTY--LNP 230 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT-----SHHH---HHHHTTCTT--STT
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH-----HHHH---HHHhccccc--CCc
Confidence 333345689999999999987775 78999999999999999999999643211 1111 111111110 000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....++ .+.+++.+||+.||++|||+.|+++
T Consensus 231 --~~~~~~----~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 --WKKIDS----APLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp --GGGSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCH----HHHHHHHHHccCChhhCcCHHHHhh
Confidence 011222 3567788999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=367.05 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=209.3
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
+++..++|...+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 444566788889999999999999999888999999998643 35678999999999999999999999986 5678999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 261 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp ECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred EeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999999999532 2235889999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
... .......++..|+|||.+..+.++.++||||||+++|||++ |+.||.... ..+... ....+...
T Consensus 337 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~-~i~~~~~~-- 404 (454)
T 1qcf_A 337 NEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIR-ALERGYRM-- 404 (454)
T ss_dssp HHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHH-HHHHTCCC--
T ss_pred Cce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHH-HHHcCCCC--
Confidence 211 11222356788999999999999999999999999999999 999985321 112111 12222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCC
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETI 634 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~ 634 (671)
.....+++ .+.+++.+||+.||++|||+++|+++|+....
T Consensus 405 ---~~~~~~~~----~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 405 ---PRPENCPE----ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp ---CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred ---CCCCCCCH----HHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11123333 36678889999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=363.92 Aligned_cols=266 Identities=28% Similarity=0.395 Sum_probs=213.9
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec--------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS--------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCV 420 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 420 (671)
...++|...+.||+|+||.||++... ++..||||+++.. .......+.+|+.+++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34567888999999999999999852 2357999999754 344456789999999999 9999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcE
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRK-------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NI 487 (671)
..+..++||||+++|+|.+++..... ...+++..++.|+.||+.||.|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999864321 245999999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005893 488 LLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGA 566 (671)
Q Consensus 488 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 566 (671)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~----- 297 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----- 297 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 999999999999999987655443334444577889999999999999999999999999999999 99998532
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCC
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLC 637 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~ 637 (671)
..... ......+.... ....+++ .+.+++.+||+.||++|||+.||++.|+.......
T Consensus 298 ---~~~~~-~~~~~~~~~~~-----~~~~~~~----~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 298 ---PVEEL-FKLLKEGHRMD-----KPSNCTN----ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp ---CHHHH-HHHHHTTCCCC-----CCSSCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred ---CHHHH-HHHHHcCCCCC-----CCccCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 12222 22222222111 1123333 36678889999999999999999999987643333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.37 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=205.5
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++..++|...+.||+|+||.||+|.+.++..||||+++... ...+++.+|+.++++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34456678889999999999999999888889999998643 345679999999999999999999999876 6789999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999943 12345899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... ......++..|+|||.+..+.++.++||||||+++|||++ |+.||.... ..+.. .....+...
T Consensus 334 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------~~~~~-~~i~~~~~~--- 400 (452)
T 1fmk_A 334 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVL-DQVERGYRM--- 400 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHH-HHHHTTCCC---
T ss_pred cee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------HHHHH-HHHHcCCCC---
Confidence 221 1223456788999999999999999999999999999999 999985321 11211 112222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQ 638 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~ 638 (671)
.....++. .+.+++.+||+.||++|||+++|+++|+.......+
T Consensus 401 --~~~~~~~~----~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 401 --PCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp --CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred --CCCCCCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 11122332 466788899999999999999999999986544433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.49 Aligned_cols=247 Identities=23% Similarity=0.263 Sum_probs=202.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||+++.. +|+.||||++++. .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888899999999999999975 6899999999753 2334567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|..++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999999864332
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.. .....+||+.|+|||++.+..++.++||||||+++|||++|+.||... +.......... +..
T Consensus 159 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~-~~~----- 222 (337)
T 1o6l_A 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILM-EEI----- 222 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-CCC-----
T ss_pred CC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC--------CHHHHHHHHHc-CCC-----
Confidence 22 233468999999999999999999999999999999999999998532 22222222221 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.+....+++ +.+++.+||+.||++|| +++||++
T Consensus 223 -~~p~~~s~~----~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 -RFPRTLSPE----AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCTTSCHH----HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCCCHH----HHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 122233333 56777799999999999 8999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=374.04 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=210.1
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecC-CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
...++|...+.||+|+||.||+|.+.. +..||||+++... ...++|.+|+.++++++||||+++++++......++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 345667888999999999999999864 8899999997643 34668999999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 296 E~~~~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 296 EFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp ECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EccCCCCHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999964 23456899999999999999999999998 999999999999999999999999999876443
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. .......+++.|+|||.+..+.++.++||||||+++|||++ |+.||.... ...+.. ....+...
T Consensus 372 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-----~~~~~~----~~~~~~~~--- 438 (495)
T 1opk_A 372 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYE----LLEKDYRM--- 438 (495)
T ss_dssp CE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGGHHH----HHHTTCCC---
T ss_pred ce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHH----HHHcCCCC---
Confidence 22 12223456788999999999999999999999999999999 999985322 112222 22221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
.....+++ .+.+++.+||+.||++|||+.||++.|+...
T Consensus 439 --~~~~~~~~----~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 --ERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp --CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred --CCCCCCCH----HHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11122333 3667888999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=337.98 Aligned_cols=257 Identities=28% Similarity=0.383 Sum_probs=208.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..++|+..+.||+|+||.||++...++..||+|+++... ....++.+|+.++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 456788889999999999999999888899999997643 2346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999853 2345899999999999999999999998 99999999999999999999999999987644332
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ........ ..+.. .
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~~--~--- 224 (268)
T 3sxs_A 160 V-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------NSEVVLKV-SQGHR--L--- 224 (268)
T ss_dssp E-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHH-HTTCC--C---
T ss_pred h-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------hHHHHHHH-HcCCC--C---
Confidence 2 2223456778999999998899999999999999999999 999985322 11222111 11111 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
......++ .+.+++..||+.||++|||+.|+++.|+...
T Consensus 225 ~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 225 YRPHLASD----TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCTTSCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCcChH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11111222 3667788999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=345.78 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=203.3
Q ss_pred hCCCCcccccCCCCcccEEEEEe-----cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Cee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-----SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 425 (671)
.++|++.+.||+|+||.||++++ .+++.||||++..........+.+|+.++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 45678889999999999999984 36789999999877766677899999999999999999999998654 457
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998542 345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCc-cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC-----C--CCCCCHHHHHHH
Q 005893 506 FAGSEGE-VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR-----G--ATAPNLLAYAWH 577 (671)
Q Consensus 506 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~-----~--~~~~~l~~~~~~ 577 (671)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+...... + ............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543322 1222345777899999999999999999999999999999999987532110 0 000001111111
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
....+... .....+++ .+.+++..||+.||++|||+.||++.|+..
T Consensus 244 ~~~~~~~~-----~~~~~~~~----~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGRL-----PRPDGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCCC-----CCCTTCCH----HHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCcC-----CCCcCcCH----HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111111 11122333 366788899999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=354.76 Aligned_cols=265 Identities=26% Similarity=0.415 Sum_probs=194.4
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEecCC----ceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEE
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLSDG----KEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g----~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 420 (671)
+++....++|+..+.||+|+||.||++..... ..||||+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 34445667899999999999999999997533 27999999753 3445678999999999999999999999998
Q ss_pred cCCee------eEEEeccCCCchhhhhcCCC---CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC
Q 005893 421 DGDEK------LLVYEFMPNSSLDAILFDPR---KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY 491 (671)
Q Consensus 421 ~~~~~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 491 (671)
..... ++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+++
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~ 172 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAE 172 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECT
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcC
Confidence 87665 89999999999999885322 2235899999999999999999999998 999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005893 492 DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPN 570 (671)
Q Consensus 492 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 570 (671)
++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~ 247 (323)
T 3qup_A 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----AE 247 (323)
T ss_dssp TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG
T ss_pred CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----HH
Confidence 99999999999987655443333334567888999999999999999999999999999999 8999864321 11
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+.. ....+... ......+. .+.+++.+||+.||++|||+.|+++.|+..
T Consensus 248 ~~~----~~~~~~~~-----~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 248 IYN----YLIGGNRL-----KQPPECME----EVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp HHH----HHHTTCCC-----CCCTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH----HHhcCCCC-----CCCCccCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 211 11111111 11122232 367788899999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=357.08 Aligned_cols=284 Identities=19% Similarity=0.206 Sum_probs=213.9
Q ss_pred HhCCCCcccccCCCCcccEEEEEecC------CceEEEEEccccchhc-----------hHHHHHHHHHHhhcCCCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSD------GKEIAVKRLSSCSEQG-----------NAEFTNEVLLILKLQHKNLVK 414 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~ 414 (671)
..++|.+.+.||+|+||.||+|.+.+ ++.||||++....... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45678899999999999999998754 4789999987543211 122345666777889999999
Q ss_pred EeeEEEcC----CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc
Q 005893 415 LLGFCVDG----DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD 490 (671)
Q Consensus 415 l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~ 490 (671)
+++++... ...++||||+ +++|.+++.. ..+.+++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998865 3478999999 9999999854 3356999999999999999999999998 99999999999999
Q ss_pred --CCCCeEEeeccccccccCCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 005893 491 --YDMNPKISDFGMARIFAGSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQS 563 (671)
Q Consensus 491 --~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~ 563 (671)
.++.+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998764332111 11234699999999999999999999999999999999999999963221
Q ss_pred CCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCc
Q 005893 564 RGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPA 643 (671)
Q Consensus 564 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~ 643 (671)
............ .....+++++.+.....+++ +.+++..||+.+|++||++.+|+++|+........+....
T Consensus 267 ----~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~ 338 (364)
T 3op5_A 267 ----DPKYVRDSKIRY-RENIASLMDKCFPAANAPGE---IAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK 338 (364)
T ss_dssp ----CHHHHHHHHHHH-HHCHHHHHHHHSCTTCCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred ----CHHHHHHHHHHh-hhhHHHHHHHhcccccCHHH---HHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence 111222222111 22344555555432222333 5567779999999999999999999988766666666667
Q ss_pred cccccC
Q 005893 644 FSFGRV 649 (671)
Q Consensus 644 ~~~~~~ 649 (671)
|.|...
T Consensus 339 ~dw~~~ 344 (364)
T 3op5_A 339 LDLSVV 344 (364)
T ss_dssp CCC---
T ss_pred cceEec
Confidence 776433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=347.90 Aligned_cols=251 Identities=21% Similarity=0.258 Sum_probs=202.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchh------chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQ------GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
.+.|++.+.||+|+||.||+++.. +|+.||+|+++..... ....+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888899999999999999975 6889999998753321 346789999999999999999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC----CeEEeecc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM----NPKISDFG 501 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 501 (671)
++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999984 3557999999999999999999999998 99999999999998876 79999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
+++...... ......||+.|+|||++....++.++||||||+++|||++|+.||... ........ ...
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~--------~~~~~~~~-i~~ 232 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLAN-ITA 232 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHH-HHT
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHH-HHh
Confidence 998764432 123457999999999999989999999999999999999999999532 11222111 112
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+... +++......+. .+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~--~~~~~~~~~s~----~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 233 VSYD--FDEEFFSQTSE----LAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TCCC--CCHHHHTTSCH----HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCC--CCchhccCCCH----HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1110 11111112222 3567778999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=337.08 Aligned_cols=253 Identities=31% Similarity=0.481 Sum_probs=195.4
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccc----hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS----EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|+..+.||+|+||.||++.. .++.||||+++... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46788889999999999999997 48899999987532 23346788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC--------CCCeEEeec
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY--------DMNPKISDF 500 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~Df 500 (671)
|||+++++|.+++. .+.+++..++.++.|++.||.|||+++..+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 346899999999999999999999987556899999999999986 678999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
|+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||... ......+....
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~~~~ 228 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI--------DGLAVAYGVAM 228 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS--------CHHHHHHHHHT
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHhhhc
Confidence 9998654322 12347899999999999999999999999999999999999998532 12222222222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.... ..+...+++ .+.+++.+||+.||++|||+.|+++.|+.
T Consensus 229 ~~~~-----~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 229 NKLA-----LPIPSTCPE----PFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp SCCC-----CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCC-----CCCCcccCH----HHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 2111 111223333 36678889999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.19 Aligned_cols=261 Identities=23% Similarity=0.297 Sum_probs=198.4
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhh--cCCCCeeeEeeEEEcC----Ceee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILK--LQHKNLVKLLGFCVDG----DEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 426 (671)
.++|+..+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46788899999999999999988 6899999998753 23345566666655 7999999999987643 4578
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH--------hCCCCceeecCCCCCcEEEcCCCCeEEe
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH--------EDSRLRIIHRDLKASNVLLDYDMNPKIS 498 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 498 (671)
+||||+++|+|.+++. ...+++..++.++.||+.||.||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 346999999999999999999999 666 9999999999999999999999
Q ss_pred eccccccccCCCCcc--ccccccccCCccchhhhccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCC
Q 005893 499 DFGMARIFAGSEGEV--NTARIVGTYGYMAPEYAMEG------LYSIKSDVFSFGVLLIEIITG----------RRNTGF 560 (671)
Q Consensus 499 Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvil~elltG----------~~p~~~ 560 (671)
|||+++......... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998765443322 12234799999999999876 456799999999999999999 666643
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 561 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.... ....................-.. .........+.+++.+||+.||++|||+.||++.|+.
T Consensus 236 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPN---DPSFEDMRKVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCS---SCCHHHHHHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCC---CcchhhhhHHHhccCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 2221 11122221111111111111110 1122345668889999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.97 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=210.6
Q ss_pred HHhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG 422 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 422 (671)
...++|...+.||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456788899999999999999985 246789999997543 23456789999999999 999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCC---------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcE
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRK---------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NI 487 (671)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999864322 225899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005893 488 LLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGA 566 (671)
Q Consensus 488 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 566 (671)
+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-- 254 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-- 254 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--
Confidence 999999999999999987665544333444567889999999999999999999999999999999 99998543211
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.........+.. .......+. .+.+++.+||+.||++|||+.||++.|+..
T Consensus 255 ------~~~~~~~~~~~~-----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 255 ------SKFYKMIKEGFR-----MLSPEHAPA----EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ------HHHHHHHHHTCC-----CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------hHHHHHhccCCC-----CCCcccCCH----HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111222222111 111122232 366778899999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.76 Aligned_cols=252 Identities=23% Similarity=0.277 Sum_probs=198.7
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 427 (671)
.++|+..++||+|+||.||+++.. +++.||||++++.. ......+..|..++.++ +||||+++++++.+....++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356888999999999999999975 57889999997532 23334578899999887 89999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++|+|..++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999884 3456999999999999999999999998 9999999999999999999999999998533
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||..................+.......
T Consensus 205 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--- 279 (396)
T 4dc2_A 205 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--- 279 (396)
T ss_dssp CTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---
T ss_pred cCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---
Confidence 2221 23446899999999999999999999999999999999999999965332221222222323333222221
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM 622 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~ 622 (671)
.+....++ .+.+++..||+.||++||++
T Consensus 280 ---~~p~~~s~----~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ---RIPRSLSV----KAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ---CCCTTSCH----HHHHHHHHHTCSCTTTSTTC
T ss_pred ---CCCCcCCH----HHHHHHHHHhcCCHhHcCCC
Confidence 12223333 35677779999999999995
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.47 Aligned_cols=258 Identities=26% Similarity=0.343 Sum_probs=200.0
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||++...+|+.||+|+++... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788899999999999999999889999999987532 2234578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++ +|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 77777643 3455899999999999999999999998 9999999999999999999999999998764322
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc--
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL-- 587 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-- 587 (671)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .................+.
T Consensus 174 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 174 R--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-----DDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST-----TTHHHHHHHHHCCCCTTTSGG
T ss_pred c--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHHCCCChHHhhh
Confidence 2 1233578999999999876 5689999999999999999999999964322 2222222222222111110
Q ss_pred --------------ccc----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 --------------IDP----LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 --------------~d~----~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+. .+...++ ..+.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFC----QEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCC----HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccC----HHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 0011122 24667888999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=342.83 Aligned_cols=271 Identities=23% Similarity=0.275 Sum_probs=212.5
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC--eeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv 428 (671)
.++|...++||+|+||.||++... +++.||||+++... ......+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 356888899999999999999975 58899999997533 334567889999999999999999999998765 67899
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE----cCCCCeEEeeccccc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL----DYDMNPKISDFGMAR 504 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 504 (671)
|||+++++|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 788889999999998
Q ss_pred cccCCCCccccccccccCCccchhhhc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAM--------EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||...... ........
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~ 237 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMY 237 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----GGCHHHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----chhHHHHH
Confidence 7654332 22357899999999986 467899999999999999999999999643221 11122222
Q ss_pred HHHhcCCc---ccc-------c--cccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 577 HLWNEGNA---LDL-------I--DPLL--TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 577 ~~~~~~~~---~~~-------~--d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
........ ... + .+.+ ...........+.+++.+||+.||++|||++|+++..+.+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 22222110 000 0 0011 12334555667788999999999999999999999887654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=345.13 Aligned_cols=256 Identities=26% Similarity=0.387 Sum_probs=204.6
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
...++|+..+.||+|+||.||++...++..||||+++... ....++.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3456788889999999999999999888899999998643 234678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 100 YMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CCTTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred ccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999854 2445999999999999999999999998 9999999999999999999999999998654322
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
. .......+|+.|+|||.+....++.++||||||+++|||++ |+.||.... ........ ..+. .
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------~~~~~~~~-~~~~-----~ 239 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHI-AQGL-----R 239 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHHHHH-HTTC-----C
T ss_pred c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------hhHHHHHH-hccc-----C
Confidence 1 11223456788999999999999999999999999999998 999985321 12222222 1111 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.......+ ..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 240 ~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 240 LYRPHLAS----EKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp CCCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCcCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 11111222 236678889999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=346.20 Aligned_cols=275 Identities=17% Similarity=0.196 Sum_probs=212.4
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||+|+. .+|+.||||++..... ...+.+|+.+++++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46788899999999999999996 5789999999875432 23578999999999 99999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC-----eEEeecccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN-----PKISDFGMARI 505 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~ 505 (671)
|+ +++|.+++... .+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999998542 456999999999999999999999998 999999999999998887 99999999987
Q ss_pred ccCCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 506 FAGSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 506 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~ 234 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-----DTLKERYQKIGD 234 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----SSHHHHHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-----ccHHHHHHHHHh
Confidence 65433221 12346899999999999999999999999999999999999999964321 222222111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCccccc
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFG 647 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~~ 647 (671)
. ..... ...+... .+ .+.+++..||+.+|++||++++|++.|+........+....|.|.
T Consensus 235 ~-~~~~~-~~~~~~~-~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 235 T-KRATP-IEVLCEN-FP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp H-HHHSC-HHHHTTT-CH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred h-hccCC-HHHHhcc-Ch----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 0 00000 0111111 12 467778899999999999999999999765444433333344443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=339.72 Aligned_cols=262 Identities=28% Similarity=0.458 Sum_probs=195.2
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
+..++|+..+.||+|+||.||+++.. ..||||+++.. .......+.+|+.++++++||||++++++. .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34567888999999999999999874 35999998743 344456799999999999999999999965 55668999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp EECCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred EEecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 999999999999853 3456999999999999999999999998 99999999999999999999999999986554
Q ss_pred CCCccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
...........||+.|+|||.+. ...++.++||||||+++|||++|+.||.... .. .........+...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~-~~~~~~~~~~~~~ 244 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------NR-DQIIEMVGRGSLS 244 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC-------CH-HHHHHHHHHTSCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc-------hH-HHHHHHhcccccC
Confidence 33333334467999999999986 5678999999999999999999999995322 11 1122222222221
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
.... .+...+++ .+.+++..||+.+|++|||+.||+++|+...
T Consensus 245 ~~~~-~~~~~~~~----~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLS-KVRSNCPK----RMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTT-SSCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchh-hccccCCH----HHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1111 11223333 3677888999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.63 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=201.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch------hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE------QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
++|...+.||+|+||.||++... +|+.||+|+++.... .....+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45788899999999999999975 688999999865322 23567899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC----CeEEeeccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM----NPKISDFGM 502 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 502 (671)
+||||+++++|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999984 3456999999999999999999999998 99999999999999887 899999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
++....... .....||+.|+|||++....++.++||||||+++|||++|+.||... .......... ..
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~~~-~~ 232 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANVS-AV 232 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHH-HT
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC--------CHHHHHHHHH-hc
Confidence 987643321 23357999999999999899999999999999999999999998532 1111111111 11
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. . .........+. .+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~-~-~~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 233 NY-E-FEDEYFSNTSA----LAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC-C-CCHHHHTTSCH----HHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC-C-cCccccccCCH----HHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 0 01111112222 3667788999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=348.12 Aligned_cols=268 Identities=16% Similarity=0.198 Sum_probs=199.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec----CCceEEEEEccccchh-----------chHHHHHHHHHHhhcCCCCeeeEee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSCSEQ-----------GNAEFTNEVLLILKLQHKNLVKLLG 417 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g 417 (671)
.++|...+.||+|+||.||++... ++..+|||++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467888999999999999999975 5778999998754321 1234667888899999999999999
Q ss_pred EEEc----CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC
Q 005893 418 FCVD----GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM 493 (671)
Q Consensus 418 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 493 (671)
++.. ....++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 9999999843 337999999999999999999999998 99999999999999887
Q ss_pred --CeEEeeccccccccCCCCc-----cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005893 494 --NPKISDFGMARIFAGSEGE-----VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGA 566 (671)
Q Consensus 494 --~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~ 566 (671)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~--- 265 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK--- 265 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT---
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence 9999999999876432211 111345799999999999999999999999999999999999999953211
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTD-TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
............... ....+...... .++. .+.+++..||+.||++||++++|++.|+...+.+
T Consensus 266 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 330 (345)
T 2v62_A 266 -DPVAVQTAKTNLLDE-LPQSVLKWAPSGSSCC----EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPL 330 (345)
T ss_dssp -CHHHHHHHHHHHHHT-TTHHHHHHSCTTSCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCC
T ss_pred -ccHHHHHHHHhhccc-ccHHHHhhccccccHH----HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcc
Confidence 111111111111111 11111111111 2332 3667777999999999999999999999876544
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=338.69 Aligned_cols=276 Identities=15% Similarity=0.195 Sum_probs=215.0
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+|+.++..+ +|+|++++++++......++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45788899999999999999996 578999999986533 233578899999999 89999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC-----eEEeecccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN-----PKISDFGMARI 505 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~Dfgla~~ 505 (671)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999998532 345999999999999999999999988 999999999999987776 99999999987
Q ss_pred ccCCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 506 FAGSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 506 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERIGEKKQ 238 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--ccHHHHHHHHhhcc
Confidence 65543221 223467999999999999999999999999999999999999999643221 11111111111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCccccc
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFG 647 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~~ 647 (671)
.... +.+...+++ .+.+++..||+.||++||++++|++.|+.....+..+....|.|+
T Consensus 239 ~~~~-----~~~~~~~~~----~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 239 STPL-----RELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp HSCH-----HHHTTTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred CccH-----HHHHhhCcH----HHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 1111 111122332 366788899999999999999999999987666655555556663
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=343.85 Aligned_cols=263 Identities=28% Similarity=0.408 Sum_probs=202.2
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
++|+..+.||+|+||.||++.. .++.||||++... .....+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 4577789999999999999998 4788999999753 34567899999999999999999999876 34789999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC-eEEeeccccccccCCCCc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN-PKISDFGMARIFAGSEGE 512 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~~ 512 (671)
+++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976444446889999999999999999999933234999999999999998887 799999998754322
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .......+..... .. +.+
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~-~~-----~~~ 225 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG------GPAFRIMWAVHNG-TR-----PPL 225 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC------SSHHHHHHHHHTT-CC-----CCC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC------ccHHHHHHHHhcC-CC-----CCc
Confidence 123468999999999999999999999999999999999999986321 1222222222221 11 112
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCCCCC
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKP 642 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p 642 (671)
...++. .+.+++.+||+.||++|||+.||++.|+.....++.+..|
T Consensus 226 ~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 226 IKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp BTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred ccccCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 223333 3667888999999999999999999998766555544443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.90 Aligned_cols=251 Identities=19% Similarity=0.229 Sum_probs=203.2
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|.+.+.||+|+||.||++... +++.||+|++... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 357888999999999999999975 5889999998754 33455788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC--CCCeEEeeccccccccCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY--DMNPKISDFGMARIFAGS 509 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~ 509 (671)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999843 3346999999999999999999999998 999999999999987 789999999999876543
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ............ ... .+
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i~~~-~~~--~~ 223 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNA-EYT--FD 223 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHT-CCC--CC
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC--------CHHHHHHHHHcC-CCC--CC
Confidence 2 223457899999999999888999999999999999999999999532 122222222211 110 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.......+. .+.+++.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~s~----~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 224 EEAFKEISI----EAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhccCCH----HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111112222 3667888999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=364.88 Aligned_cols=251 Identities=30% Similarity=0.427 Sum_probs=203.3
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC-eeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD-EKLLVY 429 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lv~ 429 (671)
+..++|+..+.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.++++++||||+++++++.+.. ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34566788899999999999999984 7899999998643 4567999999999999999999999987765 689999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHH-HCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999964 22344799999999999999999999998 999999999999999999999999999854322
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+... ...+...
T Consensus 343 ~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~----i~~~~~~--- 405 (450)
T 1k9a_A 343 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPR----VEKGYKM--- 405 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHHH----HHTTCCC---
T ss_pred c-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH----HHcCCCC---
Confidence 1 12356889999999999999999999999999999998 9999864321 222221 2222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+++ .+.+++..||+.||++|||+.+|++.|+.
T Consensus 406 --~~p~~~~~----~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 406 --DAPDGCPP----AVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp --CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCcCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 11223333 36677889999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=350.78 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=200.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCce----EEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKE----IAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
.++|+..+.||+|+||.||+|... +++. ||+|.+.... ......+.+|+.++.+++||||+++++++. +...+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 356778899999999999999964 4554 7778775432 233446778999999999999999999986 45688
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++|+|.+++.. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999854 3456999999999999999999999998 999999999999999999999999999987
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.............|+..|+|||.+..+.++.++||||||+++|||++ |+.||..... ..+.. ....+...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~----~~~~~~~~ 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPD----LLEKGERL 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHH----HHHTTCBC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHH----HHHcCCCC
Confidence 65544444445678889999999999999999999999999999999 9999964321 11211 12222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.. ...++. .+.+++.+||+.||++||++.||++.|+..
T Consensus 237 ~~-----~~~~~~----~~~~li~~~l~~dp~~Rps~~el~~~l~~~ 274 (325)
T 3kex_A 237 AQ-----PQICTI----DVYMVMVKCWMIDENIRPTFKELANEFTRM 274 (325)
T ss_dssp CC-----CTTBCT----TTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred CC-----CCcCcH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 111121 255788899999999999999999999764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=345.66 Aligned_cols=256 Identities=23% Similarity=0.278 Sum_probs=201.4
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
++|+..+.||+|+||.||+++.. +++.||||+++.. .......+.+|..++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 45788899999999999999975 5889999999753 233455688999999987 899999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|..++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999884 3356999999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||..................+....+..
T Consensus 163 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---- 236 (345)
T 3a8x_A 163 PGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---- 236 (345)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----
T ss_pred CCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----
Confidence 221 23346899999999999999999999999999999999999999964322211111122222222222221
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM------SSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~------~ev~~ 627 (671)
.+....++ .+.+++.+||+.||++||++ .|+++
T Consensus 237 --~~p~~~s~----~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 --RIPRSLSV----KAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp --CCCTTSCH----HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred --CCCCCCCH----HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 12223333 36677789999999999995 56654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=358.20 Aligned_cols=268 Identities=20% Similarity=0.256 Sum_probs=208.8
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEE
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 420 (671)
.+.++....++|+..++||+|+||+||+++.. +++.||||++++.. ......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45566677789999999999999999999976 47889999996522 122334889999999999999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
+.+..++||||+++|+|.+++.. ..+.+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999954 2456999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
|+++........ .....+||+.|+|||++. .+.++.++|||||||++|||++|+.||... +..+..
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~--------~~~~~~ 290 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--------SLVETY 290 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHH
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC--------ChhHHH
Confidence 999876443322 233468999999999987 467899999999999999999999999532 222222
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH--HhcCC
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFD--RPTMSSVVV--MLQGE 632 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPt~~ev~~--~L~~~ 632 (671)
.+....... .--+......+++ +.+++.+|+..+|++ ||+++|+++ .+++.
T Consensus 291 ~~i~~~~~~--~~~p~~~~~~s~~----~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 291 GKIMNHKER--FQFPTQVTDVSEN----AKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp HHHHTHHHH--CCCCSSCCCSCHH----HHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred Hhhhhcccc--ccCCcccccCCHH----HHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 222111000 0001111123333 556667888888887 999999987 44443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=347.19 Aligned_cols=267 Identities=29% Similarity=0.448 Sum_probs=213.1
Q ss_pred hhhHHHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeE
Q 005893 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGF 418 (671)
Q Consensus 346 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~ 418 (671)
.++++...++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||++++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 3445566778999999999999999999864 36789999997533 3445578999999999999999999999
Q ss_pred EEcCCeeeEEEeccCCCchhhhhcCCC-------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC
Q 005893 419 CVDGDEKLLVYEFMPNSSLDAILFDPR-------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY 491 (671)
Q Consensus 419 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 491 (671)
+.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 97 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~ 173 (322)
T 1p4o_A 97 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE 173 (322)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred EccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcC
Confidence 999999999999999999999985321 1245789999999999999999999998 999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCC
Q 005893 492 DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPN 570 (671)
Q Consensus 492 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~ 570 (671)
++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||... .
T Consensus 174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--------~ 245 (322)
T 1p4o_A 174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------S 245 (322)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------C
T ss_pred CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC--------C
Confidence 99999999999986544333233334567889999999999999999999999999999999 88888532 1
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
..... .....+.... ....++. .+.+++.+||+.||++|||+.|+++.|+...
T Consensus 246 ~~~~~-~~~~~~~~~~-----~~~~~~~----~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 246 NEQVL-RFVMEGGLLD-----KPDNCPD----MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHH-HHHHTTCCCC-----CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHH-HHHHcCCcCC-----CCCCCCH----HHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 12221 2222222111 1122333 3667788999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=354.49 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=195.2
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEcccc--chhchHHHHHHHHHHhhcCC--CCeeeEeeEEEcCCeee
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~ 426 (671)
+..++|++.+.||+|+||.||++...+++.||||++... .......+.+|+.++.+++| |||+++++++.+....+
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 345678899999999999999999988999999998643 34445678999999999976 99999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||| +.+++|.+++.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 86 lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9999 568899999843 456899999999999999999999998 99999999999997 578999999999876
Q ss_pred cCCCCccccccccccCCccchhhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAME-----------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
.............||+.|+|||++.. ..++.++||||||+++|||++|+.||... .......
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-------~~~~~~~ 230 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-------INQISKL 230 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC-------CSHHHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh-------hhHHHHH
Confidence 55443333345689999999999865 67899999999999999999999999532 1122222
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.......... .+....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~-----~~~~~~~----~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 231 HAIIDPNHEI-----EFPDIPE----KDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHCTTSCC-----CCCCCSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcCCccc-----CCcccCC----HHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 2221111110 1111112 23667778999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=344.67 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=197.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe-------
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------- 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------- 424 (671)
++|+..+.||+|+||.||+++.. +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888899999999999999975 7899999999743 33455679999999999999999999999865432
Q ss_pred --------------------------------------------------eeEEEeccCCCchhhhhcCCCCCCCCChHH
Q 005893 425 --------------------------------------------------KLLVYEFMPNSSLDAILFDPRKRGLLCWSK 454 (671)
Q Consensus 425 --------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 454 (671)
.++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 789999999999999997655556677888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc----------cccccccccCCc
Q 005893 455 RINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE----------VNTARIVGTYGY 524 (671)
Q Consensus 455 ~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~~y 524 (671)
++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 9999999999999999998 999999999999999999999999999876544221 112335799999
Q ss_pred cchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHH
Q 005893 525 MAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRY 604 (671)
Q Consensus 525 ~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 604 (671)
+|||.+.+..++.++||||||+++|||++|..|+.. ... ............. .......+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~-~~~~~~~~~~~~~---------~~~~~~~~ 302 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVR-IITDVRNLKFPLL---------FTQKYPQE 302 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHH-HHHHHHTTCCCHH---------HHHHCHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHH-HHHHhhccCCCcc---------cccCChhH
Confidence 999999999999999999999999999998765310 011 1111111111100 11222346
Q ss_pred HHHHHHccccCCCCCCCHHHHHH
Q 005893 605 IHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 605 ~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+++.+||+.||++|||+.|+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 78888999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.99 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=193.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--------------------------hchHHHHHHHHHHhh
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--------------------------QGNAEFTNEVLLILK 406 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~ 406 (671)
++|+..+.||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 56888899999999999999964 688999999864321 113468899999999
Q ss_pred cCCCCeeeEeeEEEc--CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCC
Q 005893 407 LQHKNLVKLLGFCVD--GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKA 484 (671)
Q Consensus 407 l~H~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp 484 (671)
++||||+++++++.+ ....++||||+++++|.+++ ..+.+++..++.++.||+.||.|||+++ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999986 56789999999999998865 3456999999999999999999999998 99999999
Q ss_pred CcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005893 485 SNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL---YSIKSDVFSFGVLLIEIITGRRNTGFN 561 (671)
Q Consensus 485 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~p~~~~ 561 (671)
+|||++.++.+||+|||+++........ .....||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999876543222 23457999999999987655 478999999999999999999998532
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 562 QSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 562 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
......... ...... . ......++ .+.+++.+||+.||++|||+.|+++
T Consensus 244 --------~~~~~~~~~-~~~~~~-~---~~~~~~~~----~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 --------RIMCLHSKI-KSQALE-F---PDQPDIAE----DLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp --------SHHHHHHHH-HHCCCC-C---CSSSCCCH----HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------cHHHHHHHH-hcccCC-C---CCccccCH----HHHHHHHHHhhcChhhCCCHHHHhc
Confidence 222222221 121111 0 01122333 3667788999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.90 Aligned_cols=261 Identities=27% Similarity=0.396 Sum_probs=209.2
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec--------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS--------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCV 420 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~ 420 (671)
...++|...+.||+|+||.||++... ++..||||+++.. .......+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34567888999999999999999863 4678999999754 334556789999999999 8999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcE
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRK-------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NI 487 (671)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999999965332 234899999999999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 005893 488 LLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGA 566 (671)
Q Consensus 488 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~ 566 (671)
+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~----- 263 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----- 263 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC-----
Confidence 999999999999999987655443333344567889999999998899999999999999999999 99998532
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
...... .....+... .....++. .+.+++.+||+.+|++|||+.||++.|+..
T Consensus 264 ---~~~~~~-~~~~~~~~~-----~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 264 ---PVEELF-KLLKEGHRM-----DKPANCTN----ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ---CHHHHH-HHHHHTCCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CHHHHH-HHHhcCCCC-----CCCccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 112221 222222111 11223333 366788899999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.52 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=210.4
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.+...++|+..+.||+|+||.||++... +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 3445677888999999999999999975 48889999997533 345678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHH-CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHh-cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999854 23456999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
.... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... .....
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~----~~~~~--- 229 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL----LEKDY--- 229 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHH----HHTTC---
T ss_pred CCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH----HhccC---
Confidence 4332 22233567889999999999999999999999999999999 9999854321 112211 11111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.......+++ .+.+++..|++.||++|||+.||++.|+.
T Consensus 230 --~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~~~~~l~~ 268 (288)
T 3kfa_A 230 --RMERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFET 268 (288)
T ss_dssp --CCCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCCCH----HHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence 1111122332 36678889999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=342.20 Aligned_cols=269 Identities=28% Similarity=0.410 Sum_probs=213.6
Q ss_pred echhhHHHHhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeE
Q 005893 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKL 415 (671)
Q Consensus 344 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 415 (671)
++...+....++|...+.||+|+||.||++.. .+++.||||+++... ......+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455566678899999999999999999984 246789999997643 33455789999999999 79999999
Q ss_pred eeEEEcCC-eeeEEEeccCCCchhhhhcCCCC-------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecC
Q 005893 416 LGFCVDGD-EKLLVYEFMPNSSLDAILFDPRK-------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRD 481 (671)
Q Consensus 416 ~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~D 481 (671)
++++...+ ..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99988765 48999999999999999965332 223899999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCC
Q 005893 482 LKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGF 560 (671)
Q Consensus 482 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~ 560 (671)
|||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987655444334445678899999999999999999999999999999998 9999853
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 561 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.... .........+... ......++ .+.+++.+||+.||++|||+.||++.|+..
T Consensus 254 ~~~~--------~~~~~~~~~~~~~-----~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKID--------EEFCRRLKEGTRM-----RAPDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCS--------HHHHHHHHHTCCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchh--------HHHHHHhccCccC-----CCCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2211 1112222222211 11122333 366788899999999999999999999753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=348.08 Aligned_cols=249 Identities=26% Similarity=0.301 Sum_probs=197.8
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 426 (671)
..++|+..+.||+|+||.||+++.. +|+.||||+++.. .......+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3467889999999999999999975 5889999999753 233455678999999988 7999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++|+|..++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999984 3456999999999999999999999998 999999999999999999999999999854
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
.... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||... +.......... +..
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~-~~~-- 241 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE--------NEDDLFEAILN-DEV-- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-CCC--
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC--------CHHHHHHHHHc-CCC--
Confidence 3222 2233468999999999999889999999999999999999999999532 22222222222 111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM------SSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~------~ev~~ 627 (671)
.+....++ .+.+++.+||+.||++||++ +|+++
T Consensus 242 ----~~p~~~~~----~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ----VYPTWLHE----DATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----CCCTTSCH----HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----CCCCCCCH----HHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11122233 35677779999999999998 77765
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=346.57 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=204.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|++.+.||+|+||.||++... +|+.||+|++..........+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57888999999999999999975 68899999998765556668999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC--CCCeEEeeccccccccCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY--DMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~ 510 (671)
++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 131 ~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 131 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999998843 3346899999999999999999999998 999999999999974 4789999999998764432
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||... .......... ..... .++
T Consensus 206 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--------~~~~~~~~i~-~~~~~--~~~ 271 (387)
T 1kob_A 206 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--------DDLETLQNVK-RCDWE--FDE 271 (387)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHH-HCCCC--CCS
T ss_pred c---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC--------CHHHHHHHHH-hCCCC--CCc
Confidence 2 22347899999999999999999999999999999999999998532 1222222221 11111 111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
......++ .+.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~~~~s~----~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 DAFSSVSP----EAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp STTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccCCH----HHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11122333 3667788999999999999999997
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=347.54 Aligned_cols=268 Identities=26% Similarity=0.400 Sum_probs=200.6
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEec----CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeE
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGF 418 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~ 418 (671)
.++++....++|...+.||+|+||.||+|... +++.||||+++.. .......+.+|+.++.+++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34555666788999999999999999999864 3457999998743 33445678999999999999999999999
Q ss_pred EEcCCe-----eeEEEeccCCCchhhhhcCC---CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc
Q 005893 419 CVDGDE-----KLLVYEFMPNSSLDAILFDP---RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD 490 (671)
Q Consensus 419 ~~~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~ 490 (671)
+.+... .++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~ 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence 987653 48999999999999988432 23456999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCC
Q 005893 491 YDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAP 569 (671)
Q Consensus 491 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~ 569 (671)
.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~ 256 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----H 256 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----G
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----H
Confidence 999999999999987654433333334567889999999999999999999999999999999 8888854321 1
Q ss_pred CHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 570 NLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 570 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
.... ....+.. ......+++ .+.+++.+||+.||++|||+.+|++.|+...
T Consensus 257 ~~~~----~~~~~~~-----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 257 EMYD----YLLHGHR-----LKQPEDCLD----ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp GHHH----HHHTTCC-----CCCBTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH----HHHcCCC-----CCCCccccH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1211 1112211 111223333 3677888999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=338.74 Aligned_cols=244 Identities=24% Similarity=0.306 Sum_probs=201.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||+++.. +|+.||+|+++... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888899999999999999975 68999999997532 234567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999984 3456899999999999999999999998 999999999999999999999999999865332
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||... +........... ..
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------~~~~~~~~i~~~-~~----- 220 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNA-EL----- 220 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHC-CC-----
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhC-CC-----
Confidence 23458999999999999999999999999999999999999999532 222222222222 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.+....++ .+.+++.+|++.||++|| +++||++
T Consensus 221 -~~p~~~~~----~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -RFPPFFNE----DVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCTTSCH----HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCH----HHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11222333 356777799999999999 8999884
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.38 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=196.4
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||+|+||.||++...+|+.||+|++.... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688889999999999999999889999999986533 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++ +|.+++.. ..+.+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 88888753 2356899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc---c-
Q 005893 512 EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL---D- 586 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~---~- 586 (671)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ........+........ .
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNV 228 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHHCCCChhhchhh
Confidence 12234789999999998764 589999999999999999999999853211 11111111111111000 0
Q ss_pred ----ccccc-----------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 ----LIDPL-----------LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ----~~d~~-----------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..++. +....++ .+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 229 TELPKYDPNFTVYEPLPWESFLKGLDE----SGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCCH----HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccccccCccHHHHhhhcCH----HHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111 1112222 3667888999999999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.83 Aligned_cols=255 Identities=31% Similarity=0.538 Sum_probs=200.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhc-------hHHHHHHHHHHhhcCCCCeeeEeeEEEcCC
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQG-------NAEFTNEVLLILKLQHKNLVKLLGFCVDGD 423 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 423 (671)
..++|+..+.||+|+||.||+++. .+++.||||++....... ...+.+|+.++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346788889999999999999997 478899999986433221 157899999999999999999999986554
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC-----eEEe
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN-----PKIS 498 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~ 498 (671)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ .+|+||||||+||+++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999888754 3456999999999999999999999875 34999999999999988776 9999
Q ss_pred eccccccccCCCCccccccccccCCccchhhhc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH
Q 005893 499 DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM--EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 499 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
|||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||..... .-.....
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~ 240 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY------GKIKFIN 240 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------CHHHHHH
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------cHHHHHH
Confidence 9999875332 223457899999999983 45678999999999999999999999964321 1111111
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+. .+.+...+++ .+.+++.+||+.||++|||++||++.|+.
T Consensus 241 ~~~~~~~-----~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 241 MIREEGL-----RPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHSCC-----CCCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHhccCC-----CCCCCcccCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1111111 1122233333 36678889999999999999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=352.24 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=201.1
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.++|+..+.||+|+||.||++.. .+|+.+|+|++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45688899999999999999986 468999999986532 344567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc---CCCCeEEeeccccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD---YDMNPKISDFGMARIF 506 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~ 506 (671)
||+++|+|.+.+. .++.+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 90 E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999988884 3456999999999999999999999998 99999999999998 4678999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||... ...... .....+...
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~--------~~~~~~-~~i~~~~~~- 231 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE--------DQHRLY-QQIKAGAYD- 231 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHH-HHHHHTCCC-
T ss_pred cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--------cHHHHH-HHHHhCCCC-
Confidence 543322 23357999999999999989999999999999999999999998532 112221 222222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+. ....++ .+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~-~~~~s~----~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 FPSPE-WDTVTP----EAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCTTT-TTTSCH----HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCccc-cccCCH----HHHHHHHHHcCCChhHCCCHHHHhc
Confidence 10110 112233 3667777999999999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=345.29 Aligned_cols=249 Identities=23% Similarity=0.304 Sum_probs=201.2
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCee
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 425 (671)
...++|...+.||+|+||.||+++.. +|+.||||+++... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45578889999999999999999975 68899999997532 23455678899999877 999999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++|+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999984 3456899999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
...... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||... +....... ...+.
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~-i~~~~-- 234 (345)
T 1xjd_A 168 NMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--------DEEELFHS-IRMDN-- 234 (345)
T ss_dssp CCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHH-HHHCC--
T ss_pred cccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC--------CHHHHHHH-HHhCC--
Confidence 433222 234468999999999999999999999999999999999999999532 11222212 22221
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMS-SVV 626 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~-ev~ 626 (671)
+.+....++ .+.+++.+||+.||++||++. ||+
T Consensus 235 ----~~~p~~~s~----~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ----PFYPRWLEK----EAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CCCCTTSCH----HHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CCCCcccCH----HHHHHHHHHhcCCHhHcCCChHHHH
Confidence 112222333 356777799999999999997 665
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=343.68 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=194.6
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee---
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK--- 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~--- 425 (671)
.++|++.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 45788899999999999999996 578899999997542 23345788999999999999999999998765543
Q ss_pred -eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 426 -LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 426 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
++||||+++++|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 89999999999999984 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCc-cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 505 IFAGSEGE-VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 505 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||... ......+.......
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~--------~~~~~~~~~~~~~~ 236 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD--------SPVSVAYQHVREDP 236 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhcCCC
Confidence 76543222 2233457899999999999999999999999999999999999999532 22333333333322
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHhc
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV-VMLQ 630 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~-~~L~ 630 (671)
... .......+. .+.+++.+||+.||++||+..+++ ..|.
T Consensus 237 ~~~---~~~~~~~~~----~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 237 IPP---SARHEGLSA----DLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp CCH---HHHSTTCCH----HHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCc---ccccCCCCH----HHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 111 011122232 366788899999999999766655 3443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.66 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=201.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.++|+..+.||+|+||.||++... +|+.||+|++... .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457888999999999999999975 6889999998643 3344567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC---CCeEEeeccccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD---MNPKISDFGMARIF 506 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 506 (671)
||+++|+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999998884 3456899999999999999999999998 9999999999999865 45999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||... ..... +.....+....
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~--------~~~~~-~~~i~~~~~~~ 249 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--------DQHRL-YAQIKAGAYDY 249 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHH-HHHHHHTCCCC
T ss_pred cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC--------CHHHH-HHHHHhCCCCC
Confidence 53322 23357999999999999989999999999999999999999998532 11121 12222222110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+ .....++ .+.+++.+||+.||++|||+.|+++
T Consensus 250 -~~~-~~~~~~~----~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 -PSP-EWDTVTP----EAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -CTT-GGGGSCH----HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -Ccc-cccCCCH----HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0012222 3667778999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=344.78 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=197.9
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|.+.+.||+|+||.||++.. .+++.||||++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5688889999999999999996 578999999986421 223457889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+ +|+|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 678888774 3456999999999999999999999998 999999999999999999999999999865433
Q ss_pred CCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
. .....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... +. ..... .
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-----~~---------~~i~~-~ 223 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN-----LF---------KKVNS-C 223 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT-----CB---------CCCCS-S
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH-----HH---------HHHHc-C
Confidence 2 1234579999999999987776 789999999999999999999996432210 00 00000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+....++ .+.+++.+||+.||++|||++|+++
T Consensus 224 ~~~~p~~~s~----~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 VYVMPDFLSP----GAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCCCTTSCH----HHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCcccCCH----HHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0111222333 3567778999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=374.52 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=208.3
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++..++|+..+.||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..++||
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 34456678889999999999999999888889999998643 345679999999999999999999999876 6789999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. .....+++..++.|+.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 341 e~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999943 12345899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
. ........++..|+|||.+..+.++.++||||||+++|||++ |+.||... ...+.. .....+...
T Consensus 417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~--------~~~~~~-~~i~~~~~~--- 483 (535)
T 2h8h_A 417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--------VNREVL-DQVERGYRM--- 483 (535)
T ss_dssp H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC--------CHHHHH-HHHHTTCCC---
T ss_pred c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHH-HHHHcCCCC---
Confidence 1 111223456788999999999999999999999999999999 89998532 111211 122222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETIT 635 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~ 635 (671)
.....++. .+.+++.+||+.||++|||+++|+++|+.....
T Consensus 484 --~~~~~~~~----~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 --PCPPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --CCCCCCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11123332 366788899999999999999999999876443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=344.64 Aligned_cols=246 Identities=24% Similarity=0.270 Sum_probs=195.1
Q ss_pred ccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCCCch
Q 005893 359 SNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSL 437 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 437 (671)
.+.||+|+||.||++.. .+|+.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56799999999999996 46899999999876666677899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE--cCCCCeEEeeccccccccCCCCcccc
Q 005893 438 DAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL--DYDMNPKISDFGMARIFAGSEGEVNT 515 (671)
Q Consensus 438 ~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~ 515 (671)
.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~ 245 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L 245 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence 888853 3345899999999999999999999998 9999999999999 5678999999999987654322 2
Q ss_pred ccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCC
Q 005893 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDT 595 (671)
Q Consensus 516 ~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 595 (671)
....||+.|+|||++....++.++||||||+++|||++|+.||... +............ +. . .......
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------~~~~~~~~i~~~~-~~-~-~~~~~~~ 314 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD--------NDAETLNNILACR-WD-L-EDEEFQD 314 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTC-CC-S-CSGGGTT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhcc-CC-C-Chhhhcc
Confidence 2347999999999999889999999999999999999999998532 1222222222211 10 0 1111122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 596 CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 596 ~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+++ .+.+++.+||+.||++|||+.|+++
T Consensus 315 ~~~----~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISE----EAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCH----HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 333 3667788999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=346.07 Aligned_cols=265 Identities=26% Similarity=0.401 Sum_probs=210.3
Q ss_pred hHHHHhCCCCcccccCCCCcccEEEEEecC-C-----ceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEE
Q 005893 348 TLDVATSNFSDSNMLGQGGFGPVYKGVLSD-G-----KEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFC 419 (671)
Q Consensus 348 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~ 419 (671)
.++...++|...+.||+|+||.||++.... + +.||+|++.... ......+.+|+.++.++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344566789999999999999999999642 2 479999997643 33456789999999999 899999999999
Q ss_pred EcCCeeeEEEeccCCCchhhhhcCCC-----------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEE
Q 005893 420 VDGDEKLLVYEFMPNSSLDAILFDPR-----------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488 (671)
Q Consensus 420 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIl 488 (671)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999985321 1345899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGAT 567 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 567 (671)
++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--- 273 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--- 273 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS---
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh---
Confidence 99999999999999987654443333344567889999999999999999999999999999999 99998532211
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.........+.. .......+ ..+.+++..||+.||++|||+.||++.|+..
T Consensus 274 -----~~~~~~~~~~~~-----~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 274 -----SKFYKLVKDGYQ-----MAQPAFAP----KNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -----HHHHHHHHHTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHhcCCC-----CCCCCCCC----HHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 111222222211 11111222 2366778899999999999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=353.08 Aligned_cols=268 Identities=19% Similarity=0.221 Sum_probs=207.6
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEE
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~ 420 (671)
.++++....++|+..+.||+|+||.||+++.. +|+.||||++++.. ......+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 45566667788999999999999999999975 68999999997522 223345789999999999999999999999
Q ss_pred cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 421 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
+.+..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999853 2346899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAM-------EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLA 573 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~ 573 (671)
|+++....... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||... +...
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~ 277 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD--------STAE 277 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHH
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC--------CHHH
Confidence 99987644322 2223468999999999987 356899999999999999999999999532 1222
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHH--HhcCCC
Q 005893 574 YAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDR---PTMSSVVV--MLQGET 633 (671)
Q Consensus 574 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Pt~~ev~~--~L~~~~ 633 (671)
...+...... ...-+.+....+++ +.+++.+||+ +|++| |+++||++ .+++..
T Consensus 278 ~~~~i~~~~~--~~~~p~~~~~~s~~----~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 278 TYGKIVHYKE--HLSLPLVDEGVPEE----ARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp HHHHHHTHHH--HCCCC----CCCHH----HHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHhccc--CcCCCccccCCCHH----HHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 2111111100 00011111233333 5667779998 99998 69999986 344443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=328.78 Aligned_cols=253 Identities=23% Similarity=0.339 Sum_probs=202.5
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lv 428 (671)
.++|+..+.||+|+||.||+|+.. ++.||||+++.. .......+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 356788899999999999999984 889999999753 344456799999999999999999999999887 678999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ .+|+||||||+||+++.++.++|.|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHS-CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhh-cccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999964 23336899999999999999999999864 3599999999999999999999999998754322
Q ss_pred CCCccccccccccCCccchhhhccCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSI---KSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||... ............+..
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~~~~~~~~~~~~~~~- 229 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--------SNMEIGMKVALEGLR- 229 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS--------CHHHHHHHHHHSCCC-
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc--------ChHHHHHHHHhcCCC-
Confidence 2346789999999998765444 899999999999999999998532 222222222222211
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+.+....++ .+.+++..||+.||++|||++|+++.|+..
T Consensus 230 ----~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 230 ----PTIPPGISP----HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ----CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 122233333 366777899999999999999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=335.05 Aligned_cols=260 Identities=26% Similarity=0.362 Sum_probs=187.1
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||+|... +|+.||+|+++... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999964 68899999987533 3344678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCC---CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 431 FMPNSSLDAILFDP---RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 431 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|++ ++|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6888887532 12345899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc--
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA-- 584 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~-- 584 (671)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ................
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTT
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhH
Confidence 3221 1223578999999999876 4689999999999999999999999953221 1111111111111000
Q ss_pred ----------------------cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 ----------------------LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ----------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+.+.+......+. .+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDG----NLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCH----HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCH----HHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00001111112222 4677888999999999999999885
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.38 Aligned_cols=257 Identities=31% Similarity=0.445 Sum_probs=205.6
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
+..++|+..+.||+|+||.||++...+++.||||+++... ...+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3446788889999999999999998888899999997543 34567899999999999999999999976 456899999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 88 ~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 88 YMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CCTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred cCCCCCHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999843 11235899999999999999999999998 9999999999999999999999999998765432
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.. ......++..|+|||.+..+.++.++||||||+++|||++ |+.||.... ..+.. .....+..
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~-~~~~~~~~----- 228 (279)
T 1qpc_A 164 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVI-QNLERGYR----- 228 (279)
T ss_dssp EE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHH-HHHHTTCC-----
T ss_pred cc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHH-HHHhcccC-----
Confidence 21 2223456788999999998899999999999999999999 899885321 11211 11222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
......++. .+.+++..|++.||++|||+.+|+++|+..
T Consensus 229 ~~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 MVRPDNCPE----ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccH----HHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 111123332 366788899999999999999999999865
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.93 Aligned_cols=255 Identities=29% Similarity=0.415 Sum_probs=206.4
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.++|+..+.||+|+||.||++...+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 456788899999999999999998888999999986432 3467899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 99999999853 2356899999999999999999999998 99999999999999999999999999986543211
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
.......++..|+|||.+....++.++||||||+++|||++ |+.||... ........ ...+.. ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~-i~~~~~-----~~ 225 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR--------SNSEVVED-ISTGFR-----LY 225 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHH-HHTTCC-----CC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC--------CHHHHHHH-HhcCCc-----CC
Confidence 11223456788999999998999999999999999999999 89998532 12222222 222211 11
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....+. .+.+++.+||+.||++||++.|+++.|+..
T Consensus 226 ~~~~~~~----~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 226 KPRLAST----HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccCcH----HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1112222 366778899999999999999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=343.98 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=188.3
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
...++|+..+.||+|+||.||+++.. +++.||||+++... ..+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34567889999999999999999975 57889999997543 3456789999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEEeeccccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISDFGMARIF 506 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~~~ 506 (671)
||+++++|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++..
T Consensus 128 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999884 3456899999999999999999999998 999999999999975 889999999999865
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~i~~~~~~- 269 (349)
T 2w4o_A 202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--------DQFMFRRILNCEYY- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--------HHHHHHHHHTTCCC-
T ss_pred Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--------cHHHHHHHHhCCCc-
Confidence 4322 12335789999999999998999999999999999999999999853211 11112222222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+ .....+. .+.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~-~~~~~~~----~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FISP-WWDEVSL----NAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCTT-TTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCc-hhhhCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1122232 3667788999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.28 Aligned_cols=253 Identities=23% Similarity=0.280 Sum_probs=200.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-----hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-----EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
+.|++.+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888899999999999999874 68999999986321 2245678999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC---eEEeecccc
Q 005893 428 VYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN---PKISDFGMA 503 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla 503 (671)
||||+++++|.+.+... .....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998877432 22345899999999999999999999998 999999999999987654 999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.... .. .......+.
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~-~~~~i~~~~ 248 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ER-LFEGIIKGK 248 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HH-HHHHHHHTC
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HH-HHHHHHcCC
Confidence 87654322 2234579999999999999999999999999999999999999985311 11 111122221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. ..+......+ ..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~--~~~~~~~~~s----~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YK--MNPRQWSHIS----ESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CCHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CCccccccCC----HHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11 0111111222 23667788999999999999999985
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=338.93 Aligned_cols=256 Identities=23% Similarity=0.380 Sum_probs=193.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEecC----CceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
..++|+..+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34578888999999999999998742 456999998753 3344567899999999999999999999974 56789
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999853 2346899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||..... ...... ...+...
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~~~~----i~~~~~~ 236 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGR----IENGERL 236 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHH----HHTTCCC
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHHHHH----HHcCCCC
Confidence 443221 1223456788999999999999999999999999999997 9999864321 122211 1121111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.+...+++ .+.+++.+||+.||++|||+.||++.|+..
T Consensus 237 -----~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 237 -----PMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp -----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 12223333 366788899999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.38 Aligned_cols=252 Identities=24% Similarity=0.374 Sum_probs=201.2
Q ss_pred hCCCCcccccCCCCcccEEEEEecC-C-------ceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD-G-------KEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
.++|...+.||+|+||.||++.... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3567888999999999999998643 3 4699999987666677789999999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC--------eE
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN--------PK 496 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~k 496 (671)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999953 2334899999999999999999999998 999999999999998887 99
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
|+|||++..... .....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+... .......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~-------~~~~~~~ 228 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA-------LDSQRKL 228 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT-------SCHHHHH
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc-------cchHHHH
Confidence 999999865422 123467899999999987 67999999999999999999965543211 1111111
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCC
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETI 634 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~ 634 (671)
....... .+....+ ..+.+++.+||+.||++|||+.|+++.|+....
T Consensus 229 -~~~~~~~-------~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 -QFYEDRH-------QLPAPKA----AELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp -HHHHTTC-------CCCCCSS----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred -HHhhccC-------CCCCCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111111 1111111 125677889999999999999999999987543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.86 Aligned_cols=248 Identities=23% Similarity=0.290 Sum_probs=191.8
Q ss_pred hCCCCcccccCCCCcccEEEEEe----cCCceEEEEEccccc----hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL----SDGKEIAVKRLSSCS----EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
.++|+..+.||+|+||.||+++. .+|+.||+|+++... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35688889999999999999986 478899999997532 2334567899999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||+++++|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999884 3456889999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ............ ..
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--------~~~~~~~~i~~~-~~ 238 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE--------NRKKTIDKILKC-KL 238 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHHT-CC
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhC-CC
Confidence 5433221 123457999999999999999999999999999999999999999532 222222222221 11
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.+....+. .+.+++.+||+.||++|| ++.|+++
T Consensus 239 ------~~p~~~~~----~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ------NLPPYLTQ----EARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCCTTSCH----HHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCCCCCCH----HHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11122332 366777799999999999 7778875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=340.92 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=207.0
Q ss_pred CCCCccc-ccCCCCcccEEEEEec---CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSN-MLGQGGFGPVYKGVLS---DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
++|.+.+ .||+|+||.||+|... ++..||||+++.. .......+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999853 5778999999864 334566799999999999999999999999 55668999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999853 3456999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 509 SEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 509 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... .... .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~-~~i~~~~~-- 231 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVM-AFIEQGKR-- 231 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHH-HHHHTTCC--
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHH-HHHhcCCc--
Confidence 33221 1223456889999999988899999999999999999999 9999853221 1111 12222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQP 639 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p 639 (671)
+.+...+++ .+.+++..||+.||++||++.||++.|+....+...+
T Consensus 232 ---~~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 232 ---MECPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ---CCCCTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---CCCCCCcCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 112223333 3667888999999999999999999998764444433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=344.95 Aligned_cols=257 Identities=27% Similarity=0.472 Sum_probs=196.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCce----EEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKE----IAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
.++|+..+.||+|+||.||+|... +++. |++|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467888999999999999999964 4554 477776542 3445678999999999999999999999998754 78
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+|+||+++|+|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999854 3456999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+... ...+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~----~~~~~~~ 238 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSI----LEKGERL 238 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHH----HHTTCCC
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHH----HHcCCCC
Confidence 54443333334567889999999999999999999999999999999 9999964321 122221 1121111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
......+. .+.+++.+||+.||++||++.||++.|+...
T Consensus 239 -----~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 239 -----PQPPICTI----DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCccCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11112232 3667888999999999999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=351.09 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=203.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56788899999999999999975 78999999997532 223457889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999984 4556999999999999999999999998 999999999999999999999999999876443
Q ss_pred CCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. ....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... ...... ....+..
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~-~i~~~~~---- 233 (476)
T 2y94_A 170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFK-KICDGIF---- 233 (476)
T ss_dssp CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHH-HHHTTCC----
T ss_pred cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHH-HHhcCCc----
Confidence 21 233579999999999988765 789999999999999999999995321 112211 2222211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQG 631 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~ 631 (671)
......++ .+.+++.+||+.||++|||+.|+++ .++.
T Consensus 234 --~~p~~~s~----~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 234 --YTPQYLNP----SVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp --CCCTTCCH----HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred --CCCccCCH----HHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 11122333 3667778999999999999999997 4544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=341.47 Aligned_cols=244 Identities=24% Similarity=0.260 Sum_probs=201.8
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46788899999999999999975 68999999986532 234567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999999843 346899999999999999999999998 999999999999999999999999999875432
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||... ......... ..+..
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i-~~~~~----- 255 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKI-VSGKV----- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHH-HHCCC-----
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC--------CHHHHHHHH-HcCCC-----
Confidence 23458999999999999999999999999999999999999998532 222222222 22221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
.+...+++ .+.+++.+||+.||++||+ ++||++
T Consensus 256 -~~p~~~~~----~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -RFPSHFSS----DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCCH----HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCH----HHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 12223333 3667777999999999998 888875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.36 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=196.8
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|+..+.||+|+||.||++... +++.||||+++... ......+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999999999999975 68899999986432 3334678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|++++.+..+. ...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99865444443 23456999999999999999999999998 9999999999999999999999999998764332
Q ss_pred CccccccccccCCccchhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc---
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD--- 586 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--- 586 (671)
. ......||+.|+|||++.+.. ++.++||||||+++|||++|..|+-... ..........+.........
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~----~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHHhCCCChhhhhh
Confidence 2 223357899999999997765 8999999999999999999988853211 11112222222211111000
Q ss_pred cc---c----cc-----ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LI---D----PL-----LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~---d----~~-----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. + +. ......+.....+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00 0 00 000001111234667888999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=353.37 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=195.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEcccc--chhchHHHHHHHHHHhhcC--CCCeeeEeeEEEcCCeeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~l 427 (671)
..++|++.+.||+|+||.||++...+++.||||++... .......+.+|+.++.+++ ||||+++++++...+..++
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 34568889999999999999999888999999998643 3445567899999999996 5999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 134 v~E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEE-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred EEe-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 999 568899999853 346889999999999999999999998 99999999999995 5899999999998765
Q ss_pred CCCCccccccccccCCccchhhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAME-----------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
............||+.|+|||++.. ..++.++|||||||++|||++|+.||.... .......
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~~~~~~ 278 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------NQISKLH 278 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CHHHHHH
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------HHHHHHH
Confidence 4433333344689999999999865 468999999999999999999999995321 1122222
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
......... .+.... ++ .+.+++.+||+.||++|||+.||++
T Consensus 279 ~~~~~~~~~-----~~~~~~-~~---~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 279 AIIDPNHEI-----EFPDIP-EK---DLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHCTTSCC-----CCCCCS-CH---HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCccccC-----CCCccc-hH---HHHHHHHHHcccChhhCCCHHHHhh
Confidence 222111110 111111 22 3567778999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=351.18 Aligned_cols=270 Identities=26% Similarity=0.355 Sum_probs=208.4
Q ss_pred hCCCCcccccCCCCcccEEEEEe-----cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc--CCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-----SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 425 (671)
.++|+..+.||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35678889999999999999984 3678999999987766667789999999999999999999999874 4568
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 899999999999999853 2345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC------CCCCCCHHHHHHHH
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR------GATAPNLLAYAWHL 578 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~------~~~~~~l~~~~~~~ 578 (671)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 65433221 223356888899999999999999999999999999999999997532110 00000111111111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
...+.. ......++ ..+.+++.+||+.||++|||+.||++.|+......
T Consensus 257 ~~~~~~-----~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 257 LEEGQR-----LPAPPACP----AEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHTTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhcccC-----CCCCCccc----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 111111 11112223 33677888999999999999999999998764433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=352.54 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=204.5
Q ss_pred hhhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEc
Q 005893 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421 (671)
Q Consensus 346 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 421 (671)
+.++....++|+..++||+|+||.||+++.. +++.||+|++++.. ......+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3455566788999999999999999999975 58899999986421 2233457899999999999999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
....++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999998843 35899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGL----YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
+++...... .......+||+.|+|||++.... ++.++||||||+++|||++|+.||... +......+
T Consensus 214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~ 284 (410)
T 3v8s_A 214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--------SLVGTYSK 284 (410)
T ss_dssp TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHH
T ss_pred eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC--------ChhhHHHH
Confidence 998754432 12233468999999999997665 789999999999999999999999532 22222222
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFD--RPTMSSVVV 627 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPt~~ev~~ 627 (671)
.......... + .....++ .+.+++.+||+.+|++ ||+++||++
T Consensus 285 i~~~~~~~~~--p-~~~~~s~----~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 285 IMNHKNSLTF--P-DDNDISK----EAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHTHHHHCCC--C-TTCCCCH----HHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHhccccccC--C-CcccccH----HHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 2211000000 0 0012233 2556777999999988 999999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.18 Aligned_cols=256 Identities=15% Similarity=0.151 Sum_probs=203.9
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEE------ecCCceEEEEEccccchhchHHHHHHHHHHhhcC---CCCeeeEee
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGV------LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ---HKNLVKLLG 417 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g 417 (671)
.+++...++|.+.+.||+|+||.||+|+ ..+++.||||+++... ..++..|+.++..++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3444566789999999999999999994 4468899999997643 345677777777775 999999999
Q ss_pred EEEcCCeeeEEEeccCCCchhhhhcCC--CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC----
Q 005893 418 FCVDGDEKLLVYEFMPNSSLDAILFDP--RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---- 491 (671)
Q Consensus 418 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---- 491 (671)
++...+..++||||+++|+|.+++... .....+++..++.|+.||+.||+|||+.+ |+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 999999999999999999999998532 13456999999999999999999999988 999999999999998
Q ss_pred -------CCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC
Q 005893 492 -------DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR 564 (671)
Q Consensus 492 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~ 564 (671)
++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 8999999999997654333333344568999999999999999999999999999999999999998432111
Q ss_pred CCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhcC
Q 005893 565 GATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDR-PTMSSVVVMLQG 631 (671)
Q Consensus 565 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Pt~~ev~~~L~~ 631 (671)
...+...+......+.+ .+++..|++.+|.+| |+++++.+.|+.
T Consensus 292 --------------------~~~~~~~~~~~~~~~~~---~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 292 --------------------ECKPEGLFRRLPHLDMW---NEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp --------------------EEEECSCCTTCSSHHHH---HHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred --------------------ceeechhccccCcHHHH---HHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 01112222222234434 456669999999999 778888887765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=329.73 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=201.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||+|+||.||++... +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 46888899999999999999975 68899999986432 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999884 3456899999999999999999999998 99999999999999999999999999986543332
Q ss_pred ccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ... +..+...... ..+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~---~~~~~~~~~~--~~~ 230 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQE---YSDWKEKKTY--LNP 230 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT-----SHH---HHHHHTTCTT--STT
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH-----HHH---HHHhhhcccc--cCc
Confidence 222334578999999999987765 78999999999999999999999643211 111 1112221110 000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....++ .+.+++.+||+.||++|||+.|+++
T Consensus 231 --~~~~~~----~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 --WKKIDS----APLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --GGGSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --hhhcCH----HHHHHHHHHCCCCchhCCCHHHHhc
Confidence 012222 3567788999999999999999985
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=342.30 Aligned_cols=249 Identities=23% Similarity=0.298 Sum_probs=200.8
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999975 5788999998642 2334567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999984 3456999999999999999999999998 999999999999999999999999999876433
Q ss_pred CCccccccccccCCccchhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAME---GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
. .....+||+.|+|||++.. ..++.++||||||+++|||++|+.||...... ......... ....
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~~-~~~~--- 236 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIVHTF-ETTV--- 236 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHHHHH-HHCC---
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHH-hhcc---
Confidence 2 2234689999999999864 45899999999999999999999999643221 222221111 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-MSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-~~ev~~ 627 (671)
..+...++. .+.+++.+||+.||++||+ +++|.+
T Consensus 237 ---~~~p~~~s~----~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---VTYPSAWSQ----EMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCCTTSCH----HHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---cCCCCcCCH----HHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111222333 3667778999999999999 777764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.12 Aligned_cols=205 Identities=20% Similarity=0.254 Sum_probs=176.0
Q ss_pred HhCCCCcccccCCC--CcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQG--GFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
..++|++.+.||+| +||.||+++.. +|+.||||+++.. .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34568889999999 99999999975 6899999999743 2344567889999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHH-TCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999854 22355999999999999999999999998 999999999999999999999999988654
Q ss_pred cCCCCc-----cccccccccCCccchhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 507 AGSEGE-----VNTARIVGTYGYMAPEYAME--GLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 507 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 322111 11123478999999999987 5799999999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.81 Aligned_cols=265 Identities=28% Similarity=0.381 Sum_probs=203.7
Q ss_pred CCcccccCCCCcccEEEEEec-----CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--CeeeE
Q 005893 356 FSDSNMLGQGGFGPVYKGVLS-----DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEKLL 427 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 427 (671)
|+..+.||+|+||.||++.+. +++.||||+++... ......+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 477899999999999988642 67899999997543 34456789999999999999999999999874 56789
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999843 34899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC----CCCCCHH--HHHHHHHh
Q 005893 508 GSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG----ATAPNLL--AYAWHLWN 580 (671)
Q Consensus 508 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~----~~~~~l~--~~~~~~~~ 580 (671)
...... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... ....... ........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 443221 2234567888999999999899999999999999999999999985321100 0000000 00111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
.+.. ......++ ..+.+++.+||+.||++|||+.||++.|+.....+
T Consensus 266 ~~~~-----~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 266 RGER-----LPRPDKCP----AEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TTCC-----CCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccC-----CCCCcccc----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 1111 11112233 34778888999999999999999999998754333
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=340.32 Aligned_cols=249 Identities=24% Similarity=0.249 Sum_probs=200.9
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 426 (671)
..++|+..+.||+|+||.||+++.. +|+.||||+++.. .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467888999999999999999975 4789999999753 223456688999999887 8999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++|+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999984 3356999999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||... +......... .+..
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~-~~~~-- 238 (353)
T 2i0e_A 172 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIM-EHNV-- 238 (353)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHH-HCCC--
T ss_pred ccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC--------CHHHHHHHHH-hCCC--
Confidence 32221 233468999999999999999999999999999999999999999532 2222222222 2211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
.+....++ .+.+++.+||+.||++||+ ++||++
T Consensus 239 ----~~p~~~s~----~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 ----AYPKSMSK----EAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----CCCTTSCH----HHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----CCCCCCCH----HHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11223333 3667777999999999995 477764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=342.69 Aligned_cols=266 Identities=21% Similarity=0.264 Sum_probs=204.9
Q ss_pred HHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----CCee
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEK 425 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 425 (671)
+..++|+..+.||+|+||.||++.. .+++.||||++..........+.+|+.++++++||||+++++++.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 4557799999999999999999997 5789999999977666667789999999999999999999999873 3467
Q ss_pred eEEEeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 426 LLVYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
++||||+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 8999999999999988542 23466999999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCcc-------ccccccccCCccchhhhccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH
Q 005893 505 IFAGSEGEV-------NTARIVGTYGYMAPEYAMEGL---YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 505 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~ 574 (671)
......... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||...... ...+...
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~ 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVALA 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhHH
Confidence 543211100 012246799999999987543 689999999999999999999998531111 0111111
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETIT 635 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~ 635 (671)
..... ........+. .+.+++.+||+.||++|||+.||++.|+.....
T Consensus 260 ----~~~~~-----~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 ----VQNQL-----SIPQSPRHSS----ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp ----HHCC-------CCCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred ----hhccC-----CCCccccCCH----HHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 11100 0001112232 366788899999999999999999999875533
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=369.11 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=199.3
Q ss_pred CCCccc-ccCCCCcccEEEEEec---CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 355 NFSDSN-MLGQGGFGPVYKGVLS---DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 355 ~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++...+ .||+|+||.||+|.+. ++..||||+++... ....+++.+|+.++++++|||||++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999864 45679999998643 3456789999999999999999999999976 5689999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999853 3456999999999999999999999998 999999999999999999999999999876443
Q ss_pred CCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 510 EGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 510 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.... ......+++.|+|||++..+.++.++||||||+++|||++ |+.||..... ..+ ......+....
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~----~~~i~~~~~~~- 559 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEV----MAFIEQGKRME- 559 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----HHH----HHHHHTTCCCC-
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHH----HHHHHcCCCCC-
Confidence 2221 1222356789999999999999999999999999999998 9999964221 111 12222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
....+++ .+.+++..||+.+|++||++.+|++.|+...
T Consensus 560 ----~p~~~~~----~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 560 ----CPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ----CCTTCCH----HHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCcCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1223333 3677888999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=339.85 Aligned_cols=261 Identities=23% Similarity=0.239 Sum_probs=200.2
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-----chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-----SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
+....++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4455678999999999999999999974 6788999998643 234456799999999999999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCC-------------------------------------CCCCCChHHHHHHHHHHHHH
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPR-------------------------------------KRGLLCWSKRINIVNGIVKG 465 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~g 465 (671)
+..++||||+++|+|.+++.... ....+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999884210 01224677788999999999
Q ss_pred HHHHHhCCCCceeecCCCCCcEEEcCCC--CeEEeeccccccccCCCCc--cccccccccCCccchhhhcc--CCCCcch
Q 005893 466 ILYLHEDSRLRIIHRDLKASNVLLDYDM--NPKISDFGMARIFAGSEGE--VNTARIVGTYGYMAPEYAME--GLYSIKS 539 (671)
Q Consensus 466 L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ks 539 (671)
|.|||+.+ |+||||||+|||++.++ .+||+|||+++.+...... .......||+.|+|||.+.. ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 8999999999865432221 12234579999999999865 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 005893 540 DVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDR 619 (671)
Q Consensus 540 DVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R 619 (671)
||||||+++|||++|+.||... ................. .+.. ...++ .+.+++.+||+.||++|
T Consensus 258 DiwslG~il~el~~g~~pf~~~--------~~~~~~~~~~~~~~~~~--~~~~-~~~~~----~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGV--------NDADTISQVLNKKLCFE--NPNY-NVLSP----LARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCTT--SGGG-GGSCH----HHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCC--------ChHHHHHHHHhcccccC--Cccc-ccCCH----HHHHHHHHHcCCChhHC
Confidence 9999999999999999998532 22222233332221111 1110 11222 36677889999999999
Q ss_pred CCHHHHHH
Q 005893 620 PTMSSVVV 627 (671)
Q Consensus 620 Pt~~ev~~ 627 (671)
|++.|+++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.44 Aligned_cols=276 Identities=18% Similarity=0.250 Sum_probs=212.4
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEE-EcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC-VDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||+++. .+|+.||||++..... ...+.+|+.++..++|++++..++.+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46788899999999999999996 5789999999865432 23688999999999988877666655 56667899999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE---cCCCCeEEeecccccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFA 507 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 507 (671)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999853 2346999999999999999999999998 9999999999999 588999999999998765
Q ss_pred CCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 508 GSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 508 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--TKRQKYERISEKKMST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch--hhhhhhhhhcccccCC
Confidence 543211 123457999999999999999999999999999999999999999753322 2222222222111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCccccc
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFG 647 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~~ 647 (671)
.. +.+...+++ .+.+++.+||+.||++|||++||++.|+........+..-.|.|+
T Consensus 238 ~~-----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 3uzp_A 238 PI-----EVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp CH-----HHHTTTSCH----HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred ch-----HHHHhhCCH----HHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 11 111123333 366788899999999999999999999876555555444446664
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=335.95 Aligned_cols=260 Identities=30% Similarity=0.448 Sum_probs=202.9
Q ss_pred HhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~ 424 (671)
..++|...+.||+|+||.||+++. .+++.||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 446788899999999999999984 24678999999743 34455678999999999999999999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCC----CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEE
Q 005893 425 KLLVYEFMPNSSLDAILFDPRK----RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKI 497 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl 497 (671)
.++||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999864321 245899999999999999999999998 999999999999984 456999
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHH
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
+|||+++...............|++.|+|||.+.+..++.++||||||+++|||++ |+.||.... .....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~- 255 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVL- 255 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHH-
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHH-
Confidence 99999986554433333344577899999999999999999999999999999998 999885321 11211
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....+... .....++. .+.+++.+||+.||++||++.||++.|+..
T Consensus 256 ~~~~~~~~~-----~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 256 EFVTSGGRM-----DPPKNCPG----PVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHHHTTCCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcCCCC-----CCCCCCCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 122222111 11123333 366788899999999999999999998754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=342.43 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=198.3
Q ss_pred hCCCCcccccCCCCcccEEEEEecC-----CceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD-----GKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
.++|...+.||+|+||.||+|.... +..||||+++.. .......+.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4567778999999999999998643 235999999753 3344557899999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999853 3356999999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 507 AGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 507 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
....... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||.... .... ......+..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~-~~~~~~~~~ 268 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------NHEV-MKAINDGFR 268 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHH-HHHHHTTCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------HHHH-HHHHHCCCc
Confidence 5432211 2223356788999999999999999999999999999999 999985321 1111 122222211
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
. .....++ ..+.+++.+||+.||++||++.||++.|+..
T Consensus 269 ~-----~~~~~~~----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 L-----PTPMDCP----SAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp C-----CCCTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred C-----CCcccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 1111222 2366788899999999999999999998764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.61 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=192.9
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
..++|+..+.||+|+||.||+++.. +++.||||++.... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3467888999999999999999975 68899999997543 234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC--eEEeeccccccccC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN--PKISDFGMARIFAG 508 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~ 508 (671)
|+++|+|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999884 3456999999999999999999999998 999999999999987765 99999999874322
Q ss_pred CCCccccccccccCCccchhhhccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIK-SDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||..... ............... .. .
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~~~~~~~-~~-~ 241 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----PRDYRKTIQRILSVK-YS-I 241 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTC-CC-C
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhcCC-CC-C
Confidence 21 1233579999999999988887665 8999999999999999999964322 122333222222111 10 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. ....++ .+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~--~~~~s~----~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 242 -PD--DIRISP----ECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp -CT--TSCCCH----HHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred -CC--cCCCCH----HHHHHHHHHccCChhHCcCHHHHHh
Confidence 00 012233 3667788999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=339.16 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=201.2
Q ss_pred HhCCCCccc-ccCCCCcccEEEEEec---CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 352 ATSNFSDSN-MLGQGGFGPVYKGVLS---DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 352 ~~~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
..++|...+ .||+|+||.||++.+. +++.||||+++... ....+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345566666 8999999999999642 46789999997543 23356799999999999999999999998 56678
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 999999999999999853 455899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ... .......+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~-~~~~~~~~~ 237 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSE-VTAMLEKGE 237 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHH-HHHHHHTTC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--------HHH-HHHHHHcCC
Confidence 65443322 1222456788999999998889999999999999999999 999985321 111 122222222
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.. .+...+++ .+.+++..||+.||++||++.||++.|+..
T Consensus 238 ~~-----~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 238 RM-----GCPAGCPR----EMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp CC-----CCCTTCCH----HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CC-----CCCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11223333 366788899999999999999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.59 Aligned_cols=251 Identities=21% Similarity=0.261 Sum_probs=202.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch------hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE------QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
.++|++.+.||+|+||.||++... +|+.||+|+++.... .....+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888899999999999999975 688999999865322 1356789999999999999999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC----CeEEeecc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM----NPKISDFG 501 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfg 501 (671)
++||||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999843 456899999999999999999999998 99999999999999887 79999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||... ......... ..
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~i-~~ 232 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANI-TS 232 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHH-HT
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH-Hh
Confidence 9987644321 23357899999999999999999999999999999999999998532 111221111 11
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... ..++.+....+. .+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~--~~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSY--DFDEEFFSHTSE----LAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCC--CCCHHHHTTCCH----HHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccc--ccChhhhcccCH----HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111 011111122232 3667888999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=342.33 Aligned_cols=245 Identities=24% Similarity=0.290 Sum_probs=192.0
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|+..++||+|+||+||+|+.. +|+.||||++... .......+..|+..+.++ +||||+++++++.++...++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357889999999999999999976 7899999998643 233344556666666665 999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+ +++|.+++.. ....++|..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6788887753 2346999999999999999999999998 99999999999999999999999999886543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..++... ..+..+..+...
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------------~~~~~~~~~~~~--- 270 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------------EGWQQLRQGYLP--- 270 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------------HHHHHHTTTCCC---
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------------cHHHHHhccCCC---
Confidence 32 2233568999999998765 7999999999999999999997665311 112222222211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.+....++ .+.+++.+||+.||++|||+.|+++
T Consensus 271 -~~~~~~~~~----~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 -PEFTAGLSS----ELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -HHHHTTSCH----HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cccccCCCH----HHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111222232 3677888999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.81 Aligned_cols=276 Identities=18% Similarity=0.250 Sum_probs=207.8
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEE-EcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC-VDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||+++. .+++.||||++..... ...+.+|+.++..++|++++..++.+ ......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 46799999999999999999996 5788999998764322 23578899999999988877766655 56677899999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE---cCCCCeEEeecccccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFA 507 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 507 (671)
|+ +++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred cc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 99 9999999853 2345999999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 508 GSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 508 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA--TKRQKYERISEKKMST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS--SSSSHHHHHHHHHHHS
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh--hhhhhhhhhhcccccc
Confidence 543211 223457899999999999999999999999999999999999999753322 2222222221111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCccccc
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFG 647 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~~ 647 (671)
.. +.+...+++ .+.+++..||+.||++|||++||+++|+........+..-.|.|+
T Consensus 238 ~~-----~~~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~ 293 (296)
T 4hgt_A 238 PI-----EVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 293 (296)
T ss_dssp CH-----HHHTTTSCH----HHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGG
T ss_pred hh-----hhhhccCCH----HHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchh
Confidence 10 111122232 366788899999999999999999999876554444433344443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.21 Aligned_cols=276 Identities=14% Similarity=0.166 Sum_probs=209.9
Q ss_pred hCCCCcccccCCCCcccEEEEEecC---------CceEEEEEccccchhchHHHHHHHHHHhhcCCCCeee---------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD---------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVK--------- 414 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 414 (671)
.++|...+.||+|+||.||+++... ++.||||++... ..+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4678889999999999999999753 789999998753 35789999999999999987
Q ss_pred ------EeeEEEc-CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcE
Q 005893 415 ------LLGFCVD-GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487 (671)
Q Consensus 415 ------l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NI 487 (671)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67789999999 99999999532 2366999999999999999999999998 99999999999
Q ss_pred EEcCCC--CeEEeeccccccccCCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 488 LLDYDM--NPKISDFGMARIFAGSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 488 ll~~~~--~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
|++.++ .+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 99999999998654322111 11335799999999999998999999999999999999999999964
Q ss_pred CCCCCCCCCCHHHHHHHHHhcCCccccccccccC-CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCC
Q 005893 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTD-TCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQP 639 (671)
Q Consensus 561 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p 639 (671)
.... ...+... ...+.. ......+..... ..+. .+.+++.+||+.||++|||++||+++|+........+
T Consensus 271 ~~~~---~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 271 CLPN---TEDIMKQ-KQKFVD-KPGPFVGPCGHWIRPSE----TLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GTTC---HHHHHHH-HHHHHH-SCCCEECTTSCEECCCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CCcC---HHHHHHH-HHhccC-ChhhhhhhccccCCCcH----HHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 3211 1111111 111111 122222222111 2232 3667777999999999999999999998876555555
Q ss_pred CCCccccc
Q 005893 640 QKPAFSFG 647 (671)
Q Consensus 640 ~~p~~~~~ 647 (671)
....+.|.
T Consensus 342 ~~~~~dw~ 349 (352)
T 2jii_A 342 PYDPIGLP 349 (352)
T ss_dssp TTSCCCCC
T ss_pred cCccccCc
Confidence 44455554
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.03 Aligned_cols=259 Identities=29% Similarity=0.431 Sum_probs=193.2
Q ss_pred CCCcccccCCCCcccEEEEEec--CC--ceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc-CCeeeEE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS--DG--KEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLV 428 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv 428 (671)
.|...+.||+|+||.||+|.+. ++ ..||||.++.. .......+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999864 22 36899998753 33455679999999999999999999999765 4577899
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999953 3445889999999999999999999998 99999999999999999999999999986544
Q ss_pred CCCcc--ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 509 SEGEV--NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 509 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.... ........ ..+...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-----~~~~~~~~----~~~~~~ 315 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYL----LQGRRL 315 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----SSCHHHHH----HTTCCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-----HHHHHHHH----HcCCCC
Confidence 32211 1233467789999999999999999999999999999999 677775322 12222221 122111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
.....++. .+.+++.+||+.||++|||+.||++.|+.....+
T Consensus 316 -----~~p~~~~~----~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 316 -----LQPEYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp -----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----CCCCCCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11122332 3667788999999999999999999998754333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.19 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=202.8
Q ss_pred CCCCcccccCCCCcccEEEEEe-----cCCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--Cee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-----SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG--DEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 425 (671)
+.|+..+.||+|+||.||++++ .+++.||||+++... ......+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4577789999999999999984 368899999997533 34456789999999999999999999999877 567
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999843 2345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCc-cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC------CCCCCCCHHHHHHHH
Q 005893 506 FAGSEGE-VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQS------RGATAPNLLAYAWHL 578 (671)
Q Consensus 506 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~------~~~~~~~l~~~~~~~ 578 (671)
....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..... ...............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6554322 222345688889999999999999999999999999999999988642110 000000111111111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 579 WNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 579 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+... .....++ ..+.+++.+||+.||++|||+.||++.|+.
T Consensus 256 ~~~~~~~-----~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 256 LKEGKRL-----PCPPNCP----DEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHTTCCC-----CCCTTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HhccCCC-----CCCCCCC----HHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111111 1112233 346778889999999999999999999974
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.94 Aligned_cols=260 Identities=21% Similarity=0.245 Sum_probs=197.4
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch---hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE---QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
-++|...+.||+|+||.||++... +++.||||++..... .....+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 367888999999999999999975 688999999975422 2346788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999843 356899999999999999999999998 99999999999999999999999999876544
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .. ............
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~-~~~~~~~~~~~~--- 253 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ--------LS-VMGAHINQAIPR--- 253 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH--------HH-HHHHHHHSCCCC---
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch--------HH-HHHHHhccCCCC---
Confidence 3221 2223578999999999999999999999999999999999999985321 11 111222221110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhcCCCCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-TMSSVVVMLQGETIT 635 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-t~~ev~~~L~~~~~~ 635 (671)
...+...+++ .+.+++.+||+.||++|| +++++++.|+.....
T Consensus 254 ~~~~~~~~~~----~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 PSTVRPGIPV----AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp GGGTSTTCCT----HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred ccccCCCCCH----HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0111223333 366778899999999999 999999999875433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.97 Aligned_cols=279 Identities=25% Similarity=0.364 Sum_probs=202.5
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
...+..+..++|+..+.||+|+||.||+|...+ .+|+|+++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 344455566789999999999999999998743 59999987432 23344577899999999999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
...++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++ ++.+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence 999999999999999999853 3346899999999999999999999998 99999999999998 67999999999
Q ss_pred cccccCCCC---ccccccccccCCccchhhhcc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005893 503 ARIFAGSEG---EVNTARIVGTYGYMAPEYAME---------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570 (671)
Q Consensus 503 a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~ 570 (671)
++....... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--------~ 247 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--------P 247 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC--------C
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC--------C
Confidence 876432211 112223468999999999864 45789999999999999999999998532 2
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCCCCCcccccc
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPAFSFGR 648 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p~~p~~~~~~ 648 (671)
.....+... .+....... ..++. .+.+++..||+.||++|||+.||+++|+...........|..+|.+
T Consensus 248 ~~~~~~~~~-~~~~~~~~~----~~~~~----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~ 316 (319)
T 2y4i_B 248 AEAIIWQMG-TGMKPNLSQ----IGMGK----EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316 (319)
T ss_dssp HHHHHHHHH-TTCCCCCCC----SSCCT----THHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred HHHHHHHhc-cCCCCCCCc----CCCCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence 222222222 221111111 11222 2667888999999999999999999999988777777888888754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=353.97 Aligned_cols=249 Identities=23% Similarity=0.253 Sum_probs=193.3
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
..++|+..+.||+|+||.||++... +|+.||||+++.. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 3467888999999999999999964 6889999999752 23344567889999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
||||+++|+|..++. ..+.+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999884 34568999999999999999999998 77 999999999999999999999999999864
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||... ............. .
T Consensus 300 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--------~~~~~~~~i~~~~-~-- 366 (446)
T 4ejn_A 300 IKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHEKLFELILMEE-I-- 366 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCC-C--
T ss_pred cCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC--------CHHHHHHHHHhCC-C--
Confidence 33222 223468999999999999999999999999999999999999999532 2222222222111 1
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.+....++ .+.+++.+||+.||++|| +++|+++
T Consensus 367 ----~~p~~~~~----~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 ----RFPRTLGP----EAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----CCCTTSCH----HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCccCCH----HHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11223333 366777899999999999 9999986
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.40 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=201.2
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|...+.||+|+||.||++... ++..||+|++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 356888899999999999999975 4778999999876556677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE---cCCCCeEEeeccccccccC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~ 508 (671)
+++++|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999988843 455899999999999999999999998 9999999999999 7889999999999987644
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||.... ....... ...+....
T Consensus 162 ~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~-~~~~~~~~-- 226 (277)
T 3f3z_A 162 GKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT--------DSEVMLK-IREGTFTF-- 226 (277)
T ss_dssp TSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH-HHHCCCCC--
T ss_pred ccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC--------HHHHHHH-HHhCCCCC--
Confidence 322 233578999999998764 58999999999999999999999985321 1122212 12221110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
........+ ..+.+++.+|++.||++|||+.|+++
T Consensus 227 ~~~~~~~~~----~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 227 PEKDWLNVS----PQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CchhhhcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001122 23667888999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=328.80 Aligned_cols=248 Identities=28% Similarity=0.434 Sum_probs=180.4
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+++. .+|+.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4678889999999999999997 478999999986432 223467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999853 3356899999999999999999999998 999999999999999999999999999875432
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..... .+
T Consensus 166 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-------~~~~~---~~ 228 (278)
T 3cok_A 166 HEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-----NTL-------NKVVL---AD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------CCS---SC
T ss_pred CCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-----HHH-------HHHhh---cc
Confidence 211 22357899999999999889999999999999999999999998643221 000 00000 01
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+....+. .+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 YEMPSFLSI----EAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCCTTSCH----HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCccccCH----HHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111222333 3667788999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=343.38 Aligned_cols=246 Identities=23% Similarity=0.255 Sum_probs=190.1
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHH-HhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLL-ILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.++|+..+.||+|+||.||+++.. +++.||||++++.. ......+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 356888999999999999999975 57889999997532 2233456667766 467899999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++|+|..++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999884 3456889999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||... +........... ..
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------~~~~~~~~i~~~-~~--- 256 (373)
T 2r5t_A 191 EHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------NTAEMYDNILNK-PL--- 256 (373)
T ss_dssp CCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--------BHHHHHHHHHHS-CC---
T ss_pred cCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhc-cc---
Confidence 3222 233468999999999999999999999999999999999999999532 222222222221 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev 625 (671)
.+....+. .+.+++.+||+.||++||++.+.
T Consensus 257 ---~~~~~~~~----~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 257 ---QLKPNITN----SARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp ---CCCSSSCH----HHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ---CCCCCCCH----HHHHHHHHHcccCHHhCCCCCCC
Confidence 11223333 35677779999999999998543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.99 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=201.7
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD---------- 421 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 421 (671)
..+|+..+.||+|+||.||++... +++.||+|+++... ..+.+|+.++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356888899999999999999985 78999999997543 246789999999999999999998864
Q ss_pred ------CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 422 ------GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 422 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
....++||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+||++++++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHH-GGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 3457899999999999999854 22356899999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ...
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----------~~~ 227 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----------SKF 227 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----------HHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----------HHH
Confidence 9999999987654322 22346899999999999999999999999999999999998875210 111
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCCCCC
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQP 639 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~~~p 639 (671)
+.....+. +...++. .+.+++.+||+.||++|||+.|+++.|+.........
T Consensus 228 ~~~~~~~~--------~~~~~~~----~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 228 FTDLRDGI--------ISDIFDK----KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHHHTTC--------CCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HHHhhccc--------ccccCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 11222221 2222333 2567778999999999999999999998765444433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=346.41 Aligned_cols=264 Identities=25% Similarity=0.270 Sum_probs=191.0
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEE-------
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCV------- 420 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~------- 420 (671)
+....+|+..++||+|+||.||+++.. +++.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 344567888999999999999999964 68899999997666666778899999999996 999999999994
Q ss_pred -cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 421 -DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 421 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
.....++||||+. |+|.+++......+.+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 2334789999996 788888754445567999999999999999999999874 3499999999999999999999999
Q ss_pred ccccccccCCCCcc----------ccccccccCCccchhhh---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005893 500 FGMARIFAGSEGEV----------NTARIVGTYGYMAPEYA---MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGA 566 (671)
Q Consensus 500 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~ 566 (671)
||+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 99998765432211 11134689999999998 5667899999999999999999999998532111
Q ss_pred CCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 567 TAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
.. ... .. ........+ ..+.+++..||+.||++|||+.|+++.|+......
T Consensus 260 ------~~----~~~-~~----~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 260 ------RI----VNG-KY----SIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------------C----CCCTTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred ------Hh----hcC-cc----cCCcccccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 00 000 00 000011111 12567788999999999999999999998764433
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=345.42 Aligned_cols=269 Identities=23% Similarity=0.278 Sum_probs=210.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC--eeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lv 428 (671)
.++|...++||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 356888899999999999999975 58999999997533 334567889999999999999999999998765 67999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE----cCCCCeEEeeccccc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL----DYDMNPKISDFGMAR 504 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~Dfgla~ 504 (671)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999965444455999999999999999999999998 9999999999999 777889999999998
Q ss_pred cccCCCCccccccccccCCccchhhhcc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAME--------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...... ........
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~----~~~~~~~~ 237 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----RRNKEVMY 237 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCT----TTCHHHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcc----cchHHHHH
Confidence 764332 2233578999999999865 56788999999999999999999999643322 11122222
Q ss_pred HHHhcCCcccccc-------------ccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 577 HLWNEGNALDLID-------------PLL--TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 577 ~~~~~~~~~~~~d-------------~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+.... .+...+. ..+ ....+......+.+++..||+.||++||++.|+++.|+..
T Consensus 238 ~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 238 KIITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHHHS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 22222 2111100 011 1123455666778899999999999999999998887653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.71 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=195.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc-----hhchHHHHHHHHHHhhc---CCCCeeeEeeEEEcC
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-----EQGNAEFTNEVLLILKL---QHKNLVKLLGFCVDG 422 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~ 422 (671)
..++|++.+.||+|+||.||+++. .+++.||||+++... ......+.+|+.+++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 468899999986322 12234566777777766 499999999999876
Q ss_pred C-----eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEE
Q 005893 423 D-----EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKI 497 (671)
Q Consensus 423 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 497 (671)
. ..++||||+. ++|.+++.. .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK-APPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT-CCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 699998854 23344999999999999999999999998 999999999999999999999
Q ss_pred eeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 498 SDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----ADQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-----HHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHH
Confidence 9999998654332 22346789999999999999999999999999999999999999853221 111111111
Q ss_pred HHhcCCcccc------ccccccC--CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 578 LWNEGNALDL------IDPLLTD--TCS-----PDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 578 ~~~~~~~~~~------~d~~l~~--~~~-----~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.......... ....+.. ..+ ++....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111110000 0000000 000 011134677888999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=325.01 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=201.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.++|++.+.||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467888999999999999999975 5889999998643 3344567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC---eEEeeccccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN---PKISDFGMARIF 506 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~ 506 (671)
||+++++|.+.+. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988874 3456899999999999999999999998 999999999999987655 999999999765
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||... ........ ...+...
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~--------~~~~~~~~-~~~~~~~- 225 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--------DQHRLYAQ-IKAGAYD- 225 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHH-HHHTCCC-
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC--------chhHHHHH-HHhcccc-
Confidence 43322 22357899999999999999999999999999999999999998532 11222111 1221111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+ .....++ .+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~-~~~~~~~----~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 YPSP-EWDTVTP----EAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCTT-TTTTSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCch-hhcccCH----HHHHHHHHHcccChhhCCCHHHHhc
Confidence 0011 0112233 3667788999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.98 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=197.4
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 456888899999999999999875 57789999986422 22345788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999884 3356899999999999999999999988 99999999999999999999999999865433
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||... ......... ....
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~-~~~~----- 223 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETYKRI-SRVE----- 223 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHH-HHTC-----
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC--------cHHHHHHHH-HhCC-----
Confidence 21 23357899999999999999999999999999999999999998532 222221111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+....+. .+.+++.+||+.||++|||+.||++
T Consensus 224 -~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 224 -FTFPDFVTE----GARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -CCCCTTSCH----HHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCCCcCCH----HHHHHHHHHhccChhhCCCHHHHhh
Confidence 111122222 3567778999999999999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.44 Aligned_cols=262 Identities=22% Similarity=0.265 Sum_probs=196.1
Q ss_pred CCCCcc-cccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDS-NMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 430 (671)
+.|.+. +.||+|+||.||+++. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456663 7899999999999996 46899999999766555667889999999985 79999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC---eEEeecccccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN---PKISDFGMARIFA 507 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgla~~~~ 507 (671)
|+++++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999843 356899999999999999999999998 999999999999998776 9999999987654
Q ss_pred CCCC-----ccccccccccCCccchhhhcc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCC---CC---H
Q 005893 508 GSEG-----EVNTARIVGTYGYMAPEYAME-----GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATA---PN---L 571 (671)
Q Consensus 508 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~---~~---l 571 (671)
.... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||.......... .. .
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223469999999999875 568899999999999999999999996533221000 00 0
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..........+... .... .....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~i~~~~~~-~~~~-~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEGKYE-FPDK-DWAHIS----CAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHCCCC-CCHH-HHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhccCcc-cCch-hcccCC----HHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11111222222110 0000 001122 23667888999999999999999997
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=332.16 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=199.8
Q ss_pred HhCCCCcccccCCCCcccEEEEEecC----CceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
..++|...+.||+|+||.||+|+..+ +..||+|++... .......+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 34568888999999999999998643 235999999764 33455679999999999999999999999764 4578
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999853 3345899999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||..... ...... ...+...
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~~~~----~~~~~~~ 233 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDVIGV----LEKGDRL 233 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGHHHH----HHHTCCC
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHHHHH----HhcCCCC
Confidence 443221 1223466889999999998999999999999999999998 9999853221 122221 1111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+++ .+.+++.+||+.||++|||+.||++.|+.
T Consensus 234 -----~~~~~~~~----~l~~li~~~l~~~p~~Rps~~ell~~L~~ 270 (281)
T 3cc6_A 234 -----PKPDLCPP----VLYTLMTRCWDYDPSDRPRFTELVCSLSD 270 (281)
T ss_dssp -----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCCCH----HHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence 11122232 36677889999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=336.10 Aligned_cols=250 Identities=23% Similarity=0.262 Sum_probs=178.1
Q ss_pred ccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEeccCCCc
Q 005893 359 SNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNSS 436 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gs 436 (671)
.+.||+|+||.||++... +++.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 6889999998653 3456788999999996 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC---CeEEeeccccccccCCCCcc
Q 005893 437 LDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM---NPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 437 L~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~ 513 (671)
|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++........
T Consensus 93 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 93 LFERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 9999843 456999999999999999999999998 99999999999998765 8999999999865443222
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......... .....+.... .....
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~-~~i~~~~~~~--~~~~~ 240 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIM-KKIKKGDFSF--EGEAW 240 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHH-HHHTTTCCCC--CSHHH
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHH-HHHHcCCCCC--Ccccc
Confidence 233578999999999999999999999999999999999999996433211 111222222 2222222110 00000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+ ..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~s----~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVS----QEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSC----HHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCC----HHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 1122 24667888999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.22 Aligned_cols=253 Identities=29% Similarity=0.393 Sum_probs=199.0
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|.....||+|+||.||+|.. .+++.||||++..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455567899999999999996 468899999998766666678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeeccccccccCCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~ 511 (671)
++++|.+++........+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999965444456788999999999999999999998 999999999999987 89999999999987543221
Q ss_pred ccccccccccCCccchhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
......|++.|+|||.+..+. ++.++||||||+++|||++|+.||.... ............. ..
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~-----~~ 244 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG-------EPQAAMFKVGMFK-----VH 244 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS-------SHHHHHHHHHHHC-----CC
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC-------chhHHHHhhcccc-----cc
Confidence 123357899999999987654 8899999999999999999999985321 1111111111111 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.+....++ .+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 PEIPESMSA----EAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCTTSCH----HHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ccccccCCH----HHHHHHHHHccCChhhCCCHHHHhc
Confidence 222233333 3667788999999999999999985
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.56 Aligned_cols=206 Identities=27% Similarity=0.321 Sum_probs=178.2
Q ss_pred echhhHHHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC-----CCCeeeEee
Q 005893 344 IDLETLDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-----HKNLVKLLG 417 (671)
Q Consensus 344 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~g 417 (671)
+.+.+.....++|.+.++||+|+||.||+++. .+++.||||+++.. ......+..|+.++.+++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34455556678999999999999999999997 46889999999753 334456778999999886 999999999
Q ss_pred EEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC------
Q 005893 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY------ 491 (671)
Q Consensus 418 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~------ 491 (671)
++...+..++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITR-NNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccc
Confidence 999999999999999 9999999854 23345899999999999999999999998 999999999999975
Q ss_pred -------------------CCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHH
Q 005893 492 -------------------DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEII 552 (671)
Q Consensus 492 -------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ell 552 (671)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 7899999999998643322 2357899999999999999999999999999999999
Q ss_pred hCCCCCCC
Q 005893 553 TGRRNTGF 560 (671)
Q Consensus 553 tG~~p~~~ 560 (671)
+|+.||..
T Consensus 254 ~g~~pf~~ 261 (360)
T 3llt_A 254 TGSLLFRT 261 (360)
T ss_dssp HSSCSCCC
T ss_pred HCCCCCCC
Confidence 99999953
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=339.09 Aligned_cols=245 Identities=30% Similarity=0.436 Sum_probs=196.9
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
+.|+..+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4478889999999999999996 578999999986432 233457889999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 677776642 2456899999999999999999999998 999999999999999999999999999865332
Q ss_pred CCccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
....||+.|+|||++. .+.++.++||||||+++|||++|+.||... ......+........ .
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~--------~~~~~~~~~~~~~~~-~ 272 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNESP-A 272 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCCC-C
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHHhcCCC-C
Confidence 2357899999999985 567899999999999999999999998422 222222333222211 1
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. ....++ + .+.+++.+||+.||++|||+.|+++
T Consensus 273 ~----~~~~~~-~---~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 273 L----QSGHWS-E---YFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp C----CCTTSC-H---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C----CCCCCC-H---HHHHHHHHHcccChhhCcCHHHHhh
Confidence 1 112223 2 2567777999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=338.03 Aligned_cols=241 Identities=24% Similarity=0.293 Sum_probs=197.7
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccch--------hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSE--------QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 423 (671)
.++|+..+.||+|+||.||+++. .+++.||||+++.... .....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46788999999999999999986 4688999999875321 12335678999999999999999999999999
Q ss_pred eeeEEEeccCCC-chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 424 EKLLVYEFMPNS-SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 424 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
..++||||+.+| +|..++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999777 9999884 3446999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------- 236 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------- 236 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------
Confidence 987644322 223578999999999988876 88999999999999999999998531110
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...... ....+++ .+.+++..||+.||++|||+.|+++
T Consensus 237 --~~~~~~--~~~~~~~----~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 --VEAAIH--PPYLVSK----ELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp --TTTCCC--CSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HhhccC--CCcccCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 0112232 3667777999999999999999997
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.10 Aligned_cols=259 Identities=27% Similarity=0.365 Sum_probs=201.3
Q ss_pred CCcccccCCCCcccEEEEEecC-C---ceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee-eEEE
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSD-G---KEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-LLVY 429 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lv~ 429 (671)
|...++||+|+||.||+|.+.+ + ..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++||
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 4456889999999999998632 2 369999987533 34456789999999999999999999999877665 8999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 103 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 103 PYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999854 3456899999999999999999999998 999999999999999999999999999865433
Q ss_pred CC--ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 510 EG--EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 510 ~~--~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.. ........+++.|+|||.+.+..++.++||||||+++|||++|..|+.... ....+... ...+...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----~~~~~~~~----~~~~~~~-- 247 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----DPFDLTHF----LAQGRRL-- 247 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----CGGGHHHH----HHTTCCC--
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----CHHHHHHH----hhcCCCC--
Confidence 21 112234577889999999999999999999999999999999665542211 11122221 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
......+. .+.+++.+||+.||++|||+.|+++.|+.....+
T Consensus 248 ---~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 248 ---PQPEYCPD----SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp ---CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---CCCccchH----HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 11122232 3667788999999999999999999998754443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=332.68 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=185.8
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
...++|...+.||+|+||.||++... +++.||||++.... .....++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 45578999999999999999999864 68899999986532 33455788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcC-----CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 429 YEFMPNSSLDAILFD-----PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
|||+++++|.+++.. ......+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999998853 123456999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCc---cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 504 RIFAGSEGE---VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 504 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
......... .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...... ... ....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~---~~~~ 240 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----KVL---MLTL 240 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----GHH---HHHH
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----hHH---HHHh
Confidence 765432211 11233578999999999876 57899999999999999999999998643211 111 1111
Q ss_pred hcCCc---cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNA---LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~---~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..... ....++.+...++. .+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QNDPPSLETGVQDKEMLKKYGK----SFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TSSCCCTTC-----CCCCCCCH----HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCCccccccccchhhhhhhH----HHHHHHHHHccCChhhCcCHHHHhh
Confidence 11110 01111222233333 3667788999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.09 Aligned_cols=260 Identities=24% Similarity=0.380 Sum_probs=196.9
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|.+.+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 4688899999999999999996 47899999998742 3344567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
||+++++|.+++... .....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999988532 23456899999999999999999999998 99999999999999999999999999886543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ......... ........
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~-~~~~~~~~-- 257 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKK-IEQCDYPP-- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHH-HHTTCSCC--
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHH-hhcccCCC--
Confidence 322 1223578999999999999999999999999999999999999985321 122222222 22222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
.....++. .+.+++.+||+.||++|||+.||+++|+...
T Consensus 258 --~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 258 --LPSDHYSE----ELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp --CCTTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CcccccCH----HHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11122233 3667778999999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.99 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=195.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|...+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46788899999999999999974 68899999987533 33457889999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE---cCCCCeEEeecccccccc
Q 005893 432 MPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFA 507 (671)
Q Consensus 432 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 507 (671)
+++++|.+++... .....+++..++.++.||+.||.|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888532 22356999999999999999999999998 9999999999999 456889999999998654
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||... ..................
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~--------~~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGT--------SLEEVQQKATYKEPNYAV 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCC
T ss_pred Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCC--------CHHHHHhhhccCCccccc
Confidence 3321 23457899999999875 57899999999999999999999998532 222222221111111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.....++ .+.+++.+||+.||++|||+.||++
T Consensus 247 ----~~~~~~~----~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 ----ECRPLTP----QAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ------CCCCH----HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----ccCcCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111232 3567778999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=332.53 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=199.2
Q ss_pred hCCCCcccccCCCCcccEEEEEecC----CceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEc-CCeee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 426 (671)
..+|+..+.||+|+||.||+|...+ ...+|+|.+.... ......+.+|+.++++++||||+++++++.. +...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3457778999999999999998642 2358999987533 3445678999999999999999999998654 45778
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999953 3456899999999999999999999998 999999999999999999999999999866
Q ss_pred cCCCCc--cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 507 AGSEGE--VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 507 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+.... ........ ..+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~~~~----~~~~ 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYL----LQGR 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-----TTTHHHHH----HTTC
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHH----hcCC
Confidence 443211 12233467889999999999999999999999999999999 455553221 11222211 1111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
. .......+. .+.+++.+||+.||++|||++|+++.|+...
T Consensus 250 ~-----~~~~~~~~~----~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 250 R-----LLQPEYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp C-----CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCCCccCCH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111122232 3667788999999999999999999998653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=330.48 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=195.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|+..+.||+|+||.||++... +|+.||||++.... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 56888999999999999999975 58999999986533 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|..++. ..+.+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999999874 3456899999999999999999999998 9999999999999999999999999998764332
Q ss_pred CccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH-----------
Q 005893 511 GEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL----------- 578 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~----------- 578 (671)
.. .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 DY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-----DQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCHHHHHH
T ss_pred cc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhcccccccccc
Confidence 21 223578999999999876 67899999999999999999999998543211 111111111
Q ss_pred HhcCCcccc---cccc-------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 579 WNEGNALDL---IDPL-------LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 579 ~~~~~~~~~---~d~~-------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+........ .++. .....+ ..+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNIS----YPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCC----HHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhccccc----HHHHHHHHHHccCChhhcCCHHHHhc
Confidence 111000000 0000 001122 23678888999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=334.23 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=196.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhh--cCCCCeeeEeeEEEcC----Cee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILK--LQHKNLVKLLGFCVDG----DEK 425 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~----~~~ 425 (671)
..++|++.+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++... ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 4467999999999999999999985 8999999986432 2344455555554 4999999999999887 678
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-----CCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS-----RLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 999999999999999843 35899999999999999999999870 112999999999999999999999999
Q ss_pred cccccccCCCCcc--ccccccccCCccchhhhccCCCCcc------hhhHHHHHHHHHHHhC----------CCCCCCCC
Q 005893 501 GMARIFAGSEGEV--NTARIVGTYGYMAPEYAMEGLYSIK------SDVFSFGVLLIEIITG----------RRNTGFNQ 562 (671)
Q Consensus 501 gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------sDVwSlGvil~elltG----------~~p~~~~~ 562 (671)
|+++......... ......||+.|+|||++.....+.+ +||||||+++|||++| +.||....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9997664433221 1223579999999999987766654 9999999999999999 44543221
Q ss_pred CCCCCCCCHHHHHHHHHhcCCccccccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 563 SRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTC-SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 563 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.. .... ............ .+.+.... ..+....+.+++.+||+.||++|||+.||++.|+..
T Consensus 267 ~~---~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 267 PS---DPSY-EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CS---SCCH-HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---CCch-hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 11 1111 111111111111 11111111 124455688899999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.86 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=203.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+.|+..+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++.+++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45788899999999999999864 68899999986533 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999984 346899999999999999999999998 99999999999999999999999999987644322
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ........ ..+.. +.
T Consensus 175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~-----~~ 238 (303)
T 3a7i_A 175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLI-PKNNP-----PT 238 (303)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHH-HHSCC-----CC
T ss_pred --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHh-hcCCC-----CC
Confidence 2234578999999999999999999999999999999999999985321 11211111 11111 12
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+...++. .+.+++..||+.||++|||+.|+++
T Consensus 239 ~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 239 LEGNYSK----PLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCSSCCH----HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CccccCH----HHHHHHHHHcCCChhhCcCHHHHhh
Confidence 2233333 3667788999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=336.57 Aligned_cols=266 Identities=26% Similarity=0.405 Sum_probs=206.1
Q ss_pred hCCCCcccccCCCCcccEEEEEe-----cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC--ee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-----SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD--EK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~ 425 (671)
.++|+..+.||+|+||.||++.+ .+++.||||++..........+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45678889999999999999984 368899999998766666778999999999999999999999987654 67
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 899999999999999854 2345899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCC-----CC-CC-CCHHHHHHH
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSR-----GA-TA-PNLLAYAWH 577 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~-----~~-~~-~~l~~~~~~ 577 (671)
........ ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... +. .. .........
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 65443221 122345677899999999888999999999999999999999887532100 00 00 000111111
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
....+.. ......++. .+.+++.+||+.||++|||+.||++.|+..
T Consensus 275 ~~~~~~~-----~~~~~~~~~----~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGR-----LPRPDGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCC-----CCCCTTCCH----HHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCC-----CCCCCcccH----HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111111 111122333 366788899999999999999999999754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=368.63 Aligned_cols=248 Identities=28% Similarity=0.388 Sum_probs=195.6
Q ss_pred cccCCCCcccEEEEEec---CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLS---DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
+.||+|+||.||+|.+. .++.||||+++... .....++.+|+.++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 46789999997533 2345789999999999999999999999864 557899999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc-c
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE-V 513 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~ 513 (671)
|+|.+++. ..+.+++..++.|+.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999994 3456999999999999999999999998 999999999999999999999999999876543322 1
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......+|+.|+|||++....++.++||||||+++|||++ |+.||.... ..+ .......+... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--------~~~-~~~~i~~~~~~-----~~ 593 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSE-VTAMLEKGERM-----GC 593 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHH-HHHHHHTTCCC-----CC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHH-HHHHHHcCCCC-----CC
Confidence 2233457789999999999999999999999999999998 999985321 111 12222222211 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
...++. .+.+++..||+.||++||++.+|++.|+..
T Consensus 594 p~~~~~----~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 PAGCPR----EMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CTTCCH----HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 223333 366788899999999999999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=325.14 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=200.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|+..+.||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46788899999999999999975 57889999986422 223457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999998843 346899999999999999999999988 999999999999999999999999998765332
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ......... ...
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~-~~~------ 228 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------HTETHRRIV-NVD------ 228 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-TTC------
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------HhHHHHHHh-ccc------
Confidence 1 233578999999999999999999999999999999999999985321 122211111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+....+. .+.+++.+|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 229 LKFPPFLSD----GSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCCTTSCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCcCCH----HHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 112222332 3567778999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=341.29 Aligned_cols=200 Identities=29% Similarity=0.492 Sum_probs=161.8
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCC--eee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGD--EKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~ 426 (671)
.++|+..+.||+|+||.||++.. .+|+.||||++... .......+.+|+.++.++. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46789999999999999999986 46899999998642 3444567889999999997 999999999998554 679
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||++ ++|..++.. +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999997 688888843 46899999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCC-------------------ccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 507 AGSEG-------------------EVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 507 ~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 43111 111233589999999999876 6789999999999999999999999953
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.16 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=205.0
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhh--cCCCCeeeEeeEEEcCC----
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILK--LQHKNLVKLLGFCVDGD---- 423 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~---- 423 (671)
....++|...+.||+|+||.||+++. +|+.||||++... ....+.+|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44557899999999999999999998 5899999999653 33467788888877 79999999999998876
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH--------hCCCCceeecCCCCCcEEEcCCCCe
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH--------EDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
..++||||+++|+|.+++.. ..+++..++.++.||+.||.||| +.+ |+||||||+|||++.++++
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999843 35899999999999999999999 666 9999999999999999999
Q ss_pred EEeeccccccccCCCCcc--ccccccccCCccchhhhccC------CCCcchhhHHHHHHHHHHHhC----------CCC
Q 005893 496 KISDFGMARIFAGSEGEV--NTARIVGTYGYMAPEYAMEG------LYSIKSDVFSFGVLLIEIITG----------RRN 557 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~ksDVwSlGvil~elltG----------~~p 557 (671)
||+|||+++......... ......||+.|+|||.+... .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765543221 22345799999999998765 234789999999999999999 566
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 558 TGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDT-CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
|...... ......+. ........ .+.+... ...+....+.+++.+||+.||++|||+.||++.|+..
T Consensus 267 ~~~~~~~---~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPS---DPSVEEMR-KVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCS---SCCHHHHH-HHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcC---cccHHHHH-HHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6432211 11222222 22222111 1111111 1234556788899999999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.33 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=202.2
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 356788899999999999999975 5788999998643 234456788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999874 3456899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||... ...+.... ......
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~~~-~~~~~~---- 232 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--------CLKETYLR-IKKNEY---- 232 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHH-HHTTCC----
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHH-HhhccC----
Confidence 222 123357899999999999889999999999999999999999998532 12222111 122111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+....++ .+.+++.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~~~----~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 --SIPKHINP----VAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --CCCTTSCH----HHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCccccCH----HHHHHHHHHcccChhhCcCHHHHhh
Confidence 11222332 3667788999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=324.24 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=198.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch------hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE------QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
++|...+.||+|+||.||++... +++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45788899999999999999975 689999999864321 23567999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC----CeEEeeccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM----NPKISDFGM 502 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 502 (671)
+||||+++++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999984 3456899999999999999999999998 99999999999998877 899999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
+........ .....|++.|+|||.+....++.++||||||+++|||++|+.||.... ..... ......
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~-~~~~~~ 226 (283)
T 3bhy_A 159 AHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------KQETL-TNISAV 226 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHH-HHHHTT
T ss_pred ceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------hHHHH-HHhHhc
Confidence 986543321 223568999999999998999999999999999999999999985321 11111 111111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... .........+ ..+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~--~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 NYD--FDEEYFSNTS----ELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCC--CCHHHHTTCC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccC--CcchhcccCC----HHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 110 1111111222 23667888999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.08 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=199.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|...+.||+|+||.||+++.. +|+.||+|+++.........+.+|+.++.+++||||+++++++.+....++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 46788899999999999999975 68999999998655445567899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE---cCCCCeEEeeccccccccCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~~~ 509 (671)
++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||++ ++++.+||+|||+++.....
T Consensus 89 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 89 SGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999998843 456899999999999999999999998 9999999999999 78899999999998754322
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..... .....+... ..
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~-~~i~~~~~~--~~ 227 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLF-EKIKEGYYE--FE 227 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHH-HHHHHCCCC--CC
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHH-HHHHcCCCC--CC
Confidence 1233578999999999999999999999999999999999999985321 11111 122222110 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.......++ .+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SPFWDDISE----SAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTTSCH----HHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCH----HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111122333 3667888999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=331.44 Aligned_cols=250 Identities=30% Similarity=0.409 Sum_probs=194.6
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-CeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~ 431 (671)
.++|+..+.||+|+||.||++.. +|+.||||+++... ..+.+.+|+.++.+++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 45688889999999999999987 58899999997543 456789999999999999999999997655 468999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHH-HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHh-cccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 999999999843 12233789999999999999999999998 9999999999999999999999999987543321
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+. .....+. ..
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~----~~~~~~~-----~~ 233 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVV----PRVEKGY-----KM 233 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHH----HHHTTTC-----CC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH----HHHhcCC-----CC
Confidence 22356889999999999999999999999999999998 9999864321 1111 1111211 11
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....+++ .+.+++.+||+.||++|||+.|+++.|+..
T Consensus 234 ~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 234 DAPDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccCCH----HHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 12223333 366777899999999999999999998753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=333.08 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=204.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|...+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 356888899999999999999975 5788999998643 234456788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999884 3456899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||... ........ ......
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------~~~~~~~~-~~~~~~---- 258 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS--------CLKETYLR-IKKNEY---- 258 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHH-HHHTCC----
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC--------CHHHHHHH-HhcCCC----
Confidence 222 123357899999999999999999999999999999999999998532 12222111 112111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGE 632 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~ 632 (671)
.+....++ .+.+++.+||+.||++|||+.|+++ .+...
T Consensus 259 --~~~~~~~~----~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 259 --SIPKHINP----VAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp --CCCTTSCH----HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred --CCCccCCH----HHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 11222333 3567778999999999999999986 45443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.85 Aligned_cols=266 Identities=26% Similarity=0.343 Sum_probs=193.2
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHH--HHHHhhcCCCCeeeEeeEEEc-----CCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNE--VLLILKLQHKNLVKLLGFCVD-----GDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E--~~~l~~l~H~niv~l~g~~~~-----~~~~ 425 (671)
.++|+..+.||+|+||.||+|+. +++.||||++..... ..+..| +..+..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788889999999999999987 689999999975332 233344 444556899999999986542 2256
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC---------CCCceeecCCCCCcEEEcCCCCeE
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED---------SRLRIIHRDLKASNVLLDYDMNPK 496 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~---------~~~~ivH~Dlkp~NIll~~~~~~k 496 (671)
++||||+++|+|.+++.. ...++..++.++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 899999999999999843 3358999999999999999999998 6 99999999999999999999
Q ss_pred EeeccccccccCCCC------ccccccccccCCccchhhhcc-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 005893 497 ISDFGMARIFAGSEG------EVNTARIVGTYGYMAPEYAME-------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQS 563 (671)
Q Consensus 497 l~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvil~elltG~~p~~~~~~ 563 (671)
|+|||+++....... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 111223579999999999876 4567899999999999999999777643222
Q ss_pred CCCCCCCHH---------HHHHHHHhcCCccccccccccCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 564 RGATAPNLL---------AYAWHLWNEGNALDLIDPLLTDTC--SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 564 ~~~~~~~l~---------~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
......... ............ .+.+.... .......+.+++.+||+.||++|||++||++.|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l 316 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence 111111110 000111111111 11111111 123445678888999999999999999999999874
Q ss_pred C
Q 005893 633 T 633 (671)
Q Consensus 633 ~ 633 (671)
.
T Consensus 317 l 317 (336)
T 3g2f_A 317 M 317 (336)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=353.48 Aligned_cols=254 Identities=26% Similarity=0.340 Sum_probs=204.7
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
..++|+..+.||+|+||.||++... +|+.||||++... .......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3466888899999999999999975 6899999999653 22345568899999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++|+|..++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 99999999999988642 2345999999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .+......
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~~~i-~~~i~~~~---- 405 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEV-ERLVKEVP---- 405 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCHHHH-HHHHHHCC----
T ss_pred cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhHHHH-HHHhhccc----
Confidence 4322 22358999999999999989999999999999999999999999643211 111111 12221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
..+...+++ .+.+++.+||+.||++|| +++||++
T Consensus 406 --~~~p~~~s~----~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 --EEYSERFSP----QARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCTTSCH----HHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --ccCCccCCH----HHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111223333 366777799999999999 7888875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=336.53 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=200.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCce--EEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKE--IAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
++|+..+.||+|+||.||+++.. ++.. +|+|+++.. .......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888899999999999999964 4554 499988753 233445788999999999 999999999999999999999
Q ss_pred EeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 429 YEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999986532 2346999999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~ 574 (671)
||+|||+++..... .......+++.|+|||.+....++.++||||||+++|||++ |+.||... .....
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--------~~~~~ 250 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAEL 250 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHH
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC--------cHHHH
Confidence 99999998743211 11223456889999999998889999999999999999998 99998532 12222
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
. .....+.. ......+++ .+.+++.+||+.||++|||+.|+++.|+..
T Consensus 251 ~-~~~~~~~~-----~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 251 Y-EKLPQGYR-----LEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp H-HHGGGTCC-----CCCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HHhhcCCC-----CCCCCCCCH----HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 22222211 111122232 366788899999999999999999988764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.60 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=197.1
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||++... +|+.||||+++.... ...+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356888899999999999999975 688999999975432 234688888887 79999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC----CCeEEeeccccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD----MNPKISDFGMARIF 506 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~~ 506 (671)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999998843 456999999999999999999999998 9999999999998543 35999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
...... ....+||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........ .....+...
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~~~~~~~-~~i~~~~~~- 241 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP-----DDTPEEIL-ARIGSGKFS- 241 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST-----TSCHHHHH-HHHHHCCCC-
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC-----cCCHHHHH-HHHccCCcc-
Confidence 543322 233578999999999988889999999999999999999999996321 11222222 222222221
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.........+. .+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~~~~~~~s~----~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 -LSGGYWNSVSD----TAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -CCSTTTTTSCH----HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -cCccccccCCH----HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111112232 3567777999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.20 Aligned_cols=251 Identities=22% Similarity=0.314 Sum_probs=196.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc----hhchHHHHHHHHHHhhcCCCCeeeEeeEEE--cCCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS----EQGNAEFTNEVLLILKLQHKNLVKLLGFCV--DGDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 425 (671)
.++|.+.+.||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367999999999999999999974 68899999997532 234567899999999999999999999985 34578
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||++++ |.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 6555543 23456999999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccchhhhccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
..............|++.|+|||++.+.. ++.++||||||+++|||++|+.||... ...... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~-~~i~~~~ 229 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--------NIYKLF-ENIGKGS 229 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHH-HHHHHCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc--------hHHHHH-HHHhcCC
Confidence 65433333334457899999999987644 478999999999999999999998532 222222 2222221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. .+...+++ .+.+++.+||+.||++|||+.|+++
T Consensus 230 ~------~~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 Y------AIPGDCGP----PLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp C------CCCSSSCH----HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C------CCCCccCH----HHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 12223333 3567778999999999999999996
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.55 Aligned_cols=262 Identities=25% Similarity=0.370 Sum_probs=195.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|+..+.||+|+||.||+++.. +|+.||||++.... ......+.+|+.++++++||||+++++++.+....++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46888899999999999999975 58899999986432 2334567899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|..++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999998863 3445999999999999999999999998 9999999999999999999999999998654332
Q ss_pred CccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH----------HHHH
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA----------WHLW 579 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~----------~~~~ 579 (671)
. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... ..+.... +..+
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHHHHH
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhhhHh
Confidence 2 12235789999999998775 7899999999999999999999998543211 0011000 0111
Q ss_pred hcCCc-cccccccccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNA-LDLIDPLLTDTCSP-----DEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~-~~~~d~~l~~~~~~-----~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..... .....+.+....+. .....+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11100 00111111111111 11234778888999999999999999885
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.36 Aligned_cols=200 Identities=26% Similarity=0.421 Sum_probs=167.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-----Ce
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 424 (671)
.++|.+.+.||+|+||.||+++.. +++.||||+++.. .......+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 457888999999999999999974 5889999999753 334456789999999999999999999999876 56
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||++ ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 69999884 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCc--------------------cccccccccCCccchhhh-ccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 505 IFAGSEGE--------------------VNTARIVGTYGYMAPEYA-MEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 505 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76543211 112446899999999986 55679999999999999999999766654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=326.70 Aligned_cols=258 Identities=28% Similarity=0.376 Sum_probs=195.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec--CCc--eEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS--DGK--EIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
.++|+..+.||+|+||.||++.+. +++ .||||+++.. .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 456888899999999999999863 233 6899998753 2344567899999999999999999999988755 8
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++|+||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 899999999999999853 2355899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
........ ......++..|+|||.+....++.++||||||+++|||++ |+.||... ............+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~--------~~~~~~~~~~~~~~ 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------NGSQILHKIDKEGE 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHHHTSCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC--------CHHHHHHHHHccCC
Confidence 65443222 2233467888999999998889999999999999999999 99998532 22222222222211
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCC
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGET 633 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~ 633 (671)
.. .....++. .+.+++.+||+.||++|||+.+|++.|+...
T Consensus 243 ~~-----~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 RL-----PRPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC-----CCCcCcCH----HHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 11 11122333 3667888999999999999999999998643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=334.27 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=193.2
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 423 (671)
.++|...+.||+|+||.||++.. .+|+.||||++... .......+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 45788899999999999999997 46899999998642 3334567889999999999999999999998763
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 359999999 8899998843 45899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
+..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ........+. .+
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~--~g 243 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKV--TG 243 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHH--HC
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHh--cC
Confidence 875432 223578999999999877 6899999999999999999999999953221 0111111110 01
Q ss_pred Ccc-ccc-------------------c---ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCC
Q 005893 583 NAL-DLI-------------------D---PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGE 632 (671)
Q Consensus 583 ~~~-~~~-------------------d---~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~ 632 (671)
... +.+ . ..+....++ .+.+++.+||+.||++|||+.|+++ .++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP----LAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH----HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCH----HHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 110 000 0 001112232 3667788999999999999999998 45544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=343.60 Aligned_cols=196 Identities=25% Similarity=0.426 Sum_probs=154.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-----Ce
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 424 (671)
.++|++.+.||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367899999999999999999864 6889999998653 334456789999999999999999999998543 46
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||+ +++|..++. ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 578888884 3456999999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCc-------------------------cccccccccCCccchhhh-ccCCCCcchhhHHHHHHHHHHHhCC
Q 005893 505 IFAGSEGE-------------------------VNTARIVGTYGYMAPEYA-MEGLYSIKSDVFSFGVLLIEIITGR 555 (671)
Q Consensus 505 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVwSlGvil~elltG~ 555 (671)
........ ......+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~ 281 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI 281 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence 76432211 112335789999999986 4567999999999999999999943
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.16 Aligned_cols=243 Identities=14% Similarity=0.147 Sum_probs=187.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccc---cchhchHHHHHHH---HHHhhcCCCCeeeEe-------e
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSS---CSEQGNAEFTNEV---LLILKLQHKNLVKLL-------G 417 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~---~~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g 417 (671)
..++|...+.||+|+||.||+|+. .+|+.||||++.. ......+.+.+|+ .++++++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 346688889999999999999996 4689999999873 2334456788999 455566899999998 6
Q ss_pred EEEcCC-----------------eeeEEEeccCCCchhhhhcCCC----CCCCCChHHHHHHHHHHHHHHHHHHhCCCCc
Q 005893 418 FCVDGD-----------------EKLLVYEFMPNSSLDAILFDPR----KRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476 (671)
Q Consensus 418 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ 476 (671)
++...+ ..++||||+ +|+|.+++.... ....+++..++.|+.||+.||+|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 665543 278999999 689999985321 1223556888899999999999999998
Q ss_pred eeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccC-----------CCCcchhhHHHH
Q 005893 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-----------LYSIKSDVFSFG 545 (671)
Q Consensus 477 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVwSlG 545 (671)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999985322 2233567 999999999887 899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 005893 546 VLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625 (671)
Q Consensus 546 vil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev 625 (671)
+++|||++|+.||....... ..+.+... ...+++ .+.+++.+||+.||++|||+.|+
T Consensus 301 ~il~elltg~~Pf~~~~~~~------------------~~~~~~~~-~~~~~~----~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALG------------------GSEWIFRS-CKNIPQ----PVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHHHSSCCC------C------------------CSGGGGSS-CCCCCH----HHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHHHCCCCCccccccc------------------chhhhhhh-ccCCCH----HHHHHHHHHcCCCchhCCCHHHH
Confidence 99999999999985322110 00111110 123333 36677789999999999999999
Q ss_pred HH
Q 005893 626 VV 627 (671)
Q Consensus 626 ~~ 627 (671)
++
T Consensus 358 l~ 359 (377)
T 3byv_A 358 ME 359 (377)
T ss_dssp HT
T ss_pred hh
Confidence 85
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=340.42 Aligned_cols=250 Identities=22% Similarity=0.283 Sum_probs=187.4
Q ss_pred CCCcc-cccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhh-cCCCCeeeEeeEEEc----CCeeeE
Q 005893 355 NFSDS-NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILK-LQHKNLVKLLGFCVD----GDEKLL 427 (671)
Q Consensus 355 ~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~l 427 (671)
+|... ++||+|+||.||++... +|+.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45554 68999999999999975 6889999998642 356788888754 589999999999875 556899
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEEeeccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISDFGMAR 504 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla~ 504 (671)
||||+++|+|.+++.. .....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 137 v~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 137 VMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEECCCSEEHHHHHHC-C---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999964 23346999999999999999999999998 999999999999997 7899999999998
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
...... .....+||+.|+|||++....++.++|||||||++|||++|+.||....... ........ ...+..
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~----i~~~~~ 284 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTR----IRMGQY 284 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS-SCCSHHHH----HHHTCC
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc-ccHHHHHH----HHcCcc
Confidence 654322 1234678999999999999999999999999999999999999996433221 11112111 111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. .-.+ ....++. .+.+++.+||+.||++|||+.|+++
T Consensus 285 ~-~~~~-~~~~~s~----~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 285 E-FPNP-EWSEVSE----EVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp C-CCTT-TTTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-CCCc-ccccCCH----HHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000 0012232 3667778999999999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=325.73 Aligned_cols=257 Identities=25% Similarity=0.325 Sum_probs=200.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc--CCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 428 (671)
++|+..+.||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 56888899999999999999975 6889999998643 33445678999999999999999999998854 5678999
Q ss_pred EeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 429 YEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDS--RLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ..+|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999999985422 2345999999999999999999999875 23499999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ..... .....+...
T Consensus 166 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~-~~i~~~~~~ 234 (279)
T 2w5a_A 166 LNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELA-GKIREGKFR 234 (279)
T ss_dssp C---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHH-HHHHHTCCC
T ss_pred eccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHH-HHHhhcccc
Confidence 543321 1223578999999999999899999999999999999999999985321 11221 222222221
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
.+...++. .+.+++.+||+.||++||++.||++.+.
T Consensus 235 -----~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 -----RIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----cCCcccCH----HHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 12223333 3667788999999999999999997664
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=345.15 Aligned_cols=196 Identities=28% Similarity=0.349 Sum_probs=163.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 423 (671)
.++|+..+.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999864 6889999999753 3344567889999999999999999999997553
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++||||++++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 469999999765 555542 23889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
+...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 8654322 22346899999999999999999999999999999999999999953
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=329.01 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=196.4
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.++|++.+.||+|+||.||++... +++.||+|++..........+.+|+.++.+++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 456888999999999999999975 5889999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 999999998753 2345899999999999999999999998 9999999999999999999999999875422110
Q ss_pred ccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 512 EVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
.......|++.|+|||.+. ...++.++||||||+++|||++|+.||... ............... .
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~~~~-~ 241 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL--------NPMRVLLKIAKSDPP-T 241 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCCC-C
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC--------CHHHHHHHHhccCCc-c
Confidence 1112347899999999984 567899999999999999999999998532 222222222222111 1
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... ...++. .+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~---~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LLT---PSKWSV----EFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CSS---GGGSCH----HHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCC---ccccCH----HHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 112222 3667788999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=347.26 Aligned_cols=255 Identities=27% Similarity=0.347 Sum_probs=204.4
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|...++||+|+||.||+++.. +|+.||||++.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999975 68999999996532 23346788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 429 YEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|||+++|+|..++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999886533 2456999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ ....
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~----~~~~~~~~~~i~-~~~~--- 410 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRVL-EQAV--- 410 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC----CCCHHHHHHHHH-HCCC---
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc----chhHHHHHHHHh-hccc---
Confidence 43322 2335899999999999999999999999999999999999999964321 112222222222 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM-----SSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~-----~ev~~ 627 (671)
.+...+++ .+.+++.+||+.||++||++ ++|++
T Consensus 411 ---~~p~~~s~----~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 ---TYPDKFSP----ASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCCTTSCH----HHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---CCCcccCH----HHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11223333 35677779999999999975 56653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=336.52 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=189.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
..++|+..+.||+|+||.||+++.. +++.||||+++.... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 3457888999999999999999864 688999999975332 2244678999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-----CCCCeEEeecccc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-----YDMNPKISDFGMA 503 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~Dfgla 503 (671)
|||++ ++|.+++. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++ +++.+||+|||++
T Consensus 112 ~e~~~-~~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 112 FEYAE-NDLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EECCS-EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EecCC-CCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99997 58988884 3445899999999999999999999998 99999999999994 4556999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc-
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE- 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~- 581 (671)
+....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.... ...........
T Consensus 185 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~~~~~~ 254 (329)
T 3gbz_A 185 RAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--------EIDQLFKIFEVL 254 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHH
T ss_pred cccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--------HHHHHHHHHHHh
Confidence 87643322 12335789999999999774 58999999999999999999999985321 11111111110
Q ss_pred CCcccc----c---------cccccCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDL----I---------DPLLTDTCSPD-----EFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~----~---------d~~l~~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+..... . .+......... ....+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 0 00000000000 1134668888999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.43 Aligned_cols=255 Identities=24% Similarity=0.283 Sum_probs=200.7
Q ss_pred hCCCCcccccCCCCcccEEEEEe----cCCceEEEEEccccc----hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCC
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL----SDGKEIAVKRLSSCS----EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 423 (671)
.++|+..+.||+|+||.||+++. .+++.||||+++... ......+.+|+.++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788899999999999999997 368899999987532 22344577899999999 6999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999843 346899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAME--GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
+........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ..............
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~~ 281 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE----KNSQAEISRRILKS 281 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS----CCCHHHHHHHHHHC
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc----cchHHHHHHHHhcc
Confidence 865432221 2234579999999999985 3478999999999999999999999964322 12222222222211
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHh
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVVML 629 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~~L 629 (671)
. +.+....+. .+.+++.+||+.||++|| +++|+++..
T Consensus 282 ~-------~~~~~~~~~----~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 E-------PPYPQEMSA----LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp C-------CCCCTTSCH----HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred C-------CCCCcccCH----HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1 112222332 366788899999999999 999998743
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.31 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=201.8
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch--------hchHHHHHHHHHHhhc-CCCCeeeEeeE
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE--------QGNAEFTNEVLLILKL-QHKNLVKLLGF 418 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~g~ 418 (671)
.....++|.+.+.||+|+||.||++... +|+.||||+++.... .....+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3344567999999999999999999985 699999999865321 1134678999999999 89999999999
Q ss_pred EEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEe
Q 005893 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKIS 498 (671)
Q Consensus 419 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 498 (671)
+......++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999984 3456999999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCccccccccccCCccchhhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHH
Q 005893 499 DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLL 572 (671)
Q Consensus 499 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~ 572 (671)
|||++........ .....||+.|+|||++.. ..++.++||||||+++|||++|+.||... ...
T Consensus 243 DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~--------~~~ 311 (365)
T 2y7j_A 243 DFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--------RQI 311 (365)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHH
T ss_pred ecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC--------CHH
Confidence 9999987654322 234579999999999863 35889999999999999999999998532 111
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 573 AYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 573 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... .....+... ...+. ....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 312 ~~~-~~i~~~~~~-~~~~~-~~~~~----~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 LML-RMIMEGQYQ-FSSPE-WDDRS----STVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHH-HHHHHTCCC-CCHHH-HSSSC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHH-HHHHhCCCC-CCCcc-cccCC----HHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 111121111 00000 01122 23667888999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.51 Aligned_cols=262 Identities=21% Similarity=0.320 Sum_probs=193.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|...+.||+|+||.||++... +++.||||+++..... ....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999999999999975 6889999998753322 122355799999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
++ ++|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 588887753 3446899999999999999999999998 99999999999999999999999999986543221
Q ss_pred ccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc---ccc
Q 005893 512 EVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA---LDL 587 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~---~~~ 587 (671)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... .........+....... ...
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhCCCChHhchhh
Confidence 1223578999999999876 568999999999999999999999995422 11222222222111110 000
Q ss_pred cc---------cc--------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCC
Q 005893 588 ID---------PL--------LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGE 632 (671)
Q Consensus 588 ~d---------~~--------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~ 632 (671)
.. +. .....+ ..+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLD----SDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hcchhhcccccccccchhhhhhcCCCC----HHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00 00 001122 23667888999999999999999987 44443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=329.27 Aligned_cols=245 Identities=22% Similarity=0.347 Sum_probs=196.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|+..+.||+|+||.||++... +++.||||+++.. ......++.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356888899999999999999975 7899999998753 234456788999999998 999999999999999999999
Q ss_pred EeccCCCchhhhhcCCC-CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC----------------
Q 005893 429 YEFMPNSSLDAILFDPR-KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---------------- 491 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---------------- 491 (671)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999985421 1256899999999999999999999998 999999999999984
Q ss_pred ---CCCeEEeeccccccccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 005893 492 ---DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT 567 (671)
Q Consensus 492 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 567 (671)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|+.++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 4479999999998764332 23589999999999766 5678999999999999999998765311
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. .+.....+.. +.+...+++ .+.+++.+||+.||++|||+.|+++
T Consensus 235 --~----~~~~~~~~~~-----~~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 --D----QWHEIRQGRL-----PRIPQVLSQ----EFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --H----HHHHHHTTCC-----CCCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --h----HHHHHHcCCC-----CCCCcccCH----HHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 1222222222 122223333 3667778999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=320.14 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=193.4
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|.+.+.||+|+||.||++... +|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 356888899999999999999975 68999999986532 23355788999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999843 345899999999999999999999998 99999999999999999999999999987544
Q ss_pred CCCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||... ..... ......+..
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~-~~~~~~~~~--- 228 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--------HVPTL-FKKIRGGVF--- 228 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHH-HHHHHHCCC---
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--------cHHHH-HHHhhcCcc---
Confidence 321 223478999999999987765 68999999999999999999998532 12222 122222211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+....+. .+.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~~~~~----~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 ---YIPEYLNR----SVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cCchhcCH----HHHHHHHHHccCChhhCCCHHHHHh
Confidence 11122232 3667788999999999999999997
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.20 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=196.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----CCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 426 (671)
+.|...+.||+|+||.||+|... ++..||+|++... .......+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34667788999999999999874 5788999998643 34455678999999999999999999999875 34578
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-CCCCeEEeecccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-YDMNPKISDFGMARI 505 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~ 505 (671)
+||||+++++|.+++. ..+.+++..++.++.||+.||.|||+.+ .+|+||||||+||+++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999984 3356899999999999999999999874 3499999999999998 789999999999975
Q ss_pred ccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
..... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||... ....... .....+...
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~-~~~~~~~~~ 248 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQIY-RRVTSGVKP 248 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHHHH-HHHTTTCCC
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc-------CcHHHHH-HHHhccCCc
Confidence 43321 22357899999999876 56999999999999999999999998532 1222222 222222211
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. +....++ .+.+++..||+.||++|||+.|+++
T Consensus 249 ~~----~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 AS----FDKVAIP----EVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GG----GGGCCCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc----cCCCCCH----HHHHHHHHHccCChhhCCCHHHHhh
Confidence 11 1122222 3667888999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.18 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=199.6
Q ss_pred HHHHhCCCCcc-cccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCC
Q 005893 349 LDVATSNFSDS-NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 423 (671)
Q Consensus 349 l~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 423 (671)
.+.-.+.|... +.||+|+||.||++... +++.||||+++... ......+.+|+.++..+ +||||+++++++.+..
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445566666 88999999999999975 68999999987532 33356789999999999 5699999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEEeec
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISDF 500 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 500 (671)
..++||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred eEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence 99999999999999998843 33456999999999999999999999998 999999999999988 789999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
|+++....... .....||+.|+|||++....++.++||||||+++|||++|+.||.... ..........
T Consensus 179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~ 247 (327)
T 3lm5_A 179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------NQETYLNISQ 247 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHH
T ss_pred ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------chHHHHHHHh
Confidence 99987643321 233578999999999999999999999999999999999999985321 1111111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. .. .. ........+. .+.+++.+||+.||++|||++|+++
T Consensus 248 ~-~~-~~-~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 248 V-NV-DY-SEETFSSVSQ----LATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp T-CC-CC-CTTTTTTSCH----HHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c-cc-cc-CchhhcccCH----HHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1 10 00 0111112222 3667788999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=330.52 Aligned_cols=264 Identities=24% Similarity=0.316 Sum_probs=194.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchh-----chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQ-----GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
..++|+..+.||+|+||.||+++.. +|+.||||++...... ....+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3467899999999999999999975 5889999998743211 124678999999999999999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++ +|..++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 78887743 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
...... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.... .................
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-----~~~~~~~i~~~~~~~~~ 234 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTE 234 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCT
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHHcCCCCh
Confidence 643322 22335789999999998654 58999999999999999999999885321 11111111111111111
Q ss_pred c---cc---ccccc---cCCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 005893 585 L---DL---IDPLL---TDTCSPD-----EFLRYIHIGLLCVQEDAFDRPTMSSVVVM 628 (671)
Q Consensus 585 ~---~~---~d~~l---~~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~ 628 (671)
. +. .+... ....+.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00 00000 0011111 11346778889999999999999999973
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=334.27 Aligned_cols=198 Identities=28% Similarity=0.408 Sum_probs=173.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|+..+.||+|+||.||++... +++.||+|++... .......+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 456888899999999999999975 6889999998754 33445678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999843 44689999999999999999999985 7 999999999999999999999999998754322
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 12235789999999999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.44 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=196.4
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--------
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 422 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 422 (671)
++|+..+.||+|+||.||+++. .+|+.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4688889999999999999997 478999999986432 23345788999999999999999999999874
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
+..++||||+++ +|...+.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 457899999985 66666543 3345999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 503 ARIFAGSEGE--VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 503 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ............
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~ 245 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLC 245 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHh
Confidence 9876532221 12234578999999998876 458999999999999999999999986322 111111111111
Q ss_pred hcCCc---cc-----cccc---cccCCCC-HHHH------HHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNA---LD-----LIDP---LLTDTCS-PDEF------LRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~---~~-----~~d~---~l~~~~~-~~~~------~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..... .. ..+. ....... .+.+ ..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 11000 00 0000 0000011 1111 23678888999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=340.09 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=190.3
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--------hhchHHHHHHHHHHhhcCCCCeeeEeeEEEc
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--------EQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~ 421 (671)
...++|...+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34578999999999999999999864 57899999986422 111224789999999999999999999975
Q ss_pred CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC---CCeEEe
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD---MNPKIS 498 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 498 (671)
.+..++||||+++|+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 456799999999999999884 4456999999999999999999999998 9999999999999754 459999
Q ss_pred eccccccccCCCCccccccccccCCccchhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 499 DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME---GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 499 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
|||+++...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ...+...
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~~- 356 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQ- 356 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS----SCCHHHH-
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc----hHHHHHH-
Confidence 999998764322 2234679999999999853 6788999999999999999999999964321 1122221
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+... . .+......+ ..+.+++.+||+.||++|||+.|+++
T Consensus 357 ---i~~~~~~-~-~~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ---ITSGKYN-F-IPEVWAEVS----EKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp ---HHTTCCC-C-CHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HhcCCCC-C-CchhhcccC----HHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1121111 0 011111222 23677888999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=331.08 Aligned_cols=254 Identities=23% Similarity=0.332 Sum_probs=201.6
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhc-----------------hHHHHHHHHHHhhcCCCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQG-----------------NAEFTNEVLLILKLQHKNLVKL 415 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l 415 (671)
.++|...+.||+|+||.||++.. +|+.||||++....... ...+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788899999999999999999 89999999986432111 1789999999999999999999
Q ss_pred eeEEEcCCeeeEEEeccCCCchhhh------hcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEE
Q 005893 416 LGFCVDGDEKLLVYEFMPNSSLDAI------LFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVL 488 (671)
Q Consensus 416 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIl 488 (671)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.||+.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 422 225679999999999999999999998 87 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSI-KSDVFSFGVLLIEIITGRRNTGFNQSRGA 566 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVwSlGvil~elltG~~p~~~~~~~~~ 566 (671)
++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 999999999999999875433 23345789999999999877 6666 999999999999999999999643211
Q ss_pred CCCCHHHHHHHHHhcCCccccc------cccc-------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 567 TAPNLLAYAWHLWNEGNALDLI------DPLL-------TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 567 ~~~~l~~~~~~~~~~~~~~~~~------d~~l-------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. .......+...... .+.. ....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 259 -----~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 -----VE-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLS----NEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -----HH-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -----HH-HHHHHhccCcCCccchhhhhccccccccccchhhcC----HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 11222222111000 0000 01222 24677888999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=334.21 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=196.8
Q ss_pred hhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEcccc--chhchHHHHHHHHHHhhcC--CCCeeeEeeEEEc
Q 005893 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQ--HKNLVKLLGFCVD 421 (671)
Q Consensus 346 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~ 421 (671)
...+....++|++.+.||+|+||.||++...+++.||||++... .......+.+|+.++.+++ |+||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 34445566789999999999999999999888999999998642 3445567899999999997 5999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
....++||| +.+++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 668899999853 456899999999999999999999998 999999999999965 899999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhcc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCC
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAME-----------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~ 570 (671)
+++...............|++.|+|||.+.. ..++.++||||||+++|||++|+.||.... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~ 244 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------N 244 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------S
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------H
Confidence 9987654433333334578999999999865 478899999999999999999999985321 1
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 571 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.............. ..+....+ ..+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~~~~~~~~~~~~-----~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 245 QISKLHAIIDPNHE-----IEFPDIPE----KDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHHHHHHHCTTSC-----CCCCCCSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHhcccc-----cCCcccch----HHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11211122111111 11111222 23667777999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.77 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=190.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEE-----------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV----------- 420 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~----------- 420 (671)
.++|...+.||+|+||.||++... +++.||||++..........+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357888999999999999999976 48999999998766666778999999999999999999999874
Q ss_pred ---cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-CCCCeE
Q 005893 421 ---DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-YDMNPK 496 (671)
Q Consensus 421 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 496 (671)
+....++||||++ |+|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456789999997 69999883 345899999999999999999999998 99999999999997 567999
Q ss_pred EeeccccccccCCCCc-cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH
Q 005893 497 ISDFGMARIFAGSEGE-VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~ 574 (671)
|+|||+++........ .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.... ....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~~~~ 233 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--------ELEQ 233 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC--------HHHH
Confidence 9999999876432211 12233567899999998865 678999999999999999999999985322 1111
Q ss_pred HHHHHhcCCc-------------cccccc----------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 575 AWHLWNEGNA-------------LDLIDP----------LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 575 ~~~~~~~~~~-------------~~~~d~----------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.......... ...+.. .+....+ ..+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGIS----REAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCC----HHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhh----HHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1111111000 000000 0011222 24677888999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.35 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=197.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
..++|+..+.||+|+||.||++... +|+.||||++.... ....+.+|+.++.+++||||+++++++......++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888999999999999999975 58999999987532 34678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++++|.+++.. ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999999842 3456899999999999999999999998 9999999999999999999999999998654332
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||... ......+..... .......+
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~~~~~~~~~~~-~~~~~~~~ 248 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI--------HPMRAIFMIPTN-PPPTFRKP 248 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHS-CCCCCSSG
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCC--------ChHHHHHHHhcC-CCcccCCc
Confidence 1 223357899999999999999999999999999999999999998532 112222221111 11111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..++ ..+.+++.+||+.||++|||+.|+++
T Consensus 249 ---~~~~----~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ---ELWS----DNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ---GGSC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1122 23667788999999999999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=343.52 Aligned_cols=261 Identities=20% Similarity=0.280 Sum_probs=202.6
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCC-CCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|++.++||+|+||.||+++. .+++.||||++...... .++..|++++..++| +++..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46788999999999999999996 56899999987653322 357889999999976 566666677778888899999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE---cCCCCeEEeecccccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARIFA 507 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~ 507 (671)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999853 2346999999999999999999999998 9999999999999 688999999999998765
Q ss_pred CCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 508 GSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 508 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~-~~ 231 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKIS-EK 231 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHH-HH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHh-hc
Confidence 543221 122468999999999999999999999999999999999999999643221 1111111111 11
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....++ .+...++. .+.+++..||+.+|++||++.+|+++|+..
T Consensus 232 ~~~~~~~-~l~~~~p~----~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 232 KVATSIE-ALCRGYPT----EFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HHHSCHH-HHHTTSCH----HHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccccHH-HHhcCCcH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1111111 11122333 367788899999999999999999988764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=328.51 Aligned_cols=259 Identities=26% Similarity=0.418 Sum_probs=198.0
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc-
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD- 421 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~- 421 (671)
++.++....++|+..+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 4445555678899999999999999999997 468899999986533 3456788999999999 89999999999987
Q ss_pred -----CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeE
Q 005893 422 -----GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496 (671)
Q Consensus 422 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 496 (671)
....++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 45789999999999999998542 3356899999999999999999999998 99999999999999999999
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l 571 (671)
|+|||++........ ......|++.|+|||++. ...++.++||||||+++|||++|+.||... ..
T Consensus 170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------~~ 239 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM--------HP 239 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS--------CH
T ss_pred EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC--------cH
Confidence 999999886543221 122357899999999986 567899999999999999999999998532 12
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+...... .... ....++. .+.+++.+||+.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~-~~~~----~~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 240 MRALFLIPRNP-APRL----KSKKWSK----KFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHHHSC-CCCC----SCSCSCH----HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhcCc-cccC----CccccCH----HHHHHHHHHhccChhhCCCHHHHhh
Confidence 22222222221 1111 1122232 3667777999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=333.28 Aligned_cols=256 Identities=26% Similarity=0.343 Sum_probs=180.3
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC------C
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG------D 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~ 423 (671)
.++|+..+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36788999999999999999986 46889999999653 334456788999999999999999999998754 4
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++|+|++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 578999999 7899888742 46999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ........+.....
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~p 249 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGTP 249 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSC
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCC
Confidence 865332 233578999999999877 6789999999999999999999999953221 11111111111110
Q ss_pred Cccccccc-----------ccc--CCCCHH-----HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NALDLIDP-----------LLT--DTCSPD-----EFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~-----------~l~--~~~~~~-----~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+.+.. .+. ...... ....+.+++.+||+.||++|||+.|+++
T Consensus 250 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 250 -GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp -CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000 000 000000 0123667888999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=356.74 Aligned_cols=250 Identities=24% Similarity=0.251 Sum_probs=202.6
Q ss_pred HHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCee
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 425 (671)
...++|+..++||+|+||.||+++.. +++.||||+++.. .......+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34567999999999999999999975 5788999999752 233456688899999987 799999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++|+|..++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999843 356999999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
...... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||... +..+...... .+..
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~-~~~~- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIM-EHNV- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHH-SSCC-
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC--------CHHHHHHHHH-hCCC-
Confidence 433222 234468999999999999999999999999999999999999999532 2222222222 2211
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM-----SSVVV 627 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~-----~ev~~ 627 (671)
.+....++ .+.+++..||+.||++||++ +||++
T Consensus 560 -----~~p~~~s~----~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 -----AYPKSMSK----EAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----CCCTTSCH----HHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----CCCccCCH----HHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 12223333 36677779999999999998 77764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=344.54 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=195.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.+.|+..+.||+|+||.||+++.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 346888999999999999999975 68899999987532 334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC---CCeEEeeccccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD---MNPKISDFGMARIF 506 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 506 (671)
||+++|+|.+.+. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999988874 3456899999999999999999999998 9999999999999764 45999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
.... ......||+.|+|||++. +.++.++||||||+++|||++|+.||.... ....... ...+...
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~-i~~~~~~- 255 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------DQEILRK-VEKGKYT- 255 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH-HHHTCCC-
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH-HHhCCCC-
Confidence 5432 223357999999999875 579999999999999999999999995321 2222222 2222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+. ....++ .+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~-~~~~s~----~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 FDSPE-WKNVSE----GAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCSGG-GTTSCH----HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCchh-cccCCH----HHHHHHHHHCCCChhhCccHHHHhc
Confidence 00111 112233 3567778999999999999999875
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.10 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=196.2
Q ss_pred chhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccch-----------hchHHHHHHHHHHhhcCCCCee
Q 005893 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE-----------QGNAEFTNEVLLILKLQHKNLV 413 (671)
Q Consensus 345 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~niv 413 (671)
...++....++|...+.||+|+||.||++...+|+.||||++..... .....+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35677788899999999999999999999988899999999864221 1236789999999999999999
Q ss_pred eEeeEEEcC-----CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEE
Q 005893 414 KLLGFCVDG-----DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488 (671)
Q Consensus 414 ~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIl 488 (671)
++++++... ...++||||++ |+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 999998543 35799999998 677777753 3456999999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT 567 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~ 567 (671)
++.++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---- 239 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF---- 239 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH----
Confidence 9999999999999997543322 2233578999999999877 6789999999999999999999999853211
Q ss_pred CCCHHHHHHHHHhcCCcc-----------ccccccccC---C----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 568 APNLLAYAWHLWNEGNAL-----------DLIDPLLTD---T----CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~-----------~~~d~~l~~---~----~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
................. +.+...+.. . ..+.....+.+++.+||+.||++|||+.|+++
T Consensus 240 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 240 -YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111111111100 000000000 0 00011223678888999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=346.07 Aligned_cols=250 Identities=28% Similarity=0.360 Sum_probs=200.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|+..+.||+|+||.||++... +|+.||||++... .......+.+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888899999999999999975 7899999998643 234566789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE---cCCCCeEEeecccccc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL---DYDMNPKISDFGMARI 505 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~Dfgla~~ 505 (671)
|||+.+++|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999998884 3456999999999999999999999998 9999999999999 5678999999999987
Q ss_pred ccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
...... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||... ......... ..+...
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i-~~~~~~ 245 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA--------NEYDILKKV-EKGKYT 245 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHH-HHCCCC
T ss_pred cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHH-HcCCCC
Confidence 654332 233579999999998865 7999999999999999999999999532 222222222 222211
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... +. ....++ .+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~-~~-~~~~s~----~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 FEL-PQ-WKKVSE----SAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCS-GG-GGGSCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC-cc-cccCCH----HHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 00 012222 3667778999999999999999985
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.37 Aligned_cols=264 Identities=21% Similarity=0.259 Sum_probs=198.7
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC--------CCCeeeEeeEEE---
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ--------HKNLVKLLGFCV--- 420 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~--- 420 (671)
.++|.+.++||+|+||.||+++. .+++.||||+++.. ......+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46799999999999999999986 46889999999753 344567889999999985 788999999988
Q ss_pred -cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCC-----
Q 005893 421 -DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDM----- 493 (671)
Q Consensus 421 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~----- 493 (671)
+....++||||+.+ +|.+.+.. .....+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVLGH-HLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCCCC-BHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEeccCc-cHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 55678999999954 55444432 2335699999999999999999999998 7 99999999999998775
Q ss_pred --------------------------------------------CeEEeeccccccccCCCCccccccccccCCccchhh
Q 005893 494 --------------------------------------------NPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529 (671)
Q Consensus 494 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 529 (671)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999865432 223478999999999
Q ss_pred hccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCC-CCCHHHHHHHHHhc--------CCc-cccccc-----cc--
Q 005893 530 AMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGAT-APNLLAYAWHLWNE--------GNA-LDLIDP-----LL-- 592 (671)
Q Consensus 530 ~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~-~~~l~~~~~~~~~~--------~~~-~~~~d~-----~l-- 592 (671)
+.+..++.++||||||+++|||++|+.||......... .............. +.. .+.... .+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999653322100 00111111111100 000 000000 00
Q ss_pred ------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 ------------TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ------------~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+.+....+.+++.+||+.||++|||+.|+++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 01234566677889999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=343.85 Aligned_cols=250 Identities=28% Similarity=0.354 Sum_probs=198.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 356888999999999999999975 6889999998642 2334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc---CCCCeEEeeccccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD---YDMNPKISDFGMARIF 506 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~ 506 (671)
||+++++|.+.+.. .+.+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999888743 356999999999999999999999998 99999999999995 4567999999999866
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||... ......... ..+....
T Consensus 175 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~~~~i-~~~~~~~ 241 (486)
T 3mwu_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--------NEYDILKRV-ETGKYAF 241 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHH-HHTCCCS
T ss_pred CCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHH-HhCCCCC
Confidence 44321 233579999999998864 6999999999999999999999998532 222222222 2222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. +. ....++ .+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~-~~-~~~~s~----~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 DL-PQ-WRTISD----DAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CS-GG-GGGSCH----HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC-cc-cCCCCH----HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00 011222 3567778999999999999999987
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=323.58 Aligned_cols=253 Identities=25% Similarity=0.327 Sum_probs=185.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc-hh-chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-EQ-GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
..++|+..+.||+|+||.||++.. .+|+.||||+++... .. ....+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 456788899999999999999997 478999999997532 22 223344555567888999999999999999999999
Q ss_pred EeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 429 YEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
|||++ |+|.+++... .....+++..++.++.||+.||.|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 5877766431 2345699999999999999999999997 7 999999999999999999999999999865
Q ss_pred cCCCCccccccccccCCccchhhh----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYA----MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
..... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||.... .............
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~ 230 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-------TPFQQLKQVVEEP 230 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-------CHHHHHHHHHHSC
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-------chHHHHHHHhccC
Confidence 44321 2234789999999996 55678999999999999999999999985321 1122222222222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... . .....++ .+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~-~----~~~~~~~----~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 SPQ-L----PADKFSA----EFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCC-C----CTTTSCH----HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC-c----ccccCCH----HHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111 1 1112233 3667788999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=323.31 Aligned_cols=256 Identities=18% Similarity=0.292 Sum_probs=195.2
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEEc--CCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVD--GDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lv~ 429 (671)
++|+..+.||+|+||.||+++. .+++.||||+++... ...+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688899999999999999986 578899999997533 457889999999997 9999999999987 56789999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~ 508 (671)
||+++++|..++. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999873 3889999999999999999999998 99999999999999776 899999999987644
Q ss_pred CCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH--------HHHH
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA--------WHLW 579 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~--------~~~~ 579 (671)
... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...+.... +...
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHHHHCHHHHHHHH
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHHHhcCCchhhhHH
Confidence 332 223478999999999877 67899999999999999999999998432111 00011100 0000
Q ss_pred hcCCc--------------cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNA--------------LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~--------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..... ...................+.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0000011111111111234677888999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=343.58 Aligned_cols=251 Identities=28% Similarity=0.333 Sum_probs=197.8
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch-------------hchHHHHHHHHHHhhcCCCCeeeEee
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-------------QGNAEFTNEVLLILKLQHKNLVKLLG 417 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g 417 (671)
..++|.+.++||+|+||.||++... +++.||||++..... .....+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3467899999999999999999975 578999999865321 23467899999999999999999999
Q ss_pred EEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC---C
Q 005893 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM---N 494 (671)
Q Consensus 418 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~ 494 (671)
++.+....++||||+++|+|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999988884 3456999999999999999999999998 99999999999998775 6
Q ss_pred eEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH
Q 005893 495 PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 495 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~ 574 (671)
+||+|||+++...... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||... .....
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--------~~~~~ 255 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ--------NDQDI 255 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHH
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC--------CHHHH
Confidence 9999999998764432 123357999999999876 57999999999999999999999999532 12222
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... ...+.... +.......++ .+.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~-i~~~~~~~--~~~~~~~~s~----~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 256 IKK-VEKGKYYF--DFNDWKNISD----EAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHH-HHHCCCCC--CHHHHTTSCH----HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH-HHcCCCCC--CccccCCCCH----HHHHHHHHHcCCChhHCCCHHHHhc
Confidence 222 22222110 0000012222 3667788999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=335.40 Aligned_cols=197 Identities=22% Similarity=0.308 Sum_probs=169.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhc------CCCCeeeEeeEEEcCCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKL------QHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 425 (671)
..+|++.+.||+|+||.||++... +++.||||+++.. ......+.+|+.++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 456888999999999999999865 5889999999763 23345677888888877 577999999999999999
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC--eEEeecccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN--PKISDFGMA 503 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla 503 (671)
++||||+. ++|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKK-NKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 688888754 23345899999999999999999999998 999999999999999887 999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 764322 2235789999999999999999999999999999999999999854
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=319.03 Aligned_cols=251 Identities=25% Similarity=0.313 Sum_probs=199.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---------hhchHHHHHHHHHHhhcC-CCCeeeEeeEEEc
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---------EQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVD 421 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~ 421 (671)
.++|+..+.||+|+||.||++... +|+.||||++.... ......+.+|+.++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 467888999999999999999975 68899999986432 122456789999999995 9999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999843 456899999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccccccccccCCccchhhhc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 502 MARIFAGSEGEVNTARIVGTYGYMAPEYAM------EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 502 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||... ......
T Consensus 170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~ 238 (298)
T 1phk_A 170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--------KQMLML 238 (298)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHH
T ss_pred chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc--------cHHHHH
Confidence 9987644322 23357899999999885 456889999999999999999999998532 111211
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.....+.... ..+. ...++ ..+.+++.+||+.||++|||+.|+++
T Consensus 239 -~~~~~~~~~~-~~~~-~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 -RMIMSGNYQF-GSPE-WDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHHHTCCCC-CTTT-GGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHhcCCccc-Cccc-ccccC----HHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1122221110 0010 01122 23667888999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.56 Aligned_cols=250 Identities=8% Similarity=0.023 Sum_probs=177.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhc--CCCCeeeEe-------eEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKL--QHKNLVKLL-------GFC 419 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~H~niv~l~-------g~~ 419 (671)
..+|...+.||+|+||.||++... +|+.||||++.... ......+.+|+.++..| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345778899999999999999964 78999999998643 23445677885555544 699988755 444
Q ss_pred EcC-----------------CeeeEEEeccCCCchhhhhcCCCCCCCCChHHH------HHHHHHHHHHHHHHHhCCCCc
Q 005893 420 VDG-----------------DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKR------INIVNGIVKGILYLHEDSRLR 476 (671)
Q Consensus 420 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~gL~~LH~~~~~~ 476 (671)
... ...++||||++ |+|.+++... ...+.+..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 432 23799999998 8999998542 233566666 788899999999999998
Q ss_pred eeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhcc--CCCCcchhhHHHHHHHHHHHhC
Q 005893 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME--GLYSIKSDVFSFGVLLIEIITG 554 (671)
Q Consensus 477 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG 554 (671)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||+++|||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999865321 113466799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc--c--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 555 RRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL--L--TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 555 ~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~--l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.||.......... +............ + ....++ .+.+++.+||+.||++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPLPD----FVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCCCH----HHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc----------hhhhhhhhccccccchhhccCCCH----HHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99997542221000 0000000000000 0 112232 3667788999999999999999974
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=326.25 Aligned_cols=262 Identities=23% Similarity=0.353 Sum_probs=196.8
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-----Cee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 425 (671)
.++|...+.||+|+||.||++... +|+.||||++.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467888999999999999999975 68899999997533 33455788999999999999999999988754 567
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689888743 45899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc--------ccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH
Q 005893 506 FAGSEGEV--------NTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 506 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
........ ......||+.|+|||++.. ..++.++||||||+++|||++|+.||...... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~ 236 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR-----HQLLLIF 236 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHH
Confidence 64322111 1123578999999998765 67899999999999999999999998643210 0111111
Q ss_pred HHHhcCCccc------------ccc----------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcC
Q 005893 577 HLWNEGNALD------------LID----------PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQG 631 (671)
Q Consensus 577 ~~~~~~~~~~------------~~d----------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~ 631 (671)
.......... .+. ..+....+ ..+.+++.+||+.||++|||+.|+++ .++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN----PKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCC----HHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 1111000000 000 00011222 23667888999999999999999987 4544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=325.82 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=193.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc--------hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS--------EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 423 (671)
.++|.+.+.||+|+||.||++... +++.||||++.... ......+.+|+.++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 356888999999999999999974 57899999986432 112335789999999999999999999987655
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC---eEEeec
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN---PKISDF 500 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Df 500 (671)
.++||||+++++|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999999884 3456899999999999999999999998 999999999999987654 999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
|+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..... ...+....
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~-- 232 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT----QVSLKDQI-- 232 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC----SSCHHHHH--
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----HHHHHHHH--
Confidence 9998754321 123357899999999974 46789999999999999999999999864321 12222221
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+... ..+......+ ..+.+++.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~--~~~~~~~~~~----~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 --TSGKYN--FIPEVWAEVS----EKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --HHTCCC--CCHHHHTTSC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HhCccc--cCchhhhhcC----HHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111110 0011111222 24677888999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.83 Aligned_cols=255 Identities=21% Similarity=0.321 Sum_probs=191.3
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe------eeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------KLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 427 (671)
.+|...+.||+|+||.||+++..++..||+|++...... ..+|+.+++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 458888999999999999999877777999988643322 2369999999999999999999965433 679
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-CCCCeEEeeccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-YDMNPKISDFGMARIF 506 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~ 506 (671)
||||++++.+..+.........+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987665544432234567999999999999999999999998 99999999999999 7899999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC--
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN-- 583 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~-- 583 (671)
...... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ........+......
T Consensus 193 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 193 IAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-----IDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp CTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCHH
T ss_pred cCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHH
Confidence 443322 235789999999998664 589999999999999999999999953221 111111111110000
Q ss_pred --------ccccc---------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 --------ALDLI---------DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 --------~~~~~---------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+.. ...+....++ .+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPP----DAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCH----HHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCH----HHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000 0011112222 4778888999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.09 Aligned_cols=258 Identities=21% Similarity=0.290 Sum_probs=191.3
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC------
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG------ 422 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------ 422 (671)
+...++|+..+.||+|+||.||++.. .+|+.||||++...... ..+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999986 57899999998653322 24799999999999999999998543
Q ss_pred --------------------------------CeeeEEEeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHH
Q 005893 423 --------------------------------DEKLLVYEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYL 469 (671)
Q Consensus 423 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~L 469 (671)
...++||||++ ++|.+.+... .....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 5777666431 2345699999999999999999999
Q ss_pred HhCCCCceeecCCCCCcEEEc-CCCCeEEeeccccccccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHH
Q 005893 470 HEDSRLRIIHRDLKASNVLLD-YDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVL 547 (671)
Q Consensus 470 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvi 547 (671)
|+.+ |+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||||++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9988 99999999999998 688999999999987644332 2234779999999998764 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC----------ccccc---------cccccCCCCHHHHHHHHHHH
Q 005893 548 LIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN----------ALDLI---------DPLLTDTCSPDEFLRYIHIG 608 (671)
Q Consensus 548 l~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~----------~~~~~---------d~~l~~~~~~~~~~~l~~l~ 608 (671)
+|||++|+.||..... ........+...... ..+.. ...+....++ .+.+++
T Consensus 232 l~ell~g~~pf~~~~~-----~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~li 302 (383)
T 3eb0_A 232 FGELILGKPLFSGETS-----IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS----LAIDLL 302 (383)
T ss_dssp HHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCH----HHHHHH
T ss_pred HHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCH----HHHHHH
Confidence 9999999999963221 111111111111100 00000 0111122222 367788
Q ss_pred HHccccCCCCCCCHHHHHH
Q 005893 609 LLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 609 ~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+||+.||++|||+.|+++
T Consensus 303 ~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHT
T ss_pred HHHccCChhhCCCHHHHhc
Confidence 8999999999999999984
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.29 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=197.6
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-----Cee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 425 (671)
.++|+..+.||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457888999999999999999964 68899999997533 33446788999999999999999999999765 357
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||++ ++|.+++.. +.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 89999997 588888742 45899999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCcc-ccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ...............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPS 252 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSCC
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCCC
Confidence 54332211 12345899999999987654 589999999999999999999999964321 122222111111110
Q ss_pred ccc---------------------cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALD---------------------LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~---------------------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... .-...+....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD----SKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCC----HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 00000111222 23678888999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.61 Aligned_cols=269 Identities=22% Similarity=0.227 Sum_probs=187.0
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe-
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE- 424 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~- 424 (671)
+......++|+..+.||+|+||.||+++.. +|+.||||++.... .....+.+++..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 345566788999999999999999999974 68899999986532 223356778888899999999999999975433
Q ss_pred ------eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH--hCCCCceeecCCCCCcEEEcC-CCCe
Q 005893 425 ------KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH--EDSRLRIIHRDLKASNVLLDY-DMNP 495 (671)
Q Consensus 425 ------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~~ 495 (671)
.++||||++++.+..+.........+++..+..++.||+.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999987544333222245567899999999999999999999 777 999999999999997 8999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~ 574 (671)
||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ......
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----~~~~~~ 243 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS-----AGQLHE 243 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh-----HHHHHH
Confidence 9999999987654332 2235789999999998654 489999999999999999999999954221 111111
Q ss_pred HHHHHhcCC------------ccccccc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 575 AWHLWNEGN------------ALDLIDP------LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 575 ~~~~~~~~~------------~~~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+...... ..+..+. .+...........+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111110000 0000000 0000111112345778888999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=326.92 Aligned_cols=255 Identities=24% Similarity=0.273 Sum_probs=188.5
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 423 (671)
.++|+..+.||+|+||.||++... +++.||||++... .......+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367888999999999999999864 6889999998652 3344567889999999999999999999998665
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999974 6777763 24889999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc-C
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE-G 582 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~-~ 582 (671)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .......... +
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~ 243 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--------IDQWNKVIEQLG 243 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHC-CC
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhC
Confidence 8654321 12335789999999999999999999999999999999999999953221 1111111110 0
Q ss_pred Cc---------------------------cccccccccCCCC---HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NA---------------------------LDLIDPLLTDTCS---PDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~---------------------------~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. .+.+...+..... ......+.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00 0000000000000 112345778888999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=339.11 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=187.6
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC----C--eeeE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG----D--EKLL 427 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~l 427 (671)
+|+..+.||+|+||.||+++.. +|+.||||++..... ...+|+.++++++||||+++++++... + ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5777899999999999999975 589999999865322 234799999999999999999998642 1 2568
Q ss_pred EEeccCCCchhhhhcC-CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-CCeEEeecccccc
Q 005893 428 VYEFMPNSSLDAILFD-PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARI 505 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Dfgla~~ 505 (671)
||||+++ +|..++.. ......+++..++.++.||++||.|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 55444422 123456999999999999999999999988 9999999999999965 5689999999987
Q ss_pred ccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc---
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE--- 581 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~--- 581 (671)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.... +....
T Consensus 207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~-~~lg~p~~ 278 (420)
T 1j1b_A 207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEII-KVLGTPTR 278 (420)
T ss_dssp CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH-HHHCSCCH
T ss_pred cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-HHhCCCCH
Confidence 644322 2235789999999998764 789999999999999999999999953211 11111111 11100
Q ss_pred -------CCcccccccc---------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 -------GNALDLIDPL---------LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 -------~~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+...+. +....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP----PEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCC----HHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1111111111 111222 34678888999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=351.41 Aligned_cols=258 Identities=23% Similarity=0.370 Sum_probs=201.9
Q ss_pred HHHHhCCCCcccccCCCCcccEEEEEecC----CceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC
Q 005893 349 LDVATSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD 423 (671)
Q Consensus 349 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~ 423 (671)
.+...++|+..+.||+|+||.||+|.+.. +..||||+++.. .....+.+.+|+.++++++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34455678889999999999999998742 457999998753 3344567899999999999999999999985 45
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence 68999999999999999853 2345899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
+........ ......+|+.|+|||.+....++.++||||||+++|||++ |+.||... ...+..... ..+
T Consensus 539 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~--------~~~~~~~~i-~~~ 608 (656)
T 2j0j_A 539 RYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--------KNNDVIGRI-ENG 608 (656)
T ss_dssp CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHHH-HHT
T ss_pred eecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHH-HcC
Confidence 876443222 2223467789999999999999999999999999999997 99998532 111222121 222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
... .+...+++ .+.+++.+||+.||++|||+.||++.|+.
T Consensus 609 ~~~-----~~~~~~~~----~l~~li~~~l~~dP~~RPs~~el~~~L~~ 648 (656)
T 2j0j_A 609 ERL-----PMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLST 648 (656)
T ss_dssp CCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-----CCCccccH----HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111 12223333 36678889999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=321.28 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=195.7
Q ss_pred HhCCCCcccccCCCCcccEEEEEe--cCCceEEEEEccccc--hhchHHHHHHHHHHhhc---CCCCeeeEeeEEE----
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL--SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKL---QHKNLVKLLGFCV---- 420 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~---- 420 (671)
..++|++.+.||+|+||.||++.. .+|+.||+|+++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457789999999999999999997 467899999986422 22223566777777766 8999999999987
Q ss_pred -cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 421 -DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 421 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
.....++||||++ |+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567889999998 6999888542 2345899999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 500 FGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 500 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~ 235 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVI 235 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHc
Confidence 99997653221 22345789999999999999999999999999999999999999853211 11111111111
Q ss_pred hcCCcccc----------cc-------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNALDL----------ID-------PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~~~~----------~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
........ .. ..+....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID----ELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC----HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccCccccccchhhhcccCcchhhhccccCC----HHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11000000 00 01112222 23667888999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=313.91 Aligned_cols=250 Identities=27% Similarity=0.344 Sum_probs=198.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
.++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.++++++||||+++++++.+....++|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457889999999999999999975 6889999998643 2345667899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC---CCeEEeeccccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD---MNPKISDFGMARIF 506 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Dfgla~~~ 506 (671)
||+++++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++.+ +.+||+|||++...
T Consensus 101 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999888743 346899999999999999999999998 9999999999999764 47999999999876
Q ss_pred cCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||... ...... .....+....
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~--------~~~~~~-~~~~~~~~~~ 241 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK--------NEYDIL-KRVETGKYAF 241 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHH-HHHHHCCCCC
T ss_pred cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCC--------CHHHHH-HHHHcCCCCC
Confidence 44322 223468899999998765 5899999999999999999999998532 122222 2222222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. + .....+. .+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~-~-~~~~~~~----~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL-P-QWRTISD----DAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS-G-GGTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-h-hhhhcCH----HHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 0 0112233 3667788999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=322.30 Aligned_cols=258 Identities=22% Similarity=0.298 Sum_probs=199.0
Q ss_pred hCCCCcccccCCCCcccEEEEEe--cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCC------eeeEeeEEEcCCe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL--SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN------LVKLLGFCVDGDE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 424 (671)
.++|++.+.||+|+||.||++.. .+++.||||+++.. ......+.+|+.++..++|+| ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788899999999999999986 36889999999753 334567889999999887654 9999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-------------
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY------------- 491 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~------------- 491 (671)
.++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKE-NGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHh-cCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8899888854 23346899999999999999999999998 999999999999987
Q ss_pred ------CCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005893 492 ------DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565 (671)
Q Consensus 492 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~ 565 (671)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~- 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK- 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH-
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH-
Confidence 678999999999864332 22357899999999999999999999999999999999999999643211
Q ss_pred CCCCCHHHHHHHHHhcCCccccc------------------------------ccccc-CCCCHHHHHHHHHHHHHcccc
Q 005893 566 ATAPNLLAYAWHLWNEGNALDLI------------------------------DPLLT-DTCSPDEFLRYIHIGLLCVQE 614 (671)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~------------------------------d~~l~-~~~~~~~~~~l~~l~~~Cl~~ 614 (671)
.......... ......+. .+... ..........+.+++.+||+.
T Consensus 241 ----~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 241 ----EHLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp ----HHHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ----HHHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 1111111110 00000000 00000 011223455678899999999
Q ss_pred CCCCCCCHHHHHH
Q 005893 615 DAFDRPTMSSVVV 627 (671)
Q Consensus 615 ~p~~RPt~~ev~~ 627 (671)
||++|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999984
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=327.44 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=192.2
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee----
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK---- 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 425 (671)
.++|...+.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999864 6899999999753 333456788999999999999999999999877655
Q ss_pred --eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 426 --LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 426 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
++||||+. ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68877762 23899999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh-c
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN-E 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-~ 581 (671)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ..+....... .
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~ 258 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--------YLDQLTQILKVT 258 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHHHh
Confidence 864332 223578999999999887 689999999999999999999999995321 1111111111 0
Q ss_pred CCc-cccccc----------------------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNA-LDLIDP----------------------LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~-~~~~d~----------------------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.. .+.+.. .+....+ ..+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRAS----PQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSC----HHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccC----hHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000 000000 0001122 34678888999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.17 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=189.5
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD---------- 421 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------- 421 (671)
.++|+..+.||+|+||.||+++.. +++.||||++... ......+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 346888899999999999999974 7899999999653 3445678999999999999999999998865
Q ss_pred ---CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEe
Q 005893 422 ---GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKIS 498 (671)
Q Consensus 422 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 498 (671)
....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3457899999999999999953 3345788999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCC------------ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005893 499 DFGMARIFAGSEG------------EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565 (671)
Q Consensus 499 Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~ 565 (671)
|||+++....... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 9999986543211 1112335789999999998754 78999999999999999998 43210
Q ss_pred CCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 566 ATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...... ........ ..+....+......+.+++.+||+.||++|||+.|+++
T Consensus 232 ---~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 232 ---MERVNI-LKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHHHH-HHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hhHHHH-HHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 011111 11111111 11111222222334667888999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.43 Aligned_cols=200 Identities=27% Similarity=0.432 Sum_probs=152.1
Q ss_pred CCc-ccccCCCCcccEEEEEec---CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc--CCeeeEEE
Q 005893 356 FSD-SNMLGQGGFGPVYKGVLS---DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLVY 429 (671)
Q Consensus 356 ~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ 429 (671)
|++ .++||+|+||.||+++.. +++.||||++.... ....+.+|+.++++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 443 458999999999999965 57899999997532 23467899999999999999999999954 66789999
Q ss_pred eccCCCchhhhhcCC------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE----cCCCCeEEee
Q 005893 430 EFMPNSSLDAILFDP------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL----DYDMNPKISD 499 (671)
Q Consensus 430 e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~D 499 (671)
||++ ++|.+++... .....+++..++.|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9997 4676666321 12235999999999999999999999998 9999999999999 7789999999
Q ss_pred ccccccccCCCCc-cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 005893 500 FGMARIFAGSEGE-VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFN 561 (671)
Q Consensus 500 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~ 561 (671)
||+++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 9999876543211 223346899999999998874 5899999999999999999999999643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=323.34 Aligned_cols=256 Identities=27% Similarity=0.379 Sum_probs=176.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHH-HHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVL-LILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
..++|...+.||+|+||.||++... +|+.||||+++... .....++..|+. +++.++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 3467888899999999999999974 68899999997542 333445556665 67778999999999999999999999
Q ss_pred EeccCCCchhhhhcC--CCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 429 YEFMPNSSLDAILFD--PRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
|||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999985 77776632 12245689999999999999999999998 7 99999999999999999999999999986
Q ss_pred ccCCCCccccccccccCCccchhhh----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYA----MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
...... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||...... ...... ...
T Consensus 176 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~-~~~ 244 (327)
T 3aln_A 176 LVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQ-VVK 244 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CC-CCC
T ss_pred cccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHH-Hhc
Confidence 543321 2234789999999998 4567899999999999999999999998642211 000000 001
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+.... +.......+++ .+.+++.+||+.||++|||+.||++
T Consensus 245 ~~~~~-~~~~~~~~~~~----~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQ-LSNSEEREFSP----SFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCC-CCCCSSCCCCH----HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCC-CCCcccccCCH----HHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111 11111122333 3667888999999999999999965
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=319.38 Aligned_cols=254 Identities=25% Similarity=0.331 Sum_probs=190.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe------
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE------ 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------ 424 (671)
++|...+.||+|+||.||++... +|+.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999974 6899999999753 23335678899999999999999999999987654
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||++ ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 489999997 68887762 24899999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ........+......
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQILKVTGVPG 244 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----HHHHHHHHHHHCBCC
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCC
Confidence 64322 223578999999999877 6789999999999999999999999853221 011111111000000
Q ss_pred ------------------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ------------------ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
......+.+. ...+.....+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000000000 001111234677888999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.19 Aligned_cols=200 Identities=24% Similarity=0.315 Sum_probs=168.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcC-CC-----CeeeEeeEEEcCCe
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HK-----NLVKLLGFCVDGDE 424 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~~ 424 (671)
..++|++.+.||+|+||.||+|... +++.||||+++.. .....++..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 4578999999999999999999965 6789999999753 233456778888888874 55 49999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc--CCCCeEEeeccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD--YDMNPKISDFGM 502 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgl 502 (671)
.++||||++ ++|.+++... ....+++..++.++.||+.||.|||.+. .+|+||||||+|||++ .++.+||+|||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999996 5998888542 2345899999999999999999999531 2399999999999994 578899999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 2235789999999999999999999999999999999999999963
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=320.91 Aligned_cols=243 Identities=24% Similarity=0.421 Sum_probs=188.8
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchh------chHHHHHHHHHHhhc----CCCCeeeEeeE
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQ------GNAEFTNEVLLILKL----QHKNLVKLLGF 418 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~g~ 418 (671)
+...++|...+.||+|+||.||++.. .+++.||||++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 33457899999999999999999986 46889999999753321 222456789999988 89999999999
Q ss_pred EEcCCeeeEEEec-cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-CCCCeE
Q 005893 419 CVDGDEKLLVYEF-MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-YDMNPK 496 (671)
Q Consensus 419 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 496 (671)
+...+..++|+|+ +.+++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999843 446899999999999999999999998 99999999999999 889999
Q ss_pred EeeccccccccCCCCccccccccccCCccchhhhccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHH
Q 005893 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYS-IKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575 (671)
Q Consensus 497 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~ 575 (671)
|+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||.... .
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~-- 244 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------E-- 244 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H--
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------H--
Confidence 99999998764432 2335689999999999877764 59999999999999999999985210 0
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 576 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. ... ..+....+. .+.+++.+||+.||++|||+.|+++
T Consensus 245 --~~-~~~------~~~~~~~~~----~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 --IL-EAE------LHFPAHVSP----DCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --HH-HTC------CCCCTTSCH----HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --Hh-hhc------cCCcccCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 111 011222333 3667888999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=325.89 Aligned_cols=262 Identities=21% Similarity=0.254 Sum_probs=197.4
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC-----------CCCeeeEeeEEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-----------HKNLVKLLGFCV 420 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~ 420 (671)
.++|...+.||+|+||.||+++. .+++.||||++... ......+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 45788899999999999999996 46889999999753 334456889999998886 899999999988
Q ss_pred cCC----eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEc-----
Q 005893 421 DGD----EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLD----- 490 (671)
Q Consensus 421 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~----- 490 (671)
... ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 89999988542 234589999999999999999999998 7 99999999999994
Q ss_pred -CCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCC
Q 005893 491 -YDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP 569 (671)
Q Consensus 491 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~ 569 (671)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~ 244 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH--SYT 244 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc--ccC
Confidence 4458999999999865432 22347899999999999999999999999999999999999999643211 111
Q ss_pred CHHHHHHHHHh-cCCcc--------------------ccccc--------cc--cCCCCHHHHHHHHHHHHHccccCCCC
Q 005893 570 NLLAYAWHLWN-EGNAL--------------------DLIDP--------LL--TDTCSPDEFLRYIHIGLLCVQEDAFD 618 (671)
Q Consensus 570 ~l~~~~~~~~~-~~~~~--------------------~~~d~--------~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~ 618 (671)
........... .+... ..+.. .+ ....+......+.+++.+||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111111000 00000 00000 00 11234556677889999999999999
Q ss_pred CCCHHHHHH
Q 005893 619 RPTMSSVVV 627 (671)
Q Consensus 619 RPt~~ev~~ 627 (671)
|||+.||++
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=322.60 Aligned_cols=243 Identities=24% Similarity=0.400 Sum_probs=196.4
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchh------chHHHHHHHHHHhhcC--CCCeeeEeeEEE
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQ------GNAEFTNEVLLILKLQ--HKNLVKLLGFCV 420 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~g~~~ 420 (671)
+...++|+..+.||+|+||.||+++. .+++.||||+++..... ....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34457789999999999999999986 46889999998653211 2234678999999996 599999999999
Q ss_pred cCCeeeEEEeccCC-CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-CCCCeEEe
Q 005893 421 DGDEKLLVYEFMPN-SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-YDMNPKIS 498 (671)
Q Consensus 421 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~ 498 (671)
..+..++|+|++.+ ++|.+++.. .+.+++..++.++.||+.||.|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 899998843 456899999999999999999999998 99999999999999 78999999
Q ss_pred eccccccccCCCCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHH
Q 005893 499 DFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH 577 (671)
Q Consensus 499 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~ 577 (671)
|||+++...... .....||+.|+|||++....+ +.++||||||+++|||++|+.||.... .
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------------~ 254 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------E 254 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------H
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------------h
Confidence 999998764322 223578999999999987776 688999999999999999999985210 0
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 578 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... .. .+....++ .+.+++.+||+.||++|||++||++
T Consensus 255 ~~~~-~~------~~~~~~~~----~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 IIRG-QV------FFRQRVSS----ECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHC-CC------CCSSCCCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhcc-cc------cccccCCH----HHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 11 11223333 3667888999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.07 Aligned_cols=251 Identities=24% Similarity=0.294 Sum_probs=183.4
Q ss_pred CCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
|...+.||+|+||+||.....+|+.||||++... ....+.+|+.++.++ +||||+++++++.+....++||||++
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456789999999998766668999999998653 234578899999886 89999999999999999999999995
Q ss_pred CchhhhhcCCCCCC----CCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC-------------CCeEE
Q 005893 435 SSLDAILFDPRKRG----LLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-------------MNPKI 497 (671)
Q Consensus 435 gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kl 497 (671)
|+|.+++....... ..++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 69999986432211 1234456789999999999999998 9999999999999754 48999
Q ss_pred eeccccccccCCCCcc--ccccccccCCccchhhhcc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005893 498 SDFGMARIFAGSEGEV--NTARIVGTYGYMAPEYAME-------GLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGAT 567 (671)
Q Consensus 498 ~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 567 (671)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--- 246 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--- 246 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH---
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh---
Confidence 9999998765443221 2234579999999999865 678999999999999999999 99998532110
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. .......... .+...........+.+++.+||+.||++|||+.||++
T Consensus 247 ----~~---~i~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ----ES---NIIRGIFSLD----EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HH---HHHHTCCCCC----CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HH---HHhcCCCCcc----cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 1111110000 0111112334456778888999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.65 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=177.6
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccch-hc-hHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-QG-NAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
..++|+..+.||+|+||.||++... +|+.||||++..... .. ...+.++..+++.++||||+++++++.+.+..++|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 3456888899999999999999975 689999999975332 22 23344555567788999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-CCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED-SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
|||+ ++.+..+.. .....+++..++.++.||+.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 555555543 2245689999999999999999999985 7 9999999999999999999999999997654
Q ss_pred CCCCccccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
.... .....|++.|+|||.+. ...++.++||||||+++|||++|+.||.... .............
T Consensus 177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~ 246 (318)
T 2dyl_A 177 DDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------TDFEVLTKVLQEE 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------SHHHHHHHHHHSC
T ss_pred CCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------ccHHHHHHHhccC
Confidence 3321 22357899999999984 4578899999999999999999999985321 1122222222221
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.. .... ...+++ .+.+++.+||+.||++||++.|+++
T Consensus 247 ~~-~~~~---~~~~~~----~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 PP-LLPG---HMGFSG----DFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC-CCCS---SSCCCH----HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC-CCCc---cCCCCH----HHHHHHHHHccCChhHCcCHHHHhh
Confidence 11 1100 012233 3667778999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.88 Aligned_cols=256 Identities=21% Similarity=0.224 Sum_probs=170.9
Q ss_pred hCCCCcc-cccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----CCeee
Q 005893 353 TSNFSDS-NMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKL 426 (671)
Q Consensus 353 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 426 (671)
.++|.+. ++||+|+||.||++... +|+.||||++.... . ...+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 46999999999999975 68999999986532 1 12222334566799999999999876 44578
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEEeecccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISDFGMA 503 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 503 (671)
+||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQE-RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHT-C-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999964 23356999999999999999999999998 999999999999976 455999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
+...... .....||+.|+|||++....++.++||||||+++|||++|+.||....... ...........+.
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~ 249 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA-----ISPGMKRRIRLGQ 249 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh-----hhhhHHHhhhccc
Confidence 8654321 223578999999999988889999999999999999999999985432210 0000000000000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcC
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQG 631 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~ 631 (671)
. .. .......++. .+.+++.+||+.||++|||+.|+++ .++.
T Consensus 250 ~-~~-~~~~~~~~~~----~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 Y-GF-PNPEWSEVSE----DAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp --CC-CTTTSTTCCH----HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred c-cc-CchhhccCCH----HHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 0 00 0000112232 3667788999999999999999997 4443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=317.40 Aligned_cols=258 Identities=19% Similarity=0.250 Sum_probs=195.3
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CC-ceEEEEEccccchhchHHHHHHHHHHhhcCCCC------eeeEeeEEEcCCe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DG-KEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN------LVKLLGFCVDGDE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 424 (671)
.++|++.+.||+|+||.||++... ++ +.||||+++.. ......+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 467889999999999999999974 34 68999999753 334567888999999997765 9999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEE---------------
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLL--------------- 489 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll--------------- 489 (671)
.++||||+ +++|.+++.. .....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 5555555533 23346899999999999999999999988 9999999999999
Q ss_pred ----cCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCC
Q 005893 490 ----DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRG 565 (671)
Q Consensus 490 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~ 565 (671)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 244 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN-- 244 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--
Confidence 67889999999999864332 2235789999999999999999999999999999999999999963221
Q ss_pred CCCCCHHHHHHHHHhcCCccccc----------ccc-------------------cc--CCCCHHHHHHHHHHHHHcccc
Q 005893 566 ATAPNLLAYAWHLWNEGNALDLI----------DPL-------------------LT--DTCSPDEFLRYIHIGLLCVQE 614 (671)
Q Consensus 566 ~~~~~l~~~~~~~~~~~~~~~~~----------d~~-------------------l~--~~~~~~~~~~l~~l~~~Cl~~ 614 (671)
........+.. ...+..+. ... +. ......+...+.+++.+||+.
T Consensus 245 ---~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 245 ---REHLVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp ---HHHHHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred ---HHHHHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 11111111111 00000000 000 00 001123344677889999999
Q ss_pred CCCCCCCHHHHHH
Q 005893 615 DAFDRPTMSSVVV 627 (671)
Q Consensus 615 ~p~~RPt~~ev~~ 627 (671)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.06 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=185.3
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEEE
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 429 (671)
....+|...++||+|+||+|+.....+|+.||||++...... .+.+|+.+++++ +||||+++++++.+....++||
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 345568888999999999966555557899999998753322 356899999999 8999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-----CCCeEEeeccccc
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-----DMNPKISDFGMAR 504 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~ 504 (671)
||++ |+|.+++... ...+.+..++.++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 6999988542 233555567789999999999999998 999999999999943 3468899999998
Q ss_pred cccCCCCc-cccccccccCCccchhhhc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 505 IFAGSEGE-VNTARIVGTYGYMAPEYAM---EGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 505 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
........ .......||+.|+|||++. ...++.++|||||||++|||++ |+.||..... ... ...
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~-~~~ 241 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQA-NIL 241 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHH-HHH
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHH-HHH
Confidence 76543221 2233467999999999987 4567889999999999999999 8999853211 011 111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..........+ .......+.+++.+||+.||++|||+.||++
T Consensus 242 ~~~~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSLDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCCTTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCccccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 11111111111 1122334667888999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.94 Aligned_cols=258 Identities=27% Similarity=0.319 Sum_probs=195.8
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc------CCee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD------GDEK 425 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 425 (671)
++|++.+.||+|+||.||++.. .+|+.||||+++.. .......+.+|+.++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999997 46899999998753 34455678999999999999999999998765 6677
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCC---eEEeeccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMN---PKISDFGM 502 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~Dfgl 502 (671)
++||||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976555557999999999999999999999998 999999999999997765 99999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
++....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ...|........
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-------~~~~~~~i~~~~ 240 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-------PVQWHGKVREKS 240 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-------HHHSSTTCC---
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-------hhhhhhhhhccc
Confidence 987644322 2335789999999999999999999999999999999999999853211 011000000000
Q ss_pred C----cccc------ccccc--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 005893 583 N----ALDL------IDPLL--TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSS 624 (671)
Q Consensus 583 ~----~~~~------~d~~l--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~e 624 (671)
. ..+. ....+ ...........+.+++..||+.||++|||+.|
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0 0000 00000 11223334456778888999999999999965
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=339.71 Aligned_cols=237 Identities=20% Similarity=0.317 Sum_probs=188.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec--CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCe-----
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS--DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDE----- 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----- 424 (671)
.++|++.+.||+|+||.||++... +|+.||||++... .......+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 468999999999999999999975 5889999998753 33445578899999999999999999999987665
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||+++++|.+++.. .+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 6999999999999999999999998 9999999999999886 99999999998
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
..... ....||+.|+|||++.++. +.++||||||+++|||++|..|+....... .
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------~ 284 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------L 284 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------C
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------c
Confidence 75432 3357899999999987654 899999999999999999988764211110 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhc
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-MSSVVVMLQ 630 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-~~ev~~~L~ 630 (671)
. ...........+.+++.+||+.||++||+ ++++...|.
T Consensus 285 ~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 P-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp C-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred c-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 00000111234678888999999999995 555655554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.98 Aligned_cols=230 Identities=13% Similarity=0.101 Sum_probs=179.4
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
.++|++.+.||+|+||.||++... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357888999999999999999975 48999999997543 23346789999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++.. + ....++.+|+.||+.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999832 2 355578899999999999999998 9999999999999999999997443
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
|++| ++.++||||||+++|||++|+.||........... . .+.. .+....
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-~----~~~~-~~~~~~-- 224 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-A----ERDT-AGQPIE-- 224 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-C----CBCT-TSCBCC--
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-H----HHHh-ccCCCC--
Confidence 4433 68899999999999999999999975332210000 0 0000 000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
...+....++ .+.+++.+||+.||++| |+.|+++.|+..
T Consensus 225 ~~~~~~~~~~----~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 225 PADIDRDIPF----QISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHHHCTTSCH----HHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hhhcccCCCH----HHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 0011122333 36678889999999999 999999999864
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=315.28 Aligned_cols=240 Identities=15% Similarity=0.142 Sum_probs=175.9
Q ss_pred HhCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCC-CCee---------e---
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQH-KNLV---------K--- 414 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H-~niv---------~--- 414 (671)
...+|...+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.++..++| +|.. .
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 344566778999999999999995 468999999987432 2336679999999999987 2211 1
Q ss_pred ---------EeeEEEc-----CCeeeEEEeccCCCchhhhhcC----CCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCc
Q 005893 415 ---------LLGFCVD-----GDEKLLVYEFMPNSSLDAILFD----PRKRGLLCWSKRINIVNGIVKGILYLHEDSRLR 476 (671)
Q Consensus 415 ---------l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ 476 (671)
+..+... ....+++|+++ +++|.+++.. ......+++..++.++.||+.||.|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12345666655 6899888731 123456889999999999999999999998
Q ss_pred eeecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhh----------ccCCCCcchhhHHHHH
Q 005893 477 IIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA----------MEGLYSIKSDVFSFGV 546 (671)
Q Consensus 477 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVwSlGv 546 (671)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998764322 233577 999999999 4556888999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHH
Q 005893 547 LLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT--DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSS 624 (671)
Q Consensus 547 il~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~e 624 (671)
++|||++|+.||...... +..+..+. ..++ ..+.+++.+||+.||++||++.|
T Consensus 306 il~elltg~~Pf~~~~~~---------------------~~~~~~~~~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAAL---------------------GGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHHSSCCCCTTGGG---------------------SCSGGGGSSCCCCC----HHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHCCCCCCCcchh---------------------hhHHHHHhhcccCC----HHHHHHHHHHccCChhhCcCHHH
Confidence 999999999999643211 01111111 1233 23667778999999999999766
Q ss_pred HH
Q 005893 625 VV 626 (671)
Q Consensus 625 v~ 626 (671)
++
T Consensus 361 ~l 362 (413)
T 3dzo_A 361 AM 362 (413)
T ss_dssp HT
T ss_pred HH
Confidence 53
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=293.95 Aligned_cols=223 Identities=22% Similarity=0.275 Sum_probs=173.2
Q ss_pred CCCCcc-cccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHH-hhcCCCCeeeEeeEEEc----CCeee
Q 005893 354 SNFSDS-NMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLI-LKLQHKNLVKLLGFCVD----GDEKL 426 (671)
Q Consensus 354 ~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 426 (671)
++|... +.||+|+||.||++.. .+++.||||+++.. ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345555 7799999999999997 46889999998642 3567888888 55699999999999886 66789
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEEeecccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISDFGMA 503 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 503 (671)
+||||+++++|.+++.. .....+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHH-CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999864 23346999999999999999999999998 999999999999998 789999999998
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
.... +..++.++||||||+++|||++|+.||....... ... .
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-------------~~~-~ 209 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-------------ISP-G 209 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------C-C
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-------------hhH-H
Confidence 6432 1346789999999999999999999985432110 000 0
Q ss_pred cccccc-c--ccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLID-P--LLT----DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d-~--~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+. . .+. ..++ ..+.+++.+||+.||++|||+.|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 210 MKTRIRMGQYEFPNPEWSEVS----EEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCSSCTTCCSSCHHHHTTSC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhccccCCchhcccCC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 0 000 1122 24667888999999999999999997
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=303.04 Aligned_cols=190 Identities=17% Similarity=0.196 Sum_probs=158.6
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccc--------hhchHHHHHHHHHHhhcC---------CCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS--------EQGNAEFTNEVLLILKLQ---------HKNLVKL 415 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 415 (671)
.++|+..+.||+|+||.||+++. +|+.||||+++... ......+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999998 78999999997532 223367889999998885 7787777
Q ss_pred eeEEE------------------------------cCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHH
Q 005893 416 LGFCV------------------------------DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG 465 (671)
Q Consensus 416 ~g~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~g 465 (671)
.+++. .....++||||+++|++.+.+. ++.+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 77643 2678899999999997665552 2458999999999999999
Q ss_pred HHHHH-hCCCCceeecCCCCCcEEEcCCC--------------------CeEEeeccccccccCCCCccccccccccCCc
Q 005893 466 ILYLH-EDSRLRIIHRDLKASNVLLDYDM--------------------NPKISDFGMARIFAGSEGEVNTARIVGTYGY 524 (671)
Q Consensus 466 L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y 524 (671)
|.||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999876432 34799999
Q ss_pred cchhhhccCCCCcchhhHHHHHH-HHHHHhCCCCC
Q 005893 525 MAPEYAMEGLYSIKSDVFSFGVL-LIEIITGRRNT 558 (671)
Q Consensus 525 ~aPE~~~~~~~s~ksDVwSlGvi-l~elltG~~p~ 558 (671)
+|||++.+.. +.++|||||+++ .+++++|..||
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence 9999998665 899999998777 77788888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=275.96 Aligned_cols=184 Identities=16% Similarity=0.130 Sum_probs=129.7
Q ss_pred ccCCCCcccEEEEE-ecCCceEEEEEcccc----------chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSC----------SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 361 ~lg~G~~g~Vy~~~-~~~g~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
..+.|++|.+..++ ..-|+.+++|++... .+...++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35666776666544 335889999998642 233456799999999999 799999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||++|++|.++|.. .+.++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999943 4556653 58999999999999998 99999999999999999999999999987654
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCC
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~ 556 (671)
.... ....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 3322 334689999999998864 56788999999999887766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=253.87 Aligned_cols=185 Identities=18% Similarity=0.207 Sum_probs=145.8
Q ss_pred CcccccCCCCcccEEEEEecCCceEEEEEccccch--------hchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 357 SDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE--------QGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
...++||+|+||.||++.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 578899998643211 1134589999999999999999777777778888999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++++|.+++.. +..++.||++||.|||+++ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 4589999999999999998 999999999999999 999999999997644
Q ss_pred CCCcc-----ccccccccCCccchhhhcc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 005893 509 SEGEV-----NTARIVGTYGYMAPEYAME--GLYSIKSDVFSFGVLLIEIITGRRNT 558 (671)
Q Consensus 509 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVwSlGvil~elltG~~p~ 558 (671)
..... ......||+.|||||++.. ..|+..+|+|+..+-.++-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 1134689999999999976 56888999999999999988877665
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=193.47 Aligned_cols=103 Identities=21% Similarity=0.430 Sum_probs=92.7
Q ss_pred CCCCCCCCCCCCCCCCCCchHHHHHHHHHHHHhhhcccC--CccccccC-CCCCcEEEEEeccCCCChhhhHHHHHHHHH
Q 005893 30 DSPPYNTCSSSAADSGHAGAIYSNLKKVLISLALNASAA--KFSDASSG-NDSDRVYGLYMCLNYISNDTCNNCITTATQ 106 (671)
Q Consensus 30 ~~~~~~~C~~~~~~~~~~s~~~~nl~~~~~~l~~~~~~~--~f~~~~~g-~~~~~v~g~~~Cr~d~~~~~C~~C~~~a~~ 106 (671)
+.++++.|++ ++|+++|+|++||+.||+.|+++++.+ +|++...| .++++|||++|||||+++++|..||+.|+.
T Consensus 3 t~~v~~~Cn~--~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~ 80 (108)
T 3a2e_A 3 TAFVSSACNT--QKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVN 80 (108)
T ss_dssp CCEEEEEECS--SBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHT
T ss_pred cceeeeecCC--CccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHH
Confidence 3457889976 599999999999999999999998876 45555554 456999999999999999999999999999
Q ss_pred HHHhhCCCCccceEEccceEeeeccccc
Q 005893 107 DITKLCPNKTDAIVWEEVCQLRYAYGNF 134 (671)
Q Consensus 107 ~~~~~C~~~~~a~~~~~~C~~ry~~~~f 134 (671)
.+.+.||++++|+||++.|+||||+++|
T Consensus 81 ~~~~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 81 RIFSICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp THHHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHHHHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999999998
|
| >3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba} | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=182.83 Aligned_cols=103 Identities=26% Similarity=0.490 Sum_probs=94.0
Q ss_pred CccccCCCCCCchhhHHHHHHHHHHHHHhhhcCCCCccccccccccCCCCCcEEEEEeeecCCChhcHHHHHHHHHHHhh
Q 005893 143 NIPKYNRKNISEPERYRSVVNNTLNNLTKLAAFDPSNEMYATGEVPFTNSDTLYALVQCTKDLSADDCDACLNKAIADIL 222 (671)
Q Consensus 143 ~~~~~~~~~~~~~~~f~~~l~~ll~~l~~~aa~~~~~~~~a~g~~~~~~~~~vyglaqC~~Dls~~~C~~CL~~a~~~~~ 222 (671)
.+..||.++++.++.|.++|+.||..|+..|+.+ ..+|+++..+..++++||||+||+||+++++|+.||+.++.+++
T Consensus 6 v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s--~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~ 83 (108)
T 3a2e_A 6 VSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFS--GYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIF 83 (108)
T ss_dssp EEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGT--TSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHH
T ss_pred eeeecCCCccCCCChHHHHHHHHHHHHHhhCccc--cCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999999998765 35777777665667899999999999999999999999999999
Q ss_pred hhcCCCcCcEEeccceeEEeeecee
Q 005893 223 SCCYFSRGARLLSRSCYLRYELYAF 247 (671)
Q Consensus 223 ~~c~~~~g~~v~~~~C~lry~~~~f 247 (671)
++|++++||+||+++|+||||+++|
T Consensus 84 ~~C~~~~g~~i~~~~C~lRY~~~~F 108 (108)
T 3a2e_A 84 SICNNAIGARVQLVDCFIQYEQRSF 108 (108)
T ss_dssp HHTTSBSSEEEEETTEEEEEESSCC
T ss_pred HHCCCCceEEEECCCEEEEEeCCcC
Confidence 9999999999999999999999988
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=207.92 Aligned_cols=154 Identities=18% Similarity=0.111 Sum_probs=122.7
Q ss_pred hhhHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccch------------------hchHHHHHHHHHHhhc
Q 005893 346 LETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE------------------QGNAEFTNEVLLILKL 407 (671)
Q Consensus 346 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l 407 (671)
+..+......|...+.||+|+||.||++...+|+.||||+++.... .....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555666778899999999999999997799999999964221 1345688999999999
Q ss_pred CCCCeeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcE
Q 005893 408 QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487 (671)
Q Consensus 408 ~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NI 487 (671)
+ | +++.+++. .+..++||||+++++|.+ +.. .....++.||+.||.|||+.+ |+||||||+||
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NI 224 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNV 224 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHE
Confidence 9 4 56666543 356699999999999988 411 234579999999999999998 99999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhcc
Q 005893 488 LLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532 (671)
Q Consensus 488 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 532 (671)
|++ ++.+||+|||+++. +..++|||++..
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 999 99999999999863 345789998743
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.2e-18 Score=175.82 Aligned_cols=136 Identities=19% Similarity=0.186 Sum_probs=106.0
Q ss_pred CCcccccCCCCcccEEEEEe-cCCce--EEEEEccccchh------------------------chHHHHHHHHHHhhcC
Q 005893 356 FSDSNMLGQGGFGPVYKGVL-SDGKE--IAVKRLSSCSEQ------------------------GNAEFTNEVLLILKLQ 408 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 408 (671)
|+..+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 68888 999987542111 1135789999999998
Q ss_pred CCCe--eeEeeEEEcCCeeeEEEeccCC-C----chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHH-hCCCCceeec
Q 005893 409 HKNL--VKLLGFCVDGDEKLLVYEFMPN-S----SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH-EDSRLRIIHR 480 (671)
Q Consensus 409 H~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH-~~~~~~ivH~ 480 (671)
|+++ ..++.. ...+|||||+.+ | +|.++... .++..+..++.||+.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 334432 356899999942 4 56555421 235567889999999999999 887 9999
Q ss_pred CCCCCcEEEcCCCCeEEeeccccccc
Q 005893 481 DLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 481 Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
||||.|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999998754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-16 Score=168.13 Aligned_cols=144 Identities=15% Similarity=0.160 Sum_probs=102.5
Q ss_pred hHHHHhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccch--------------hchH--------HHHHHHHHHh
Q 005893 348 TLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE--------------QGNA--------EFTNEVLLIL 405 (671)
Q Consensus 348 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~--------------~~~~--------~~~~E~~~l~ 405 (671)
.+.....-|++.+.||+|+||.||+|...+|+.||||+++.... .... ....|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 34443444889999999999999999998999999998753110 0011 1234666666
Q ss_pred hcCCCCeeeEeeEEEcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 005893 406 KLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKAS 485 (671)
Q Consensus 406 ~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~ 485 (671)
++.+.++....-+.. ...+|||||++++.|..+.. ......++.||+.+|.+||+.+ ||||||||.
T Consensus 169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 665444322111111 23479999999998876542 1234568899999999999988 999999999
Q ss_pred cEEEcCCCC----------eEEeecccccc
Q 005893 486 NVLLDYDMN----------PKISDFGMARI 505 (671)
Q Consensus 486 NIll~~~~~----------~kl~Dfgla~~ 505 (671)
|||+++++. +.|+||+.+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999988763 89999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.5e-11 Score=123.87 Aligned_cols=142 Identities=17% Similarity=0.079 Sum_probs=111.7
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
..|.....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. |..+.+++++..+.+..++||||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 46777788888899999998764 6899999987532223345889999999884 677888999998888899999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED---------------------------------------- 472 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~---------------------------------------- 472 (671)
+|.+|.+.+. +......++.+++++|..||+.
T Consensus 93 ~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 93 DGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp SSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred CCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999987641 1223347889999999999981
Q ss_pred ----------------CCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 473 ----------------SRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 473 ----------------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11459999999999999876566799998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=8e-11 Score=118.06 Aligned_cols=135 Identities=16% Similarity=0.113 Sum_probs=100.0
Q ss_pred CCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCC--eeeEeeEEEcCCeeeEEEeccC
Q 005893 356 FSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN--LVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 356 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~ 433 (671)
+......+.|..+.||+....+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++...++..++||||++
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 3333333456669999998777888999997653 2235778999999886545 4558888887778899999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS---------------------------------------- 473 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~---------------------------------------- 473 (671)
+.+|. ... .+ ...++.++++.|..||+..
T Consensus 99 G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 99 GQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp SEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred CcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 98884 211 11 2356788888888888743
Q ss_pred ---------------CCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 474 ---------------RLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 474 ---------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
+..++|+|++|.||+++++..+.|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887667799999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=1.9e-09 Score=113.79 Aligned_cols=141 Identities=16% Similarity=0.236 Sum_probs=106.2
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEcc--ccc-hhchHHHHHHHHHHhhcC--CCCeeeEeeEEEcC---CeeeEEEe
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLS--SCS-EQGNAEFTNEVLLILKLQ--HKNLVKLLGFCVDG---DEKLLVYE 430 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lv~e 430 (671)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.|. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 567899999999998875 4678899876 322 122346788999999986 45678888888766 34789999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS------------------------------------- 473 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~------------------------------------- 473 (671)
|+++..+.+.. ...++...+..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998874421 123678888899999999999999731
Q ss_pred ------------------CCceeecCCCCCcEEEcCCCC--eEEeecccccc
Q 005893 474 ------------------RLRIIHRDLKASNVLLDYDMN--PKISDFGMARI 505 (671)
Q Consensus 474 ------------------~~~ivH~Dlkp~NIll~~~~~--~kl~Dfgla~~ 505 (671)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.88 E-value=2.6e-09 Score=109.99 Aligned_cols=187 Identities=17% Similarity=0.232 Sum_probs=121.1
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCC--eeeEeeEEEcCC---eeeEEEecc
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKN--LVKLLGFCVDGD---EKLLVYEFM 432 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lv~e~~ 432 (671)
.+.++.|....||+.. ..+++|+.... .....+.+|..+++.+ .+.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568899999999852 57999986542 3345788999999888 3333 334444433332 347899999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS--------------------------------------- 473 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--------------------------------------- 473 (671)
+|..|..... ..++..++..++.++++.|..||+..
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865331 23667777888888888888888621
Q ss_pred ----------------CCceeecCCCCCcEEEcC--CCCeEEeeccccccccCCCCccccc------------cccccCC
Q 005893 474 ----------------RLRIIHRDLKASNVLLDY--DMNPKISDFGMARIFAGSEGEVNTA------------RIVGTYG 523 (671)
Q Consensus 474 ----------------~~~ivH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~------------~~~gt~~ 523 (671)
...++|+|++|.||++++ +..+.|+||+.+............. ......+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 245899999999999998 4567899999876532210000000 0000001
Q ss_pred ccc-hhhhccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 005893 524 YMA-PEYAMEGLYSIKSDVFSFGVLLIEIITGRRNT 558 (671)
Q Consensus 524 y~a-PE~~~~~~~s~ksDVwSlGvil~elltG~~p~ 558 (671)
... |+.... .....+.|+++.++|++.+|+.++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 122 222111 122368999999999999998664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3.5e-06 Score=86.48 Aligned_cols=135 Identities=20% Similarity=0.170 Sum_probs=95.0
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCC---CeeeEeeEEE-cCCeeeEEEeccCCC
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHK---NLVKLLGFCV-DGDEKLLVYEFMPNS 435 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lv~e~~~~g 435 (671)
+.++.|....||+. |+.+++|+... ......+..|..++..|.+. .+.+.+.+.. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899987 67899998542 23345788999999999652 3556666664 345578999999998
Q ss_pred chhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 005893 436 SLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED------------------------------------------- 472 (671)
Q Consensus 436 sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~------------------------------------------- 472 (671)
.|..... ..++......++.++++.|..||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8876321 1134455556666666666666643
Q ss_pred --------------CCCceeecCCCCCcEEEcC---CCCe-EEeecccccc
Q 005893 473 --------------SRLRIIHRDLKASNVLLDY---DMNP-KISDFGMARI 505 (671)
Q Consensus 473 --------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~Dfgla~~ 505 (671)
....++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 8999997764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3.6e-06 Score=84.57 Aligned_cols=133 Identities=19% Similarity=0.184 Sum_probs=96.6
Q ss_pred cCCCCcc-cEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEeccCCCchh
Q 005893 362 LGQGGFG-PVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNSSLD 438 (671)
Q Consensus 362 lg~G~~g-~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 438 (671)
+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +--+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445555 58987754 4678999986543 3446788999988874 444677888888889999999999998887
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 005893 439 AILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS--------------------------------------------- 473 (671)
Q Consensus 439 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~--------------------------------------------- 473 (671)
+.... .......+..+++..|..||...
T Consensus 109 ~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 109 QVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 65421 12233456677777777777421
Q ss_pred ----------CCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 474 ----------RLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 474 ----------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
...++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1248999999999999987777799998765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=3.4e-06 Score=88.45 Aligned_cols=80 Identities=4% Similarity=-0.005 Sum_probs=55.9
Q ss_pred ccc-CCCCcccEEEEEec-------CCceEEEEEccccc---hhchHHHHHHHHHHhhcC-C--CCeeeEeeEEEcC---
Q 005893 360 NML-GQGGFGPVYKGVLS-------DGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQ-H--KNLVKLLGFCVDG--- 422 (671)
Q Consensus 360 ~~l-g~G~~g~Vy~~~~~-------~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~--- 422 (671)
+.| +.|....+|+.... +++.+++|+..... ......+..|..+++.|. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 557 88889999998764 26789999875432 111235678888888874 2 3566778777655
Q ss_pred CeeeEEEeccCCCchhh
Q 005893 423 DEKLLVYEFMPNSSLDA 439 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~ 439 (671)
...++||||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=4.2e-05 Score=81.38 Aligned_cols=75 Identities=13% Similarity=0.177 Sum_probs=49.3
Q ss_pred ccccCCCCcccEEEEEec-CCceEEEEEccccch-------hchHHHHHHHHHHhhcCC--CCee-eEeeEEEcCCeeeE
Q 005893 359 SNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSE-------QGNAEFTNEVLLILKLQH--KNLV-KLLGFCVDGDEKLL 427 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~niv-~l~g~~~~~~~~~l 427 (671)
.+.||.|..+.||++... +++.++||....... .....+..|.++++.+.+ +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999764 468899998653211 123456778888887732 3433 45543 3455689
Q ss_pred EEeccCCC
Q 005893 428 VYEFMPNS 435 (671)
Q Consensus 428 v~e~~~~g 435 (671)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.85 E-value=4.8e-05 Score=78.90 Aligned_cols=140 Identities=14% Similarity=0.199 Sum_probs=78.9
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcC-----CCCeeeEe-e--EEEcCCeeeEEEec
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-----HKNLVKLL-G--FCVDGDEKLLVYEF 431 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-g--~~~~~~~~~lv~e~ 431 (671)
+.|+.|..+.||+....+| .+++|+.... ...+..|..++..|. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999887554 5999988752 123344555555442 34443311 1 12235667899999
Q ss_pred cCCCchhh-----------h---hcC----C--C-C----CCCCChHHHH------------------------------
Q 005893 432 MPNSSLDA-----------I---LFD----P--R-K----RGLLCWSKRI------------------------------ 456 (671)
Q Consensus 432 ~~~gsL~~-----------~---l~~----~--~-~----~~~l~~~~~~------------------------------ 456 (671)
++|..+.. . ++. . . . .....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99865420 0 110 0 0 0 0112332210
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 457 -NIVNGIVKGILYLHE----------DSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 457 -~i~~qia~gL~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.+...+..++.+|++ ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445667763 124569999999999999888899999999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.84 E-value=5.2e-05 Score=76.82 Aligned_cols=79 Identities=20% Similarity=0.262 Sum_probs=57.0
Q ss_pred CCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCC---CCeeeEeeEEEcCCeeeEEEec
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH---KNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lv~e~ 431 (671)
.....+.+|.|..+.||+..+.||+.|++|+...........|..|...|+.|.. --+.+++++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 3444677999999999999999999999998765444444467889998888742 223445544 234789999
Q ss_pred cCCCch
Q 005893 432 MPNSSL 437 (671)
Q Consensus 432 ~~~gsL 437 (671)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00023 Score=72.79 Aligned_cols=138 Identities=18% Similarity=0.150 Sum_probs=91.5
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcC---CCCeeeEeeEEEcCCeeeEEEeccCCC
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPNS 435 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lv~e~~~~g 435 (671)
.+.|+.|....+|+... +++.+++|+.... ....+..|...|+.|. ...+.+++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999876 5678999987542 2456788988888873 356788888888778899999999987
Q ss_pred chhh--------h---hcCCCC-C----------C--------CCChHHHH---HHH----------------HHHHHH-
Q 005893 436 SLDA--------I---LFDPRK-R----------G--------LLCWSKRI---NIV----------------NGIVKG- 465 (671)
Q Consensus 436 sL~~--------~---l~~~~~-~----------~--------~l~~~~~~---~i~----------------~qia~g- 465 (671)
.+.. . |+.... . + .-+|.... ++. ..+..-
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1 121111 0 0 12454321 111 111111
Q ss_pred HHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeecc
Q 005893 466 ILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFG 501 (671)
Q Consensus 466 L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 501 (671)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123321 2356799999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00029 Score=75.45 Aligned_cols=78 Identities=13% Similarity=0.090 Sum_probs=47.7
Q ss_pred CCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcccccccc--ccCCccchhhhccC---CCCcchhhHHHHHHH
Q 005893 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIV--GTYGYMAPEYAMEG---LYSIKSDVFSFGVLL 548 (671)
Q Consensus 474 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~s~ksDVwSlGvil 548 (671)
...++|+|++|.|||++.++ ++|+||+.+..-... ....... -...|.+|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45699999999999998876 999999987642111 0000001 11345666544311 112235566888888
Q ss_pred HHHHhCC
Q 005893 549 IEIITGR 555 (671)
Q Consensus 549 ~elltG~ 555 (671)
|+.++++
T Consensus 307 ~~~y~~~ 313 (420)
T 2pyw_A 307 WNLFNKR 313 (420)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8877754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0012 Score=67.73 Aligned_cols=142 Identities=15% Similarity=0.089 Sum_probs=78.5
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCC--eeeEeeE------EEcCCeeeEEEec
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN--LVKLLGF------CVDGDEKLLVYEF 431 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lv~e~ 431 (671)
+.|+.|....+|+....+| .+++|+..... ....+..|+.++..|...+ +.+++.. ....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788889999887555 78899887521 2234556777777663222 2223311 1123456899999
Q ss_pred cCCCchhhh--------------hcCC----CCC-----CCCChHHHHH------------HHHHHHHHHHHHHhC----
Q 005893 432 MPNSSLDAI--------------LFDP----RKR-----GLLCWSKRIN------------IVNGIVKGILYLHED---- 472 (671)
Q Consensus 432 ~~~gsL~~~--------------l~~~----~~~-----~~l~~~~~~~------------i~~qia~gL~~LH~~---- 472 (671)
++|..+... ++.. ... ....|...+. +...+.+.+..+++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 988654210 1100 000 0112322111 011234455555532
Q ss_pred CCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 473 ~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.+..++|+|+++.|||++++..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23469999999999999987656899998664
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00092 Score=67.99 Aligned_cols=71 Identities=11% Similarity=0.146 Sum_probs=44.9
Q ss_pred ccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCe-eeEeeEEEcCCeeeEEEecc-CCCc
Q 005893 359 SNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFM-PNSS 436 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~-~~gs 436 (671)
.+.|+.|....+|+. +.+++|+........ ....+|...++.+...++ .+++++ ..+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567888999999998 678999876532221 123467777777643233 345543 344567899999 6655
Q ss_pred h
Q 005893 437 L 437 (671)
Q Consensus 437 L 437 (671)
|
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00084 Score=72.04 Aligned_cols=72 Identities=17% Similarity=0.267 Sum_probs=48.6
Q ss_pred cccCCCCcccEEEEEecC--------CceEEEEEccccchhchHHHHHHHHHHhhcCCCCe-eeEeeEEEcCCeeeEEEe
Q 005893 360 NMLGQGGFGPVYKGVLSD--------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e 430 (671)
+.|+.|-...+|+....+ ++.+++|+.... .....+..|..++..|...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 457888889999998753 478999988432 111355678888888843333 556665432 38999
Q ss_pred ccCCCch
Q 005893 431 FMPNSSL 437 (671)
Q Consensus 431 ~~~~gsL 437 (671)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0037 Score=64.44 Aligned_cols=141 Identities=14% Similarity=0.083 Sum_probs=71.2
Q ss_pred cccCCCCccc-EEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCC--CCeeeEeeEEEcCCeeeEEEeccCCCc
Q 005893 360 NMLGQGGFGP-VYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH--KNLVKLLGFCVDGDEKLLVYEFMPNSS 436 (671)
Q Consensus 360 ~~lg~G~~g~-Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~gs 436 (671)
+.|+.|.... +|+....+|+.+++|....... ..+..|+.++..+.. -.+.+++.+.... .+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 3465555444 6676654467788886544321 223456666666632 2344566553322 378999997766
Q ss_pred hhhhhc---------------------CCCC--CCCCChHHHH-------HH-------------HHHHHHHHHHHH---
Q 005893 437 LDAILF---------------------DPRK--RGLLCWSKRI-------NI-------------VNGIVKGILYLH--- 470 (671)
Q Consensus 437 L~~~l~---------------------~~~~--~~~l~~~~~~-------~i-------------~~qia~gL~~LH--- 470 (671)
+.+.+. .... ...++..... .+ ...+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 543321 1000 0111111100 00 001112222221
Q ss_pred hCCCCceeecCCCCCcEEEcCC----CCeEEeecccccc
Q 005893 471 EDSRLRIIHRDLKASNVLLDYD----MNPKISDFGMARI 505 (671)
Q Consensus 471 ~~~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~~ 505 (671)
......++|||+.+.||+++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1124569999999999999875 6789999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0043 Score=63.67 Aligned_cols=142 Identities=18% Similarity=0.174 Sum_probs=80.9
Q ss_pred cccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCC--CeeeEeeE-----EEcCCeeeEEEecc
Q 005893 360 NMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHK--NLVKLLGF-----CVDGDEKLLVYEFM 432 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lv~e~~ 432 (671)
..|+ |....||+....+|+.+++|+..... .....+..|..++..|... .+++++.. ....+..++++||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 78889998877778789999986421 2334566788887777422 23444432 11234557899999
Q ss_pred CCCchhh-----h---------hc----CCC--CCCCCChHHH----HHH---------------HHHHHHHHHHHHh--
Q 005893 433 PNSSLDA-----I---------LF----DPR--KRGLLCWSKR----INI---------------VNGIVKGILYLHE-- 471 (671)
Q Consensus 433 ~~gsL~~-----~---------l~----~~~--~~~~l~~~~~----~~i---------------~~qia~gL~~LH~-- 471 (671)
++..+.. + ++ ... ....+++... ..+ ...+...+..+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8765421 0 11 000 1111222211 001 0111122233322
Q ss_pred --CCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 472 --DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 472 --~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
..+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234689999999999999 4 899999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0035 Score=65.84 Aligned_cols=140 Identities=15% Similarity=0.182 Sum_probs=82.8
Q ss_pred cccCCCCcccEEEEEec--------CCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEe
Q 005893 360 NMLGQGGFGPVYKGVLS--------DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~--------~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 430 (671)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.|. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45767888889998864 2478999986432 223456678999988874 3223556666543 29999
Q ss_pred ccCCCchhhh-----------------hcCC--CCCCCCC--hHHHHHHHHHHHH-------------------HHHHHH
Q 005893 431 FMPNSSLDAI-----------------LFDP--RKRGLLC--WSKRINIVNGIVK-------------------GILYLH 470 (671)
Q Consensus 431 ~~~~gsL~~~-----------------l~~~--~~~~~l~--~~~~~~i~~qia~-------------------gL~~LH 470 (671)
|+++..|..- |+.. ...+... |.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 1111 1111222 4455555544322 233332
Q ss_pred ----hC-CCCceeecCCCCCcEEEcCC----CCeEEeeccccc
Q 005893 471 ----ED-SRLRIIHRDLKASNVLLDYD----MNPKISDFGMAR 504 (671)
Q Consensus 471 ----~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~Dfgla~ 504 (671)
.. ....++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 21 24569999999999999876 789999998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0064 Score=65.56 Aligned_cols=74 Identities=16% Similarity=0.119 Sum_probs=47.9
Q ss_pred ccccCCCCcccEEEEEecC-CceEEEEEccccchhchHHHHHHHHHHhhcCCCCe-eeEeeEEEcCCeeeEEEeccCCCc
Q 005893 359 SNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYEFMPNSS 436 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e~~~~gs 436 (671)
.+.|+.|-...+|+....+ +..+++|+....... ......|..++..|...++ .++++.+. + .+|+||+++..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999998765 478999987543221 1122578888888865555 45666652 2 35999998755
Q ss_pred h
Q 005893 437 L 437 (671)
Q Consensus 437 L 437 (671)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0028 Score=66.44 Aligned_cols=73 Identities=10% Similarity=0.080 Sum_probs=44.0
Q ss_pred cccCCCCcccEEEEEecC---------CceEEEEEccccchhchHHHHHHHHHHhhcCCCC-eeeEeeEEEcCCeeeEEE
Q 005893 360 NMLGQGGFGPVYKGVLSD---------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~---------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~ 429 (671)
+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...+ ..++++.. ..++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 457778888999988654 268899987653221 112457888887774333 33566543 237899
Q ss_pred eccCCCch
Q 005893 430 EFMPNSSL 437 (671)
Q Consensus 430 e~~~~gsL 437 (671)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.01 Score=61.37 Aligned_cols=32 Identities=25% Similarity=0.394 Sum_probs=27.9
Q ss_pred CCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 474 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.56 E-value=0.084 Score=50.08 Aligned_cols=100 Identities=12% Similarity=0.049 Sum_probs=64.7
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
.-+|.++|. ....++++.++|.++.|.+..|.-+-.... -..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 347888884 245679999999999999999877622110 11233457899999999988764 1110
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT 553 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt 553 (671)
.....+.+||... ...+.+.=|||||+++|.-+-
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122356787653 345688899999999999886
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.03 E-value=0.1 Score=55.46 Aligned_cols=141 Identities=15% Similarity=0.147 Sum_probs=84.6
Q ss_pred ccccCCCCcccEEEEEecC--------CceEEEEEccccchhchHHHHHHHHHHhhcCCCC-eeeEeeEEEcCCeeeEEE
Q 005893 359 SNMLGQGGFGPVYKGVLSD--------GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN-LVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lv~ 429 (671)
.+.|..|-...+|+....+ ++.+++|+....... ..+..+|..+++.+...+ ..++++.+ ..++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3567778888999988753 578999987543322 123457888887774323 34455433 237899
Q ss_pred eccCCCchhhh-h----------------cC--------CC--CCCCCChHHHHHHHHHH-------------------H
Q 005893 430 EFMPNSSLDAI-L----------------FD--------PR--KRGLLCWSKRINIVNGI-------------------V 463 (671)
Q Consensus 430 e~~~~gsL~~~-l----------------~~--------~~--~~~~l~~~~~~~i~~qi-------------------a 463 (671)
||+++..|..- + +. .. ...+.-|.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998664210 0 00 00 11112244444444332 1
Q ss_pred HHHHHHH---------------------hCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 464 KGILYLH---------------------EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 464 ~gL~~LH---------------------~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
..+.+|. ...+..++|+|+.+.||+ ++++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233332 112356899999999999 8888999999998763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.93 E-value=0.29 Score=51.59 Aligned_cols=30 Identities=23% Similarity=0.340 Sum_probs=25.1
Q ss_pred ceeecCCCCCcEEE------cCCCCeEEeecccccc
Q 005893 476 RIIHRDLKASNVLL------DYDMNPKISDFGMARI 505 (671)
Q Consensus 476 ~ivH~Dlkp~NIll------~~~~~~kl~Dfgla~~ 505 (671)
.++|+|+.+.|||+ +++..++++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.03 E-value=0.12 Score=35.21 Aligned_cols=6 Identities=0% Similarity=-0.147 Sum_probs=2.3
Q ss_pred hhhhee
Q 005893 292 GYFFAA 297 (671)
Q Consensus 292 ~~~~~~ 297 (671)
++++++
T Consensus 30 ~~~~~R 35 (44)
T 2l2t_A 30 FAVYVR 35 (44)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 334443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=81.61 E-value=1.5 Score=28.84 Aligned_cols=16 Identities=19% Similarity=0.310 Sum_probs=7.0
Q ss_pred hhhhHHHHHHHHHHHH
Q 005893 272 WMIIILAAVAAFLLLV 287 (671)
Q Consensus 272 ~~~ii~~~v~~~~ll~ 287 (671)
+..+++++++++++++
T Consensus 13 IAGiVvG~v~gv~li~ 28 (38)
T 2k1k_A 13 IVAVIFGLLLGAALLL 28 (38)
T ss_dssp HHHHHHHHHHHHHHHH
T ss_pred eeeeehHHHHHHHHHH
Confidence 3344444444444333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.96 E-value=4.3 Score=38.41 Aligned_cols=113 Identities=12% Similarity=0.136 Sum_probs=74.2
Q ss_pred CCCCeeeEeeEEEcCCeeeEEEeccCCC-chhhhhcCCCCCCCCChHHHHHHHHHHHHHHH-HHHhCCCCceeecCCCCC
Q 005893 408 QHKNLVKLLGFCVDGDEKLLVYEFMPNS-SLDAILFDPRKRGLLCWSKRINIVNGIVKGIL-YLHEDSRLRIIHRDLKAS 485 (671)
Q Consensus 408 ~H~niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~-~LH~~~~~~ivH~Dlkp~ 485 (671)
.||++ -..+-.+++...+.++.-+++ ++.. + ..++...+++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 68888 333445666766767655333 3332 2 23778889999998887666 5543 577889999
Q ss_pred cEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhh-HHHHHHHHHHHhCCCCCC
Q 005893 486 NVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDV-FSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 486 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDV-wSlGvil~elltG~~p~~ 559 (671)
||+++.++.++|.-.|+-..+ +|.- .+ ..|. -++=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l-------------------pP~e-----~~-ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL-------------------PPDE-----WD-DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB-------------------SSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC-------------------CCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764322 2211 11 1122 357778888888877663
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=80.53 E-value=3.8 Score=38.64 Aligned_cols=116 Identities=10% Similarity=0.072 Sum_probs=78.1
Q ss_pred cCCCCeeeEeeEEEcCCeeeEEEeccC-CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCC
Q 005893 407 LQHKNLVKLLGFCVDGDEKLLVYEFMP-NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKAS 485 (671)
Q Consensus 407 l~H~niv~l~g~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~ 485 (671)
..||++++. .+-.+++...+.++.-+ .-++.. -..++...+++++.+|+....+++. -+|--|.|.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 368998876 45566666666666543 223322 2347788999999999888766654 467889999
Q ss_pred cEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 005893 486 NVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTG 559 (671)
Q Consensus 486 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~ 559 (671)
||+++.++.+++.=.|+...+ +|. ..+...=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999877764332 111 11112223357788889999988774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 671 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-61 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 2e-70
Identities = 70/280 (25%), Positives = 125/280 (44%), Gaps = 22/280 (7%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
+ +G G FG VYKG + + +++ + Q F NEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+G+ + +V ++ SSL L + K I+I +G+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM-- 531
IIHRDLK++N+ L D+ KI DFG+A + + G ++ G+ +MAPE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 532 -EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590
+ YS +SDV++FG++L E++TG+ + N + G L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRGY-LSPDLS 232
Query: 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ C + C+++ +RP ++ ++
Sbjct: 233 KVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 2e-66
Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 24/277 (8%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
LG G FG V+ G + ++AVK L F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+L + ++ E+M N SL L P L +K +++ I +G+ ++ E +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEERN 129
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
IHRDL+A+N+L+ ++ KI+DFG+AR+ +E + APE G
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
++IKSDV+SFG+LL EI+T R + + N ++ P
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMT----------NPEVIQNLERGYRMVRP--- 232
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
D C + + LC +E DRPT + +L+
Sbjct: 233 DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 3e-64
Identities = 64/289 (22%), Positives = 119/289 (41%), Gaps = 26/289 (8%)
Query: 362 LGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD 421
+G+G FG V++G G+E+AVK SS E+ + E+ + L+H+N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 422 GDEKL----LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED----- 472
+ LV ++ + SL L R + I + G+ +LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA--RIVGTYGYMAPEYA 530
+ I HRDLK+ N+L+ + I+D G+A + ++ A VGT YMAPE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 531 MEGL------YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL--WNEG 582
+ + ++D+++ G++ EI G ++ +L+ + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 583 NALDLIDPLLTDTCSPDEFLRYIH-IGLLCVQEDAFDRPTMSSVVVMLQ 630
+ P + + E LR + I C + R T + L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-64
Identities = 71/277 (25%), Positives = 115/277 (41%), Gaps = 24/277 (8%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
S + +G G FG V+ G + ++A+K + +F E +++KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+L G C++ LV+EFM + L + +RGL + + + +G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYLE 118
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
+IHRDL A N L+ + K+SDFGM R + ++ + +PE
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFS 177
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
YS KSDV+SFGVL+ E+ + + N+S + + L P
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------VEDISTGFRLYKP--- 224
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
S I C +E DRP S ++ L
Sbjct: 225 RLASTH----VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 9e-64
Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 24/290 (8%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
+ LGQG FG V+ G + +A+K L F E ++ KL+H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+L + +V E+M SL L L + +++ I G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVE--- 130
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
R+ +HRDL+A+N+L+ ++ K++DFG+AR+ +E + APE A+ G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
++IKSDV+SFG+LL E+ T R + LD ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVP-----------------YPGMVNREVLDQVERGYR 232
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKPA 643
C P+ + C +++ +RPT + L+ + +P
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 2e-62
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 349 LDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGN-AEFTNEVLLILK 406
+++ +F + LG G G V+K G +A K + + + E+ ++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 407 LQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGI 466
+V G E + E M SLD +L +K G + + ++KG+
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 467 LYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMA 526
YL + +I+HRD+K SN+L++ K+ DFG++ S VGT YM+
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMS 171
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
PE YS++SD++S G+ L+E+ GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-62
Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 24/277 (8%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
+ + LG G FG V G ++A+K + EF E +++ L H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
+L G C ++ E+M N L L + R R + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE--- 117
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
+ +HRDL A N L++ K+SDFG++R E + + PE M
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
+S KSD+++FGVL+ EI + + + + + I L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK-----------------MPYERFTNSETAEHIAQGLR 219
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ I C E A +RPT ++ +
Sbjct: 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (526), Expect = 4e-62
Identities = 73/314 (23%), Positives = 126/314 (40%), Gaps = 48/314 (15%)
Query: 345 DLETLDVATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLS-SCSEQGNAEF 397
L +L+ +N +G+G FG V++ +AVK L S A+F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 398 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-------- 449
E L+ + + N+VKLLG C G L++E+M L+ L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 450 -------------LCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPK 496
L ++++ I + G+ YL E + +HRDL N L+ +M K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 497 ISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
I+DFG++R ++ +M PE Y+ +SDV+++GV+L EI +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 557 NTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDA 616
+ + + +GN L + C + ++ LC +
Sbjct: 241 QPYYGMAHEEV--------IYYVRDGNILACP-----ENCPLE----LYNLMRLCWSKLP 283
Query: 617 FDRPTMSSVVVMLQ 630
DRP+ S+ +LQ
Sbjct: 284 ADRPSFCSIHRILQ 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (521), Expect = 2e-61
Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 24/278 (8%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL 412
++ + + LG G +G VY+GV +AVK L + + EF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNL 75
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
V+LLG C ++ EFM +L L + R + + + I + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
+ IHRDL A N L+ + K++DFG++R+ G + + APE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 533 GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592
+SIKSDV++FGVLL EI T + + + +L++
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP-----------------YPGIDLSQVYELLEKDY 233
Query: 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ + C Q + DRP+ + + +
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (520), Expect = 3e-61
Identities = 70/308 (22%), Positives = 128/308 (41%), Gaps = 42/308 (13%)
Query: 343 YID---LETLDVATSNFSDS---------NMLGQGGFGPVYKGVLSDGKE----IAVKRL 386
+ID E + A F+ ++G G FG V G L + +A+K L
Sbjct: 3 FIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL 62
Query: 387 -SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPR 445
S +E+ +F +E ++ + H N++ L G +++ EFM N SLD+ F +
Sbjct: 63 KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQ 120
Query: 446 KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
G + + ++ GI G+ YL + +HRDL A N+L++ ++ K+SDFG++R
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 506 FAGSEGEVNTARIVG---TYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQ 562
+ +G + APE ++ SDV+S+G+++ E+++
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------ 231
Query: 563 SRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTM 622
+ + ++ I+ D + L C Q+D RP
Sbjct: 232 -----------RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 623 SSVVVMLQ 630
+V L
Sbjct: 281 GQIVNTLD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 6e-61
Identities = 74/278 (26%), Positives = 112/278 (40%), Gaps = 30/278 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 414 KLLGFCVDGDEKL-LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
+LLG V+ L +V E+M SL L R R +L + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
+HRDL A NVL+ D K+SDFG+ + + ++ + APE E
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALRE 174
Query: 533 GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592
+S KSDV+SFG+LL EI + R P +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------------EKGYKMDA 221
Query: 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
D C P + C DA RP+ + L+
Sbjct: 222 PDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 6e-61
Identities = 67/291 (23%), Positives = 126/291 (43%), Gaps = 29/291 (9%)
Query: 348 TLDVATSNFSDSNMLGQGGFGPVYKGVLSDGKE-----IAVKRLS-SCSEQGNAEFTNEV 401
T ++ S + ++G G FG VYKG+L +A+K L +E+ +F E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 402 LLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG 461
++ + H N+++L G +++ E+M N +LD F K G + + ++ G
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT-ARIVG 520
I G+ YL + +HRDL A N+L++ ++ K+SDFG++R+ T +
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 521 TYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580
+ APE ++ SDV+SFG+++ E++T + +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-----------------RPYWELS 218
Query: 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631
+ I+ D + + C Q++ RP + +V +L
Sbjct: 219 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-59
Identities = 74/301 (24%), Positives = 121/301 (40%), Gaps = 35/301 (11%)
Query: 338 KAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSDGK----EIAVKRLSSCSEQG 393
Q I +L V +F+ ++G+G FG VY G L D AVK L+ ++ G
Sbjct: 16 AVQHVVIGPSSLIV---HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 70
Query: 394 N-AEFTNEVLLILKLQHKNLVKLLGFCVDGDEK-LLVYEFMPNSSLDAILFDPRKRGLLC 451
++F E +++ H N++ LLG C+ + L+V +M + L + + +
Sbjct: 71 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 130
Query: 452 WSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511
+ + + + +HRDL A N +LD K++DFG+AR E
Sbjct: 131 DLIGFGLQVAK-----GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 512 EVNTAR--IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP 569
+ + +MA E ++ KSDV+SFGVLL E++T +
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------- 238
Query: 570 NLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVML 629
N +L LL PD + L C A RP+ S +V +
Sbjct: 239 NTFDITVYLLQG-------RRLLQPEYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRI 288
Query: 630 Q 630
Sbjct: 289 S 289
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-59
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 29/302 (9%)
Query: 349 LDVATSNFSDSNM-LGQGGFGPVYKGVL---SDGKEIAVKRLSSCSEQGNAE-FTNEVLL 403
L + N +++ LG G FG V +GV ++A+K L +E+ + E E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 404 ILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIV 463
+ +L + +V+L+G C + +LV E L L R+ + S +++ +
Sbjct: 63 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVS 119
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVN-TARIVGTY 522
G+ YL +HRDL A NVLL KISDFG+++ + +
Sbjct: 120 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 523 GYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582
+ APE +S +SDV+S+GV + E ++ + +
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----------------KPYKKMKGP 219
Query: 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITLCQPQKP 642
+ I+ C P+ + C DRP +V ++ +L +
Sbjct: 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
Query: 643 AF 644
Sbjct: 280 HH 281
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (505), Expect = 7e-59
Identities = 78/285 (27%), Positives = 121/285 (42%), Gaps = 44/285 (15%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGN---AEFTNEVLLILKLQ 408
FSD +G G FG VY + + + +A+K++S +Q N + EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILY 468
H N ++ G + LV E+ S+ D + + L + + +G ++G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 469 LHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE 528
LH +IHRD+KA N+LL K+ DFG A I A VGT +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPE 181
Query: 529 YAM---EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585
+ EG Y K DV+S G+ IE+ + N +AL
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP------------------PLFNMNAMSAL 223
Query: 586 DLI----DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626
I P L + F ++ C+Q+ DRPT ++
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-58
Identities = 78/325 (24%), Positives = 123/325 (37%), Gaps = 53/325 (16%)
Query: 342 FYIDLETLD------VATSNFSDSNMLGQGGFGPVYKGVLSD------GKEIAVKRLSSC 389
FY+D + N +LG G FG V ++AVK L
Sbjct: 19 FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 78
Query: 390 SEQGNAE-FTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKR 447
++ E +E+ ++ +L H+N+V LLG C L++E+ L L R++
Sbjct: 79 ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 138
Query: 448 --------------------GLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNV 487
+L + + + KG+ +L +HRDL A NV
Sbjct: 139 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNV 195
Query: 488 LLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVL 547
L+ + KI DFG+AR V +MAPE EG+Y+IKSDV+S+G+L
Sbjct: 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGIL 255
Query: 548 LIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHI 607
L EI + N A + L G +D + + I
Sbjct: 256 LWEIFSLGVNPYPGIPVDAN-------FYKLIQNGFKMD-----QPFYATEE----IYII 299
Query: 608 GLLCVQEDAFDRPTMSSVVVMLQGE 632
C D+ RP+ ++ L +
Sbjct: 300 MQSCWAFDSRKRPSFPNLTSFLGCQ 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-58
Identities = 70/294 (23%), Positives = 115/294 (39%), Gaps = 36/294 (12%)
Query: 343 YIDLETLDVATSNFSDSNMLGQGGFGPVYKGVLSD---GKEIAVKRLSSCSEQGNA--EF 397
Y+D + L + + LG G FG V KG K +AVK L + + E
Sbjct: 2 YLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 55
Query: 398 TNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRIN 457
E ++ +L + +V+++G C + + +LV E L+ L + + I
Sbjct: 56 LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIE 111
Query: 458 IVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA- 516
+V+ + G+ YL +HRDL A NVLL KISDFG+++ E
Sbjct: 112 LVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 517 RIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576
+ APE +S KSDV+SFGVL+ E + + +
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----------------KPY 211
Query: 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+++ C + LC D +RP ++V + L+
Sbjct: 212 RGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-58
Identities = 74/320 (23%), Positives = 115/320 (35%), Gaps = 48/320 (15%)
Query: 342 FYIDLETL------DVATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSC 389
YID L + + S LG G FG V + +AVK L
Sbjct: 5 VYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64
Query: 390 SEQGNAE-FTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRK- 446
+ E +E+ ++ L H N+V LLG C G L++ E+ L L R
Sbjct: 65 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 447 --------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD 492
L ++ + KG+ +L IHRDL A N+LL +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHG 181
Query: 493 MNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEII 552
KI DFG+AR V +MAPE +Y+ +SDV+S+G+ L E+
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 553 TGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCV 612
+ + + + + EG L + + I C
Sbjct: 242 SLGSSPYPGMPVDSK-------FYKMIKEG-----FRMLSPEHAPAE----MYDIMKTCW 285
Query: 613 QEDAFDRPTMSSVVVMLQGE 632
D RPT +V +++ +
Sbjct: 286 DADPLKRPTFKQIVQLIEKQ 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 2e-57
Identities = 67/283 (23%), Positives = 122/283 (43%), Gaps = 29/283 (10%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKE----IAVKRLS-SCSEQGNAEFTNEVLLILKL 407
+ F +LG G FG VYKG+ + +G++ +A+K L + S + N E +E ++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 408 QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
+ ++ +LLG C+ +L+ LD + + + +N I KG+
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLD---YVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAP 527
YL R++HRDL A NVL+ + KI+DFG+A++ E E + +MA
Sbjct: 126 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 528 EYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587
E + +Y+ +SDV+S+GV + E++T + +
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDGIPASEISSI 225
Query: 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
++ P + I + C DA RP +++
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-57
Identities = 76/307 (24%), Positives = 128/307 (41%), Gaps = 49/307 (15%)
Query: 327 YQHVRGRDDDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKR 385
Y+HV DL +DF+ + L G G FG VYK A K
Sbjct: 1 YEHVT---RDLNPEDFWEIIGEL-------------GDGAFGKVYKAQNKETSVLAAAKV 44
Query: 386 LSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPR 445
+ + SE+ ++ E+ ++ H N+VKLL + ++ EF ++DA++
Sbjct: 45 IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--E 102
Query: 446 KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505
L S+ + + + YLH+ +IIHRDLKA N+L D + K++DFG++
Sbjct: 103 LERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 159
Query: 506 FAGSEGEVNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGF 560
+ ++ +GT +MAPE M + Y K+DV+S G+ LIE+
Sbjct: 160 NTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP--- 214
Query: 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPD--EFLRYIHIGLLCVQEDAFD 618
+L + L P S + +FL+ C++++
Sbjct: 215 --HHELNPMRVL----LKIAKSEPPTLAQP---SRWSSNFKDFLK------KCLEKNVDA 259
Query: 619 RPTMSSV 625
R T S +
Sbjct: 260 RWTTSQL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 7e-57
Identities = 83/312 (26%), Positives = 131/312 (41%), Gaps = 35/312 (11%)
Query: 335 DDLKAQDFYIDLETLDVATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLS- 387
+ A D Y + +VA + S LGQG FG VY+GV +A+K ++
Sbjct: 2 EYFSAADVY-VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 388 SCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKR 447
+ S + EF NE ++ + ++V+LLG G L++ E M L + L R
Sbjct: 61 AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120
Query: 448 GL-------LCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500
SK I + I G+ YL+ + + +HRDL A N ++ D KI DF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177
Query: 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560
GM R ++ + + +M+PE +G+++ SDV+SFGV+L EI T
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 561 NQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP 620
S EG LD D PD + +C Q + RP
Sbjct: 238 GLSNEQ--------VLRFVMEGGLLDKPDNC------PDML---FELMRMCWQYNPKMRP 280
Query: 621 TMSSVVVMLQGE 632
+ ++ ++ E
Sbjct: 281 SFLEIISSIKEE 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-56
Identities = 62/273 (22%), Positives = 112/273 (41%), Gaps = 33/273 (12%)
Query: 362 LGQGGFGPVYKGVLSD-GKEIAVKRLS--SCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G F VYKG+ ++ E+A L ++ F E ++ LQH N+V+
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 419 CVDGDEK----LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
+ +LV E M + +L L ++ ++ + I+KG+ +LH +
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 475 LRIIHRDLKASNVLL-DYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEG 533
IIHRDLK N+ + + KI D G+A + S ++GT +MAPE E
Sbjct: 134 -PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YEE 187
Query: 534 LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593
Y DV++FG+ ++E+ T + P
Sbjct: 188 KYDESVDVYAFGMCMLEMATSE-------------YPYSECQNAAQIYRRVTSGVKPASF 234
Query: 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626
D + E I C++++ +R ++ ++
Sbjct: 235 DKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 6e-56
Identities = 72/281 (25%), Positives = 112/281 (39%), Gaps = 30/281 (10%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLLILKLQHKN 411
++ +G G +G K SDGK + K L S +E +EV L+ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 412 LVKLLGFCVDGDEKLL--VYEFMPNSSLDAILFDPRK-RGLLCWSKRINIVNGIVKGILY 468
+V+ +D L V E+ L +++ K R L + ++ + +
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 469 LHE--DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMA 526
H D ++HRDLK +NV LD N K+ DFG+ARI VGT YM+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMS 182
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGRR-NTGFNQSRGATAPNLLAYAWHLWNEGNAL 585
PE Y+ KSD++S G LL E+ T F+Q EG
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE----------LAGKIREGKFR 232
Query: 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626
+ DE I + + RP++ ++
Sbjct: 233 RIPYRY------SDELNEII---TRMLNLKDYHRPSVEEIL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-55
Identities = 63/274 (22%), Positives = 110/274 (40%), Gaps = 25/274 (9%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS-SCSEQGNAEFTNEVLLILKLQHKNL 412
++ LG+G +G V V + +AVK + + E+ + L H+N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
VK G +G+ + L E+ L + + + ++ G++YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQLMAGVVYLHG- 121
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM- 531
+ I HRD+K N+LLD N KISDFG+A +F + E ++ GT Y+APE
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 532 EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591
++ DV+S G++L ++ G P+ + W E
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWD--------QPSDSCQEYSDWKEKKTYLNPWKK 231
Query: 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625
+ L +H + E+ R T+ +
Sbjct: 232 I-----DSAPLALLH---KILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 6e-55
Identities = 65/295 (22%), Positives = 119/295 (40%), Gaps = 41/295 (13%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVLSDG---KEIAVKRLS-SCSEQGNAEFTNEVLLILKL-Q 408
++ +++G+G FG V K + + A+KR+ S+ + +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 409 HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAIL-------------FDPRKRGLLCWSKR 455
H N++ LLG C L E+ P+ +L L L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNT 515
++ + +G+ YL + + IHRDL A N+L+ + KI+DFG++R E V
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 516 ARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYA 575
+MA E +Y+ SDV+S+GVLL EI++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----------------P 226
Query: 576 WHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ + + + + C +E ++RP+ + ++V L
Sbjct: 227 YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-54
Identities = 70/284 (24%), Positives = 103/284 (36%), Gaps = 30/284 (10%)
Query: 355 NFSDSNMLGQGGFGPVYKGVL----SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKL 407
+ LG G FG V +G +AVK L + +F EV + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 408 QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
H+NL++L G + K+ V E P SL + +G + +G+
Sbjct: 69 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF-AGSEGEVNTARIVGTYGYMA 526
YL R IHRDL A N+LL KI DFG+ R + V + + A
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586
PE +S SD + FGV L E+ T + + + EG L
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------LHKIDKEGERLP 235
Query: 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ C D ++ + C DRPT ++ L
Sbjct: 236 RP-----EDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 7e-54
Identities = 59/282 (20%), Positives = 102/282 (36%), Gaps = 43/282 (15%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQH 409
+F LG+G FG VY +A+K L + EV + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
N+++L G+ D L+ E+ P ++ L +K + + + + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYC 122
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
H R+IHRD+K N+LL KI+DFG + S + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI- 588
++ K D++S GVL E + G+ + I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYKRIS 217
Query: 589 --DPLLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPTMSSVV 626
+ D + + + ++ + RP + V+
Sbjct: 218 RVEFTFPDFVTEGARDLIS------RLLKHNPSQRPMLREVL 253
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-53
Identities = 66/277 (23%), Positives = 126/277 (45%), Gaps = 32/277 (11%)
Query: 353 TSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKN 411
++ +GQG G VY + ++ G+E+A+++++ + NE+L++ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+V L + GDE +V E++ SL ++ + + + ++ + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS 134
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
++IHRD+K+ N+LL D + K++DFG + + +T +VGT +MAPE
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 532 EGLYSIKSDVFSFGVLLIEIITGRR-NTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590
Y K D++S G++ IE+I G N R A +L +L +P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----------ALYLIATNGTPELQNP 239
Query: 591 LLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPTMSSV 625
+ S +FL C+ D R + +
Sbjct: 240 ---EKLSAIFRDFLN------RCLDMDVEKRGSAKEL 267
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-52
Identities = 76/299 (25%), Positives = 110/299 (36%), Gaps = 41/299 (13%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV------LSDGKEIAVKRLSSCSEQGNAE--FTNEVLLIL 405
LG+G FG V + + + +AVK L + + +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 406 KLQHKNLVKLLGFCV-DGDEKLLVYEFMPNSSLDAILFDPRK-------------RGLLC 451
H N+V LLG C G +++ EF +L L R + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 452 WSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511
I + KG+ +L + IHRDL A N+LL KI DFG+AR
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNL 571
V +MAPE + +Y+I+SDV+SFGVLL EI + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV-------KI 242
Query: 572 LAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
EG + D +P+ L C + RPT S +V L
Sbjct: 243 DEEFCRRLKEGTRMRAPDY-----TTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-52
Identities = 76/300 (25%), Positives = 120/300 (40%), Gaps = 43/300 (14%)
Query: 354 SNFSDSNMLGQGGFGPVYKGVL--------SDGKEIAVKRL-SSCSEQGNAEFTNEVLLI 404
LG+G FG V + ++AVK L S +E+ ++ +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 405 LKL-QHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGL-------------L 450
+ +HKN++ LLG C ++ E+ +L L R GL L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 451 CWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510
++ + +G+ YL + IHRDL A NVL+ D KI+DFG+AR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPN 570
T +MAPE + +Y+ +SDV+SFGVLL EI T +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246
Query: 571 LLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+ L EG+ +D C+ + + C RPT +V L
Sbjct: 247 -----FKLLKEGHRMDKP-----SNCTNE----LYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-51
Identities = 59/275 (21%), Positives = 103/275 (37%), Gaps = 29/275 (10%)
Query: 361 MLGQGGFGPVYKGVLSDGKE----IAVKRLSSCSEQGNAE-FTNEVLLILKLQHKNLVKL 415
+G+G FG V++G+ + +A+K +C+ E F E L + + H ++VKL
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 416 LGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRL 475
+G + + ++ E L + F ++ L + I + + YL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---K 127
Query: 476 RIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY 535
R +HRD+ A NVL+ + K+ DFG++R S ++ +MAPE +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRF 186
Query: 536 SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDT 595
+ SDV+ FGV + EI+ E +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGE-------RLPMPPN 233
Query: 596 CSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
C P + C D RP + + L
Sbjct: 234 CPPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-49
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQHK 410
+F +LG+G F V L+ +E A+K L E T E ++ +L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 411 NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLH 470
VKL D ++ + N L + K G + IV + YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 471 EDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
IIHRDLK N+LL+ DM+ +I+DFG A++ + + VGT Y++PE
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 531 MEGLYSIKSDVFSFGVLLIEIITGRR 556
E SD+++ G ++ +++ G
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (433), Expect = 3e-48
Identities = 48/198 (24%), Positives = 85/198 (42%), Gaps = 11/198 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
LG G FG V++ + G A K + + E E+ + L+H LV L
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
D +E +++YEFM L + + + + + + + KG+ ++HE +H
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHL 148
Query: 481 DLKASNVLLDYDMNP--KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIK 538
DLK N++ + K+ DFG+ + + GT + APE A
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 539 SDVFSFGVLLIEIITGRR 556
+D++S GVL +++G
Sbjct: 206 TDMWSVGVLSYILLSGLS 223
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 9e-47
Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 11/198 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
LG G FG V++ V + G+ K +++ NE+ ++ +L H L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
D E +L+ EF+ L + + + ++ IN + +G+ ++HE I+H
Sbjct: 97 DKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 481 DLKASNVLLDYDMNP--KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIK 538
D+K N++ + KI DFG+A E T + APE
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFY 208
Query: 539 SDVFSFGVLLIEIITGRR 556
+D+++ GVL +++G
Sbjct: 209 TDMWAIGVLGYVLLSGLS 226
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (412), Expect = 3e-45
Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 32/287 (11%)
Query: 348 TLDVATSNFSDSNMLGQGGFGPVYKGVLSD-GKEIAVKRLS---SCSEQGNAEFTNEVLL 403
T++ +FS ++G+GGFG VY +D GK A+K L +QG NE ++
Sbjct: 2 TMN----DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM 57
Query: 404 ILKLQ---HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVN 460
+ + +V + D+ + + M L L + G+ +
Sbjct: 58 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAA 114
Query: 461 GIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVG 520
I+ G+ ++H +++RDLK +N+LLD + +ISD G+A F+ + VG
Sbjct: 115 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVG 167
Query: 521 TYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579
T+GYMAPE +G+ Y +D FS G +L +++ G F Q + + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMA 225
Query: 580 NE------GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP 620
E L++ LL + L + G V+E F R
Sbjct: 226 VELPDSFSPELRSLLEGLL--QRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-45
Identities = 51/213 (23%), Positives = 100/213 (46%), Gaps = 8/213 (3%)
Query: 347 ETLDVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE-FTNEVLLI 404
+ DV +++ + +G+G +G V + +A+K++S Q + E+ ++
Sbjct: 2 QVFDV-GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60
Query: 405 LKLQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVK 464
L+ +H+N++ + + + ++ + A L+ K L + I++
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120
Query: 465 GILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTA-RIVGTYG 523
G+ Y+H ++HRDLK SN+LL+ + KI DFG+AR+ V T
Sbjct: 121 GLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 524 YMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGR 555
Y APE + Y+ D++S G +L E+++ R
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (406), Expect = 5e-45
Identities = 53/280 (18%), Positives = 102/280 (36%), Gaps = 29/280 (10%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFC 419
+G G FG +Y G ++ G+E+A+K C + + + E + +Q + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 420 -VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
+GD ++V E + S D + + + ++ I Y+H I
Sbjct: 72 GAEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFI 125
Query: 479 HRDLKASNVL---LDYDMNPKISDFGMARIFAGSEGEVN-----TARIVGTYGYMAPEYA 530
HRD+K N L I DFG+A+ + + + + GT Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 531 MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590
+ S + D+ S G +L+ G ++ + +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-------KRQKYERISEKKMSTPIE 238
Query: 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
+L P EF Y++ C D+P S + + +
Sbjct: 239 VLCKGY-PSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (393), Expect = 4e-43
Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 8/199 (4%)
Query: 360 NMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGN-AEFTNEVLLILKLQHKNLVKLLG 417
++LG G F V K +A+K ++ + +G NE+ ++ K++H N+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
G L+ + + L + ++G ++ ++ + YLH+ +
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSI 537
+ LD D ISDFG++++ + GT GY+APE + YS
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSK 188
Query: 538 KSDVFSFGVLLIEIITGRR 556
D +S GV+ ++ G
Sbjct: 189 AVDCWSIGVIAYILLCGYP 207
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV 413
+++D+ ++G G FG VY+ L G+ +A+K++ Q E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 414 KLLGFCVDGDEK------LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
+L F EK LV +++P + R + L + + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGSEGEVNTARIVGTYGYMA 526
Y+H I HRD+K N+LLD D K+ DFG A+ GE N + I Y
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRAP 191
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
Y+ DV+S G +L E++ G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 360 NMLGQGGFGPVYKGV-LSDGKEIAVKRL-----SSCSEQGNAEFTNEVLLILKLQHKNLV 413
+ LG+G F VYK + + +A+K++ S + N E+ L+ +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 414 KLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS 473
LL LV++FM +L S + ++G+ YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME- 532
I+HRDLK +N+LLD + K++DFG+A+ F V T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 533 GLYSIKSDVFSFGVLLIEIITGR 555
+Y + D+++ G +L E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 42/198 (21%), Positives = 85/198 (42%), Gaps = 12/198 (6%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
LG+G FG V++ V S K K + E+ ++ +H+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 421 DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHR 480
+E ++++EF+ + + L + ++ V+ + + + +LH I H
Sbjct: 72 SMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 481 DLKASNVLLDYDMNP--KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIK 538
D++ N++ + KI +FG AR + N + Y APE + S
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 539 SDVFSFGVLLIEIITGRR 556
+D++S G L+ +++G
Sbjct: 184 TDMWSLGTLVYVLLSGIN 201
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 1e-42
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 15/207 (7%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQH 409
+F LG G FG V+ +G+ A+K L + +E L++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
++++ G D + ++ +++ L ++L ++ V L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
II+RDLK N+LLD + + KI+DFG A+ T + GT Y+APE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEV 172
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGRR 556
Y+ D +SFG+L+ E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (385), Expect = 2e-42
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQHKNLVKLL 416
+LG GG V+ L +++AVK L + F E L H +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 417 GFCVDGDEKL----LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
+V E++ +L I+ G + + I ++ + + + H+
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSHQ- 129
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV-NTARIVGTYGYMAPEYAM 531
IIHRD+K +N+++ K+ DFG+AR A S V TA ++GT Y++PE A
Sbjct: 130 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187
Query: 532 EGLYSIKSDVFSFGVLLIEIITGRR 556
+SDV+S G +L E++TG
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 3e-42
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS---------SCSEQGNAEFTNEVLLI 404
N+ +LG+G V + + KE AVK + ++ EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 405 LKLQ-HKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIV 463
K+ H N+++L LV++ M L L ++ L + I+ ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120
Query: 464 KGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYG 523
+ I LH+ L I+HRDLK N+LLD DMN K++DFG + E + GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPS 174
Query: 524 YMAPEYAMEGL------YSIKSDVFSFGVLLIEIITGR 555
Y+APE + Y + D++S GV++ ++ G
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 64/245 (26%), Positives = 105/245 (42%), Gaps = 14/245 (5%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE----FTNEVLLILKLQH 409
+F MLG+G FG V+ + A+K L + + + +L L +H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 410 KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYL 469
L + + V E++ L + + S+ I+ G+ +L
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 470 HEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEY 529
H I++RDLK N+LLD D + KI+DFGM + + + NT GT Y+APE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 174
Query: 530 AMEGLYSIKSDVFSFGVLLIEIITGRRN-TGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588
+ Y+ D +SFGVLL E++ G+ G ++ + + + W E A DL+
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 234
Query: 589 DPLLT 593
L
Sbjct: 235 VKLFV 239
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (383), Expect = 5e-42
Identities = 45/293 (15%), Positives = 97/293 (33%), Gaps = 31/293 (10%)
Query: 350 DVATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ 408
+V ++ +G+G FG +++G L + +++A+K + +E L
Sbjct: 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLA 58
Query: 409 H-KNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
+ + F +G +LV + + S D + ++ +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQ 115
Query: 468 YLHEDSRLRIIHRDLKASNVLLDYDMNP-----KISDFGMARIFAGSEGEVN-----TAR 517
+HE +++RD+K N L+ + + DFGM + + + +
Sbjct: 116 SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172
Query: 518 IVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWH 577
+ GT YM+ + S + D+ + G + + + G +G A
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS-----LPWQGLKAATN---KQK 224
Query: 578 LWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630
G P+EF +Y+H P + +
Sbjct: 225 YERIGEKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-40
Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 21/285 (7%)
Query: 355 NFSDSNMLGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKN 411
NF +G+G +G VYK G+ +A+K RL + +E + E+ L+ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+VKLL ++ LV+EF+ D + + + +++G+ + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPE-YA 530
R++HRDLK N+L++ + K++DFG+AR F V T Y APE
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEILL 175
Query: 531 MEGLYSIKSDVFSFGVLLIEIITGRR--------NTGFNQSRGATAPNLLAYAWHLWNEG 582
YS D++S G + E++T R + F R P+ + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 583 NALDLIDPLLTDTCSPDEFLRYIHIGLL--CVQEDAFDRPTMSSV 625
D L LL + D R + +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 56/276 (20%), Positives = 101/276 (36%), Gaps = 45/276 (16%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAE------FTNEVLLILKLQ--HKN 411
+LG GGFG VY G+ +SD +A+K + E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 412 LVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
+++LL + D +L+ E +RG L + +++ + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 472 DSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
++HRD+K N+L+D + K+ DFG + + GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWI 181
Query: 531 M-EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589
+ + V+S G+LL +++ G + +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD---------------------IPFEHDEEIIRGQ 220
Query: 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625
S + H+ C+ DRPT +
Sbjct: 221 VFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-40
Identities = 58/282 (20%), Positives = 112/282 (39%), Gaps = 24/282 (8%)
Query: 362 LGQGGFGPVYKG--VLSDGKEIAVKRLSSCSEQGNAE--FTNEVLLILKL---QHKNLVK 414
+G+G +G V+K + + G+ +A+KR+ + + EV ++ L +H N+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLD---AILFDPRKRGLLCWSKRINIVNGIVKGILYLHE 471
L C + +D D + +++ +++G+ +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 472 DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
R++HRDLK N+L+ K++DFG+ARI++ +V T Y APE +
Sbjct: 135 ---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLL 188
Query: 532 EGLYSIKSDVFSFGVLLIEIITGR---RNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588
+ Y+ D++S G + E+ + R + G + W AL
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248
Query: 589 DPLLTDTCSPDEFLRYIHIGLL-----CVQEDAFDRPTMSSV 625
++F+ I C+ + R + S
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (367), Expect = 7e-40
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 11/204 (5%)
Query: 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNL 412
+ +G+G +G VYK + G+ A+K RL E + E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 413 VKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
VKL +LV+E + + G L + + ++ GI Y H+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHD- 118
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM- 531
R++HRDLK N+L++ + KI+DFG+AR F + T Y AP+ M
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 532 EGLYSIKSDVFSFGVLLIEIITGR 555
YS D++S G + E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-39
Identities = 61/277 (22%), Positives = 105/277 (37%), Gaps = 39/277 (14%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRL------SSCSEQGNAEFTNEVLLILKLQHKNLVK 414
LG G F V K S G + A K + SS + EV ++ ++QH N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 415 LLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
L + + +L+ E + L ++ L + + I+ G ++
Sbjct: 78 LHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG---VYYLHS 131
Query: 475 LRIIHRDLKASNVLLDYDMNP----KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYA 530
L+I H DLK N++L P KI DFG+A I GT ++APE
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIV 188
Query: 531 MEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590
+++D++S GV+ +++G + G T LA + E +
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANVSAVNYE------FED 237
Query: 591 LLTDTCSPD--EFLRYIHIGLLCVQEDAFDRPTMSSV 625
S +F+R + +D R T+
Sbjct: 238 EYFSNTSALAKDFIR------RLLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 8e-38
Identities = 57/274 (20%), Positives = 102/274 (37%), Gaps = 32/274 (11%)
Query: 361 MLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGF 418
+LG G G V + ++ A+K L C + EV L + Q ++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDV 73
Query: 419 CVDGDEK----LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSR 474
+ L+V E + L + + D R + I+ I + I YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHS--- 129
Query: 475 LRIIHRDLKASNVLLDYDMNP---KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAM 531
+ I HRD+K N+L K++DFG A+ + T Y+APE
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLG 186
Query: 532 EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591
Y D++S GV++ ++ G F + + LA + + P
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPP--FY------SNHGLAISPGMKTRIRMGQYEFPN 238
Query: 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSV 625
+ +E I ++ + R T++
Sbjct: 239 PEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 354 SNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLLILKLQHK 410
S + +GQG FG V+K G+++A+K++ + E E+ ++ L+H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 411 NLVKLLGFCVDGDEK--------LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGI 462
N+V L+ C LV++F + S+ ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQML 126
Query: 463 VKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTAR--IVG 520
+ G L+ R +I+HRD+KA+NVL+ D K++DFG+AR F+ ++ V
Sbjct: 127 LNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 521 TYGYMAPEYAM-EGLYSIKSDVFSFGVLLIEIITGRR 556
T Y PE + E Y D++ G ++ E+ T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-37
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 10/198 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVK--RLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G+G +G V+K + +A+K RL E + E+ L+ +L+HKN+V+L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 419 CVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478
+ LV+EF + G L + + ++KG+ + H ++
Sbjct: 70 LHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVL 123
Query: 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIK 538
HRDLK N+L++ + K+++FG+AR F G +A +V + LYS
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 539 SDVFSFGVLLIEIITGRR 556
D++S G + E+ R
Sbjct: 183 IDMWSAGCIFAELANAGR 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 8e-36
Identities = 50/210 (23%), Positives = 83/210 (39%), Gaps = 12/210 (5%)
Query: 351 VATSNFSDSNMLGQGGFGPVYKGV-LSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILK 406
V ++F +LG+G FG V + G+ A+K L ++ A E ++
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 407 LQHKNLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGI 466
+H L L D V E+ L L + + + IV
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA- 117
Query: 467 LYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMA 526
L +++RD+K N++LD D + KI+DFG+ + GT Y+A
Sbjct: 118 --LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLA 173
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGRR 556
PE + Y D + GV++ E++ GR
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 2e-34
Identities = 52/199 (26%), Positives = 79/199 (39%), Gaps = 15/199 (7%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS---SCSEQGNAEFTNEVLLILKLQHKNLVKLLG 417
LG G FG V G A+K L + NE ++ + LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 418 FCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
D +V E++ + + L + G IV YLH L +
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHS---LDL 162
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSI 537
I+RDLK N+L+D +++DFG A+ G + GT +APE + Y+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEIILSKGYNK 217
Query: 538 KSDVFSFGVLLIEIITGRR 556
D ++ GVL+ E+ G
Sbjct: 218 AVDWWALGVLIYEMAAGYP 236
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-34
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRL--SSCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G G +G V V G ++A+K+L SE E+ L+ ++H+N++ LL
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 419 CVDGD------EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
+ + LV FM + K L + +V ++KG+ Y+H
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLKGLRYIHA- 139
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
IIHRDLK N+ ++ D KI DFG+AR + + V T Y APE +
Sbjct: 140 --AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILN 192
Query: 533 GL-YSIKSDVFSFGVLLIEIITGR 555
+ Y+ D++S G ++ E+ITG+
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 47/223 (21%), Positives = 99/223 (44%), Gaps = 24/223 (10%)
Query: 343 YIDLETLDVATSNFSD---SNMLGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFT 398
Y D E+ V N D LG+G + V++ + +++ +++ VK L ++ +
Sbjct: 21 YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 77
Query: 399 NEVLLILKLQ-HKNLVKLLGFCVDGDEKL--LVYEFMPNSSLDAILFDPRKRGLLCWSKR 455
E+ ++ L+ N++ L D + LV+E + N+ + L
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDI 131
Query: 456 INIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD-MNPKISDFGMARIFAGSEGEVN 514
+ I+K + Y H + I+HRD+K NV++D++ ++ D+G+A + +
Sbjct: 132 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---E 185
Query: 515 TARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRR 556
V + + PE ++ +Y D++S G +L +I +
Sbjct: 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-30
Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 21/203 (10%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS--SCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G G G V + +A+K+LS ++ E++L+ + HKN++ LL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 419 CV------DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHED 472
+ + LV E M + I + + ++ ++ GI +LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHSA 138
Query: 473 SRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAME 532
IIHRDLK SN+++ D KI DFG+AR S V T Y APE +
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG 192
Query: 533 GLYSIKSDVFSFGVLLIEIITGR 555
Y D++S G ++ E++ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 8e-30
Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 18/217 (8%)
Query: 351 VATSNFSDSNMLGQGGFGPVYKGVL----SDGKEIAVKRLS----SCSEQGNAEFTNEVL 402
V NF +LG G +G V+ GK A+K L + E
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 403 LILKLQHK-NLVKLLGFCVDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNG 461
++ ++ LV L + L+ +++ L L + + +
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI-- 138
Query: 462 IVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGT 521
+L L +L II+RD+K N+LLD + + ++DFG+++ F E E GT
Sbjct: 139 ----VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGT 193
Query: 522 YGYMAPEYAMEGL--YSIKSDVFSFGVLLIEIITGRR 556
YMAP+ G + D +S GVL+ E++TG
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 11/198 (5%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLS--SCSEQGNAEFTNEVLLILKLQHKNLVKLLGF 418
+G G +G V G +AVK+LS S E+ L+ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 419 CVDGDE-KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRI 477
+ ++ + A L + K L ++ I++G+ Y+H I
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 478 IHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSI 537
IHRDLK SN+ ++ D KI DFG+AR + T + + Y+
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 538 KSDVFSFGVLLIEIITGR 555
D++S G ++ E++TGR
Sbjct: 199 TVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 2e-27
Identities = 41/209 (19%), Positives = 79/209 (37%), Gaps = 18/209 (8%)
Query: 362 LGQGGFGPVYKGV-LSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCV 420
LG G F V+ + + +A+K + + +E+ L+ ++ + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 421 DGDEKLLVY-------------EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGIL 467
+ KLL + F L + + I ++ G+
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 468 YLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMA 526
Y+H R IIH D+K NVL++ D + +A + + + + T Y +
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 527 PEYAMEGLYSIKSDVFSFGVLLIEIITGR 555
PE + + +D++S L+ E+ITG
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.2 bits (236), Expect = 4e-23
Identities = 32/205 (15%), Positives = 64/205 (31%), Gaps = 33/205 (16%)
Query: 360 NMLGQGGFGPVYKGVLSDGKEIAVKRL----------SSCSEQGNAEFTNEVLLILKLQH 409
++G+G V+ E VK + G+ F+ + + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 410 KNLVKLLGFCV----DGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKG 465
+ L KL G V + ++ E + R + +++ I++
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELID--------AKELYRVRVENPDE--VLDMILEE 115
Query: 466 ILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYM 525
+ + I+H DL NVL+ + I DF + R V
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDV----RN 167
Query: 526 APEYAMEGLYSIKSDVFSFGVLLIE 550
Y Y + D+ S +++
Sbjct: 168 IITY-FSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 671 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.47 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.72 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=412.56 Aligned_cols=264 Identities=28% Similarity=0.436 Sum_probs=203.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
..++|+..+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.++++++|||||++++++.+ +..++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 4567888999999999999999874 36999998643 34556789999999999999999999998754 5689999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 83 Ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999854 3345999999999999999999999988 999999999999999999999999999876554
Q ss_pred CCccccccccccCCccchhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAME---GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..........||+.|||||++.. +.++.++|||||||++|||+||+.||.... .. .........+....
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~-------~~-~~~~~~~~~~~~~p 229 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-------NR-DQIIFMVGRGYLSP 229 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------CH-HHHHHHHHHTSCCC
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC-------hH-HHHHHHHhcCCCCC
Confidence 44444455689999999999864 458999999999999999999999995321 11 11222222222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
.. +.+...+++ .+.+++.+||+.||++|||++||++.|+.....+
T Consensus 230 ~~-~~~~~~~~~----~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 230 DL-SKVRSNCPK----AMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CG-GGSCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cc-hhccccchH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11 112233333 3667788999999999999999999998654433
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=408.19 Aligned_cols=255 Identities=28% Similarity=0.404 Sum_probs=197.4
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
++|+..+.||+|+||.||+|++.+++.||||+++... ...++|.+|+.++++++|||||+++|++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5677889999999999999999888899999997643 445689999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+|+|.+++.. ....++|..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 9999998853 3456899999999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLT 593 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 593 (671)
......||+.|+|||++.++.++.++|||||||++|||+|+..|+.. .....+... ....+.. ....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~-------~~~~~~~~~-~i~~~~~-----~~~p 224 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVE-DISTGFR-----LYKP 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC-------SCCHHHHHH-HHHHTCC-----CCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC-------CCCHHHHHH-HHHhcCC-----CCCc
Confidence 22335789999999999999999999999999999999995444321 112222222 2222211 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 594 DTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 594 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
..+++ .+.+++.+||+.||++||||+||++.|+..
T Consensus 225 ~~~~~----~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 RLAST----HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCH----HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 22232 366788899999999999999999999753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-50 Score=405.80 Aligned_cols=256 Identities=30% Similarity=0.440 Sum_probs=205.5
Q ss_pred HhCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
..++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 345677889999999999999999888899999997643 345679999999999999999999998754 567999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++|+|.+++.. .....++|..+++|+.||++||.|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 89 ~~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999998743 23345899999999999999999999988 99999999999999999999999999997654432
Q ss_pred ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
. ......||+.|+|||++..+.++.++|||||||++|||+||..|+... ....+. ......+. .+.
T Consensus 165 ~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-------~~~~~~-~~~i~~~~-----~~~ 230 (272)
T d1qpca_ 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEV-IQNLERGY-----RMV 230 (272)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHH-HHHHHTTC-----CCC
T ss_pred c-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC-------CCHHHH-HHHHHhcC-----CCC
Confidence 2 233457899999999999999999999999999999999976654321 111121 12222221 111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
....+++ .+.+++.+||+.||++||||+||+++|+.
T Consensus 231 ~p~~~~~----~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 RPDNCPE----ELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccChH----HHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2223333 36678889999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-49 Score=405.55 Aligned_cols=260 Identities=28% Similarity=0.408 Sum_probs=211.3
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
++..++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+.++++++|||||++++++.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 344566788899999999999999975 58899999997543 3456899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|..++.. .....+++..++.|+.||+.||.|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 92 ~E~~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 999999999999854 33457999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.... ......|++.|+|||++.++.++.++|||||||++|||++|..|+... ..... .++....+..
T Consensus 168 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-------~~~~~-~~~~i~~~~~---- 234 (287)
T d1opja_ 168 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------IDLSQ-VYELLEKDYR---- 234 (287)
T ss_dssp SSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-------CCHHH-HHHHHHTTCC----
T ss_pred CCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-------chHHH-HHHHHhcCCC----
Confidence 4322 233356889999999999999999999999999999999977765321 11111 2223333221
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+.....+++ .+.+++.+||+.||++|||++||++.|+..
T Consensus 235 -~~~~~~~~~----~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 -MERPEGCPE----KVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp -CCCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -CCCCccchH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 112223333 366788899999999999999999999764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=400.77 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=201.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46888899999999999999974 68999999986533 23345689999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+++|+|.+++. ..+.+++.+++.++.||+.||.|||+++ |+||||||+|||+++++++||+|||+++.......
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 4557999999999999999999999998 99999999999999999999999999997655443
Q ss_pred ccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 512 EVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
.......+||+.|||||++.+..+ +.++|||||||++|||++|+.||...... .. .. ............
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-----~~-~~--~~~~~~~~~~~~-- 228 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----CQ-EY--SDWKEKKTYLNP-- 228 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-----SH-HH--HHHHTTCTTSTT--
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH-----HH-HH--HHHhcCCCCCCc--
Confidence 333445689999999999988876 57899999999999999999999643211 11 11 111111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....++ .+.+++.+||+.||++|||++|+++
T Consensus 229 --~~~~s~----~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --WKKIDS----APLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGGSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCH----HHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011222 3556777999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=399.52 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=206.5
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688899999999999999996 468999999997655556678999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++.. +.+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999998742 45999999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
.....+||+.|+|||++.++.++.++|||||||++|||++|+.||... +.....+.....+...-. .
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~~~~~~~~~~~----~ 238 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--------NPLRALYLIATNGTPELQ----N 238 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHHCSCCCS----S
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC--------CHHHHHHHHHhCCCCCCC----C
Confidence 233468999999999999999999999999999999999999999422 222333333333221111 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+++ .+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~s~----~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSA----IFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCH----HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence 112232 3667778999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-49 Score=407.84 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=194.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCc---eEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGK---EIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~---~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
++|+..++||+|+||+||+|++. +++ .||||++.. ......+.|.+|+.+|++++|||||+++|++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45667789999999999999974 232 589998865 3445566899999999999999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|.+++.. ..+.++|.+++.++.||++||.|||+++ |+||||||+||||+.++++||+|||+++....
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998853 3456999999999999999999999988 99999999999999999999999999987655
Q ss_pred CCCcc---ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 509 SEGEV---NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 509 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
..... ......||+.|||||.+.++.++.++|||||||++|||+| |+.||... ...+.... ...+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~--------~~~~~~~~-i~~~~~ 251 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------TNQDVINA-IEQDYR 251 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHHHH-HHTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC--------CHHHHHHH-HHcCCC
Confidence 43322 1223467899999999999999999999999999999998 89998532 11222222 222211
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 585 LDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 585 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
. .....++ ..+.+++.+||+.||++|||+.||++.|+.
T Consensus 252 ~-----~~~~~~~----~~l~~li~~cl~~~P~~RPs~~ei~~~L~~ 289 (299)
T d1jpaa_ 252 L-----PPPMDCP----SALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289 (299)
T ss_dssp C-----CCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C-----CCCccch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 1112233 336678889999999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=396.17 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=209.7
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMP 433 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 433 (671)
++|+..++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788999999999999999999888899999998643 345689999999999999999999999999999999999999
Q ss_pred CCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc
Q 005893 434 NSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV 513 (671)
Q Consensus 434 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 513 (671)
+|+|..++.. ....+++..+++++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999998753 4456899999999999999999999988 999999999999999999999999999876544332
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......||+.|+|||.+.+..++.++||||||+++|||+| |+.||... ...+..... .++... ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~--------~~~~~~~~i-~~~~~~-----~~ 222 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF--------TNSETAEHI-AQGLRL-----YR 222 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS--------CHHHHHHHH-HTTCCC-----CC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC--------CHHHHHHHH-HhCCCC-----CC
Confidence 2334578999999999999999999999999999999998 89898532 222222222 222111 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
....++ .+.+++.+||+.||++|||++||++.|..
T Consensus 223 p~~~~~----~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASE----KVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccH----HHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122232 36677789999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=399.39 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=203.0
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.++|++.+.||+|+||.||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|++. ++..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 3567888999999999999999988889999999754 344568999999999999999999999985 45689999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|..++.. ...+.++|.+++.++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++........
T Consensus 94 ~~g~l~~~~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhh-cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 99999988853 23346999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......||+.|+|||++..+.++.++||||||+++|||++|..|+... ....+.. .....+.. ...
T Consensus 170 -~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-------~~~~~~~-~~i~~~~~-----~~~ 235 (285)
T d1fmka3 170 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------MVNREVL-DQVERGYR-----MPC 235 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-------CCHHHHH-HHHHTTCC-----CCC
T ss_pred -eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-------CCHHHHH-HHHHhcCC-----CCC
Confidence 233457899999999999999999999999999999999977665321 1222222 22222211 112
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCCCCCC
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGETITL 636 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~~~~~ 636 (671)
...++. .+.+++.+||+.||++|||+++|+++|+..-...
T Consensus 236 ~~~~~~----~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 PPECPE----SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CcccCH----HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 233333 3667888999999999999999999998754333
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=392.69 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=203.1
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||+||+++.. +|+.||+|++.+. .......+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999999999999975 6889999998642 2334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999984 3456999999999999999999999998 999999999999999999999999999865433
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||... +..+.. .....+..
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~-~~i~~~~~----- 221 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETY-KRISRVEF----- 221 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHH-HHHHTTCC-----
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC--------CHHHHH-HHHHcCCC-----
Confidence 2 23468999999999999999999999999999999999999999532 222222 22222221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+....++ .+.+++.+||+.||++|||++|+++
T Consensus 222 -~~p~~~s~----~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -TFPDFVTE----GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCccCCH----HHHHHHHHHccCCHhHCcCHHHHHc
Confidence 12223333 3566777999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=403.20 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=204.8
Q ss_pred CCCCccc-ccCCCCcccEEEEEec---CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSN-MLGQGGFGPVYKGVLS---DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv 428 (671)
++|...+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|+.++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3445555 4999999999999863 34579999997543 4456789999999999999999999999865 568899
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|.+++.. .++.+++..+++++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999998743 3456999999999999999999999998 99999999999999999999999999998755
Q ss_pred CCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 509 SEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 509 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||..... .+. ......+...+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~-~~~i~~~~~~~ 232 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEV-MAFIEQGKRME 232 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHH-HHHHHTTCCCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHH-HHHHHcCCCCC
Confidence 43322 2234578999999999999999999999999999999998 9999963211 111 22233333221
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
+...+++ .+.+++.+||+.||++|||+.+|++.|+..
T Consensus 233 -----~p~~~~~----~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 -----CPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----CCTTCCH----HHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCcCCH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2233443 366788899999999999999999999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=405.69 Aligned_cols=260 Identities=28% Similarity=0.405 Sum_probs=207.3
Q ss_pred HHhCCCCcccccCCCCcccEEEEEecC-C-----ceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcC
Q 005893 351 VATSNFSDSNMLGQGGFGPVYKGVLSD-G-----KEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDG 422 (671)
Q Consensus 351 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~ 422 (671)
+..++|++.++||+|+||+||+|++.. + ..||+|++... .......+.+|+.++.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 344678889999999999999998643 2 26999998643 344556789999999998 899999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCC--------------------CCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRK--------------------RGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDL 482 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dl 482 (671)
+..++||||+++|+|.++|...+. ...+++..++.++.||+.||.|||+++ |+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 999999999999999999965322 245899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 005893 483 KASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFN 561 (671)
Q Consensus 483 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~ 561 (671)
||+|||++.++.+||+|||+++...............||+.|||||++.++.++.++|||||||++|||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987665554444445678999999999999999999999999999999998 89998532
Q ss_pred CCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhc
Q 005893 562 QSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQ 630 (671)
Q Consensus 562 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~ 630 (671)
... ....+....+... .....+++ .+.+++.+||+.||++|||++||+++|.
T Consensus 271 ~~~--------~~~~~~~~~~~~~-----~~p~~~~~----~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVD--------ANFYKLIQNGFKM-----DQPFYATE----EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCS--------HHHHHHHHTTCCC-----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHH--------HHHHHHHhcCCCC-----CCCCcCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 1122223332211 11223333 3667888999999999999999999985
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=401.40 Aligned_cols=256 Identities=26% Similarity=0.455 Sum_probs=197.6
Q ss_pred CCCCcccccCCCCcccEEEEEecCC-----ceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDG-----KEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
+.|+..++||+|+||.||+|.+.+. ..||||+++.. ......+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999997532 36999999753 34445679999999999999999999999999999999
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+.+++|.+++.. ..+.++|.+++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999888743 3456999999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCc-cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGE-VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... .......||+.|||||++.++.++.++|||||||++|||++|..|+.... ...+ ..+....+..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~-~~~~i~~~~~-- 231 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHE-VMKAINDGFR-- 231 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHH-HHHHHHTTCC--
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHH-HHHHHhccCC--
Confidence 43322 22334578999999999999999999999999999999999766653211 1111 1222222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+.....++ ..+.+++.+||+.||++||||.||+++|+.
T Consensus 232 ---~~~~~~~~----~~l~~li~~cl~~~p~~RPt~~eil~~L~~ 269 (283)
T d1mqba_ 232 ---LPTPMDCP----SAIYQLMMQCWQQERARRPKFADIVSILDK 269 (283)
T ss_dssp ---CCCCTTCB----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CCCchhhH----HHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence 11112222 346778889999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=393.85 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=193.2
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc--CCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD--GDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lv 428 (671)
++|++.+.||+|+||+||+++.. +|+.||||++... .+...+.+.+|+.++++++|||||++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 46888999999999999999964 6899999998653 34445678999999999999999999999875 3457899
Q ss_pred EeccCCCchhhhhcCC-CCCCCCChHHHHHHHHHHHHHHHHHHhCC--CCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 429 YEFMPNSSLDAILFDP-RKRGLLCWSKRINIVNGIVKGILYLHEDS--RLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~gL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
|||+++|+|.+++... ...+.+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998532 23567999999999999999999999864 23599999999999999999999999999987
Q ss_pred ccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 506 FAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 506 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
....... .....||+.|||||++.+..++.++|||||||++|||+||+.||... ...+.. .....+...
T Consensus 164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~--------~~~~~~-~~i~~~~~~ 232 (269)
T d2java1 164 LNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--------SQKELA-GKIREGKFR 232 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHH-HHHHHTCCC
T ss_pred cccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--------CHHHHH-HHHHcCCCC
Confidence 6543322 23468999999999999999999999999999999999999999532 222222 222233222
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+...++++ +.+++.+||+.||++|||++|+++
T Consensus 233 -----~~~~~~s~~----l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 -----RIPYRYSDE----LNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCTTSCHH----HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCcccCHH----HHHHHHHHcCCChhHCcCHHHHHh
Confidence 122334433 667777999999999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=397.92 Aligned_cols=247 Identities=28% Similarity=0.391 Sum_probs=197.5
Q ss_pred cccCCCCcccEEEEEecC---CceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEeccCC
Q 005893 360 NMLGQGGFGPVYKGVLSD---GKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFMPN 434 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~---g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 434 (671)
++||+|+||+||+|.+.+ ++.||||+++.. .....++|.+|+.++++++|||||+++|++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998643 467999999743 23335679999999999999999999999865 457899999999
Q ss_pred CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCcc-
Q 005893 435 SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEV- 513 (671)
Q Consensus 435 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 513 (671)
|+|.+++. ....+++..++.|+.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999984 3456999999999999999999999988 9999999999999999999999999998765543332
Q ss_pred ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccccc
Q 005893 514 NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLL 592 (671)
Q Consensus 514 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 592 (671)
......||+.|+|||.+.++.++.++|||||||++|||+| |+.||... ...+. ......+... .+
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~--------~~~~~-~~~i~~~~~~-----~~ 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM--------KGSEV-TAMLEKGERM-----GC 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC--------CHHHH-HHHHHTTCCC-----CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC--------CHHHH-HHHHHcCCCC-----CC
Confidence 2334578999999999999999999999999999999998 89998532 11222 2222333221 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 593 TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 593 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
...+++ .+.+++.+||+.||++|||++||+++|+.
T Consensus 232 p~~~~~----~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPR----EMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCH----HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCH----HHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 223333 36678889999999999999999998875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=395.92 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=203.0
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
+.|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35788899999999999999974 68899999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++.. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 99999998743 3456999999999999999999999998 9999999999999999999999999997643221
Q ss_pred cccccccccCCccchhhhc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 513 VNTARIVGTYGYMAPEYAM-----EGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ... ..+.... .....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----~~~---~~~i~~~-~~~~~ 235 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MRV---LLKIAKS-EPPTL 235 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGH---HHHHHHS-CCCCC
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----HHH---HHHHHcC-CCCCC
Confidence 1223468999999999984 45689999999999999999999999853221 111 2222222 11111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..+ ..+++ .+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~---~~~s~----~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQP---SRWSS----NFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSG---GGSCH----HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Ccc---ccCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 12232 3567777999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=393.14 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=201.3
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .......+.+|+.++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4588899999999999999997 46899999998642 2334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|.+++. ..+.+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999884 4567999999999999999999999998 999999999999999999999999999987554
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||... +......+. ..+..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i-~~~~~----- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEYLIFQKI-IKLEY----- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHH-HTTCC-----
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc--------CHHHHHHHH-HcCCC-----
Confidence 4333344568999999999999999999999999999999999999999532 222222222 22221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVV 626 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~ 626 (671)
.+....+++ +.+++.+||+.||++|||++|++
T Consensus 228 -~~p~~~s~~----~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 -DFPEKFFPK----ARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -CCCTTCCHH----HHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -CCCccCCHH----HHHHHHHHccCCHhHCcCHHHHc
Confidence 122334433 56777799999999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=395.65 Aligned_cols=265 Identities=27% Similarity=0.412 Sum_probs=212.6
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEE
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFC 419 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~ 419 (671)
.+++...++|+..+.||+|+||+||+|++. +++.||||+++... .....+|.+|+.++++++||||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 345556678999999999999999999864 35689999997543 33456799999999999999999999999
Q ss_pred EcCCeeeEEEeccCCCchhhhhcCCC---------------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCcee
Q 005893 420 VDGDEKLLVYEFMPNSSLDAILFDPR---------------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRII 478 (671)
Q Consensus 420 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~iv 478 (671)
......+++|||+++|+|.+++.... ....+++..++.|+.||+.||+|||+++ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999985322 1234899999999999999999999998 99
Q ss_pred ecCCCCCcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCC-CC
Q 005893 479 HRDLKASNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR-RN 557 (671)
Q Consensus 479 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p 557 (671)
||||||+||||+.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765544333444567899999999999999999999999999999999986 45
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 558 TGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 558 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
|... ...+.... ..++...+ +...+++ .+.+++.+||+.+|++||||.||+++|+..
T Consensus 243 ~~~~--------~~~e~~~~-v~~~~~~~-----~p~~~~~----~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGM--------AHEEVIYY-VRDGNILA-----CPENCPL----ELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTS--------CHHHHHHH-HHTTCCCC-----CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCC--------CHHHHHHH-HHcCCCCC-----CCccchH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5322 22222222 33333221 2223343 367888899999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=383.88 Aligned_cols=246 Identities=25% Similarity=0.360 Sum_probs=194.9
Q ss_pred CcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEc----CCeeeEEE
Q 005893 357 SDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD----GDEKLLVY 429 (671)
Q Consensus 357 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lv~ 429 (671)
+..++||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44567999999999999975 6889999998643 34445678999999999999999999999875 34578999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc-CCCCeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD-YDMNPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~ 508 (671)
||+++|+|.+++. ..+.+++..++.++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999984 3456999999999999999999999875 4599999999999996 578999999999986433
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
.. ....+||+.|||||++. +.++.++|||||||++|||++|+.||... .+... ..+....+....
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~-------~~~~~-~~~~i~~~~~~~-- 232 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC-------QNAAQ-IYRRVTSGVKPA-- 232 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC-------SSHHH-HHHHHTTTCCCG--
T ss_pred Cc----cCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCc-------ccHHH-HHHHHHcCCCCc--
Confidence 21 23468999999999876 46999999999999999999999999522 12222 222233322211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+....+++ +.+++.+||+.||++|||++|+++
T Consensus 233 --~~~~~~~~~----~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 --SFDKVAIPE----VKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --GGGGCCCHH----HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCccCCHH----HHHHHHHHccCCHhHCcCHHHHhC
Confidence 122223333 567778999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=404.94 Aligned_cols=199 Identities=29% Similarity=0.410 Sum_probs=176.4
Q ss_pred HhCCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
..++|++.+.||+|+||+||+|+.. +|+.||+|+++.. .......+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4578999999999999999999964 6899999998753 3344567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
||+++|+|.+++. +.+.+++..+..++.||+.||.|||+ ++ |+||||||+|||+++++++||+|||+++....
T Consensus 84 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999984 34569999999999999999999997 46 99999999999999999999999999986543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
.. ....+||+.|+|||++.+.+|+.++||||+||++|||++|+.||..
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 21 2346899999999999999999999999999999999999999964
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.7e-47 Score=388.89 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=188.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
+.|+..+.||+|+||+||+++.. +|+.||||++.... ......+.+|+.++++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 56888999999999999999975 68899999986532 23345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc---CCCCeEEeeccccccccC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD---YDMNPKISDFGMARIFAG 508 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~ 508 (671)
+++|+|.+++. ..+.+++..+..++.||+.||.|||+++ |+||||||+|||+. +++.+||+|||+++....
T Consensus 89 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 89 VSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred cCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999999984 3556999999999999999999999998 99999999999994 578999999999986543
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... ....+||+.|||||++.++.++.++|||||||++|||++|+.||... ........... +... .
T Consensus 163 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~-~~~~--~ 228 (307)
T d1a06a_ 163 GSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE--------NDAKLFEQILK-AEYE--F 228 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHT-TCCC--C
T ss_pred CCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHhc-cCCC--C
Confidence 322 23458999999999999999999999999999999999999999532 22222222222 2111 1
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
........+++ +.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~s~~----~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 DSPYWDDISDS----AKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CTTTTTTSCHH----HHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCccccCCCHH----HHHHHHHHccCCHhHCcCHHHHhc
Confidence 11122233433 667788999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-46 Score=392.79 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=208.3
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|++.+.||+|+||.||+++. .+|+.||||++........+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688899999999999999996 468999999998766666778999999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc--CCCCeEEeeccccccccCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD--YDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 510 (671)
++|+|.+++.. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++......
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999998843 3456999999999999999999999998 99999999999995 46889999999998765433
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. .....||+.|||||++.+..++.++|||||||++|||++|+.||... +..+...... ..... ...
T Consensus 181 ~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~-~~~~~--~~~ 246 (350)
T d1koaa2 181 S---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVK-SCDWN--MDD 246 (350)
T ss_dssp C---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHH-HTCCC--SCC
T ss_pred c---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--------CHHHHHHHHH-hCCCC--CCc
Confidence 2 23468999999999999999999999999999999999999999532 2222222222 11110 011
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hcCC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM--LQGE 632 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~--L~~~ 632 (671)
.....+++ .+.+++.+||+.||++|||++|+++. |+..
T Consensus 247 ~~~~~~s~----~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 247 SAFSGISE----DGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp GGGGGCCH----HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred ccccCCCH----HHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11112232 35677779999999999999999983 5443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-46 Score=388.93 Aligned_cols=244 Identities=30% Similarity=0.433 Sum_probs=198.9
Q ss_pred CCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
.|+..+.||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 478889999999999999996 468899999987533 2334568999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+++|+|..++. .++.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 999999987663 3456999999999999999999999998 999999999999999999999999999865332
Q ss_pred CccccccccccCCccchhhhcc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAME---GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL 587 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 587 (671)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||... .......+....... ..
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~--------~~~~~~~~i~~~~~~-~~ 234 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAMSALYHIAQNESP-AL 234 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--------CHHHHHHHHHHSCCC-CC
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHhCCCC-CC
Confidence 23579999999999863 46899999999999999999999998422 222222233222211 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 IDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
....+++ .+.+++.+||+.||++|||++|+++
T Consensus 235 ----~~~~~s~----~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 ----QSGHWSE----YFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----SCTTSCH----HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCH----HHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1122333 3567777999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=394.27 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=198.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCc----eEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGK----EIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
++|+..++||+|+||+||+|.+. +|+ .||+|+++. ...+..++|.+|+.++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 45888999999999999999864 444 589998865 3344567899999999999999999999999865 5678
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
++||+.+|+|.+++.. ....+++..+++++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8899999999888753 4556999999999999999999999988 9999999999999999999999999999876
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
............||+.|+|||++.++.++.++|||||||++|||+| |+.||.... ...+.. ....+...
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~----~i~~~~~~- 232 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISS----ILEKGERL- 232 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHH----HHHHTCCC-
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHH----HHHcCCCC-
Confidence 6554444445678999999999999999999999999999999999 788885432 112222 22222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.....+++ .+.+++.+||+.||++|||+.||++.|+.
T Consensus 233 ----~~p~~~~~----~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 233 ----PQPPICTI----DVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp ----CCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCcccCH----HHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 11122332 36678889999999999999999988764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.7e-46 Score=389.53 Aligned_cols=257 Identities=22% Similarity=0.276 Sum_probs=209.1
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|++.+.||+|+||.||+|+. .+|+.||||+++.........+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4688899999999999999996 469999999998766666677899999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc--CCCCeEEeeccccccccCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD--YDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~~~ 510 (671)
++|+|.+++. .....+++.+++.|+.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+++......
T Consensus 109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 9999988763 23446999999999999999999999998 99999999999998 67899999999998765433
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. .....||+.|+|||++.+..++.++|||||||++|||+||+.||... ........... +... ...
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~-~~~~--~~~ 249 (352)
T d1koba_ 184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--------DDLETLQNVKR-CDWE--FDE 249 (352)
T ss_dssp C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--------SHHHHHHHHHH-CCCC--CCS
T ss_pred c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHh-CCCC--CCc
Confidence 2 23457899999999999999999999999999999999999999532 22222222222 1111 111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCCC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGET 633 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~~ 633 (671)
......+++ +.+++.+||+.||++|||+.|+++ .+++..
T Consensus 250 ~~~~~~s~~----~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 250 DAFSSVSPE----AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp STTTTSCHH----HHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ccccCCCHH----HHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 111233333 667788999999999999999987 365543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=385.71 Aligned_cols=248 Identities=30% Similarity=0.415 Sum_probs=194.2
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-CeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-DEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~~ 432 (671)
++|+..+.||+|+||.||+|++ .|+.||||+++.. ...+.+.+|+.++++++||||++++|++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4566788999999999999998 5789999999753 3446799999999999999999999999754 5679999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++.. +....++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHH-HHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999999853 22335899999999999999999999988 999999999999999999999999999865332
Q ss_pred cccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccccc
Q 005893 513 VNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDPL 591 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 591 (671)
.....++..|+|||++.++.++.++||||||+++|||+| |+.|+.... ...+... ...+.. +.
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----~~~~~~~----i~~~~~-----~~ 220 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPR----VEKGYK-----MD 220 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHH----HTTTCC-----CC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----HHHHHHH----HHcCCC-----CC
Confidence 223467889999999999999999999999999999998 677765322 1222222 222211 12
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 592 LTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 592 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
+....++ .+.+++.+||+.||++|||+.||+++|+.
T Consensus 221 ~~~~~~~----~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 221 APDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCccCCH----HHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 2223333 36677889999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=386.42 Aligned_cols=265 Identities=28% Similarity=0.396 Sum_probs=201.2
Q ss_pred hhHHHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeE
Q 005893 347 ETLDVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGF 418 (671)
Q Consensus 347 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~ 418 (671)
.++++..++|+..++||+|+||.||+|.+. +++.||||+++.. .......+.+|...+.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344455577888999999999999999863 3468999999753 334455688888888877 68999999999
Q ss_pred EEcCC-eeeEEEeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCC
Q 005893 419 CVDGD-EKLLVYEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKA 484 (671)
Q Consensus 419 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp 484 (671)
+...+ ..++||||+++|+|.+++...+ ....+++..++.++.||++||.|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 87654 5789999999999999986422 1345899999999999999999999998 99999999
Q ss_pred CcEEEcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCC
Q 005893 485 SNVLLDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR-RNTGFNQS 563 (671)
Q Consensus 485 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~~ 563 (671)
+||||++++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+||. .||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998766555444455568999999999999999999999999999999999975 56642211
Q ss_pred CCCCCCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 564 RGATAPNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 564 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
. .........+...+ +....++ .+.+++.+||+.||++|||++||+++|++
T Consensus 243 ----~----~~~~~~~~~~~~~~-----~~~~~~~----~l~~li~~cl~~dP~~Rpt~~eil~~L~~ 293 (299)
T d1ywna1 243 ----D----EEFCRRLKEGTRMR-----APDYTTP----EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293 (299)
T ss_dssp ----S----HHHHHHHHHTCCCC-----CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----H----HHHHHHHhcCCCCC-----CCccCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1 11222333332221 2223333 36778889999999999999999999975
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=379.78 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=196.9
Q ss_pred hCCCCcccccCCCCcccEEEEEec--CC--ceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS--DG--KEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEK 425 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~ 425 (671)
.++|+..+.||+|+||.||+|++. ++ ..||||+++.. .....++|.+|+.++++++|||||+++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 356888899999999999999863 22 36899998753 23345679999999999999999999999965 467
Q ss_pred eEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 426 LLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 426 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
++||||+++|+|.+++.. ..+.+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999988753 3456999999999999999999999988 99999999999999999999999999998
Q ss_pred ccCCCCcc-ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 506 FAGSEGEV-NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 506 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
........ ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.. .+..+......+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~--------~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG--------LNGSQILHKIDKEGE 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHHHHHHHTSCC
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC--------cCHHHHHHHHHhCCC
Confidence 75543322 2334578889999999999999999999999999999998 8999842 233333334433332
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..+ ....+++ .+.+++.+||+.||++|||+.||+++|++
T Consensus 233 ~~~-----~~~~~~~----~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 RLP-----RPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCC-----CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCC-----CcccccH----HHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 211 1123333 36678889999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=380.28 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=202.5
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc------hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS------EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
+.|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5688899999999999999997 468999999986422 123567999999999999999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC----CeEEeeccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM----NPKISDFGM 502 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Dfgl 502 (671)
+||||+++|+|.+++. ..+.+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999984 3456999999999999999999999998 99999999999998776 599999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||... +..+..... ...
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i-~~~ 231 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANV-SAV 231 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHH-HTT
T ss_pred hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC--------CHHHHHHHH-Hhc
Confidence 987644322 23357899999999999999999999999999999999999999532 222222222 121
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
... ..+......++ .+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~--~~~~~~~~~s~----~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 232 NYE--FEDEYFSNTSA----LAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCC--CCHHHHTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCC--CCchhcCCCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 01111122232 3667788999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=385.09 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=193.9
Q ss_pred hCCCCcccccCCCCcccEEEEEecC----CceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeE
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSD----GKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLL 427 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 427 (671)
.++|+..+.||+|+||.||+|++.. +..||||+++.. .......+.+|+.++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4568888999999999999998642 346899998753 3344567999999999999999999999985 467899
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFA 507 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~ 507 (671)
||||+++|+|..++.. ....+++..++.++.||+.||.|||+++ |+||||||+||++++++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999988743 3456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccc
Q 005893 508 GSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGATAPNLLAYAWHLWNEGNALD 586 (671)
Q Consensus 508 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 586 (671)
..... ......||+.|+|||.+.++.++.++|||||||++|||++ |+.||..... ..+.. ....+...
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~~----~i~~~~~~- 228 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIG----RIENGERL- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHH----HHHTTCCC-
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHHH----HHHcCCCC-
Confidence 43322 2334678999999999999999999999999999999998 8888864321 12222 12222221
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 587 LIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 587 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
.+...+++ .+.+++.+||+.||++|||++||++.|+.
T Consensus 229 ----~~~~~~~~----~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 229 ----PMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ----CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCCCCCCH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12233443 36677789999999999999999998875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=387.47 Aligned_cols=260 Identities=29% Similarity=0.401 Sum_probs=207.2
Q ss_pred HhCCCCcccccCCCCcccEEEEEecC--------CceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVLSD--------GKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD 421 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~ 421 (671)
..++|+..+.||+|+||.||+|+... +..||||+++... .....++.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 34567778999999999999998532 2479999997543 34557888999999888 89999999999999
Q ss_pred CCeeeEEEeccCCCchhhhhcCCC-------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEE
Q 005893 422 GDEKLLVYEFMPNSSLDAILFDPR-------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488 (671)
Q Consensus 422 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIl 488 (671)
++..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccccee
Confidence 999999999999999999996432 1245899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIIT-GRRNTGFNQSRGAT 567 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~p~~~~~~~~~~ 567 (671)
++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||++ |+.||...
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~------ 241 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------ 241 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC------
Confidence 99999999999999998766555445556789999999999999999999999999999999998 68787422
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
... ..+..+..+...+ ....+++ .+.+++.+||+.||++|||+.||+++|++.
T Consensus 242 --~~~-~~~~~i~~~~~~~-----~p~~~~~----~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 242 --PVE-ELFKLLKEGHRMD-----KPSNCTN----ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp --CHH-HHHHHHHTTCCCC-----CCSSCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CHH-HHHHHHHcCCCCC-----CCccchH----HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 2233333332221 1223333 367888899999999999999999999753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=382.06 Aligned_cols=262 Identities=29% Similarity=0.443 Sum_probs=212.1
Q ss_pred HHHhCCCCcccccCCCCcccEEEEEec------CCceEEEEEcccc-chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC
Q 005893 350 DVATSNFSDSNMLGQGGFGPVYKGVLS------DGKEIAVKRLSSC-SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG 422 (671)
Q Consensus 350 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~ 422 (671)
++..++|+..+.||+|+||.||+|.+. +++.||||+++.. ..+....|.+|+.++++++|||||+++|++...
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 344567778899999999999999863 3578999999753 344455789999999999999999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCC-------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 423 DEKLLVYEFMPNSSLDAILFDP-------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
+..++||||+++|+|.+++... .....+++..+.+++.|+++||.|||+++ |+||||||+|||+++++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceE
Confidence 9999999999999999987532 22345789999999999999999999987 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCCCCCCCCHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGR-RNTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~p~~~~~~~~~~~~~l~~~ 574 (671)
||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+||. .|+.. ....+.
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~~~~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSNEQV 244 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCHHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC--------CCHHHH
Confidence 999999998776554444455567899999999999999999999999999999999985 55532 222232
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.. ...++...+ ....+++ .+.+++.+||+.+|++||||+||+++|++.
T Consensus 245 ~~-~i~~~~~~~-----~p~~~~~----~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 LR-FVMEGGLLD-----KPDNCPD----MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HH-HHHTTCCCC-----CCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HH-HHHhCCCCC-----CcccchH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 22 222332211 1123333 377888899999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=389.09 Aligned_cols=260 Identities=27% Similarity=0.386 Sum_probs=209.1
Q ss_pred HhCCCCcccccCCCCcccEEEEEe------cCCceEEEEEccccc-hhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCC
Q 005893 352 ATSNFSDSNMLGQGGFGPVYKGVL------SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGD 423 (671)
Q Consensus 352 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~ 423 (671)
..++|+..++||+|+||.||+|++ .+++.||||+++... .....++.+|+.++.++ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 345677789999999999999985 245689999997543 34455789999999999 6999999999999999
Q ss_pred eeeEEEeccCCCchhhhhcCCC---------------CCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEE
Q 005893 424 EKLLVYEFMPNSSLDAILFDPR---------------KRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVL 488 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIl 488 (671)
..++||||+++|+|.+++.... ....+++..+++++.||+.||+|||+++ ++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 9999999999999999986432 2335899999999999999999999998 999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCCCCC
Q 005893 489 LDYDMNPKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITG-RRNTGFNQSRGAT 567 (671)
Q Consensus 489 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~p~~~~~~~~~~ 567 (671)
++.++.+||+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|+ ++|+.....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---- 253 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---- 253 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH----
Confidence 999999999999999987665555555567899999999999999999999999999999999995 444432211
Q ss_pred CCCHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 568 APNLLAYAWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 568 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
....++....+.. +......+ ..+.+++.+||+.||++|||++||+++|++
T Consensus 254 ----~~~~~~~i~~~~~-----~~~~~~~~----~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 254 ----DSKFYKMIKEGFR-----MLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp ----SHHHHHHHHHTCC-----CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCC-----CCCccccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 1112222222221 11112222 236778889999999999999999999985
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=382.25 Aligned_cols=247 Identities=23% Similarity=0.269 Sum_probs=204.4
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+++. .+|+.||||++++. .......+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5688899999999999999996 47899999999753 2334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|..++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999884 4556899999999999999999999998 999999999999999999999999999865433
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||... +..... +....+.+
T Consensus 159 ~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~--------~~~~~~-~~i~~~~~----- 222 (337)
T d1o6la_ 159 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLF-ELILMEEI----- 222 (337)
T ss_dssp TC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHH-HHHHHCCC-----
T ss_pred Cc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc--------CHHHHH-HHHhcCCC-----
Confidence 22 233468999999999999999999999999999999999999999532 222222 22222221
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
.+...++++ +.+++.+||+.||++||+ ++|+++
T Consensus 223 -~~p~~~s~~----~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -RFPRTLSPE----AKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCTTSCHH----HHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCCHH----HHHHHHhhccCCchhhcccccccHHHHHc
Confidence 122334443 567777999999999995 788875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-45 Score=374.16 Aligned_cols=258 Identities=23% Similarity=0.319 Sum_probs=200.1
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc---hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC----e
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS---EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD----E 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~ 424 (671)
.++|++.+.||+|+||.||+++. .+|+.||||+++... ......+.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35688999999999999999996 478999999997533 233457899999999999999999999988654 3
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||+++++|..++. ..+.+++.+++.++.||+.||+|||+++ |+||||||+|||++.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999998874 3456999999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCC-ccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 505 IFAGSEG-EVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 505 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
....... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.. ....+..++....+.
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~--------~~~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG--------DSPVSVAYQHVREDP 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC--------cCHHHHHHHHHhcCC
Confidence 6543322 2233446899999999999999999999999999999999999999953 223333444444332
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhcC
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-TMSSVVVMLQG 631 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-t~~ev~~~L~~ 631 (671)
... .......++ .+.+++.+||+.||++|| |++++++.|..
T Consensus 232 ~~~---~~~~~~~s~----~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 232 IPP---SARHEGLSA----DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCG---GGTSSSCCH----HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCC---chhccCCCH----HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 211 111223333 366777799999999999 89999887753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-45 Score=378.37 Aligned_cols=244 Identities=24% Similarity=0.316 Sum_probs=202.5
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||+||+++. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999997 46899999998642 2334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+++|+|..++. ....+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999884 4556888999999999999999999998 999999999999999999999999999876432
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
....+||+.|||||++.+..++.++|||||||++|||++|+.||... +......+... +..
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~-~~~----- 218 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILN-AEL----- 218 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHH-CCC-----
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc--------CHHHHHHHHHc-CCC-----
Confidence 22468999999999999999999999999999999999999999532 22222222222 211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.+....+++ +.+++.+||+.||++|| |++|+++
T Consensus 219 -~~p~~~s~~----~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 -RFPPFFNED----VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCTTSCHH----HHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHH----HHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 112233333 56777799999999996 8999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=379.47 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=199.9
Q ss_pred ccccCCCCcccEEEEEecCC----ceEEEEEccc-cchhchHHHHHHHHHHhhcCCCCeeeEeeEEEc-CCeeeEEEecc
Q 005893 359 SNMLGQGGFGPVYKGVLSDG----KEIAVKRLSS-CSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVD-GDEKLLVYEFM 432 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~l~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~ 432 (671)
.++||+|+||+||+|++.++ ..||||+++. ......++|.+|++++++++|||||+++|++.. +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36799999999999997432 2589999975 345556789999999999999999999999876 45789999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
++|+|.+++.. ....+++..+++++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998854 3445788899999999999999999998 999999999999999999999999999876544322
Q ss_pred c--ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 513 V--NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 513 ~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. ......||+.|+|||.+..+.++.++||||||+++|||+||+.|+..... ...+... ...+...
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----~~~~~~~----i~~g~~~----- 253 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVY----LLQGRRL----- 253 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHH----HHTTCCC-----
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----HHHHHHH----HHcCCCC-----
Confidence 2 22335789999999999999999999999999999999998888753221 1112221 1222211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.....+++ .+.+++.+||+.||++||+|.||++.|++.
T Consensus 254 ~~p~~~~~----~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 254 LQPEYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CCCTTCCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccCcH----HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122232 366788899999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=378.12 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=200.2
Q ss_pred CCCCcccccCCCCcccEEEEEecC-Cc--eEEEEEcccc-chhchHHHHHHHHHHhhc-CCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSD-GK--EIAVKRLSSC-SEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lv 428 (671)
++|+..++||+|+||.||+|++.+ |. .||||+++.. .....+.+.+|++++.++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 567778999999999999999753 43 5788887643 334556799999999998 799999999999999999999
Q ss_pred EeccCCCchhhhhcCC-------------CCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCe
Q 005893 429 YEFMPNSSLDAILFDP-------------RKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNP 495 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 495 (671)
|||+++|+|.++|... .....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999998 9999999999999999999
Q ss_pred EEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCC-CCCCCCCCCCCCCCHHHH
Q 005893 496 KISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRR-NTGFNQSRGATAPNLLAY 574 (671)
Q Consensus 496 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-p~~~~~~~~~~~~~l~~~ 574 (671)
||+|||+++...... ......||..|+|||.+.++.++.++||||||+++|||++|.. ||.. .+..+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~--------~~~~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--------MTCAEL 235 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT--------CCHHHH
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC--------CCHHHH
Confidence 999999998643222 1223568999999999999999999999999999999999765 5532 122222
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 575 AWHLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 575 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
... ..++.. +.....+++ .+.+++.+||+.||++||||+||++.|+..
T Consensus 236 ~~~-i~~~~~-----~~~~~~~~~----~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 236 YEK-LPQGYR-----LEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHH-GGGTCC-----CCCCTTBCH----HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH-HHhcCC-----CCCCccCCH----HHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222 222211 112222333 366777899999999999999999988764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=377.44 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=197.7
Q ss_pred CCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC----eeeEEEe
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKLLVYE 430 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lv~e 430 (671)
+|...+.||+|+||.||+|++ +|+.||||+++.... .....+.|+..+.+++|||||++++++.+.+ ..++|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 455668899999999999997 688999999975322 2222344555666789999999999998654 5789999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC-----CCceeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS-----RLRIIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
|+++|+|.+++.. ..++|..+++++.|++.||.|||+.. ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999953 35899999999999999999999741 23599999999999999999999999999997
Q ss_pred ccCCCCcc--ccccccccCCccchhhhccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCC------CH
Q 005893 506 FAGSEGEV--NTARIVGTYGYMAPEYAMEGL------YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAP------NL 571 (671)
Q Consensus 506 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~------~l 571 (671)
........ ......||+.|+|||++.... ++.++|||||||++|||+||..|+........... .-
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 75543322 233468999999999986542 67799999999999999999888753222111110 11
Q ss_pred HHHHHHHHhcCCccccccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcC
Q 005893 572 LAYAWHLWNEGNALDLIDPLLTDTC-SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQG 631 (671)
Q Consensus 572 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~ 631 (671)
..........+. .++.+.... +.+....+.+++.+||+.||++|||+.||++.|+.
T Consensus 238 ~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 111122221111 122221111 22345568889999999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-44 Score=367.60 Aligned_cols=250 Identities=25% Similarity=0.313 Sum_probs=201.1
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccch---------hchHHHHHHHHHHhhcC-CCCeeeEeeEEEcC
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSE---------QGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDG 422 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~ 422 (671)
++|+..+.||+|+||+||+++. .+|+.||||+++.... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788899999999999999996 4789999999864321 12345889999999996 99999999999999
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
+..++||||+++|+|.+++. .++.+++.+++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999994 3557999999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhcc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHH
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAME------GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAW 576 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~ 576 (671)
++....... .....||+.|+|||++.. ..++.++||||+||++|||++|+.||... +.....
T Consensus 157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~--------~~~~~~- 224 (277)
T d1phka_ 157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR--------KQMLML- 224 (277)
T ss_dssp CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHH-
T ss_pred eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC--------CHHHHH-
Confidence 987654322 234579999999999853 35788999999999999999999999532 222222
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 577 HLWNEGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 577 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.....++.. . .......+++ .+.+++.+||+.||++|||++||++
T Consensus 225 ~~i~~~~~~-~-~~~~~~~~s~----~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 225 RMIMSGNYQ-F-GSPEWDDYSD----TVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHHTCCC-C-CTTTGGGSCH----HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhCCCC-C-CCcccccCCH----HHHHHHHHHccCChhHCcCHHHHHc
Confidence 222222221 0 1111112333 3667888999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-44 Score=379.22 Aligned_cols=244 Identities=24% Similarity=0.274 Sum_probs=202.7
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 429 (671)
++|++.+.||+|+||.||+++.. +|+.||||++... .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46888999999999999999974 6999999998642 2234567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGS 509 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~ 509 (671)
||+.+|+|..++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999884 3456999999999999999999999998 999999999999999999999999999876432
Q ss_pred CCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc
Q 005893 510 EGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID 589 (671)
Q Consensus 510 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d 589 (671)
.....||+.|||||++.+..++.++|||||||++|||+||+.||... +......+.. .+..
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~-~~~~----- 255 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIV-SGKV----- 255 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHH-HCCC-----
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--------CHHHHHHHHh-cCCC-----
Confidence 22358999999999999999999999999999999999999999522 2222222222 2211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCC-----CCHHHHHH
Q 005893 590 PLLTDTCSPDEFLRYIHIGLLCVQEDAFDR-----PTMSSVVV 627 (671)
Q Consensus 590 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R-----Pt~~ev~~ 627 (671)
.+...++++ +.+++.+||+.||++| ||++|+++
T Consensus 256 -~~p~~~s~~----~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RFPSHFSSD----LKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCCHH----HHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCccCCHH----HHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 112233443 5677779999999999 48999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-45 Score=377.02 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=200.4
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc---chhchHHHHHHHHHHh-hcCCCCeeeEeeEEEcCCeeeEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC---SEQGNAEFTNEVLLIL-KLQHKNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lv 428 (671)
++|++.+.||+|+||+||+|+.. +|+.||||++++. .......+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 56888999999999999999974 6899999999742 2334455667777665 68999999999999999999999
Q ss_pred EeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccC
Q 005893 429 YEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAG 508 (671)
Q Consensus 429 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~ 508 (671)
|||+++|+|.+++. ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 4456899999999999999999999998 99999999999999999999999999986544
Q ss_pred CCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccc
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLI 588 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 588 (671)
... ......||+.|+|||++.++.++.++|||||||++|||++|+.||... +.... +.....+.+
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~-~~~i~~~~~---- 220 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--------DEEEL-FHSIRMDNP---- 220 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHH-HHHHHHCCC----
T ss_pred ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--------CHHHH-HHHHHcCCC----
Confidence 332 233468999999999999999999999999999999999999999532 22222 222222221
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 005893 589 DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMS-SVVV 627 (671)
Q Consensus 589 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~-ev~~ 627 (671)
.+....+++ +.+++.+||+.||++|||+. ||++
T Consensus 221 --~~p~~~s~~----~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRWLEKE----AKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTTSCHH----HHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCccCCHH----HHHHHHHhcccCCCCCcCHHHHHHh
Confidence 222233433 56777799999999999996 6753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=370.92 Aligned_cols=261 Identities=23% Similarity=0.274 Sum_probs=195.7
Q ss_pred ccccCCCCcccEEEEEec-CCceEEEEEccccchh-----chHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 359 SNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQ-----GNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 359 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
.++||+|+||+||+|+.. +|+.||||+++..... ....+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999974 6899999998643221 1346889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCCc
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEGE 512 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~ 512 (671)
.++++..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 988877665 34566999999999999999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccccc--
Q 005893 513 VNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLID-- 589 (671)
Q Consensus 513 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-- 589 (671)
....+||+.|+|||++... .++.++|||||||++|||++|+.||..... .+......+...........+
T Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCTTTSSSTT
T ss_pred --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-----HHHHHHHHHhcCCCChhhccchh
Confidence 2235799999999998654 679999999999999999999999853211 111111111111111000000
Q ss_pred ----c-cc--cCCCCHHH-----HHHHHHHHHHccccCCCCCCCHHHHHH--HhcCC
Q 005893 590 ----P-LL--TDTCSPDE-----FLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGE 632 (671)
Q Consensus 590 ----~-~l--~~~~~~~~-----~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~ 632 (671)
. .. ....+..+ ...+.+++.+||+.||++|||++|+++ .|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 00 00111111 134778888999999999999999997 46543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-44 Score=371.60 Aligned_cols=250 Identities=18% Similarity=0.229 Sum_probs=202.6
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEecc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEFM 432 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 432 (671)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .+...+.+|+.+|+.++|||||++++++.+++..++||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 56888999999999999999975 68899999997643 33456889999999999999999999999999999999999
Q ss_pred CCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCC--CCeEEeeccccccccCCC
Q 005893 433 PNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYD--MNPKISDFGMARIFAGSE 510 (671)
Q Consensus 433 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~~~ 510 (671)
++|+|.+++.. ....+++.+++.|+.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999999843 2346999999999999999999999998 9999999999999854 589999999998764432
Q ss_pred CccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCccccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDLIDP 590 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 590 (671)
. .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||... +..+........ ... ++.
T Consensus 159 ~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--------~~~~~~~~i~~~-~~~--~~~ 224 (321)
T d1tkia_ 159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNA-EYT--FDE 224 (321)
T ss_dssp E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHT-CCC--CCH
T ss_pred c---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHhC-CCC--CCh
Confidence 2 23357899999999999999999999999999999999999999532 222222222222 110 111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 591 LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 591 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.....+++ .+.+++.+||+.||++|||++|+++
T Consensus 225 ~~~~~~s~----~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAFKEISI----EAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTSCH----HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112233 2567788999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-44 Score=380.66 Aligned_cols=248 Identities=26% Similarity=0.325 Sum_probs=196.5
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEccccc---hhchHHHHH---HHHHHhhcCCCCeeeEeeEEEcCCeee
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCS---EQGNAEFTN---EVLLILKLQHKNLVKLLGFCVDGDEKL 426 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~g~~~~~~~~~ 426 (671)
++|++.++||+|+||.||+|+.. +|+.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999974 68999999986421 122233344 466777778999999999999999999
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
+||||+++|+|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999984 3456889999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL 585 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 585 (671)
.... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... .......... ...
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~-~~~--- 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMT-LTM--- 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHS-SSC---
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhc-ccC---
Confidence 5432 234589999999999975 4689999999999999999999999964322 1222211111 111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 005893 586 DLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT-----MSSVVV 627 (671)
Q Consensus 586 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt-----~~ev~~ 627 (671)
...+...++++ +.+++.+||+.||++||| ++|+++
T Consensus 225 ---~~~~~~~~s~~----~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ---AVELPDSFSPE----LRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CCCCCSSSCHH----HHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCCCCCCCHH----HHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11122234443 667778999999999999 688875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=365.02 Aligned_cols=266 Identities=23% Similarity=0.314 Sum_probs=200.5
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|++.+.||+|+||+||+|+. .+|+.||||+++... +.....+.+|+.++++++|||||++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999996 568999999996432 2345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
|+.++.+..... ...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997665554432 34556999999999999999999999998 9999999999999999999999999998764433
Q ss_pred CccccccccccCCccchhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh-cCCccccc
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN-EGNALDLI 588 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~ 588 (671)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||.... -....+.... .+...+..
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~ 226 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--------EIDQLFRIFRTLGTPDEVV 226 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHHCCCCTTT
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--------HHHHHHHHHHhcCCCchhh
Confidence 2 223358999999999887665 5889999999999999999999995321 1111111111 01111100
Q ss_pred cc----------cccC--CCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCCCC
Q 005893 589 DP----------LLTD--TCSP-----DEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGETI 634 (671)
Q Consensus 589 d~----------~l~~--~~~~-----~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~~~ 634 (671)
.+ .+.. .... .....+.+++.+||+.||++|||++|+++ .|++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 00 0000 0000 00134667788999999999999999998 3655443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=371.83 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=193.5
Q ss_pred CCCCccc-ccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhc-CCCCeeeEeeEEEc----CCeee
Q 005893 354 SNFSDSN-MLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKL-QHKNLVKLLGFCVD----GDEKL 426 (671)
Q Consensus 354 ~~~~~~~-~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~ 426 (671)
++|.+.+ .||+|+||.||+|+. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4677664 699999999999996 56899999998642 3567899887655 89999999999875 35679
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC---CCCeEEeecccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY---DMNPKISDFGMA 503 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Dfgla 503 (671)
+||||+++|+|.+++.. +....+++.+++.|+.||+.||.|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999964 33456999999999999999999999998 999999999999985 467999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
+....... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ............+.
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~-----~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-----AISPGMKTRIRMGQ 233 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------CCCSCS
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH-----HHHHHHHHHHhcCC
Confidence 87654332 23458999999999999999999999999999999999999999643211 11111000000100
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
. .+.......-...+.+++.+||+.||++|||+.|+++
T Consensus 234 ~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 Y------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0100000111234677888999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-43 Score=361.69 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=198.2
Q ss_pred CCCCcccccCCCCcccEEEEEecCCceEEEEEccccc--hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCS--EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
++|+..++||+|+||+||+|+.++|+.||||+++... +.....+.+|+.++++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999899999999996532 33356899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCCC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSEG 511 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~ 511 (671)
+.++.+..+. ...+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9888877776 44567999999999999999999999988 99999999999999999999999999987644322
Q ss_pred ccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcccc---
Q 005893 512 EVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNALDL--- 587 (671)
Q Consensus 512 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~--- 587 (671)
......|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ...................
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-----HHHHHHHHHhhCCCChhhccch
Confidence 22334789999999998754 569999999999999999999999953211 1111111111111100000
Q ss_pred -----cc-----------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 588 -----ID-----------PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 588 -----~d-----------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.+ .......+ ..+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~s----~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 229 TELPKYDPNFTVYEPLPWESFLKGLD----ESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGSTTCCTTCCCCCCCCGGGTCCSCC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhcccccccccCcchhhhcccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00111222 23667788999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=362.53 Aligned_cols=239 Identities=25% Similarity=0.418 Sum_probs=193.0
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccch------hchHHHHHHHHHHhhcC--CCCeeeEeeEEEcCCe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSE------QGNAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDE 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~ 424 (671)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5688899999999999999996 4689999999864221 11234678999999986 8999999999999999
Q ss_pred eeEEEeccCC-CchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-CCCeEEeeccc
Q 005893 425 KLLVYEFMPN-SSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-DMNPKISDFGM 502 (671)
Q Consensus 425 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~Dfgl 502 (671)
.++||||+.+ +++.+++. .+..+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 57777763 3456999999999999999999999998 999999999999985 47999999999
Q ss_pred cccccCCCCccccccccccCCccchhhhccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc
Q 005893 503 ARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLY-SIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE 581 (671)
Q Consensus 503 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~ 581 (671)
++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... ....
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i~~- 218 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIR- 218 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHH-
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------HHhh-
Confidence 98653321 234689999999999987775 577999999999999999999985211 1111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 582 GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 582 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+. ..+...++++ +.+++.+||+.||++|||++|+++
T Consensus 219 ~~------~~~~~~~s~~----~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 219 GQ------VFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CC------CCCSSCCCHH----HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cc------cCCCCCCCHH----HHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 1122334443 667777999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=355.93 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=192.9
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cC-CceEEEEEcccc--chhchHHHHHHHHHHhhc---CCCCeeeEeeEEEc----
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SD-GKEIAVKRLSSC--SEQGNAEFTNEVLLILKL---QHKNLVKLLGFCVD---- 421 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---- 421 (671)
.++|++.+.||+|+||+||+++. .+ ++.||||+++.. .......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 567999998642 222233466777777666 79999999999863
Q ss_pred -CCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeec
Q 005893 422 -GDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDF 500 (671)
Q Consensus 422 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 500 (671)
....+++|||++++++..... .....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 245789999999888765543 34556899999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 501 GMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 501 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~ 232 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIG 232 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHC
T ss_pred hhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhhC
Confidence 998764322 223346899999999999999999999999999999999999999953211 111111111111
Q ss_pred cCCccc----------cc-------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 581 EGNALD----------LI-------DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 581 ~~~~~~----------~~-------d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...... .. .+.+....++ .+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE----LGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH----HHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCchhcccccccchhhhhccccccchhhccccCCH----HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000 00 0011112222 3567778999999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=350.60 Aligned_cols=263 Identities=23% Similarity=0.308 Sum_probs=194.1
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC--------
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-------- 422 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------- 422 (671)
++|++.+.||+|+||+||+|+. .+|+.||||++... .......+.+|+.+|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5788899999999999999997 47899999998642 334456788999999999999999999998653
Q ss_pred CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccc
Q 005893 423 DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGM 502 (671)
Q Consensus 423 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgl 502 (671)
...++||||++++++..+. .....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4578999999888877654 34556889999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcc--ccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005893 503 ARIFAGSEGEV--NTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLW 579 (671)
Q Consensus 503 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~ 579 (671)
++......... .....+||+.|+|||++... .++.++|||||||++|||++|+.||.... .........+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-----~~~~~~~i~~~~ 238 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQHQLALISQLC 238 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHH
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-----HHHHHHHHHHhc
Confidence 98765433221 12235799999999998765 68999999999999999999999985321 111111111111
Q ss_pred hcCC--ccccc---------cccccCCCCH-HH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 580 NEGN--ALDLI---------DPLLTDTCSP-DE------FLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 580 ~~~~--~~~~~---------d~~l~~~~~~-~~------~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
.... ..... .......... +. ...+++++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 1100 00000 0000001111 11 123567888999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=353.69 Aligned_cols=270 Identities=26% Similarity=0.328 Sum_probs=194.3
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC------
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD------ 423 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------ 423 (671)
.++|+..+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 45788899999999999999996 46899999999753 3344567889999999999999999999998665
Q ss_pred eeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeecccc
Q 005893 424 EKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMA 503 (671)
Q Consensus 424 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla 503 (671)
..++||||+ +.+|..++. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 468999999 567777663 345999999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhc-
Q 005893 504 RIFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNE- 581 (671)
Q Consensus 504 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~- 581 (671)
+..... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..... .............
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKVTGTP 238 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCC
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-----HHHHHHHHhccCCC
Confidence 875432 2335789999999998764 578999999999999999999999853211 0010000000000
Q ss_pred --------------------CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCCCCCCCCC
Q 005893 582 --------------------GNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGETITLCQP 639 (671)
Q Consensus 582 --------------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~~~~~~~p 639 (671)
......--..+....++ .+++++.+||+.||++|||++|+++ .|+.....-..|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~ 314 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP----LAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH----HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCH----HHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence 00000000111122333 3567778999999999999999998 366544333344
Q ss_pred CCCcc
Q 005893 640 QKPAF 644 (671)
Q Consensus 640 ~~p~~ 644 (671)
..+.+
T Consensus 315 ~~~~~ 319 (346)
T d1cm8a_ 315 QVQKY 319 (346)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 44433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=354.33 Aligned_cols=264 Identities=20% Similarity=0.310 Sum_probs=195.4
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccc-hhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCC----eee
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCS-EQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGD----EKL 426 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 426 (671)
+++|+..+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 34688899999999999999986 579999999997533 334567889999999999999999999987653 235
Q ss_pred EEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccc
Q 005893 427 LVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIF 506 (671)
Q Consensus 427 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~ 506 (671)
++++|+.+|+|.+++.. +.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 56667789999999842 35999999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCc-cccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCc
Q 005893 507 AGSEGE-VNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNA 584 (671)
Q Consensus 507 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~ 584 (671)
...... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||...... ...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~-----~~~~~~~~~~~~~~~ 234 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL-----DQLNHILGILGSPSQ 234 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHHHHCSCCH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHH-----HHHHHHhhhccCCCh
Confidence 443222 22344679999999999855 46789999999999999999999999532210 011111011100000
Q ss_pred ccc-----------c--c--------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hcCC
Q 005893 585 LDL-----------I--D--------PLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVM--LQGE 632 (671)
Q Consensus 585 ~~~-----------~--d--------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~--L~~~ 632 (671)
... . . ..+....++ .+++++.+||+.||++|||++|+++. |+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS----KALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCH----HHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCH----HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000 0 0 000111222 36788889999999999999999973 5433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-41 Score=348.61 Aligned_cols=260 Identities=18% Similarity=0.245 Sum_probs=194.6
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCee-eEeeEEEcCCeeeEEEec
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV-KLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~ 431 (671)
++|++.+.||+|+||.||+|+. .+|+.||||++..... ..++..|+++++.++|+|++ .+.++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4688999999999999999996 4689999999875432 23578899999999877655 455556777888999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEc---CCCCeEEeeccccccccC
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLD---YDMNPKISDFGMARIFAG 508 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Dfgla~~~~~ 508 (671)
+. ++|...+. ...+.+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+..
T Consensus 85 ~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 55555443 23456999999999999999999999998 99999999999985 456799999999998765
Q ss_pred CCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCC
Q 005893 509 SEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGN 583 (671)
Q Consensus 509 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (671)
..... ......||+.|||||.+.+..++.++|||||||++|||++|+.||....... ............. ...
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~-~~~~~~~~~~~~~-~~~ 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-KRQKYERISEKKM-STP 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHH-HSC
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH-HHHHHHHhhcccC-CCC
Confidence 43221 2234689999999999999999999999999999999999999996533221 1111111111100 111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 584 ALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 584 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
.+.+...++++ +.+++..||+.+|++||+++++.++|+..
T Consensus 237 -----~~~~~~~~p~~----~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 -----IEVLCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----HHHHTTTSCHH----HHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----hhHhccCCCHH----HHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 11122233433 66777799999999999999999888754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=358.07 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=189.6
Q ss_pred CCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC------CeeeE
Q 005893 355 NFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG------DEKLL 427 (671)
Q Consensus 355 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~~~l 427 (671)
+|...++||+|+||+||+|+.. +|+.||||+++..... +.+|+.++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4666789999999999999974 6899999999754322 34799999999999999999998643 24689
Q ss_pred EEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccc
Q 005893 428 VYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIF 506 (671)
Q Consensus 428 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~ 506 (671)
||||++++.+..+.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765554432345567999999999999999999999988 99999999999999775 8999999999876
Q ss_pred cCCCCccccccccccCCccchhhhcc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHH----------H
Q 005893 507 AGSEGEVNTARIVGTYGYMAPEYAME-GLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAY----------A 575 (671)
Q Consensus 507 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~----------~ 575 (671)
...+.. ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+... .
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~----~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH----HHHHHHHHHHCCCCHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH----HHHHHHHHHhCCChHHh
Confidence 544322 23578999999998765 57899999999999999999999999533211 001110 0
Q ss_pred HHHHhcCC----ccccc----cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 576 WHLWNEGN----ALDLI----DPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 576 ~~~~~~~~----~~~~~----d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
+....... ..... ........++ .+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP----EAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCH----HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhccchhhccccccccCchhhhcccCCCH----HHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110000 00000 0001112233 3667778999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-41 Score=344.99 Aligned_cols=261 Identities=15% Similarity=0.186 Sum_probs=202.4
Q ss_pred hCCCCcccccCCCCcccEEEEEec-CCceEEEEEccccchhchHHHHHHHHHHhhcCC-CCeeeEeeEEEcCCeeeEEEe
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQH-KNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 430 (671)
.++|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+|++.++.++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 467899999999999999999964 688999999865332 2356789999999965 899999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcC-----CCCeEEeecccccc
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDY-----DMNPKISDFGMARI 505 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~Dfgla~~ 505 (671)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 6898888743 3346899999999999999999999998 999999999999974 57899999999998
Q ss_pred ccCCCCcc-----ccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh
Q 005893 506 FAGSEGEV-----NTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN 580 (671)
Q Consensus 506 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~ 580 (671)
+....... ......||+.|||||.+.+..++.++||||||+++|||++|+.||...... .......+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-----~~~~~~~~i~~ 230 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----TNKQKYERIGE 230 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----CHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-----hHHHHHHHHHh
Confidence 65432211 223468999999999999999999999999999999999999999643221 22221111111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhcCC
Q 005893 581 EGNALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVVMLQGE 632 (671)
Q Consensus 581 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~~L~~~ 632 (671)
..... .-+.+...+++ .+.+++..|++.+|++||+++.+.+.|+..
T Consensus 231 ~~~~~--~~~~l~~~~p~----~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 231 KKQST--PLRELCAGFPE----EFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHHHS--CHHHHTTTSCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ccCCC--ChHHhcCCCCH----HHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 10000 00112223343 366677799999999999999998888764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=349.38 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=197.6
Q ss_pred CCCCcccccCCCCcccEEEEEec----CCceEEEEEcccc----chhchHHHHHHHHHHhhcCC-CCeeeEeeEEEcCCe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS----DGKEIAVKRLSSC----SEQGNAEFTNEVLLILKLQH-KNLVKLLGFCVDGDE 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~ 424 (671)
++|++.+.||+|+||+||+++.. +|+.||||+++.. .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56888999999999999999852 4789999998642 22334568899999999976 899999999999999
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.+++|||+.+|+|.+++. ..+.++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999984 3445778889999999999999999998 9999999999999999999999999998
Q ss_pred cccCCCCccccccccccCCccchhhhccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcC
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEG--LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEG 582 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~ 582 (671)
.+...... ......|++.|++||.+... .++.++|||||||+||||++|+.||...... ..... ..+.....
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~-i~~~~~~~ 251 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAE-ISRRILKS 251 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHH-HHHHHHHC
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHHhcccC
Confidence 65433222 22345799999999998754 4688999999999999999999999643221 12222 22221111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 005893 583 NALDLIDPLLTDTCSPDEFLRYIHIGLLCVQEDAFDRP-----TMSSVVV 627 (671)
Q Consensus 583 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----t~~ev~~ 627 (671)
.. .+....++ .+.+++.+||+.||++|| |++|+++
T Consensus 252 ~~------~~~~~~s~----~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 EP------PYPQEMSA----LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC------CCCTTSCH----HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC------CCcccCCH----HHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 12223333 366777799999999999 4788886
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=340.37 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=199.7
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcCCeeeEEEe
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 430 (671)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .......+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4688899999999999999996 46889999998643 23445678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccccccCCC
Q 005893 431 FMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMARIFAGSE 510 (671)
Q Consensus 431 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~ 510 (671)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988874 4566889999999999999999999998 9999999999999999999999999998765433
Q ss_pred CccccccccccCCccchhhhccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHhcCCcc----
Q 005893 511 GEVNTARIVGTYGYMAPEYAMEGL-YSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWNEGNAL---- 585 (671)
Q Consensus 511 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~~~~~~---- 585 (671)
.. .....+++.|+|||.+.... ++.++|||||||++|||++|+.||.... ...................
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC----CHHHHHHHHHhhcCCCChhhhhh
Confidence 22 22346778899999987654 6899999999999999999999973211 1111111111111111000
Q ss_pred --ccccc----cc-----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 586 --DLIDP----LL-----TDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 586 --~~~d~----~l-----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
...+. .. .....+..-..+.+++.+|++.||++|||++||++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 00 00011111123667788999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-40 Score=341.55 Aligned_cols=192 Identities=21% Similarity=0.391 Sum_probs=166.2
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcC--CeeeEEE
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDG--DEKLLVY 429 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~ 429 (671)
++|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+|+.+|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 468999999997543 456889999999995 99999999998754 4588999
Q ss_pred eccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCC-CeEEeeccccccccC
Q 005893 430 EFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDM-NPKISDFGMARIFAG 508 (671)
Q Consensus 430 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~ 508 (671)
||+++++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997764 34899999999999999999999998 99999999999998655 699999999987654
Q ss_pred CCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 005893 509 SEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGF 560 (671)
Q Consensus 509 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~ 560 (671)
... .....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||..
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 332 2335789999999998765 479999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=342.82 Aligned_cols=267 Identities=24% Similarity=0.302 Sum_probs=197.0
Q ss_pred hCCCCcccccCCCCcccEEEEEe-cCCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC-----Ce
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG-----DE 424 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 424 (671)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.. .......+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45799999999999999999996 47999999999753 233455788999999999999999999998743 34
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.+++++|+.+|+|.+++. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788889999999983 235999999999999999999999998 9999999999999999999999999987
Q ss_pred cccCCCCccccccccccCCccchhhhccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHHHh-cC
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEG-LYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHLWN-EG 582 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~~~-~~ 582 (671)
.... ......|++.|+|||...+. .++.++|||||||++|||++|+.||.... .......... .+
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--------~~~~~~~i~~~~~ 236 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--------HIDQLKLILRLVG 236 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHHHC
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHHhcC
Confidence 5422 22335789999999987665 46899999999999999999999985321 1111111100 00
Q ss_pred Ccc-cc------------cc-------c---cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhcCCCCCCC
Q 005893 583 NAL-DL------------ID-------P---LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV--MLQGETITLC 637 (671)
Q Consensus 583 ~~~-~~------------~d-------~---~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~--~L~~~~~~~~ 637 (671)
... +. .. . ......++ .+.+++.+||+.||++|||++|+++ .|+.....-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~----~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~ 312 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP----LAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCH----HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCH----HHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCcc
Confidence 000 00 00 0 00011222 3667888999999999999999997 5654433333
Q ss_pred CCCCCc
Q 005893 638 QPQKPA 643 (671)
Q Consensus 638 ~p~~p~ 643 (671)
.|..+.
T Consensus 313 ~~~~~~ 318 (348)
T d2gfsa1 313 EPVADP 318 (348)
T ss_dssp CCCCCC
T ss_pred CCCCCC
Confidence 333333
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=342.64 Aligned_cols=254 Identities=23% Similarity=0.242 Sum_probs=186.9
Q ss_pred CCCCcccccCCCCcccEEEEEec-CCceEEEEEcccc--chhchHHHHHHHHHHhhcCCCCeeeEeeEEEcC------Ce
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVLS-DGKEIAVKRLSSC--SEQGNAEFTNEVLLILKLQHKNLVKLLGFCVDG------DE 424 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~------~~ 424 (671)
++|++.++||+|+||+||+|+.. +|+.||||+++.. .......+.+|+.++++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57899999999999999999975 6999999999743 334455789999999999999999999999643 57
Q ss_pred eeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 425 KLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 425 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
.++||||+.++.+..+. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 79999999776665442 34889999999999999999999998 9999999999999999999999999988
Q ss_pred cccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHHHHHHHH------
Q 005893 505 IFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLLAYAWHL------ 578 (671)
Q Consensus 505 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~~~~~~~------ 578 (671)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||.... ......+.
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--------~~~~~~~i~~~~~~ 236 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--------YIDQWNKVIEQLGT 236 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHHHCC
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC--------HHHHHHHHHHhccC
Confidence 654322 2234578999999999999999999999999999999999999985321 11111110
Q ss_pred ----------------HhcCC-c-----cccccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 005893 579 ----------------WNEGN-A-----LDLIDPLLTDTC---SPDEFLRYIHIGLLCVQEDAFDRPTMSSVVV 627 (671)
Q Consensus 579 ----------------~~~~~-~-----~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPt~~ev~~ 627 (671)
..... . ............ .......+.+++.+|++.||++|||++||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 0 001111111111 1122345788889999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-36 Score=316.61 Aligned_cols=282 Identities=19% Similarity=0.191 Sum_probs=199.2
Q ss_pred CCCCcccccCCCCcccEEEEEe-cCCceEEEEEccccchhchHHHHHHHHHHhhcC-----------CCCeeeEeeEEEc
Q 005893 354 SNFSDSNMLGQGGFGPVYKGVL-SDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-----------HKNLVKLLGFCVD 421 (671)
Q Consensus 354 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~ 421 (671)
.+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3588899999999999999996 479999999997643 23456778888888775 5789999988764
Q ss_pred C--CeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHh-CCCCceeecCCCCCcEEEcCCCC----
Q 005893 422 G--DEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHE-DSRLRIIHRDLKASNVLLDYDMN---- 494 (671)
Q Consensus 422 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~---- 494 (671)
. ...+++++++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4556677766555443333333456678899999999999999999998 66 999999999999986653
Q ss_pred --eEEeeccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCCCCCCCCHH
Q 005893 495 --PKISDFGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLIEIITGRRNTGFNQSRGATAPNLL 572 (671)
Q Consensus 495 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~p~~~~~~~~~~~~~l~ 572 (671)
++|+|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||...... ......
T Consensus 169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~--~~~~~~ 241 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH--SYTKDD 241 (362)
T ss_dssp EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----------CHH
T ss_pred ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc--cccchh
Confidence 999999998764322 23357899999999999999999999999999999999999998643221 111111
Q ss_pred HHHHHH-HhcCCc-----------c---------ccccc----------cccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 005893 573 AYAWHL-WNEGNA-----------L---------DLIDP----------LLTDTCSPDEFLRYIHIGLLCVQEDAFDRPT 621 (671)
Q Consensus 573 ~~~~~~-~~~~~~-----------~---------~~~d~----------~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPt 621 (671)
...... ..-+.. . ..+.. .............+.+++.+|++.||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 111110 000000 0 00000 0011234556667889999999999999999
Q ss_pred HHHHHHH--hcC--CCCCCCCCCCCcccc
Q 005893 622 MSSVVVM--LQG--ETITLCQPQKPAFSF 646 (671)
Q Consensus 622 ~~ev~~~--L~~--~~~~~~~p~~p~~~~ 646 (671)
++|+++. +++ ...+...|.+|.+..
T Consensus 322 a~e~L~Hp~f~~~~~~~~~~~p~~~~~~~ 350 (362)
T d1q8ya_ 322 AGGLVNHPWLKDTLGMEEIRVPDRELYGS 350 (362)
T ss_dssp HHHHHTCGGGTTCTTCTTCCCTTSCTTCB
T ss_pred HHHHhcCcccCCCCCcccCCCCCcccCCC
Confidence 9999873 542 244555666666543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=6.4e-23 Score=195.19 Aligned_cols=169 Identities=18% Similarity=0.153 Sum_probs=120.9
Q ss_pred cccccCCCCcccEEEEEecCCceEEEEEccccch------------------hchHHHHHHHHHHhhcCCCCeeeEeeEE
Q 005893 358 DSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSE------------------QGNAEFTNEVLLILKLQHKNLVKLLGFC 419 (671)
Q Consensus 358 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~~ 419 (671)
+.++||+|+||.||+|+..+|+.||||+++.... ........|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4678999999999999988899999998753110 0122345688889999999999887663
Q ss_pred EcCCeeeEEEeccCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCCCCceeecCCCCCcEEEcCCCCeEEee
Q 005893 420 VDGDEKLLVYEFMPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDSRLRIIHRDLKASNVLLDYDMNPKISD 499 (671)
Q Consensus 420 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 499 (671)
..+++|||+++..+.. +++.....++.|++.+|.|||+++ |+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 2479999998866543 334445689999999999999998 9999999999999965 489999
Q ss_pred ccccccccCCCCccccccccccCCccchhhhccCCCCcchhhHHHHHHHH
Q 005893 500 FGMARIFAGSEGEVNTARIVGTYGYMAPEYAMEGLYSIKSDVFSFGVLLI 549 (671)
Q Consensus 500 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVwSlGvil~ 549 (671)
||++.............+.+. . -.|. ..+.|+.++|+||..--++
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred CCCcccCCCCCcHHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 999876533221110000000 0 0111 1356788999999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=3e-07 Score=89.63 Aligned_cols=143 Identities=17% Similarity=0.102 Sum_probs=99.2
Q ss_pred hCCCCcccccCCCCcccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcC-CCCeeeEeeEEEcCCeeeEEEec
Q 005893 353 TSNFSDSNMLGQGGFGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ-HKNLVKLLGFCVDGDEKLLVYEF 431 (671)
Q Consensus 353 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 431 (671)
-..|...+..+-++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+++..++||++
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 34555555544444568998765 56678899887654444556778888887773 43456778888888889999999
Q ss_pred cCCCchhhhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 005893 432 MPNSSLDAILFDPRKRGLLCWSKRINIVNGIVKGILYLHEDS-------------------------------------- 473 (671)
Q Consensus 432 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~~-------------------------------------- 473 (671)
+++..+...... ......++.++++.|..||+..
T Consensus 92 l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 92 ADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred cccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999888665421 1123345666677777777421
Q ss_pred ------------------CCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 474 ------------------RLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 474 ------------------~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
...++|+|+.|.|||++++...-|.||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247999999999999987667799998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=2.6e-05 Score=74.89 Aligned_cols=129 Identities=17% Similarity=0.136 Sum_probs=86.4
Q ss_pred cCCCCc-ccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcC--CCCeeeEeeEEEcCCeeeEEEeccCCCchh
Q 005893 362 LGQGGF-GPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQ--HKNLVKLLGFCVDGDEKLLVYEFMPNSSLD 438 (671)
Q Consensus 362 lg~G~~-g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 438 (671)
+..|.. +.||+...+++..+++|....... ..+..|...++.+. .-.+.+++.+..+++..++||+++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444443 578999887888899998765432 24567777777763 333566788888888889999999887764
Q ss_pred hhhcCCCCCCCCChHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 005893 439 AILFDPRKRGLLCWSKRINIVNGIVKGILYLHED---------------------------------------------- 472 (671)
Q Consensus 439 ~~l~~~~~~~~l~~~~~~~i~~qia~gL~~LH~~---------------------------------------------- 472 (671)
... .. ...++.++++.|.-||+.
T Consensus 95 ~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 321 11 112233444444444421
Q ss_pred ---------CCCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 473 ---------SRLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 473 ---------~~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 12248999999999999987667899998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.47 E-value=0.00019 Score=73.67 Aligned_cols=75 Identities=12% Similarity=0.168 Sum_probs=46.9
Q ss_pred cccCCCCcccEEEEEecC-CceEEEEEcccc----c---hhchHHHHHHHHHHhhc-CC--CCeeeEeeEEEcCCeeeEE
Q 005893 360 NMLGQGGFGPVYKGVLSD-GKEIAVKRLSSC----S---EQGNAEFTNEVLLILKL-QH--KNLVKLLGFCVDGDEKLLV 428 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~-g~~vavK~l~~~----~---~~~~~~~~~E~~~l~~l-~H--~niv~l~g~~~~~~~~~lv 428 (671)
+.||.|....||+....+ ++.++||.-... . .........|.+.|..+ .+ ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 458999999999998754 678999964321 1 11223345677777665 22 334455544 45567899
Q ss_pred EeccCCCc
Q 005893 429 YEFMPNSS 436 (671)
Q Consensus 429 ~e~~~~gs 436 (671)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.01 E-value=0.0005 Score=68.41 Aligned_cols=136 Identities=16% Similarity=0.108 Sum_probs=77.6
Q ss_pred cccEEEEEecCCceEEEEEccccchhchHHHHHHHHHHhhcCCCCee--eEe-----eEEEcCCeeeEEEeccCCCchhh
Q 005893 367 FGPVYKGVLSDGKEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNLV--KLL-----GFCVDGDEKLLVYEFMPNSSLDA 439 (671)
Q Consensus 367 ~g~Vy~~~~~~g~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~-----g~~~~~~~~~lv~e~~~~gsL~~ 439 (671)
--.||+....+|+.+++|+.+.. ....+++..|...+..|...++. ..+ .........+.++++++|..++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999999999999998753 23456677888888877432221 111 12233456678999987654321
Q ss_pred ------------------hhcC--CCCCCCCChH-------------------HHHHHHHHHHHHHHHHHh----CCCCc
Q 005893 440 ------------------ILFD--PRKRGLLCWS-------------------KRINIVNGIVKGILYLHE----DSRLR 476 (671)
Q Consensus 440 ------------------~l~~--~~~~~~l~~~-------------------~~~~i~~qia~gL~~LH~----~~~~~ 476 (671)
.... ...+..+++. ....+...+...+..+.. ..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0000 0111112211 111112222223333322 22456
Q ss_pred eeecCCCCCcEEEcCCCCeEEeecccccc
Q 005893 477 IIHRDLKASNVLLDYDMNPKISDFGMARI 505 (671)
Q Consensus 477 ivH~Dlkp~NIll~~~~~~kl~Dfgla~~ 505 (671)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 46899997753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.54 E-value=0.0035 Score=63.81 Aligned_cols=72 Identities=17% Similarity=0.254 Sum_probs=48.0
Q ss_pred cccCCCCcccEEEEEecCC--------ceEEEEEccccchhchHHHHHHHHHHhhcCCCCe-eeEeeEEEcCCeeeEEEe
Q 005893 360 NMLGQGGFGPVYKGVLSDG--------KEIAVKRLSSCSEQGNAEFTNEVLLILKLQHKNL-VKLLGFCVDGDEKLLVYE 430 (671)
Q Consensus 360 ~~lg~G~~g~Vy~~~~~~g--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lv~e 430 (671)
+.|+.|-.-.+|+...+++ +.|.+++.-.. .......+|..+++.+.-.++ .++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 5677788889999886543 45777776532 223356688888888743344 46777653 268999
Q ss_pred ccCCCch
Q 005893 431 FMPNSSL 437 (671)
Q Consensus 431 ~~~~gsL 437 (671)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.72 E-value=0.039 Score=53.64 Aligned_cols=31 Identities=32% Similarity=0.300 Sum_probs=27.0
Q ss_pred CCceeecCCCCCcEEEcCCCCeEEeeccccc
Q 005893 474 RLRIIHRDLKASNVLLDYDMNPKISDFGMAR 504 (671)
Q Consensus 474 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfgla~ 504 (671)
+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3469999999999999988777899999764
|